{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "qwen3-8b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions_in_experiment": 750
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Chevron's outstanding loan to Petroboscan was **$560 million**, and Chevron held a **39.2% ownership interest** in Petroboscan as of the 2022 reporting period. This information is detailed in Note 15 of the 2022 10-K filing, which states the loan amount and ownership percentage.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. (1) CORRECTNESS: Both key facts are accurate - the outstanding loan amount of $560 million and the 39.2% ownership interest in Petroboscan as of 2022. The LLM correctly interpreted the ground truth's '$560' as '$560 million' (standard financial reporting format), which is semantically equivalent and appropriate. (2) QUANTITATIVE ACCURACY: Both numeric values match the ground truth exactly: $560 million loan and 39.2% ownership. No calculation errors present. (3) MULTI-HOP SYNTHESIS: The answer correctly synthesizes two distinct pieces of information (loan amount and ownership percentage) from the 2022 reporting period, properly attributing both to Chevron's relationship with Petroboscan. (4) ENTITY ACCURACY: All entities correctly identified - Chevron, Petroboscan, 2022 reporting period. (5) COMPLETENESS: The answer addresses both parts of the multi-part question fully. The LLM also provides helpful context by referencing Note 15 of the 2022 10-K filing, which adds credibility and specificity. Minor note: The ground truth shows '$560' without explicit 'million' designation, but the LLM's interpretation as '$560 million' is the standard and correct financial reporting convention. No material errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 364,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "The sale of Dermstore LLC generated $356 million in cash and a $335 million pretax gain, resulting in a total financial impact of $691 million. This is detailed in Note 3 of the 2021 Form 10-K, which states the cash proceeds and the recognized pretax gain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data is correct: $356 million in cash received, $335 million pretax gain recognized, and the total financial impact of $691 million ($356M + $335M = $691M). The calculation is accurate. The answer correctly identifies Target Corporation as the company, Dermstore LLC as the asset sold, and properly synthesizes the multi-hop information by combining both the cash proceeds and pretax gain to arrive at the total financial impact. The reference to Note 3 of the 2021 Form 10-K adds appropriate contextual detail and demonstrates proper sourcing. The only minor consideration is that the LLM adds a citation reference that, while helpful, goes slightly beyond what was explicitly required in the ground truth answer. However, this is a strength rather than a weakness as it demonstrates proper documentation. The semantic meaning is identical to the ground truth, and all factual information is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 281,
        "total_tokens": 1391
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "Amgen's total recorded Product Sales revenue from sales to BeiGene under their collaboration agreement from 2021 to 2023 was **$261 million**, calculated as follows: $125 million in 2023, $64 million in 2022, and $72 million in 2021. These figures are explicitly stated in the document on page 131.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data is correct: $72 million (2021), $64 million (2022), $125 million (2023), and the total of $261 million. The calculation is accurate ($72M + $64M + $125M = $261M). The answer correctly identifies all entities (Amgen, BeiGene, collaboration agreement) and the correct time period (2021-2023). The multi-hop reasoning is sound - the model synthesized the three individual year figures into the correct total. The answer addresses all parts of the question comprehensively. The only minor point is that the LLM cites 'page 131' as the source, which cannot be verified from the ground truth answer provided, but this does not affect the factual accuracy of the financial data itself. The presentation is clear and the numbers are presented in both individual years and total form, matching the ground truth answer semantically and factually.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 266,
        "total_tokens": 1396
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "Under the 2007 Omnibus Incentive Plan, **127 million shares** of Danaher common stock were authorized for issuance. As of December 31, 2021, **approximately 50 million shares** remained available for issuance under the plan, as stated in the document.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-part question. (1) CORRECTNESS: Both key numeric values are correct - 127 million shares authorized and approximately 50 million shares remaining available as of December 31, 2021. These match the ground truth exactly. (2) QUANTITATIVE ACCURACY: All numbers are precise and correctly stated. The use of 'approximately 50 million' appropriately reflects the ground truth language. No calculation errors present. (3) QUALITATIVE ACCURACY: The answer correctly identifies all required entities (Danaher, 2007 Omnibus Incentive Plan, December 31, 2021 date) and synthesizes the information appropriately. The reasoning is sound and directly answers both sub-questions. (4) COMPLETENESS: The answer fully addresses both parts of the question - authorized shares and available shares as of the specified date. (5) SEMANTIC EQUIVALENCE: The wording is clear and conveys the exact same information as the ground truth. Minor note: The phrase 'as stated in the document' adds a slight attribution qualifier not in the original answer, but this is a minor stylistic addition that doesn't detract from accuracy. Overall, this is a well-executed response with perfect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 354,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm. This amount was distributed as $1.05 billion in 2023 and $305.0 million in 2024, as stated in Note 4 of the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data matches the ground truth exactly: total of $1.355 billion, with $1.05 billion in 2023 and $305.0 million in 2024. The answer correctly identifies all entities (LLY, olanzapine portfolio, Zyprexa, Cheplapharm) and properly synthesizes the multi-hop information across years. The distribution across 2023 and 2024 is correctly stated. The answer includes an additional detail (reference to Note 4 of the 10-K filing) that provides helpful context without introducing any inaccuracies. The only minor consideration is that the LLM answer adds a citation reference that wasn't in the ground truth, but this is supplementary information that enhances rather than detracts from the answer. The semantic meaning is perfectly aligned with the ground truth, and all calculations are accurate (1.05 + 0.305 = 1.355 billion).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 260,
        "total_tokens": 1375
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded $298 million in goodwill from the acquisition of Terran Orbital. Of the $314 million total purchase consideration, $231 million was paid in cash (net of cash acquired), with the remaining $83 million consisting of previously held investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all parts of the multi-part question. Quantitative verification: (1) Goodwill amount of $298 million is correct; (2) Total purchase consideration of $314 million is correct; (3) Cash paid of $231 million is correct; (4) The arithmetic check: $231M + $83M = $314M is accurate. The LLM correctly synthesized information across multiple data points from the acquisition. The answer goes slightly beyond the ground truth by providing additional context ('net of cash acquired' and specifying that the remaining $83 million consisted of 'previously held investments'), which adds helpful clarification without contradicting the original answer. The multi-hop reasoning is sound - the model correctly identified the acquisition, extracted the goodwill amount, identified the total purchase consideration, and broke down the cash vs. non-cash components. All entities are correctly identified (Lockheed Martin, Terran Orbital). The only minor distinction is that the LLM provided more granular detail about the composition of non-cash consideration, which represents a slight enhancement rather than an error. The answer is semantically equivalent to and factually consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 349,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was **$3,616 million**, as reported in Note 15 of the 10-K filing. Chevron owns **50%** of GS Caltex Corporation, and the carrying value reflects this ownership percentage, as the investment is accounted for using the equity method. The carrying value aligns with Chevron's 50% equity stake in the joint venture.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021 ($1,357 million in 2021 vs. $1,160 million in 2020). The average revenue per car for this category rose by $155, from $5,269 in 2020 to $5,424 in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The revenue increase of $197 million is correct, and the average revenue per car increase of $155 is correct. (2) QUANTITATIVE ACCURACY: All numbers are verified as correct: $1,357 million (2021), $1,160 million (2020), difference of $197 million, $5,269 (2020 per car), $5,424 (2021 per car), and difference of $155. The arithmetic is accurate: $1,357M - $1,160M = $197M and $5,424 - $5,269 = $155. (3) MULTI-HOP REASONING: The answer correctly synthesizes information across two metrics (total revenue and per-car revenue) and two time periods (2020 and 2021), demonstrating proper multi-hop reasoning. (4) COMPLETENESS: The answer addresses both parts of the multi-part question fully - the total revenue change and the average revenue per car change. (5) ADDED VALUE: The LLM provides supporting detail (specific revenue figures for each year and per-car figures) that goes beyond the ground truth while remaining accurate, which enhances clarity without introducing errors. The only minor distinction is that the LLM provides more granular detail than the ground truth statement, but this is supplementary and correct, not contradictory.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 355,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "The total net revenue contribution of Restasis in 2024 was **$224 million**, representing a **48.7% decline** compared to 2023 based on actual currency rates. This is derived from the \"Restasis\" row in the product revenue table on Page 43, which shows a 2024 total of $224 million (down from $436 million in 2023) with a -48.7% percentage change at actual currency rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth exactly - Restasis 2024 net revenue of $224 million and the 48.7% decline compared to 2023 are both correct. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct: $224M (2024), $436M (2023), and -48.7% decline. The calculation is verifiable: ($224M - $436M) / $436M = -48.7%, which is mathematically accurate. (3) MULTI-HOP REASONING: The answer correctly synthesizes information by identifying the source (product revenue table on Page 43), extracting the relevant data points across two fiscal years, and calculating the percentage change at actual currency rates as specified in the question. (4) ENTITY ACCURACY: Restasis is correctly identified as the product, 2024 and 2023 are the correct fiscal years, and the metric (net revenue contribution and percentage decline at actual currency rates) is properly identified. (5) COMPLETENESS: The answer addresses both parts of the multi-part question - the total net revenue contribution amount and the percentage decline. The additional context provided (source citation and prior year comparison) enhances clarity without introducing any inaccuracies. The answer demonstrates sound financial analysis and proper understanding of currency rate impacts on year-over-year comparisons.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 381,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio as of December 31, 2023, was **12.9%**, while the Minimum Capital Adequacy requirement for CET1 under Basel III was **4.5%**. The difference between the two is **8.4 percentage points**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative values are correct: CET1 ratio of 12.9%, minimum requirement of 4.5%, and the calculated difference of 8.4 percentage points. The calculation is accurate (12.9% - 4.5% = 8.4%). The entity identification is correct (Capital One Financial Corp), the metric is properly identified (Common Equity Tier 1 capital ratio), and the date is accurate (December 31, 2023). The multi-hop reasoning is sound - the model correctly synthesized the actual ratio from the filing with the regulatory minimum requirement and performed the subtraction accurately. The answer provides appropriate context by noting the Basel III framework. The only minor distinction from the ground truth is the slightly more detailed presentation (mentioning Basel III), which adds helpful context without introducing any inaccuracy. The semantic meaning is identical to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 270,
        "total_tokens": 1411
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "Lockheed Martin's pretax pension expense for nonqualified defined benefit pension plans in 2023 was **$64 million**, compared to **$81 million in 2022** and **$56 million in 2021**. This reflects a decrease from 2022 but an increase from 2021, as noted in Note 11 of the 2023 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data is correct: 2023 pension expense of $64 million, 2022 of $81 million, and 2021 of $56 million. The year-over-year comparisons are accurate (decrease from 2022, increase from 2021). The answer correctly identifies the company (Lockheed Martin), the specific metric (pretax pension expense for nonqualified defined benefit pension plans), and all three fiscal years requested. The multi-hop reasoning is sound, synthesizing the three-year comparison as requested. The answer includes appropriate context by referencing Note 11 of the 2023 10-K filing, which adds credibility and specificity. The only minor observation is that the LLM could have been slightly more explicit about the magnitude of changes (e.g., a $17 million decrease from 2022, an $8 million increase from 2021), but this is not required by the question and the answer as provided is semantically complete and factually accurate. The wording is clear and professional, matching the ground truth answer in substance while providing additional citation detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 313,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "The net carrying amount of BlackRock's investor/customer relationships decreased by $45 million from December 31, 2022 ($492 million) to December 31, 2023 ($447 million). This decrease was primarily driven by an $84 million increase in accumulated amortization, which outweighed the $39 million increase in the gross carrying amount during the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key figures and overall change in net carrying amount ($45 million decrease from $492M to $447M), and properly explains the relationship between accumulated amortization and net carrying value. However, there is a critical calculation error in the accumulated amortization increase. The ground truth states accumulated amortization increased from $254 million to $338 million, which is a $84 million increase ($338M - $254M = $84M). The LLM correctly states this $84 million figure. However, when verifying the gross carrying amount change: Ground truth shows $746M to $785M = $39M increase, which the LLM also correctly states. The math checks out: $39M increase in gross amount minus $84M increase in accumulated amortization = $45M decrease in net carrying amount. Upon closer inspection, all numbers in the LLM answer are actually correct and match the ground truth. The reasoning is sound and explains the multi-hop relationship between gross carrying amount, accumulated amortization, and net carrying amount. The answer addresses all parts of the question comprehensively. The only minor issue is that the LLM uses slightly different phrasing ('primarily driven by' vs the ground truth's more detailed explanation of the relationship), but this is semantically equivalent. The answer demonstrates proper synthesis of the three interconnected financial metrics across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 397,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, was $400 million. UPS classified this debt as long-term on its consolidated balance sheet despite its 2024 maturity, based on its intent and ability to refinance the debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly matches the ground truth. (1) CORRECTNESS: All factual information is correct - the principal amount of $400 million is accurate, the interest rate of 2.200% is correct, the date of December 31, 2023 is correct, and the 2024 maturity is correct. The classification as long-term debt despite near-term maturity is accurately stated. (2) QUANTITATIVE ACCURACY: The $400 million figure is precisely correct with no calculation errors. The date references (December 31, 2023 and 2024 maturity) are accurate. (3) QUALITATIVE ACCURACY: The reasoning is sound - the answer correctly identifies that UPS classified this debt as long-term based on its intent and ability to refinance, which is the proper accounting treatment under ASC 470. The multi-hop synthesis is correct: identifying the specific debt instrument (2.200% senior notes), the principal amount, the balance sheet classification, and the rationale for that classification. (4) ENTITY ACCURACY: UPS is correctly identified, the debt instrument is correctly specified, and the time period is accurate. (5) SEMANTIC EQUIVALENCE: The LLM answer uses nearly identical wording to the ground truth, conveying the exact same information with only minor stylistic variations (e.g., 'was' vs implied present tense). The answer fully addresses both parts of the multi-part question: the principal amount and the classification rationale. No material information is omitted or misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 410,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "Cisco's available-for-sale debt investments decreased by **$5,727 million** (from $15,592 million as of July 29, 2023, to $9,865 million as of July 27, 2024). This decrease contributed to a **$8,292 million reduction** in the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities during the fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: All key numbers are correct - the $5,727 million decrease in available-for-sale debt investments matches the ground truth exactly. The $8,292 million total reduction is also correct. The LLM provides additional context by showing the beginning and ending balances ($15,592 million to $9,865 million), which correctly represents the $5,727 million decrease. (2) COMPLETENESS: The answer addresses both parts of the question: (a) the decrease in available-for-sale debt investments, and (b) the impact on the total of the three financial asset categories. (3) ENTITY ACCURACY: Cisco is correctly identified, the fiscal year ending July 27, 2024 is correct, and all financial metrics are properly named. (4) MULTI-HOP REASONING: The LLM correctly synthesizes that the $5,727 million decrease in debt investments, combined with the $2,615 million decrease in cash and equivalents and the $50 million increase in equity securities, results in the net $8,292 million reduction. The calculation is sound: -$5,727M - $2,615M + $50M = -$8,292M. (5) SEMANTIC EQUIVALENCE: The LLM conveys the same information as the ground truth, though it phrases the impact slightly differently ('contributed to' vs 'resulted in'), which is semantically equivalent. The only minor difference is that the LLM doesn't explicitly state the individual components of the total change (the $2,615M and $50M figures), but it correctly identifies the net impact. This is a minor omission that doesn't affect the core correctness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 446,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31, 2023, **7,661,431 shares** remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan. Of these, **2,452,443 shares** could be granted as awards other than options or stock appreciation rights. This information is explicitly stated in **Note 15** of the 10-K filing (page 85) and corroborated by the \"Equity Compensation Plans Table\" on page 105.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) QUANTITATIVE ACCURACY: Both key numbers are correct - 7,661,431 shares remained available for equity grants, and 2,452,443 shares could be granted as awards other than options or stock appreciation rights. These match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - total shares available AND the subset that could be granted as non-option/non-SAR awards. (3) ENTITY ACCURACY: All entities are correctly identified - Linde plc, the 2021 Long Term Incentive Plan, and the specific date of December 31, 2023. (4) MULTI-HOP REASONING: The answer correctly synthesizes the relationship between the two numbers (2,452,443 is a subset of 7,661,431), demonstrating proper understanding of the hierarchical nature of the data. (5) ADDITIONAL VALUE: The LLM provides helpful context by citing specific sources (Note 15, page 85, and the Equity Compensation Plans Table on page 105), which adds credibility and verifiability without being excessive. The formatting is clear and professional. No calculation errors, no missing information, and no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 336,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The total payments received from settling the forward interest rate swap contracts associated with the 2023 Notes, March 2022 Notes, and September 2022 Notes were **$247 million (2023 Notes)**, **$143 million (March 2022 Notes)**, and **$136 million (September 2022 Notes)**, totaling **$526 million**. These cash inflows are classified in the consolidated statements of cash flows as financing activities, reflecting the settlement of derivatives tied to debt issuances. The settlements reduced the company's cash outflows related to interest payments on the notes, thereby improving cash flow from financing activities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $247M (2023 Notes), $143M (March 2022 Notes), $136M (September 2022 Notes), and $526M total. The arithmetic is accurate. (2) All three note issuances are correctly identified and synthesized. (3) The answer correctly identifies this as a multi-hop question requiring synthesis across multiple debt instruments. (4) The format variations are handled appropriately.\n\nWEAKNESSES: (1) CLASSIFICATION DISCREPANCY: The LLM states these are 'classified in the consolidated statements of cash flows as financing activities,' but the ground truth indicates they are 'classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.' This is a material difference - the classification depends on the nature of the hedged item, not automatically as financing activities. This represents a factual error in the reasoning about cash flow classification. (2) INTERPRETATION ISSUE: The LLM's explanation that 'settlements reduced the company's cash outflows related to interest payments' is an inference not explicitly stated in the ground truth. The ground truth simply states the settlements 'directly contributed to the company's cash flows' without specifying the mechanism. (3) MISSING NUANCE: The ground truth emphasizes that classification is 'based on the nature of the underlying hedged items,' which is an important accounting principle that the LLM oversimplifies.\n\nMULTI-HOP REASONING: The model correctly synthesized information across three separate debt instruments and calculated the total. However, the reasoning about cash flow classification contains an error that affects the qualitative accuracy of the explanation.\n\nOVERALL: The quantitative answer is perfect, but the qualitative explanation of how these settlements impact cash flow classification contains a significant inaccuracy that prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 518,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "NextEra Energy's ownership interest in XPLR is approximately **52.6%**, held through its limited partner interest in XPLR OpCo. The principal equity method investees, including XPLR, primarily own **electric generation facilities and natural gas pipelines**, as noted in the 2024 10-K filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE - OWNERSHIP PERCENTAGE MISMATCH: The LLM provides a specific ownership interest of 52.6%, but the ground truth indicates the ownership interest ranges from approximately 33.3% to 85.0%. This is a significant factual error. The LLM's answer provides a single point estimate rather than the range requested in the question. The ground truth explicitly states a range, suggesting XPLR may have multiple ownership structures or the ownership varies by entity/subsidiary. The LLM's specific 52.6% figure may represent one particular interest level but fails to capture the full scope of NextEra's ownership interests in XPLR as indicated in the filing. CORRECT ELEMENTS: The LLM correctly identifies that the principal equity method investees, including XPLR, primarily own electric generation facilities and natural gas pipelines - this matches the ground truth exactly. The LLM also correctly cites the 2024 10-K filing as the source. MULTI-HOP REASONING: The question asks for two distinct pieces of information: (1) the ownership interest range and (2) the types of assets owned. The LLM addresses both but fails on the first component by providing a single percentage rather than a range. The asset type information is accurate and complete. QUANTITATIVE ACCURACY: The 52.6% figure is presented as definitive when the ground truth shows a range (33.3%-85.0%). This represents a fundamental misunderstanding or incomplete extraction of the ownership structure from the filing. The LLM may have found one specific ownership percentage but missed the broader range context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 435,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The total fair value of Corporate notes and obligations as of January 31, 2024, is **$2,978 million**, as reported in the fair value hierarchy table (Level 2). This compares to an amortized cost of **$3,014 million**, resulting in an **unrealized loss of $36 million**. For the prior year (January 31, 2023), the fair value was **$3,354 million** versus an amortized cost of **$3,442 million**, reflecting an unrealized loss of **$88 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that make it largely incorrect. CRITICAL ISSUES: (1) The ground truth specifies the fair value of Corporate notes and obligations is $3,354 million with amortized cost of $3,442 million and unrealized loss of $92 million. The LLM provides completely different numbers for what appears to be the current year: $2,978 million fair value, $3,014 million amortized cost, and $36 million unrealized loss. These numbers do not match the ground truth at all. (2) The LLM introduces a prior year comparison (January 31, 2023) showing $3,354 million fair value and $3,442 million amortized cost with $88 million unrealized loss. While these numbers are closer to the ground truth figures, the ground truth question asks for THE total fair value and comparison, implying a single period answer, not a year-over-year comparison. The LLM appears to have confused which year's data corresponds to the ground truth. (3) The calculation of unrealized loss is correct in methodology (amortized cost minus fair value), but applied to wrong numbers. For the numbers provided by LLM for 2024: $3,014M - $2,978M = $36M is mathematically correct, but these are not the correct figures from the filing. (4) The LLM's inclusion of prior year data ($3,354M/$3,442M/$88M loss) is suspiciously close to the ground truth but with a $4M discrepancy in the unrealized loss calculation ($3,442M - $3,354M = $88M, which matches). This suggests the LLM may have accessed some correct data but misattributed it to the wrong fiscal year. The question asks specifically about the fair value hierarchy table data without specifying a date, and the ground truth answer provides single figures without year qualification, suggesting these are the primary/current period figures being requested. The LLM's answer fails to provide the correct primary answer and instead provides incorrect current year figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 519,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "The total number of locomotives operated by UNP in 2024 was **7,026**, comprising **6,106 owned locomotives** and **920 leased locomotives**. This figure is derived from the sum of owned and leased units listed in the locomotive table on page 19 of the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data matches the ground truth exactly: total locomotives (7,026), owned locomotives (6,106), and leased locomotives (920). The arithmetic is correct (6,106 + 920 = 7,026). The answer properly addresses all parts of the multi-part question: (1) total number of locomotives, (2) breakdown of owned vs. leased, and (3) how these components contribute to the total. Entity identification is correct (UNP, 2024). The reasoning is sound and the synthesis is appropriate. The LLM provides additional context by citing the source (page 19 of 10-K filing), which adds credibility without introducing errors. The only minor distinction from the ground truth is the additional sourcing detail, which is supplementary and does not detract from accuracy. The answer demonstrates proper multi-hop synthesis by combining owned and leased data to arrive at the total figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 270,
        "total_tokens": 1374
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net change in the value of Brands/Tradenames for LIN in 2024 was a decrease of **$137 million**. This change was driven by **foreign currency translation** reducing the value by **$107 million** and **amortization expense** reducing it by **$36 million**. These factors, along with disposals and other adjustments, contributed to the overall decline in the net balance of Brands/Tradenames.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the net change was a decrease of $137 million, but the ground truth clearly shows the net change was $370 million (from $2,609M in 2023 to $2,239M in 2024). This is a major calculation error. The LLM appears to have only summed the two specific factors mentioned ($107M + $36M = $143M, then rounded or miscalculated to $137M) rather than calculating the actual net change in the balance sheet value. (2) INCOMPLETE ANALYSIS - The ground truth explains that the $143 million in combined reductions from FX translation and amortization was only PART of the total $370 million decline, with the remainder explained by other factors. The LLM fails to capture this critical distinction and doesn't explain the full composition of the $370 million change. (3) MISSING CONTEXT - The ground truth mentions that additions were $0 million and there was a $4 million positive adjustment under 'Other', which provides important context about the waterfall analysis. The LLM omits these details. (4) CORRECT ELEMENTS - The LLM correctly identifies that FX translation reduced value by $107 million and amortization expense was $36 million, and correctly identifies LIN as the company. However, these correct elements are embedded in a fundamentally incorrect overall answer about the net change magnitude. The answer demonstrates partial understanding of the components but fails at the primary calculation required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 411,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "The total fair value of Coca-Cola's long-term debt, including the current portion, was $40,311 million at the end of 2021, compared to $43,218 million at the end of 2020. This represents a decrease of $2,907 million, or approximately 6.7%, in dollar value from 2020 to 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different financial metric than what was asked. CRITICAL ERRORS: (1) WRONG METRIC: The question specifically asks about 'Corporate Bonds and Debt Securities' (fair value of specific securities), but the LLM provided data on 'long-term debt including current portion' (total debt obligations). These are distinct financial line items. (2) WRONG NUMBERS: The LLM states $40,311 million (2021) and $43,218 million (2020), but the ground truth shows $1,023 million (2021) and $1,042 million (2020) - a difference of approximately 39x. (3) WRONG CALCULATION: The LLM calculated a $2,907 million decrease, but the correct answer is a $19 million decrease. (4) WRONG PERCENTAGE: The LLM calculated 6.7% decrease, but the correct percentage is approximately 1.8% decrease. The LLM appears to have confused total debt obligations with the fair value of specific corporate bond securities holdings, which are different accounting categories. The question requires identifying a specific asset category (Corporate Bonds and Debt Securities at fair value), but the LLM provided aggregate debt information instead. This is a multi-hop synthesis failure where the model failed to identify the correct financial metric from the 10-K filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 362,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is **$42.5 million**. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because the performance criteria for the awards have not yet been achieved. The units are subject to a three-year measurement period, and vesting occurs on January 1, 2027, contingent on meeting performance conditions. Since the awards are not yet earned, they do not impact net income or dilutive effect calculations for 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the maximum potential fair value at grant date as $42.5 million, matching the ground truth exactly. The quantitative accuracy is perfect on this key metric. The explanation for why these units are not reflected as a material dilutive effect is substantially correct and semantically equivalent to the ground truth. The LLM provides additional specific details (three-year measurement period, January 1, 2027 vesting date, performance conditions contingency) that enhance the answer's completeness and demonstrate understanding of the underlying mechanics. The core reasoning is sound: performance conditions have not been met, therefore the units are not yet earned and do not impact 2023 dilutive calculations. The only minor distinction is that the ground truth uses the phrase 'have not yet met the performance conditions necessary to be considered earned' while the LLM says 'performance criteria for the awards have not yet been achieved' - these are semantically equivalent statements. The LLM's additional contextual details about the three-year measurement period and January 1, 2027 vesting date add value and demonstrate deeper understanding of the award structure, though these specifics are not explicitly required by the question. The answer fully addresses both parts of the multi-part question: (1) the fair value amount and (2) the explanation for non-dilutive treatment. No calculation errors are present, and all entities and time periods are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 418,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "The amortized cost of Covered Bonds held by CRM as of January 31, 2023, was $105 million, while the fair value was $101 million. The difference between the amortized cost and fair value is $4 million, which represents the **unrealized loss** on these bonds. \n\n**Answer:** The amortized cost of Covered Bonds was $105 million, and the fair value was $101 million, resulting in an **unrealized loss of $4 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: amortized cost of $105 million, fair value of $101 million, and unrealized loss of $4 million. The calculation is correct ($105M - $101M = $4M unrealized loss). The answer properly identifies the company (CRM), the asset type (Covered Bonds), and the fiscal year (2023, specified as January 31, 2023). The LLM correctly synthesizes the multi-hop information by: (1) identifying the specific financial metrics from the filing, (2) calculating the difference, and (3) correctly labeling this difference as an unrealized loss. The reasoning is sound and logically presented. The answer addresses all parts of the question comprehensively. Minor note: The LLM provides slightly more context by specifying the exact date (January 31, 2023) which adds clarity without introducing any inaccuracy. The presentation is clear with appropriate emphasis on key figures. No calculation errors, no missing information, and no entity confusion detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 301,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "Union Pacific's Multiple Purpose locomotives have **13.36% leased** (920 leased out of 6,893 total). In contrast, the **Switching** and **Other** categories combined have **0% leased** locomotives, as both categories report no leased units. Thus, the proportion of leased locomotives in Multiple Purpose is significantly higher than in the combined Switching and Other categories.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct but contains a minor numerical discrepancy. Ground truth states 13.35% of Multiple Purpose locomotives are leased, while the LLM reports 13.36%. This is a very small difference (0.01 percentage points) that could result from rounding variations in the underlying calculation (920/6,893 = 0.13354... which rounds to 13.35% at two decimal places, or 13.36% if rounded differently). The LLM provides additional detail by showing the actual counts (920 leased out of 6,893 total), which adds transparency but wasn't required by the question. The core answer correctly identifies that Switching and Other categories have 0% leased locomotives, making the comparison valid. The reasoning is sound: the LLM correctly synthesizes information across multiple locomotive categories and accurately compares the proportions. The answer fully addresses both parts of the multi-part question (percentage of leased Multiple Purpose locomotives AND comparison to Switching/Other categories). The semantic meaning matches the ground truth - both convey that Multiple Purpose has a significant proportion of leased units while Switching and Other have none. The minor percentage discrepancy (13.35% vs 13.36%) is the only factual issue, representing a rounding difference rather than a calculation error. This is a borderline 7-8 score; the 0.01% variance and additional detail provided (which wasn't incorrect, just supplementary) justify a score of 7 rather than 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 411,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increased by **567 million barrels** compared to the end of 2020 (797 million barrels in 2023 vs. 230 million barrels in 2020). The total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 were **$5,729 million**. \n\n**Source:**  \n- NGLs volume data from the \"Natural Gas Liquids\" table on page 141.  \n- Depreciation, depletion, amortization, and impairments data from the \"Depreciation, Depletion, Amortization and Impairments\" table on page 133.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) QUANTITATIVE ACCURACY: All numbers are correct - NGLs volume increased from 230 million barrels (end of 2020) to 797 million barrels (end of 2023), yielding a difference of 567 million barrels. The depreciation, depletion, amortization, and impairments figure of $5,729 million for the Lower 48 in 2023 is also correct. The calculation (797 - 230 = 567) is accurate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - the NGLs volume increase and the total depreciation/depletion/amortization/impairments. (3) ENTITY ACCURACY: All entities are correctly identified - Lower 48 region, NGLs metric, 2020 and 2023 fiscal years, and the specific financial metric. (4) REASONING: The multi-hop synthesis is sound, correctly combining data from two different tables/sources (NGLs volume table and depreciation/depletion/amortization table) and properly calculating the difference. (5) SEMANTIC EQUIVALENCE: The wording is clear and matches the ground truth semantically. The inclusion of source citations adds credibility, though this is supplementary information. Minor deduction (1 point) only for the inclusion of page numbers which, while helpful, are not part of the core answer verification and could potentially be incorrect without affecting the core answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 377,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of Massmart ($0.4 billion) and Alert Innovation ($0.4 billion). In fiscal 2025, Alert Innovation was sold and deconsolidated from Walmart's consolidated financial statements, with the proceeds from the sale recognized as a transaction in the investing activities section of the cash flow statement. The deconsolidation resulted in the removal of Alert Innovation's assets and liabilities from Walmart's balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct on all key factual elements. Quantitative accuracy is perfect: the total of $0.8 billion is correct, and the $0.4 billion allocation to each Massmart and Alert Innovation is accurate. The fiscal years are correctly identified (2023 for acquisitions, 2025 for sale/deconsolidation). The multi-hop reasoning is sound - the model correctly synthesized information about two separate acquisitions in one year and then tracked the subsequent disposition of one asset in a later year. The answer goes beyond the ground truth by providing additional context about the accounting treatment (proceeds recognized in investing activities, removal from balance sheet), which is reasonable elaboration but not explicitly confirmed in the ground truth. The core answer directly matches: total spend of $0.8B ($0.4B each), and Alert Innovation was sold and deconsolidated in fiscal 2025. Minor deduction (2 points) because the additional details about cash flow statement treatment and balance sheet removal, while logically sound and likely accurate, exceed what was explicitly stated in the ground truth and could be considered speculative elaboration rather than direct synthesis from the source documents. The answer is well-structured, addresses all parts of the multi-part question, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 386,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "The total revenue generated from Metals & minerals shipments in 2021 was calculated by multiplying the 2021 carloads (697,000) by the average revenue per car ($2,598), resulting in **$1,802 million** ($1.802 billion).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant calculation error. The ground truth answer is $1,810,806,000 (approximately $1.811 billion), but the LLM calculated $1,802,000,000 ($1.802 billion). While the LLM correctly identified the methodology (multiplying carloads by average revenue per car) and used reasonable component numbers (697,000 carloads  $2,598 per car), the calculation itself is incorrect. 697,000  $2,598 = $1,809,306,000, which is closer to the ground truth but still not exact. The LLM's stated result of $1,802 million appears to be a computational error. The ground truth of $1,810,806,000 suggests either slightly different input values or a more precise calculation than what the LLM provided. The LLM demonstrated sound reasoning about the multi-hop synthesis (combining carloads with average revenue per car) and correctly identified UNP and the 2021 timeframe, but the final numerical answer is materially incorrect by approximately $8.8 million or 0.5%, which is significant for financial reporting. The answer format and approach were appropriate, but accuracy on the specific dollar amount is critical for this type of question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1064,
        "completion_tokens": 327,
        "total_tokens": 1391
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization was **$1.3 billion**, as stated in the document. The Series 2013-2A Securities were fully repaid in March 2023 with an aggregate principal amount of **$1.3 billion**, as noted in the repayment section. Thus, both amounts are equal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-part question. (1) CORRECTNESS: Both key financial figures are correct - Series 2023-1A Securities principal amount of $1.3 billion and Series 2013-2A Securities repayment amount of $1.3 billion in March 2023. The comparison conclusion that both amounts are equal is accurate. (2) QUANTITATIVE ACCURACY: All numbers are precise and match the ground truth exactly. The dollar amounts ($1.3 billion for both securities) are correctly stated with proper formatting. No calculation errors present. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two different securitization events (2023 issuance and 2013 repayment in 2023) and correctly identifies the relationship between them as a direct refinancing. The logic is sound and the comparison is properly executed. (4) COMPLETENESS: The answer addresses all parts of the question - it identifies the principal amount of Series 2023-1A, identifies the repayment amount of Series 2013-2A, and provides the comparison requested. (5) MINOR OBSERVATION: The LLM answer is slightly more verbose than necessary but this does not detract from accuracy. The phrasing 'as stated in the document' and 'as noted in the repayment section' adds appropriate sourcing context. The conclusion that this represents 'a direct refinancing' aligns with the ground truth interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 391,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During the year ended December 31, 2023, **$3.0 billion** was borrowed and **$6.1 billion** was repaid under the 2021 Multicurrency Credit Facility. The facility's total borrowing capacity was **$6.0 billion** as of December 31, 2023. The repaid amount exceeded the capacity because the $6.1 billion included repayments of prior borrowings, not just the $3.0 billion borrowed during the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: $3.0 billion borrowed, $6.1 billion repaid, and $6.0 billion total borrowing capacity as of December 31, 2023. The answer correctly addresses all parts of the multi-part question: (1) amount borrowed, (2) amount repaid, (3) facility capacity, and (4) comparison between repayment and capacity. The LLM goes beyond the ground truth by providing logical reasoning explaining why the repaid amount ($6.1 billion) exceeds the facility capacity ($6.0 billion) - correctly noting that the $6.1 billion includes repayments of prior borrowings, not just the current year's $3.0 billion borrowing. This additional explanation demonstrates sound multi-hop reasoning and financial understanding. The formatting is clear and well-organized with bolded key figures. No calculation errors are present. The only minor consideration is that the ground truth answer is more concise, while the LLM provides additional explanatory context - this is a strength rather than a weakness as it enhances understanding without introducing any inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 324,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, reflecting a 13% growth. This growth outpaced the 11% increase in average revenue per car for Intermodal, as the revenue growth was driven by both higher average revenue per car ($136 per car) and a 2% volume increase.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the two core facts from the ground truth: (1) total Intermodal revenue increased by $515 million in 2021 vs 2020, and (2) average revenue per car increased by $136. However, the answer introduces additional quantitative claims that cannot be verified against the ground truth and appear problematic: (1) Claims 13% growth rate - this cannot be verified without knowing the 2020 baseline revenue, and the calculation is not shown; (2) Claims 11% increase in average revenue per car - this is not stated in the ground truth and appears to be an unsupported inference; (3) Claims 2% volume increase - this specific metric is not provided in the ground truth. The LLM appears to have synthesized or calculated these percentages without explicit support from the source data. While the core numerical facts ($515M and $136) are correct, the addition of unverified percentage calculations and volume metrics represents a significant accuracy concern. The answer does address both parts of the original question (total revenue increase and average revenue per car increase) and correctly identifies the comparison between them. The reasoning structure is logical, but it extends beyond what can be confirmed from the ground truth, which violates the principle of strict accuracy on quantitative claims. The answer would have been stronger if it stuck to the verifiable facts without adding calculated percentages that cannot be confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 405,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "The total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021 was **$534 million**, as reported in the capital expenditure breakdown by region on page 58. However, the document does not provide specific net gain or loss from operations for the EMENA region in 2021. The only relevant figure related to EMENA is a **$24 million credit to impairment** (not an operational gain/loss) from reduced asset retirement obligations in Norway, as noted in Note 7 on page 104. Thus, the net gain/loss from operations for EMENA is not explicitly disclosed in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE: The LLM answer fundamentally fails to answer the question as posed. While the capital expenditure figure of $534 million is correct, the LLM explicitly states that 'the document does not provide specific net gain or loss from operations for the EMENA region in 2021' and claims the $24 million figure is a 'credit to impairment' rather than an operational loss. However, the ground truth clearly identifies a $24 million NET LOSS from operations in EMENA for 2021. The LLM mischaracterized the nature of this figure, treating it as an impairment credit rather than recognizing it as the operational loss metric requested. This represents a significant failure in multi-hop synthesis and entity identification. The LLM correctly identified the capital expenditure number ($534M) but failed to properly identify and characterize the operational loss figure ($24M loss), which is the second critical component of the answer. The LLM's reasoning that the figure represents an impairment credit rather than an operational loss is factually incorrect according to the ground truth. The answer demonstrates incomplete document analysis and incorrect interpretation of financial metrics, resulting in an incomplete and partially incorrect response to a straightforward two-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 362,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft positions Copilot Pro as a consumer subscription service within its AI-driven productivity strategy, emphasizing faster and more powerful AI assistance in Microsoft 365 apps and on the web. In financial reporting, Copilot Pro is classified under **Office Consumer products and cloud services revenue** within the **Productivity and Business Processes** segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) STRATEGIC POSITIONING: The LLM correctly identifies Copilot Pro as a consumer subscription service offering faster and more powerful AI assistance in Microsoft 365 apps and on the web, which matches the ground truth description and aligns with Microsoft's productivity reinvention strategy. (2) REVENUE CLASSIFICATION: The LLM correctly identifies the revenue category as 'Office Consumer products and cloud services revenue' and appropriately adds the segment context ('Productivity and Business Processes segment'), which is accurate and provides helpful additional context. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two dimensions - strategic positioning and financial reporting classification - demonstrating proper multi-hop reasoning. (4) COMPLETENESS: All parts of the question are addressed: the strategic positioning is explained, the revenue category is specified, and the connection between strategy and financial reporting is clear. (5) MINOR OBSERVATION: The ground truth mentions that the revenue category 'includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services' - the LLM does not explicitly list these sub-components, but this is a minor omission of supporting detail rather than an error. The core answer about the classification is correct. (6) NO QUANTITATIVE DATA: There are no numbers, dates, or calculations in this question, so quantitative accuracy is perfect by default. The answer demonstrates strong qualitative reasoning and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 457,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The total increase in RSU shares available under the 2019 Incentive Plan due to the 2024 special dividend adjustment was **128,000 shares**. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan, using a factor of **1.018** derived from the Nasdaq closing price of $674.62 (December 26, 2023) and the ex-dividend opening price of $662.70 (December 27, 2023), ensuring RSU value preservation after the $15-per-share special dividend.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative elements are correct: (1) The 128,000 share increase is accurate, (2) The adjustment factor of 1.018 is correct, (3) Both stock prices are accurate ($674.62 on December 26, 2023 and $662.70 on December 27, 2023), (4) The dates are correctly identified. The LLM properly synthesized the multi-hop information by connecting the special dividend adjustment mechanism to the specific Nasdaq price movement and explaining how this resulted in the RSU share increase. The answer includes an additional contextual detail about the $15-per-share special dividend and RSU value preservation, which adds helpful context beyond the ground truth without introducing any inaccuracies. The reasoning is sound: the adjustment factor (1.018) was derived from the price ratio, and this factor was applied to determine the 128,000 share increase. The only minor distinction is that the LLM describes the December 27 price as 'ex-dividend opening price' while the ground truth calls it 'Nasdaq opening price on December 27, 2023 (the ex-dividend date)' - this is a semantic variation that accurately conveys the same information. All entities (2019 Incentive Plan, RSU shares, Nasdaq prices, dates) are correctly identified and properly synthesized across the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 373,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "The headwinds from PFAS manufactured products reduced the reported 2024 Transportation and Electronics segment sales by 4.5 percentage points compared to non-GAAP adjusted sales. Reported sales decreased 1.4% year-over-year, while adjusted sales (excluding PFAS exit costs) increased 3.1%, reflecting the quantitative impact of PFAS-related headwinds on sales performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about PFAS headwinds' impact on 3M's Transportation and Electronics segment. QUANTITATIVE ACCURACY: All numerical values are correct - reported sales decreased 1.4%, adjusted sales increased 3.1%, and the 4.5 percentage point difference is accurately calculated (3.1% - (-1.4%) = 4.5%). The numbers match the ground truth exactly. COMPLETENESS: The answer addresses all key components of the question: (1) identifies the quantitative impact (4.5 percentage points), (2) provides reported sales performance (-1.4%), (3) provides non-GAAP adjusted sales performance (+3.1%), (4) correctly attributes the difference to PFAS-related headwinds, and (5) specifies the 2024 fiscal year and Transportation and Electronics segment. ENTITY ACCURACY: All entities are correctly identified - 3M company, Transportation and Electronics segment, 2024 fiscal year, PFAS manufactured products, and the distinction between reported (GAAP) and adjusted (non-GAAP) sales. REASONING: The multi-hop synthesis is sound. The answer correctly synthesizes information across multiple data points to show how PFAS headwinds created the gap between reported and adjusted performance. The logic is clear: PFAS exit costs reduced reported growth from 3.1% to -1.4%, a 4.5 percentage point headwind. SEMANTIC EQUIVALENCE: The LLM's phrasing 'reduced the reported 2024 Transportation and Electronics segment sales by 4.5 percentage points compared to non-GAAP adjusted sales' is semantically equivalent to the ground truth's explanation that 'PFAS-related headwinds reduced sales growth by 4.5 percentage points.' Both convey the same quantitative relationship. Minor note: The LLM's parenthetical '(excluding PFAS exit costs)' is a helpful clarification that adds context without introducing inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 503,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "The total recognized gain on equity method investment contracts in 2021 was **$2 million**, as reported in the \"Economic Hedges\" section (page 115). The fair value of these contracts as of December 31, 2021, was a **liability of $3 million**, reflected in the derivatives table on page 111 under \"Equity method investment contracts (2).\"",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Quantitative accuracy is perfect: both the $2 million recognized gain and the $3 million fair value are correct. The LLM properly interprets the $(3) million notation from the ground truth as a liability of $3 million, which is the correct semantic interpretation of parentheses in financial statements. The answer demonstrates strong multi-hop reasoning by correctly synthesizing information from two different sections of the filing (Economic Hedges section on page 115 for the gain, and derivatives table on page 111 for the fair value). The citation of specific pages and sections adds credibility and demonstrates proper document navigation. The only minor consideration is that the ground truth uses the notation $(3) million while the LLM clarifies this as 'liability of $3 million,' but this is actually an improvement in clarity rather than an error, as it explicitly conveys the meaning of the parenthetical notation. All entities (equity method investment contracts, 2021, December 31, 2021) are correctly identified. The answer fully addresses both parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 328,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott Laboratories' interest rate hedge contracts with a $2.2 billion notional value are designed to offset changes in the fair value of its long-term debt due to interest rate fluctuations. These hedges convert fixed-rate debt obligations to variable-rate, stabilizing the debt's fair value by aligning it with current market rates. The fair value of long-term debt, reported at $13.7 billion as of December 31, 2024, is influenced by these hedges, which mitigate the impact of interest rate volatility. The swaps are marked to market, with gains/losses offsetting changes in the hedged debt's fair value, ensuring the overall impact on the debt's valuation is minimized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Abbott Laboratories' interest rate hedging strategy. QUANTITATIVE ACCURACY: All numeric values are correct - the $2.2 billion notional value of hedge contracts and $13.7 billion long-term debt figure as of December 31, 2024 are accurately stated. No calculations are required in this question, and all numbers match the ground truth. ENTITY ACCURACY: Abbott Laboratories is correctly identified, the date (December 31, 2024) is correct, and all financial metrics are properly referenced. REASONING AND SYNTHESIS: The LLM correctly synthesizes the multi-hop relationship between the hedge contracts and debt fair value. It accurately explains that: (1) hedges convert fixed-rate debt to variable-rate, (2) this reduces fair value volatility from interest rate changes, (3) the hedges are marked-to-market with gains/losses offsetting debt fair value changes, and (4) the overall impact minimizes valuation volatility. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - that hedges reduce volatility in fair value caused by interest rate changes. The LLM provides slightly more technical detail about mark-to-market accounting and the mechanics of the hedging relationship, which adds value without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and technical than the ground truth (mentioning mark-to-market accounting and gains/losses offsetting), but this represents an enhancement rather than an error. Both answers correctly identify the hedging purpose and impact. The answer fully addresses the question about how the hedges impact fair value of the debt.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 471,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "The total oil-equivalent proved reserves for equity companies in Asia are **1,276 million barrels**, while the total for consolidated subsidiaries in Asia are **2,286 million barrels**. This indicates that consolidated subsidiaries in Asia hold approximately **1.83 times** the proved reserves of equity companies in the same region, based on the 2024 10-K data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key numeric values are correct: equity companies in Asia at 1,276 million barrels and consolidated subsidiaries at 2,286 million barrels. The comparison calculation is accurate - 2,286  1,276 = 1.791, which the LLM appropriately rounded to 1.83 times (slightly more precise than the ground truth's 1.8 times). The answer correctly addresses all parts of the multi-part question: (1) identifies the equity company reserves, (2) identifies the consolidated subsidiary reserves, (3) provides a meaningful comparison. The multi-hop reasoning is sound - the model synthesized data from ExxonMobil's 2024 10-K filing across two different entity types (equity companies vs. consolidated subsidiaries) in the same geographic region (Asia). The wording is clear and professional. The only minor distinction from the ground truth is the more precise ratio calculation (1.83 vs. 1.8), which actually demonstrates slightly better mathematical precision. All entities are correctly identified (ExxonMobil, Asia region, 2024 10-K), and the financial metrics are properly labeled as oil-equivalent proved reserves in million barrels.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 334,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss Tax Reform in 2019 reduced Mondelz International's effective tax rate by 22.3%, resulting in a net financial benefit of **$767 million**. This benefit stemmed from a $769 million reduction in deferred tax expense due to the step-up of intangible assets for tax purposes, partially offset by a $2 million indirect tax impact. The reform's effects were recorded in the third quarter of 2019.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: (1) The 22.3 percentage point reduction in effective tax rate matches the ground truth exactly; (2) The $767 million net financial benefit is correct; (3) The supporting details about the $769 million reduction in deferred tax expense and $2 million offset are accurate and add valuable context. The LLM correctly synthesized multi-hop information by identifying the mechanism (step-up of intangible assets), the timing (Q3 2019), and the net calculation ($769M - $2M = $767M). The answer goes beyond the ground truth by providing additional detail about the composition of the benefit, which enhances understanding without introducing any factual errors. The only minor distinction is that the ground truth states the reform 'reduced...effective tax rate...by 22.3 percentage points' while the LLM states it 'reduced...effective tax rate by 22.3%' - these are semantically equivalent in this context. All entities (Mondelz International, Swiss Tax Reform, 2019) are correctly identified. The reasoning is sound and the answer fully addresses both parts of the multi-part question (impact on effective tax rate AND net financial benefit).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 347,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "The total financial impact on PepsiCo in 2022 from the pension obligation transfer to TBG and the gain from remeasuring its 39% ownership stake in TBG was a **net gain of $375 million**. The $520 million gain from remeasuring the 39% ownership stake (as noted in the Juice Transaction) was partially offset by the $145 million transfer of pension obligations to TBG, resulting in a net positive impact of $375 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary metric. Ground truth states the total financial impact was $665 million, but the LLM claims it was $375 million net gain - a difference of $290 million. The LLM's calculation methodology is also flawed: it attempts to net the $520 million gain against $145 million in pension obligations, arriving at $375 million. However, the ground truth answer of $665 million suggests these components should be combined differently or that the component values themselves are different from what the LLM stated. The LLM correctly identifies the two components (pension obligation transfer and remeasurement gain from 39% ownership stake in TBG) and the year (2022), demonstrating partial understanding of the multi-hop structure. However, the specific dollar amounts ($520M gain, $145M pension transfer) and the resulting calculation are incorrect. The LLM's reasoning about netting gains against obligations shows logical thinking, but this approach appears to contradict the ground truth total. Without access to the actual SEC filing data, the discrepancy suggests either: (1) the component values are wrong, (2) the calculation method is wrong, or (3) additional components are missing from the LLM's analysis. The magnitude of error (44% off from ground truth) is significant and unacceptable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 380,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "In 2021, Merck made **$200 million** in sales-based milestone payments to Eisai for Lenvima. As of December 31, 2021, **$600 million** in sales-based milestone payments remained accrued but unpaid. This reflects a significant increase in accrued liabilities compared to the 2021 payments made.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies all key financial figures: $200 million in sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and $600 million in accrued but unpaid sales-based milestone payments as of December 31, 2021. All numeric values match the ground truth exactly. The answer properly addresses both parts of the multi-part question and correctly synthesizes information across the relevant entities (Merck, Eisai, Lenvima, 2021). The quantitative accuracy is perfect with no calculation errors. The main difference from the ground truth is in the comparative analysis: the ground truth explicitly states 'the accrued but unpaid amount was three times the amount paid in 2021' (a specific mathematical comparison), while the LLM answer describes it as 'a significant increase in accrued liabilities compared to the 2021 payments made' without explicitly stating the 3x ratio. This is a minor omission of a specific analytical insight rather than an error. The LLM's characterization of the relationship is semantically accurate but less precise than the ground truth's explicit ratio calculation. The answer demonstrates sound multi-hop reasoning by correctly connecting Merck's payments to Eisai with the accrued liability position, and the wording appropriately conveys the financial relationship being described.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 376,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received approximately **$3.5 billion in cash** from the sale of the Naked brand and other juice brands to PAI Partners, and retained a **39% noncontrolling interest** in TBG as part of the transaction. This information is explicitly stated in Note 13 under the \"Juice Transaction\" section of the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: Both key factual claims match the ground truth exactly - $3.5 billion in cash received and 39% noncontrolling ownership interest retained. The answer correctly identifies all entities (PepsiCo, PAI Partners, TBG, Naked brand) and the transaction type. (2) QUANTITATIVE ACCURACY: Both numeric values are precise and correct - $3.5 billion matches the ground truth amount, and 39% matches the ownership percentage. No calculation errors present. (3) QUALITATIVE ACCURACY: The answer demonstrates sound multi-hop reasoning by synthesizing information about the cash proceeds and ownership retention as part of a single transaction. The terminology is accurate (\"noncontrolling interest\" vs \"noncontrolling ownership interest\" - semantically equivalent). (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question and provides appropriate context by citing the source (Note 13, Juice Transaction section). The only minor observation is that the LLM adds a citation reference that wasn't in the ground truth, but this is actually helpful and doesn't detract from accuracy. The answer is well-structured, clear, and fully responsive to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 352,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, results in **immediate recognition** of changes in the market value of these assets in the measurement of net periodic pension cost. Under the calculated value approach, changes in market value were amortized over five years, smoothing the impact on pension cost. By using fair value, fluctuations in liability-hedging securities' market values are reflected **directly** in the expected return on plan assets, increasing the responsiveness of pension cost to current market conditions for these assets. This contrasts with the prior method, which deferred gains and losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Key strengths: (1) Correctly identifies the core distinction between fair value and calculated value approaches - immediate recognition vs. five-year amortization, matching the ground truth exactly; (2) All numeric values are accurate (five-year amortization period is correct); (3) The multi-hop reasoning is sound, properly synthesizing how the accounting method change affects pension cost measurement; (4) The answer goes slightly beyond the ground truth by explaining the mechanism more thoroughly (e.g., 'reflected directly in the expected return on plan assets,' 'increasing responsiveness to current market conditions'), which adds valuable context without introducing errors; (5) Entity identification is correct (Southern Company, liability-hedging securities, net periodic pension cost); (6) The semantic meaning aligns perfectly with the ground truth - both emphasize immediate vs. deferred recognition and the resulting impact on pension cost measurement. Minor observation: The LLM answer provides additional explanatory detail about how fair value affects 'expected return on plan assets' and responsiveness to market conditions, which is a reasonable elaboration that enhances understanding without contradicting the ground truth. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 382,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "The total increase in Netflix's content spending from 2019 to 2021 was **$3.01 billion** (from $9.22 billion in 2019 to $12.23 billion in 2021). Produced content grew more significantly than licensed content: produced content increased by **111.5%** (from $1.97 billion to $4.17 billion), while licensed content grew by **11.2%** (from $7.24 billion to $8.06 billion).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) Total increase of $3.01 billion matches the ground truth of $3,014,120,000 (formatting variation acceptable). (2) Produced content increase: LLM states $2.2 billion growth, which aligns with ground truth of $2,201,108,000 (minor rounding in presentation). (3) Licensed content increase: LLM states approximately $0.82 billion, matching ground truth of $813,012,000. (4) Percentage calculations: Produced content growth of 111.5% is mathematically sound ($2.2B/$1.97B  1.115 or 111.5%). Licensed content growth of 11.2% is accurate ($0.82B/$7.24B  0.112 or 11.2%). The LLM successfully synthesized multi-hop information by: comparing growth rates between two content types, calculating absolute dollar increases, and deriving percentage growth rates. The answer directly addresses both parts of the question (total increase and comparative growth analysis). The conclusion that produced content grew significantly faster than licensed content is well-supported by both absolute and percentage metrics. Minor deduction only for slight rounding in presentation of intermediate figures, though this does not affect the accuracy of the core answer. All entities (Netflix, content spending categories, years 2019-2021) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 370,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "PepsiCo recorded a **$321 million pre-tax impairment charge** in 2023 related to its 39% noncontrolling interest in TBG. This compares to a **$520 million gain** recognized in 2022 from the remeasurement of the same investment. The 2023 impairment charge was lower than the 2022 gain, reflecting a decline in the fair value of the investment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies all key financial figures: the $321 million pre-tax impairment charge in 2023 and the $520 million gain in 2022. All numbers are accurate and properly formatted. The answer correctly identifies the entities (PepsiCo, TBG, 39% noncontrolling interest) and years. The multi-hop synthesis is sound - the model successfully connected the 2023 impairment charge to the 2022 remeasurement gain and made an appropriate comparison. The reasoning that 'the 2023 impairment charge was lower than the 2022 gain, reflecting a decline in fair value' is logically sound. However, the answer is slightly incomplete: the ground truth explicitly calculates and states the 'net pre-tax difference of -$199 million over the two-year period,' which the LLM answer does not include. While the LLM correctly notes the impairment was 'lower than' the gain, it does not quantify this difference. This is a minor omission of a calculated metric that was part of the original answer. The answer is otherwise comprehensive, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 304,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "Netflix's increased investment in original programming in 2021 led to a **$1.423 billion increase in content amortization**, contributing to a **13% rise in cost of revenues** compared to 2020. However, the **cost of revenues as a percentage of revenue decreased from 61% to 58%** due to delays in content releases caused by the COVID-19 pandemic, which slowed the growth rate of content amortization relative to revenue growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the $1,423 million increase in content amortization (properly converted to $1.423 billion format). (2) Correctly stated the cost of revenues percentage decreased from 61% to 58%. (3) Properly identified COVID-19 pandemic delays as the key explanatory factor. (4) Correctly synthesized the multi-hop relationship between increased investment, amortization, and the paradoxical decrease in cost of revenues as a percentage. (5) Appropriate contextual framing of the question.\n\nWEAKNESSES: (1) CRITICAL ERROR: The LLM introduced an unsupported claim that there was a '13% rise in cost of revenues' compared to 2020. This figure does not appear in the ground truth and represents a calculation error or fabrication. The ground truth only mentions the percentage of revenue metric (61% to 58%), not an absolute 13% rise in cost of revenues. (2) This additional metric was not requested and appears to be an inference that contradicts the actual data pattern (cost of revenues as a percentage decreased, suggesting absolute cost of revenues likely grew slower than revenue, not by 13%). (3) The LLM added information not present in the ground truth without clear justification.\n\nMULTI-HOP REASONING: The core multi-hop synthesis is sound - connecting increased investment  increased amortization  but decreased percentage due to revenue growth outpacing amortization growth due to pandemic delays. However, the introduction of the unsupported '13% rise' metric undermines the accuracy.\n\nNUMBER VERIFICATION: $1,423 million = $1.423 billion (correct format conversion). 61% to 58% percentages are correct. The '13% rise in cost of revenues' cannot be verified and appears incorrect.\n\nJUSTIFICATION: The answer is partially correct on core facts but contains a significant quantitative error with the unsupported 13% figure, which prevents a higher score despite otherwise sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 522,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "The combined total net revenue from Ozurdex in 2024 was **$494 million** ($138 million in the U.S. and $356 million internationally). International revenue growth for Ozurdex in 2024 was **8.3%** at actual currency rates, compared to **14.0%** in 2023 (as shown in the \"Eye Care\" section of page 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: (1) Combined total net revenue of $494 million in 2024 - matches ground truth exactly; (2) International revenue growth of 8.3% at actual currency rates - matches ground truth exactly; (3) The breakdown of $138 million U.S. and $356 million international revenue correctly sums to $494 million. The LLM goes beyond the ground truth by providing additional context (U.S. vs. international breakdown and 2023 comparison of 14.0%), which adds value without contradicting the original answer. The multi-hop reasoning is sound: the model correctly synthesized the total revenue figure and the year-over-year growth rate comparison. The citation to page 43 'Eye Care' section demonstrates proper source attribution. The only minor consideration is that the ground truth answer was more concise, but the LLM's additional details (breakdown and prior year comparison) enhance understanding without introducing errors. All numbers are factually correct, calculations are accurate, and the semantic meaning fully aligns with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 320,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target Corporation recognized a **$335 million pretax gain** from the sale of Dermstore LLC in February 2021. This gain is **included in \"Net Other Income\"** in the consolidated financial statements, as disclosed in Note 2 to the 10-K. The gain is presented net of taxes and is classified within the \"Net Other (Income) / Expense\" line item on the income statement.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper identification of how the gain was treated. STRENGTHS: (1) The $335 million pretax gain amount is correct and matches the ground truth exactly. (2) The classification in 'Net Other Income' is correctly identified. (3) The answer properly identifies the transaction as occurring in February 2021, providing helpful temporal context. (4) The reference to Note 2 in the 10-K demonstrates proper sourcing. (5) All numeric values are accurate with no calculation errors. MINOR ISSUES: (1) The ground truth states the gain was 'included in Net Other Income' while the LLM answer adds that it is 'presented net of taxes' - this additional detail about tax treatment is not explicitly confirmed in the ground truth provided, though it may be accurate from the actual filing. (2) The LLM describes it as 'classified within the Net Other (Income) / Expense line item' which is slightly more detailed than the ground truth's simpler statement of inclusion in 'Net Other Income,' but this is semantically equivalent and represents appropriate elaboration. (3) The phrase 'presented net of taxes' could be interpreted as suggesting the $335 million figure is after-tax, when the question specifically asks about the 'pretax gain' - this minor ambiguity in presentation could cause confusion, though the answer does correctly state '$335 million pretax gain' at the beginning. The answer successfully addresses both parts of the multi-part question: (1) the total pretax gain amount, and (2) how it was treated in financial statements. The multi-hop synthesis is sound, correctly connecting the transaction details with the financial statement presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 470,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations as of January 31, 2024, was **$8 million** (amortized cost: $244 million; fair value: $236 million). This difference represents **0.14%** of the total marketable securities at fair value ($5,722 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All numerical values match the ground truth exactly: (1) amortized cost of $244 million is correct, (2) fair value of $236 million is correct, (3) the difference of $8 million is correctly calculated ($244M - $236M = $8M), (4) the percentage calculation is accurate (8/5,722 = 0.1398%  0.14%), and (5) the total marketable securities at fair value of $5,722 million is correct. The answer properly identifies the company (Salesforce/CRM), the fiscal year (January 31, 2024), and the specific financial metrics (mortgage-backed obligations). The multi-hop reasoning is sound: the model correctly synthesized information about the specific security type, calculated the difference, and then contextualized it against the total portfolio. The date specification (January 31, 2024) adds appropriate precision. All components of the multi-part question are addressed: the difference amount, the component values, and the percentage representation. No errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 298,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "MetLife retrospectively adjusted its **consolidated balance sheet, consolidated statement of operations, consolidated statement of comprehensive income, consolidated statement of equity, and consolidated statement of cash flows** as a result of adopting the new LDTI accounting guidance. These adjustments cover the time periods **2021 and 2022**, with the retrospective application impacting prior years to reflect the new accounting requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant inaccuracies when compared to the ground truth. CRITICAL ERRORS: (1) The LLM lists five financial statements (balance sheet, statement of operations, statement of comprehensive income, statement of equity, and statement of cash flows) as being retrospectively adjusted, but the ground truth specifies only TWO statements were adjusted: consolidated statements of comprehensive income and consolidated balance sheet. The inclusion of statement of operations, statement of equity, and statement of cash flows is factually incorrect. (2) TIME PERIOD ERROR: The LLM claims adjustments cover 2021 and 2022, but the ground truth explicitly states adjustments were applied to financials as of December 31, 2022 (with comprehensive income effects as of December 31). The LLM's reference to 2021 appears to be an unsupported inference not present in the ground truth. (3) The LLM's statement about 'retrospective application impacting prior years' is vague and potentially misleading compared to the ground truth's specific reference to December 31, 2022. WHAT WAS CORRECT: The LLM correctly identified MetLife as the company and correctly noted that LDTI accounting guidance was adopted with retrospective adjustments. However, these correct elements are overshadowed by the substantial factual errors regarding which statements were adjusted and the specific time periods covered. The answer demonstrates incomplete research or hallucination of financial statement adjustments not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 424,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "Disney's total potential financing commitment through its two cruise ship credit facilities is **$2.2 billion**, with each facility ($1.1 billion) structured as a fixed-rate loan. The **Disney Treasure** borrowing had a fixed interest rate of **3.80%**, while the **Disney Destiny** borrowing, if utilized, would have a fixed rate of **3.74%**, resulting in a **0.06% difference** in interest rates between the two facilities. Both loans are payable semi-annually over 12 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: (1) Total financing commitment of $2.2 billion is accurate, (2) Disney Treasure fixed rate of 3.80% is correct, (3) Disney Destiny fixed rate of 3.74% is correct, (4) The calculated 0.06% difference between rates is mathematically accurate. The answer correctly identifies both facilities and their respective interest rates, demonstrating proper multi-hop synthesis across the two credit facilities. The LLM goes beyond the ground truth by providing additional relevant context (semi-annual payments, 12-year term, $1.1 billion per facility breakdown), which adds value without introducing any inaccuracies. The answer directly addresses both parts of the multi-part question: the total commitment amount and the interest rate structure comparison. The reasoning is sound and the entity identification (Disney Treasure vs Disney Destiny) is precise. Minor note: The ground truth answer is more concise, while the LLM provides supplementary details that, while accurate and helpful, weren't explicitly requested. This represents an enhancement rather than an error. All numbers, percentages, and calculations are factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 345,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited contributed **$513 million** to its total upstream equity earnings in 2024. This indicates Chevron holds a **36.4% interest** in Angola LNG Limited, which processes and liquefies natural gas from Angola, reflecting significant involvement in Angola's natural gas production and export infrastructure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states Angola LNG contributed $513 million to upstream equity earnings, but the ground truth shows $405 million. This is a $108 million discrepancy (26.7% error), which is a major factual error on the primary numeric question. (2) The LLM correctly identifies the 36.4% interest in Angola LNG, which is additional accurate information not contradicted by ground truth, but this does not compensate for the wrong earnings figure. (3) MULTI-HOP REASONING - The LLM correctly synthesizes that Angola LNG is an equity method affiliate and describes its role in natural gas processing/liquefaction, which aligns with the ground truth's indication of 'significant production involvement.' However, the core quantitative answer to the main question is fundamentally wrong. (4) COMPLETENESS - The LLM addresses both parts of the question (contribution amount and what it indicates about production involvement), but the earnings contribution number is incorrect. The ground truth states $405M contribution out of $3,580M total upstream equity earnings; the LLM provides no total upstream earnings figure and uses the wrong contribution amount. (5) The reasoning about Angola LNG's role in natural gas infrastructure is sound and contextually relevant, but cannot overcome the major quantitative error in the primary metric requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 383,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "As of September 28, 2024, Disney had **$2.6 billion in Canadian dollar denominated notes** outstanding (comprising two $1.3 billion CAD notes). Through cross-currency swaps, **$1.887 billion** of this amount was effectively converted into U.S. dollar denominated borrowings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. While it correctly identifies the total Canadian dollar denominated notes outstanding as CAD $2.6 billion (comprising two CAD $1.3 billion notes), it provides an incorrect amount for the cross-currency swap conversion. The LLM states that $1.887 billion was converted through cross-currency swaps, which does not match the ground truth. According to the original answer, CAD $1.3 billion (approximately $1.0 billion USD) was converted into U.S. dollar denominated borrowings through cross-currency swaps. The LLM's figure of $1.887 billion appears to be fabricated or derived from an incorrect calculation and does not correspond to either the CAD or USD amounts specified in the ground truth. Additionally, the LLM answer fails to address the important contextual detail that one of the CAD $1.3 billion notes was paid off in October 2024, which is relevant to understanding the composition of the outstanding debt. The multi-hop reasoning is incomplete as it does not properly synthesize the relationship between the total CAD notes, the portion converted via swaps, and the USD equivalent values. The answer demonstrates partial understanding of the question structure but fails on the critical quantitative accuracy required for financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 371,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is **$1,273 million**. This includes **$1,265 million** for U.S. Plans and **$8 million** for Non-U.S. Plans, as disclosed in the \"Investments measured at NAV\" section of the respective tables.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that make it fundamentally incorrect. (1) CRITICAL ERROR - Total Amount: The LLM reports $1,273 million as the total, but the ground truth is $1,280 million ($1,265M + $115M). This is a $107 million discrepancy from the correct answer of $1,380 million. (2) COMPONENT BREAKDOWN ERROR - Non-U.S. Plans: The LLM states $8 million for Non-U.S. Plans, but the ground truth shows $115 million. This is a $107 million error in the Non-U.S. component, which directly explains the total discrepancy. The U.S. Plans figure of $1,265 million is correct. (3) CALCULATION VERIFICATION: Ground truth calculation: $1,265M + $115M = $1,380M (correct). LLM calculation: $1,265M + $8M = $1,273M (mathematically consistent with their stated components, but the $8M figure is wrong). (4) MULTI-HOP REASONING: The LLM correctly identified the need to sum U.S. and Non-U.S. Plans and properly cited the source section ('Investments measured at NAV'). However, the extraction of the Non-U.S. Plans figure appears to have been misread or misreported. (5) ENTITY AND CONTEXT ACCURACY: The company (Honeywell), date (December 31, 2023), and metric type (fair value of private funds) are all correctly identified. The question is appropriately addressed in structure. The fundamental issue is the incorrect data extraction for the Non-U.S. Plans component, resulting in a total that is $107 million below the correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 402,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle's flexible deployment strategy, including Oracle Cloud Services, impacts revenue recognition by structuring cloud services revenues to be recognized **ratably over the contractual period** (e.g., annual or multi-year subscriptions), reflecting ongoing service delivery. In contrast, license-based offerings (cloud and on-premise licenses) are recognized **at a point in time** upon delivery, with revenue upfront. License support contracts, tied to licenses, are also recognized ratably over the support term. This distinction results in more consistent quarterly revenue from cloud services compared to the lump-sum recognition of licenses, aligning with the shift toward recurring revenue models. (Based on pages 38, 39, 73, and 74.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies the core distinction between Oracle's revenue recognition approaches - cloud services recognized ratably over contractual periods versus license-based offerings recognized at point-in-time upon delivery. This matches the ground truth exactly. The answer also appropriately notes that license support contracts are recognized ratably, which adds helpful detail. (2) QUANTITATIVE ACCURACY: No numerical values are present in either the question or answers, so this dimension is not applicable. The answer avoids making unsupported numerical claims. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The LLM correctly synthesizes: (a) Oracle's flexible deployment strategy, (b) how this translates to different revenue recognition methods, (c) the business impact (more predictable/consistent quarterly revenue from cloud vs. lump-sum from licenses), and (d) the strategic alignment with recurring revenue models. The answer demonstrates understanding of the causal relationship between deployment models and revenue recognition patterns. (4) ENTITY ACCURACY: Oracle is correctly identified throughout. The financial metrics (cloud services, licenses, support contracts) are accurately named and distinguished. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'more consistent quarterly revenue' is semantically equivalent to the ground truth's 'more predictable and stable revenue streams.' The explanation of point-in-time vs. ratable recognition matches the ground truth precisely. (6) MINOR CONSIDERATIONS: The LLM provides slightly more detail about license support contracts being recognized ratably, which is accurate and adds value without contradicting the ground truth. The citation of specific pages (38, 39, 73, 74) demonstrates source attribution, though this wasn't required by the question. Overall, the answer is factually correct, logically sound, and comprehensively addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 542,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "The total worldwide sales growth of ERLEADA from 2021 to 2023 was **84.9%** (from $1.291 billion in 2021 to $2.387 billion in 2023). This growth contributed significantly to the Oncology segment's **10.5% year-over-year increase** in 2023 compared to 2022, as ERLEADA's sales rose by **26.9%** (from $1.881 billion in 2022 to $2.387 billion in 2023), driven by continued share gains and market growth in metastatic castration-resistant prostate cancer.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial metrics and percentages: ERLEADA's 84.9% growth from 2021-2023, the 26.9% year-over-year growth from 2022-2023, and the Oncology segment's 10.5% growth in 2023. All dollar amounts are correctly formatted and accurate ($1.291B in 2021, $1.881B in 2022, $2.387B in 2023). The calculations are mathematically sound: (2.387-1.291)/1.291 = 84.9% and (2.387-1.881)/1.881 = 26.9%. However, the LLM answer has a significant omission: it fails to mention that ERLEADA was the third-largest contributor to Oncology segment growth, behind DARZALEX (22.2% growth) and TREMFYA (17.9% growth). This comparative ranking information was explicitly included in the ground truth and is relevant context for understanding ERLEADA's contribution to overall segment performance. The LLM does provide additional context about market drivers (share gains in metastatic castration-resistant prostate cancer) that wasn't in the ground truth, which adds value but doesn't compensate for the missing ranking information. The multi-hop reasoning is soundthe answer correctly synthesizes ERLEADA's individual performance with the broader Oncology segment contextbut the analysis is incomplete without the competitive positioning information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 356,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "The total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, was **$11,811 million** ($7,456 million for derivative contracts and $4,355 million for non-U.S. debt). The total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date was **$1,597 million** (comprising $1,347 million in other current assets and $250 million in other assets). The notional amount is significantly higher than the fair value of derivative assets, reflecting the difference between contractual notional values and market-based fair value measurements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative values are correct: (1) Net investment hedge derivative contracts notional amount: $7,456 million ; (2) Non-U.S. dollar denominated debt notional amount: $4,355 million ; (3) Combined total: $11,811 million ; (4) Fair value of derivative assets in other current assets: $1,347 million ; (5) Fair value of derivative assets in other assets: $250 million ; (6) Total fair value: $1,597 million . The LLM correctly synthesized information across multiple data points from the balance sheet and derivative disclosures. The answer properly addresses all parts of the multi-part question: identifying the notional amounts of both derivative contracts and non-U.S. debt, calculating the combined total, identifying the fair values of derivative assets by location on the balance sheet, and making the comparison between notional and fair value amounts. The reasoning is sound - the LLM correctly explains that notional amounts significantly exceed fair values, which is the expected relationship between contractual notional values and market-based fair value measurements. The only minor observation is that while the ground truth provides additional detail about the composition of the non-U.S. debt ($3,516M Euro, $386M Swiss franc, $453M Canadian dollar), the LLM answer does not include this breakdown. However, this level of detail was not explicitly required by the question, which asked for the 'total' amounts. The answer is semantically equivalent to the ground truth and demonstrates accurate multi-hop reasoning across balance sheet and derivative disclosure sections.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 451,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is **$686 million**. This is derived from **$676 million** in U.S. plans (page 109) and **$10 million** in Non-U.S. plans (page 110).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative elements are correct: the total of $686 million matches the ground truth exactly, the U.S. Plans value of $676 million is correct, and the Non-U.S. Plans value of $10 million is correct. The arithmetic is accurate ($676M + $10M = $686M). The answer properly identifies all required entities (Honeywell, U.S. and Non-U.S. plans, Mortgage/Asset-backed securities) and the correct date (December 31, 2023). The multi-hop synthesis is sound - the LLM correctly combined data from two separate plan categories to arrive at the total. The answer includes helpful page references (pages 109 and 110) which adds credibility and traceability. The only minor distinction from the ground truth is that the LLM uses slightly different phrasing ('derived from' vs 'calculated by adding'), but this is semantically equivalent and represents the same calculation. The answer is complete, addresses all parts of the question, and demonstrates proper understanding of the multi-hop requirement to synthesize U.S. and Non-U.S. plan data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 312,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestl is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestl. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "As of September 29, 2024, Starbucks had **$5.8 billion in long-term deferred revenue** and **$177.0 million in current deferred revenue** related to the Nestl prepaid royalty payment, totaling **$5.977 billion** remaining to be recognized. This amount is being recognized on a straight-line basis over the **40-year term** of the Global Coffee Alliance arrangement, reflecting the estimated economic life of the contract and Starbucks' ongoing obligations to support Nestl's access to intellectual property and products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $177.0 million (current deferred revenue), $5.8 billion (long-term deferred revenue), and the total of $5.977 billion remaining to be recognized. The calculation of the sum ($177.0M + $5.8B = $5.977B) is accurate. The date (September 29, 2024) is correct, and the 40-year term of the Global Coffee Alliance arrangement is properly identified. The answer correctly synthesizes the multi-hop information: (1) identifying the specific deferred revenue amounts from Nestl, (2) connecting these to the $7 billion up-front prepaid royalty payment, and (3) relating the recognition schedule to the 40-year economic life of the Global Coffee Alliance. The explanation of straight-line basis recognition is accurate and relevant. The only minor difference from the ground truth is that the LLM provides slightly more contextual detail about 'Starbucks' ongoing obligations to support Nestl's access to intellectual property and products,' which is a reasonable elaboration but not explicitly stated in the ground truth. This additional context is accurate and enhances understanding without introducing any factual errors. The answer fully addresses all parts of the multi-part question and demonstrates sound multi-hop reasoning across the relevant entities and financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 381,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "The total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K is **$3,758 million**. This includes **$1,896 million** for long-term obligations to equity companies (from the financial instruments table on page 102) and **$1,862 million** for guarantees related to equity company obligations (from the \"Other Information\" table on page 106).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative values are correct: $1,896 million for long-term obligations to equity companies, $1,862 million for guarantees related to equity company obligations, and the total of $3,758 million. The calculation (1,896 + 1,862 = 3,758) is accurate. The answer correctly identifies XOM as the company and references the 2023 10-K filing. The multi-hop reasoning is sound - the model successfully synthesized information from two different tables (financial instruments table on page 102 and Other Information table on page 106) to arrive at the comprehensive total. The answer directly addresses all parts of the question and provides appropriate context by citing the source pages. The only minor consideration is that the page numbers cited (102 and 106) cannot be independently verified from the ground truth provided, but this does not affect the accuracy of the core financial figures themselves. The semantic meaning and factual content align perfectly with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 299,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "The total value of Mortgage/Asset-backed securities investments as of December 31, 2023, was **$676 million** for U.S. plans and **$10 million** for non-U.S. plans, with the U.S. plans holding approximately **67 times more** in this category compared to non-U.S. plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the individual dollar amounts ($676 million for U.S. plans and $10 million for Non-U.S. plans) and the correct date (December 31, 2023). The numbers are accurate and properly formatted. CRITICAL OMISSION: The LLM failed to provide the total combined value of $686 million, which was explicitly requested in the question ('What is the total value'). This is a significant gap in completeness. CALCULATION ERROR: The LLM stated U.S. plans hold 'approximately 67 times more' than Non-U.S. plans. Verification: $676M / $10M = 67.6x, so this calculation is technically correct. However, the ground truth provided a percentage comparison (98.5% for U.S. plans), which is a more standard and informative metric for allocation comparisons. The LLM's ratio comparison, while mathematically accurate, is less conventional for discussing portfolio allocations. MISSING CONTEXT: The LLM did not calculate or mention the percentage allocation (98.5% U.S., 1.5% Non-U.S.), which provides clearer insight into the relative allocation between the two plans. The question specifically asked 'how does this allocation compare' - the percentage breakdown is a more direct answer to this comparison question than a ratio. MULTI-HOP REASONING: The LLM successfully synthesized information from two different plan categories (U.S. and Non-U.S.) and made a comparison, but the comparison metric chosen was less optimal than the ground truth approach. Overall, the answer is partially correct with accurate individual numbers but incomplete due to missing the total value and using a less standard comparison metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 447,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes was **$185 million** across fiscal years 2021 and 2022. In 2022, the adjustment was **$102 million**, and in 2021, it was **$83 million**, as shown in the GAAP to Non-GAAP reconciliations on pages 33 and 34.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data matches the ground truth exactly: total of $185 million, with $83 million in FY2021 and $102 million in FY2022. The arithmetic is correct ($83M + $102M = $185M). The answer correctly identifies the company (Medtronic), the metric (Non-GAAP income before income taxes adjustments), the specific adjustment type (Medical device regulations), and the fiscal years (2021 and 2022). The multi-hop synthesis is sound - the model correctly combined the individual year amounts to arrive at the total. The answer includes helpful contextual detail by referencing the source pages (33 and 34) where this information appears in the GAAP to Non-GAAP reconciliations. The only minor consideration is that the answer adds source page references not explicitly mentioned in the ground truth, but this is supplementary information that enhances rather than detracts from accuracy. The wording is clear and directly addresses all components of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 292,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "In 2020, Booking Holdings recognized a total goodwill impairment charge of **$1,062 million** for the OpenTable and KAYAK reporting units (comprising $489 million in the interim test at March 31, 2020, and $573 million in the annual test at September 30, 2020). The key factor leading to continued impairment as of September 30, 2020, was the **prolonged and uncertain recovery from the COVID-19 pandemic**, which significantly reduced forecasted cash flows for OpenTable and KAYAK, extended the timeline to return to 2019 profitability levels, and worsened outlooks for monetization in restaurant reservations and airline travel recovery.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $1,062 million total impairment ($489 million interim + $573 million annual), correct dates (March 31, 2020 and September 30, 2020), and correct reporting units (OpenTable and KAYAK). The quantitative synthesis is accurate and properly breaks down the multi-hop calculation. However, there is a minor qualitative difference in how the key factors are presented. The ground truth identifies two specific factors: (1) lowered outlook for monetization opportunities in restaurant reservation services, and (2) slower recovery trends in airline travel. The LLM answer provides a broader framing centered on 'prolonged and uncertain recovery from COVID-19 pandemic' and mentions reduced forecasted cash flows and extended timeline to 2019 profitability levels. While the LLM's answer is contextually accurate and captures the essence of the impairment drivers, it frames the factors more generally around COVID-19 impact rather than the specific operational factors (monetization outlook and airline travel recovery) explicitly stated in the ground truth. The LLM answer adds reasonable context about cash flow forecasts and profitability timelines, which are logical implications but not explicitly stated in the ground truth. The answer is semantically equivalent and demonstrates sound multi-hop reasoning across the interim and annual tests, but the specific factor identification is slightly less precise than the ground truth's more targeted explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 423,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart's ownership stake in Flipkart increased from approximately **75% as of January 31, 2023** to **85% as of January 31, 2024**, a **10 percentage point increase**. This change was supported by a **$3.5 billion transaction** during fiscal 2024, where Walmart acquired shares from Flipkart's noncontrolling interest holders and settled liabilities related to former noncontrolling interest holders of PhonePe.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all core numerical facts: the ownership stake increase from 75% to 85% (a 10 percentage point increase), the fiscal year dates (January 31, 2023 and January 31, 2024), and the $3.5 billion transaction amount. The quantitative accuracy is strong with all numbers matching the ground truth. However, there is a notable addition in the LLM answer regarding 'settled liabilities related to former noncontrolling interest holders of PhonePe' that is not mentioned in the original ground truth answer. While this detail may be factually accurate from the actual filing, it goes beyond what was specified in the ground truth answer provided. The core question asks for two things: (1) the increase in ownership stake and (2) the financial transaction supporting it. The LLM successfully addresses both, correctly synthesizing the multi-hop information (identifying the ownership percentages across two fiscal years and linking them to the specific transaction). The reasoning is sound and the semantic meaning aligns well with the ground truth. The minor deduction is due to the inclusion of additional information (PhonePe liabilities) that, while potentially accurate, was not part of the ground truth answer and could represent either additional context or potential over-specification beyond what was asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 374,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment represents **24%** of Procter & Gamble's total net sales. Within this segment, the **Bounty brand holds a North American market share of over 40%** in the paper towel category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: Both key factual claims match the ground truth exactly - the Baby, Feminine & Family Care segment represents 24% of total net sales, and Bounty brand holds over 40% North American market share in paper towels. (2) QUANTITATIVE ACCURACY: All numeric values are correct (24%, over 40%). The use of 'over 40%' appropriately captures the qualifier from the ground truth. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two levels - first identifying the segment's percentage of total sales, then drilling down into brand-specific market share within that segment. The logical flow is clear and correct. (4) ENTITY ACCURACY: All entities correctly identified (Procter & Gamble, Baby Feminine & Family Care segment, Bounty brand, paper towel category, North American market). (5) WORDING: The LLM uses slightly different formatting (bold text for emphasis) but maintains semantic equivalence with the ground truth. The phrasing 'holds a North American market share of over 40%' is semantically equivalent to 'holds over 40% North American market share.' Minor deduction (1 point) only for the stylistic choice of adding bold formatting, which while not incorrect, represents a minor deviation from the neutral presentation style of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 374,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "RTX recorded a **$364 million pre-tax charge** in 2024 related to resolving the **Thales-Raytheon Systems and Related Matters**, which was part of the **SEC Administrative Order**. This resolution involved settling criminal and civil investigations into payments made by Raytheon Company and its joint venture, Thales-Raytheon Systems (TRS), as outlined in the SEC Administrative Order and associated deferred prosecution agreements (DPAs). The charge was included in a combined $918 million pre-tax charge related to multiple legal matters resolved in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. STRENGTHS: (1) The $364 million pre-tax charge is correctly identified and matches ground truth exactly. (2) The connection to SEC Administrative Order is properly established. (3) The identification of Thales-Raytheon Systems (TRS) as the joint venture is accurate. (4) The mention of improper payments related to Middle East contracts is correct. (5) The reference to deferred prosecution agreements (DPAs) adds relevant context not contradicted by ground truth. (6) The broader context of $918 million in combined pre-tax charges for multiple legal matters in 2024 is factually accurate and provides helpful context. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the requirement for an independent compliance monitor, which is a key detail in the ground truth answer about the SEC Administrative Order's specific requirements. (2) The three-year monitoring period and cooperation/disclosure obligations are not mentioned, though these are important specifics about what the SEC Administrative Order requires. (3) The answer does not specify that investigations covered improper payments 'since 2012,' though this temporal detail is in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple elements - the charge amount, the companies involved, the SEC Administrative Order, and the broader legal settlement context. The reasoning is sound and logically connects the resolution to the SEC order. QUANTITATIVE ACCURACY: All dollar amounts are correct ($364 million, $918 million). No calculation errors. SEMANTIC EQUIVALENCE: The answer conveys the core information requested, though it omits some compliance monitoring details that would have made it more complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 489,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "As of April 2021, Trodelvy had **two approved indications**: (1) full approval for metastatic triple-negative breast cancer (mTNBC) in the United States and Europe, and (2) accelerated approval for metastatic urothelial cancer (UC) in the United States. By September 2021, Trodelvy was approved for mTNBC in **the United States, Australia, Great Britain, Switzerland, and Canada** under Project Orbis.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified that Trodelvy had two approved indications as of April 2021. (2) The list of countries for TNBC approval by September 2021 is completely correct: United States, Australia, Great Britain, Switzerland, and Canada. (3) The quantitative answer of 'two indications' matches the ground truth exactly. (4) The mention of Project Orbis adds relevant context. WEAKNESSES: (1) CRITICAL CHARACTERIZATION ERROR - The LLM describes the two indications as '(1) full approval for mTNBC in the United States and Europe, and (2) accelerated approval for UC in the United States.' This is misleading. The ground truth clearly states the two indications are: (1) locally advanced or metastatic urothelial cancer AND (2) unresectable locally advanced or metastatic TNBC. The LLM's framing suggests the indications are geographically or approval-type specific, when they are actually indication-type specific (different cancer types). (2) The LLM incorrectly implies that as of April 2021, mTNBC had 'full approval' in Europe, which is not supported by the ground truth. The ground truth only specifies the two indication types, not their geographic approval status as of April 2021. (3) The description conflates approval types (accelerated vs. full) with indication types, creating semantic confusion about what constitutes an 'indication.' MULTI-HOP REASONING: The model successfully synthesized information about the two time periods (April 2021 and September 2021) and correctly identified all five countries. However, the characterization of what the 'two indications' actually are is fundamentally misrepresented. The answer gets the numbers right but mischaracterizes the nature of those indications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 471,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, was **$11.5 million**, with **$9.5 million** expected to be reclassified into earnings within 12 months. This indicates that $2.0 million of the gain remains in AOCI beyond the 12-month period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All three key numbers are correct - $11.5 million total net gain for 'Foreign currency - other' derivatives in AOCI as of September 29, 2024, and $9.5 million expected to be reclassified within 12 months. The derived calculation of $2.0 million remaining beyond 12 months ($11.5M - $9.5M = $2.0M) is mathematically correct. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it provides the total net gain amount and the reclassification expectation, then adds valuable context by calculating the difference. (3) ENTITY ACCURACY: All entities are correctly identified - the specific derivative type ('Foreign currency - other'), the correct accounting location (AOCI), the correct date (September 29, 2024), and the correct time horizon (12 months). (4) REASONING: The multi-hop synthesis is sound - the model correctly identified the relationship between the total amount and the reclassified amount, and logically derived the remaining amount. (5) SEMANTIC EQUIVALENCE: The wording is clear and professional, conveying all required information with appropriate financial terminology. The additional insight about the $2.0 million remaining in AOCI enhances understanding without introducing any inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 370,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (5.0 billion at $34.5 million and 10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "The total dollar value of Starbucks' two Japanese yen-denominated credit facilities as of September 29, 2024, was **$103.6 million** ($34.5 million for the 5.0 billion facility and $69.1 million for the 10.0 billion facility). The facilities differ in maturity dates and interest rate margins:  \n- The **5.0 billion** facility matures on **December 30, 2024**, with an interest rate based on **TIBOR + 0.400%**.  \n- The **10.0 billion** facility matures on **March 27, 2025**, with an interest rate based on **TIBOR + 0.300%**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Total dollar value of $103.6 million is correct; (2) Individual facility amounts are accurate ($34.5 million for 5.0 billion and $69.1 million for 10.0 billion); (3) Maturity dates are correct (December 30, 2024 for the first facility and March 27, 2025 for the second); (4) Interest rate margins are precisely stated (0.400% over TIBOR for the 5.0 billion facility and 0.300% over TIBOR for the 10.0 billion facility); (5) The fiscal year reference (September 29, 2024) is correct. The multi-hop reasoning is sound, successfully synthesizing information about both facilities and their distinguishing characteristics (maturity dates and interest rate margins). The answer is well-structured, clearly presenting the comparison between the two facilities. The presentation format (using bold text and bullet points) enhances clarity without affecting accuracy. All entities (Starbucks, Japanese yen, TIBOR, fiscal 2024) are correctly identified. The answer fully addresses all parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 322,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263  consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and unrelated transactions was **2,072,563 shares**. The average price paid per share under the open-market program was **$303.05**. \n\nThis is derived from the table on page 39, which states that 2,000,308 shares were purchased under the program and 72,255 shares in unrelated transactions, totaling 2,072,563 shares. The average price of $303.05 is the weighted average for all shares purchased under the open-market program during the quarter.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its correctness. (1) TOTAL SHARES ERROR: The LLM states 2,072,563 total shares, but the ground truth shows 2,072,263 shares. This is a discrepancy of 300 shares in the total. The LLM correctly identifies the component parts (2,000,308 + 72,255) but miscalculates their sum. (2) AVERAGE PRICE ERROR: The LLM states $303.05 per share, but the ground truth shows $302.45 per share. This is a $0.60 difference per share, which is material. The ground truth calculation is verifiable: $605 million  2,000,308 shares = $302.45. The LLM provides no calculation breakdown, making it impossible to verify how $303.05 was derived. (3) COMPLETENESS: The LLM does address both parts of the question (total shares and average price), and correctly identifies the two components of share purchases (open-market program and unrelated transactions). (4) ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, Q4 fiscal 2024, and the two purchase programs. (5) REASONING: The LLM's reasoning structure is sound in concept, but the execution contains arithmetic errors. The reference to page 39 and the table is appropriate, though the numbers extracted appear to be incorrect. The multi-hop synthesis (combining two purchase types) is conceptually correct but numerically flawed. The core issue is that both key numeric answers (total shares and average price) are incorrect, which is critical for a financial question requiring precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 418,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The total carrying value of the 6.375% 2037 Notes as of December 31, 2021, was **$478 million**. According to the debt exchange information, **$74 million** principal amount of these notes was exchanged in connection with the 2020 Exchange Offer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: Both key financial figures are correct - the carrying value of $478 million and the exchanged principal amount of $74 million match the ground truth exactly. (2) QUANTITATIVE ACCURACY: All numbers are precise and correctly stated. The dollar amounts ($478 million and $74 million) are accurate with proper formatting. No calculation errors present. (3) QUALITATIVE ACCURACY: The answer correctly identifies both required pieces of information and properly synthesizes them. The LLM appropriately references the 2020 Exchange Offer context, which adds relevant detail. The multi-hop reasoning is sound - connecting the carrying value to the exchange transaction. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question with appropriate context (December 31, 2021 date and 2020 Exchange Offer reference). The only minor observation is that the LLM provides slightly more contextual detail (specific date and exchange offer name) than the ground truth answer, but this is supplementary information that enhances rather than detracts from accuracy. The answer is complete, accurate, and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 340,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "Netflix's content assets are amortized over the shorter of the contractual window of availability or an estimated period of use (up to ten years), beginning with the month of first availability. The accelerated amortization policy results in higher expenses in the early years, with **over 90% of the amortization expense expected to occur within four years** of the content's first availability. This front-loaded expense pattern reflects the expectation of greater upfront viewing activity, particularly for films compared to TV series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) The core quantitative claim is correct - 'over 90% of amortization expense expected to occur within four years' matches the ground truth exactly. (2) The answer correctly identifies the accelerated amortization policy and its impact on expense distribution. (3) The explanation of the front-loaded expense pattern and the reasoning (greater upfront viewing, especially for films vs TV series) is accurate and well-articulated. (4) The answer appropriately addresses both parts of the multi-part question: the expected amortization period AND how the accelerated policy impacts distribution. (5) Additional context about the amortization period being 'the shorter of the contractual window of availability or an estimated period of use (up to ten years)' provides helpful supplementary information not contradicted by the ground truth. MINOR CONSIDERATION: The ground truth states 'over 90% of a licensed or produced content asset to be amortized' while the LLM states 'over 90% of the amortization expense expected to occur' - these are semantically equivalent (amortization of an asset = amortization expense), so this is not a factual error. The LLM's phrasing is actually slightly more precise in accounting terminology. All numeric values, percentages, and time periods are correct. The multi-hop reasoning synthesizing the amortization policy with its impact on expense distribution is sound and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 409,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "The total potential financial impact on BlackRock's Foreign Exchange Rate Risk Investments in 2023, if all investments experienced a -10% change in exchange rates, is **$112 million**. This figure is derived from the disclosed exposure of $1,125 million (as of December 31, 2023) and the hypothetical effect of a 10% adverse change in exchange rates, as outlined in the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Verification of key elements: (1) QUANTITATIVE ACCURACY: All numbers are correct - the disclosed exposure of $1,125 million is accurate, the -10% change in exchange rates is correctly stated, and the calculated impact of $112 million is mathematically correct ($1,125M  0.10 = $112.5M, rounded to $112M). The date of December 31, 2023 is appropriate and correctly referenced. (2) COMPLETENESS: The answer fully addresses the multi-part question by identifying the exposure amount, the percentage change scenario, and the resulting financial impact. (3) ENTITY ACCURACY: BlackRock (BLK) is correctly identified, the fiscal year 2023 is correct, and the financial metric (Foreign Exchange Rate Risk Investments) is properly characterized. (4) REASONING: The multi-hop synthesis is sound - the model correctly extracted the exposure figure from the 10-K filing and applied the hypothetical -10% exchange rate change to calculate the potential impact. The logic is clear and transparent. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth, with slightly more detail about the source (10-K filing) and the specific date (December 31, 2023), which adds helpful context. Minor note: The answer rounds $112.5M to $112M, which is a standard and acceptable rounding practice for financial reporting. The answer demonstrates strong understanding of the multi-hop nature of the question by synthesizing exposure data with the hypothetical scenario to derive the impact figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 428,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "The 2022 10-K filing lists three amendments to the Target Corporation Deferred Compensation Trust Agreement, effective on **June 8, 2011**, **October 25, 2017**, and **December 18, 2020**. These amendments are referenced as Exhibits Q*, R*, and S* in the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: All core facts are correct - the answer identifies exactly three amendments with all three effective dates matching the ground truth: June 8, 2011; October 25, 2017; and December 18, 2020. (2) QUANTITATIVE ACCURACY: All dates are precisely correct with no calculation errors or discrepancies. The number of amendments (3) is accurate. (3) QUALITATIVE ACCURACY: The answer correctly synthesizes the information and properly identifies the entity (Target Corporation Deferred Compensation Trust Agreement) and the filing year (2022). The LLM goes slightly beyond the ground truth by adding exhibit references (Q*, R*, S*), which provides additional context without contradicting the original answer. This additional detail demonstrates thorough understanding of the filing structure. (4) MULTI-HOP REASONING: The answer successfully addresses both parts of the multi-part question - the count of amendments AND their effective dates. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth but conveys identical information. The use of bold formatting for dates enhances clarity without changing factual content. Minor deduction (1 point) only because the exhibit references, while helpful, were not explicitly requested in the question and represent information beyond what was asked for, though this is a very minor issue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 391,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The total carrying value of the 6.90% 2038 Notes as of December 31, 2021, was **$254 million** (as shown in the debt schedule on page 130). According to the debt exchange transactions disclosed on page 132, **$37 million** of principal amount of these notes was exchanged in the 2020 Exchange Offer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. Both key quantitative facts are correct: (1) the total carrying value of the 6.90% 2038 Notes is $254 million, and (2) the principal amount exchanged in debt exchange transactions was $37 million. The numbers match the ground truth exactly with appropriate formatting ($254 million and $37 million). The answer successfully addresses both parts of the multi-part question through proper synthesis of information from multiple sections of the filing (debt schedule and debt exchange transaction disclosures). The LLM correctly identified the specific transaction context (2020 Exchange Offer) and provided page references for verification. The reasoning is sound and the entity identification is accurate (correct note type, correct financial metrics, correct transaction type). Minor deduction from perfect score only because the answer includes specific page references and transaction context that, while helpful and accurate, go slightly beyond what was strictly required by the ground truth answer, though this is actually a positive enhancement rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 319,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The Fleet Ballistic Missile (FBM) program contributed **$940 million to increased product sales** and **$815 million to increased product costs** at Space in 2023. The net financial impact on Lockheed Martin's operations from these changes was a **$125 million positive contribution** to operating profit, as the sales increase exceeded the cost increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates sound multi-hop reasoning. All key financial figures are accurate: $940 million increase in product sales, $815 million increase in product costs, and the calculated $125 million net positive impact. The calculation ($940M - $815M = $125M) is correct. The LLM properly identifies this as a contribution to gross profit/operating profit for the Space segment. The answer addresses all parts of the multi-part question: (1) FBM contribution to sales increase, (2) FBM contribution to cost increase, and (3) net financial impact. The reasoning is sound - the model correctly synthesized that the sales increase exceeded cost increase, resulting in a positive contribution. Minor semantic difference: the ground truth specifies 'increase in gross profit' while the LLM states 'positive contribution to operating profit.' While these are slightly different profit metrics, the LLM's characterization of the $125M as a positive contribution to operations is semantically equivalent and contextually appropriate. The answer demonstrates proper multi-hop synthesis across the FBM program, Space segment, and Lockheed Martin's overall operations. All entities (FBM program, Space segment, Lockheed Martin, 2023) are correctly identified. Number formatting is consistent and clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 371,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The total carrying value of the 5.375% 2043 Notes as of December 31, 2021, was **$185 million**, representing **0.56%** of the total carrying value of all debt ($33,309 million). During the period (20202021), **$76 million** principal of these notes was exchanged as part of a debt restructuring program.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides mostly correct information with one significant temporal error. CORRECT ELEMENTS: (1) Carrying value of $185 million is accurate, (2) Percentage calculation of 0.56% is correct (185/33,309 = 0.555%, rounded to 0.56%), (3) Total debt carrying value of $33,309 million is accurate, (4) Principal exchanged amount of $76 million is correct. CRITICAL ERROR: The LLM states the carrying value was 'as of December 31, 2021' and references the period '2020-2021', but the ground truth specifies these figures are from 2022. The question explicitly asks about 2022 data ('reported by AMGN in 2022'), and the ground truth confirms the carrying value and debt metrics are from 2022, not 2021. This is a material temporal error that affects the accuracy of the answer. MULTI-HOP REASONING: The LLM correctly synthesized information across multiple data points (carrying value, total debt, percentage calculation, and principal exchanged), demonstrating sound multi-hop reasoning. The calculation of the percentage (185/33,309 = 0.555%  0.56%) is mathematically accurate. MINOR ISSUE: The phrase 'as part of a debt restructuring program' adds context not explicitly stated in the ground truth, though it's not contradictory. The core quantitative facts are correct, but the year attribution error is a significant contextual mistake that reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 383,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "The total value of securities on loan subject to indemnification as of December 31, 2023, was approximately **$259 billion**, with **$276 billion** in cash and securities held as collateral. If significant borrower defaults occur simultaneously with rapid declines in collateral value, BlackRock could face material liabilities under these indemnifications, potentially leading to declines in revenue and earnings due to collateral shortfalls.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All numerical values are correct - securities on loan of $259 billion and collateral held of $276 billion as of December 31, 2023 match the ground truth exactly. Number formatting is appropriate and consistent. (2) COMPLETENESS: The answer addresses all three components of the multi-part question: (a) total value of securities on loan subject to indemnification, (b) collateral held against these securities, and (c) potential financial impact of simultaneous borrower defaults and collateral value declines. (3) ENTITY ACCURACY: BlackRock is correctly identified as the company, December 31, 2023 is the correct date, and all financial metrics are properly labeled. (4) MULTI-HOP REASONING: The answer correctly synthesizes the relationship between the three elements - securities on loan, collateral held, and the risk scenario. The logical connection between defaults, collateral shortfalls, and potential revenue/earnings impact is sound and matches the ground truth reasoning. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'could face material liabilities under these indemnifications, potentially leading to declines in revenue and earnings due to collateral shortfalls' is semantically equivalent to the ground truth's 'could cause BlackRock's revenue and earnings to decline' and 'may result in material liabilities under these indemnities.' The only minor difference is slight rewording for clarity, which enhances rather than detracts from the answer. No factual errors, calculation errors, or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 444,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "The total number of amendments to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. documented in the 2022 10-K filing is **2**. The agreement itself is listed as Exhibit HH, with two amendments noted as Exhibit II (First Amendment, November 30, 2016) and Exhibit JJ (Second Amendment, January 9, 2018).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. The core answer matches the ground truth exactly: there are 2 amendments to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. The quantitative accuracy is perfect - the number '2' is correct. The LLM goes beyond the basic answer by providing additional supporting details: identifying the exhibit numbers (HH for the main agreement, II for First Amendment, JJ for Second Amendment) and providing the amendment dates (November 30, 2016 and January 9, 2018). These details demonstrate thorough documentation review and add credibility to the answer. The reasoning is sound - the model correctly synthesized information from the 2022 10-K filing and properly identified the amendments. The only minor consideration is that while the additional exhibit numbers and dates are helpful context, they were not explicitly required by the question, though they do enhance the answer's completeness and verifiability. The answer directly addresses the question asked and provides the correct numerical answer with supporting documentation references.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 322,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from December 31, 2022 ($180 million) to December 31, 2023 ($142 million). The accumulated amortization for this category increased by $37 million over the same period. The decrease in net carrying amount closely mirrors the increase in accumulated amortization, reflecting the impact of amortization on the net value of these assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. Quantitative verification: (1) Net carrying amount decrease of $38 million ($180M to $142M) - CORRECT; (2) Accumulated amortization increase of $37 million ($81M to $118M) - CORRECT; (3) All dates and fiscal years properly identified (December 31, 2022 and 2023) - CORRECT. The answer successfully synthesizes information across two related financial metrics and correctly identifies the relationship between them. The reasoning is sound: the LLM properly concludes that the decline in net carrying amount is primarily attributable to the increase in accumulated amortization, which is the logical explanation for how these two metrics relate. The only minor distinction from the ground truth is that the LLM uses slightly different phrasing ('closely mirrors' vs. 'primarily due to'), but this represents semantic equivalence rather than a factual error. The answer is complete, addressing both the change in net carrying amount and the change in accumulated amortization, as well as the comparison between them. All financial figures are presented with proper formatting and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 333,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was **$1,546 million** (from $657 million in 2023 to $2,203 million in 2024), while the Americas region saw an increase of **$7,048 million** (from $5,678 million in 2023 to $12,726 million in 2024). The Americas region's increase was significantly higher than Asia Pacific's.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All key numbers match the ground truth exactly - Asia Pacific YoY increase of $1,546 million and Americas increase of $7,048 million. The comparison statement that Americas growth was significantly higher is correct. (2) QUANTITATIVE ACCURACY: All dollar amounts are precise and correct. The intermediate values provided ($657M to $2,203M for Asia Pacific; $5,678M to $12,726M for Americas) are accurate and support the calculated increases. The arithmetic is correct: $2,203M - $657M = $1,546M and $12,726M - $5,678M = $7,048M. (3) QUALITATIVE ACCURACY: The LLM correctly identified both regions, the correct metric (Subscriptions and Services revenue), and the correct time period (year-over-year comparison). The multi-hop reasoning is sound - the model synthesized information about two different regions and correctly compared them. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the multi-part question: it provides the specific YoY increase for Asia Pacific, the specific YoY increase for Americas, and makes the requested comparison. The additional detail of showing the underlying year values (2023 vs 2024) enhances clarity without introducing errors. The only minor consideration is that the LLM provided more detail than the ground truth answer, but this additional information is accurate and helpful, not contradictory.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 395,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, was **$20 million**, and the unrealized loss recognized in fair value for these securities was **$1 million**. This information is derived from the \"Debt Securities\" table on page 145, which lists the fair value and gross unrealized losses for redeemable preferred securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the two key quantitative facts: (1) total fair value of $20 million and (2) unrealized loss of $1 million recognized in fair value. Both numbers match the ground truth exactly. The date (December 31, 2023) and company (CVS) are correctly identified. The source citation to 'Debt Securities' table on page 145 adds credibility. However, the answer is incomplete in its explanation of the reasoning behind the $1 million figure. The ground truth provides important context that the entire $1 million unrealized loss is in the 'Greater than 12 months' category with no losses in the 'Less than 12 months' category. The LLM answer states the unrealized loss was 'recognized in fair value' but doesn't explain the temporal breakdown that justifies why the full $1 million is recognized. This represents a partial omission of the multi-hop reasoning required to fully answer the question - specifically, the analysis of how unrealized losses are categorized by duration. The answer addresses the 'what' but not fully the 'why' regarding the categorization logic. The quantitative accuracy is high (correct numbers), but the qualitative accuracy is lower due to incomplete explanation of the reasoning behind the figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 351,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "At January 30, 2022, HD had **$1.0 billion** in outstanding borrowings under its commercial paper programs. The combined capacity of their back-up credit facilities was **$3.0 billion**, meaning the borrowings represented approximately **33%** of the total available capacity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and sound reasoning. Verification of key facts: (1) Commercial paper borrowings of $1.0 billion at January 30, 2022 - CORRECT; (2) Combined back-up credit facility capacity of $3.0 billion - CORRECT; (3) Percentage calculation of 33% ($1.0B / $3.0B) - CORRECT and properly computed. The answer successfully synthesizes multi-hop information by combining the commercial paper borrowing amount with the back-up facility capacity to make a meaningful comparison. The LLM correctly identifies that borrowings were fully covered by available capacity. Minor omission: The original answer provides additional detail about the composition of the $3.0 billion capacity (five-year $2.0 billion facility plus 364-day $1.0 billion facility), which the LLM answer does not include. However, this compositional detail is not essential to answering the core question about total capacity and comparison. The LLM's presentation is clear and directly addresses both parts of the multi-part question. All numeric values are accurate, calculations are correct, and the reasoning is sound. The slight deduction reflects the omission of the facility breakdown detail, though this does not materially affect the correctness of the answer to the stated question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 367,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "Amgen's total revenue from sales to BeiGene in 2023 was **$125 million**, and the company incurred **$40 million** in profit and loss sharing expenses related to these products during the same year. These figures are detailed in the \"BeiGene, Ltd.\" section of the 10-K filing (page 131).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: Both key financial figures are correct - $125 million in revenue from sales to BeiGene and $40 million in profit and loss sharing expenses in 2023. The answer directly addresses both parts of the multi-part question. (2) QUANTITATIVE ACCURACY: All numbers match the ground truth exactly. The dollar amounts are presented in the same format ($125 million, $40 million) as the original answer, with no calculation errors. (3) QUALITATIVE ACCURACY: The answer correctly identifies Amgen as the subject company, BeiGene as the counterparty, 2023 as the fiscal year, and properly distinguishes between revenue and profit/loss sharing expenses. The multi-hop synthesis is sound - the model correctly combined information about both revenue and expense metrics for the same business relationship. (4) CONTEXTUAL RELEVANCE: The answer is appropriately focused on the specific question asked and provides the exact information requested. The addition of a page reference (page 131) adds helpful context without detracting from accuracy. The only minor observation is that the page reference, while helpful, is not part of the ground truth answer, but this represents an enhancement rather than an error. Overall, this is a well-executed response that accurately synthesizes multi-hop financial information from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 384,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was **$1,645 million** (from $1,241 million in 2023 to $2,886 million in 2024). The valuation method for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023, involved using **quoted prices on the active exchange identified as the principal market** for the underlying crypto assets (Level 2 fair value measurement). Since no safeguarding loss events occurred in 2023, the liability and asset were recorded at the same value, reflecting fair value based on observable market inputs.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN VALUATION METHOD CLASSIFICATION: The LLM answer contains a fundamental factual error regarding the fair value measurement level. The LLM states the asset was valued using 'quoted prices on the active exchange identified as the principal market' which describes Level 1 fair value measurement (quoted prices in active markets). However, the ground truth explicitly states the asset was categorized under 'Significant Other Observable Inputs (Level 2)' - a different and lower level of fair value hierarchy. This is a material mischaracterization of the valuation methodology. QUANTITATIVE ACCURACY: The dollar amounts are correct ($1,241M in 2023, $2,886M in 2024, $1,645M increase). The calculation is accurate. QUALITATIVE ACCURACY ISSUES: (1) The LLM incorrectly identifies the fair value measurement level (Level 1 vs Level 2), which is a core part of the question asking how the increase 'relates to the valuation method.' (2) The LLM adds unsupported information about 'no safeguarding loss events occurred in 2023' which is not in the ground truth and appears to be fabricated reasoning. (3) The LLM's explanation of Level 2 as 'quoted prices on the active exchange' is incorrect - Level 2 uses 'other observable market data' not active market quotes (which is Level 1). MULTI-HOP REASONING: The LLM failed to correctly synthesize the relationship between the liability increase and the asset's Level 2 valuation methodology. The ground truth establishes that the liability tracks the asset's valuation which uses Level 2 inputs. The LLM misidentified this as Level 1. CONTEXTUAL RELEVANCE: While the answer addresses the question structure, it provides incorrect information about the core valuation method, making it contextually misleading despite correct dollar amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 488,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "As of December 31, 2024, UnitedHealth Group had **48 million shares** available for future grants under its 2020 Stock Incentive Plan. The plan explicitly references **stock options, restricted shares, restricted stock units (RSUs), performance-based RSUs, and deferred stock units** as types of share-based awards. These details are outlined in the \"Share-Based Compensation\" section (Page 63) and supported by exhibit descriptions in the document.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The quantitative answer is completely accurate - 48 million shares available for future grants as of December 31, 2024 is correct. (2) The date and company identification are correct. (3) The core share count is properly formatted and matches ground truth exactly. (4) The answer correctly identifies multiple types of share-based awards referenced in the plan. WEAKNESSES: (1) The LLM answer includes 'deferred stock units' and 'restricted shares' which are not explicitly mentioned in the ground truth answer. The ground truth specifically references 'Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards.' (2) While the LLM mentions 'stock options' (which aligns with Non-Qualified Stock Option Awards), the inclusion of 'deferred stock units' and 'restricted shares' as separate categories goes beyond what the ground truth explicitly states. (3) The reference to 'Page 63' and exhibit descriptions adds specificity not present in the ground truth, which could be accurate but cannot be verified against the provided ground truth. MULTI-HOP REASONING: The answer correctly synthesizes the share count with the types of awards, addressing both parts of the multi-part question. However, the types of awards listed diverge from the ground truth's explicit references. The ground truth is more conservative in listing only the explicitly referenced award types from form agreements, while the LLM expands this list. This represents a minor but notable discrepancy in completeness and accuracy of the award types enumerated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 439,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "The remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028 is **$1 billion**. This compares to the **$129 million** in revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner, as noted in the 2024 Form 10-K. The $1 billion represents significantly higher contracted revenue for future periods compared to the 2024 true-up adjustment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses all components of the multi-hop question. (1) QUANTITATIVE ACCURACY: Both key figures are correct - $1 billion in remaining contracted revenue for 2025-2028 deliveries and $129 million from the 2024 one-time sales true-up settlement. The numbers match the ground truth exactly with proper formatting. (2) COMPLETENESS: The answer addresses all parts of the question: identifies the remaining contracted revenue amount, specifies the time period (2025-2028), identifies the 2024 comparison figure, and explains the relationship between the two amounts. (3) ENTITY ACCURACY: Correctly identifies Pfizer as the company, Paxlovid as the product, the specific time periods (2025-2028 and 2024), and the nature of the 2024 transaction (one-time sales true-up settlement with a commercialization partner). (4) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - combining future contracted revenue expectations with a specific 2024 transaction and making the appropriate comparison. The logic is sound: the $1 billion future revenue is correctly characterized as 'significantly higher' than the $129 million 2024 adjustment. (5) SEMANTIC EQUIVALENCE: The wording is clear and professional, conveying the same information as the ground truth while adding helpful context (reference to 2024 Form 10-K). Minor note: The LLM uses 'true-up adjustment' in the final sentence while the original uses 'true-up settlement agreement' - both are semantically equivalent descriptions of the same transaction. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 451,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "The parental guarantee from Berkshire Hathaway Inc. covers the ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, as stated in the document. However, the exact amount of reserves covered by the guarantee is not explicitly quantified in the provided text. The guarantee secures NICO's obligations, with the consideration paid under the agreement deposited into a collateral trust account. While the document mentions the deferred gain liability and collateral details, it does not specify a numerical value for the guarantee's coverage of the ceded reserves. Thus, the guarantee ensures coverage of the ceded loss reserves, but the precise amount is not detailed in the text. \n\n**Answer:** The parental guarantee from Berkshire Hathaway Inc. covers the ceded loss reserves under the 2017 agreement, but the exact amount is not specified in the provided documents.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to provide the key factual information requested. (1) CRITICAL ERROR - Quantitative Accuracy: The ground truth clearly states that $12.4 billion in ceded loss reserves were covered by the Berkshire Hathaway parental guarantee as of December 31, 2023. The LLM explicitly states 'the exact amount of reserves covered by the guarantee is not explicitly quantified in the provided text' and concludes 'the exact amount is not specified in the provided documents.' This is factually wrong - the answer should have provided the $12.4 billion figure. (2) Multi-hop Reasoning: The question requires synthesizing three pieces of information: (a) AIG's ceded loss reserves under the 2017 NICO agreement, (b) the amount as of December 31, 2023, and (c) the coverage by Berkshire Hathaway's parental guarantee. The LLM failed to complete this synthesis and instead claimed the information was unavailable. (3) Entity Accuracy: While the LLM correctly identified AIG, NICO, Berkshire Hathaway, and the 2017 agreement, it failed to extract the critical quantitative data point. (4) The LLM's hedging language ('not explicitly quantified,' 'not specified') suggests the model either lacked access to the correct source documents or failed to extract available information. The ground truth demonstrates this information was available and should have been provided. This is a clear case where the LLM provided an incomplete and incorrect answer when a specific numerical answer existed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 419,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "PayPal purchased approximately $1.8 billion in credit receivables for its merchant finance offerings in both the years ended December 31, 2021 and 2020. As of December 31, 2021, the outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of participation interest sold. The difference between the purchased amount and the outstanding balance reflects charge-offs, recoveries, and the reduction from participation interest sold to WebBank ($63 million in 2021).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $1.8 billion in credit receivables purchased for both 2021 and 2020, $1.4 billion outstanding balance as of December 31, 2021, and $63 million participation interest sold to WebBank. The answer correctly addresses all parts of the multi-part question: (1) total credit receivables purchased in both years, (2) outstanding balance as of year-end 2021, and (3) the relationship between these figures. The LLM demonstrates sound multi-hop reasoning by synthesizing information across multiple data points and explaining the reconciliation between purchased amounts and outstanding balances through charge-offs, recoveries, and participation interest sold. The explanation of why the outstanding balance is lower than purchased amounts (charge-offs, recoveries, and participation interest) shows logical understanding of the underlying business dynamics. The only minor distinction from the ground truth is that the LLM answer phrases the relationship slightly differently ('The difference between the purchased amount and the outstanding balance reflects...') rather than stating it as 'PayPal maintains a significant portion of the credit risk,' but this is semantically equivalent and arguably more specific. All numbers, dates, and entities are correctly identified and presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 382,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "Costco's Japanese subsidiary issued a total of approximately **$500** in Guaranteed Senior Notes in November 2023. By July 2024, **$77** of this debt had been repaid.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains severe quantitative errors that make it fundamentally incorrect. (1) UNIT OMISSION - The LLM states '$500' and '$77' without specifying 'million', which is a critical omission. The ground truth clearly states '$500 million' and '$77 million'. While the numeric values 500 and 77 are correct, omitting 'million' changes the magnitude by a factor of 1,000,000, making the answer misleading and factually incorrect. (2) QUANTITATIVE ACCURACY - The numbers themselves (500 and 77) are correct, but the missing unit designation is a fundamental error in financial reporting. In financial contexts, omitting 'million' when discussing debt issuance is not a minor formatting variationit's a material error that could be misinterpreted as $500 and $77 respectively, rather than $500 million and $77 million. (3) MULTI-HOP REASONING - The model correctly identified both components of the multi-part question (issuance amount and repayment amount) and synthesized information appropriately, which is positive. (4) ENTITY ACCURACY - Costco's Japanese subsidiary, November 2023 issuance, and July 2024 repayment timeline are all correctly identified. The term 'Guaranteed Senior Notes' is correctly used. (5) CONTEXTUAL RELEVANCE - The answer addresses the question appropriately in structure and scope. The primary failure is the critical omission of the 'million' unit designation, which is unacceptable in financial reporting and makes the answer materially incorrect despite having the right numeric values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 424,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $44 million (from $53 million in 2021 to $9 million in 2022). The net gains realized from these investments during the same period were $9 million. Thus, the decrease in value exceeded the net gains realized by **$35 million**. \n\n**Answer:** The decrease in the value of available-for-sale debt investments exceeded the net gains realized by $35 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. (1) CRITICAL ERRORS: The LLM states the decrease in available-for-sale debt investments was $44 million, but the ground truth shows it was $3,259 million - a massive discrepancy of $3,215 million. The LLM also misidentifies what the $44 million represents (claiming it's the change in investment value when it actually represents the change in net gains). (2) CALCULATION VERIFICATION: The LLM's final answer of $35 million is completely wrong. The correct calculation should be: $3,259 million (decrease in investment value) minus $44 million (decrease in net gains) = $3,215 million. The LLM appears to have confused different financial metrics entirely. (3) MULTI-HOP REASONING: The LLM failed to properly synthesize the two required pieces of information: (a) the decrease in available-for-sale debt investment values from 2021 to 2022, and (b) the change in net gains realized. Instead, it conflated these metrics and used incorrect source numbers. (4) ENTITY/METRIC CONFUSION: The LLM seems to have mixed up what metrics represent what - treating the $44 million figure as the investment value decrease when it actually represents the net gains change. The answer demonstrates fundamental misunderstanding of the question's requirements and contains no correct numerical values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 375,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "The total unused short-term credit capacity available to Amazon as of December 31, 2021, combining its $7.0 billion unsecured revolving credit facility (with no borrowings outstanding) and $7.2 billion in unused letters of credit, is **$14.2 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. Verification of key elements: (1) Unsecured revolving credit facility: $7.0 billion - CORRECT, matches ground truth exactly; (2) Unused letters of credit: $7.2 billion - CORRECT, matches ground truth exactly; (3) No borrowings outstanding under Credit Agreement - CORRECT, explicitly stated and matches ground truth; (4) Total calculation: $7.0B + $7.2B = $14.2B - CORRECT, arithmetic is accurate; (5) Date: December 31, 2021 - CORRECT, matches question and ground truth; (6) Company: Amazon - CORRECT, properly identified. The LLM successfully synthesized information across multiple components (revolving credit facility + letters of credit) to arrive at the correct total. The answer is well-structured, clearly presents both components and their values, explains the reasoning (no borrowings outstanding), and provides the correct final answer. All numeric values match the ground truth precisely, and the multi-hop reasoning connecting the two credit sources to the total is sound and clearly explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 312,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "The total cash outflow for acquisitions in 2023 was **$3.61 billion**, with **$2.70 billion** specifically allocated to the acquisition of The Binding Site Group. This is detailed in the \"Investing Activities\" section of Page 24, which states that acquisitions of The Binding Site Group and CorEvitas, LLC used $2.70 billion and $0.91 billion, respectively.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: (1) Total cash outflow for acquisitions in 2023: $3.61 billion - matches ground truth exactly; (2) The Binding Site Group acquisition: $2.70 billion - matches ground truth exactly; (3) The LLM correctly identifies the additional acquisition detail (CorEvitas, LLC for $0.91 billion), which when summed ($2.70B + $0.91B = $3.61B) validates the total and demonstrates sound multi-hop reasoning. The answer properly synthesizes information across the filing, correctly identifying the source (Investing Activities section, Page 24) and providing context about multiple acquisitions. The answer addresses all parts of the multi-part question: total cash outflow amount, specific allocation to The Binding Site Group, and supporting detail. Number formatting is consistent and clear. The only minor consideration is that the LLM provides additional information (CorEvitas acquisition details) beyond what was strictly asked, though this actually strengthens the answer by providing verification of the total. No calculation errors, no entity confusion, and the semantic meaning perfectly aligns with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 340,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Union Pacific leases 36.6% of its chassis units (17,705 out of 48,340 total) and 1.14% of its containers (545 out of 47,984 total). This indicates a significantly higher proportion of chassis units are leased compared to containers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Verification of key numbers: (1) Chassis leased percentage: 17,705 / 48,340 = 0.3663 = 36.6%  (2) Containers leased percentage: 545 / 47,984 = 0.01136 = 1.14%  (3) All unit counts are correct: 17,705 leased chassis, 48,340 total chassis, 545 leased containers, 47,984 total containers. The LLM correctly synthesized the multi-hop comparison between chassis and container leasing proportions. The only minor difference from ground truth is the container percentage is stated as 1.14% rather than 1.1% - this is actually MORE precise (1.136% rounds to 1.14%), though ground truth rounded to 1.1%. This is not an error but rather a rounding choice difference. The LLM properly identified the key insight that chassis have significantly higher leasing reliance (36.6%) compared to containers (1.14%), demonstrating sound reasoning across the multi-hop synthesis. All entities (Union Pacific, chassis, containers, highway revenue equipment) are correctly identified. The answer is complete, addressing both the specific percentages and the comparative analysis requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 329,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "The referenced exhibits identify **two** supplemental indentures related to Senior Notes that include the 2035 Note: the **Fifth Supplemental Indenture** (dated September 14, 2015) and the **Tenth Supplemental Indenture** (dated November 20, 2024). The most recent agreement involved **Computershare Trust Company, National Association** as trustee.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the two supplemental indentures (Fifth Supplemental Indenture dated September 14, 2015, and Tenth Supplemental Indenture dated November 20, 2024) with accurate dates and the correct trustee (Computershare Trust Company, National Association). All numeric values and dates are factually correct. The answer successfully synthesizes multi-hop information by identifying both indentures and determining which trustee was involved in the most recent agreement. However, the LLM answer omits the additional contextual detail that Computershare Trust Company, National Association is the successor to Wells Fargo Bank, which was included in the ground truth answer. This is a minor omission that doesn't affect the core correctness of the answer but represents a slight loss of completeness. The answer directly addresses all parts of the multi-part question: (1) the number of supplemental indentures (two), (2) their identification (Fifth and Tenth), and (3) the trustee in the most recent agreement (Computershare Trust Company, National Association). The reasoning is sound and the information is presented clearly and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 330,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "The expensing methodology for non-employee director deferred stock units granted in 2023 differs from prior awards (pre-2022) by expensing them on a straight-line basis over the requisite service period (aligned with vesting timelines), whereas pre-2022 awards vested immediately and were expensed on the grant date. For 2023 awards, vesting occurs on the earlier of the first anniversary of the grant date or the day preceding the next Annual Meeting of Shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) CORRECTNESS: All factual information matches the ground truth. The expensing methodology comparison is correct: 2023 awards use straight-line basis over requisite service period vs. pre-2022 awards expensed on grant date with immediate vesting. The vesting timeline for 2023 awards is accurately stated as the earlier of first anniversary of grant date or day preceding next Annual Meeting of Shareholders. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this criterion is not applicable. All dates and temporal references are correct. (3) ENTITY ACCURACY: Non-employee director deferred stock units are correctly identified; years (2023, pre-2022) are properly referenced; the distinction between award cohorts is clear and accurate. (4) REASONING: The multi-hop synthesis is sound - the answer correctly connects the expensing methodology to the vesting schedule and explains the causal relationship (straight-line expensing aligns with vesting timelines). The comparison between 2023 and pre-2022 awards is logically structured. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical meaning to the ground truth with slightly different wording. The phrase 'aligned with vesting timelines' in parentheses adds helpful context without introducing inaccuracy. Minor note: The ground truth mentions 'subject to acceleration in certain circumstances' which the LLM answer omits, but this is a minor detail that doesn't affect the core answer to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 437,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was **$254 million**. However, the provided document pages do not include data on total identifiable assets for this specific region and business unit, making it impossible to calculate the required percentage.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is partially correct but fundamentally incomplete. CORRECT ELEMENTS: (1) The operating profit figure of $254 million is accurate. INCORRECT/MISSING ELEMENTS: (1) The LLM claims that identifiable assets data is not available in the provided documents, but according to the ground truth, the identifiable assets were $698 million for this region and business unit. This is a critical omission that prevents the LLM from completing the multi-hop analysis. (2) The LLM failed to calculate or provide the percentage (36.4%) that represents the operating profit as a portion of identifiable assets. MULTI-HOP REASONING FAILURE: The question requires synthesizing three pieces of information: (a) operating profit amount, (b) identifiable assets amount, and (c) calculating the percentage relationship. The LLM successfully identified (a) but failed to locate or synthesize (b) and (c). This represents a failure in the core multi-hop synthesis task. The LLM's claim that data is unavailable contradicts the ground truth, suggesting either a document access issue or incomplete information retrieval. For a multi-hop financial question, providing only 1 of 3 required data points (33% completion) with an incorrect assertion about data availability significantly undermines the answer's value. The answer demonstrates partial competence (correct on one number) but fails the primary objective of answering the complete question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 398,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV totaled **$1.7 billion**, and resales to the JV amounted to **$121 million**. The loan provided to the ATMP JV during the same year was **$100 million**. Thus, the combined purchases and resales ($1.821 billion) significantly exceed the loan amount ($100 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: purchases of $1.7 billion, resales of $121 million, combined total of $1.821 billion, and loan amount of $100 million. The calculation of the combined total ($1.7B + $121M = $1.821B) is accurate. The comparison between the combined purchases/resales ($1.821 billion) and the loan ($100 million) is correctly characterized as 'significantly exceed.' The answer properly identifies all entities (AMD, ATMP JV) and the fiscal year (2024). The multi-hop reasoning is sound - the model correctly synthesized information about three separate financial transactions and made the appropriate comparison. The only minor distinction from the ground truth is that the LLM answer does not explicitly mention 'October 2024' as the timing of the loan, though this is a minor contextual detail that doesn't affect the core answer's accuracy. The wording is clear and the semantic meaning matches the ground truth perfectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 289,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021 was **$156 million** ($2,620 million in 2021 - $2,464 million in 2019). In contrast, the Research and medical products segment saw a much larger increase of **$11,290 million** ($24,802 million in 2021 - $13,512 million in 2019). The Research and medical products segment's growth was significantly higher, reflecting a much greater expansion compared to the Analytical and physical instrumentation line.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All numerical values match the ground truth exactly: (1) Analytical and physical instrumentation increase of $156 million ($2,620M in 2021 vs $2,464M in 2019) - calculations verified as correct; (2) Research and medical products increase of $11,290 million ($24,802M in 2021 vs $13,512M in 2019) - calculations verified as correct. The multi-hop reasoning is sound, correctly synthesizing information across two different product lines/segments and comparing their growth rates. The answer properly addresses both parts of the question: the specific revenue increase for each segment and the comparative analysis showing that Research and medical products grew significantly more than Analytical and physical instrumentation. The wording is clear and the conclusion appropriately characterizes the relative magnitude of growth between the two segments. No factual errors, calculation errors, or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 282,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "Microsoft's SQL Server product line contributes to the Intelligent Cloud segment's financial performance by being a core component of the **Server Products and Cloud Services** category, which generated $67.3 billion in revenue in 2022 (Page 96). As a key server product, SQL Server drives revenue through volume licensing, OEM partnerships, and cloud integration with Azure, aligning with the segment's focus on hybrid cloud solutions and enterprise database needs. Its inclusion in the segment's revenue streams directly supports the Intelligent Cloud's growth and profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies SQL Server as a core component of the Intelligent Cloud segment and accurately describes its revenue drivers (volume licensing, OEM partnerships, cloud integration with Azure). The qualitative reasoning about SQL Server's role in hybrid cloud solutions and enterprise database needs is sound and relevant. However, there is a significant quantitative issue: the LLM cites '$67.3 billion in revenue in 2022' for 'Server Products and Cloud Services' category, but this number cannot be verified against the ground truth and appears to conflate the entire Intelligent Cloud segment revenue with a specific product category. The ground truth does not provide this specific $67.3B figure for Server Products and Cloud Services alone. Additionally, the LLM answer omits an important detail from the ground truth: the specific mention of Client Access Licenses (CALs) as a revenue mechanism that provides access rights to server products and is reported alongside server product revenue. The answer also lacks the explicit mention of retail packaged products as a distribution channel. The multi-hop reasoning is partially completeit connects SQL Server to the Intelligent Cloud segment and identifies key revenue drivers, but it doesn't fully synthesize the complete revenue structure (volume licensing, OEM, retail, and CALs) as comprehensively as the ground truth. The citation to 'Page 96' suggests source documentation but the specific figure needs verification. Overall, the core conceptual understanding is correct, but the quantitative claim and some structural details are incomplete or potentially inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 451,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The total change in value of Insurance Buy-in Contracts from December 31, 2022 ($950 million), to December 31, 2024 ($1,390 million) is a **decrease of $440 million**. This reflects a **$655 million increase** from 2022 to 2023 and a **$215 million decrease** from 2023 to 2024, as shown in the fair value changes table on page 110.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental mathematical contradiction that makes it factually incorrect. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the total change is a 'decrease of $440 million' when calculating $1,390M - $950M = $440M. This is mathematically wrong. A change from $950M to $1,390M is an INCREASE of $440M, not a decrease. The ground truth correctly identifies this as a net increase of $440 million. (2) CORRECT ELEMENTS: The LLM does correctly identify the three year-end balances ($950M in 2022, $1,605M in 2023, $1,390M in 2024) and correctly calculates the year-over-year changes ($655M increase from 2022-2023 and $215M decrease from 2023-2024). (3) MULTI-HOP REASONING: While the LLM successfully synthesizes information across the three time periods and provides the intermediate year balance, the fundamental error in characterizing the overall change as a 'decrease' when it is actually an 'increase' represents a critical failure in reasoning and mathematical accuracy. (4) SEMANTIC EQUIVALENCE FAILURE: This is not a wording issuethe LLM explicitly states the opposite direction of change from what the numbers demonstrate. Saying a change from $950M to $1,390M is a 'decrease' is factually incorrect regardless of wording variations. The ground truth answer is clear and correct; the LLM answer contradicts its own calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 383,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "The total value of TI common stock held in U.S. and non-U.S. defined contribution plans as of December 31, 2024, was **$852 million (U.S.) + $34 million (non-U.S.) = $886 million**. Dividends paid on these shares during 2024 totaled **$26 million**, as dividends from non-U.S. plans were not material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. (1) CORRECTNESS: Both key figures match the ground truth exactly - $886 million total value and $26 million in dividends paid during 2024. The breakdown showing $852 million (U.S.) + $34 million (non-U.S.) = $886 million is mathematically accurate and provides helpful detail. (2) QUANTITATIVE ACCURACY: All numbers are correct. The arithmetic is sound: $852M + $34M = $886M. The dividend figure of $26 million matches ground truth. (3) MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two dimensions - geographic split (U.S. vs. non-U.S.) and temporal (as of December 31, 2024 vs. during 2024). The model properly combined the U.S. and non-U.S. plan values to reach the total. (4) ADDITIONAL CONTEXT: The LLM provided supplementary information noting that 'dividends from non-U.S. plans were not material,' which adds reasonable context without contradicting the ground truth. This suggests the $26 million figure represents the material dividend payments. (5) MINOR CONSIDERATION: The ground truth answer provides the total without the geographic breakdown, while the LLM provides both the breakdown and total. This is additive information that enhances rather than detracts from the answer. The answer fully addresses both parts of the multi-part question (total value and dividends paid).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 383,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K was **$1,250 million**. This amount is **exactly half** of the combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes, which totaled **$2,250 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN COMPARISON CALCULATION: The LLM states the 5.300% Senior Notes ($1,250 million) are 'exactly half' of the combined principal of the other three notes ($2,250 million). This is mathematically incorrect. $1,250M is NOT half of $2,250M (half would be $1,125M). The correct comparison is that $1,250M represents approximately 55.6% of $2,250M, as stated in the ground truth. The LLM correctly identified all individual principal amounts ($1,250M, $1,000M, $750M, $500M) and correctly calculated the combined total of $2,250M, but made a fundamental arithmetic error in the comparative analysis. The LLM also failed to provide the correct percentage calculation (55.6%) that was included in the ground truth answer. While the LLM addressed all parts of the question and correctly identified the entities and years, the core comparison metric is wrong, which is a significant factual error in a financial analysis context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 279,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "The total weighted-average grant-date fair value of all Service-Based RSUs outstanding at the beginning of 2024 and still outstanding at the end of 2024 is **$183.41** (as of December 31, 2024), as reported in Table 10.1 of Note 10 in the 2024 10-K filing. This figure accounts for grants, vesting, and forfeitures during the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly matches the ground truth. (1) QUANTITATIVE ACCURACY: The key figure of $183.41 million is correct and properly formatted. The answer correctly identifies this as the total weighted-average grant-date fair value of Service-Based RSUs. (2) COMPLETENESS: The answer fully addresses the multi-part question by identifying RSUs that were outstanding at both the beginning and end of 2024, and explicitly states that the figure accounts for grants, vesting, and forfeitures during the year. (3) ENTITY ACCURACY: All entities are correct - Service-Based RSUs, 2024 fiscal year, December 31, 2024 end date, and proper reference to the 10-K filing. (4) REASONING: The multi-hop synthesis is sound - the answer correctly identifies that the $183.41 million represents RSUs that persisted through the entire year after accounting for all activity (grants, vesting, forfeitures). (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, with slightly more detail about the source (Table 10.1 of Note 10) which adds credibility without contradicting the core answer. Minor note: The LLM includes parenthetical reference to the filing source which, while helpful, is not explicitly required by the question, but this is a strength rather than a weakness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 370,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS's estimation process for uncertain tax positions involves a two-step evaluation: first, determining if a tax position is more likely than not to be sustained upon audit, and second, measuring the largest tax benefit likely to be realized. Changes in these estimates can result in adjustments to the tax provision, either recognizing benefits or incurring additional charges. The measurement criteria rely on probabilistic assessments of audit outcomes and the most likely settlement amounts, with quarterly reevaluations considering factors like tax law changes and audit progress.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of UPS's uncertain tax position estimation process and correctly identifies the core two-step evaluation framework. The answer accurately captures: (1) the first step of determining if a position is 'more likely than not' to be sustained on audit, (2) the second step of measuring the largest tax benefit likely to be realized, and (3) the quarterly reevaluation process based on changing circumstances. The LLM correctly notes that adjustments can result in either recognizing benefits or recording additional charges to the tax provision. The answer appropriately references probabilistic assessments and settlement amounts as measurement criteria. No quantitative errors are present (no specific numbers were required in this question). The main minor weakness is that the LLM answer could have been slightly more explicit about the specific mechanism of recording the difference between recognizable benefits and total claimed benefits as a liability, which is mentioned in the ground truth. The LLM's phrasing of 'adjustments to the tax provision' is semantically equivalent but slightly less precise than the ground truth's explicit reference to recording the difference as a liability. The answer demonstrates solid multi-hop reasoning by synthesizing information from both financial statement notes and management discussion sections as requested. Overall, the answer is substantially correct and complete, with only minor omissions in specificity regarding the liability recording mechanism.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 426,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "The total capital expenditure in Africa/Eurasia in 2021 was **$33 million**, as stated in the \"Capital expenditures\" table on page 117. Organic sales in this region increased by **7.0%** in 2021, as noted in the discussion on page 43.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE ACCURACY: Both key numeric values are correct - $33 million for capital expenditure and 7.0% for organic sales growth in Africa/Eurasia for 2021. These match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the question comprehensively - it provides the capital expenditure figure and the organic sales increase percentage. (3) ENTITY ACCURACY: All entities are correctly identified - the region (Africa/Eurasia), the year (2021), and the metrics (capital expenditure and organic sales growth). (4) MULTI-HOP REASONING: The answer correctly synthesizes information from two different sources (capital expenditures table on page 117 and discussion on page 43), demonstrating proper multi-hop reasoning across the filing. (5) SEMANTIC EQUIVALENCE: The wording is clear and directly matches the ground truth information. The answer even provides helpful source citations (page numbers) which adds credibility without detracting from accuracy. No calculation errors, no missing information, and all facts are verifiable against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1096,
        "completion_tokens": 332,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by 14.9% from $2,994 million in 2020 to $3,440 million in 2021. This growth, along with market recovery and new product gains in the Vision franchise, contributed to the Vision segment's overall 19.6% sales increase from $3,919 million to $4,688 million during the same period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: All financial numbers are factually correct. Contact Lenses/Other sales figures ($2,994M in 2020 to $3,440M in 2021) are accurate. Vision segment sales figures ($3,919M to $4,688M) are accurate. The percentage calculations are correct: 14.9% growth for Contact Lenses/Other [(3,440-2,994)/2,994 = 14.9%] and 19.6% for Vision segment [(4,688-3,919)/3,919 = 19.6%]. WEAKNESSES: The LLM answer fails to directly address the core analytical requirement of the question. The ground truth explicitly calculates that Contact Lenses/Other sales increase of $446M accounted for approximately 58% of the total Vision segment growth of $769M. The LLM answer mentions the $446M increase implicitly (through the percentage) but does NOT provide the key metric: the absolute dollar contribution ($446M) or the percentage contribution (58%) that Contact Lenses/Other represented of total segment growth. Instead, the LLM provides percentage growth rates, which are mathematically correct but don't directly answer 'how did this growth contribute to the overall increase.' The LLM also adds contextual information about 'market recovery and new product gains' which, while potentially relevant, is not grounded in the specific numbers provided and represents speculation beyond the quantitative facts. MULTI-HOP REASONING: The LLM correctly synthesizes data across two metrics (Contact Lenses/Other and Vision segment) but fails to complete the final analytical step of determining the proportional contribution. This is a significant gap in addressing the second part of the question about contribution to overall growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 443,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "The consolidation of AspenTech into Emerson's financial statements in 2022 (via the Heritage AspenTech acquisition) positively impacted the Control Systems & Software segment's 2023 earnings compared to 2022, with earnings increasing by 21% ($437 to $529). However, margins declined 3.1 percentage points to 11.6%, primarily due to $249 of incremental intangibles amortization from the acquisition. This amortization, along with other acquisition-related costs, negatively affected margin performance in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent the impact of AspenTech's consolidation:\n\n1. DIRECTIONAL ERROR - CRITICAL: The LLM states AspenTech 'positively impacted' earnings in 2023, when the ground truth shows it had a devastating negative impact. AspenTech went from $12M earnings in 2022 to a $107M loss in 2023 - a $119M deterioration. This is the opposite of 'positive impact.'\n\n2. MISSING KEY NUMBERS: The LLM completely omits the critical AspenTech earnings figures ($12M in 2022, $107M loss in 2023) that are central to understanding the consolidation's impact. These numbers directly explain why segment earnings remained flat despite revenue growth.\n\n3. INCORRECT EXPLANATION: The LLM attributes margin decline primarily to '$249 of incremental intangibles amortization,' but the ground truth clearly identifies AspenTech's $107M loss as the primary driver of the 3.1 percentage point margin decline. While amortization may be a contributing factor, it is not presented as the primary cause in the ground truth.\n\n4. INCOMPLETE ANALYSIS: The LLM fails to explain the paradox that segment earnings remained flat ($529M in both years per ground truth, though LLM states $437 to $529 growth) despite revenue growth - which is directly explained by AspenTech's poor performance offsetting other segment gains.\n\n5. SEGMENT EARNINGS DISCREPANCY: The LLM states earnings 'increased by 21% ($437 to $529)' but the ground truth indicates 2022 earnings were $437M and 2023 were $529M, which is technically a 21% increase. However, this masks the critical point that this flat/modest growth occurred DESPITE revenue growth, because AspenTech's $119M deterioration offset other gains.\n\n6. CORRECT ELEMENTS: The LLM correctly identifies the 3.1 percentage point margin decline to 11.6%, and correctly notes the acquisition occurred in 2022.\n\nThe fundamental issue is that the LLM presents an incomplete and misleading narrative that obscures AspenTech's severely negative impact on segment performance, which is the core answer to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 564,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation, specifically related to the interchange multidistrict litigation. This liability is recovered under the U.S. Retrospective Responsibility Plan through a downward adjustment to the conversion rate of class B common stock into class A common stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The $861 million liability amount is correct, the fiscal year (2022) is correct, and the recovery mechanism (downward adjustment to conversion rate of class B to class A common stock) is accurately described. (2) QUANTITATIVE ACCURACY: The $861 million figure is precisely correct with no calculation errors or discrepancies. (3) QUALITATIVE ACCURACY: The LLM correctly identified all entities (Visa, U.S. covered litigation, U.S. Retrospective Responsibility Plan, class B/A common stock conversion) and synthesized the multi-hop information appropriately. The addition of context about 'interchange multidistrict litigation' provides helpful specificity without contradicting the ground truth. (4) MULTI-HOP REASONING: The answer properly connects the liability amount to the recovery mechanism, demonstrating sound synthesis across the question's two components. (5) SEMANTIC EQUIVALENCE: The wording 'converted into' vs 'to' is a minor stylistic variation with no impact on meaning. The answer is semantically equivalent to the ground truth while being slightly more detailed. No material omissions or errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 350,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "The total financial impact of Pfizer's historical ownership of Meridian in 2021 included a **$345 million pre-tax charge** in the second quarter related to a legal matter and an **$167 million after-tax loss** in the fourth quarter from the sale of Meridian. These adjustments directly affected the company's financial results for 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified both key financial figures ($345 million pre-tax charge in Q2 and $167 million after-tax loss in Q4) and properly attributed them to the correct quarters and events (legal matter and sale of Meridian). The numbers are accurate and the temporal sequencing is correct. CRITICAL WEAKNESS: The LLM failed to synthesize the complete answer to the question. The ground truth explicitly states the 'total financial impact' was a '$512 million negative impact' - this is the sum of the two components ($345M + $167M = $512M). The LLM provided the component parts but did not calculate or state the total combined impact, which was the core ask of the question. The question specifically asks for 'total financial impact...including both operational results and post-closing adjustments,' requiring synthesis of both figures into a single total. QUANTITATIVE ACCURACY: Both individual numbers are correct (7/10 - would be higher but missing the critical total calculation). QUALITATIVE ACCURACY: The reasoning identifies the correct events and quarters but fails at the synthesis step required for a multi-hop question (5/10). CONTEXTUAL RELEVANCE: The answer is relevant and addresses the Meridian ownership impact in 2021, but incompletely (7/10). The LLM essentially provided a list of components rather than the synthesized total answer that was requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 386,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of **3.0% plus a 2.0% leverage buffer**, totaling **5.0%**, to avoid restrictions on capital distributions and bonus payments. Its insured depository institution subsidiaries, however, are required to maintain a **minimum SLR of 6.0%** to be considered \"well capitalized\" under the PCA framework. The difference lies in the regulatory thresholds: the Corporations requirement includes a leverage buffer, while subsidiaries higher SLR is tied to PCA capital adequacy standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative values are correct: Bank of America Corporation's minimum SLR of 3.0% plus 2.0% leverage buffer totaling 5.0%, and the insured depository institution subsidiaries' requirement of 6.0%. The multi-hop synthesis is sound - the answer correctly identifies and compares the requirements for both the parent company and subsidiaries, explaining the regulatory framework (PCA) and the purpose of the requirements (avoiding restrictions on capital distributions and bonus payments). The explanation of the difference between the two requirements is clear and accurate: the Corporation's requirement includes a leverage buffer component, while the subsidiaries' higher threshold is tied to PCA well-capitalized standards. The wording is slightly different from the ground truth but semantically equivalent and arguably clearer in its explanation. The answer demonstrates proper understanding of Basel 3 regulatory requirements and their application across different entity types within the BofA corporate structure. No factual errors, calculation errors, or omissions of material information were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 331,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "The adoption of the credit loss guidance on January 1, 2020, required MetLife to recognize an allowance for credit losses (ACL) for mortgage loans at the time of purchase, based on expected lifetime credit loss, rather than waiting for losses to be incurred. Under the new guidance, ACL is established to reflect the portion of amortized cost not expected to be collected, incorporating judgments about past events, current conditions, and forecasted economic factors. This replaced the prior incurred loss model, which recognized credit losses only when it was probable that amounts due would not be collected. The timing of credit loss recognition shifted to a more forward-looking, proactive approach, impacting the accounting treatment of mortgage loans by requiring earlier and more comprehensive ACL provisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies all key elements: (1) The adoption date of January 1, 2020 is correct; (2) The shift from incurred loss model to expected loss model is accurately described; (3) The requirement to establish ACL at time of purchase based on expected lifetime credit losses is correct; (4) The timing change from recognizing losses only when probable to a forward-looking approach is accurately captured; (5) The description of ACL reflecting the portion of amortized cost not expected to be collected is correct and adds helpful detail. The LLM answer actually provides more comprehensive detail than the ground truth by explaining that ACL incorporates judgments about past events, current conditions, and forecasted economic factors, which is accurate and relevant context. No quantitative errors are present (no numbers to verify). The multi-hop reasoning is sound - the answer correctly synthesizes the accounting change and its impact on mortgage loan treatment. The only minor distinction is that the LLM answer is slightly more detailed and technical than the ground truth, but this represents an enhancement rather than an error. The semantic meaning is fully aligned with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 355,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime loss model under CECL. For **leveraged lease receivables**, the Company now estimates expected lifetime credit loss using a **probability of default and loss given default model**, incorporating third-party credit ratings, historical default data, and non-guaranteed residual value assessments. For **mortgage loans**, the ACL is calculated based on expected lifetime credit loss over the contractual term, adjusted for prepayments, using **discounted cash flow analysis** and considering past events, current, and forecasted economic conditions. The methodology involves pooling loans with similar risk characteristics and evaluating individually those with dissimilar risks, with inputs including credit ratings, historical data, and market forecasts.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly identifies the shift from incurred loss model to expected lifetime credit loss model (CECL) on January 1, 2020 - this is accurate; (2) Accurately describes the probability of default and loss given default model for leveraged lease receivables with correct inputs (third-party credit ratings, historical default data); (3) Correctly identifies the expected lifetime credit loss approach for mortgage loans with appropriate adjustments for prepayments; (4) Properly mentions consideration of past events and current/forecasted economic conditions; (5) No quantitative errors - all dates and model descriptions are accurate. MINOR ENHANCEMENTS IN LLM ANSWER: (1) The LLM adds 'non-guaranteed residual value assessments' for leveraged leases, which is a reasonable and likely accurate detail not explicitly mentioned in the ground truth but consistent with leveraged lease accounting; (2) The LLM specifies 'discounted cash flow analysis' for mortgage loans, which is a more detailed methodology than the ground truth provides; (3) The LLM adds information about pooling loans with similar risk characteristics and individual evaluation of dissimilar risks - this is standard CECL methodology and appropriate context. POTENTIAL CONCERNS: (1) The ground truth doesn't explicitly mention 'discounted cash flow analysis' for mortgage loans, though this is a standard approach under CECL; (2) The ground truth doesn't mention the pooling methodology, though this is standard practice. These additions appear to be reasonable elaborations consistent with CECL guidance rather than errors. The answer comprehensively addresses all parts of the multi-part question: timing (January 1, 2020), change in methodology (incurred to expected lifetime), specific models (PD/LGD for leases, DCF for mortgages), and inputs (credit ratings, historical data, economic conditions). The multi-hop synthesis is sound, correctly connecting the adoption date to the specific changes for each asset type.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 555,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments' structural cost advantage in manufacturing analog products using 300-millimeter wafers reduces per-unit production costs by approximately 40% compared to 200-millimeter wafers, enhancing gross margins (67.5% in 2021) and operational efficiency. This cost advantage, combined with fixed-cost spreading across higher output, strengthens profitability and cash flow generation, enabling significant shareholder returns through dividends and stock repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) Correctly identifies the 40% cost reduction per unpackaged chip using 300mm vs 200mm wafers - this matches the ground truth exactly. (2) Properly synthesizes the multi-hop connection: cost advantage  higher gross margins  stronger cash flow generation  shareholder returns. (3) Accurately mentions the gross margin figure of 67.5% in 2021, which provides concrete supporting evidence. (4) Correctly identifies the mechanism (fixed-cost spreading across higher output) that explains how the cost advantage translates to profitability. (5) Appropriately references TI's capital allocation strategy (dividends and stock repurchases) as manifestations of cash return capability. (6) All entities correctly identified (Texas Instruments, 300mm/200mm wafers, analog products). MINOR CONSIDERATIONS: (1) The ground truth emphasizes 'maximizing long-term free cash flow per share growth' as TI's stated objective, while the LLM answer focuses more on the mechanism and outcomes rather than explicitly stating this objective. However, the LLM's framing is semantically equivalent and actually more directly addresses the 'how' aspect of the question. (2) The ground truth mentions 'greater control over the supply chain' as an additional benefit, which the LLM answer doesn't explicitly state, though this is a relatively minor omission given the comprehensive coverage of the main mechanisms. QUANTITATIVE VERIFICATION: The 40% cost reduction figure is correct and properly contextualized. The 67.5% gross margin for 2021 is a specific, verifiable data point that strengthens the answer. MULTI-HOP REASONING: The answer successfully connects the structural cost advantage through manufacturing efficiency to financial outcomes (margins, cash flow, shareholder returns), demonstrating sound multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 509,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "The total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, was **$1,000 million**, while the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, had a value of **$500 million** as of the same date. Thus, the 1.5-Year notes were twice the value of the 2-Year notes. \n\n(Answer derived from Page 87 of TMO_10k_2022.pdf, which lists the December 31, 2021, balances for these specific debt instruments.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: (1) 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes valued at $1,000 million as of December 31, 2021 - CORRECT; (2) 2-Year Floating Rate (SOFR + 0.39%) Senior Notes due October 18, 2023, valued at $500 million as of December 31, 2021 - CORRECT; (3) The comparison calculation (1.5-Year notes are twice the value of 2-Year notes) is accurate and properly derived from the two values. The answer correctly identifies the company (TMO), the specific debt instruments with their exact interest rate spreads, the relevant date (December 31, 2021), and performs the multi-hop synthesis by comparing the two debt values. The citation to Page 87 of TMO_10k_2022.pdf adds credibility and demonstrates proper source attribution. The wording is clear and semantically equivalent to the ground truth. Minor deduction (1 point) only because the citation reference, while helpful, was not explicitly required by the question and could be considered supplementary rather than core to the answer itself. Overall, this is an excellent response that fully addresses the multi-part question with accurate numbers, proper entity identification, and sound comparative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 357,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "As of December 31, 2023, a total of **70 million shares** were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined. The **2020 Stock Incentive Plan** had **53 million shares** available, while the **ESPP** had **17 million shares** available, making the 2020 plan the larger of the two.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All numeric values match the ground truth exactly: 53 million shares under the 2020 Stock Incentive Plan, 17 million shares under the ESPP, and 70 million shares combined total. The date (December 31, 2023) is correct. The answer correctly identifies both plans by their full names and accurately addresses all parts of the multi-part question: (1) total shares available combined, (2) shares available under each plan separately, and (3) which plan had more shares available. The reasoning is sound - the model correctly synthesized information across both plans and made the appropriate comparison showing the 2020 Stock Incentive Plan had more shares (53M vs 17M). The calculation of the combined total (53 + 17 = 70) is accurate. The answer is well-structured, clear, and provides all requested information with proper emphasis on key figures. No factual errors, omissions, or calculation mistakes are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 282,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "The total liability for postemployment benefits reported by CAT in 2023 was **$701 million** (non-current liability), as disclosed in Note 12 of the 10-K filing (page 93). The pension benefits freeze effective December 31, 2019, eliminated the **rate of compensation increase assumption** for U.S. pension plans, as noted in the actuarial assumptions table (page 46). This freeze also removed the need to account for future salary growth in benefit calculations, impacting assumptions related to service cost and plan obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM reports $701 million as the total postemployment benefits liability, but the ground truth states $621 million. This is a significant discrepancy of $80 million (12.9% error). The ground truth provides a detailed breakdown: $56 million for other postemployment benefits + $565 million for non-qualified deferred compensation = $621 million total. The LLM's $701 million figure is incorrect and not supported by the ground truth. (2) COMPLETENESS - The LLM fails to provide the breakdown of the $621 million liability into its components ($56M OPEB + $565M non-qualified deferred compensation), which is essential information in the ground truth answer. (3) PENSION FREEZE IMPACT - The LLM correctly identifies that the pension benefits freeze occurred December 31, 2019, and mentions elimination of compensation increase assumptions. However, the ground truth specifically states the freeze 'eliminated service cost and rendered certain actuarial assumptions no longer applicable,' while the LLM focuses narrowly on the 'rate of compensation increase assumption' without mentioning the elimination of service cost. The LLM's explanation is partially correct but incomplete regarding the full impact. (4) MULTI-HOP REASONING - The LLM attempts to cite specific page numbers (page 93, page 46) which adds apparent credibility but the core number ($701M vs $621M) is fundamentally wrong, suggesting either citation errors or misreading of the source documents. (5) SEMANTIC EQUIVALENCE - While the LLM's discussion of how the freeze impacted assumptions has some merit, the primary quantitative answer is factually incorrect, which is the most critical element of this question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 472,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was **$4,726 million**, combining **$2,555 million** from investment funds (Level 1: $170 million, NAV: $2,385 million) and **$2,171 million** from equity securities (Level 1). This represents a **decrease of $142 million** from the prior year's total of **$4,868 million** (2023: $2,797 million from investment funds and $2,071 million from equity securities).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: 2024 total of $4,726 million ($2,555M investment funds + $2,171M equity securities), 2023 total of $4,868 million ($2,797M investment funds + $2,071M equity securities), and the year-over-year decrease of $142 million. The calculation is verified: $4,868M - $4,726M = $142M decrease. The answer correctly identifies all entities (Merck, U.S. Pension Plans, developed markets equities) and time periods (2024 vs 2023). The multi-hop synthesis is sound, combining information about both investment funds and equity securities across two years. The LLM provides additional context by breaking down the Level 1 and NAV components for investment funds ($170M Level 1 + $2,385M NAV = $2,555M), which adds helpful detail without contradicting the ground truth. The answer directly addresses both parts of the question: the 2024 total and the year-over-year comparison. Minor note: The additional breakdown of Level 1 and NAV components, while accurate and helpful, goes slightly beyond what was explicitly requested, but this enhances rather than detracts from the answer's quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 331,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "As of December 31, 2024, approximately **135 million shares** of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, with **47 million shares remaining available** for issuance (excluding shares underlying outstanding awards). This information is explicitly stated in the document's discussion of the plan's structure and share availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly matches the ground truth. Quantitative verification: (1) 135 million shares authorized since inception - CORRECT, (2) 47 million shares remaining available as of December 31, 2024 - CORRECT. Both numbers match the original answer exactly. The answer correctly identifies all key entities: Danaher, the 2007 Omnibus Incentive Plan, common stock, and the specific date (December 31, 2024). The LLM appropriately addresses all parts of the multi-part question: authorization amount, remaining availability, and the plan's role in issuing stock options, RSUs, and PSUs. The reasoning is sound - the answer correctly synthesizes that the remaining 47 million represents shares available after accounting for shares already issued through various award types. The parenthetical clarification '(excluding shares underlying outstanding awards)' adds helpful context that aligns with standard plan accounting. Minor observation: The LLM's phrasing 'approximately 47 million shares' uses 'approximately' while the ground truth states 'approximately 47 million' - this is semantically equivalent and appropriate given typical rounding in financial disclosures. The answer is well-structured, directly responsive, and contains no factual errors or calculation mistakes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 365,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenuesincluding those from Google Play, hardware, and Google Cloudare increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The growth in Google Play's revenue contribution, as part of non-advertising revenues, could potentially lower Google's overall profit margins. Non-advertising revenues, including Google Play, typically have lower margins compared to advertising revenues, as highlighted in the document (page 30). The text notes that revenues from non-advertising streams like YouTube and Google Play monetize at a lower rate than traditional search ads, and margins on these revenues vary significantly. As Google Play's revenue grows, it may dilute overall profit margins, given the differing margin profiles between advertising (higher margins) and non-advertising (lower margins) streams.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core concept that Google Play's growth in non-advertising revenues could lower overall profit margins due to lower margins compared to advertising revenues. The reasoning about margin dilution is sound and aligns with the ground truth. However, there are several issues: (1) The LLM mentions 'YouTube and Google Play monetize at a lower rate than traditional search ads' - the ground truth does not specifically mention YouTube in this context, and the LLM appears to conflate different revenue streams. The ground truth focuses on Google Play, hardware, and Google Cloud as non-advertising revenues, not YouTube (which is primarily advertising-based). (2) The LLM cites 'page 30' as a source, but the ground truth references the '2022 10-K filing' without specifying a page number. This citation detail cannot be verified against the ground truth. (3) The LLM answer lacks specificity about the types of Google Play revenues (app sales, in-app purchases, digital content) that the ground truth explicitly mentions. (4) The ground truth includes a more nuanced point about potential offsets ('unless offset by efficiencies or higher-margin offerings'), which the LLM answer omits. (5) No quantitative data is provided in either answer, so quantitative accuracy is limited, but the LLM's reference to 'lower rate' and 'vary significantly' aligns with ground truth language. The multi-hop reasoning is present but incomplete - the LLM successfully synthesizes the relationship between revenue growth and margin impact but misidentifies some revenue stream components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 440,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge credit quality risk. The company expects these instruments to reduce overall risk exposure by mitigating potential losses from adverse changes in credit ratings or spreads associated with its debt securities portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all seven specific financial instruments that CVS uses for hedging: interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps. The list is complete and accurate with no numeric errors. However, there is a notable semantic difference in how the expected impact is described. The ground truth states that these instruments 'reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately' - emphasizing the nuanced trade-off that individual instruments may carry their own risks but collectively reduce overall risk. The LLM answer simplifies this to 'reduce overall risk exposure by mitigating potential losses from adverse changes in credit ratings or spreads' - which is partially correct but misses the important caveat about the individual risks these instruments introduce. The LLM's explanation focuses narrowly on credit-related benefits rather than acknowledging the broader risk profile (interest rate risk, equity price risk) that the ground truth emphasizes. The answer is not wrong per se, but it provides an incomplete characterization of how CVS views the risk-return trade-off of these hedging instruments. The multi-hop reasoning is sound (correctly synthesizing the instruments and their purpose), but the qualitative nuance about the complexity of hedging is lost.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 405,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was **$691 million**. This includes **$682 million** for U.S. Pension Plans (from page 101) and **$9 million** for Other Postretirement Benefit Plans (from page 103).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and matches the ground truth perfectly. (1) All numbers are correct: $691 million total, $682 million for U.S. Pension Plans, and $9 million for Other Postretirement Benefit Plans. (2) The calculation is accurate: $682M + $9M = $691M. (3) The multi-hop reasoning is sound - the model correctly synthesized information from two different benefit plan categories (U.S. Pension Plans and Other Postretirement Benefit Plans) and summed them appropriately. (4) The answer is complete, addressing all parts of the question by identifying both component amounts and the total. The inclusion of page references (pages 101 and 103) adds helpful context without detracting from accuracy. The wording is clear and the semantic meaning perfectly aligns with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 242,
        "total_tokens": 1389
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "The total number of freight cars Union Pacific (UNP) owns and leases as of December 31, 2024, is **56,176** (33,704 owned + 22,472 leased). In 2024, UNP spent **$788 million** on acquiring freight cars, as detailed in the capital investments table, which includes lease buyouts of $143 million. This figure is part of the broader $3.4 billion 2024 capital plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR ON PRIMARY METRIC: The LLM answer contains a major factual error on the spending amount. The ground truth states UNP spent $143 million on acquiring freight cars in 2024, but the LLM claims they spent $788 million. While the LLM correctly identifies that $143 million represents lease buyouts, it incorrectly inflates the total acquisition spending to $788 million. This is a fundamental misinterpretation of the question and the data. The question specifically asks 'how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?' - the answer should be $143 million, not $788 million. The LLM appears to have confused total capital investments ($788M or part of the $3.4B capital plan) with freight car acquisition spending specifically. CORRECT ELEMENTS: (1) The freight car count of 56,176 is accurate, (2) The breakdown of 33,704 owned + 22,472 leased is correct and helpful, (3) The identification of $143 million as lease buyouts is correct, (4) The reference to the $3.4 billion 2024 capital plan is contextually relevant. INCORRECT ELEMENTS: (1) The $788 million figure for freight car acquisition spending is wrong - this appears to be a broader capital investment category, not specifically freight car acquisitions, (2) The synthesis of 'capital plan and lease buyout figures' was misinterpreted - the question asks for the combined spending on acquiring freight cars, which should be $143 million based on the ground truth. The LLM failed the core requirement of the multi-hop question by providing an incorrect final answer despite getting intermediate facts right.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 449,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "The changes in non-marketable equity securities contributed **$8,318 million** to the overall increase in other income (expense), net from 2020 to 2021. This is derived from the difference in unrealized gains on non-marketable equity securities, which rose from $1,531 million in 2020 to $9,849 million in 2021, as detailed in the document. While the total increase in other income (expense), net was $5.2 billion, the non-marketable equity securities' unrealized gains accounted for a significant portion of this growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error in the primary quantitative claim. The ground truth states that changes in non-marketable equity securities contributed $6.9 billion to the increase in other income (expense), net from 2020 to 2021. The LLM answer claims $8,318 million ($8.318 billion), which is significantly different from the correct figure. This is a major discrepancy of approximately $1.4 billion or 20% error on the primary metric being asked. While the LLM correctly identifies the year-over-year comparison (2020 to 2021) and attempts to show the calculation methodology by citing the unrealized gains figures ($1,531 million in 2020 to $9,849 million in 2021), the derived contribution amount is incorrect. The calculation shown ($9,849M - $1,531M = $8,318M) is mathematically correct for those specific numbers, but these appear to be the wrong figures or the wrong calculation method for determining the contribution to the overall increase in other income (expense), net. The LLM also correctly notes that the total increase in other income (expense), net was $5.2 billion and acknowledges that non-marketable equity securities were a significant driver, but the specific contribution amount is wrong. The ground truth also mentions that this was partially offset by a $1.3 billion increase in accrued performance fees, which the LLM answer does not address. The multi-hop reasoning is partially attempted but fails due to the incorrect primary number, making the synthesis unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 417,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "The total value of forward contracts associated with ASR transactions in 2022 and 2023 was **$0.7 billion** ($0.3 billion for the 2022 Barclays ASR and $0.4 billion for the 2023 Citibank ASR). These contracts were initially classified as equity instruments within **capital surplus** and were reclassified to **treasury stock** upon final settlement in February 2022 and February 2023, respectively.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong alignment to the ground truth. STRENGTHS: (1) Total value of $0.7 billion is correct, with accurate breakdown of $0.3 billion (2022) and $0.4 billion (2023). (2) Correct identification of initial classification as equity instruments within capital surplus. (3) Correct identification of reclassification to treasury stock upon final settlement. (4) Proper multi-hop synthesis across years and transaction types. (5) Good contextual detail by naming the counterparties (Barclays and Citibank). MINOR ISSUES: (1) The LLM provides specific settlement dates (February 2022 and February 2023) that are not present in the ground truth answer. While these dates may be factually correct from the source documents, they represent additional detail beyond what was in the original answer, creating a slight discrepancy in scope. (2) The naming of specific counterparties (Barclays and Citibank) is helpful context but also goes beyond the ground truth statement. These additions don't contradict the ground truth but represent embellishment. VERIFICATION: All core numbers are accurate ($0.7B total, $0.3B and $0.4B components), the classification pathway (equity instruments  capital surplus  treasury stock) is correct, and the multi-hop reasoning properly synthesizes information across 2022 and 2023 transactions. The answer fully addresses both parts of the question: total value and classification treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 403,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Lowe's Companies Benefit Restoration Plan, as amended, supplements the defined contribution 401(k) Plan to address restrictions under the Internal Revenue Code of 1986. It provides for employee salary deferrals and employer contributions (in the form of a Company Match) to restore benefits for employees whose 401(k) benefits are restricted by IRC provisions, ensuring compliance with tax code limitations on retirement plan contributions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core relationship between the Benefit Restoration Plan and the 401(k) Plan, and accurately describes the supplemental nature of the plan for addressing IRC restrictions. The answer correctly mentions that the plan addresses restrictions under the Internal Revenue Code of 1986 and involves both employee deferrals and employer matching contributions. However, there is a significant quantitative omission: the ground truth specifies that the Company Match varies up to a maximum of 4.25% of eligible compensation, which is a key factual detail that the LLM answer fails to include. This is a material omission because the question specifically asks about the relationship in terms of addressing restrictions, and the specific matching percentage is an important quantitative element of how the plan functions. The LLM answer is more general in its description of 'employer contributions (in the form of a Company Match)' without providing the specific 4.25% figure. The reasoning is sound and the semantic understanding is correct - the answer properly synthesizes that the Benefit Restoration Plan supplements the 401(k) Plan for restricted participants - but the missing specific percentage metric prevents a higher score. The answer demonstrates good qualitative understanding of the multi-hop relationship between the two plans and their purpose under IRC provisions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 391,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was **$1.65 billion** ($950 million for CS&Co and $700 million for TDAC). The total borrowing capacity under these facilities was **$1.8 billion** for uncommitted lines (excluding the secured lines, which are not explicitly tied to a stated capacity). The outstanding amount ($1.65 billion) is less than the total borrowing capacity ($1.8 billion), indicating unused capacity.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all key financial figures: $1.65 billion total outstanding ($950M CS&Co + $700M TDAC), and $1.8 billion total borrowing capacity. The arithmetic is accurate. However, there are notable issues with the reasoning and completeness: (1) The LLM states the $1.8 billion capacity is 'for uncommitted lines (excluding the secured lines, which are not explicitly tied to a stated capacity)' - this is contradictory and confusing since the question specifically asks about secured uncommitted lines of credit, and the ground truth clearly indicates the $1.8 billion IS the total borrowing capacity for these secured facilities. (2) The LLM fails to calculate or mention the utilization rate of 91.7% that the ground truth explicitly provides. This is a significant omission since the question asks 'how does this compare' - the utilization percentage is the most direct and meaningful comparison metric. (3) The statement 'indicating unused capacity' is vague and less informative than the specific 91.7% utilization rate. The LLM correctly synthesizes the multi-hop information (combining CS&Co and TDAC figures) and identifies the correct entities and time period (December 31, 2023). The core numbers are right, but the analysis lacks the key insight (utilization rate) that directly answers the comparative aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 379,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 totaled **$850 million** (comprising $290 million in U.S. pension plans and $560 million in non-U.S. pension plans). The combined value of hedge funds/limited partnerships and real estate investments was **$1,109 million** (U.S. pension plans: $682 million in hedge funds/limited partnerships + $381 million in real estate; non-U.S. pension plans: $38 million in hedge funds/limited partnerships + $8 million in real estate). Thus, mutual, pooled, and commingled funds were **$259 million less** than the combined total of hedge funds/limited partnerships and real estate.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative measures. Ground truth states mutual, pooled, and commingled funds totaled $87 (in millions, implied), while the LLM claims $850 million - a 10x overstatement. The ground truth shows hedge funds/limited partnerships and real estate combined at $14 million, but the LLM reports $1,109 million - a 79x overstatement. Most critically, the LLM reaches the opposite conclusion: it claims mutual funds were $259 million LESS than the combined hedge/real estate total, when the ground truth clearly states mutual funds ($87M) were GREATER than the combined total ($14M). The LLM's breakdown by U.S. and non-U.S. pension plans appears to be fabricated detail not present in the ground truth. The calculation of $259 million difference is arithmetically correct given the LLM's numbers ($850M - $1,109M = -$259M), but the underlying numbers are entirely wrong. The LLM did address all parts of the question (mutual funds value, hedge/real estate combined, and comparison), but with completely incorrect data, leading to an inverted conclusion. This represents a catastrophic failure in factual accuracy despite addressing the question structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 338,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "The treatment of LTIP units as participating securities under the two-class method requires allocating a portion of earnings to these units based on their right to receive distributions equal to 10% of the Operating Partnership's regular quarterly distributions. This allocation reduces the earnings available to common shareholders, thereby lowering basic and diluted EPS. Since LTIP units are not dilutive, their impact is already reflected in the EPS calculation without adjusting the weighted average shares outstanding. The distributions to LTIP units are explicitly recognized as participating securities, ensuring they share in earnings before EPS is determined for common stockholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The 10% distribution percentage is accurately stated; (2) The identification of LTIP units as participating securities under the two-class method is correct; (3) The recognition that earnings are allocated to participating securities is accurate; (4) The statement that LTIP units share in earnings before EPS determination is conceptually sound. PROBLEMATIC ASPECTS: (1) The claim that 'LTIP units are not dilutive' is misleading or potentially incorrect - the ground truth does not make this assertion, and participating securities by definition affect EPS calculations through the two-class method, which is a form of impact on per-share metrics; (2) The statement that their impact is 'already reflected in the EPS calculation without adjusting the weighted average shares outstanding' is partially correct but oversimplifies - the two-class method allocates earnings, not shares, but this is still a material impact on EPS; (3) The phrase 'ensuring they share in earnings before EPS is determined for common stockholders' is somewhat awkwardly worded and could be clearer. MULTI-HOP REASONING: The LLM correctly synthesizes that the 10% distribution right leads to treatment as participating securities, which then impacts EPS through the two-class method. However, it introduces a potentially incorrect characterization about dilution that is not supported by the ground truth. The ground truth emphasizes that the allocation of earnings affects the resulting EPS figure, while the LLM focuses on the mechanics of the two-class method but makes an unsupported claim about non-dilution. QUANTITATIVE ACCURACY: The 10% figure is correct; no calculations are required or presented. SEMANTIC EQUIVALENCE: While the LLM conveys much of the same information, the assertion about non-dilution and the specific mechanics described diverge from the ground truth's emphasis on how the allocation affects the resulting EPS figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 541,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "The total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, is **$3,315 million**. This entity is classified as a **Variable Interest Entity (VIE)** in NEE's financial reporting structure. NEE holds a 52.6% noncontrolling interest in XPLR through its limited partner interest in XPLR OpCo, and since NEE does not have a controlling financial interest, it accounts for the investment under the equity method without consolidation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong alignment to the ground truth. STRENGTHS: (1) The $3,315 million investment amount is exactly correct. (2) The VIE classification is correctly identified. (3) The equity method accounting treatment is correctly stated. (4) The explanation that NEE lacks controlling financial interest is accurate. (5) The 52.6% noncontrolling interest percentage is provided as additional context. (6) The answer correctly addresses both parts of the multi-part question: the quantitative amount and the classification/governance structure. MINOR WEAKNESSES: (1) The ground truth explicitly states NEE is 'not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest,' while the LLM answer states 'NEE does not have a controlling financial interest' but doesn't explicitly mention the lack of control over significant activities. This is a minor omission of a specific governance characteristic mentioned in the ground truth. (2) The ground truth uses the phrase 'accounted for under the equity method' while the LLM says 'accounts for the investment under the equity method without consolidation' - the addition of 'without consolidation' is accurate and helpful but represents slight rewording. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information about the investment amount, ownership structure, entity classification, and accounting treatment, demonstrating proper multi-hop reasoning across the financial reporting structure. CALCULATION/VERIFICATION: No calculations required; the single numeric value ($3,315 million) is accurate. The percentage (52.6%) appears reasonable for a noncontrolling interest context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 472,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde uses three distribution methods to supply process gases: on-site (or tonnage), merchant (or bulk liquid), and packaged (or cylinder gases). The on-site delivery method differs by requiring larger customer volumes and featuring long-term contracts (typically 1020 years) with minimum purchase requirements and price escalation provisions, whereas merchant and packaged methods generally use shorter-term contracts (37 years or 13 years, respectively) without minimum volume commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All core facts match the ground truth - three distribution methods (on-site, merchant, packaged) are correctly identified with alternative terminology provided (tonnage, bulk liquid, cylinder gases). Contract durations are accurate: 10-20 years for on-site, 3-7 years for merchant, 1-3 years for packaged. The distinction regarding minimum purchase requirements is correctly stated. (2) QUANTITATIVE ACCURACY: All numeric values are precise and match ground truth exactly - the contract duration ranges (10-20, 3-7, 1-3 years) are all correct. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes the comparison across all three methods, properly identifying that on-site serves largest volume requirements while merchant and packaged do not have minimum commitments. The addition of 'price escalation provisions' for on-site contracts is a reasonable elaboration not contradicted by ground truth. (4) ENTITY ACCURACY: Linde is correctly identified, and all distribution method names and characteristics are accurate. (5) SEMANTIC EQUIVALENCE: The answer conveys identical information to ground truth with slightly enhanced detail (alternative method names, mention of price escalation). The phrasing 'larger customer volumes' is semantically equivalent to 'largest volume requirements.' Minor enhancement: The LLM provides alternative terminology for each method, which adds helpful context without introducing errors. No factual discrepancies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 430,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, required stockholder approval of an amendment to the Amended and Restated Certificate of Incorporation to increase the number of authorized shares. This amendment was necessary to accommodate the split, as outlined in the 2022 10-K filing (page 79). The prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock (page 89) was a separate corporate action focused on share buybacks, unrelated to the stock split's condition. The stock split's condition was solely the amendment to the Certificate of Incorporation, not tied to the repurchase authorization.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE WITH MULTI-HOP REASONING: The LLM answer fundamentally misinterprets the relationship between the stock split and the repurchase authorization. The ground truth explicitly states that the stock split 'relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split.' This indicates a direct causal relationship: the repurchase program created a need for authorized shares, and the stock split required additional authorized shares to maintain adequate capacity for both operations and the buyback program. The LLM incorrectly characterizes these as 'separate corporate actions' and 'unrelated,' which contradicts the ground truth's explicit statement of their relationship. QUANTITATIVE ACCURACY: All numbers are correct ($50.0 billion, 20-for-one split, dates February 2022 and April 2021). Page references appear reasonable. QUALITATIVE ACCURACY: The LLM correctly identifies that stockholder approval of an amendment to increase authorized shares was required as a condition for the stock split. However, it fails to explain WHY this condition was necessary in relation to the repurchase authorization. The ground truth explains that the increase in authorized shares was needed 'to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program.' The LLM's statement that the condition was 'solely the amendment to the Certificate of Incorporation, not tied to the repurchase authorization' directly contradicts the ground truth's explanation of their interconnection. MULTI-HOP REASONING: The question asks how the stock split 'relates to' the prior repurchase authorization. The LLM fails to synthesize this relationship, instead treating them as independent events. This is a fundamental failure in multi-hop reasoning that significantly undermines the answer's correctness despite accurate individual facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 547,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023 was **$293 million**, as stated in the segment reporting section (Page 102). The committed capital contributions outstanding to Ultium Cells Holdings LLC as of December 31, 2023, were **$800 million**, noted in the discussion of variable interest entities (Page 80).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE ACCURACY: Both numeric values are correct - $293 million for equity earnings contribution matches the ground truth exactly, and $800 million for committed capital contributions is the correct representation of $0.8 billion (proper format conversion). (2) COMPLETENESS: The answer addresses both parts of the two-part question: equity earnings contribution in 2023 AND committed capital contributions outstanding as of December 31, 2023. (3) ENTITY ACCURACY: All entities are correctly identified - GM, Ultium Cells Holdings LLC, the correct fiscal year (2023), and the correct date (December 31, 2023). (4) MULTI-HOP REASONING: The answer correctly synthesizes information from two different sections of the 10-K filing (segment reporting on Page 102 and variable interest entities discussion on Page 80), demonstrating proper multi-hop synthesis across the document. (5) SEMANTIC EQUIVALENCE: The answer uses clear, professional language that conveys the exact same information as the ground truth. The format variation ($800 million vs $0.8 billion) is properly handled and both are mathematically equivalent. The inclusion of page references adds helpful context without detracting from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 364,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "The total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 was **$729 million** in its consolidated financial statements, comprising **$682 million** in U.S. pension plans, **$38 million** in non-U.S. pension plans, and **$9 million** in other postretirement benefit plan assets. This dual reporting reflects the company's exposure to such vehicles across both pension and postretirement benefit plans, with the majority of the investment concentrated in pension plans. The inclusion of these assets in both categories underscores the company's strategic use of alternative investments to diversify returns and manage long-term risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims $729 million total in consolidated financial statements, but the ground truth clearly states $720 million in consolidated financial statements and $9 million in other postretirement benefit plan assets (totaling $729 million across both categories). The LLM incorrectly attributes the $729 million figure to consolidated statements alone. (2) BREAKDOWN ERRORS: The LLM provides a breakdown of $682 million (U.S. pension plans) + $38 million (non-U.S. pension plans) + $9 million (other postretirement) = $729 million. However, the ground truth does not provide this level of detail or these specific sub-allocations. The LLM appears to have fabricated or misinterpreted the pension plan breakdown. (3) DUAL REPORTING MISUNDERSTANDING: The ground truth explicitly states the dual reporting as: $720 million in consolidated financial statements AND $9 million in other postretirement benefit plan assets. The LLM conflates these categories by suggesting the $729 million is all in consolidated statements, fundamentally misrepresenting how the company reports these investments across different categories. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the two separate reporting categories. The question asks about dual reporting reflecting overall exposure, which requires understanding that $720M + $9M = $729M total exposure across two distinct reporting categories, not $729M within one category. (5) SEMANTIC ISSUES: While the LLM's commentary about strategic diversification is reasonable, it cannot compensate for the fundamental numerical and categorical errors. The core answer structure is inverted from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 493,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The increased use of e-commerce by retail tenants reduces demand for physical retail space, leading to lower occupancy rates and downward pressure on rental rates. As retailers shift to online sales, some close underperforming stores, creating vacancies that are difficult for Simon Property Group (SPG) to re-lease at attractive terms. Additionally, tenants may underreport sales (e.g., curbside pickups or online sales), reducing overage rent collections. This shift also enhances tenants' bargaining power, forcing SPG to offer concessions or lower rents to retain tenants, ultimately harming leasing outcomes and rental income stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the e-commerce impact on SPG's leasing challenges and is largely accurate. STRENGTHS: (1) Correctly identifies the core mechanism: e-commerce reduces demand for physical retail space, leading to lower occupancy and downward rental pressure. (2) Accurately captures the bargaining power dynamic where creditworthy tenants gain leverage. (3) Correctly notes that SPG must offer concessions and lower rents to retain tenants. (4) No quantitative errors - no specific numbers were provided in either answer, so quantitative accuracy is perfect. (5) Multi-hop reasoning is sound: e-commerce  reduced demand  vacancies  bargaining power  concessions  financial harm. MINOR DIFFERENCES: (1) The LLM answer introduces the concept of tenants underreporting sales (curbside pickups, online sales reducing overage rent), which is a valid related concern but is NOT explicitly mentioned in the ground truth answer. This is an addition rather than an error. (2) The ground truth specifically mentions 'tenant improvements' and 'lease modifications' as increased spending needs, while the LLM answer uses the broader term 'concessions.' These are semantically similar but the ground truth is more specific. (3) The ground truth emphasizes the 'oversupply of vacant space' more explicitly, while the LLM focuses on difficulty re-leasing at attractive terms. Both convey the same underlying problem. ASSESSMENT: The LLM answer is factually correct and addresses all key elements of the ground truth answer. The additional detail about overage rent underreporting is a reasonable inference from e-commerce practices but goes slightly beyond what was explicitly stated in the ground truth. The core reasoning about e-commerce impact on leasing and rental rates is accurate and well-synthesized. The answer appropriately addresses how this contributes to SPG's difficulties in leasing and maintaining rental rates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 527,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas corporate income tax legislation was a **$34 million reduction in 2024** (part of a $34 million total reduction including Louisiana), a **$114 million reduction in 2023** (part of a $114 million total reduction including Nebraska, Iowa, Kansas), and a **$95 million reduction in 2022** (part of a $95 million total reduction including Nebraska, Iowa, and Idaho). The 2023 impact was higher than 2022, while 2024's impact was lower than 2023. Note: The document does not specify Arkansas's exact share of the reductions in each year.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three key dollar amounts ($34M for 2024, $114M for 2023, $95M for 2022) and accurately noted the comparative relationships (2023 > 2022 > 2024). The numbers themselves are factually accurate. CRITICAL WEAKNESSES: (1) The LLM failed to complete the primary calculation requested in the question - it did not compute the cumulative 2024+2023 total ($148M) or the comparison difference ($53M greater than 2022). The ground truth explicitly states 'totaling $148 million over the two years' and 'greater than the 2022 impact by $53 million.' (2) The LLM introduced unnecessary and confusing information about other states (Louisiana, Nebraska, Iowa, Kansas, Idaho) that was not part of the original question, which specifically asked about Arkansas legislation only. (3) Most problematically, the LLM added a disclaimer stating 'The document does not specify Arkansas's exact share of the reductions in each year' - this directly contradicts the ground truth which provides specific Arkansas figures. This suggests the LLM was uncertain about the data or conflating Arkansas-specific impacts with multi-state impacts. (4) The answer fails to directly answer the comparative question posed ('how does this compare to the 2022 impact'). While the LLM notes directional comparisons, it does not provide the quantitative comparison ($53M difference) that the ground truth specifies. MULTI-HOP REASONING: The question requires synthesizing data across three years and performing calculations. The LLM identified individual year amounts but failed to synthesize them into the cumulative total and comparative analysis requested. This is a significant gap in multi-hop reasoning completion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 469,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEEs cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE's limited partner interest in XPLR OpCo could impact its financial obligations and liquidity if XPLR is unable to access capital on commercially reasonable terms. This scenario could impair XPLR's ability to consummate acquisitions or meet obligations, reducing cash distributions to NEE and potentially lowering the value of NEE's investment. Additionally, if XPLR requires NEE to provide funds through guarantees or upstream dividends, it could strain NEE's liquidity and financial flexibility, as NEE's ability to meet its obligations depends on its subsidiaries' cash flows and dividend-paying capacity.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about how NEE's limited partner interest in XPLR OpCo could impact its financial obligations and liquidity. STRENGTHS: (1) Correctly identifies the primary risk that XPLR's inability to access capital would reduce cash distributions to NEE; (2) Accurately notes the dilution risk from issuance of additional common units; (3) No quantitative errors or incorrect numbers/dates; (4) Properly synthesizes the multi-hop relationship between XPLR's capital access, distributions, and NEE's liquidity. WEAKNESSES: (1) The LLM introduces concepts about guarantees and upstream dividends that are not explicitly mentioned in the ground truth answer - while these are plausible financial mechanisms, they represent speculation beyond what the ground truth establishes; (2) The ground truth specifically emphasizes that reduced distributions directly impact NEE's ability to pay dividends, which the LLM mentions but frames differently (as 'financial flexibility' rather than dividend-paying capacity); (3) The LLM's framing around 'impair XPLR's ability to consummate acquisitions' is slightly different from the ground truth's 'hinder its ability to complete acquisitions or meet growth opportunities' - semantically similar but the ground truth more explicitly connects this to growth opportunities. MULTI-HOP REASONING: The LLM correctly synthesizes the chain: XPLR capital access  cash distributions to NEE  NEE's financial obligations and liquidity. The reasoning is sound and logical. The answer is substantively correct on the main points but introduces some elements not grounded in the original answer, which prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 458,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "The fair value of mortgage-backed obligations reported in the \"Marketable securities\" section and the \"Fair Value\" column of the marketable securities table are the same. Both columns reflect the same fair value amount of **$236 million** as of January 31, 2024, as shown in the tables on page 77 and the fair value hierarchy table on page 79. There is no difference between the two.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual question. The ground truth clearly states there IS a difference of $58 between the two fair value amounts ($178 vs $236), but the LLM claims there is NO difference and that both are $236 million. This is a critical factual error. The LLM correctly identified that the question is about comparing two sections of marketable securities data and understood the contextual relevance of the question (hence the 8 on contextual relevance), but completely failed on the actual quantitative comparison. The LLM appears to have only found one value ($236 million) and incorrectly concluded both sections report the same amount, when in fact the 'Marketable securities' section reports $178 and the 'Fair Value' column reports $236, creating a $58 difference. This represents a failure in multi-hop synthesis - the model needed to extract and compare values from two different sections but only identified one value. The quantitative accuracy is severely compromised by the incorrect conclusion that there is no difference when the correct answer is a $58 difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 318,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "The revenue recognition method for Google Play, which is reported on a **net basis** (as a facilitator of transactions between developers and users), reduces the gross revenue recognized compared to a gross basis. This net recognition directly impacts financial reporting by lowering the reported revenue for non-advertising segments like Google Play. As non-advertising revenues grow, their lower inherent margins (due to higher cost-of-revenue expenses, such as developer service fees) further compress overall margins. The net basis also means that the associated costs (e.g., service fees) are fully offset against revenue, amplifying the margin pressure from non-advertising revenues compared to higher-margin advertising segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies that Google Play revenue is reported on a net basis, matching the ground truth exactly; (2) Accurately explains the core mechanism - that Google acts as a facilitator earning a service fee, which is the correct performance obligation analysis; (3) Properly synthesizes the multi-hop relationship between revenue recognition method, non-advertising revenue growth, and margin compression; (4) Correctly identifies that net basis reporting reduces reported revenue compared to gross basis; (5) Accurately notes that non-advertising revenues have lower margins than advertising revenues, creating margin pressure. MINOR WEAKNESSES: (1) The LLM adds some interpretive detail about 'cost-of-revenue expenses' and 'developer service fees' being 'fully offset against revenue' that goes slightly beyond what the ground truth explicitly states - the ground truth focuses on the net basis method and margin impact without detailing the specific mechanics of cost offsetting; (2) The phrase 'amplifying the margin pressure' is a reasonable inference but represents slight elaboration beyond the ground truth's more straightforward statement that the trend 'could adversely affect overall margins.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dates were provided in either answer, so this dimension scores perfectly as there are no calculations to verify. MULTI-HOP REASONING: The answer successfully synthesizes three key elements: (1) revenue recognition method (net basis), (2) impact on reported revenue, and (3) effect on margins given increasing non-advertising revenue share. The logical chain is sound and matches the ground truth's reasoning. SEMANTIC EQUIVALENCE: The core message is equivalent - net basis reporting reduces revenue recognition, and growing non-advertising revenues with lower margins negatively impact overall profitability. The LLM's additional mechanistic detail about cost offsetting is reasonable but slightly speculative.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 552,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "General Motors made committed capital contributions of $800 million to Ultium Cells Holdings LLC in 2023, representing a decrease from the $1.4 billion committed in 2022, as stated in Note 11 of the 2023 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: All numbers are correct - $800 million (2023) matches the ground truth's $0.8 billion (same value, different format), and $1.4 billion (2022) is accurate. The year-over-year comparison is correct. (2) COMPLETENESS: The answer addresses both parts of the question: (a) the 2023 committed capital contribution amount, and (b) the comparison to the previous year. (3) ENTITY ACCURACY: All entities are correctly identified - General Motors, Ultium Cells Holdings LLC, and the correct fiscal years (2023 and 2022). (4) REASONING: The multi-hop synthesis is sound - the model correctly identified the 2023 commitment, retrieved the 2022 commitment, and made the appropriate year-over-year comparison. (5) SEMANTIC EQUIVALENCE: The LLM uses $800 million while the ground truth uses $0.8 billion - these are semantically equivalent and both acceptable formats. The LLM does not explicitly state the $0.6 billion reduction calculation that appears in the ground truth, but this is a minor omission since the comparison is clearly stated. The citation to 'Note 11 of the 2023 10-K filing' adds credibility and specificity. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 365,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "Mastercard paid a total cash consideration of $2.8 billion for all acquisitions in 2024, including the $2.7 billion paid for RF UlEmate Parent, Inc. (Recorded Future). Of this amount, $1.736 billion was attributed to goodwill, as disclosed in the acquisition details.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor discrepancies. Verification of key facts: (1) Total cash consideration of $2.8 billion for all 2024 acquisitions - CORRECT, matches ground truth exactly. (2) Goodwill attribution - The LLM states $1.736 billion while ground truth states $1.7 billion. This is a minor variance of $36 million (approximately 2% difference). The LLM's more precise figure ($1.736B) could represent rounding differences in the source data or a more granular disclosure level, but it deviates slightly from the ground truth baseline of $1.7 billion. (3) RF UlEmate Parent, Inc. identification - CORRECT, the LLM helpfully adds the alternative name 'Recorded Future' which provides useful context. (4) Multi-hop synthesis - The answer correctly synthesizes that RF UlEmate Parent, Inc. was one of multiple acquisitions in 2024 and properly attributes the $2.7 billion to this specific acquisition while maintaining the $2.8 billion total for all acquisitions. The reasoning is sound and demonstrates proper understanding of the multi-hop nature of the question. The answer addresses all parts of the question comprehensively. The minor goodwill discrepancy ($1.736B vs $1.7B) prevents a perfect score, though this could reflect different rounding methodologies in the source filings. Overall, the answer demonstrates strong accuracy with only a marginal numerical variance on one metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 392,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "The total amount spent by UNP on freight car lease buyouts from 2022 to 2024 was **$270 million** ($143 million in 2024, $57 million in 2023, and $70 million in 2022). This aligns with the company's 2025 capital plan, which includes **$3.4 billion** for acquiring freight cars to support replacement and growth opportunities, reflecting continued investment in freight car assets as part of its strategic capital allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE VERIFICATION: All numbers are correct - the three-year total of $270 million is accurate, with the yearly breakdown correct ($70M in 2022, $57M in 2023, $143M in 2024). The 2025 capital plan figure of $3.4 billion is also correct. The sum verification: $70M + $57M + $143M = $270M is mathematically accurate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it provides the total freight car lease buyout spending (2022-2024) and explains the relationship to the 2025 capital plan. (3) ENTITY ACCURACY: UNP is correctly identified, all years are accurate (2022, 2023, 2024, 2025), and the financial metrics are properly labeled. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three years of historical spending and connects it to forward-looking capital planning, demonstrating sound logical reasoning about the relationship between past spending patterns and future strategic allocation. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth (e.g., 'acquiring freight cars to support replacement and growth opportunities' vs 'acquiring freight cars to support asset replacement and growth opportunities'), but the semantic meaning is identical. The LLM presents the yearly figures in reverse chronological order compared to the ground truth, but this is a presentation choice that doesn't affect accuracy. Minor deduction only because the ground truth explicitly states this is 'part of a broader $3.4 billion investment strategy' while the LLM says 'as part of its strategic capital allocation' - slightly less specific but semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 466,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "The total notional amount of accelerated share repurchase agreements under the 2021 Repurchase Program, based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023, was **$3.5 billion**. This includes the $1.5 billion ASR with Barclays (entered in 2022) and the $2.0 billion ASR with Citibank (entered in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All key facts are correct - the total notional amount of $3.5 billion matches the ground truth exactly, and the component amounts ($1.5 billion for 2022 and $2.0 billion for 2023) are accurate. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The calculation is sound: $1.5B + $2.0B = $3.5B. The answer correctly identifies the specific ASR transactions and their amounts. (3) QUALITATIVE ACCURACY: The LLM demonstrates proper multi-hop reasoning by synthesizing information across two separate years (2022 and 2023) and correctly attributing the transactions to specific counterparties (Barclays and Citibank). The answer properly identifies these as part of the 2021 Repurchase Program. The reasoning is logical and complete. (4) ENTITY ACCURACY: All entities are correctly identified - CVS Health Corporation, the 2021 Repurchase Program, the years 2022 and 2023, and the counterparty banks. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly enhanced detail (naming the counterparties), which adds value without contradicting the original answer. The only minor difference is that the LLM provides additional context by naming Barclays and Citibank as counterparties, which is not contradicted by the ground truth and represents appropriate elaboration. The answer fully addresses the multi-part question about forward contract amounts and initial treasury stock transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 419,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "GM's reliance on full-size ICE pickup trucks for near-term profitability is balanced against its strategic shift toward EVs, as outlined in the 10-K. The company acknowledges that near-term profitability depends on ICE vehicles, particularly full-size SUVs and pickups, while its long-term strategy hinges on transitioning to EVs to meet regulatory and market demands. However, this dual focus exposes GM to risks: declining ICE demand could reduce short-term margins, while EV development faces challenges like high costs, supply chain complexities, and uncertain consumer adoption. The forward-looking risks emphasize that failure to manage this transition could jeopardize both short-term financial stability and long-term growth, requiring careful balancing of current ICE profits with EV investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of GM's strategic position and the core tension between ICE profitability and EV transition. STRENGTHS: (1) Correctly identifies that GM depends on full-size ICE pickup trucks for near-term profitability; (2) Accurately captures the dual risk framework - short-term margin pressure from declining ICE demand and long-term growth challenges from EV transition; (3) Properly synthesizes the multi-hop relationship between ICE cash generation and EV funding; (4) Appropriately references forward-looking statement risks; (5) Mentions relevant challenges like supply chain complexity and consumer adoption uncertainty. WEAKNESSES: (1) The original answer emphasizes that ICE trucks 'generate the highest profit margins and fund the company's strategic shift toward EVs' - a more explicit causal link showing ICE profits directly finance EV development. The LLM answer mentions this but less directly; (2) The original answer specifically highlights the risk that 'a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition' - creating a clear dual jeopardy scenario. The LLM answer conveys this but with slightly less emphasis on the funding mechanism; (3) The LLM answer adds 'full-size SUVs' alongside pickups, which is reasonable but the original focuses specifically on 'full-size ICE pickup trucks'; (4) No quantitative data provided in either answer (no specific margin percentages, revenue figures, or investment amounts), so quantitative accuracy is assessed on logical consistency rather than numerical verification. The LLM answer maintains logical consistency throughout. MULTI-HOP REASONING: The answer correctly synthesizes information across three dimensions: (1) current ICE profitability, (2) EV strategic shift, and (3) the interconnection between them. The reasoning that declining ICE demand reduces funding for EV development is sound and matches the ground truth logic. SEMANTIC EQUIVALENCE: The LLM answer conveys substantially the same core message as the original - that GM faces a dual risk where ICE decline threatens both immediate and long-term stability through reduced funding for the transition. The phrasing differs but the fundamental insight is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 613,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "Chevron's asset impairment assessments and upstream investment decisions are influenced by uncertainty in the energy transition's pace, as outlined in the 10-K filing. The company considers factors like commodity price volatility, regulatory changes, and carbon costs in its impairment evaluations, which are critical for determining whether asset values remain recoverable. For example, significant downward revisions in crude oil or natural gas reserves, or shifts in regulatory requirements (e.g., environmental laws), may trigger impairment charges. Additionally, uncertainty around the energy transition affects upstream investment decisions by altering capital expenditure plans and project timelines, as Chevron adjusts for potential changes in market demand, regulatory pressures, and technological advancements. This uncertainty necessitates ongoing reassessment of asset values and investment priorities to align with evolving economic and regulatory conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core topic. Both responses correctly identify that Chevron evaluates energy transition uncertainty as a key factor in asset impairment assessments and upstream investment decisions. The LLM answer accurately captures the main elements: (1) commodity price volatility and regulatory changes as key factors, (2) carbon costs in impairment evaluations, (3) potential impairment charges from downward reserve revisions, (4) impact on capital expenditure plans and project timelines, and (5) the need for ongoing reassessment of asset values. The answer demonstrates sound multi-hop reasoning by synthesizing how energy transition uncertainty flows through to both impairment assessments and investment decisions. No quantitative errors are present (no specific numbers were required in either answer). The LLM answer is slightly less comprehensive than the ground truth in that it doesn't explicitly mention: (a) the specific impact on upstream earnings and cash flows, (b) the potential for reduced demand for traditional oil and gas products, or (c) the connection to lower-carbon energy solutions as an alternative investment area. However, these omissions are relatively minor contextual details rather than core factual errors. The answer is well-structured, logically sound, and appropriately addresses the question's multi-part nature regarding both asset impairment assessments and upstream investment decisions. The semantic meaning aligns well with the ground truth despite different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 432,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard's Consumer Engagement Services, part of its broader payment solutions, enhance its global payments network by driving customer acquisition, improving transaction volumes, and fostering brand preference through tailored digital experiences and security features. These services generate additional revenue streams via transaction-based fees and contribute to financial performance by supporting growth in gross dollar volume and net income, as highlighted in its 2024 financial results.",
      "correctness_score": 5,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant factual errors and unsupported claims that diverge from the ground truth.\n\n(1) WHAT WAS CORRECT/INCORRECT:\nCorrect elements:\n- Identifies Consumer Engagement Services as part of Mastercard's payment solutions\n- Recognizes the services enhance the global payments network\n- Acknowledges contribution to financial performance\n- Mentions security features as relevant\n\nIncorrect/Unsupported elements:\n- Claims services \"generate additional revenue streams via transaction-based fees\" - NOT supported in ground truth, which focuses on network utility and payment flows\n- References \"2024 financial results\" with specific metrics (gross dollar volume, net income) - NO specific financial data provided in ground truth; this appears to be fabricated specificity\n- Emphasizes \"customer acquisition\" and \"brand preference through tailored digital experiences\" - ground truth focuses on \"principled and responsible use of secure data\" and \"attract and retain consumers and merchants\"\n- The framing around \"transaction-based fees\" and revenue streams is not mentioned in the ground truth\n\n(2) QUANTITATIVE ACCURACY:\nScore: 2/10 - The LLM references \"2024 financial results\" but provides NO actual numbers, percentages, or dollar amounts. The ground truth contains no specific financial metrics either, but the LLM's invocation of specific results without data is misleading and inaccurate. The answer fabricates specificity without substantiation.\n\n(3) MULTI-HOP REASONING ASSESSMENT:\nThe LLM attempts to synthesize: Consumer Engagement Services  network enhancement  financial performance. However, the reasoning pathway differs significantly from ground truth:\n- Ground truth: secure data use  attract/retain customers  network utility  payment flows  financial performance\n- LLM answer: digital experiences/security  customer acquisition  transaction fees  revenue growth\nThe LLM's causal chain introduces mechanisms (transaction-based fees, revenue streams) not present in the ground truth.\n\n(4) JUSTIFICATION FOR SCORES:\n- Correctness (5/10): Core concept correct but significant factual deviations and unsupported claims reduce score substantially\n- Quantitative (2/10): References financial results without providing any actual data; fabricates specificity\n- Qualitative (6/10): Reasoning is logical but diverges from ground truth's emphasis on data responsibility and network interdependence\n- Contextual (7/10): Addresses the question's core topic but introduces elements not grounded in the source material",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 690,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "The total net cash outflow impact from Walmart's acquisition of Alert Innovation in fiscal 2023 and its subsequent sale in fiscal 2025 was **$0.4 billion**. The acquisition in fiscal 2023 involved a $0.4 billion cash outflow, while the sale in fiscal 2025 is not explicitly detailed in the provided pages, suggesting no additional cash impact is specified. Thus, the net cash outflow is attributed solely to the initial acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the total net cash outflow impact as $0.4 billion, matching the ground truth exactly. The quantitative accuracy is perfect - the $0.4 billion acquisition cost in fiscal 2023 is correctly stated, and the calculation that this represents the total net cash outflow is accurate. The multi-hop reasoning is sound: the model correctly synthesizes that the acquisition involved a $0.4 billion cash outflow in fiscal 2023 and that the deconsolidation in fiscal 2025 resulted in no additional net cash impact, leading to a total net outflow of $0.4 billion. The entity identification is correct (Walmart, Alert Innovation, fiscal years 2023 and 2025). The only minor weakness is that the LLM's explanation of the fiscal 2025 deconsolidation is somewhat tentative ('is not explicitly detailed in the provided pages, suggesting no additional cash impact is specified'), whereas the ground truth more definitively states 'realized no net cash inflow from its deconsolidation.' However, this is a minor semantic difference in how the information is presented rather than a factual error. The answer demonstrates proper understanding of the multi-hop nature of the question by correctly combining the acquisition cost with the deconsolidation impact to arrive at the final answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 365,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes **LTIP units** (Long-Term Incentive Performance Units). No adjustment was made to net income attributable to common stockholders because **no securities had a material dilutive effect** during the periods reported, and adjusting for non-dilutive items (like limited partner income) would not impact earnings per share.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that LTIP Units are part of the potentially dilutive securities and accurately states that no adjustment was made because these securities had no material dilutive effect. The reasoning about non-dilutive items is logically sound. WEAKNESSES: (1) INCOMPLETE ENTITY IDENTIFICATION - The ground truth specifies 'units exchangeable for common stock AND LTIP Units' as the combined total, but the LLM only mentions LTIP units, omitting the units exchangeable for common stock component. This is a significant omission for a multi-hop synthesis question. (2) MISSING QUANTITATIVE DATA - The question asks for 'the combined total' which implies a specific number should be provided. Neither answer provides actual numerical values (e.g., total shares/units count), though the ground truth also lacks this specificity. However, the LLM should have attempted to quantify or at least acknowledge the missing quantitative component more explicitly. (3) INCOMPLETE SYNTHESIS - The question requires synthesizing information from 'both disclosures' about LTIP Units, suggesting multiple sources need to be combined. The LLM's answer doesn't demonstrate clear synthesis across multiple disclosure sources. (4) REASONING CLARITY - The parenthetical explanation about 'limited partner income' appears tangential and may introduce confusion rather than clarity, as it's not clearly connected to the LTIP Units discussion. The core reasoning about material dilutive effect is correct but incompletely supported. CALCULATION/NUMBER VERIFICATION: No specific numbers are provided in either answer to verify, which is a limitation of both responses but particularly problematic for a question asking for a 'combined total.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 474,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The total value of Investments measured at NAV across both disclosed asset categories (Pension and Health Care and Life Plans) in the 2023 10-K filing for VZ is **$4,437 million** ($4,432 million for Pension Plans and $5 million for Health Care and Life Plans). This compares to total investments at fair value of **$9,565 million** ($9,104 million for Pension Plans and $461 million for Health Care and Life Plans). The NAV-measured investments represent a portion of the total fair value investments, with the remainder classified under other fair value measurement methods (e.g., Level 1, 2, or 3).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all major quantitative dimensions. Ground truth states: NAV investments total $14 million ($9M + $5M), representing 3.1% of total fair value investments of $902 million ($441M + $461M). The LLM provides completely different numbers: $4,437 million for NAV investments and $9,565 million for total fair value investments. These figures are off by orders of magnitude (approximately 317x larger for NAV and 10.6x larger for total fair value). The LLM also incorrectly identifies the asset categories as 'Pension and Health Care and Life Plans' when the ground truth refers to two distinct categories with different values. While the LLM correctly identifies VZ and the 2023 10-K filing, and attempts to address the comparison question, the core numerical data is entirely wrong. The calculation of the percentage relationship (3.1%) is also not addressed or calculated by the LLM. The multi-hop reasoning fails at the fundamental data retrieval stage, making the entire answer unreliable. This represents a critical failure in quantitative accuracy for a financial question where precise numbers are essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 328,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "GM reported **$293 million** in equity earnings from Ultium Cells Holdings LLC in 2023. These earnings were disclosed in the **\"Automotive and other cost of sales\"** category of the consolidated financial statements, as noted in Note 8 of the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: All factual information matches the ground truth exactly - the $293 million equity earnings figure is correct, the company (GM/General Motors) is correctly identified, the investee (Ultium Cells Holdings LLC) is correct, and the year (2023) is correct. The financial statement category 'Automotive and other cost of sales' is accurately stated. (2) QUANTITATIVE ACCURACY: The $293 million figure is precisely correct with no calculation errors or discrepancies. The number format is clear and matches the ground truth. (3) QUALITATIVE ACCURACY: The LLM correctly synthesized the multi-hop information - identifying that this is equity earnings from a specific joint venture/investee, properly categorizing it within the consolidated financial statements, and noting the source (Note 8 of the 10-K). The reasoning is sound and demonstrates proper understanding of how equity earnings from investees are reported. (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses both parts of the multi-part question: the amount of equity earnings and the financial statement category. The additional detail about Note 8 adds helpful context without introducing any inaccuracies. Minor note: The LLM added a reference to 'Note 8' which, while helpful, is not explicitly mentioned in the ground truth answer, but this represents a value-add rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 397,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "The equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, reflecting a 0.1 percentage point reduction. This shift is part of a broader ownership structure where Public Investors (Class A) increased slightly (88.8% to 89.9%), while Mastercard Foundation (Class A) decreased (10.4% to 9.3%). The decline in Class B ownership aligns with the Foundation's structured share sales and potential conversions of Class B to Class A shares, which may have redistributed ownership toward Public Investors and reduced the influence of non-voting Class B holders.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Class B stockholder ownership decreased from 0.8% in 2023 to 0.7% in 2024, representing a 0.1 percentage point reduction. All quantitative data matches the ground truth exactly. The answer goes beyond the ground truth by providing additional context about the broader ownership structure changes (Public Investors increasing from 88.8% to 89.9%, Mastercard Foundation decreasing from 10.4% to 9.3%), which adds valuable insight into how the Class B decline fits within the overall ownership dynamics. The reasoning about potential Class B to Class A conversions and the redistribution of ownership toward Public Investors is logical and contextually appropriate, though this additional analysis was not explicitly required by the question. The answer demonstrates strong multi-hop synthesis by connecting the Class B decline to broader ownership structure shifts. Minor deduction from perfect score because the additional context about conversions and Foundation share sales, while reasonable inference, goes slightly beyond what was explicitly confirmed in the ground truth statement, which only noted the decline as 'minor.' However, this represents enhancement rather than error, making it a strength rather than weakness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 358,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "Walmart's total cash outflow related to Alert Innovation in fiscal 2023 was **$400 million**, as the company acquired the entity during that year. In the following fiscal year (2024), there is no mention of significant cash flows related to Alert Innovation. However, the entity was **subsequently sold and deconsolidated in fiscal 2025**, as noted in the document.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) QUANTITATIVE ACCURACY: The $400 million figure is correct and properly formatted as equivalent to the $0.4 billion stated in the ground truth. The numeric values match perfectly across both answers. (2) COMPLETENESS: The answer addresses both parts of the question - the fiscal 2023 cash outflow ($400M/0.4B acquisition) and the subsequent fiscal 2025 deconsolidation/sale. The LLM appropriately notes that fiscal 2024 had no significant Alert Innovation cash flows, which is a reasonable inference given the ground truth doesn't mention fiscal 2024 activity. (3) ENTITY ACCURACY: Walmart (WMT) is correctly identified, fiscal years are accurate (2023 acquisition, 2025 sale/deconsolidation), and the entity name 'Alert Innovation' is correct throughout. (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the fiscal 2023 acquisition event with the fiscal 2025 deconsolidation event, demonstrating proper cross-year information synthesis. (5) SEMANTIC EQUIVALENCE: The answer conveys identical information to the ground truth, with $400 million and $0.4 billion being properly recognized as equivalent values. The only minor observation is that the LLM's statement about 'no mention of significant cash flows' in fiscal 2024 is an inference rather than explicitly stated in the ground truth, but this is a reasonable and accurate inference that doesn't detract from the answer's quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 417,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "The total principal repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024 was **$1.5 billion** ($500 million for the 0.600% Notes and $1.0 billion for the 5.00% Notes). As of December 31, 2023, the facility's remaining borrowing capacity was **$6.0 billion**, as the repayments in early 2024 occurred after the end of the 2023 fiscal year and thus did not impact the capacity as of that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: All numbers are correct - $1.5 billion total principal repaid, broken down correctly as $500 million (0.600% Notes) + $1.0 billion (5.00% Notes), and $6.0 billion remaining borrowing capacity as of December 31, 2023. The arithmetic is sound. (2) COMPLETENESS: The answer addresses both parts of the question: (a) total principal repaid in early 2024 with the breakdown, and (b) the remaining borrowing capacity as of December 31, 2023. (3) ENTITY ACCURACY: Correctly identifies the 2021 Multicurrency Credit Facility, the specific note types with their interest rates, and the relevant fiscal year (2023). (4) REASONING: The LLM demonstrates sound multi-hop reasoning by correctly synthesizing that: the repayments occurred in early 2024 (after the December 31, 2023 measurement date), therefore the $6.0 billion capacity figure as of December 31, 2023 was not impacted by those early 2024 repayments. This temporal logic is correct and important. (5) MINOR OMISSION: The LLM answer does not include the sublimit details ($3.5 billion for multicurrency, $200 million for letters of credit, $50 million for swingline loans) that were mentioned in the ground truth. However, these sublimits are contextual details that don't directly answer the core question about total principal repaid and remaining capacity. The answer correctly states the key figure of $6.0 billion total remaining capacity. The omission of sublimit details is minor and does not significantly detract from the answer's accuracy or usefulness in addressing the specific question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 457,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel's use of EUV in the Intel 4 and Intel 3 process nodes marks a progression toward advanced transistor architectures, with EUV enabling smaller features and improved performance-per-watt. The document states that High Numerical Aperture EUV is part of Intel's roadmap beyond the Intel 20A node, which introduces Ribbon FET and PowerVia. The next-generation High Numerical Aperture EUV is expected to be integrated into the Intel 18A node, which follows Intel 20A and focuses on further refinements to RibbonFET and advanced packaging technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Intel's EUV progression and advanced transistor architectures. STRENGTHS: (1) All key entities correctly identified: Intel 4, Intel 3, Intel 20A, Intel 18A nodes are all properly named and sequenced. (2) Core technical concepts accurately conveyed: EUV usage for small features, performance-per-watt improvements, RibbonFET (gate-all-around), PowerVia (backside power delivery), and High Numerical Aperture EUV are all correctly described. (3) Multi-hop synthesis is sound: The answer correctly traces the progression from Intel 4/3 (EUV foundation) through Intel 20A (RibbonFET + PowerVia introduction) to Intel 18A (High Numerical Aperture EUV integration). (4) The answer correctly identifies Intel 18A as the node expected to introduce High Numerical Aperture EUV, matching the ground truth. (5) No numeric errors or calculation issues present. MINOR OBSERVATIONS: (1) The LLM mentions 'advanced packaging technologies' in relation to Intel 18A, which is not explicitly mentioned in the ground truth answer. However, this is a reasonable inference and does not contradict the provided information. (2) The phrasing differs slightly from ground truth (e.g., 'next-generation High Numerical Aperture EUV is expected to be integrated' vs. 'will incorporate next-generation High Numerical Aperture EUV'), but the semantic meaning is equivalent. (3) The answer could have been slightly more explicit about Meteor Lake as an example application of Intel 4, though this is a minor omission. Overall, the LLM answer successfully synthesizes information across multiple process nodes and correctly identifies the relationship between EUV progression and advanced transistor architectures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 486,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "The total combined value of investments in U.S. Treasuries and agencies in the 2023 10-K filing by VZ is **$1,550 million** ($1,412 million in Pension Plans and $138 million in Health Care and Life Plans). This compares to total cash and cash equivalents of **$1,983 million** ($1,956 million in Pension Plans and $27 million in Health Care and Life Plans). Thus, investments in U.S. Treasuries and agencies are **$433 million less** than total cash and cash equivalents.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key numeric values. Ground truth states: U.S. Treasuries and agencies total = $239 million ($101M + $138M), and cash and cash equivalents = $57 million ($30M + $27M). The LLM provided: U.S. Treasuries and agencies = $1,550 million ($1,412M + $138M) and cash and cash equivalents = $1,983 million ($1,956M + $27M). These numbers are dramatically different from the ground truth - off by a factor of 6-7x. The LLM correctly identified that it should compare the two categories and calculate the difference, showing sound reasoning structure. However, the actual numeric values are completely wrong. The LLM correctly identified the two asset categories (Pension Plans and Health Care and Life Plans) and attempted the proper multi-hop synthesis by combining values across categories. The comparison logic is sound (showing which is larger and by how much), but this correct reasoning is applied to entirely incorrect numbers. The only number that matches ground truth is the $138 million for Health Care and Life Plans U.S. Treasuries and agencies. All other values are incorrect: $1,412M vs $101M (off by 1,311M), $1,956M vs $30M (off by 1,926M), and $27M matches but the total is wrong. The calculation of the $433 million difference is mathematically correct given the LLM's numbers, but since those numbers are wrong, the final answer is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 387,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "The total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021 was **$10,901 million**. Of this, **$6,149 million** of the total goodwill from these acquisitions was specifically attributed to Aldevron.  \n\n**Source:** Page 74 details the breakdown of net cash consideration and goodwill for the 2021 acquisitions, separating Aldevron ($9,561 million cash consideration and $6,149 million goodwill) from the other 11 businesses ($1,340 million cash consideration and $1,038 million goodwill).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key numbers: (1) Total net cash consideration of $10,901 million is correct ($9,561M for Aldevron + $1,340M for other 11 businesses = $10,901M). (2) Goodwill attributed to Aldevron of $6,149 million is correct. (3) The answer correctly identifies that total goodwill was $7,187 million ($6,149M + $1,038M = $7,187M), though the LLM does not explicitly state the total goodwill figure or the breakdown of goodwill between Aldevron and the other 11 businesses. The LLM successfully synthesizes information across multiple data points: identifying the specific cash consideration for each acquisition group and the corresponding goodwill allocation. All numeric values are accurate with proper formatting. The answer directly addresses both sub-questions: (a) total net cash consideration paid, and (b) goodwill attributed to Aldevron. The source citation adds credibility. Minor deduction: The answer could have been slightly more complete by explicitly stating the total goodwill of $7,187 million and the $1,038 million goodwill for the other 11 businesses, which would provide fuller context to the answer, though this is not strictly required by the question as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 358,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, was **$800 million**. This amount is **less than** the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date, which was **$2,268 million** (as reported in the \"Investments in Nonconsolidated Affiliates\" table on page 76). The difference reflects additional investments and adjustments in the carrying value, including equity method accounting and goodwill.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All numbers are correct - $800 million committed capital contribution (equivalent to $0.8 billion in ground truth), $2,268 million carrying amount, and the comparison showing the carrying amount exceeds the committed contribution. The format variation ($800 million vs $0.8 billion) is acceptable and demonstrates proper understanding. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - the committed capital contribution amount and the comparison to the carrying amount. (3) ENTITY ACCURACY: All entities are correctly identified (GM, Ultium Cells Holdings LLC, December 31, 2023, Investments in Nonconsolidated Affiliates). (4) REASONING: The multi-hop synthesis is sound - the model correctly identified that the carrying amount ($2,268M) exceeds the committed contribution ($800M) and provided logical explanation that the difference reflects additional investments and equity method accounting adjustments. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth, with the additional context about equity method accounting and goodwill being a reasonable elaboration. Minor deduction (1 point) only because the ground truth's phrasing 'GM had not fully funded its committed capital contribution' is slightly more direct than the LLM's explanation, though both convey the same meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 396,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 were **$5,729 million** (as reported in Note 24, page 133). The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was **$37,185 million** (calculated as total proved/unproved properties of $74,014 million minus accumulated depreciation/depletion/amortization of $36,829 million, per page 157). The depreciation amount represents approximately **15.4%** of the net book value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all key metrics. Verification of numbers: (1) Depreciation, depletion, amortization, and impairments for Lower 48 in 2023: $5,729 million - CORRECT; (2) Net book value of proved and unproved properties as of Dec 31, 2023: $37,185 million - CORRECT; (3) Total proved/unproved properties: $74,014 million - CORRECT; (4) Accumulated depreciation/depletion/amortization: $36,829 million - CORRECT; (5) Percentage calculation: $5,729M / $37,185M = 15.4% - CORRECT. The LLM correctly synthesized multi-hop information by: identifying the 2023 depreciation figure, locating the net book value, and calculating the comparison ratio. The answer includes proper source citations (Note 24, page 133; page 157) which adds credibility. The LLM answer is more concise than the ground truth but covers all essential information. The ground truth provides additional context about accumulated depreciation totaling $42,558 million when combined with 2023 figures, which the LLM answer does not explicitly state, but this is a minor omission since the question asks for comparison, not cumulative analysis. The percentage comparison (15.4%) is a valuable analytical addition that directly addresses the 'how does it compare' portion of the question. All calculations are mathematically sound and all entities (Lower 48 region, 2023, December 31, 2023) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 392,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was **$6.1 billion**, including **842.6 million EUR** (equivalent to **$919.1 million**). This repayment activity significantly reduced the company's outstanding revolving indebtedness under the facility, as reflected in the **$723.4 million** outstanding balance as of December 31, 2023, compared to prior periods. The repayments, combined with borrowings of **$3.0 billion**, resulted in a net reduction of revolving debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all key metrics and multi-hop synthesis. QUANTITATIVE VERIFICATION: All primary numbers are correct - $6.1 billion total repayment, 842.6 million EUR, $919.1 million EUR equivalent, and $3.0 billion borrowings all match ground truth exactly. The $723.4 million outstanding balance figure is additional contextual information not contradicted by the ground truth. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) total repayment amount including both USD and EUR components, and (2) the effect on overall revolving indebtedness. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple data points - combining the repayment figures with borrowing activity to explain the net reduction in revolving debt. The logic is sound: large repayments ($6.1B) minus borrowings ($3.0B) resulted in net debt reduction. ENTITY ACCURACY: Correctly identifies the 2021 Multicurrency Credit Facility and the fiscal year 2023. MINOR CONSIDERATIONS: The ground truth mentions specific purposes for borrowing (repaying the 2021 USD Two Year Delayed-Draw Term Loan and general corporate purposes), which the LLM answer omits. However, this is a minor contextual detail that doesn't affect the core answer to the question asked. The LLM's inclusion of the $723.4 million outstanding balance provides additional relevant context about the facility's status. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 425,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 has led to ongoing closure activities at coal ash impoundments, with costs incorporated into rate proceedings for recovery. The company has submitted and begun implementing closure plans, including excavating high-priority sites and relocating coal ash to engineered landfills or for beneficial reuse. These compliance costs are recoverable through retail and wholesale rates, as amended contracts (e.g., 2017 wholesale rate schedules) allow recovery of expenditures related to closure, mitigating direct operational cost impacts while ensuring regulatory compliance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies the North Carolina Coal Ash Management Act of 2014 as the regulatory framework; (2) Accurately references completion of excavation at high-priority sites and closure activities across jurisdictions; (3) Correctly identifies coal combustion residuals (CCR) movement to engineered landfills or reuse as the operational mechanism; (4) Accurately cites 2017 wholesale rate schedules/amended contracts as the cost recovery mechanism; (5) Properly synthesizes that compliance costs are incorporated into rate proceedings for recovery. MINOR GAPS: (1) The LLM answer states 'three of the four high-priority North Carolina sites' were completed in the original answer but the LLM response doesn't specify this quantitative detail - it says 'high-priority sites' more generally without the 3-of-4 specification; (2) The original answer explicitly mentions the glossary definition of the Coal Ash Act indicating regulatory significance, while the LLM answer focuses primarily on operational/financial impacts without explicitly acknowledging the glossary reference mentioned in the question. QUANTITATIVE VERIFICATION: All numbers and dates mentioned (2014, 2017) are correct. The reference to 'amended contracts' and 'wholesale rate schedules' aligns with ground truth. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across business section (closure activities, costs) and regulatory framework (Coal Ash Act compliance), connecting operational activities to financial recovery mechanisms. The logic flow is sound and demonstrates understanding of how regulatory compliance translates to operational and financial impacts. SEMANTIC EQUIVALENCE: The answer conveys the core relationship between compliance requirements and operational/cost impacts effectively, though with slightly less specificity on the 3-of-4 site completion detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 543,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel's Agilex FPGA family enhances its IPU platforms by providing high-performance, power-efficient programmable logic for dynamic workloads, enabling cloud and communications providers to offload infrastructure processing tasks from CPUs. The Intel eASIC N5X, a structured ASIC, complements Agilex by offering lower cost and power consumption for specialized applications like 5G acceleration, while bridging the gap between FPGAs and standard-cell ASICs in IPUs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information about Intel's FPGA and eASIC technologies. STRENGTHS: (1) Correctly identifies Agilex FPGA family as enabling cloud and communications providers to offload processing from CPUs, matching the ground truth's core claim about reducing overhead and freeing CPU performance. (2) Accurately describes Intel eASIC N5X as offering lower cost and power consumption compared to FPGAs, which aligns with ground truth's statement about 'lower unit cost and lower power.' (3) Properly positions eASIC N5X as complementary to Agilex, bridging FPGA and ASIC solutions. (4) No quantitative errors - no specific numbers, dates, or percentages are provided in either answer, so quantitative accuracy is not a differentiator. (5) Multi-hop reasoning is sound: correctly synthesizes the relationship between Agilex FPGAs, eASIC N5X, and IPU platforms across multiple entities. MINOR GAPS: (1) The LLM answer does not explicitly mention that Agilex is built on Intel 10nm SuperFin technology, which is a technical detail in the ground truth. (2) Does not explicitly state that Agilex is 'already being deployed' at multiple cloud service providers, though it implies deployment capability. (3) Mentions '5G acceleration' as a specific application for eASIC N5X, which is not explicitly stated in the ground truth (though not contradicted). (4) The phrase 'structured ASIC' is used correctly but the ground truth emphasizes 'next-generation Intel eASIC device' more explicitly. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information that Agilex enables IPU platforms for cloud/communications workloads and that eASIC N5X provides a complementary lower-cost, lower-power alternative. The core relationship and functional roles are accurately captured. The answer is appropriately detailed without being overly verbose, and maintains contextual relevance to the question about how these technologies work together.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 541,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "Danaher had **24,000 employees in North America** and **3,000 employees in Other Developed Markets** as of December 31, 2023. These regions collectively represent **42.86%** of the total global workforce (27,000 employees / 63,000 total employees).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the question. Verification of key facts: (1) North America employees: 24,000  matches ground truth; (2) Other Developed Markets employees: 3,000  matches ground truth; (3) Percentage calculation: 27,000 / 63,000 = 42.86%  correct and matches ground truth; (4) Total global workforce: 63,000  matches ground truth. The multi-hop reasoning is sound - the model correctly identified both regional employee counts, summed them (27,000), calculated the percentage against total workforce, and presented all information clearly. The date reference (December 31, 2023) adds appropriate temporal context. Minor note: The LLM explicitly shows the calculation (27,000 / 63,000) which enhances transparency and verifiability. All numeric values are accurate, the percentage is correctly calculated, and the answer fully addresses the comparative and aggregate aspects of the question. The presentation is clear and well-organized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 286,
        "total_tokens": 1407
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, was **$557 million**, which is **equal to the total derivative assets** reported on the balance sheet for the same year. This is reflected in the \"DERIVATIVE ASSETS AT FAIR VALUE\" line item for foreign exchange forwards and options in the 2023 table (page 74) and confirmed by the \"TOTAL DERIVATIVE ASSETS\" of $557 million on the balance sheet (page 83). No other derivative assets were reported for 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information is correct. The $557 million figure for Nike's foreign exchange forwards and options as of May 31, 2023 matches the ground truth exactly. The statement that this equals total derivative assets is accurate. The conclusion that all derivative assets were composed of foreign exchange forwards and options is correct. (2) QUANTITATIVE ACCURACY: The $557 million figure is precise and correctly stated. No calculations were required, but the comparison logic is sound - the LLM correctly identifies that the FX forwards/options total equals the total derivative assets. (3) QUALITATIVE ACCURACY: The LLM demonstrates strong multi-hop reasoning by synthesizing information across multiple balance sheet locations (page 74 for derivative assets detail and page 83 for balance sheet total). The reasoning that 'no other derivative assets were reported for 2023' is a valid inference from the equality of the two figures and is consistent with the ground truth. (4) ENTITY ACCURACY: Nike is correctly identified, the fiscal year (May 31, 2023) is correct, and the financial metrics (foreign exchange forwards and options, derivative assets) are properly identified. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, with slightly more detail about source documentation (page references). The phrasing 'equal to' and 'matches' are semantically equivalent. Minor enhancement: The LLM provides additional context with page references, which adds value without introducing errors. The answer fully addresses both parts of the multi-part question (what is the total FX forwards/options value, and how does it compare to total derivative assets).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 481,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, a rise of **$1,662 million**. The number of productive wells in the Lower 48 region grew from **16,527** (14,251 oil + 2,276 gas) in 2023 to **16,527** (assuming 2022 data aligns with 2023 figures, as no 2021 productive well count is explicitly provided in the documents). However, the 2021 productive well data is not directly available in the provided pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors and fails to properly address the multi-part question. CORRECT ELEMENTS: (1) The depreciation, depletion, amortization, and impairments expense figures are accurate: $4,067 million (2021), $5,729 million (2023), and the $1,662 million increase is correctly calculated. MAJOR ERRORS: (1) PRODUCTIVE WELLS DATA - The LLM provides completely incorrect well counts. The ground truth states the Lower 48 region had 87 productive wells in 2021 and 38 in 2023 (a decrease of 49 wells). The LLM instead provides 16,527 wells (14,251 oil + 2,276 gas), which appears to be data from a different region or aggregated company-wide data, not specific to Lower 48. (2) INCOMPLETE ANSWER - The LLM acknowledges that '2021 productive well data is not directly available' and provides 2023 data only, failing to complete the multi-hop synthesis required by the question. The question explicitly asks for the change in productive wells from 2021 to 2023, and the ground truth clearly shows this decreased from 87 to 38. (3) REASONING FAILURE - The LLM's statement 'assuming 2022 data aligns with 2023 figures' demonstrates faulty logic and an inability to locate or synthesize the required historical data. The multi-hop reasoning required here involves extracting two distinct metrics (depreciation expense AND productive well counts) across two years for a specific region, and the LLM only partially succeeds on the first metric while completely failing on the second. The answer is approximately 50% correct on the depreciation question but 0% correct on the productive wells question, making the overall response significantly deficient.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 457,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "The total combined value of investments in U.S. Treasuries and agencies from Verizon's 2023 10-K is **$1,550 million** ($1,412 million in pension plans and $138 million in health care and life plans). The pension plans allocate **~15.5%** of their total fair-value investments ($1,412M / $9,104M) to U.S. Treasuries and agencies, while health care plans allocate **~29.9%** ($138M / $461M). This reflects a higher concentration in U.S. Treasuries and agencies within health care plans compared to pension plans.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors and fails to address the core question. MAJOR ISSUES: (1) WRONG TOTAL: LLM reports $1,550 million as the combined total, but ground truth clearly states $2,953 million from both tables. This is a fundamental calculation error - the LLM appears to have only summed $1,412M + $138M, missing the second table's $1,541 million entirely. (2) INCOMPLETE SYNTHESIS: The question explicitly asks about 'both tables' and 'two different categorizations.' The ground truth identifies two separate tables with different values ($1,412M in first table, $1,541M in second table). The LLM only references one set of numbers and completely misses the second table's data. (3) MISINTERPRETATION: The LLM interprets the two categorizations as 'pension plans' vs 'health care plans' rather than recognizing them as two separate fair-value investment tables with different Level 1/Level 2 breakdowns. This shows fundamental misunderstanding of the filing structure. (4) MISSING FAIR VALUE LEVEL ANALYSIS: The ground truth emphasizes the Level 1 vs Level 2 categorization ($1,274M vs $138M in first table; $1,312M vs $229M in second table), which is central to understanding fair value measurement. The LLM completely omits this critical analysis. (5) INCORRECT PERCENTAGES: While the LLM's percentage calculations ($1,412M/$9,104M = 15.5%) may be mathematically correct, they're based on a misinterpretation of what the two categorizations represent and don't address the actual question about comparing allocation between the two tables. The answer demonstrates a failure to perform proper multi-hop synthesis across both tables and provides a total that is off by $1,403 million (47% error).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 469,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024. In 2023, the amount was $502 million, and in 2024, it was $347 million, as reflected in the \"CASHANDEQUIVALENTS\" column of the fair value measurements table.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The primary answer of a $155 million decrease is correct and matches the ground truth exactly. (2) QUANTITATIVE ACCURACY: All numbers are verified as correct - 2023 amount of $502 million, 2024 amount of $347 million, and the calculated difference of $155 million ($502M - $347M = $155M). The arithmetic is sound. (3) QUALITATIVE ACCURACY: The answer correctly identifies Nike as the company, the correct fiscal years (2023 to 2024), and the correct metric (timed deposits classified as cash and equivalents). The reference to the 'fair value measurements table' and 'CASHANDEQUIVALENTS' column provides appropriate contextual detail showing the source of the data. (4) MULTI-HOP REASONING: The answer successfully synthesizes information by combining the decrease amount with the underlying year-over-year values, demonstrating proper multi-hop synthesis. (5) SEMANTIC EQUIVALENCE: The wording is clear and professional, conveying all necessary information. The only minor observation is that the LLM provided additional supporting detail (the specific 2023 and 2024 values) beyond what was strictly required by the question, but this is a strength rather than a weakness as it enhances transparency and verifiability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1087,
        "completion_tokens": 361,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled **$6,790 million in 2023** (Alaska: $1,061M + Lower 48: $5,729M) compared to **$5,795 million in 2022** (Alaska: $941M + Lower 48: $4,854M). This represents an **increase of $995 million** (17.1%) from 2022 to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All key facts are correct: (1) 2023 combined total of $6,790 million matches ground truth exactly; (2) 2022 combined total of $5,795 million matches ground truth exactly; (3) Year-over-year increase of $995 million is correctly calculated ($6,790M - $5,795M = $995M); (4) The breakdown by segment is provided and verifiable (Alaska 2023: $1,061M + Lower 48 2023: $5,729M = $6,790M; Alaska 2022: $941M + Lower 48 2022: $4,854M = $5,795M); (5) The percentage increase of 17.1% is accurately calculated ($995M / $5,795M = 0.1717 or 17.17%, rounded to 17.1%). The answer successfully synthesizes multi-hop information across two operational segments and two fiscal years, directly addressing all parts of the question. The presentation is clear, well-organized, and includes helpful supporting details (segment breakdowns and percentage change) that enhance understanding without introducing any inaccuracies. No errors detected in numbers, calculations, entity identification, or reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 301,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "The total fair value of PayPal Holdings, Inc.'s crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2022, was **$604 million** each, totaling **$1.208 billion**. These are reflected in the fair value disclosures as Level 2 measurements, using quoted prices from the principal market for the underlying crypto assets, as there are no active markets for the liability or asset itself. The amounts are recorded within \"prepaid expenses and other current assets\" and \"accrued expenses and other current liabilities\" on the consolidated balance sheets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The $604 million figure is accurate for the fair value amounts, (2) Level 2 fair value measurement classification is correct, (3) Company name and date (December 31, 2022) are correct, (4) The general description of using quoted prices from principal markets is appropriate. CRITICAL ERROR: The LLM states the total is '$1.208 billion' by adding $604M + $604M. However, the ground truth indicates the TOTAL fair value is $604 million for BOTH the liability and asset combined, not $604 million each. The LLM misinterpreted the structure - there is one $604 million total that represents both the safeguarding liability and corresponding safeguarding asset (they are offsetting positions). This is a significant quantitative error that inflates the total by 100%. MINOR ISSUES: (1) The balance sheet line item references ('prepaid expenses and other current assets' and 'accrued expenses and other current liabilities') are reasonable but not explicitly confirmed in the ground truth, which only mentions they appear in financial assets and liabilities tables. (2) The explanation of Level 2 methodology is reasonable but adds detail not explicitly stated in the ground truth. The core misunderstanding about whether $604M is per item or total significantly impacts the accuracy of the answer, despite getting the individual fair value amount and classification correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 402,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "The net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024 was a **cash outflow of $2.8 billion**. This reflects the $3.5 billion Walmart paid to increase its ownership of Flipkart (and settle PhonePe liabilities) and the $0.7 billion received from new equity funding for PhonePe, resulting in a net cash outflow of $3.5B - $0.7B = **$2.8 billion**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM states a net cash outflow of $2.8 billion, but the ground truth is $0.2 billion - a 14x overstatement. The LLM incorrectly cites $3.5 billion paid to increase ownership, when the correct amount is $0.9 billion. This is a massive factual error ($3.5B vs $0.9B). (2) ENTITY CONFUSION: The LLM conflates Flipkart with PhonePe, stating 'Walmart paid to increase its ownership of Flipkart (and settle PhonePe liabilities)' when the question specifically asks about PhonePe ownership changes. This is a critical entity identification error. (3) CALCULATION ERROR: Even accepting the LLM's stated numbers, the math is wrong. The LLM claims $3.5B - $0.7B = $2.8B, which is arithmetically correct, but the $3.5B figure itself is incorrect per the ground truth. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the two components: it should have identified $0.9B outflow (to increase ownership) + $0.7B inflow (from equity funding) = $0.2B net outflow. Instead, it used entirely wrong base numbers. (5) MISSING CONTEXT: The LLM provides no clear breakdown of the PhonePe-specific transactions, instead mixing in Flipkart references. The correct answer clearly separates the $0.9B payment to noncontrolling interest holders from the $0.7B equity funding received, netting to $0.2B. The LLM's answer is not a minor rounding or presentation difference - it represents fundamental factual inaccuracy across all key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 422,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was a **decrease of $8 million** ($476 million in 2024 vs. $484 million in 2023). The IIC-approved affiliate sales mechanism influenced this outcome by enabling increased affiliate sales volume (up 131.7% to $139 million in 2024), driven by higher demand from affiliated companies. However, this was offset by a significant decline in non-affiliate wholesale revenues ($337 million in 2024 vs. $424 million in 2023), primarily due to the expiration of power sales agreements and lower KWH sales volume. Affiliate sales under the IIC mechanism helped stabilize revenue but did not fully counteract the non-affiliate decline.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core quantitative finding. Ground truth states a NET INCREASE of $69 million in total wholesale revenues for 2024 vs 2023, but the LLM claims a DECREASE of $8 million. This is a critical factual error that contradicts the ground truth by approximately $77 million in direction and magnitude. The LLM provides specific dollar amounts ($476M vs $484M) that do not align with the ground truth's calculation methodology. The ground truth explicitly states the increase comes from combining a $77M increase from one segment with a net $79M increase minus $87M decrease from another segment, totaling $69M. The LLM's numbers and percentages (131.7% affiliate increase, $139M affiliate sales, $337M non-affiliate 2024 vs $424M 2023) cannot be verified against the ground truth and appear to be fabricated or from incorrect sources. Regarding the IIC-approved mechanism: The ground truth correctly identifies a 165.5% rise in KWH sales volume under the IIC-approved FERC pricing mechanism at marginal cost. The LLM states 131.7% increase, which is incorrect. The LLM does acknowledge the IIC mechanism's role in stabilizing revenue, which is directionally correct, but this cannot compensate for the fundamental error in the net change calculation. The multi-hop reasoning is flawed because the LLM failed to correctly synthesize the two-segment revenue changes into the proper net total. The answer demonstrates a complete misunderstanding of the financial data structure and provides contradictory directional findings (increase vs decrease).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 435,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "The total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites, is $20 billion for Arizona, more than $20 billion for Ohio, and approximately $10.5 billion for the global packaging sites, totaling more than $50.5 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all components of the multi-hop question. Verification of numbers: (1) Arizona: $20 billion - CORRECT, (2) Ohio: more than $20 billion - CORRECT, (3) Global packaging sites (Rio Rancho and Malaysia): $10.5 billion - CORRECT. Calculation verification: $20B + $20B+ + $10.5B = $50.5B+ - CORRECT. The LLM properly synthesized information across three geographic locations and correctly identified the total as 'more than $50.5 billion' which matches the ground truth. Minor observation: The LLM uses 'approximately $10.5 billion' for packaging sites while ground truth states '$10.5 billion' without the qualifier, but this is a negligible semantic difference that doesn't affect accuracy. The answer demonstrates sound multi-hop reasoning by combining investments from Arizona, Ohio, and global packaging sites into a coherent total. All entities (Intel, IDM 2.0 strategy, specific locations) are correctly identified. The response is complete, addressing all parts of the question with accurate financial figures and proper synthesis across multiple investment announcements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 321,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "Danaher recorded approximately **$3.9 billion** of goodwill from the acquisition of Abcam. The Veralto separation resulted in a **$2.6 billion net cash inflow** to Danaher prior to the distribution date, primarily from the Veralto Distribution proceeds used to redeem commercial paper and fund other obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies both key quantitative facts: (1) $3.9 billion in goodwill from Abcam acquisition, and (2) $2.6 billion net cash inflow from Veralto separation. The number formatting is appropriate and matches the ground truth. However, there is a notable omission in completeness: the ground truth specifically mentions that $1.0 billion of the commercial paper was redeemed, which is a concrete detail that demonstrates how the cash was used. The LLM answer states the proceeds were 'used to redeem commercial paper and fund other obligations' but does not specify the $1.0 billion amount. This is a material detail that was in the original answer. The multi-hop reasoning is sound - the model correctly synthesized information about both the Abcam acquisition and the Veralto separation impact on cash position. The semantic meaning is largely preserved, though the specificity of the $1.0 billion redemption detail represents an incomplete answer to the full scope of the question. The answer demonstrates good understanding of the multi-part question structure and addresses both components, but falls short of full completeness due to the missing specific redemption amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 338,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was **$468 million**, as reflected in the reclassifications from accumulated other comprehensive income (AOCI) to income. This compares to the fair value of these derivatives at year-end, which totaled **$223 million net** (assets of $343 million minus liabilities of $120 million). The net gain recognized in income exceeds the year-end fair value, reflecting cumulative reclassifications of prior-period gains and losses, as well as changes in exchange rates during the year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that make it fundamentally incorrect: (1) MAJOR ERROR - Net gain amount: LLM states $468 million, but ground truth is $24 million. This is a 1,850% overstatement and represents a complete factual failure on the primary metric requested. (2) MAJOR ERROR - Fair value of assets: LLM states $343 million, but ground truth is $557 million. This is a 38% understatement. (3) MAJOR ERROR - Fair value of liabilities: LLM states $120 million, but ground truth is $180 million. This is a 33% understatement. (4) CALCULATION ERROR - LLM calculates net fair value as $223 million ($343M - $120M), which is arithmetically correct for those numbers, but since both underlying values are wrong, the calculation is based on false premises. (5) CONCEPTUAL CONFUSION - The LLM appears to have confused the net gain recognized in income ($24M) with reclassifications from AOCI, introducing an explanation that doesn't match the ground truth data. (6) INCOMPLETE COMPARISON - While the LLM attempts to compare the gain to fair value, it does so using entirely incorrect numbers. The ground truth shows a $24M gain against $557M in assets and $180M in liabilities, which is a meaningful comparison the LLM failed to capture. The LLM's reasoning about cumulative reclassifications and exchange rate changes may be conceptually sound, but it's applied to wrong numbers. This answer would mislead any user relying on it for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 408,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is **$57,695 million** (as shown in the \"Total Company\" column for Lower 48 in the 2022 row of the table on page 161). This compares to the 2022 depreciation, depletion, amortization, and impairments for the Lower 48 region of **$4,854 million** (from the \"Depreciation, Depletion, Amortization and Impairments\" table on page 133). The discounted future net cash flows are significantly higher than the depreciation-related expenses, reflecting the estimated future cash generation potential of the region versus the non-cash asset consumption charges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM provides $57,695 million for the combined discounted future net cash flows from the Lower 48 region, but the ground truth states $55,912 million. This is a significant discrepancy of $1,783 million (approximately 3.2% difference), which is material and cannot be dismissed as a rounding or formatting variation. The LLM cites 'page 161' and 'Total Company column' but provides an incorrect figure. The depreciation, depletion, amortization, and impairments figure of $4,854 million is correct and matches the ground truth. The LLM correctly identifies that equity affiliates contributed no discounted future net cash flows from the Lower 48 (as stated in the ground truth), though this detail is not explicitly mentioned in the LLM answer. The reasoning about comparing future cash flows to depreciation-related expenses is sound and appropriate. However, the fundamental error in the primary quantitative metric (the combined total of discounted future net cash flows) is a major factual error that undermines the entire answer. The LLM demonstrates good understanding of the question structure and provides relevant contextual analysis, but the incorrect primary number is a critical failure for a financial question where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 361,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "The total value of Loans and Interest Receivable, Held for Sale reported by PayPal as of December 31, 2023, was **$563 million**. This amount is recorded at the **lower of cost or fair value**, with fair value determined using **significant unobservable inputs** (Level 3). The fair value is based on the price PayPal expects to receive from its agreement with the global investment firm, which is derived from loan and risk classifications. Since the reported value already reflects the lower of cost or fair value, there is no explicit quantitative difference stated; however, the fair value is explicitly tied to unobservable inputs (the expected sale price).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. (1) QUANTITATIVE ACCURACY: The $563 million figure is correct and matches the ground truth exactly. The date (December 31, 2023) is accurate. No calculation errors present. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the total value of Loans and Interest Receivable, Held for Sale ($563 million), and (b) the comparison to fair value based on unobservable inputs (Level 3). The LLM correctly identifies that the entire amount uses Level 3 inputs. (3) ENTITY ACCURACY: PayPal is correctly identified, the metric (Loans and Interest Receivable, Held for Sale) is correct, and the fiscal period (December 31, 2023) is accurate. (4) REASONING: The multi-hop synthesis is sound. The LLM correctly connects the reported value to the fair value measurement methodology and explains that Level 3 inputs (significant unobservable inputs) are used. The explanation about 'lower of cost or fair value' accounting treatment adds helpful context. (5) SEMANTIC EQUIVALENCE: The LLM's statement that 'the fair value is entirely based on Level 3 inputs' is semantically equivalent to the ground truth's 'measured using significant unobservable inputs (Level 3).' Minor strength: The LLM provides additional context about the measurement methodology (lower of cost or fair value, expected sale price from investment firm agreement) that, while not explicitly required, demonstrates deeper understanding. The only minor limitation is that the LLM could have been slightly more explicit in stating that 100% of the $563 million is Level 3, though this is clearly implied in the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 455,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "Under the 2021 Multicurrency Credit Facility, $3.0 billion was borrowed and $6.1 billion was repaid during the year ended December 31, 2023. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid. The Multicurrency Facility had significantly higher repayments ($6.1B) compared to borrowings ($3.0B), while the Credit Facility had higher borrowings ($3.1B) than repayments ($2.6B).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with all key financial figures accurately stated. Quantitative verification: (1) 2021 Multicurrency Credit Facility: $3.0B borrowed and $6.1B repaid - CORRECT; (2) 2021 Credit Facility: $3.1B borrowed and $2.6B repaid - CORRECT; (3) All numbers match ground truth exactly. The LLM correctly synthesized the multi-hop information by comparing both facilities across the same time period (year ended December 31, 2023). The answer addresses all parts of the question: amounts borrowed, amounts repaid, and comparative analysis between the two facilities. The LLM provided additional context by noting the net positions (higher repayments vs borrowings for Multicurrency, higher borrowings vs repayments for Credit Facility), which demonstrates sound reasoning. Minor deduction: The ground truth explicitly calculated net positions ($3.1B net repayment for Multicurrency and $0.5B net borrowing for Credit Facility), while the LLM described the pattern qualitatively without stating these exact net figures. This is a minor omission of calculated detail rather than an error. The semantic meaning and factual content are equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 336,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "The audit procedures applied to both Georgia Power and Mississippi Power included testing management's controls over evaluating the likelihood of cost recovery in future rates, reviewing regulatory orders and precedents, testing incurred costs for completeness/accuracy, obtaining management representations about recoverability, and evaluating disclosures related to regulatory risks. These procedures reflect subjectivity due to reliance on assumptions about future regulatory decisions by commissions, which involve complex judgments about potential outcomes impacting cost recovery and rate adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core audit procedures and correctly identifies both Georgia Power and Mississippi Power as the relevant entities. The answer accurately captures the main audit procedures: testing management's controls over evaluating likelihood of cost recovery in future rates, and reviewing regulatory orders and precedents. The explanation of subjectivity involving future regulatory decisions is semantically equivalent to the ground truth's description of 'significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.' However, the LLM answer includes two additional procedures not mentioned in the ground truth: (1) 'testing incurred costs for completeness/accuracy' and (2) 'obtaining management representations about recoverability.' While these are reasonable audit procedures that could be applied in such contexts, they are not explicitly stated in the original answer. The LLM also adds 'evaluating disclosures related to regulatory risks,' which is a reasonable inference but not explicitly mentioned in the ground truth. The answer correctly emphasizes the subjectivity and complexity of assessing future regulatory outcomes. No quantitative data was required for this question, so quantitative accuracy is perfect. The multi-hop reasoning is sound - the answer correctly synthesizes information about both utilities and connects the audit procedures to the underlying subjectivity. The main weakness is the introduction of procedures not explicitly confirmed in the ground truth, which could represent either appropriate elaboration or minor factual divergence depending on the actual filing content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 462,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The decline in Comirnaty's global revenue in 2023, driven by reduced supply to BioNTech and lower sales, significantly impacted Pfizer's operational results by reducing gross profit and cost of sales by $9.4 billion. This decline also contributed to a $3.5 billion revenue reversal related to U.S. government inventory returns. Under the BioNTech collaboration, Pfizer shares development and commercialization costs equally, with future milestone payments (up to $200 million) and royalty obligations, which will shape future financial commitments. Additionally, Pfizer's restructuring programs and cost-reduction initiatives aim to align expenses with declining revenue streams, including adjustments to its cost base through severance, implementation costs, and operational realignment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported information not present in the ground truth. CRITICAL ERRORS: (1) The LLM claims a '$9.4 billion' reduction in gross profit and cost of sales - this specific figure is not mentioned in the ground truth and appears to be fabricated or misattributed. (2) The LLM references a '$3.5 billion revenue reversal related to U.S. government inventory returns' - this is not mentioned in the ground truth answer and represents an unsupported claim. (3) The LLM states 'Pfizer shares development and commercialization costs equally' - the ground truth specifies 'tiered royalties and share gross profits,' which is different from equal cost-sharing. (4) The LLM mentions 'future milestone payments (up to $200 million)' - this specific figure is not in the ground truth. WHAT WAS CORRECT: (1) The LLM correctly identifies the revenue decline in Comirnaty from 2022 to 2023. (2) The LLM correctly notes the collaboration agreement with BioNTech involves ongoing financial obligations. (3) The LLM appropriately mentions restructuring and cost-reduction initiatives. MISSING KEY INFORMATION: The LLM fails to mention the critical 70% revenue drop percentage ($37,806M to $11,220M), the specific reasons for decline (lower contracted deliveries, transition to traditional U.S. commercial market), and the geographic specifics of Pfizer's retained rights (excluding Germany, Turkey, and certain Asian regions). The answer introduces multiple unsupported financial figures that undermine credibility and suggest either hallucination or confusion with other financial data. The multi-hop reasoning is partially sound but built on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 466,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024, as reported in Note 4 of the 2024 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and matches the ground truth perfectly. All quantitative elements are correct: (1) The year-over-year decrease of $11 million is accurate ($46M - $35M = $11M decrease); (2) The May 31, 2023 value of $46 million is correct; (3) The May 31, 2024 value of $35 million is correct; (4) The company (NKE/Nike) is correctly identified; (5) The financial metric (U.S. Agency securities held as short-term investments) is correctly identified. The LLM answer goes slightly beyond the ground truth by adding a citation reference ('as reported in Note 4 of the 2024 10-K filing'), which is appropriate additional context that enhances the answer without introducing any inaccuracies. The multi-hop reasoning is sound - the model correctly synthesized the comparison between two fiscal years and calculated the year-over-year change. The answer is complete, addresses all parts of the question, and maintains semantic equivalence with the ground truth while providing helpful sourcing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 295,
        "total_tokens": 1403
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was a **decrease of $77 million**. This reflects the $77 million repayment of notes in July 2024, as there were no new issuances of Guaranteed Senior Notes during the 2024 fiscal year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. Ground truth states the net change was an INCREASE of $423 million, while the LLM claims a DECREASE of $77 million - these are directionally opposite and numerically different. The LLM's reasoning that 'there were no new issuances' and only a '$77 million repayment' contradicts the ground truth which indicates a net positive change of $423 million. This suggests either: (1) there were significant new issuances the LLM failed to identify, or (2) the repayment amount cited is incorrect. The LLM demonstrates incomplete multi-hop synthesis - it appears to have identified only one transaction (the July 2024 repayment) without accounting for other issuances or transactions that would be necessary to arrive at the correct net change. The answer is contextually relevant to the question asked (addressing Costco's Japanese subsidiary and 2024 Guaranteed Senior Notes), but the factual content is substantially wrong. The quantitative error is critical: $423M increase vs. $77M decrease represents a $500M discrepancy in the net change calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 318,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "The total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments as of December 31, 2024, was **$0.5 billion**. This compares to **$4.2 billion** in cash, cash equivalents, and marketable securities held by the company in the U.S. as of the same date. The cash holdings are significantly higher, reflecting 3M's substantial liquidity position.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies both key financial figures: $0.5 billion in stand-alone letters of credit, bank guarantees, and similar instruments, and $4.2 billion in U.S.-held cash, cash equivalents, and marketable securities as of December 31, 2024. All numeric values are accurate and properly formatted. The comparison statement that 'cash holdings are significantly higher' is logically sound and semantically equivalent to the ground truth's statement about the instruments representing 'approximately 11.9% of U.S.-held liquidity.' However, the LLM answer omits the specific percentage calculation (11.9%) that was included in the ground truth answer. While the LLM correctly synthesizes the multi-hop information (identifying both values and making a comparison), it provides a qualitative comparison rather than the quantitative percentage comparison that was part of the original answer. This is a minor but notable omission - the question asks 'how does this compare,' and while the LLM provides a valid comparison statement, it doesn't include the precise percentage metric that quantifies the relationship. The answer demonstrates sound reasoning and correctly addresses the core question, but lacks the complete analytical depth of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 356,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "In Q4 2023, Meta estimated that duplicate accounts represented approximately **10%** of its worldwide MAUs, while false accounts accounted for about **4%**. Duplicate accounts constituted a higher percentage compared to false accounts during the same period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct on all key factual elements. Quantitative accuracy is perfect: both the 10% figure for duplicate accounts and 4% figure for false accounts match the ground truth exactly, and the time period (Q4 2023) is correct. The entity identification is accurate (Meta, worldwide MAUs). The multi-hop reasoning is sound - the model correctly synthesized information about two different account types and made an appropriate comparison. However, there is a minor qualitative difference: the ground truth explicitly states that duplicate accounts were 'more than twice as prevalent' (a specific quantitative comparison: 10% is 2.5x greater than 4%), while the LLM answer only states that duplicate accounts 'constituted a higher percentage' without specifying the magnitude of the difference. This is a minor omission of analytical detail rather than an error. The LLM answer is clear, well-formatted, and directly addresses all parts of the question. The semantic meaning is equivalent to the ground truth, with only the explicit quantitative comparison being less detailed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 314,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Pfizer paid an upfront cash payment of **$75 million** to BioNTech for the shingles mRNA vaccine collaboration and **$150 million** to Biohaven for migraine treatment rights outside the U.S. The upfront cash payment to Biohaven ($150 million) was higher than the cash portion paid to BioNTech ($75 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) CORRECTNESS: All factual information is correct - BioNTech received $75 million upfront for the shingles mRNA vaccine collaboration, and Biohaven received $150 million upfront for migraine treatment rights outside the U.S. (2) QUANTITATIVE ACCURACY: Both dollar amounts are precisely correct ($75M and $150M), and the comparison is accurate. The LLM correctly identifies that Biohaven's payment was $75 million higher than BioNTech's payment. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two separate Pfizer partnerships (BioNTech and Biohaven) and correctly compares the upfront payments. The reasoning is sound and logical. (4) COMPLETENESS: The answer addresses both parts of the question - the specific upfront payment to BioNTech, the specific upfront payment to Biohaven, and the comparison between them. The only minor difference from the ground truth is that the LLM states 'The upfront cash payment to Biohaven ($150 million) was higher than the cash portion paid to BioNTech ($75 million)' rather than explicitly stating 'resulting in a $75 million difference,' but this is semantically equivalent and actually provides the same comparative information. The LLM's phrasing is clear and directly answers the comparison question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 381,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is **$120 million**. This figure is derived from the \"Derivative Liabilities at Fair Value\" section on page 74, which specifically lists $120 million for foreign exchange forwards and options. While the note mentions potential netting reductions, the question explicitly asks for total liabilities, and the $120 million reflects the gross liability amount disclosed in the financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect on the primary metric. The ground truth states the total liabilities are $115 million ($110 million from hedging instruments + $5 million from non-hedging instruments), but the LLM claims $120 million. This is a $5 million discrepancy, which is material and represents a 4.3% error. The LLM's reasoning about 'gross liability amount' and reference to page 74 appears to be fabricated or misinterpreted, as it does not align with the actual filing data. The question explicitly asks for the total considering both hedging and non-hedging instruments, which requires multi-hop synthesis. The ground truth correctly breaks down the components ($110M + $5M = $115M), demonstrating proper synthesis across derivative categories. The LLM failed to: (1) provide the correct total amount, (2) break down the hedging vs. non-hedging components, and (3) accurately synthesize the multi-hop information. The LLM's citation of a specific page and 'Derivative Liabilities at Fair Value' section cannot be verified against the ground truth and appears to be an unsupported claim. This is a critical failure on a straightforward numerical question with clear ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 339,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to hold customer-held cryptocurrencies, which is disclosed alongside risk concentrations in customer accounts. This liability is tied to the company's exposure to credit risk, as concentrations in customer balances (including crypto assets) could lead to potential losses if customers default or if crypto assets lose value. The disclosure highlights that PayPal's credit risk is tied to the liquidity and solvency of customer accounts, with significant portions of receivables and transaction expenses concentrated in specific partners or customers, amplifying exposure to credit-related volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant conceptual errors that misrepresent PayPal's crypto asset safeguarding liability and credit risk exposure. CRITICAL ERRORS: (1) The LLM incorrectly states that credit risk arises from 'customer default or crypto asset loss value' - this fundamentally misunderstands the nature of the liability. The ground truth correctly identifies that crypto assets are NOT PayPal's assets but are safeguarded through a liability mechanism, meaning PayPal's credit risk comes from the financial institutions holding customer funds, not from customers themselves or asset volatility. (2) The LLM conflates customer account credit risk with crypto safeguarding liability credit risk - these are distinct exposures. The ground truth clearly separates them: crypto safeguarding liability creates credit risk through institutional counterparty exposure (where funds are deposited), not through customer solvency. (3) The LLM mentions 'receivables and transaction expenses concentrated in specific partners or customers' which is not part of the ground truth answer and appears to be a mischaracterization of the crypto safeguarding liability disclosure. CORRECT ELEMENTS: The LLM correctly identifies that PayPal recognizes a crypto asset safeguarding liability and that this connects to risk concentration disclosures. However, the reasoning about WHY this creates credit risk is fundamentally wrong. The ground truth's key insight - that credit risk arises from FDIC insurance limits being exceeded at financial institutions holding customer funds - is completely absent from the LLM answer. The LLM's explanation about customer defaults and crypto volatility represents a misunderstanding of how safeguarding liabilities work in this context. No quantitative errors are present (no specific numbers were provided in either answer), but the qualitative reasoning is substantially flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 515,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "Under the 2019 Plan, **689,202 LTIP units** were issued net of forfeitures. These units did **not have a material dilutive effect** on potential stock dilution for the year ended December 31, 2024, as explicitly stated in the document.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-part question. (1) QUANTITATIVE ACCURACY: The specific number of 689,202 LTIP units issued net of forfeitures under the 2019 Plan is correctly stated and matches the ground truth exactly. The numeric value is precise and properly formatted. (2) COMPLETENESS: The answer addresses both parts of the question: (a) the number of LTIP units issued net of forfeitures, and (b) the impact on potential stock dilution. Both components are covered comprehensively. (3) ENTITY ACCURACY: All entities are correctly identified - the 2019 Plan, LTIP units, the year ended December 31, 2024, and the concept of stock dilution are all accurate. (4) REASONING: The multi-hop synthesis is sound. The answer correctly identifies that while these units were potentially dilutive securities, they did not have a material dilutive effect on the company's stock for the specified period. This demonstrates proper understanding of the distinction between being a potentially dilutive security and having an actual material dilutive impact. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'did not have a material dilutive effect' is semantically equivalent to the ground truth statement that they 'did not have a material dilutive effect.' The answer is clear, direct, and factually correct. Minor deduction from perfect score (9 vs 10) only because the LLM could have slightly expanded on why these units were considered potentially dilutive despite lacking material impact, though this is not required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 430,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "The total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products was **$0.28 per share**, compared to **$0.90 per share** in 2022. This represents a decrease in the per-share impact from 2022 to 2024, as noted in the \"Earnings (loss) from continuing operations per diluted share\" table on page 20 of the 10-K filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the 2024 impact was $0.28 per share, but the ground truth clearly indicates it was $0.20 per share. This is a factual error of $0.08 per share (40% discrepancy). The 2022 figure of $0.90 is correct. (2) DIRECTIONAL INTERPRETATION - The LLM correctly identifies both figures as reductions/negative impacts, which aligns with ground truth. (3) MISSING SYNTHESIS - The ground truth explicitly states the combined impact over two years was $1.10 ($0.20 + $0.90), which the LLM failed to calculate or mention. The question asks for comparison between 2024 and 2022, and while the LLM provides both years, it misses the total combined impact calculation. (4) ENTITY/METRIC ACCURACY - Correctly identifies 3M, PFAS products, earnings per diluted share, and the relevant years. (5) REASONING - The LLM attempts to reference a specific page/table but provides incorrect numerical data, suggesting either misreading of source material or hallucination. The core multi-hop requirement (comparing 2024 to 2022 and calculating combined impact) is only partially addressed. The primary failure is the incorrect 2024 figure ($0.28 vs. $0.20), which is a material factual error in a financial context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 353,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "The volume changes in KWH sales governed by the Intercompany Interchange Contract (IIC) significantly impacted Southern Company's wholesale revenue in 2024. Wholesale revenues to non-affiliates decreased by $87 million (20.5%) due to a 30.8% drop in KWH sales from ended power sales agreements, while revenues to affiliates surged by $79 million (131.7%) from a 165.5% increase in KWH sales driven by affiliated energy needs. These shifts, governed by the IIC, resulted in a net $4 million decline in total wholesale revenues ($476 million vs. $484 million in 2023), reflecting the contrasting volume trends between affiliate and non-affiliate markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop financial question. QUANTITATIVE VERIFICATION: All key numbers are correct - $87 million (20.5%) decrease in non-affiliate revenues, 30.8% KWH volume drop, $79 million (131.7%) increase in affiliate revenues, 165.5% KWH volume increase, and the net $4 million decline in total wholesale revenues ($476M vs $484M in 2023). All calculations are accurate and properly formatted. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple dimensions - connecting KWH volume changes to revenue impacts, distinguishing between affiliate and non-affiliate transactions, and explaining the net effect on overall wholesale revenue. The reasoning correctly identifies that external market conditions (ended power agreements) reduced non-affiliate revenue while internal energy transfers under the IIC increased affiliate revenue. ENTITY ACCURACY: Correctly identifies Southern Company system, the IIC (Intercompany Interchange Contract), FERC approval context, and the 2024 timeframe with 2023 comparison. COMPLETENESS: Addresses all aspects of the question - volume changes, revenue impacts, the IIC governance, and overall wholesale revenue performance. The answer provides clear context about why each change occurred (ended agreements for non-affiliates, increased affiliated energy demand for affiliates). MINOR OBSERVATION: The ground truth mentions the power agreements ended in May 2023, while the LLM answer references this as context for 2024 impacts without explicitly stating the May 2023 date. However, this is a very minor omission that doesn't affect the core accuracy of the answer. The LLM answer actually adds value by explicitly calculating and stating the net $4 million decline, which provides additional quantitative clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 503,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of 1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission (IDPC) imposed an administrative fine of **EUR 1.2 billion** and issued corrective orders requiring Meta to suspend unlawful data transfers under the GDPR. Compliance with these orders could increase Meta's operational costs in Europe due to the need to modify data processing practices, implement additional safeguards, and potentially restrict data transfers, thereby raising compliance complexity and expenses.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 1.2 billion financial penalty and the corrective orders requiring suspension of unlawful data transfers. The quantitative information is entirely accurate - the penalty amount matches the ground truth exactly (EUR 1.2 billion). The answer correctly identifies the Irish Data Protection Commission as the regulatory body and accurately describes the nature of the corrective orders related to GDPR compliance and data transfer restrictions. The multi-hop reasoning is sound, connecting the penalty and corrective orders to their operational impact on Meta's European costs through increased compliance complexity and safeguards. However, there are minor omissions in completeness: (1) The ground truth specifically mentions 'Chapter V of the GDPR' as the regulatory framework for alignment, which the LLM answer does not explicitly reference; (2) The ground truth specifies 'EEA Facebook user data in the United States' as the specific data transfer concern, while the LLM uses more general language about 'data transfers.' These omissions are relatively minor and do not affect the core accuracy of the answer. The LLM's phrasing about 'modify data processing practices, implement additional safeguards, and potentially restrict data transfers' is semantically equivalent to the ground truth's description of 'additional steps to align its data processing operations.' The answer appropriately addresses both parts of the multi-part question: the penalty amount and the operational cost implications. Overall, this is a strong response with accurate numbers and sound reasoning, with only minor contextual details missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 466,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "The Home Depot emphasizes product depth and job lot quantities to meet Pros' complex purchase needs, such as specialized materials for large projects, which differentiates them from competitors and supports their strategy to serve professional customers effectively. Risks highlighted include losing competitive advantage, reduced sales, and adverse financial impacts if these offerings are not maintained, as failure to meet Pro demands could harm customer relationships, market share, and profitability (pages 6, 14, 15).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and addresses the multi-part question effectively. STRENGTHS: (1) Correctly identifies the core strategy of product depth and job lot quantities for Pros; (2) Accurately captures the purpose of meeting complex purchase needs; (3) Properly synthesizes the risks highlighted (losing competitive advantage, reduced sales, adverse financial impacts); (4) No quantitative errors present; (5) Appropriately references multiple pages (6, 14, 15) suggesting multi-hop synthesis across the document. MINOR WEAKNESSES: (1) The LLM answer adds interpretive details like 'specialized materials for large projects' and 'customer relationships' that, while logically sound and contextually relevant, go slightly beyond what the ground truth explicitly states; (2) The ground truth specifically mentions 'competitive delivery and pickup options' as part of the competitiveness requirement, which the LLM answer does not explicitly reference, though it does mention 'competitive advantage' more broadly; (3) The ground truth's specific mention of 'reduce profit margins' is captured in the LLM's 'profitability' reference, though less precisely. MULTI-HOP REASONING: The LLM successfully synthesizes information about how product depth/job lot quantities support Pro strategy AND identifies the risks if not maintained, demonstrating proper multi-hop synthesis. The answer is semantically equivalent to the ground truth despite slightly different wording and minor elaborations that don't contradict the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 428,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the companys ability to readily redeem these investments.",
      "llm_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures is **$177 million** ($83 million in 2021 and $94 million in 2020). This exclusion indicates complexity in valuation, as these investments are classified as Level 3, requiring unobservable inputs like actuarial present value calculations and combining market data with proprietary models, reflecting the lack of a single observable market price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the quantitative aspects. The total value of $177 million is correct, and the component breakdown ($83 million in 2021 and $94 million in 2020) is accurate. The calculation is verified correctly. The answer properly addresses both parts of the multi-part question: (1) the total value across disclosures, and (2) what the exclusion indicates about valuation complexity. The LLM correctly identifies that these investments are excluded from the fair value hierarchy and explains the complexity through reference to Level 3 inputs and unobservable inputs. However, there is a minor discrepancy in the qualitative explanation: the ground truth emphasizes 'lack of observable market data or restrictions limiting redemption ability,' while the LLM focuses on 'Level 3 classification requiring unobservable inputs like actuarial present value calculations.' While both explanations are reasonable interpretations of why these investments are excluded, the LLM's explanation slightly shifts the emphasis from the ground truth's focus on market data availability and redemption restrictions to a more technical description of valuation methodology. The LLM answer is semantically sound and demonstrates proper multi-hop synthesis across the two disclosure periods, correctly combining the values from both years. The reasoning about complexity is logical and well-articulated, though it could have more directly aligned with the specific factors mentioned in the ground truth (observable market data and redemption restrictions).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 431,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal uses loss curves in conjunction with macroeconomic forecasts to estimate credit losses for both merchant and consumer receivables. For **merchant receivables**, macroeconomic factors such as forecasted unemployment rates and retail e-commerce sales are applied, with loss curves adjusted by geography, delinquency, and origination period. For **consumer receivables**, factors include household disposable income, retail e-commerce sales, and (until Q1 2023) unemployment rates, with loss curves applied by geography, delinquency, and origination period. Both categories incorporate qualitative adjustments and external macroeconomic forecasts to refine loss estimates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about PayPal's credit loss methodology. STRENGTHS: (1) Correctly identifies the core methodology: loss curves applied to both merchant and consumer receivables with macroeconomic forecasts; (2) Accurately specifies merchant receivables factors: unemployment rates and retail e-commerce sales, with loss curves adjusted by geography, delinquency, and origination period - matches ground truth; (3) Accurately specifies consumer receivables factors: household disposable income and retail e-commerce sales - matches ground truth; (4) Correctly notes the temporal detail about unemployment rates being applied until Q1 2023 for consumer receivables, which adds specificity beyond the ground truth; (5) Properly synthesizes the multi-hop relationship between loss curves, macroeconomic factors, and allowance calculations; (6) Appropriately mentions qualitative adjustments as refinements to the methodology. MINOR CONSIDERATIONS: (1) The ground truth emphasizes that macroeconomic inputs 'directly influence the projected loss rates, which are then applied to the principal amounts of receivables' - the LLM answer implies this relationship but doesn't explicitly state the mechanism as clearly; (2) The LLM adds the detail about unemployment rates being applied 'until Q1 2023' for consumer receivables, which is accurate but represents additional specificity not in the ground truth statement (this is actually a positive addition showing deeper knowledge); (3) Both answers correctly identify that loss curves are applied by geography, delinquency, and origination period for both categories. MULTI-HOP REASONING: The answer successfully synthesizes information across the different receivable categories and correctly distinguishes between merchant and consumer-specific macroeconomic factors while maintaining the common framework of loss curves. The reasoning is sound and logically structured. ENTITY ACCURACY: PayPal correctly identified, metrics correctly named (allowance for credit losses, merchant receivables, consumer receivables), time periods appropriately referenced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 585,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operationssuch as extreme weather, pandemics, or labor issuescould delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco's reliance on its manufacturing and distribution facilities for private-label items like Kirkland Signature exposes it to operational risks such as supply chain disruptions, labor issues, or production delays, which could impair product availability and quality, harming brand loyalty. Additionally, any failure to maintain consistent quality or competitive pricing for Kirkland Signature could erode member trust, negatively impacting sales and gross margins, as these private-label products typically carry higher margins than national brands.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core risks associated with Costco's Kirkland Signature private-label brand and manufacturing/distribution reliance. The answer accurately captures: (1) operational risks from supply chain disruptions, labor issues, and production delays; (2) the impact on product availability and quality; (3) the connection to brand loyalty and member trust; (4) the importance of higher margins for private-label products; and (5) the potential negative impact on gross margins. No quantitative errors are presentno specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is perfect. The multi-hop reasoning is sound: the answer correctly synthesizes that operational disruptions  inconsistent availability/quality  reduced member acceptance  negative impact on brand loyalty and margins. However, there are minor omissions compared to the ground truth: (1) The LLM answer doesn't explicitly mention specific types of disruptions like 'extreme weather' or 'pandemics' (though it does mention 'supply chain disruptions' which is broader); (2) The ground truth emphasizes that Kirkland products 'represent a growing portion of overall sales,' which adds context about the magnitude of risk exposurethe LLM answer doesn't capture this; (3) The ground truth mentions 'processing, packaging, and manufacturing facilities' specifically, while the LLM generalizes to 'manufacturing and distribution facilities.' These are minor semantic differences rather than factual errors. The LLM answer also adds a relevant point about 'competitive pricing' that isn't explicitly in the ground truth but is logically sound. Overall, the answer demonstrates solid understanding of the multi-hop relationship between operational risks, product quality, brand loyalty, and financial performance, with only minor contextual details missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 511,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The total grant date fair value of performance-based LTIP units for the 2021 and 2022 LTI Programs was **$19.4 million** ($5.7 million for 2021 and $13.7 million for 2022). This compares to **$11.2 million** in time-based restricted stock units (RSUs) granted in those years ($4.3 million for 2021 and $6.9 million for 2022). Performance-based LTIP units had a higher total grant date fair value than time-based RSUs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary numbers requested. (1) PERFORMANCE-BASED LTIP UNITS TOTAL: LLM states $19.4 million ($5.7M in 2021 + $13.7M in 2022), but ground truth is $39.0 million ($18.4M in 2021 + $20.6M in 2022). This is a major discrepancy - the LLM's figure is approximately 50% of the correct total. (2) TIME-BASED RSU TOTAL: LLM correctly states $11.2 million ($4.3M in 2021 + $6.9M in 2022), matching ground truth exactly. (3) CALCULATION VERIFICATION: The LLM's own stated components ($5.7M + $13.7M = $19.4M) are arithmetically correct, but the underlying component values are wrong. The ground truth components ($18.4M + $20.6M = $39.0M) are also arithmetically correct. (4) MULTI-HOP REASONING: The LLM correctly synthesized the comparison structure (performance-based vs. time-based across 2021-2022) and properly concluded that performance-based units had higher value. However, this conclusion is based on incorrect numbers. (5) ENTITY ACCURACY: Years (2021, 2022) and metrics (grant date fair value, LTIP units, RSUs) are correctly identified. The fundamental issue is that the LLM retrieved or calculated wrong dollar amounts for the performance-based LTIP units - nearly double the stated figures. This is a critical failure on the primary quantitative metric of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 381,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "The total fair value of U.S. municipal securities held by 3M as of December 31, 2024, is **$20 million**, and these securities are classified as **Level 3** in the fair value hierarchy. This classification is due to their valuation methodology, which references the carrying value of corresponding finance lease obligations, as noted in Note 18 of the 10-K filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR - QUANTITATIVE MISMATCH: The LLM states the fair value is $20 million, but the ground truth clearly indicates it is $16 million. This is a significant factual error on the primary numeric value requested. The difference of $4 million represents a 25% overstatement and cannot be dismissed as a formatting variation. CORRECT ELEMENTS: The LLM correctly identifies the Level 3 classification in the fair value hierarchy and accurately explains the valuation methodology (referencing the carrying value of corresponding finance lease obligations). The citation to Note 18 of the 10-K is appropriate and adds credibility. The reasoning about why these securities are Level 3 is sound and matches the ground truth explanation. ASSESSMENT: While the qualitative aspects of the answer (classification level, valuation methodology explanation, and reasoning) are correct and well-articulated, the fundamental quantitative error severely undermines the answer's value. The question explicitly asks for 'the total fair value,' making the dollar amount the primary deliverable. Providing $20 million instead of $16 million is a material factual error that would mislead a user relying on this information for financial analysis or reporting. The multi-hop reasoning is sound (connecting valuation methodology to fair value hierarchy classification), but the incorrect starting number compromises the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 393,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "In Q4 2023, Meta estimated that approximately **3%** of its worldwide Monthly Active Users (MAP) consisted solely of violating accounts. The estimation process faces challenges due to **limited visibility into WhatsApp user activity caused by encryption**, which restricts access to data signals like IP addresses or device information. This reliance on fewer data points (e.g., phone numbers) for WhatsApp complicates accurate identification of violating accounts, highlighting the inherent difficulties in measuring such accounts across encrypted platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: The core factual claim that approximately 3% of Meta's worldwide MAP in Q4 2023 consisted of violating accounts is correct. The explanation of challenges related to encrypted platforms like WhatsApp is accurate. (2) QUANTITATIVE ACCURACY: The 3% figure is precisely correct with no calculation errors. The time period (Q4 2023) is correctly identified. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop reasoning: it identifies the specific metric (MAP), the time period (Q4 2023), the percentage (3%), and explains the methodological challenges. The explanation of encryption limiting visibility and forcing reliance on fewer data signals (phone numbers, device information) is semantically equivalent to the ground truth. The LLM adds helpful detail by mentioning IP addresses as an example of restricted data signals, which is a reasonable elaboration. (4) ENTITY ACCURACY: Meta is correctly identified, Q4 2023 is correct, MAP (Monthly Active Users) is correctly referenced, and WhatsApp is properly identified as an encrypted platform. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'limited visibility into WhatsApp user activity caused by encryption' conveys the same meaning as the ground truth's 'limited visibility' due to encryption. The explanation of relying on 'fewer data signals such as phone numbers and device information' matches the ground truth exactly. Minor difference: The LLM specifies 'IP addresses' as a restricted signal while ground truth mentions 'device information' - this is a reasonable elaboration rather than an error. Overall, the answer demonstrates sound multi-hop reasoning across the question's components and maintains factual accuracy throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 488,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "Pfizer made an upfront cash payment of $75 million and an equity investment of $150 million in its collaboration with BioNTech for the shingles vaccine program. For the Comirnaty (COVID-19 vaccine) program, there is no explicit mention of upfront payments or equity investments by Pfizer in the provided documents. The collaboration details for Comirnaty focus on shared development costs and revenue-sharing arrangements, with BioNTech paying Pfizer its share of prior development costs in 2021. Thus, the total amount for the shingles vaccine program is **$225 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect. Ground truth states the total upfront payments and equity investments for BOTH the shingles vaccine and Comirnaty programs combined was $375 million. The LLM answer provides only $225 million (claiming $75M upfront + $150M equity for shingles only) and explicitly states there is 'no explicit mention' of upfront payments or equity investments for Comirnaty. This represents a critical failure in multi-hop synthesis. The LLM appears to have missed or misinterpreted the Comirnaty collaboration financial terms in the SEC filings. The answer is incomplete - it only addresses the shingles program and incorrectly concludes that Comirnaty had no upfront payments or equity investments. The $375M ground truth figure clearly indicates that both programs had associated upfront payments and/or equity investments that should sum to this total. The LLM's reasoning that 'collaboration details for Comirnaty focus on shared development costs and revenue-sharing arrangements' may be partially accurate but does not address the specific upfront payments and equity investments that are part of the ground truth answer. The quantitative error is significant ($225M vs $375M = $150M shortfall, a 40% undercount), and the qualitative reasoning failed to synthesize information across both vaccine programs as required by the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 383,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "The total net income contribution from COP's EMENA operations was a net loss of $24 million in 2021, $6 million in 2020, and $1 million in 2019, totaling a $17 million net loss over the period. In contrast, the Lower 48 region reported a net loss of $8 million in 2021, $804 million in 2020, and $402 million in 2019, totaling a $1,214 million net loss. Thus, EMENA's net loss was significantly smaller than the Lower 48's.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical errors that fundamentally undermine its accuracy:\n\n1. MAJOR CALCULATION ERROR - Lower 48 Total: The LLM states Lower 48 had a total of $1,214 million net loss, but this is incorrect. The ground truth shows: $402M (2019) + $804M (2020) + (-$8M) (2021) = $1,198M net income, not a net loss. The LLM incorrectly labeled this as a 'net loss' when it should be 'net income.' The correct total is $1,198M (not $1,214M as stated).\n\n2. INCORRECT CHARACTERIZATION OF LOWER 48: The LLM describes Lower 48 as having a 'total net loss' when it actually had a total net income of $1,198M. This is a fundamental mischaracterization of the region's performance.\n\n3. ARITHMETIC ERROR: $402M + $804M - $8M = $1,198M, not $1,214M. The LLM's calculation is off by $16M.\n\n4. FLAWED COMPARISON LOGIC: The LLM concludes 'EMENA's net loss was significantly smaller than the Lower 48's,' which is nonsensical. EMENA had a $17M net loss while Lower 48 had a $1,198M net income. The comparison should highlight that Lower 48 vastly outperformed EMENA by $1,215M ($1,198M - (-$17M) = $1,215M, close to the ground truth's $1,223M difference calculation).\n\n5. EMENA CALCULATION: The LLM correctly calculates EMENA's cumulative result as $17M net loss ($1M + $6M - $24M = -$17M).\n\n6. MISSING CONTEXT: The LLM fails to properly contextualize that Lower 48 was a highly profitable region while EMENA was a loss-making region, which is the key insight the question seeks.\n\nThe answer demonstrates poor numerical reasoning and misinterprets the financial results, leading to an incorrect and misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 448,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is **$3.72 million** (from $172,912 thousand to $169,192 thousand). This decrease contributes to the overall **$11.22 million** reduction in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties,' as the remaining decrease of $7.50 million (from the 7.50% preferred units) accounts for the rest of the decline.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the dollar amount decrease in 'Other noncontrolling redeemable interests' as $3.72 million (or $3,720 thousand), matching the ground truth calculation of $172,912 - $169,192 = $3,720. The overall decrease of $11.22 million in the combined metric is also correct ($195,949 - $184,729 = $11,220). The LLM properly converts the thousands format to millions for presentation, which is acceptable formatting variation. However, the answer has a critical omission: it fails to calculate and present the percentage contribution (33.1%) that the ground truth explicitly provides. The LLM instead mentions that the remaining $7.50 million comes from '7.50% preferred units,' which is a partial explanation but doesn't directly address how the $3.72 million decrease contributes proportionally to the total decline. The multi-hop reasoning is partially soundthe LLM correctly synthesizes the decrease amounts across the two metricsbut it doesn't complete the full analysis by calculating the percentage contribution. The answer is mostly correct on the quantitative side but incomplete on the analytical side, missing the key insight about the 33.1% contribution ratio that was explicitly requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 349,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "The total fair value of foreign corporate debt and asset-backed securities held by 3M as of December 31, 2024, was **$55 million** ($31 million for foreign corporate debt and $24 million for asset-backed securities). This compares to **$0** for both categories in the prior year (2023), reflecting a significant increase in 2024. \n\n**Source:** Page 67 and Page 82 of the 10-K filing detail the fair values of these securities under Note 13 (Marketable Securities) and Note 18 (Fair Value Measurements).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $55 million total for 2024 ($31M foreign corporate debt + $24M asset-backed securities), and $0 for 2023. The arithmetic is accurate. ENTITY ACCURACY: Correctly identifies MMM/3M (both acceptable references to the same company), correct fiscal years (2024 vs 2023), and correct financial metrics (fair value of specific asset categories). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) total fair value as of Dec 31, 2024, (2) breakdown by asset category, (3) comparison to prior year, and (4) characterization of the change. MULTI-HOP REASONING: The model correctly synthesized information across multiple data points - combining two asset categories, comparing across two fiscal years, and presenting the comparison clearly. SEMANTIC EQUIVALENCE: The wording is clear and matches the ground truth meaning precisely. MINOR CONSIDERATIONS: The LLM provides additional context (source citations to specific pages and notes) which, while not required, adds credibility and is helpful. The characterization of the change as 'significant' is reasonable given the movement from $0 to $55M. No factual errors detected. The answer demonstrates sound multi-hop reasoning by correctly identifying and combining the relevant data points across years and asset categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 388,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "Meta's Family metrics (MAP and ARPP) are subject to technical errors and data limitations, including algorithmic inaccuracies, incomplete data signals (e.g., encrypted WhatsApp activity), and challenges in attributing multiple accounts to unique users. These factors could lead to variations in MAP and ARPP. The company estimates the error margin for Family metrics is approximately **3% of worldwide MAP**, though actual variations may exceed this due to evolving methodologies, data limitations, or unanticipated changes in user behavior.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 3% error margin for Family metrics, which is the key quantitative finding. It accurately describes the types of technical errors and data limitations (algorithmic inaccuracies, encrypted data challenges, multiple account attribution issues). The answer correctly identifies MAP and ARPP as the relevant metrics and acknowledges the relationship between MAP accuracy and ARPP reliability.\n\nWEAKNESSES: (1) CRITICAL OMISSION - The LLM fails to provide the concrete calculation that grounds the abstract 3% figure. The ground truth specifies that with ~3.3 billion worldwide MAP in 2023, the 3% margin translates to approximately 99 million users. This is a significant quantitative detail that directly answers 'by what approximate margin' the metrics could vary. The LLM states the percentage but doesn't translate it to absolute numbers, which is essential for understanding the practical impact. (2) INCOMPLETE SYNTHESIS - The answer doesn't fully synthesize how the error margin affects business decisions, investor perceptions, and advertising investments, which the ground truth emphasizes. (3) VAGUE LANGUAGE - The phrase 'though actual variations may exceed this' introduces uncertainty not clearly supported by the ground truth, which presents the 3% as Meta's own estimate. (4) MISSING CONTEXT - The answer doesn't explain the specific methodologies (complex algorithms, machine learning models, user survey data calibrated against IP addresses and device information) that the ground truth details.\n\nNUMERIC VERIFICATION: The 3% figure is correct. However, the failure to calculate or mention the 99 million user variance (3% of 3.3 billion) is a significant gap in answering the 'approximate margin' portion of the question.\n\nMULTI-HOP REASONING: The answer partially addresses the multi-hop nature (technical errors  MAP/ARPP accuracy  business impact) but doesn't complete the chain by quantifying the actual margin of variation in absolute terms.\n\nSEMANTIC EQUIVALENCE: While the wording differs from ground truth, the core concepts are present but incompletely developed. The answer reads as a partial response that identifies the right framework but doesn't fully execute the quantitative analysis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 608,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store) contributes to fulfilling 50% of U.S. online orders through stores by leveraging its physical retail network as a fulfillment hub. As outlined in the supply chain section, BOPIS enables customers to pick up online orders at local stores, reducing delivery times and costs while utilizing store locations for order fulfillment. This integration of online and in-store capabilities, alongside other programs like BOSS (Buy Online, Ship to Store), allows The Home Depot to efficiently manage order fulfillment through its store network, directly supporting the 50% fulfillment rate mentioned.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates solid understanding of the multi-hop question. STRENGTHS: (1) Correctly identifies BOPIS as Buy Online, Pickup In Store and accurately explains its function; (2) Accurately references the 50% U.S. online orders fulfillment through stores metric; (3) Properly synthesizes the connection between BOPIS and the supply chain goal; (4) Adds relevant context about reducing delivery times and costs, which is logically sound; (5) Mentions BOSS (Buy Online, Ship to Store) as a complementary program, showing broader understanding of fulfillment strategies; (6) All quantitative references (50%) are accurate. MINOR WEAKNESSES: (1) The original answer emphasizes BOPIS as part of 'a broader set of store-based fulfillment options' while the LLM answer introduces BOSS without explicit confirmation this was mentioned in the original filing context - this is a minor addition that doesn't contradict but goes slightly beyond the ground truth; (2) The LLM answer provides more operational detail (reducing delivery times and costs) which, while logical and likely accurate, isn't explicitly confirmed in the ground truth answer provided. The core multi-hop reasoning is sound: BOPIS definition  enables online orders with in-store pickup  supports 50% fulfillment goal through stores. The answer correctly synthesizes information across the glossary definition and supply chain section as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 405,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley recognizes compensation expense for Deferred Cash-Based Compensation (DCP) awards over the vesting period, adjusting for changes in the fair value of referenced investments. This deferral aligns with the timing of vesting, with expense recognition tied to the vesting schedule. In contrast, carried interest compensation is recognized immediately when portions of realized or unrealized carried interest are allocated to employees, reflecting direct profit-sharing without a vesting period. The nature of DCP awards involves performance-linked investments with deferred recognition, while carried interest compensation is based on profit allocation, recognized as it is allocated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the fundamental distinction between DCP and carried interest compensation recognition. Both the original and LLM answers correctly identify that DCP expense is recognized over the vesting period with fair value adjustments, while carried interest is recognized immediately upon allocation. The core factual content is accurate. (2) QUANTITATIVE ACCURACY: No numerical values, dates, or calculations are present in either answer, so this dimension receives full marks. The question is qualitative in nature and does not require quantitative verification. (3) QUALITATIVE ACCURACY: The LLM answer successfully synthesizes the multi-hop comparison across two different compensation types. It correctly identifies: (a) DCP timing: vesting period with fair value adjustments; (b) Carried interest timing: immediate recognition; (c) Nature distinction: DCP is deferred/performance-linked vs. carried interest is profit-sharing/allocation-based. The reasoning is sound and logically structured. Minor wording differences exist (e.g., 'performance-linked investments' vs. 'referenced investments selected by employees'), but these are semantically equivalent and reflect acceptable variation in expression. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the multi-part question: timing differences (vesting period vs. immediate), nature of awards (deferred vs. profit-sharing), and the underlying principles distinguishing the two approaches. The answer is appropriately focused and comprehensive. MINOR OBSERVATION: The LLM answer uses slightly more concise phrasing ('performance-linked investments' vs. the original's 'referenced investments selected by employees'), but this represents acceptable semantic variation rather than factual error. The substance and accuracy remain intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 526,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is **$169,192 thousand** ($169.192 million). This figure is explicitly stated in the \"Other noncontrolling redeemable interests\" line of the table on pages 126, 128, and 129 of the 10-K filing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The ground truth states that the total amount of noncontrolling redeemable interests in properties classified as temporary equity is $0, as neither Simon Property Group nor the Operating Partnership reported any such interests redeemable at amounts in excess of fair value. The LLM instead provides a figure of $169,192 thousand ($169.192 million) and claims this is from 'Other noncontrolling redeemable interests' on pages 126, 128, and 129. This represents a critical factual error - the LLM has either misidentified the relevant line item or misunderstood what the question is asking. The question specifically asks for noncontrolling redeemable interests in properties classified as temporary equity that are redeemable at amounts in excess of fair value. The $169,192 thousand figure appears to be from a different line item (possibly general 'other noncontrolling redeemable interests' rather than those specifically meeting the criteria of being in temporary equity and redeemable at amounts exceeding fair value). The LLM failed to properly synthesize the multi-hop requirement: identifying which interests are (1) noncontrolling, (2) in properties, (3) classified as temporary equity, and (4) redeemable at amounts in excess of fair value. The correct answer of $0 indicates neither entity had such interests meeting all these criteria. The LLM's citation of specific pages does not validate an incorrect number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 405,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets as of December 31, 2021, is **$8,922 million** ($8,846 million for NEE's nuclear decommissioning fund and $76 million for FPL's storm fund). The carrying amount of NEE's special use funds on its consolidated balance sheet for the same date is **$906 million**, which is significantly lower than the fair value. This discrepancy reflects the difference between amortized cost (carrying amount) and market-based fair value measurements for these assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN CARRYING AMOUNT: The LLM states the carrying amount of NEE's special use funds is $906 million, but the ground truth clearly states it is $2,505 million. This is a significant factual error (off by $1,599 million or 63%). CORRECT ELEMENTS: (1) Fair value total of $8,922 million is correct, (2) NEE nuclear decommissioning fund fair value of $8,846 million is correct, (3) FPL storm fund fair value of $76 million is correct, (4) The comparison between fair value and carrying amount is conceptually sound. REASONING QUALITY: The LLM correctly synthesized the multi-hop information by combining NEE and FPL data and comparing to the consolidated balance sheet. The explanation about amortized cost vs. fair value is reasonable. However, the fundamental error in the carrying amount figure undermines the entire comparison and conclusion. The discrepancy explanation (difference between amortized cost and market-based fair value) is semantically similar to the ground truth but is based on an incorrect carrying amount figure. MULTI-HOP SYNTHESIS: The model correctly identified and combined data from multiple entities (NEE and FPL) and compared to the consolidated balance sheet, but the execution failed due to the wrong carrying amount number. This is a quantitative accuracy failure that significantly impacts the correctness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 379,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Ciscos consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Ciscos overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC (Asia Pacific, Japan, and China) serves as both a geographic segment for operational management and a component of Cisco's consolidated financial reporting. As a segment, it is used by Cisco's management to allocate resources, assess regional performance, and make decisions based on revenue ($7.7 billion in 2024) and gross margin ($5.187 billion in 2024). However, in consolidated reporting, APJC's financials are aggregated with other segments (Americas, EMEA) to reflect the company's overall financial position. This dual role influences internal performance measurement by focusing segment-specific metrics (revenue, gross margin) while ensuring alignment with consolidated goals, though non-operational expenses (e.g., R&D, G&A) are excluded from segment reporting, limiting full cost visibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a solid understanding of APJC's dual role as both an operating segment and consolidated reporting component, and correctly identifies the key conceptual framework (revenue/gross margin included, R&D/G&A excluded from segment reporting). However, there are significant quantitative accuracy issues that prevent a higher score. The LLM provides specific financial figures ($7.7 billion revenue and $5.187 billion gross margin for APJC in 2024) that cannot be verified against the ground truth knowledge graph provided. The original answer deliberately avoids citing specific numbers, suggesting these figures may not be reliably sourced or may be incorrect. This is a critical flaw in a financial evaluation context where precision is paramount. The qualitative reasoning is sound - the answer correctly explains the dual role, the distinction between segment metrics and consolidated reporting, and the exclusion of certain expenses from segment reporting. The multi-hop synthesis is appropriate, connecting operational management, financial reporting, and internal performance measurement. The answer is contextually relevant and addresses all parts of the question. However, the introduction of unverified specific numbers (particularly the gross margin figure of $5.187 billion, which appears suspiciously precise) represents a factual accuracy problem that cannot be overlooked in financial analysis. The answer would have been stronger by following the ground truth's approach of discussing the significance conceptually without introducing potentially incorrect specific figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 442,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "In 2024, **44%** of Verizon Business Group's total revenues ($13.1 billion) came from the **Business Markets and Other** segment. This segment incorporates **FWA broadband** as part of its wireless services, offering fixed connectivity solutions comparable to residential Fios services but tailored for small and medium businesses, enabling them to access high-speed internet via Verizon's 5G or 4G LTE networks without traditional landline infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 44% percentage, $13.1 billion revenue figure, and the implicit calculation (44% of total = $13.1B) are all accurate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the percentage and revenue amount for Business Markets and Other segment, and (b) how FWA broadband is incorporated into the segment's offerings. (3) ENTITY ACCURACY: Correctly identifies Verizon Business Group, Business Markets and Other segment, and FWA broadband. Year 2024 is correctly referenced. (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesized that FWA broadband is part of the wireless services within this segment and that it serves small and medium businesses. (5) SEMANTIC EQUIVALENCE: The LLM answer provides additional helpful context beyond the ground truth (mentioning 5G/4G LTE networks and comparison to Fios services) which enhances understanding without contradicting the original answer. The phrase 'fixed connectivity solutions comparable to residential services' in the ground truth is appropriately expanded to 'comparable to residential Fios services' in the LLM answer, which is more specific and accurate. The mention of 'without traditional landline infrastructure' adds relevant technical context. All core facts match the ground truth exactly, and the additional details are accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 409,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $52 million (comprising $1 million in receivables and $51 million in payables). This compares to the total notional amount of $16.2 billion for all foreign currency forward exchange contracts held by Abbott as of December 31, 2024. The fair value of interest rate hedges is significantly lower than the notional amount of foreign currency contracts, reflecting the net liability position of the interest rate swaps versus the gross notional exposure of the foreign exchange contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its correctness. QUANTITATIVE ISSUES: (1) Interest rate hedge fair value: LLM states $52 million total ($1M receivables + $51M payables), but ground truth is $50 million ($1M receivables + $51M payables). The arithmetic is wrong - $1M + $51M = $52M, not $50M as stated in ground truth, but the LLM's calculation of $52M is actually mathematically correct for those component values. However, the ground truth explicitly states the total is $50 million, suggesting the component breakdown may differ from what the LLM presented. This is a critical discrepancy. (2) Foreign currency forward exchange contracts notional amount: LLM states $16.2 billion, but ground truth clearly states $23.2 billion. This is a major error - a $7 billion difference representing approximately 30% variance from the correct figure. This is not a rounding or formatting issue but a factual error. QUALITATIVE ASSESSMENT: The LLM correctly identified both metrics being compared (interest rate hedge fair value vs. foreign currency contract notional amounts) and properly understood the multi-hop nature of the question requiring synthesis across two different derivative categories. The reasoning about comparing fair value to notional amounts is sound and contextually appropriate. The explanation of why these values differ (net liability position vs. gross notional exposure) demonstrates good analytical thinking. COMPLETENESS: The answer addresses both parts of the multi-part question and attempts the comparison requested. ENTITY ACCURACY: Abbott is correctly identified, and the date (December 31, 2024) is correct. The main failures are in the specific numerical values, particularly the foreign currency contract notional amount which is significantly understated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 494,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "The relationship between proved undeveloped reserves and net acreage in Asia for Equity Companies indicates a higher ratio of reserves per acre compared to consolidated subsidiaries. Equity Companies in Asia have 1,503 million oil-equivalent barrels (MEB) of proved undeveloped reserves across 19,000 net acres, yielding ~79.1 barrels per acre. In contrast, consolidated subsidiaries in Asia hold 1,315 MEB of proved undeveloped reserves across 227,000 net acres, averaging ~5.79 barrels per acre. This disparity suggests Equity Companies may face challenges in efficiently utilizing their land for reserve development, potentially due to project-specific constraints or less mature development timelines, while consolidated subsidiaries demonstrate more efficient land-to-reserve conversion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) ACREAGE NUMBERS WRONG: LLM states consolidated subsidiaries have 227,000 net acres, but ground truth shows 640,000 net acres - this is a 60% understatement. LLM states Equity Companies have 19,000 acres when ground truth shows 19 thousand acres (same value but LLM's unit conversion is inconsistent with how it treats the other number). (2) CALCULATION ERRORS: LLM calculates ~79.1 barrels per acre for Equity Companies (1,503M / 19,000 = 79.1), but ground truth expresses this as 79.1 MILLION barrels per THOUSAND acres, which is the correct metric. LLM's calculation of ~5.79 barrels per acre for consolidated subsidiaries is wrong - should be 1,315M / 640,000 = 2.05 million barrels per thousand acres. (3) INVERTED CONCLUSION: Most critically, LLM concludes that Equity Companies 'may face challenges in efficiently utilizing their land' when the ground truth explicitly states Equity Companies are 'significantly more efficient in terms of reserves per acre.' The LLM has reversed the interpretation entirely. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the comparative analysis - it misidentified which entity is more efficient and drew the opposite conclusion from what the data supports. (5) METRIC INCONSISTENCY: LLM uses 'barrels per acre' while ground truth uses 'million barrels per thousand acres' - while these could be equivalent if calculated correctly, the LLM's actual numbers don't match either metric properly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 411,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities ensures that the Parent Company is fully liable for these obligations, providing a critical layer of financial support to the subsidiary. Under the amended and restated support agreement, in a resolution scenario, the Parent Company is obligated to contribute its contributable assets to supported entities (including Morgan Stanley Holdings LLC), while the Funding IHC would provide capital and liquidity. This guarantee, along with secured obligations under the support agreement, reinforces the Parent Company's commitment to maintaining the Firm's operational and financial stability during resolution, ensuring obligations to subsidiaries are met through asset-backed commitments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core concepts and relationships. STRENGTHS: (1) Correctly identifies the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities and its significance; (2) Accurately describes the amended and restated support agreement obligations; (3) Properly explains the interconnection between the guarantee and support agreement in a resolution scenario; (4) Correctly identifies the Funding IHC's role in providing capital and liquidity; (5) No quantitative errors or incorrect numbers/dates. MINOR ISSUES: (1) The LLM mentions 'Morgan Stanley Holdings LLC' as a supported entity, while the ground truth does not specifically name this entity in the context provided - this is a minor addition that doesn't contradict the ground truth but adds specificity not explicitly stated; (2) The phrase 'secured obligations under the support agreement' is slightly imprecise - the ground truth emphasizes 'unconditional' and 'contributable assets' rather than 'secured obligations,' though the semantic meaning is largely preserved; (3) The LLM answer is slightly more concise than the ground truth, omitting some contextual detail about how these mechanisms are 'interconnected' in the broader organizational structure, though the core relationship is still conveyed. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple concepts (guarantee, support agreement, resolution scenario, capital/liquidity distribution) and explains their relationships appropriately. The logic flow is sound and demonstrates understanding of how these financial commitments work together during resolution events.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 461,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klpierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klpierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The Bipartisan Budget Act of 2015's partnership tax audit rules could require Simon Property Group (SPG) to bear additional financial obligations if audit adjustments are made to its joint ventures, including those managed by third parties like Klpierre and The Taubman Realty Group, LLC. Under the Act, audit adjustments to partnership-level items (and partners' shares) are assessed at the partnership level, potentially imposing taxes, interest, or penalties on the partnership. While SPG is a REIT and not subject to corporate taxes, it may still face economic burdens from these obligations as a partner, particularly if the partnership lacks available elections to mitigate liability. This could increase SPG's financial exposure through its joint ventures.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism of the Bipartisan Budget Act of 2015's partnership tax audit rules and their potential impact on SPG through joint ventures. The answer accurately describes that: (1) audit adjustments are assessed at the partnership level, (2) SPG could bear economic burdens through its joint venture investments, (3) specific third-party managers (Klpierre and The Taubman Realty Group, LLC) are mentioned, and (4) the lack of available elections to mitigate liability is noted. The reasoning about SPG's exposure as a partner is sound and the multi-hop synthesis across the Act's provisions and SPG's joint venture structure is logical. However, there are notable omissions: (1) The ground truth specifies '84 joint venture properties and entities' - a specific quantitative detail that the LLM answer completely omits. This is a material factual detail that should have been included. (2) The ground truth explicitly mentions that SPG 'applies the equity method of accounting to these joint ventures' - an important accounting detail that provides context for why SPG would be liable. (3) The ground truth notes the potential for 'material adverse effects on SPG's financial position' - a specific characterization of impact that the LLM answer only vaguely references as 'increase SPG's financial exposure.' (4) The ground truth clarifies that SPG and its subsidiary REITs 'may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly' - a comparative analysis that helps explain why this is problematic. The LLM answer's mention that 'SPG is a REIT and not subject to corporate taxes' is somewhat relevant but doesn't capture the full nuance. The quantitative accuracy score is reduced due to the missing '84 joint venture properties' figure, which is a specific, verifiable number from the ground truth. The qualitative accuracy remains strong because the reasoning about partnership-level assessments and SPG's exposure is fundamentally correct, even if incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 553,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "Lockheed Martin's 2020 AMMROC investment impairment ($128 million pre-tax, reducing net earnings by $96 million after-tax) and 2021 RMS restructuring charges ($36 million pre-tax, $28 million after-tax) collectively decreased net earnings from continuing operations by $124 million ($96M + $28M) and reduced diluted earnings per share by $0.36 ($0.20 from AMMROC + $0.16 from RMS charges). These charges contributed to the decline in net earnings from $6.888 billion (2020) to $6.315 billion (2021) and a drop in diluted EPS from $24.50 to $22.76.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN PER-SHARE CALCULATIONS: The LLM answer contains significant factual errors in the per-share impact figures. Ground truth states AMMROC impairment reduced EPS by $0.34 per share and RMS restructuring reduced EPS by $0.10 per share. The LLM incorrectly states $0.20 from AMMROC and $0.16 from RMS, totaling $0.36 combined - these numbers are factually wrong. The correct combined per-share impact should be $0.44 ($0.34 + $0.10), not $0.36. CORRECT ELEMENTS: The pre-tax and after-tax dollar amounts for both charges are accurate ($128M pre-tax AMMROC, $96M after-tax; $36M pre-tax RMS, $28M after-tax). The net earnings reduction figures are correct ($96M in 2020, $28M in 2021). PROBLEMATIC ADDITIONS: The LLM adds context about net earnings declining from $6.888B to $6.315B and EPS from $24.50 to $22.76, which while potentially accurate, goes beyond the ground truth answer and introduces additional data points that weren't part of the original answer. More critically, these figures don't align with the per-share calculations provided (the $0.36 EPS reduction doesn't match the $24.50 to $22.76 decline of $1.74). MULTI-HOP REASONING: The model correctly identified both events and attempted to synthesize them across years, but failed in the critical calculation of combined per-share impact. The fundamental error in EPS calculations undermines the entire answer despite getting the dollar amounts correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 397,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The year-over-year change in the balance of channel partner financing subject to guarantees decreased by $11 million, from $125 million as of July 29, 2023, to $114 million as of July 27, 2024. This reduction reflects a lower maximum potential future payment obligation under guarantees, which aligns with Cisco's liquidity management strategy outlined in the MD&A. The company emphasizes its ability to meet liquidity needs through cash flows, access to capital markets, and committed credit lines, with commitments like financing guarantees being part of its broader contractual obligations. The decrease in guarantees may alleviate future cash outflows, supporting liquidity and capital resource flexibility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core quantitative facts. Ground truth states the balance decreased from $1.7 billion (fiscal 2023) to $1.2 billion (fiscal 2024), a $0.5 billion decrease. The LLM provides completely different numbers: $125 million to $114 million, an $11 million decrease. These are off by a factor of approximately 13-14x, representing a critical factual error. The fiscal years cited in the LLM answer (July 29, 2023 and July 27, 2024) appear to be dates rather than fiscal year designations, which is a minor presentation issue but the underlying numbers are wrong. The LLM does correctly identify that there was a year-over-year decrease and attempts to relate this to Cisco's liquidity management strategy, which shows some understanding of the multi-hop reasoning required. However, the qualitative discussion about liquidity management, while reasonable in tone, cannot compensate for the massive quantitative error in the primary metric being asked about. The answer fails on the most critical evaluation criterion: factual accuracy of financial numbers. The LLM appears to have referenced different or incorrect data points entirely, possibly confusing different line items or fiscal periods in the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 353,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The total value of 'Investments measured at NAV' for the pension plans in the 2024 10-K filing is $2,656 million, while for the healthcare and life plans, it is $5 million. The difference is $2,651 million, with the pension plans having the higher value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its correctness. Ground truth states: first category = $2,656 million, second category = $3 million, difference = $2,653 million. LLM states: pension plans = $2,656 million (correct), healthcare/life plans = $5 million (INCORRECT - should be $3 million), difference = $2,651 million (INCORRECT - should be $2,653 million). The LLM correctly identified the first category value ($2,656M) and correctly identified which category has higher value, but made two critical errors: (1) reported the second category as $5 million instead of $3 million, a $2 million discrepancy, and (2) calculated the difference as $2,651 million instead of $2,653 million, a $2 million calculation error. These errors appear related - if the second value were $5M instead of $3M, the difference would indeed be $2,651M, suggesting the LLM may have misread or misremembered the second category value. The entity identification (pension plans vs healthcare/life plans) appears reasonable and contextually relevant, but the specific numeric values are materially incorrect. The reasoning structure is sound, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 336,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott's production focus on Diabetes Care Devices, such as continuous glucose monitoring (CGM) systems, drove the 18.1% revenue increase in its Diabetes Care business in 2024, as highlighted in the segment analysis (Page 29). The growth reflects strong demand for CGM systems and other diabetes management solutions. Revenue recognition follows the **transfer-of-control principle** (Note 1), where revenue is recognized upon shipment or delivery, with provisions for returns and discounts. For multi-obligation contracts (e.g., devices and associated services), revenue is allocated based on standalone selling prices, aligning with ASC 606 standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the 18.1% revenue increase and proper articulation of the transfer-of-control revenue recognition principle. STRENGTHS: (1) Correctly identifies the 18.1% growth rate; (2) Accurately describes the transfer-of-control principle as the basis for revenue recognition; (3) Properly references ASC 606 standards and multi-obligation contract allocation methodology; (4) Provides specific examples (CGM systems) that support the production focus; (5) Mentions relevant accounting details like provisions for returns and discounts. MINOR WEAKNESSES: (1) The LLM does not explicitly state the $6.805 billion revenue figure for 2024 Diabetes Care business, which is a key quantitative detail in the ground truth; (2) While the LLM mentions 'Page 29' and 'Note 1,' these specific filing references add credibility but are not verified against the actual 10-K structure; (3) The answer goes slightly beyond the ground truth by adding ASC 606 detail and multi-obligation contract allocation, which is technically correct but represents inference rather than direct ground truth synthesis. MULTI-HOP REASONING: The answer successfully synthesizes the relationship between production focus (Diabetes Care Devices), revenue growth (18.1%), and accounting policy (transfer-of-control), demonstrating sound multi-hop reasoning. The connection between CGM demand and revenue increase is logical and well-supported. QUANTITATIVE VERIFICATION: The 18.1% figure is correct and properly contextualized. The absence of the $6.805 billion figure prevents a perfect score, though this omission is relatively minor given the question's focus on the relationship between production focus and revenue increase rather than absolute revenue amounts. Overall, the answer is substantially correct with minor gaps in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 507,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "The Home Depot's emphasis on project planning tools enhances its competitive positioning with Pros by addressing their complex purchase needs, as outlined in the 2024 10-K. The document highlights that Pros prioritize dedicated sales support, competitive credit options, project planning tools, and job-lot quantities for specialized products. By investing in differentiated capabilities like enhanced order management systems, Pro Xtra loyalty programs, and tailored online experiences, The Home Depot differentiates itself from competitors, meeting Pros' expectations for efficiency, customization, and reliability in both in-store and digital platforms. This focus strengthens its ability to serve Pros' unique requirements, reinforcing its market position in the home improvement sector.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core question about Home Depot's project planning tools and competitive positioning with Pros. STRENGTHS: (1) Correctly identifies the key connection between project planning tools and Pro customer needs; (2) Accurately references specific Pro requirements mentioned in the 2024 10-K (dedicated sales support, competitive credit options, job-lot quantities); (3) Properly synthesizes multi-hop information by connecting tools to competitive differentiation; (4) No quantitative errors or incorrect numbers/dates; (5) Correctly names the company, filing year, and relevant programs (Pro Xtra); (6) Demonstrates sound reasoning about how these capabilities strengthen market position. MINOR GAPS: (1) The LLM answer is more expansive and detailed than the ground truth, adding specific program names (Pro Xtra, enhanced order management systems) and platform details (in-store and digital) that, while accurate and relevant, go slightly beyond what the ground truth explicitly emphasizes; (2) The ground truth emphasizes the 'interconnected shopping experience' as critical, which the LLM answer addresses implicitly through 'tailored online experiences' and platform integration but doesn't explicitly use this framing; (3) The LLM answer could have more directly emphasized the 'interconnected' nature of the shopping experience as a unifying concept. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth - that project planning tools address Pro needs and strengthen competitive positioning - just with additional supporting detail. The reasoning is logically sound and multi-hop synthesis is correct (connecting tools  Pro needs  competitive advantage). No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 490,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "The total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024 is **56,689,904 shares**. This figure is derived from the sum of 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP, as disclosed in the equity compensation plan information on page 32.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All numerical values match the ground truth exactly: (1) Total shares: 56,689,904 - CORRECT, (2) 2003 Incentive Program: 47,088,821 shares - CORRECT, (3) 2004 Non-Employee Director Restricted Stock Plan: 238,700 shares - CORRECT, (4) Pioneer LTIP: 9,362,383 shares - CORRECT. The arithmetic is verified: 47,088,821 + 238,700 + 9,362,383 = 56,689,904. All three entities (plans) are correctly identified and named. The multi-hop synthesis is sound - the model correctly aggregated share counts across three separate equity compensation plans. The answer directly addresses the question about shares available for award as of end of 2024. The inclusion of the source reference (page 32) adds credibility without being required. The semantic meaning is identical to the ground truth, with clear presentation of both the total and component figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 265,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The reclassification of Customer receivables in 2023 resulted in a **$4,432 million decrease** to both interest income and interest expense in the Institutional Securities segment. This adjustment, which aligned prior-period presentations with the current format, had **no effect on net interest income** and was entirely recorded within the Institutional Securities segment. The specific financial adjustment amount explicitly tied to this change is **$4,432 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The $4,432 million figure is correctly stated as the adjustment amount for both interest income and interest expense decreases. The statement that this had no effect on net interest income is accurate. The identification of the Institutional Securities segment as the location of this adjustment is correct. (2) QUANTITATIVE ACCURACY: The specific dollar amount of $4,432 million is precisely correct and properly formatted. No calculation errors are present. The answer correctly identifies this as the explicit financial adjustment amount tied to the reclassification. (3) QUALITATIVE ACCURACY: The reasoning is sound - the answer correctly synthesizes that the reclassification affected both interest income and interest expense equally, resulting in no net impact on net interest income. The multi-hop reasoning correctly connects the reclassification event to its dual impact on both income statement line items within a specific segment. The answer appropriately notes this was a presentation alignment adjustment. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all components of the multi-part question: the impact on interest income (decrease of $4,432M), the impact on interest expense (decrease of $4,432M), the segment identification (Institutional Securities), and the specific adjustment amount ($4,432M). The only minor observation is that the LLM uses slightly more explicit formatting with bold text compared to the ground truth's narrative style, but this is a stylistic choice that enhances clarity rather than detracting from accuracy. The semantic meaning is identical to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 476,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were **$208 million** ($133 million in 2019 and $75 million in 2021). Net investment hedge derivatives include **cross-currency interest rate swaps, forward contracts**, and **non-U.S. dollar denominated debt** designated to hedge net investments in non-U.S. operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the quantitative components. All dollar amounts are correct: $208 million total ($133 million in 2019 and $75 million in 2021), and the arithmetic is accurate. The multi-hop synthesis correctly combines data from two different years and properly calculates the combined total. Entity identification is correct (net investment hedge derivatives, fiscal years 2019 and 2021). The answer correctly identifies cross-currency interest rate swaps and forward contracts as types of net investment hedge derivatives, which matches the ground truth. However, the LLM answer adds 'non-U.S. dollar denominated debt designated to hedge net investments in non-U.S. operations' as an additional type of contract included in this category. While this additional information may be contextually relevant to net investment hedges, the ground truth specifically lists only 'cross-currency interest rate swaps and forward contracts' as the types included in the net investment hedge derivatives category according to the disclosures. This represents a minor expansion beyond what was explicitly stated in the ground truth answer. The core answer to both parts of the question (the combined amount and the types of contracts) is substantially correct, with the caveat that the LLM provided supplementary information not explicitly confirmed in the ground truth. The answer is well-structured, clear, and addresses all parts of the multi-part question effectively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 411,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their 2021 amendments was **$5.8 billion**. This capacity exceeded the maximum aggregate outstanding balance of **$2.1 billion** during the year ended December 31, 2021, indicating the company had significant unused borrowing capacity under the facilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental and significant factual error in the primary quantitative claim. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the total combined borrowing capacity is $5.8 billion, but the ground truth clearly establishes it is $9.5 billion ($5.0 billion Credit Facility + $4.5 billion Supplemental Facility). This is a $3.7 billion discrepancy - a 38.9% understatement of the actual capacity. This is not a minor rounding difference or format variation; it represents a fundamental misunderstanding or misreporting of the facility amounts. (2) PARTIAL CREDIT FOR MAXIMUM BALANCE: The LLM correctly identifies the maximum aggregate outstanding balance as $2.1 billion, which matches the ground truth. (3) REASONING QUALITY: While the LLM correctly reasons that the maximum balance is lower than capacity (indicating conservative leverage), this reasoning is based on an incorrect capacity figure. The comparison logic is sound, but applied to wrong numbers. (4) MISSING DETAIL: The LLM fails to provide the breakdown of the two facilities and their individual amendments, which the ground truth specifies: Credit Facility $5.0B (from $4.0B + $1.0B optional increase) and Supplemental Facility $4.5B (increased from $3.5B). This omission represents incomplete synthesis of the multi-hop information required. (5) ENTITY ACCURACY: Company name and year are correct, but the core financial metrics are substantially wrong. The error is too large to be a transcription mistake and suggests the LLM either hallucinated the $5.8B figure or confused it with another metric. This is a critical failure on the primary quantitative question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 457,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs in 2021 contributed **$140 million** to RMS' operating profit increase. This is explicitly stated in the document, which notes that RMS' operating profit rose by $183 million in 2021, driven primarily by higher operating profit of approximately $140 million from Sikorsky helicopter programs due to higher risk retirements (Black Hawk and CH-53K), increased production volume, and reduced charges on the CRH program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All key facts are correct - the $140 million contribution from risk retirements on Black Hawk and CH-53K programs is accurately stated, and the overall $183 million increase in RMS operating profit is correctly cited. (2) QUANTITATIVE ACCURACY: All numbers are precise and match the ground truth exactly: $140 million for the specific contribution, $183 million for total increase. The percentage increase (11%) mentioned in ground truth is not included in LLM answer, but this is a minor omission. (3) MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple factors - it identifies the specific $140 million contribution while also acknowledging other contributing factors (higher production volume, reduced CRH charges), demonstrating proper multi-hop synthesis. (4) ENTITY ACCURACY: All entities are correctly identified - RMS (Rotorcraft and Mission Systems), Black Hawk, CH-53K, CRH programs, and the 2021 fiscal year. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as ground truth with slightly different wording but equivalent meaning. The only minor gap is the omission of the 11% percentage increase mentioned in the ground truth, but this doesn't materially affect the answer to the specific question asked about the dollar contribution. The answer directly addresses both parts of the question: how the increase contributed (through risk retirements) and the specific dollar amount ($140 million).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 419,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "The total financial impact of energy-related derivatives on Southern Company's natural gas revenues and cost of natural gas in 2021 was a **$144 million decrease** (a $117 million reduction in natural gas revenues and a $27 million reduction in cost of natural gas). In 2019, the impact was a **$233 million increase** (a $223 million gain in natural gas revenues and a $10 million gain in cost of natural gas). This reflects a significant shift from positive to negative effects between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. CORRECT ELEMENTS: (1) 2021 impact correctly identified as $144 million loss/decrease; (2) 2019 impact correctly identified as $233 million gain/increase; (3) Year-over-year comparison correctly calculated as a $377 million swing ($144M loss + $233M gain = $377M difference); (4) All entities correctly identified (Southern Company/SO, natural gas revenues, cost of natural gas, energy-related derivatives); (5) Correct fiscal years (2019 and 2021). ADDITIONAL STRENGTHS: The LLM answer goes beyond the ground truth by providing granular breakdowns of the 2021 impact ($117M reduction in revenues, $27M reduction in costs) and 2019 impact ($223M gain in revenues, $10M gain in costs). These component figures sum correctly to the totals ($117M + $27M = $144M; $223M + $10M = $233M), demonstrating sound mathematical reasoning. The characterization of the shift from positive to negative effects is accurate and adds helpful context. MINOR CONSIDERATIONS: The ground truth simply states the impacts as a loss and gain without the component breakdown, but the LLM's additional detail is consistent with and supportive of the ground truth figures. The wording differs slightly ('decrease' vs 'loss', 'increase' vs 'gain') but these are semantically equivalent. The multi-hop synthesis is soundcorrectly combining information about natural gas revenues and cost of natural gas impacts across two different years and calculating the comparative difference. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 425,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "Cisco's losses from privately held investments decreased by $29 million in 2024 compared to 2023 ($164 million vs. $193 million). This reduction contributed to the overall net losses on investments narrowing by $11 million, from $177 million in 2023 to $166 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. Quantitative verification: (1) Losses from privately held investments: $193M (2023) to $164M (2024) - CORRECT; (2) Change calculation: $193M - $164M = $29M improvement - CORRECT; (3) Overall net losses: $177M (2023) to $166M (2024) - CORRECT; (4) Overall impact: $177M - $166M = $11M positive shift - CORRECT. All numbers match the ground truth exactly. The LLM correctly synthesized the multi-hop relationship showing how the $29M improvement in privately held investment losses contributed to the $11M improvement in overall net losses on investments. The reasoning is sound and logically presented. Minor note: The LLM uses slightly different phrasing ('losses narrowing' vs 'improving') but this is semantically equivalent and actually quite appropriate. The answer is complete, addressing both the change in privately held investment losses and the impact on overall net gains/losses. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 298,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "VZ made aggregate principal repayments of **$4.5 billion** in 2024 related to anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was **$13.0 billion** ($8.0 billion for 2021 and $5.0 billion for 2022). Thus, the 2024 repayments represent approximately **34.6%** of the combined outstanding balances from these facilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key quantitative facts are correct: (1) $4.5 billion principal repayment in 2024 for ABS Notes redemptions - matches ground truth exactly; (2) $8.0 billion outstanding balance for 2021 ABS Financing Facility as of Dec 31, 2024 - correct; (3) $5.0 billion outstanding balance for 2022 ABS Financing Facility as of Dec 31, 2024 - correct; (4) $13.0 billion aggregate total - correctly calculated and matches ground truth. The LLM also correctly calculated the percentage comparison (4.5/13.0 = 34.6%), which adds analytical value beyond the ground truth answer. Multi-hop reasoning is sound: the model correctly synthesized information about the 2024 repayments and compared them to the combined outstanding balances of both facilities as of the specified date. Entity identification is accurate (VZ, ABS Notes, 2021 and 2022 facilities). The answer is well-organized and provides both the direct comparison and a percentage metric that contextualizes the relationship between repayments and outstanding balances. Minor note: The LLM provides slightly more analytical insight (the percentage calculation) than the ground truth, which is a value-add rather than an error. All numbers, dates, and calculations are factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 361,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL capital transition provisions impact the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets as follows:  \n\n1. **Tier 1 Leverage Ratio**: The provisions adjust the calculation of adjusted average assets, which are used to determine total leverage exposure. These adjustments, including the phased-out CECL capital benefit, reduce deductions from Tier 1 capital (e.g., goodwill and intangibles) and modify the denominator in the leverage ratio formula (Tier 1 capital / total leverage exposure). This results in a higher Tier 1 leverage ratio due to lower leverage exposure adjustments.  \n\n2. **Standardized Approach for First Republic Assets**: The transition provisions permit the application of the Standardized approach to certain First Republic-related assets, which affects risk-weighted assets (RWA) calculations. This approach uses different risk weights than the Advanced approach, potentially reducing RWA for these assets. Lower RWA impacts capital ratios (e.g., Tier 1 and Total capital ratios) by increasing capital adequacy, as RWA is in the denominator of the capital ratio formulas.  \n\nThese adjustments ensure compliance with regulatory requirements while reflecting the transitional impact of CECL on capital metrics.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the question structure but contains significant conceptual and directional errors that undermine its accuracy. Here's the detailed assessment:\n\n(1) WHAT WAS CORRECT:\n- The answer correctly identifies that CECL capital transition provisions affect both the Tier 1 leverage ratio and the Standardized approach application to First Republic assets\n- Correctly names JPMorgan Chase and First Republic\n- Correctly identifies that goodwill and intangible assets are involved in the calculation\n- Correctly notes that the Standardized approach uses different risk weights than Advanced approach\n- Correctly identifies that RWA is in the denominator of capital ratio formulas\n\n(2) WHAT WAS INCORRECT/PROBLEMATIC:\n- DIRECTIONAL ERROR on Tier 1 leverage ratio impact: The LLM states the provisions \"reduce deductions from Tier 1 capital\" and result in \"a higher Tier 1 leverage ratio due to lower leverage exposure adjustments.\" The ground truth indicates the provisions \"adjust quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital.\" The LLM's characterization of the direction and mechanism appears inverted or oversimplified.\n- INCOMPLETE MECHANISM: The ground truth emphasizes that adjustments account for assets \"that must be deducted from Tier 1 capital, such as goodwill and intangible assets.\" The LLM's explanation of how these deductions work in the leverage ratio calculation is vague and potentially misleading.\n- SPECULATIVE LANGUAGE: The LLM uses phrases like \"potentially reducing RWA\" and \"potentially increasing capital adequacy\" which introduce uncertainty not present in the ground truth's more definitive statement.\n- MISSING SPECIFICITY: The ground truth specifically mentions \"quarterly average assets\" as the adjustment mechanism, which the LLM generalizes to \"adjusted average assets\" without the temporal specificity.\n\n(3) MULTI-HOP REASONING ASSESSMENT:\nThe LLM attempts to synthesize information across two dimensions (Tier 1 leverage ratio and Standardized approach), but the synthesis appears incomplete. The ground truth presents these as interconnected effects on \"regulatory capital reporting and leverage ratio computation,\" suggesting a more integrated relationship than the LLM's two-part breakdown suggests. The LLM treats them somewhat independently rather than showing how they work together in the overall capital framework.\n\n(4) QUANTITATIVE ACCURACY:\nNo specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so quantitative accuracy cannot be fully assessed. However, the directional claims about ratio impacts (higher vs. lower) represent quantitative assertions that appear problematic.\n\n(5) JUSTIFICATION FOR SCORES:\n- Correctness Score (5): The answer addresses the right topics and companies but contains directional/conceptual errors in explaining the mechanisms, particularly regarding the Tier 1 leverage ratio impact. The answer is partially correct but significantly flawed.\n- Quantitative Accuracy (6): No specific numbers to verify, but directional claims about ratio impacts are questionable.\n- Qualitative Accuracy (5): The reasoning structure is present but the explanation of mechanisms is incomplete or potentially incorrect, particularly regarding how deductions from Tier 1 capital affect the leverage ratio calculation.\n- Contextual Relevance (6): The answer addresses the question asked and identifies relevant concepts, but the explanation lacks the precision and accuracy needed for a regulatory/technical financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 951,
        "total_tokens": 2428
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSEs additional independence and financial expert requirements.",
      "llm_answer": "Simon has implemented governance policies including a Code of Business Conduct and Ethics, independent board composition (with at least a majority of directors qualifying as independent under NYSE standards), and specialized committees (Audit and Compensation) composed entirely of independent members meeting NYSE financial expertise requirements. These policies align with NYSE listing standards by ensuring board independence, conflict-of-interest mitigation, and adherence to corporate governance best practices. Additionally, the Simon charter mandates independent director approval for property sales to avoid conflicts, further reinforcing ethical conduct and compliance with NYSE requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core governance policies and NYSE compliance requirements. Strengths: (1) Correctly identifies all major governance mechanisms: Code of Business Conduct and Ethics, independent board composition (majority requirement), and specialized committees (Audit and Compensation) with independent members; (2) Accurately reflects NYSE listing standards alignment; (3) No quantitative errors in the answer (no specific numbers provided to verify, which is appropriate for this qualitative question); (4) Properly synthesizes multi-hop information about governance policies and their alignment with NYSE requirements. Weaknesses: (1) The LLM introduces a specific detail about 'independent director approval for property sales' that is not mentioned in the ground truth answer. While this may be accurate from the source documents, it represents information beyond what was provided in the original answer, creating a potential discrepancy; (2) The ground truth explicitly mentions 'governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company' and 'written charters for each of the standing committees' - the LLM answer mentions charters implicitly but doesn't explicitly reference the comprehensive governance principles framework or the detailed scope of what these principles cover; (3) The ground truth specifically notes the Simon family affiliation restriction ('not affiliated with the Simon family'), which the LLM omits. Overall, the answer captures the essential governance framework and NYSE alignment correctly, with minor omissions of specific details from the ground truth rather than factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 479,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method means changes in cost estimates directly adjust profit booking rates. Increases in profit booking rates (e.g., due to risk retirement) occur when estimated costs decrease, boosting profit, while decreases happen when costs rise, reducing profit. These changes are recognized in the period they are determined, immediately impacting segment operating profit and margin, with adjustments reflecting the cumulative effect of revised estimates on revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Lockheed Martin's percentage-of-completion cost-to-cost method and its impact on profit booking rates. STRENGTHS: (1) Correctly identifies the core mechanism: cost estimate changes directly affect profit booking rates; (2) Accurately explains the directional relationship: decreased costs increase profit booking rates (via risk retirement), increased costs decrease rates; (3) Properly states that changes are recognized in the period determined; (4) Correctly identifies the impact on segment operating profit and margin; (5) No quantitative errors or incorrect numbers/dates; (6) Multi-hop reasoning is sound - synthesizes the relationship between cost estimates, profit rates, and financial reporting. MINOR CONSIDERATIONS: (1) The LLM uses 'cumulative effect of revised estimates' while ground truth uses 'inception-to-date effect' - these are semantically equivalent concepts describing the same thing (cumulative/inception-to-date both refer to the total effect from contract start); (2) The LLM answer is slightly more concise than ground truth but captures all essential information; (3) Both answers correctly note that impacts can be favorable or unfavorable (LLM implies this through 'boosting profit' vs 'reducing profit'). The answer demonstrates accurate understanding of the accounting method, proper synthesis of how cost changes flow through to financial metrics, and correct identification of the timing of recognition. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 419,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "The combined increase in Services Revenue for the APJC region from 2023 to 2024 was **$89 million** (4% growth). However, the document does not provide explicit data for \"Total Balance\" for the APJC region, making it unclear how to quantify the combined increase with this metric. The percentage growth in Services Revenue (4%) is directly stated in the Services Revenue by Segment table (page 42). Without additional context or data on \"Total Balance,\" the question cannot be fully answered as posed.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and incomplete. CRITICAL ERRORS: (1) The LLM correctly identifies the $89 million Services Revenue increase and 4% growth rate, but FAILS to provide the Total Balance increase of $8,358 million, which is explicitly stated in the ground truth. (2) The LLM claims 'the document does not provide explicit data for Total Balance for the APJC region,' but the ground truth demonstrates this data exists and should have been found. (3) The LLM fails to calculate or provide the combined increase of $8,447 million ($89M + $8,358M), which is the primary answer to the question. (4) The LLM only partially answers the question by addressing Services Revenue growth but abandoning the analysis when encountering Total Balance data. WHAT WAS CORRECT: The $89 million Services Revenue increase and 4% growth percentage are accurate. WHAT WAS MISSING: The entire Total Balance component ($8,358 million increase) and the combined total ($8,447 million). This represents a failure in multi-hop synthesis - the question explicitly asks for a combined increase across two metrics, and the LLM provided only one metric while claiming the other was unavailable. The ground truth confirms both data points exist in the source material. The LLM's approach of stating 'the question cannot be fully answered' when data is actually available demonstrates inadequate document analysis and information retrieval.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 396,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "The total notional value of Abbott's interest rate hedge contracts as of December 31, 2024, was **$2.2 billion**, while foreign currency forward exchange contracts totaled **$23.191 billion** (as per the table on page 41). Combined, these instruments reflect Abbott's strategy to mitigate market risk by hedging against interest rate fluctuations and foreign exchange rate volatility, ensuring stability in cash flows and fair value of debt and intercompany transactions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides partially correct information with significant quantitative discrepancies. CORRECT ELEMENTS: (1) Interest rate hedge contracts value of $2.2 billion is accurate; (2) The general strategy description about hedging interest rate and foreign exchange risk is semantically correct; (3) The mention of page 41 as source shows proper documentation. CRITICAL ERRORS: (1) Foreign currency forward exchange contracts stated as $23.191 billion, but ground truth shows $23.2 billion - while this is a minor rounding difference, the LLM failed to provide the breakdown that ground truth specifies ($7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables); (2) MAJOR OMISSION: The LLM states the combined total implicitly but does NOT explicitly calculate or state the total notional value of $25.4 billion ($2.2B + $23.2B), which is a key requirement of the question asking for 'total notional value'; (3) The LLM provides less detailed breakdown of the foreign currency contracts' composition. MULTI-HOP REASONING: The answer demonstrates adequate synthesis of interest rate and foreign exchange strategies but fails to complete the full calculation requested. The qualitative explanation of Abbott's risk management strategy is sound and addresses the second part of the question appropriately. The answer is incomplete because it doesn't explicitly state the combined total of $25.4 billion, which is a direct answer to the primary question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 418,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "McDonald's accounts for franchisees as separate entities, with revenues recognized from franchised operations (e.g., royalties and rent) but without consolidating their financial statements. The Companys consolidation policy excludes franchisees, as they are not variable interest entities (VIEs) requiring consolidation, and their results are not material to the consolidated financial statements. Operational materiality is addressed by noting that transactions with franchisees (e.g., purchases/sales of restaurants) were not significant to the Companys financials, ensuring franchisees operations do not distort consolidated results.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN CORE FACTS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that franchisees 'are not variable interest entities (VIEs) requiring consolidation,' but the ground truth explicitly states that MCD 'does not consolidate variable interest entities, such as those involving franchisees' and applies 'a scope exception under variable interest entity consolidation guidance.' This is a major semantic reversal - the ground truth indicates franchisees ARE treated as VIEs but are excluded via a scope exception, while the LLM incorrectly claims they are NOT VIEs. This represents a fundamental misunderstanding of the consolidation policy. CORRECT ELEMENTS: The LLM correctly identifies that (1) franchisee results are not consolidated, (2) revenues are recognized from franchised operations (royalties/rent), (3) materiality is a key factor, and (4) franchisee operations don't distort consolidated results. MISSING/INCOMPLETE ELEMENTS: The LLM fails to clearly articulate the specific scope exception mechanism under VIE guidance that MCD applies. The phrase 'not material to the consolidated financial statements' is present but the LLM doesn't emphasize that results are deemed immaterial 'both individually and in aggregate' as stated in the ground truth. REASONING QUALITY: The multi-hop synthesis is partially sound but undermined by the VIE classification error. The logic connecting materiality to non-consolidation is present but incomplete. QUANTITATIVE ACCURACY: No specific numbers or dates were required in either answer, so this dimension is neutral (7/10 for general accuracy of concepts). OVERALL ASSESSMENT: While the LLM captures the general framework of franchisee accounting treatment, the critical error regarding VIE classification significantly undermines the answer's correctness and demonstrates incomplete understanding of MCD's specific consolidation policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 526,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation includes off-balance sheet exposures added to adjusted average assets, which increases total leverage exposure and thereby reduces the SLR. If the SLR falls below the required threshold of 5.0% (3.0% minimum plus a 2.0% buffer), the bank faces limitations on capital distributions (e.g., dividends, share repurchases) and discretionary bonus payments for executives. As of 2024, the SLR was 6.1%, above the requirement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong alignment to the ground truth. STRENGTHS: (1) All key numeric values are accurate - correctly identifies the 3.0% minimum threshold, 2.0% buffer, and 5.0% total requirement. (2) Accurately describes the SLR calculation components including off-balance sheet exposures and adjusted average assets. (3) Correctly identifies consequences of falling below threshold (restrictions on dividends, share repurchases, discretionary bonuses). (4) The 2024 SLR figure of 6.1% is provided as additional context, which is factually accurate and relevant. (5) Multi-hop reasoning is sound - properly synthesizes how off-balance sheet exposures and adjusted assets combine to affect the ratio. MINOR WEAKNESSES: (1) The phrasing 'increases total leverage exposure and thereby reduces the SLR' could be slightly clearer - while technically correct, it might benefit from explicitly stating that higher leverage exposure in the denominator reduces the ratio. (2) The answer adds the 2024 SLR figure (6.1%) which, while accurate and helpful, goes slightly beyond what was explicitly in the ground truth answer, though this is a minor enhancement rather than an error. (3) The ground truth emphasizes that adjusted average assets account for 'on-balance sheet assets like goodwill and intangible assets' - the LLM answer mentions adjusted average assets but doesn't explicitly detail what adjustments are made, though this is a minor omission. QUANTITATIVE VERIFICATION: All percentages (3.0%, 2.0%, 5.0%, 6.1%) are correct. QUALITATIVE ASSESSMENT: The reasoning correctly connects the components of the SLR calculation to the consequences of non-compliance. The answer demonstrates proper understanding of the multi-hop relationship between calculation methodology and regulatory consequences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 495,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31, 2021, the total borrowings under the Credit Facilities were **$1.175 billion** ($125.0 million under the Credit Facility and $1.05 billion under the Supplemental Facility). This amount was significantly below the **$4.5 billion maximum borrowing capacity** of the Supplemental Facility, as outlined in its amended terms.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the total borrowings of $1.175 billion ($125 million + $1.05 billion) as of December 31, 2021, and accurately states the $4.5 billion maximum borrowing capacity figure. However, there is a notable incompleteness in the answer. The ground truth specifies that the Supplemental Facility had a maximum borrowing capacity of $3.5 billion that 'could be increased to $4.5 billion during its term.' The LLM answer only mentions the $4.5 billion figure without acknowledging the base $3.5 billion capacity or the conditional increase provision. This is a material omission because the question specifically asks about 'the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms,' which should include both the base amount and the increase option. The LLM's statement that the amount was 'significantly below' the $4.5 billion is accurate and provides useful context for comparison. All numeric values are correct and properly formatted. The multi-hop reasoning is sound in synthesizing the borrowing breakdown and comparing it to capacity. The answer is contextually relevant and addresses the core question, but the incomplete disclosure of the full amended terms (missing the $3.5B base with $4.5B increase option) represents a significant gap in comprehensiveness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 371,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021 was **$500 million**, compared to **$572 million** in 2020. This represents a **12.59% decrease** ((572 - 500)/572 * 100).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key facts are correct: (1) 2021 notional amount of $500 million is correct, (2) 2020 notional amount of $572 million is correct, (3) the percentage decrease calculation is accurate at 12.59% (verified: (572-500)/572 * 100 = 72/572 * 100 = 12.59%). The answer properly addresses all parts of the multi-part question by providing both the 2021 amount, the 2020 comparison amount, and the percentage change. The calculation is shown explicitly, demonstrating sound mathematical reasoning. The only minor distinction from the ground truth is that the ground truth states 'approximately 12.6%' while the LLM provides the more precise '12.59%' - this is actually an improvement in precision rather than an error. The multi-hop synthesis is correct: the answer successfully combines data from two different years and performs the appropriate comparative analysis. Entity identification is accurate (Lockheed Martin, interest rate swaps, correct fiscal years). The answer is semantically equivalent to and factually consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 314,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Powers financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The disagreement between Georgia Power and other Vogtle Owners over cost-sharing provisions has led to significant financial exposure for Georgia Power, as unresolved disputes over cost thresholds and COVID-19 impacts triggered incremental charges. Specifically, Georgia Power recorded a **$440 million pre-tax charge in Q4 2021** related to these provisions, with potential additional charges of up to **$460 million** based on the project's capital cost forecast. These charges are **non-recoverable from retail customers**, directly increasing Georgia Power's financial burden. Cumulative charges from 20182021, including $460 million in Q2 2020 and $480 million in Q4 2021, further illustrate the material impact of the disagreement on its financial exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a significant factual error regarding the $460 million charge. The ground truth states this is a POTENTIAL FUTURE charge 'based on the current project capital cost forecast,' not a charge that was already recorded. The LLM incorrectly states '$460 million in Q2 2020' which contradicts the ground truth and introduces a false historical charge. The ground truth only confirms the $440 million Q4 2021 charge as actually recorded. (2) The LLM mentions '$480 million in Q4 2021' which does not appear in the ground truth at all - this is a fabricated number. The ground truth clearly states $440 million in Q4 2021, not $480 million. (3) The reference to '$460 million in Q2 2020' is entirely unsupported by the ground truth, which makes no mention of a 2020 charge of this amount. (4) MULTI-HOP REASONING - While the LLM correctly identifies the core dispute (cost-sharing thresholds and the $18.38 billion threshold mentioned in ground truth), it fails to properly distinguish between recorded charges versus potential future charges. The ground truth clearly separates: (a) $440M actually recorded in Q4 2021, and (b) $460M as a potential additional charge. The LLM conflates these and adds unsupported historical charges. (5) POSITIVE ELEMENTS - The LLM correctly identifies: the $440 million Q4 2021 charge, the $460 million potential exposure, non-recoverability from retail customers, and the general nature of the disagreement. However, the fabricated numbers ($480M, $460M in Q2 2020) are serious factual errors that undermine credibility. The answer demonstrates partial understanding but contains material inaccuracies that would mislead readers about Georgia Power's actual financial charges.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 484,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported total Digital Media ARR of **$12.24 billion** at the end of fiscal 2021. The specific Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence for businesses is the **Adobe Experience Platform**, which connects Adobe's comprehensive set of solutions to strengthen its competitive advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The Digital Media ARR figure of $12.24 billion at the end of fiscal 2021 is correct and matches the ground truth exactly. No calculation errors present. (2) ENTITY ACCURACY: All entities are correctly identified - Adobe, Digital Media ARR, fiscal 2021, Adobe Experience Cloud, and Adobe Experience Platform are all accurate. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two distinct parts of the question: (a) identifying the correct financial metric and amount, and (b) identifying the specific Experience Cloud solution with its purpose. The connection between the Experience Platform and customer journey management/intelligence delivery is correctly established. (4) COMPLETENESS: Both sub-questions are fully addressed. The answer identifies the exact ARR amount and the specific solution (Adobe Experience Platform) with its strategic purpose. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth. The phrasing 'connects Adobe's comprehensive set of solutions to strengthen its competitive advantage' is semantically equivalent to 'strengthening Adobe's differentiation and competitive advantage.' Minor difference: The LLM adds the phrase 'connects Adobe's comprehensive set of solutions' which provides additional context but doesn't contradict the ground truth. This is a minor enhancement rather than an error. Overall, the answer demonstrates accurate fact retrieval, correct calculations, proper entity identification, and sound multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 443,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "The total fair value of interest rate hedge contracts as of December 31, 2024, was **$52 million** ($1 million receivable and $51 million payable), compared to **$95 million** ($95 million payable) in 2023. This reflects a **decrease of $43 million** from 2023 to 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental and critical errors in understanding how to calculate the total fair value of interest rate hedge contracts. (1) MAJOR CALCULATION ERROR: The LLM incorrectly calculated the 2024 total fair value as $52 million by adding the receivable and payable positions ($1M + $51M = $52M). The correct approach is to net these positions: $1M (receivable) - $51M (payable) = -$50M. The ground truth correctly identifies this as -$50 million, representing a net payable position. (2) INCORRECT 2023 COMPARISON: The LLM states 2023 was $95 million, but this is also incorrect in context. The ground truth shows 2023 was -$95 million (a net payable position of $95M), not a positive $95M. The LLM failed to recognize the negative sign indicating a payable position. (3) WRONG YEAR-OVER-YEAR CHANGE: The LLM calculated a decrease of $43 million ($95M - $52M), but this is mathematically and conceptually wrong. The correct calculation is: -$50M (2024) minus -$95M (2023) = +$45M improvement, which the ground truth correctly identifies. The LLM's calculation of $43M is also arithmetically incorrect for their stated values. (4) CONCEPTUAL MISUNDERSTANDING: The LLM appears to not understand that interest rate hedge contracts with both receivable and payable positions should be netted to determine the overall fair value position. The negative values indicate net payable positions, which is a critical distinction in financial reporting. (5) ENTITY AND METRIC ACCURACY: While Abbott and the correct year (2024 vs 2023) are identified, the fundamental misunderstanding of how to calculate and interpret the fair value metric makes the answer substantially incorrect. The question specifically asks about 'both the receivable and (payable) positions,' which the LLM acknowledged but then mishandled in calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 497,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "The combined total of discounted future net cash flows from equity companies in Asia is **$34,170 million** (as of December 31, 2024), and the total proved reserves (oil-equivalent) for equity companies in Asia is **1,276 million barrels**. However, the question asks for this as a percentage, which requires aligning different units (dollars vs. barrels). Based on the standardized measure table in the 2024 10-K, the **discounted future net cash flows for equity companies in Asia** is **34,170 million dollars**, and the **total proved reserves (oil-equivalent)** for equity companies in Asia is **1,276 million barrels**. Since the units are not directly comparable, the percentage cannot be calculated as a standard ratio. However, if the question intends to reference the **percentage of total discounted cash flows from equity companies in Asia relative to all equity companies**, the value is **34,170 / 37,866  90.3%**. \n\n**Answer:** The combined total of discounted future net cash flows from equity companies in Asia is **$34,170 million**, and the total proved reserves (oil-equivalent) for equity companies in Asia is **1,276 million barrels**. However, due to differing units, a direct percentage cannot be calculated without additional context. If the question refers to the percentage of equity companies in Asia's cash flows relative to all equity companies, it is approximately **90.3%**. \n\n**Final Answer:** Based on the provided data, the percentage is **not directly calculable** due to differing units, but the discounted future net cash flows for equity companies in Asia are **$34,170 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: (1) WRONG PRIMARY NUMBER: LLM states discounted future net cash flows for equity companies in Asia is $34,170 million, but ground truth is $60,780 million - this is a 43.8% understatement of the key financial metric. (2) CORRECT SECONDARY NUMBER: LLM correctly identifies total proved reserves (oil-equivalent) as 1,276 million barrels, matching ground truth. (3) CALCULATION ERROR: LLM fails to perform the requested calculation. Ground truth correctly calculates $60,780M / 1,276M barrels = $47.63 per barrel. LLM instead calculates 34,170/37,866 = 90.3%, which is an entirely different metric (percentage of equity companies in Asia relative to all equity companies) - this is not what was asked. (4) REASONING FLAW: LLM claims 'units are not directly comparable' and that 'percentage cannot be calculated as a standard ratio,' but the ground truth demonstrates this is incorrect. The question asks for cash flows per barrel (or as a percentage/ratio), which is a standard industry metric. LLM's interpretation that this cannot be calculated shows fundamental misunderstanding. (5) MULTI-HOP SYNTHESIS: LLM failed to correctly synthesize the two data points from the filing into the requested metric. The ground truth shows the correct approach: divide total discounted cash flows by total proved reserves to get cash flow per barrel ($47.63). (6) ANSWER QUALITY: LLM provides multiple conflicting interpretations and ultimately states the answer is 'not directly calculable,' which contradicts the ground truth that clearly calculates this metric. The LLM's answer is confusing, internally contradictory, and factually incorrect on the primary number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 457,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan Chase's capital allocation to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and the GSIB surcharge, ensures adherence to the supplementary leverage ratio (SLR) requirements. The SLR of 6.1% (as of December 31, 2024) exceeds the 3.0% minimum and the additional 2.0% buffer, reflecting sufficient Tier 1 capital relative to total leverage exposure. The allocation methodology incorporates regulatory capital requirements, including Basel III RWA and GSIB surcharge adjustments, to maintain compliance while accounting for stress scenarios and ensuring excess capital is retained in Corporate to support leverage ratios.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key regulatory framework (Basel III Standardized RWA, GSIB surcharge, SLR requirements) and accurately states that JPMorgan Chase's SLR exceeds minimum requirements. The answer appropriately mentions the 3.0% minimum SLR and 2.0% buffer, and correctly notes that capital allocation incorporates stress scenarios. The reasoning about maintaining sufficient Tier 1 capital relative to leverage exposure is sound.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces a specific SLR figure of 6.1% as of December 31, 2024, which is not mentioned in the ground truth and cannot be verified. This is a significant addition of unverified data. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes that the combined SLR threshold is 5.0% (3.0% minimum + 2.0% buffer), which the LLM mentions but does not explicitly synthesize as a combined requirement. (3) MISSING DETAIL - The ground truth specifically explains that SLR is calculated as Tier 1 capital divided by total leverage exposure (including quarterly average assets adjusted for certain deductions and off-balance sheet exposures), which the LLM only vaguely references as 'total leverage exposure.' (4) MISSING CONSEQUENCE - The ground truth explicitly states that failure to maintain the 5.0% threshold would restrict capital distributions (dividends and share repurchases), which the LLM omits. (5) VAGUE ALLOCATION DESCRIPTION - The LLM states 'excess capital is retained in Corporate' but the ground truth provides more specific context about how capital depletion simulations in stress scenarios drive allocation decisions.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between Basel III RWA, GSIB surcharge, and SLR requirements, but fails to fully integrate all components of the ground truth answer regarding stress scenario simulations and capital distribution restrictions.\n\nNUMERIC VERIFICATION: The 6.1% SLR figure appears to be introduced without ground truth support. The 3.0% minimum and 2.0% buffer are correct. The implicit 5.0% combined threshold is correct but not explicitly stated by the LLM.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 576,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "The total potential borrowing capacity available to Simon Property Group after amendments in 2021 was **$9.5 billion**, combining the Credit Facility's $5.0 billion aggregate size and the Supplemental Facility's $4.5 billion maximum. Both facilities have identical interest rate structures under Daily SOFR Loans, with rates set at **SOFR plus 72.5 basis points** plus a spread adjustment for LIBOR transition, as outlined in their respective amendments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) CORRECTNESS: All key facts are correct - the total borrowing capacity of $9.5 billion is accurate, the Credit Facility amount of $5.0 billion is correct, the Supplemental Facility amount of $4.5 billion is correct, and the SOFR rate of SOFR plus 72.5 basis points is accurate. The statement that both facilities have identical interest rate structures is correct. (2) QUANTITATIVE ACCURACY: All numerical values are precise and correctly formatted. The calculation of $5.0B + $4.5B = $9.5B is accurate. The 72.5 basis points figure is exact. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information about both facilities and their amendments in 2021, properly identifies the two separate facilities and their respective sizes, and accurately compares the interest rate structures. The mention of the spread adjustment for LIBOR-to-SOFR transition is appropriate context. (4) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) total borrowing capacity post-amendments, and (b) interest rate structure comparison between facilities. The answer correctly identifies that the rates are identical between the two facilities. Minor note: The answer could have been slightly more explicit about the 2021 amendment timing in the opening clause, though it is mentioned. Overall, this is a comprehensive, accurate response with proper synthesis of multi-hop information across the two facilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 421,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a **$540 million increase in RMS net sales** and a **$560 million increase in RMS product costs**. These figures are derived from RMS's 2021 results, where higher production volume on Black Hawk, CH-53K, and CRH programs drove the sales growth, while elevated production costs reflected the expanded output.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: Both key financial figures match the ground truth exactly - $540 million increase in RMS net sales and $560 million increase in product costs. The answer correctly identifies these as direct results of increased Sikorsky helicopter production volume in 2021. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The $540M and $560M figures are stated clearly with proper formatting. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by connecting production volume increases to both revenue and cost impacts. The answer correctly identifies the RMS segment and provides specific program names (Black Hawk, CH-53K, CRH) that support the explanation, showing deeper contextual understanding. The logical connection between higher production output and both sales growth and cost escalation is clearly articulated. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the multi-part question - how production volume impacted net sales, how it impacted product costs, and the specific dollar amounts for each metric. The response is appropriately focused on the RMS segment and 2021 timeframe as required. Minor note: The LLM provides additional context (specific program names) beyond the ground truth, which adds value without contradicting the core answer. This represents appropriate elaboration rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 406,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "McDonald's recurring transactions with franchisees, such as purchases and sales of restaurant businesses, are accounted for in **operating income** rather than as separate gains/losses. These transactions are not material to the consolidated financial statements, as noted in the \"Summary of Significant Accounting Policies\" (Page 45). Gains or losses from such sales are directly recorded in operating income, reflecting their recurring nature. Additionally, the Company does not consolidate franchisees under variable interest entity guidance, ensuring these transactions remain distinct from consolidated operations, with impacts limited to operating income.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that gains/losses from restaurant business sales are recorded in operating income, matching the ground truth; (2) Accurately states that franchisees are not consolidated under variable interest entity guidelines, which is a key point in the ground truth; (3) Properly explains that the financial impact is reflected through gains/losses at point of sale rather than ongoing consolidated operations; (4) Correctly characterizes these as recurring transactions that are part of the business model. MINOR ISSUES: (1) The LLM adds a specific reference to 'Page 45' and 'Summary of Significant Accounting Policies' which cannot be verified against the ground truth and may be a hallucination of specific document details; (2) The phrase 'not material to the consolidated financial statements' is introduced by the LLM but is not explicitly stated in the ground truth, which focuses on the accounting treatment rather than materiality assessment; (3) The ground truth emphasizes these transactions are 'aimed at maintaining an optimal ownership mix,' which the LLM does not mention, though this is a relatively minor contextual detail. MULTI-HOP REASONING: The LLM successfully synthesizes the two key elements: (1) operating income treatment of gains/losses and (2) non-consolidation of franchisees, and correctly links them to explain the overall financial reporting impact. The logic is sound and the synthesis is appropriate. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are required in this question, so this dimension is not heavily tested. The answer contains no numerical errors. OVERALL: The answer demonstrates solid understanding of McDonald's accounting policies for franchisee transactions and correctly addresses the question's core requirements, with only minor additions/omissions that don't materially affect the accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 537,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "Chevron's use of derivative commodity instruments in 2023 did not materially impact its financial position, as the change in fair value of these instruments was not significant. The company's internal Risk Control group monitors market risk daily, ensuring alignment with risk management policies and compliance reviews by the Audit Committee. Fair value measurements, derived from published market quotes and third-party data, were non-material to results of operations, with the company employing a Value-at-Risk (VaR) model to quantify potential losses, which were also not material.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that derivative commodity instruments had no material impact on Chevron's financial position in 2023 - this matches the ground truth; (2) Accurately describes the Risk Control group's daily monitoring of market exposure; (3) Correctly notes Audit Committee review of risk management policies; (4) Properly identifies that fair value measurements were non-material to results of operations; (5) Appropriately mentions the use of Value-at-Risk (VaR) model for quantifying potential losses. MINOR ISSUES: (1) The LLM answer adds specific detail about 'published market quotes and third-party data' for fair value measurements - while this is likely accurate, it goes slightly beyond what the ground truth explicitly states, though it doesn't contradict it; (2) The mention of VaR model is a reasonable addition that demonstrates understanding of risk management practices, though the ground truth doesn't explicitly reference this specific methodology. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three key areas: (a) derivative impact on financial position, (b) Risk Control group monitoring practices, and (c) fair value measurements and their materiality. The logical flow connecting these elements is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - that derivatives were non-material and that risk management practices were in place and monitored. No numerical values are provided in either answer (which is appropriate given the 'non-material' nature of the impact), so quantitative accuracy is not compromised. The answer is well-structured and directly responsive to all parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 493,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is a **net benefit of $720 million**. This reflects the impact of the provisions on CET1 capital, as detailed in Note (b) on page 105, which specifies the $720 million benefit for 2024. While the allowance for credit losses included in Tier 2 capital (e.g., $20,992 million as of 2024) is part of the CECL provisions, it does not directly affect CET1 capital. Thus, the question's reference to both components is resolved by focusing on the CET1-specific benefit of $720 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to properly address the multi-hop question. Key issues: (1) QUANTITATIVE ERROR - The LLM identifies only $720 million as the total impact, but the ground truth specifies $1.261 billion as the total impact. The LLM incorrectly dismisses the $541 million allowance for credit losses component as not affecting CET1 capital, which contradicts the ground truth that explicitly states this amount 'impacts CET1 capital through regulatory capital calculations.' (2) INCOMPLETE SYNTHESIS - The question explicitly asks for 'both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital.' The ground truth correctly synthesizes both components ($720M + $541M = $1.261B), while the LLM only addresses one component and incorrectly argues the second doesn't apply. (3) FLAWED REASONING - The LLM's logic that Tier 2 capital components don't affect CET1 is incorrect in this regulatory context. The ground truth clarifies that the $541 million allowance 'impacts CET1 capital through regulatory capital calculations,' meaning it must be included in the total impact calculation. (4) MISSING CONTEXT - The LLM fails to recognize that the question specifically asks for the 'total impact' considering both components, which requires adding both the AOCI benefit and the Tier 2 allowance impact. The LLM's dismissal of the second component represents a failure in multi-hop reasoning and synthesis. The correct answer should be $1.261 billion, not $720 million.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 421,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was a **$129 million realized and unrealized gain** from the investment in and note with AerCap, as reported in Note 19 (Other Income (Loss)). This gain is separate from the equity method income, which is part of the broader $345 million in other income for 2023. The question specifically highlights realized/unrealized gains, so the $129 million is the key figure. No additional net income contribution from AerCap is explicitly quantified in the provided pages. \n\n**Answer:** GE recorded a $129 million realized and unrealized gain from AerCap-related transactions in 2023, which represents the total financial impact as detailed in Note 19.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is significantly incomplete and misses the core requirement of the question. CRITICAL ERRORS: (1) The LLM only identifies the $129 million realized/unrealized gain but completely omits the $2,525 million net income contribution from AerCap, which is a major component of the total financial impact. (2) The ground truth answer clearly states the total impact is $2,654 million ($2,525M + $129M), but the LLM provides only $129 million as the answer. (3) The LLM explicitly states 'No additional net income contribution from AerCap is explicitly quantified in the provided pages,' which is factually incorrect according to the ground truth - the $2,525 million net income contribution clearly exists in the source documents. (4) The question asks for 'total financial impact...considering both the net income contribution AND the realized/unrealized gains' (emphasis on both), but the LLM only addresses one component. QUANTITATIVE ACCURACY: The $129 million figure is correct but incomplete - it represents only 4.9% of the actual total impact. The missing $2,525 million is a massive omission. QUALITATIVE ACCURACY: The reasoning fails to synthesize the multi-hop requirement of combining two separate financial metrics (net income and gains/losses) into a single total impact figure. The LLM appears to have narrowly focused on one data point rather than performing the required synthesis. CONTEXTUAL RELEVANCE: While the $129 million figure is relevant, it does not answer the actual question asked, which requires a comprehensive total that includes both components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 435,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Of this amount, $20 million was allocated to goodwill, representing the excess of the consideration transferred over the fair value of net assets acquired.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly matches the ground truth. (1) QUANTITATIVE ACCURACY: Both key financial figures are correct - total consideration of $301 million and goodwill allocation of $20 million. The numbers are presented in identical format and are factually accurate. (2) COMPLETENESS: The answer addresses all parts of the multi-part question: identifies the acquiring company (Merck), the target company (Immune Design), the total consideration amount, the goodwill portion, and the basis for the goodwill calculation (excess of consideration over fair value of net assets). (3) ENTITY ACCURACY: All entities are correctly identified - Merck as acquirer, Immune Design as target, and the financial metrics are properly labeled. (4) REASONING: The multi-hop reasoning is sound - the answer correctly synthesizes that goodwill represents the difference between total consideration paid ($301M) and the fair value of net assets acquired (implicitly $281M). The explanation of goodwill as 'the excess of the consideration transferred over the fair value of net assets acquired' is conceptually correct and matches the ground truth explanation. (5) SEMANTIC EQUIVALENCE: The LLM answer uses nearly identical wording to the ground truth, with only minor stylistic variations ('Out of this' vs 'Of this amount') that do not affect meaning. The answer is complete, accurate, and properly synthesizes the acquisition information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 400,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees contribute to McDonald's revenue through **rent, royalties (based on a percentage of sales), minimum rent payments, and initial fees** under conventional franchise agreements. For developmental licensees and affiliates, revenue includes royalties and initial fees.  \n\nThe co-investment by McDonald's in franchisee restaurant improvements results in **capitalized costs** for the Company, which are allocated between Property and Equipment and Accounts Receivable. Upon project completion, any adjustments to these allocations may **impact depreciation expense**, though the document notes such adjustments are typically **immaterial**. This occurs because McDonald's funds portions of improvements, leading to higher capitalized assets and corresponding depreciation charges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-part question about franchisee financial contributions and co-investment impacts. (1) CORRECTNESS: The answer correctly identifies all primary revenue sources from franchisees (rent, royalties based on percentage of sales, minimum rent payments, and initial fees), matching the ground truth exactly. The explanation of co-investment mechanics is accurate - McDonald's funds improvements, allocates costs between Property and Equipment and Accounts Receivable, and adjustments to these allocations impact depreciation expense. The characterization of adjustments as 'typically immaterial' aligns with the ground truth statement. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in either the question or ground truth, so this dimension is not applicable. The answer avoids making unsupported numerical claims. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes: (a) how franchisees contribute revenue (multiple streams), (b) how McDonald's co-invests in improvements, (c) how costs are allocated, and (d) how this allocation impacts depreciation. The logical flow from co-investment  capitalization  allocation  depreciation impact is clear and accurate. (4) ENTITY ACCURACY: McDonald's is correctly identified throughout; the distinction between conventional franchisees and developmental licensees/affiliates is appropriately noted. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'capitalized costs' and 'higher capitalized assets and corresponding depreciation charges' conveys the same meaning as the ground truth's discussion of cost allocation and depreciation expense impact. Minor strength: The answer adds helpful context by distinguishing between conventional franchisees and developmental licensees, which shows deeper understanding. The only minor consideration is that the answer could have been slightly more explicit about the 'final cost allocations' aspect mentioned in ground truth, but this is a very minor omission that doesn't affect overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 572,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "The value of Goldman Sachs' securities backed by real estate decreased by **$120 million** from December 2023 ($689 million) to December 2024 ($569 million). The primary cause of the unrealized losses on Level 3 investments in 2023 related to this category was **ongoing weakness in the commercial real estate market**, as noted in the Level 3 rollforward commentary for 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE VERIFICATION: All numbers are correct - the $120 million decrease is accurately calculated ($689M - $569M = $120M), December 2023 and December 2024 values are both correct ($689M and $569M respectively). (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the decrease amount and specific values, and (b) the primary cause of unrealized losses. (3) ENTITY ACCURACY: Goldman Sachs is correctly identified, the time periods (December 2023 to December 2024, and 2023 for the cause) are accurate, and the financial metric (securities backed by real estate, Level 3 investments) is correctly specified. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two distinct requirements - connecting the valuation change data with the explanation of unrealized losses from the Level 3 rollforward commentary. The reasoning is sound and logical. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'ongoing weakness in the commercial real estate market' is semantically equivalent to the ground truth's 'weakness in the commercial real estate market' - both convey the same causal explanation. The addition of 'ongoing' and reference to 'Level 3 rollforward commentary' provides appropriate context without deviating from the ground truth. Minor note: The LLM slightly enhances the answer by noting the source ('Level 3 rollforward commentary for 2023'), which adds credibility without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 421,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "American Tower incurred an additional cost of **$80.1 million** in prepayment consideration beyond the principal amount when repaying the CoreSite Debt. The previously reported outstanding balance as of December 31, 2021, was **$955.1 million**. The additional cost ($80.1 million) is significantly lower than the principal amount, representing the prepayment fee for early repayment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that substantially undermine its accuracy. (1) CRITICAL ERRORS: The LLM reports only $80.1 million in additional costs, but the ground truth specifies $87.9 million total ($80.1 million prepayment consideration + $7.8 million accrued interest). The LLM completely omitted the $7.8 million accrued interest component, which is a material omission. (2) OUTSTANDING BALANCE ERROR: The LLM states the outstanding balance as of December 31, 2021 was $955.1 million, but the ground truth clearly indicates it was $875 million. This is a $80.1 million discrepancy - the LLM appears to have confused the prepayment consideration amount with the outstanding balance figure. (3) TOTAL REDEMPTION PRICE: The ground truth specifies the total redemption price was $962.9 million ($875M principal + $87.9M additional costs), but the LLM does not provide this calculation or total. (4) MULTI-HOP SYNTHESIS: The question requires synthesizing three pieces of information: (a) additional costs beyond principal, (b) breakdown of those costs, and (c) comparison to December 31, 2021 balance. The LLM only partially addresses (a), completely misses (b) by omitting accrued interest, and gets (c) factually wrong. (5) INCOMPLETE ANSWER: The LLM fails to address the complete picture of additional costs ($87.9M total) and provides an incorrect comparison baseline. The reasoning about the prepayment fee being 'significantly lower than the principal amount' is somewhat logical but based on incorrect foundational numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 427,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "GE's collections from CFM International contributed $0.9 billion to the reduction in current receivables in 2024, as noted in the cash flow statement (page 15). This offset higher volume growth in receivables. The business relationship with CFM International, a joint venture jointly owned with Safran Aircraft Engines, involves substantial sales of parts and services, as outlined in the equity method investments section (page 44). This partnership underpins the financial interaction, with GE providing critical components and services to CFM International.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE ACCURACY: The LLM answer states that collections from CFM International contributed '$0.9 billion to the reduction in current receivables,' but the ground truth indicates the impact was '$(0.9) billion' (negative $0.9 billion) from current receivables that was 'partially offset' by collections. The LLM reversed the sign and magnitude of the financial impact. The ground truth shows collections PARTIALLY OFFSET a negative impact, not that collections themselves were $0.9 billion positive. This is a fundamental misrepresentation of the cash flow dynamics. QUALITATIVE ASSESSMENT: The LLM correctly identified CFM International as a joint venture with Safran Aircraft Engines and correctly noted the substantial sales of parts and services relationship. However, the core quantitative claim is inverted - the LLM presents collections as a positive $0.9B contribution when the ground truth indicates a $(0.9)B negative impact from receivables that was only partially offset by collections. The LLM also adds page references (pages 15 and 44) that cannot be verified against the ground truth. MULTI-HOP REASONING: The LLM did synthesize information about the business relationship correctly (joint venture structure + parts/services sales), but failed on the primary quantitative component of the question. The semantic meaning of the financial interaction is fundamentally altered by the sign error. This is not a minor wording difference but a material misstatement of financial impact direction and magnitude.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 425,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments, was a **$276 million increase** in operating revenues. This figure is detailed in the EU&I segment's operating revenue variance on page 47, attributed to higher pricing from the Ohio rate case and prior year deferrals. Additionally, a $6 million increase from Ohio tax reform deferrals is noted in the EU&I segment's operating revenues on page 55, further supporting the combined impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Key strengths: (1) The primary figure of $276 million matches the ground truth exactly, correctly identifying this as the total financial impact on operating revenues in 2023. (2) The answer properly characterizes this as an 'increase' in operating revenues, which is semantically appropriate and factually accurate. (3) The multi-hop synthesis is sound - the answer correctly combines information about Ohio tax reform deferrals and the Duke Energy Ohio electric rate case as required by the question. (4) The answer provides additional supporting detail by citing specific page references (pages 47 and 55) and breaking down components ($276 million from rate case and prior year deferrals, plus $6 million from Ohio tax reform deferrals), which demonstrates thorough research and understanding. (5) All entities are correctly identified (Duke Energy, Ohio, EU&I segment, 2023). Minor considerations: The answer goes slightly beyond the ground truth by providing additional granular detail ($6 million breakdown), but this is supplementary information that doesn't contradict the core answer and actually strengthens the response. The ground truth states the total impact was $276 million, and the LLM correctly identifies this figure while providing context about its composition. No calculation errors are present, and the reasoning about combining prior year deferrals and current year pricing adjustments is logically sound and directly addresses the multi-part nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 426,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "Adobe's Digital Media segment generated **$11.52 billion** in revenue during fiscal 2021. Of this, **Creative Cloud contributed $9.55 billion** (82.9%) and **Document Cloud contributed $1.97 billion** (17.1%), as disclosed in the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: Digital Media segment revenue of $11.52 billion, Creative Cloud contribution of $9.55 billion, and Document Cloud contribution of $1.97 billion. The LLM provides more precise percentage calculations (82.9% and 17.1%) compared to the ground truth's rounded percentages (83% and 17%). Verification of calculations: $9.55B / $11.52B = 0.8289 = 82.89%  82.9% (correct); $1.97B / $11.52B = 0.1710 = 17.10%  17.1% (correct); $9.55B + $1.97B = $11.52B (correct sum). The answer properly addresses all parts of the multi-part question: total revenue amount, Creative Cloud revenue and percentage, and Document Cloud revenue and percentage. All entities are correctly identified (Adobe, Digital Media segment, Creative Cloud, Document Cloud, fiscal 2021). The only minor distinction is that the LLM provides more granular percentage precision (to one decimal place) than the ground truth (rounded to whole numbers), which represents an enhancement rather than an error. The answer is well-structured, cites the 10-K filing source, and demonstrates sound multi-hop reasoning by synthesizing segment-level data with product-level breakdowns.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 345,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was **$722 million**, comprising a **$222 million increase in advertising expenses** (from marketing) and **$499.99 million in personnel-related costs** (including $116 million from marketing and $384 million from technology departments). \n\n**Answer:** The total increase was **$722 million**, driven by a $222 million rise in advertising expenses and $499.99 million in personnel-related costs from marketing and technology departments.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all components of the multi-hop question. Verification of key numbers: (1) Total increase of $722 million - CORRECT; (2) Advertising expenses increase of $222 million - CORRECT; (3) Marketing personnel costs of $116 million - CORRECT; (4) Technology personnel costs of $384 million - CORRECT. The LLM correctly synthesized information across multiple departments and cost categories. Minor issue: The LLM states '$499.99 million in personnel-related costs' while the ground truth specifies '$500 million.' This appears to be a rounding presentation choice ($116M + $384M = $500M exactly), and the LLM's use of $499.99 million is technically a slight deviation from the ground truth figure, though the difference is negligible (0.01%). The calculation verification: $222M + $500M = $722M is correct. The LLM properly identified all entities (NFLX, 2021, marketing and technology departments) and correctly synthesized the multi-hop information across advertising and personnel cost categories. The reasoning is sound and the answer is well-structured. The only minor deduction is for the $499.99M vs $500M discrepancy, which suggests possible rounding in the LLM's source or calculation, though this is a very minor issue that doesn't materially affect the accuracy of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 372,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "General Motors includes its equity earnings from Ultium Cells Holdings LLC in **Automotive and other cost of sales**, reflecting the entity's integral role in supplying battery cells for EVs. This treatment indicates that GM treats the stake as a core component of its EV production strategy, directly linking the financial performance of Ultium Cells to the cost structure of EV manufacturing. By consolidating these earnings into cost of sales, GM emphasizes the strategic importance of securing battery supply chain control to support its electric vehicle initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both answers correctly identify that: (1) GM reports equity earnings from Ultium Cells Holdings LLC within Automotive and other cost of sales, (2) this reflects Ultium Cells' integral role in EV production, and (3) the financial treatment indicates GM views the stake as a core operational component rather than a separate investment. The LLM answer adds valuable context by explaining that this consolidation 'emphasizes the strategic importance of securing battery supply chain control,' which is a logical extension of the ground truth's core assertion about alignment with EV manufacturing strategy. No quantitative data was required for this question, so quantitative accuracy is perfect. The multi-hop reasoning is sound: the answer correctly synthesizes the connection between equity earnings reporting location, operational integration, and strategic EV production implications. The only minor distinction is that the LLM provides slightly more elaboration on the 'why' (supply chain control emphasis) compared to the ground truth's more direct statement, but this represents enhancement rather than deviation. All entities (General Motors, Ultium Cells Holdings LLC) are correctly identified, and the financial treatment description is accurate. The semantic meaning is fully preserved and enhanced with appropriate strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 392,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average price of U.S. Henry Hub natural gas decreased by **60%** in 2023 ($2.56/MCF) compared to 2022 ($6.36/MCF). Chevron's international natural gas realizations fell by **21%** (from $9.75/MCF in 2022 to $7.69/MCF in 2023), reflecting a smaller decline than the domestic Henry Hub price trend.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor rounding differences. Verification of key numbers: (1) Henry Hub prices are correct: $6.36/MCF (2022) and $2.56/MCF (2023). (2) Chevron international natural gas realizations are correct: $9.75/MCF (2022) and $7.69/MCF (2023). (3) Percentage calculations: The ground truth states 59.8% decrease for Henry Hub; the LLM rounded this to 60%, which is a minor rounding variation (59.8% rounds to 60% at one decimal place). The ground truth states 21.1% for Chevron; the LLM rounded to 21%, also a minor rounding variation. Both rounding choices are reasonable and commonly acceptable in financial reporting. (4) Multi-hop synthesis: The LLM correctly synthesized information across two entities (U.S. Henry Hub and Chevron international) and two time periods (2022 and 2023), properly comparing the relative magnitude of price declines. (5) Reasoning quality: The LLM correctly identified that the U.S. natural gas price drop was significantly steeper than the international decline, and appropriately noted the comparison. The only minor omission is that the ground truth provides additional context about international prices being linked to crude oil benchmarks, which the LLM did not include, but this is a contextual detail rather than a factual error. The core answer is accurate and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 375,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "Goldman Sachs' level 3 credit derivatives are sensitive to changes in credit spreads and recovery rates, which are significant unobservable inputs. Higher credit spreads or lower recovery rates increase the fair value of purchased credit protection, as these factors reflect greater credit risk. Conversely, lower credit spreads or higher recovery rates decrease the valuation. The broad range of credit spreads (81,328 bps) and recovery rates (20%70%) used in valuations underscores the potential for significant valuation fluctuations based on market conditions and unobservable inputs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Goldman Sachs' level 3 credit derivatives valuation sensitivity. STRENGTHS: (1) Correctly identifies the directional relationships - higher credit spreads/lower recovery rates increase fair value of purchased credit protection, and vice versa. (2) Accurately conveys the core mechanism: credit spreads and recovery rates are significant unobservable inputs affecting valuation. (3) Provides specific quantitative ranges (8-1,328 bps for credit spreads, 20%-70% for recovery rates) that add concrete detail and demonstrate knowledge of actual filing data. (4) Explains the compounding effect of broad variability in risk factors. (5) Properly synthesizes multi-hop information about how unobservable inputs drive valuation fluctuations. MINOR GAPS: (1) The original answer emphasizes 'upfront credit points' as an additional input alongside credit spreads - the LLM answer focuses primarily on spreads and recovery rates but doesn't explicitly mention upfront credit points. (2) The original answer mentions specific underlying risk factors (leverage, volatility, industry, borrowing costs, macroeconomic conditions) that contribute to the wide range of inputs - the LLM answer references 'market conditions' more generally but doesn't enumerate these specific factors. These are relatively minor omissions that don't significantly detract from the core answer. QUANTITATIVE VERIFICATION: The specific ranges provided (8-1,328 bps and 20%-70%) appear reasonable for credit derivatives valuations and are presented as illustrative of the broad variability, which aligns with the ground truth's emphasis on 'wide range.' The answer correctly maintains the directional sensitivity relationships and doesn't contain calculation errors. REASONING QUALITY: The multi-hop synthesis is sound - the answer connects unobservable inputs  valuation sensitivity  fair value impact, which is the core logic required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 531,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The repayment of CoreSite Debt in January 2022 reduced AMT's total liabilities by $955.1 million (the carrying value of the debt) plus $7.8 million in accrued interest and $80.1 million in prepayment consideration, totaling $962.9 million. This repayment directly decreased AMT's long-term obligations, improving its capital structure by reducing leverage. The alignment between the repayment amount and the carrying value ($955.1 million) indicates that the debt was recorded at its fair value on the balance sheet, with the slight excess in repayment reflecting accrued interest and prepayment terms, not a misvaluation. The close proximity of the repayment amount to the carrying value confirms the debt's valuation was accurate and reflective of its market terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) The LLM introduces numbers ($7.8 million in accrued interest and $80.1 million in prepayment consideration) that are NOT mentioned in the original answer or ground truth. These appear to be fabricated details not supported by the source material. (2) The LLM calculates a total repayment of $962.9 million ($955.1M + $7.8M + $80.1M), which is not corroborated by the ground truth. The original answer states the repayment totaled $955.1 million. (3) The LLM's interpretation that the excess represents 'accrued interest and prepayment terms' contradicts the ground truth, which explicitly states the alignment between repayment amount and carrying value indicates the debt was at fair value with 'minimal unamortized discounts or premiums.' CORRECT ELEMENTS: The LLM correctly identifies that the repayment reduced long-term obligations and improved capital structure/leverage ratios. The core insight about fair value alignment is present but muddled by the introduction of unsupported additional amounts. REASONING QUALITY: While the LLM attempts to explain the valuation implications, it does so by adding unverified financial components rather than relying on the actual disclosed information. The multi-hop reasoning is compromised by these fabrications. The answer demonstrates partial understanding of capital structure impacts but fails on factual accuracy regarding the specific transaction amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 417,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "Adobe's potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing could result in increases to its tax liabilities, as outlined in Note 10 of its 10-K. The company has established reserves for such exposures, and the estimated range of potential decreases in unrecognized tax benefits is $0 to approximately $5 million over the next 12 months. While the impact on financial position would depend on the final outcomes of examinations, the existing reserves suggest Adobe has accounted for significant uncertainty, limiting the potential adverse effect on its results or balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key quantitative metric: the estimated range of potential decreases in unrecognized tax benefits of $0 to approximately $5 million over the next 12 months. This matches the ground truth exactly. The answer correctly identifies Adobe as the company, references Note 10 of the 10-K filing, and accurately describes the nature of the tax examination (intercompany transfer pricing practices). The multi-hop reasoning is sound, synthesizing information about: (1) the nature of the tax examination, (2) the quantified range of potential adjustments, (3) the existence of established reserves, and (4) the impact on financial position. The LLM appropriately notes that reserves have been established to address exposures and that the impact depends on examination outcomes. However, there is a minor semantic difference in emphasis: the ground truth emphasizes that actual adjustments 'could exceed these reserves, leading to significant fluctuations,' while the LLM states that existing reserves 'limit the potential adverse effect.' The ground truth conveys more uncertainty and potential for adverse impact, whereas the LLM's framing suggests the reserves provide more protection. This represents a slight difference in tone regarding risk assessment rather than factual error. The LLM answer is more conservative in its assessment of potential impact, which could be seen as either appropriately cautious or slightly understating the uncertainty mentioned in the ground truth. All numeric values are correct, entity identification is accurate, and the multi-hop synthesis across the tax examination details, reserve information, and financial impact is properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 478,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "The combined growth percentage of alliance revenue related to Lenvima was **21% in 2021** (from $580 million in 2020 to $704 million in 2021) and **44% in 2020** (from $404 million in 2019 to $580 million in 2020). This growth aligns with Merck's oncology strategy of leveraging combination therapies, such as Keytruda paired with Lenvima for endometrial carcinoma and RCC, to expand treatment options and drive revenue through synergistic product partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: The growth percentages are correct (21% in 2021, 44% in 2020), and the supporting dollar amounts are accurate ($580M in 2020, $704M in 2021, $404M in 2019). The calculations are mathematically sound: (704-580)/580 = 21.4%  21% and (580-404)/404 = 43.6%  44%. The combined growth concept is properly addressed by presenting both years' growth rates. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) growth percentages for both years, (2) combined growth context, and (3) relationship to Merck's oncology strategy. ENTITY ACCURACY: All entities are correctly identified - Lenvima, Keytruda, Merck, endometrial carcinoma, and RCC are all accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: financial data (alliance revenue growth), product information (Lenvima and Keytruda), and strategic context (combination therapy approach). The connection between Lenvima's revenue growth and Merck's broader oncology strategy through combination therapies is logically sound and well-articulated. MINOR CONSIDERATIONS: The LLM answer provides additional supporting detail (specific dollar amounts) that enhances clarity beyond the ground truth, which is a positive addition. The wording differs slightly from the ground truth but conveys equivalent semantic meaning. No factual errors or calculation mistakes are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 411,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "GM's investment in Ultium Cells Holdings LLC in 2024 directly contributed **$0.7 billion** to its EBIT-adjusted performance. This is quantified in the GMNA EBIT-adjusted section (Page 34), which attributes the increase in EBIT-adjusted for 2024 to \"increased equity earnings related to Ultium Cells Holdings LLC of $0.7 billion.\" This equity income positively impacted EBIT-adjusted by offsetting costs and improving overall profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. (1) CORRECTNESS: The core claim that GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings to EBIT-adjusted performance in 2024 is factually correct and matches the ground truth exactly. The quantification of $0.7 billion is precise and accurate. (2) QUANTITATIVE ACCURACY: The $0.7 billion figure is correct with no calculation errors. The number format is appropriate and matches the ground truth. (3) ENTITY ACCURACY: All entities are correctly identified - GM (General Motors), Ultium Cells Holdings LLC, the year 2024, and the metric EBIT-adjusted are all accurate. (4) MULTI-HOP REASONING: The answer correctly synthesizes the relationship between the investment, equity earnings, and EBIT-adjusted impact. The logic is sound: equity earnings from the investment directly increased EBIT-adjusted performance. (5) COMPLETENESS: The answer addresses both parts of the question - how the investment impacted EBIT-adjusted performance (positively) and by how much ($0.7 billion). The reference to Page 34 and the GMNA EBIT-adjusted section adds credibility, though this specific page reference cannot be verified from the ground truth. (6) MINOR CONSIDERATIONS: The explanation that the equity income 'offset costs and improved overall profitability' is a reasonable interpretation of how equity earnings impact EBIT-adjusted, though the ground truth simply states it 'directly increased' performance. This is a minor semantic variation that doesn't detract from accuracy. Overall, the answer demonstrates strong understanding of the multi-hop relationship between the investment, equity earnings, and financial performance metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 470,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "Goldman Sachs, as a registered security-based swap dealer, is subject to SEC regulations requiring public trade reporting and capital/margin rules for swaps. The SEC's new monthly short position reporting requirement for institutional managers (effective January 2025) adds another layer of transparency, potentially influencing its derivatives reporting by necessitating integration of short position data into existing swap-related disclosures. This interaction may require enhanced reporting systems to align with both the SEC's short position rules and its swap dealer obligations, ensuring consistency in transparency practices for equity-linked derivatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the regulatory interaction but with some notable differences from the ground truth. STRENGTHS: (1) Correctly identifies the January 2025 effective date for the SEC's monthly short position reporting requirement; (2) Accurately recognizes Goldman Sachs' status as a registered security-based swap dealer; (3) Properly identifies the complementary nature of the two regulatory regimes; (4) Correctly notes that the new rule adds transparency and accountability layers; (5) Appropriately mentions capital, margin, and record-keeping obligations. WEAKNESSES: (1) The LLM introduces the concept of 'equity-linked derivatives' and 'swap-related disclosures' which, while plausible, are not explicitly mentioned in the ground truth and may overreach beyond what the interaction actually requires; (2) The ground truth emphasizes that the new rule applies to 'institutional investment managers meeting specified thresholds' - the LLM doesn't clearly articulate whether Goldman Sachs itself must report as an institutional manager or whether this is a separate obligation; (3) The ground truth focuses on 'short position data in equity securities' being reported monthly, while the LLM shifts focus to 'equity-linked derivatives' which is a different concept; (4) The ground truth emphasizes monitoring 'large positions and short-selling activity' as the SEC's oversight goal, which the LLM doesn't explicitly capture. MULTI-HOP REASONING: The LLM correctly synthesizes that Goldman Sachs has dual obligations (as a swap dealer AND potentially as an institutional manager), but the connection between these two roles could be clearer. The answer suggests integration of short position data into swap disclosures, which is speculative beyond what the ground truth states. QUANTITATIVE ACCURACY: No numerical errors; date (January 2025) is correct. SEMANTIC EQUIVALENCE: The core message aligns - the new rule complements existing obligations and requires enhanced reporting - but the specific mechanisms and focus areas differ slightly from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 562,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBGs future performance.",
      "llm_answer": "The remeasurement of PepsiCo's 39% noncontrolling interest in TBG at fair value following the Juice Transaction resulted in a **$520 million gain** in 2022, recognized in the Europe division. This gain reflected the fair value adjustment using the transaction price, discounted cash flows, and an option pricing model tied to PepsiCo's liquidation preference in TBG. The transaction structure involved **$3.5 billion in cash** and retention of the 39% equity interest, with the remeasurement capturing the value of the retained stake. The after-tax impact reduced net income attributable to PepsiCo by **$2.837 billion** in total, with a **$2.04 per share** effect, highlighting the combined cash and equity components of the deal.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces numbers NOT in the ground truth: '$2.837 billion' reduction in net income and '$2.04 per share' effect are presented as facts but are NOT mentioned in the original answer and appear to be fabricated or incorrectly sourced. These are critical financial metrics that cannot be verified against the ground truth. (2) CORRECT ELEMENTS - The LLM correctly identifies: the $520 million gain, the 39% noncontrolling interest, the $3.5 billion cash proceeds, the transaction involving juice brands (Tropicana, Naked), and the valuation methodology (transaction price, DCF, option pricing model). (3) PROBLEMATIC ADDITIONS - The mention of 'Europe division' and the specific per-share impact ($2.04) are not in the ground truth and appear to be hallucinated details. The claim about 'liquidation preference' is also not mentioned in the original answer. (4) MULTI-HOP REASONING - The LLM correctly synthesizes the dual nature of the transaction (cash + retained equity), which is sound. However, the introduction of unverified financial metrics undermines the answer's reliability. (5) SEMANTIC ISSUES - While the core narrative about the transaction structure is correct, the addition of unsupported quantitative claims significantly damages credibility. The ground truth focuses on the $520M gain and transaction structure; the LLM adds material financial impacts that cannot be verified. This represents a critical failure in financial accuracy where invented numbers are presented as fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 427,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "GE's retained ownership interests contributed $518 million to total other income in 2024 and $5,778 million in 2023. This represents a significant decrease of approximately 91% from 2023 to 2024, primarily due to the full monetization of GE's GE HealthCare stake in 2024, which accounted for $5,242 million in proceeds, compared to substantial gains from retained interests in 2023. \n\n**Source:** Note 19 (\"Other Income (Loss)\") on page 68 of GE_10k_2024.pdf.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures: $5,778 million in 2023 and $518 million in 2024, matching the ground truth exactly. The year-over-year decrease calculation of approximately 91% is mathematically accurate ($5,260M / $5,778M  91%). The answer appropriately addresses the multi-part question by comparing both years and explaining the significant decline.\n\nHowever, there are notable omissions and inaccuracies:\n\n1. BAKER HUGHES SPECIFICITY: The ground truth explicitly mentions that Baker Hughes contributed $10 million in realized and unrealized gains in 2023, and $0 in 2024. The LLM answer does not provide this specific Baker Hughes contribution detail, instead focusing on the broader GE HealthCare monetization as the primary driver of the decline. While the LLM correctly identifies that GE HealthCare's $5,242 million in proceeds was a major factor, it fails to address the specific Baker Hughes component that was explicitly requested in the question.\n\n2. INCOMPLETE SYNTHESIS: The question specifically asks about \"retained ownership interests, including its stake in Baker Hughes.\" The LLM answer addresses the overall contribution figures but does not break down the Baker Hughes component separately, which was a key part of the original question's multi-hop requirement.\n\n3. ACCURACY OF EXPLANATION: The LLM's explanation that the decline was \"primarily due to the full monetization of GE's GE HealthCare stake in 2024\" is reasonable and supported by the $5,242 million figure, but it doesn't fully explain why Baker Hughes went from $10 million to $0, which is part of the complete picture.\n\n4. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($5,778M, $518M, $5,260M decrease, $5,242M GE HealthCare proceeds). The percentage calculation (91% decrease) is accurate.\n\nThe answer demonstrates solid understanding of the overall financial performance and correctly synthesizes the year-over-year comparison, but falls short on the specific Baker Hughes component that was explicitly mentioned in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 558,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "The total fair value of Mortgage-Backed Obligations as of January 31, 2024, is **$236 million**, as disclosed in both the \"Marketable Securities\" section (page 75) and the fair value hierarchy table (page 77). These obligations represent **1.95%** of the total assets measured at fair value ($12,079 million) for the same period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical errors in both quantitative accuracy and completeness. (1) MAJOR ERROR - Total Fair Value: The LLM reports only $236 million as the total, but the ground truth clearly states the total should be $358 million ($236 million + $122 million from two separate disclosures). The LLM failed to identify and sum the second disclosure of $122 million, which is a fundamental multi-hop synthesis failure. (2) MAJOR ERROR - Percentage Calculation: The LLM calculates 1.95% using only $236 million divided by $12,079 million. However, the correct calculation should use the combined total of $358 million divided by the combined total assets of $24,089 million ($12,079M + $12,010M), which equals approximately 1.49%. The LLM's percentage is also incorrect even for its own incomplete numerator. (3) INCOMPLETE SYNTHESIS: The question explicitly asks for information from 'two separate disclosures,' but the LLM only identified one disclosure amount ($236 million) and completely missed the second disclosure ($122 million). This represents a failure in multi-hop reasoning across multiple sections of the 10-K. (4) PARTIAL CREDIT: The LLM correctly identified the date (January 31, 2024), correctly identified one of the fair value amounts ($236 million), and correctly identified one of the total asset values ($12,079 million). However, these correct elements are overshadowed by the failure to synthesize all required information and the resulting calculation errors. The answer demonstrates incomplete document analysis and inadequate multi-hop synthesis across the two required disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 443,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix's strategy of offering varied membership plans across countries contributed to the 7% increase in average monthly revenue per paying membership in 2021 by enabling price adjustments tailored to local market conditions, including favorable foreign exchange fluctuations. This strategy, combined with growth in the number of paying memberships (11% year-over-year), drove the overall 19% revenue growth for the year. The diversified pricing model allowed Netflix to capture higher revenue per member in regions with greater willingness to pay, while expanding its global footprint.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: 7% increase in average monthly revenue per paying membership, 11% growth in paying memberships, and 19% overall revenue growth in 2021. The multi-hop synthesis is sound, correctly connecting the varied membership plan strategy to pricing flexibility, which drove both the per-member revenue increase and overall revenue growth. The answer properly identifies Netflix as the company and 2021 as the relevant year. One minor addition in the LLM answer is the mention of 'favorable foreign exchange fluctuations,' which is not explicitly stated in the ground truth but is a reasonable contextual factor that could have contributed to revenue growth and is not contradicted by the original answer. The LLM also adds the insight about 'capturing higher revenue per member in regions with greater willingness to pay,' which provides additional strategic context beyond the ground truth but remains accurate and relevant. The reasoning chain is logical: localized pricing strategies  7% ARPU increase + 11% membership growth  19% revenue growth. All quantitative values are accurate, and the semantic meaning aligns well with the ground truth despite slightly different wording and minor additional context provided by the LLM.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 365,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP program influences its pharmaceutical segment revenue via alliance revenue streams. As of 2021, Lenvima generated $704 million in alliance revenue, reflecting Merck's share of profits from sales in approved indications like hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). The LEAP program's ongoing Phase 3 trials, including LEAP-002 for first-line HCC, aim to expand Lenvima's indications, potentially increasing future revenue. However, some trials (e.g., LEAP-007, LEAP-011) were discontinued due to futility, which may limit revenue growth in those areas. The current approved indications and ongoing trials collectively shape Merck's revenue potential through this collaboration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses: STRENGTHS: (1) Correctly identifies the LEAP program and its role in the collaboration; (2) Accurately mentions discontinued trials (LEAP-007, LEAP-011) due to futility; (3) Correctly identifies approved indications (HCC, RCC); (4) Properly explains the alliance revenue model concept; (5) Appropriately notes that ongoing trials aim to expand indications. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites '$704 million in alliance revenue' as of 2021 for Lenvima, but this specific figure cannot be verified against the ground truth and appears to be an unsupported claim without proper sourcing; (2) INCOMPLETE SYNTHESIS - The answer mentions HCC as an approved indication generating revenue, but the ground truth explicitly states the FDA issued a CRL (Complete Response Letter) for first-line HCC treatment based on KEYNOTE-524/Study 116, meaning this was NOT approved; (3) MISSING KEY DETAIL - The answer fails to mention the CRL for first-line HCC and the ongoing LEAP-002 trial to address FDA concerns, which is critical context for understanding current revenue impact; (4) INCOMPLETE INDICATION LIST - The ground truth specifies endometrial carcinoma and RCC as approved indications, but the LLM only mentions HCC and RCC, omitting endometrial carcinoma; (5) REASONING GAP - The answer doesn't adequately explain how the CRL and trial discontinuations negatively impact near-term revenue potential, which is central to understanding the current influence on pharmaceutical segment revenue. The multi-hop reasoning is partially sound but lacks the nuance of distinguishing between approved vs. pending indications and their respective revenue implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 479,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "Chevron's total cost incurred by consolidated companies in 2023 was **$24.6 billion** (as stated in the reconciliation table on page 103). The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion, as per the reconciliation table) is **$11.0 billion**. The difference is **$13.6 billion**. \n\n**Answer:** Chevron's total cost exceeded the combined total of expensed exploration costs and the PDC acquisition cost by **$13.6 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All numerical values are correct: (1) Total cost incurred by consolidated companies in 2023: $24.6 billion , (2) Expensed exploration costs: $0.5 billion , (3) PDC Energy acquisition cost: $10.5 billion , (4) Combined total: $11.0 billion , (5) Final difference: $13.6 billion . The multi-hop reasoning is sound - the model correctly synthesized information across multiple data points (total costs, exploration costs, acquisition cost) and performed the correct arithmetic ($24.6B - $11.0B = $13.6B). The answer addresses all parts of the question comprehensively. The LLM provided helpful context by citing the source (page 103 reconciliation table), which adds credibility. The only minor observation is that the answer could have been slightly more concise, but the additional detail about source documentation is actually beneficial. All entities are correctly identified (Chevron, PDC Energy, Inc., 2023), and the semantic meaning perfectly matches the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 297,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower determines the fair value of its 2024 performance-based restricted stock units (PSUs) with a market condition component using a **Monte Carlo simulation model**, which calculates the probability of satisfying market condition requirements. The specific market metric used is **relative total shareholder return** measured against the **REIT constituents included in the S&P 500 Index**. This approach is detailed in the document's discussion of PSUs on pages 126 and 99.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies all key components: (1) The valuation method is Monte Carlo simulation model - CORRECT; (2) The purpose is to evaluate probability of satisfying market condition requirements - CORRECT; (3) The specific market metric is relative total shareholder return - CORRECT; (4) The benchmark is REIT constituents in the S&P 500 Index - CORRECT. The answer demonstrates proper multi-hop synthesis by connecting the valuation methodology to the specific metric and benchmark used. The LLM provides additional context by citing specific page numbers (126 and 99), which adds credibility though this detail wasn't in the ground truth. There are no quantitative errors, no missing entities, and the reasoning is sound. The wording differs slightly from the ground truth but conveys identical semantic meaning. The only minor consideration is that the LLM added page references not explicitly mentioned in the ground truth, but this is supplementary information that doesn't contradict or diminish the core answer. All factual elements match the original answer precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 323,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "The Caterpillar Inc. Supplemental Employees' Investment Plan has **four amendments** documented across the filings. The **fourth amendment** became effective as of **July 1, 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) CORRECTNESS: Both key factual claims match the ground truth exactly - there are four amendments documented, and the fourth amendment's effective date is July 1, 2022. (2) QUANTITATIVE ACCURACY: The number '4' (amendments) and the date 'July 1, 2022' are both precisely correct with no calculation errors or discrepancies. (3) ENTITY ACCURACY: The company name 'Caterpillar Inc.' and the plan name 'Supplemental Employees' Investment Plan' are correctly identified. (4) COMPLETENESS: The answer addresses both parts of the question - the total number of amendments and the specific effective date of the fourth amendment. (5) MULTI-HOP REASONING: The answer correctly synthesizes information that would require cross-referencing multiple filings to identify all amendments and locate the specific effective date of the fourth one. (6) SEMANTIC EQUIVALENCE: The wording is clear and directly matches the ground truth without unnecessary elaboration or deviation. No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1094,
        "completion_tokens": 313,
        "total_tokens": 1407
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "In 2024, the amortized cost of Corporate Notes and Obligations was $3,014 million, while their fair value under Level 2 inputs (active markets) was $2,978 million, resulting in a $36 million difference. This fair value under Level 2 inputs directly matches the reported fair value in the marketable securities table, indicating no additional adjustments were needed for Level 2 categorization.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally misrepresent the ground truth. Specific issues: (1) MAJOR ERROR - The LLM states the fair value under Level 2 inputs is $2,978 million, but the ground truth clearly indicates the Level 2 fair value is $2,557 million. This is a $421 million discrepancy. (2) MAJOR ERROR - The LLM conflates two different fair value figures. The $2,978 million is the overall fair value from the marketable securities table, NOT the Level 2 categorized value. (3) MISSING CRITICAL INFORMATION - The LLM fails to identify and report the $2,557 million Level 2 fair value figure at all, which is essential to answering the question. (4) INCORRECT COMPARISON - The LLM claims the Level 2 fair value 'directly matches the reported fair value in the marketable securities table,' which is false. The ground truth explicitly states these are significantly different ($2,978M vs $2,557M, a $421M difference). (5) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks for a comparison between overall fair value and Level 2 categorized fair value. The LLM completely fails to make this comparison and instead incorrectly equates the two values. The correct answer should identify: amortized cost $3,014M, overall fair value $2,978M (difference of $36M), Level 2 fair value $2,557M, and the $421M difference between overall and Level 2 fair values. The LLM gets only the first two numbers correct but then provides entirely incorrect information about the Level 2 categorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 417,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, comprising two $1.1 billion credit facilities: one for the Disney Treasure (3.80% fixed interest rate) and another for the anticipated Disney Destiny (3.74% fixed interest rate). The interest rates are nearly identical, with the Disney Destiny facility having a slightly lower rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: total financing of $2.2 billion, two $1.1 billion facilities, Disney Treasure at 3.80% fixed rate, and Disney Destiny at 3.74% fixed rate. The multi-hop synthesis is sound - the model correctly identified both cruise ships, their respective financing amounts, and accurately compared the interest rates. The answer addresses all parts of the question: (1) total amount secured ($2.2B), (2) breakdown by ship ($1.1B each), (3) interest rate comparison (3.80% vs 3.74%). The characterization of rates as 'nearly identical' with Disney Destiny being 'slightly lower' is accurate and appropriate given the 6 basis point difference. The only minor distinction from the ground truth is stylistic - the LLM uses slightly different phrasing ('comprising two $1.1 billion credit facilities' vs the ground truth's sequential description), but this is semantically equivalent and arguably clearer. No calculation errors, no missing entities, and the reasoning correctly synthesizes information across multiple data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 314,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron's Tengizchevroil stake represents **58.7%** of its total equity method investments ($27,368 million out of $46,618 million in total equity method investments as of December 31, 2024). This stake is directly tied to production volumes from the Kazakhstan joint venture, which accounted for **26,000 barrels per day of crude oil** and **113 billion cubic feet per day of natural gas** in 2024, reflecting its significance as a core asset in Chevron's upstream operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core percentage (58.7%) and the investment amounts ($27,368 million out of $46,618 million), which matches the ground truth. The answer also appropriately addresses the multi-hop nature of the question by connecting the investment stake to production volumes. However, there is a critical issue: the LLM provides specific production volume figures (26,000 barrels per day of crude oil and 113 billion cubic feet per day of natural gas in 2024) that are NOT present in the ground truth answer. The ground truth only states that Tengizchevroil 'is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan' without providing specific production metrics. This represents a potential hallucination or unverified data insertion. The LLM's reasoning about the relationship between the investment and production is sound and logical, and the answer is well-structured and relevant to the question. The percentage calculation (27,368/46,618 = 58.7%) is mathematically correct. The main weakness is the introduction of specific production figures that cannot be verified against the ground truth, which violates the principle of strict accuracy on quantitative data. The answer would have been stronger if it either: (1) omitted the specific production figures, or (2) clearly indicated these were estimates or from a specific source. The semantic equivalence is good for the investment portion, but the unverified production data significantly undermines confidence in the overall response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 431,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "Changes in credit spreads or upfront credit points directly impact the fair value of Goldman Sachs' level 3 credit derivatives. An increase in credit spreads or upfront credit points, or a decrease in recovery rates, increases the fair value of purchased credit protection, as these factors reflect higher risk premiums or upfront payments for credit risk. Valuation techniques include **option pricing models**, **correlation models**, and **discounted cash flow models**, with multiple techniques often used together to determine fair value. These inputs are critical in assessing the risk and pricing of credit derivatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies that increases in credit spreads or upfront credit points increase fair value of purchased credit protection - this matches the ground truth exactly. (2) Accurately lists all three valuation techniques: option pricing models, correlation models, and discounted cash flow models - these match the ground truth precisely. (3) No quantitative errors or incorrect numbers/dates. (4) Properly synthesizes the multi-hop relationship between input changes and fair value impacts. (5) Adds helpful context about recovery rates and risk premiums, which is relevant and accurate. MINOR CONSIDERATIONS: (1) The ground truth is concise and direct, while the LLM answer provides additional explanation about recovery rates and how these factors reflect risk premiums. While this additional context is accurate and helpful, it goes slightly beyond what was explicitly stated in the ground truth. (2) The phrasing differs (e.g., 'combination of' vs listing techniques separately) but conveys the same semantic meaning. (3) The answer appropriately emphasizes that multiple techniques are often used together, which aligns with the ground truth's 'combination' language. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between input variables (credit spreads, upfront credit points, recovery rates) and their impact on fair value measurement, and properly identifies the valuation methodologies used. The reasoning is sound and logically structured. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 439,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "If AMT fails to meet the Minimum DSCR (1.15x), it would trigger an \"amortization period\" under their securitization agreements, requiring excess cash flow to be applied to repay principal on secured debt rather than being distributed for capital expenditures like communications site construction. This would directly limit AMT's ability to fund global site development, as cash flow would be diverted to debt service. Additionally, failure to meet DSCR covenants under their credit facilities could result in default, forcing immediate repayment of outstanding debt and further restricting liquidity for new investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism (amortization period triggered by failure to meet 1.15x DSCR) and accurately describes the primary impact (excess cash flow diverted to debt repayment rather than distributions for capital expenditures). The answer correctly states the Minimum DSCR threshold of 1.15x and accurately explains the consequence of diverting cash flow from capital expenditures. However, there are notable differences from the ground truth: (1) The LLM answer omits the specific quantitative detail about the planned construction of 1,950 to 2,550 communications sites globally - this is a material omission as it provides concrete context for the scale of impact. (2) The LLM answer introduces additional information about default under credit facilities and forced immediate repayment, which goes beyond what the ground truth specifies and may introduce scope creep beyond the specific securitization mechanism described in the 10-K. (3) The ground truth specifically mentions the 'Cash Trap Reserve Account' mechanism, which the LLM answer does not reference. The LLM answer demonstrates sound multi-hop reasoning by connecting the DSCR covenant failure to the amortization period to the restriction on distributions to the impact on capital expenditures. The quantitative accuracy is strong (1.15x DSCR is correct), but the omission of the specific site construction numbers (1,950-2,550) represents a loss of important quantitative context. The reasoning is logical and well-structured, though it ventures slightly beyond the specific mechanisms outlined in the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 444,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "Caterpillar's use of historical claim rates to estimate product warranty liability is a critical audit matter due to the significant judgment and subjectivity involved in determining the liability. PricewaterhouseCoopers LLP emphasized the need for rigorous testing of controls and independent actuarial evaluations to ensure the reasonableness of these estimates. As of December 31, 2024, the financial estimate of this liability is **$1,700 million**, as disclosed in Note 21 of the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key components of the multi-hop question. (1) CORRECTNESS: The answer correctly identifies that Caterpillar uses historical claim rates applied to current field population and dealer inventory, correctly names PricewaterhouseCoopers LLP as the auditor, and accurately states the December 31, 2024 warranty liability as $1,700 million. The answer properly explains why this is a critical audit matter (significant judgment, subjectivity, and effort required). (2) QUANTITATIVE ACCURACY: The $1,700 million figure is correct and properly formatted. The date (December 31, 2024) is accurate. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop relationship between: (a) Caterpillar's methodology (historical claim rates), (b) the auditor's identification of this as a CAM, and (c) the resulting financial estimate. The explanation of why it's a critical audit matter is sound and aligns with ground truth. The mention of Note 21 adds appropriate specificity. Minor enhancement: The LLM adds details about 'rigorous testing of controls and independent actuarial evaluations' which, while reasonable audit procedures, are not explicitly stated in the ground truth but represent reasonable inference about audit procedures for such matters. (4) CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question's three components: the methodology, the CAM identification, and the financial estimate. The response is well-structured and appropriately detailed. No material omissions or irrelevant information. The only minor distinction from ground truth is that the LLM provides slightly more detail about audit procedures than explicitly stated in the original answer, but this does not constitute an errorit represents reasonable contextual knowledge about audit procedures for critical audit matters.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 518,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "The difference between Disney's stated interest rate (7.93%) on Asia Theme Parks borrowings and the effective interest rate (5.75%) on its senior unsecured notes reflects a lower true cost of capital for the Asia Theme Parks debt. This is due to the impact of interest rate swaps and hedging instruments, which reduce the effective rate despite the higher stated rate. In contrast, senior unsecured notes have a stated rate (4.06%) and effective rate (4.71%), indicating a higher relative cost of capital compared to the Asia Theme Parks borrowings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM states the effective interest rate on senior unsecured notes is 5.75%, but the ground truth clearly states it is 4.71% - this is a 1.04 percentage point error. The LLM also introduces a stated rate of 4.06% for senior unsecured notes that does not appear in the ground truth. (2) LOGICAL CONTRADICTION: The LLM claims Asia Theme Parks debt has a 'lower true cost of capital' despite the higher stated rate (7.93%), attributing this to hedging instruments. However, the ground truth indicates the opposite - that Asia Theme Parks debt carries a 'significantly higher cost of capital' with a 3.22 percentage point premium. This is a fundamental misinterpretation of the cost of capital relationship. (3) REASONING FAILURE: The LLM's multi-hop synthesis is backwards. It incorrectly concludes that senior unsecured notes have 'higher relative cost of capital compared to Asia Theme Parks borrowings,' when the ground truth clearly establishes that Asia Theme Parks borrowings are more expensive (7.93% vs 4.71%, a 3.22 point difference). (4) INCOMPLETE ANALYSIS: While the LLM mentions hedging instruments, it fails to address the actual factors mentioned in the ground truth (risk profile, collateralization, market conditions) that explain the premium. The answer demonstrates a fundamental misunderstanding of the question and provides inverted conclusions about which debt category is more expensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 423,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was **$10,487 million**, as noted in the \"Gross Investment at Cost and Additions at Cost\" section of Note 19 (page 91). The acquisition primarily contributed **2.2 TCF of purchases in the DJ basin** in 2023, as stated in the \"Purchases\" section of page 115.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: Both key facts are correct - the capitalized cost of $10,487 million matches the ground truth exactly, and the 2.2 TCF contribution in the DJ Basin is also correct. (2) QUANTITATIVE ACCURACY: All numbers are precise and match ground truth without error. The dollar amount ($10,487 million) and the volume metric (2.2 TCF) are both accurate. (3) QUALITATIVE ACCURACY: The answer correctly identifies all required entities (Chevron, PDC acquisition, 2023, DJ Basin) and synthesizes information across multiple sections of the filing (Note 19 for capitalized cost and page 115 for purchases). The multi-hop reasoning is sound - connecting the acquisition to both its cost and its contribution to basin purchases. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question and provides appropriate source citations (Note 19, page 91, page 115) that enhance credibility. Minor note: The answer uses 'dj basin' (lowercase) while ground truth uses 'DJ Basin' (uppercase), but this is a trivial formatting difference that does not affect correctness. The answer is comprehensive, well-sourced, and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 341,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "MetLife retrospectively adjusted its **consolidated balance sheet, statement of operations, statement of comprehensive income, statement of equity, and statement of cash flows** under the new LDTI accounting guidance. These adjustments recalculated historical financial statements to reflect the guidance's impact on reserves, liabilities, and income recognition, ensuring consistency in reporting. The retrospective application revealed increased net income (e.g., $2,558M to $5,302M for 2022) and reclassified items like future policy benefits and deferred policy acquisition costs, demonstrating how LDTI altered the measurement of insurance liabilities and income.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and overstatements compared to the ground truth. CRITICAL ISSUES: (1) SCOPE OVERSTATEMENT: The ground truth specifies that MetLife retrospectively adjusted only the 'consolidated statement of operations' and 'consolidated statements of comprehensive income.' The LLM incorrectly claims adjustments were made to the balance sheet, statement of equity, and statement of cash flows - these are not mentioned in the ground truth and represent a material factual error. (2) UNVERIFIED NUMBERS: The LLM provides specific financial figures ($2,558M to $5,302M for 2022) that are not present in the ground truth answer. Without verification against the actual filing, these numbers cannot be confirmed as accurate and appear to be fabricated or incorrectly sourced. (3) INCOMPLETE ALIGNMENT: While the LLM correctly identifies MetLife and the LDTI guidance, it goes beyond what the ground truth establishes by adding details about 'future policy benefits' and 'deferred policy acquisition costs' reclassifications that are not mentioned in the original answer. (4) MULTI-HOP REASONING: The LLM attempts to provide more comprehensive synthesis but does so by introducing unverified information rather than accurately synthesizing from the source material. The ground truth is clear and specific about which statements were adjusted; the LLM's expansion beyond this scope suggests either hallucination or reliance on unverified sources. CORRECT ELEMENTS: The LLM correctly identifies MetLife, the LDTI guidance, and the concept of retrospective application. The general understanding that LDTI had material effects on financial reporting is correct. However, the specific financial statements listed and the numerical examples provided are not supported by the ground truth and represent significant accuracy failures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 503,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "The Solar Turbines Incorporated Managerial Retirement Objective Plan has **two amendments** documented in the Caterpillar Inc. 2024 10-K filing: the **First Amendment** dated December 10, 2014, and the **Second Amendment** effective **January 1, 2022**. The most recent amendment is the Second Amendment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the question. Verification of key facts: (1) Number of amendments: Both answers correctly identify TWO amendments - CORRECT. (2) Most recent amendment: Both identify the Second Amendment as most recent - CORRECT. (3) Effective date of most recent amendment: Both state January 1, 2022 - CORRECT. (4) Additional detail provided: The LLM answer includes the First Amendment date (December 10, 2014), which is additional contextual information not in the ground truth but adds value without contradicting it. The LLM answer fully addresses both parts of the multi-part question: (a) how many amendments (two), and (b) effective date of most recent (January 1, 2022). All dates and numbers are accurate. The reasoning is sound - the model correctly identified that the Second Amendment is the most recent of the two amendments. The only minor distinction is that the LLM provided supplementary information (First Amendment date) beyond what was in the ground truth, but this is not an error and demonstrates more complete documentation. The answer is well-structured, clear, and semantically equivalent to the ground truth while providing additional helpful context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 346,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina Rate Case Order resulted in a **$35 million decrease** in the \"Impairment of Assets and Other Charges\" for Duke Energy Carolinas and Duke Energy Progress combined. Specifically, Duke Energy Progress saw a **$22 million decrease** (page 53), while Duke Energy Carolinas experienced a **$13 million decrease** (page 52). This reduction was reflected in the consolidated statements of operations as a **$35 million decrease** in the impairment of assets and other charges line item, primarily due to prior year rate case impacts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth states: (1) Total impact of $68 million across both entities, (2) Duke Energy Carolinas: $35 million, (3) Duke Energy Progress: $33 million. LLM answer states: (1) Total of $35 million (incorrect - should be $68M), (2) Duke Energy Progress: $22 million decrease (incorrect - should be $33M), (3) Duke Energy Carolinas: $13 million decrease (incorrect - should be $35M). The LLM has provided completely different numbers that don't match the ground truth on any metric. Additionally, the LLM characterizes these as 'decreases' while the ground truth simply states they were 'recorded' as charges/impacts - this is a semantic mischaracterization. The multi-hop synthesis is failed: the LLM did not correctly identify the individual company impacts or calculate the correct total. The answer appears to reference page numbers (52, 53) but provides incorrect data, suggesting potential hallucination or misreading of source documents. All three component numbers are wrong, the total is wrong, and the characterization of the impact differs from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 321,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "Starbucks generates 12% of its total net revenues from licensed stores, which receive a margin on branded products and supplies sold to licensees, along with royalties on retail sales and license fees. While licensed stores typically have lower gross margins compared to company-operated stores, their higher operating margins offset the lower revenue contribution, as licensees bear operating costs and capital investments. The exact financial impact in terms of profit is not quantified in the document, but the structure emphasizes revenue sharing through margins, royalties, and fees.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 12% revenue contribution from licensed stores and accurately describes the revenue structure (margins on products, royalties, and license fees). The quantitative accuracy is strong - the 12% figure is correct and properly attributed to fiscal 2024. However, there are some qualitative differences from the ground truth: (1) The LLM introduces a comparison about 'lower gross margins' vs 'higher operating margins' that is not explicitly stated in the ground truth, which could be seen as adding interpretation beyond what was provided. (2) The ground truth emphasizes that the licensed model 'benefits Starbucks by shifting operating costs and capital investments to licensees, thereby improving overall operating margins' - this is the key strategic benefit. The LLM captures this concept but frames it differently ('licensees bear operating costs and capital investments'), which is semantically equivalent but less directly tied to the margin improvement benefit. (3) The LLM appropriately notes that 'exact financial impact in terms of profit is not quantified,' which shows good judgment about document limitations. The multi-hop reasoning is sound - the answer correctly synthesizes information about revenue structure and operational benefits. The main weakness is that the LLM's framing of gross vs. operating margins introduces a distinction not clearly present in the ground truth, and the emphasis on the strategic benefit (margin improvement through cost shifting) could be stronger. Overall, the answer is substantially correct with minor qualitative differences in emphasis and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 449,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brandswhich represent approximately one-third of its overall sales and generally carry higher marginsits results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "Target faces the risk of adverse impacts on its results of operations and financial condition if it fails to successfully develop, source, and market its owned and exclusive brands. These brands account for approximately one-third of sales and carry higher margins, but their reliance on longer lead times, increased responsible sourcing risks, and supply chain complexities could lead to inventory shortages, higher costs, or reputational harm. Additionally, disruptions in sourcing or marketing could exacerbate competitive pressures and reduce profitability. (Based on page 11 of the 2023 10-K.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and addresses the core financial risks posed by Target's owned and exclusive brands. STRENGTHS: (1) Correctly identifies that owned/exclusive brands represent approximately one-third of sales - matches ground truth exactly; (2) Accurately captures that these brands carry higher margins than national brands; (3) Properly synthesizes the multi-hop connection between longer lead times, responsible sourcing risks, and supply chain vulnerabilities; (4) Correctly identifies the key risks: inventory shortages, higher costs, reputational harm, and reduced profitability; (5) Appropriately notes the impact on financial performance and results of operations. MINOR WEAKNESSES: (1) The LLM answer mentions 'competitive pressures' as a consequence, which is a reasonable inference but not explicitly stated in the ground truth - this is a minor addition that doesn't contradict the source material; (2) The ground truth emphasizes 'misjudging rapidly changing consumer preferences' and 'supply chain disruptions' more explicitly, while the LLM answer generalizes these as 'supply chain complexities' - still semantically accurate but slightly less specific; (3) The LLM answer could have been more explicit about the 'longer-term forecasting of consumer demand' aspect mentioned in the ground truth. QUANTITATIVE VERIFICATION: The 'approximately one-third of sales' figure is correct and matches the ground truth exactly. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: (1) brand contribution to sales and margins, (2) sourcing complexity, (3) lead time implications, (4) supply chain risks, and (5) financial impact. The logical chain is sound and complete. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 531,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "The 2024 10-K incorporated **four amendments** to the Caterpillar Inc. Deferred Employees' Investment Plan by reference from prior SEC filings. The most recent two amendments were:  \n1. **Fourth Amendment** (effective July 1, 2022), incorporated from the **Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022**.  \n2. **Third Amendment** (effective January 1, 2022), incorporated from the **Company's Annual Report on Form 10-K for the year ended December 31, 2021**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all components of the multi-part question. QUANTITATIVE ACCURACY: All numeric values and dates are correct - four amendments total, Third Amendment effective January 1, 2022, Fourth Amendment effective July 1, 2022. ENTITY ACCURACY: All entities correctly identified - Caterpillar Inc., Deferred Employees' Investment Plan, Form 10-K for year ended December 31, 2021, Form 10-Q for quarter ended September 30, 2022. COMPLETENESS: The answer addresses both sub-questions: (1) the total number of amendments (four), and (2) the specific SEC filings containing the most recent two amendments. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple SEC filings and time periods, properly identifying which amendments came from which filings. MINOR ISSUE: The LLM answer lists the Fourth Amendment first and Third Amendment second (reverse chronological order by amendment number but chronological by effective date), whereas the ground truth lists Third Amendment first then Fourth Amendment. However, both amendments are correctly identified with accurate dates and source filings. The ordering difference is a minor presentation variation that does not affect factual accuracy. The answer demonstrates sound multi-hop reasoning by correctly linking amendments to their source filings and effective dates. All specific exhibit numbers and filing types are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 400,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "Under the 2013 Equity Incentive Plan, **73 million shares** remained available for future grant or issuance as of January 31, 2025. The outstanding equity awards related to this plan included **stock options**, **restricted stock awards and units**, and **performance-based stock units**. These awards are detailed in the \"Common Stock\" section (page 87) and further described in the stock option and restricted stock activity tables (pages 8586).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly identifies 73 million shares available for future grant/issuance under the 2013 Equity Incentive Plan; (2) Accurately lists all three types of outstanding equity awards: stock options, restricted stock awards and units, and performance-based stock units; (3) Provides appropriate contextual details including the filing date (January 31, 2025) and page references to the 10-K; (4) Uses proper terminology and semantic equivalence (e.g., 'stock options' for 'options outstanding'). MINOR CONSIDERATION: The ground truth states '73 shares' while the LLM specifies '73 million shares.' In the context of equity plans, the unit specification (million) is standard practice and more precise, though the ground truth answer appears to have omitted the unit. This is a formatting/precision enhancement rather than an error. The LLM correctly interprets that equity plan share counts are typically expressed in millions. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information about both the quantitative aspect (shares available) and qualitative aspects (types of awards) from the 2024 10-K filing. All entities are correctly identified (2013 Equity Incentive Plan, equity award types, filing year). The answer is complete, accurate, and directly addresses both parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 386,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestl, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestl, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestl through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "The document states that \"most\" of Starbucks' Channel Development revenues in fiscal 2024 come from the Global Coffee Alliance with Nestl through product sales and royalties. However, it does not provide a specific percentage. The total Channel Development revenue for fiscal 2024 was $1,769.8 million, but no breakdown of contributions from Nestl versus other sources is given. Thus, the exact percentage cannot be determined from the provided information.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and aligns well with the ground truth. Both answers correctly identify that: (1) the document states 'most' of Channel Development revenues come from the Global Coffee Alliance with Nestl, (2) no exact percentage is disclosed, and (3) the percentage is therefore indeterminate from the provided information. The LLM answer adds a specific quantitative detail (total Channel Development revenue of $1,769.8 million for fiscal 2024) that the ground truth does not mention, which is accurate and helpful context. The LLM correctly notes that while 'most' implies >50%, the exact figure is not provided. The reasoning is sound and the multi-hop synthesis is appropriatethe answer correctly synthesizes that despite having revenue figures, the lack of a specific breakdown prevents calculating the exact percentage. Minor difference: the ground truth explicitly states the percentage is 'greater than 50%' while the LLM implies this through 'most' without explicitly stating the >50% threshold, but this is a minor semantic difference. The LLM's inclusion of the total Channel Development revenue figure demonstrates good contextual understanding, though it's not strictly necessary to answer the question. No calculation errors present. All entities (Starbucks, Nestl, Global Coffee Alliance, Channel Development, fiscal 2024) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 386,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "MetLife retrospectively adjusted its **consolidated balance sheet, statement of operations, statement of comprehensive income, and statement of cash flows** due to the adoption of the new LDTI accounting guidance. The tables in the 2023 10-K (pages 162166) illustrate specific adjustments, including changes to **net income**, **assets/liabilities** (e.g., deferred policy acquisition costs, future policy benefits), **comprehensive income components** (e.g., unrealized investment gains, foreign currency translation), and **cash flow line items** (e.g., operating activities, financing activities). These adjustments reflect the retrospective application of LDTI guidance to prior periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer claims that MetLife retrospectively adjusted the 'consolidated balance sheet' and 'statement of comprehensive income,' but the ground truth explicitly states only the 'consolidated statement of operations' and 'consolidated statements of cash flows' were retrospectively adjusted. The LLM introduced two financial statements that were NOT adjusted according to the original answer. (2) OVERSPECIFICATION - The LLM provides specific page numbers (162-166) and detailed line items (deferred policy acquisition costs, future policy benefits, unrealized investment gains, foreign currency translation) that are not mentioned in the ground truth. While these details might be accurate from the actual filing, they go beyond what the ground truth confirms and represent unsupported elaboration. (3) INCOMPLETE ACCURACY - The LLM correctly identifies that the consolidated statement of operations and cash flows were adjusted, but this is obscured by the incorrect inclusion of balance sheet and comprehensive income statement adjustments. (4) MULTI-HOP REASONING - The model failed to correctly synthesize the specific financial statements affected. The question asks for 'specific financial statements' and the LLM provided four statements when only two were adjusted. (5) QUANTITATIVE ISSUES - No specific numbers or calculations were required in this question, but the page number citation (162-166) cannot be verified against the ground truth and may be inaccurate. The core factual error regarding which statements were adjusted is a fundamental failure to answer the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 452,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "In 2022, the value of equity method investment contracts was a liability of $3 million, while total asset derivatives amounted to $790 million. This indicates that equity method investment contracts represented a negligible portion of MDLZ's derivative portfolio, highlighting their minimal significance compared to other derivative instruments like commodity and currency contracts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - CRITICAL FAILURES: The LLM states total asset derivatives were $790 million in 2022, but the ground truth shows $393 million. This is a 101% overstatement ($397 million error). The equity method investment contracts value is stated as a 'liability of $3 million' when ground truth shows it as $3 million (asset), introducing incorrect characterization. (2) CALCULATION ERROR: The LLM correctly identifies the contracts as 'negligible' but the actual percentage would be 3/393 = 0.76% (less than 1%), not based on the inflated $790M figure which would yield only 0.38%. (3) MULTI-HOP REASONING: The LLM attempts to synthesize the comparison and provides context about derivative types (commodity and currency contracts), which shows some reasoning effort, but this is undermined by the fundamental numerical errors. (4) ENTITY ACCURACY: Company (MDLZ) and year (2022) are correct, but the financial metrics are significantly misstated. (5) SEMANTIC EQUIVALENCE: While the conclusion about 'minimal significance' is directionally correct, it's based on wrong numbers. The ground truth's specific percentage calculation (less than 1%) is more precise than the LLM's vague 'negligible' characterization. The $397 million discrepancy in total asset derivatives is a critical factual error that undermines the entire answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 385,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The freezing of U.S. pension benefits as of December 31, 2019, rendered the expected rate of compensation increase assumption obsolete for CAT's postemployment benefit plan accounting. This assumption, which previously factored into calculating pension obligations and costs, is no longer applicable because frozen benefits eliminate future compensation-related accruals. As a result, actuarial calculations for U.S. pension plans now exclude this assumption, impacting the sensitivity of obligations and costs to compensation trends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) CORRECTNESS: The core factual claim is correct - the freezing of U.S. pension benefits as of December 31, 2019, did result in the discontinuation of the 'expected rate of compensation increase' assumption. The LLM correctly identifies this key actuarial assumption change. (2) QUANTITATIVE ACCURACY: No numeric values, percentages, or dollar amounts are present in either the question or answers, so this dimension is not applicable. The date (December 31, 2019) is correctly referenced. (3) ENTITY ACCURACY: CAT is correctly identified as the company in question. The pension benefit freeze date is accurate. The actuarial assumption terminology ('expected rate of compensation increase') is correctly stated. (4) REASONING & SYNTHESIS: The LLM provides sound multi-hop reasoning by explaining the causal chain: benefit freeze  no future compensation-related accruals  assumption becomes obsolete  removed from calculations. This logic is accurate and well-articulated. The answer goes beyond the ground truth by explaining the practical implications (sensitivity to compensation trends), which adds helpful context without introducing errors. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth ('discontinuation' = 'rendered obsolete' = 'no longer applicable'). The wording is more detailed and explanatory than the ground truth, but maintains factual accuracy. Minor enhancement: The LLM provides additional context about the impact on sensitivity calculations, which is a reasonable inference but not explicitly stated in the ground truth. This is a strength rather than a weakness as it demonstrates deeper understanding without contradicting the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 484,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are higher-margin and more profitable, allows the company to prioritize these products in its hardware business, potentially improving profitability. However, this focus also exposes the hardware business to supply chain risks, as the document notes that supply chain shortages and disruptions (e.g., from the COVID-19 pandemic) have increased production costs and inventory risks. While the emphasis on engineered systems may enhance profitability through better margin management, supply chain vulnerabilities related to specialized components and single-source dependencies could still impact hardware operations and profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements when compared to the ground truth. CORRECT ELEMENTS: (1) Correctly identifies Oracle Engineered Systems as a strategic focus, (2) Accurately notes supply chain disruptions and increased production costs, (3) Mentions inventory risks and COVID-19 pandemic impacts, (4) Acknowledges specialized components and potential single-source dependencies. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM characterizes engineered systems as 'higher-margin and more profitable' and suggests they 'enhance profitability through better margin management' - the ground truth does NOT support this positive framing. Instead, the ground truth emphasizes vulnerability and negative impacts. (2) The LLM presents a balanced view ('may enhance profitability...could still impact') when the ground truth is more definitive about negative impacts: supply chain disruptions have 'negatively impacted operating cash flows' and the company 'cannot always pass these increased costs on to customers.' (3) The LLM fails to mention key consequences from the ground truth: higher inventory purchases to secure capacity, increased inventory excess and obsolescence risk, and lost sales/delayed revenue recognition. (4) The reasoning is somewhat speculative ('potentially improving profitability') rather than grounded in the filing's actual reported impacts. MULTI-HOP REASONING: The LLM partially synthesizes the relationship between strategic focus and supply chain vulnerability, but misses the critical causal chain: strategic focus on complex engineered systems  reliance on third-party suppliers  supply chain disruptions  increased costs  inability to pass costs to customers  reduced profitability. The ground truth presents a clear negative impact narrative, while the LLM presents an ambiguous, hedged response that doesn't fully capture the documented challenges. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. The qualitative accuracy is significantly lower because the LLM's characterization of the business impact diverges from the ground truth's documented negative consequences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 584,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area was **$3,555 million** ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This total grew by **14.5%** compared to 2022, outperforming the overall Pulmonary Hypertension category's **11.6%** growth rate.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the combined revenue ($3,555 million) and the individual breakdowns ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI), which matches the ground truth exactly. The overall Pulmonary Hypertension category growth rate of 11.6% is also correct. However, there is a critical error in the growth rate calculation for the combined UPTRAVI and OPSUMIT total. The LLM states the combined total grew by 14.5%, but the ground truth indicates that OPSUMIT grew 10.6% and UPTRAVI grew 19.7%. The LLM appears to have calculated or stated an incorrect combined growth rate of 14.5% instead of properly synthesizing the individual growth rates. The correct weighted combined growth rate would be approximately 14.6% ((1,973  0.106 + 1,582  0.197) / 3,555  14.6%), which is close to but not exactly 14.5%. More importantly, the ground truth answer emphasizes that BOTH individual products outperformed the category growth rate (10.6% and 19.7% vs 11.6%), whereas the LLM only states the combined total outperformed the category. The LLM failed to provide the individual growth rates for each product, which is a significant omission in addressing the multi-hop nature of the question. The answer is partially correct on the revenue figures but incomplete and potentially inaccurate on the growth rate analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 374,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings by **$2.2 billion** in 2024, as part of the $3.5 billion total increase in U.S. upstream earnings. This contribution was driven by higher sales volumes, including from legacy PDC assets, and the absence of decommissioning charges. The corresponding impact on net oil-equivalent production was an increase of **250,000 barrels per day (19%)**, primarily due to the full-year production from legacy PDC assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts match the ground truth: (1) $2.2 billion increase in U.S. upstream earnings from legacy PDC Energy assets in 2024 - CORRECT, (2) 250,000 barrels per day increase in net oil-equivalent production - CORRECT, (3) 19% increase in production - CORRECT. The answer correctly identifies CVX (Chevron) as the company and 2024 as the fiscal year. Multi-hop synthesis is sound: the model properly connected the PDC Energy acquisition contribution to both earnings impact and production impact. The LLM appropriately contextualized the $2.2 billion figure within the broader $3.5 billion total U.S. upstream earnings increase, demonstrating understanding of the relative contribution. The explanation of drivers (higher sales volumes, absence of decommissioning charges, full-year production from legacy PDC assets) adds relevant context without introducing errors. The answer is well-structured, addresses both parts of the multi-part question, and maintains semantic equivalence with the ground truth while providing additional helpful context. No calculation errors detected. Minor: the additional contextual information about the $3.5 billion total and decommissioning charges, while accurate and helpful, goes slightly beyond the strict question scope, but this is a strength rather than a weakness as it demonstrates deeper understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 392,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "MetLife adjusted its **consolidated balance sheet, statement of operations, statements of comprehensive income, statements of equity, and statements of cash flows** as a result of the retrospective application of the new LDTI accounting guidance. This widespread adjustment across multiple financial statements implies the guidance significantly impacted the company's historical financial reporting, altering key line items such as net income, assets, liabilities, equity, and cash flows, reflecting a broad scope of application.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - FACTUAL INACCURACY: The LLM answer significantly overstates the scope of adjusted financial statements. The ground truth explicitly states that MetLife adjusted only TWO specific financial statements: (1) consolidated statements of equity and (2) consolidated statements of comprehensive income. The LLM answer claims FIVE statements were adjusted: consolidated balance sheet, statement of operations, statements of comprehensive income, statements of equity, and statements of cash flows. This is a material factual error that contradicts the original answer. While the LLM correctly identifies that comprehensive income and equity statements were adjusted, it incorrectly adds balance sheet, statement of operations, and cash flows without evidence from the ground truth. The LLM's reasoning about 'widespread adjustment' and 'broad scope' is therefore based on false premises. The LLM does correctly understand that the guidance had broad impact on financial reporting and correctly identifies MetLife as the company. However, the core factual claim about WHICH statements were adjusted is wrong, which is the primary focus of the question. The answer demonstrates partial understanding of the LDTI guidance's impact but fails on the specific factual requirement of identifying the exact financial statements adjusted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 373,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was **$3 million** (liability), while the total fair value of net investment hedge contracts was **$24 million** (asset). The equity method contracts were disclosed in the derivatives fair value table as a liability, and the net investment hedge contracts were reported as a net asset.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper comparison. Strengths: (1) Both key numbers are correct - equity method investment contracts at $3 million and net investment hedge contracts at $24 million; (2) The date (December 31, 2022) is correctly identified; (3) The comparison is properly made showing the relative magnitude difference; (4) Additional context about asset/liability classification is provided, which adds helpful detail. Minor issue: The ground truth states the equity method investment contracts value as '$(3) million' (negative/liability notation), while the LLM clarifies this as '$3 million (liability)' - this is semantically equivalent and arguably clearer, though the original notation explicitly showed the negative sign. The LLM's interpretation that this represents a liability is correct and the parenthetical clarification enhances understanding. The answer fully addresses both parts of the multi-part question (the specific fair value and the comparison), demonstrates proper multi-hop synthesis by connecting the two contract types, and provides accurate financial data. The reasoning is sound and the conclusion about the relative magnitude difference is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 348,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "The net assets of Universal Beijing Resort decreased from $600 million as of December 31, 2023 ($7.8 billion assets - $7.2 billion liabilities) to $300 million as of December 31, 2024 ($7.3 billion assets - $7.0 billion liabilities), reflecting a $300 million decline. This reduction is primarily due to lower asset growth ($500 million decrease in assets) and a smaller decrease in liabilities ($200 million reduction). These changes are reported in Comcast's consolidated balance sheets under the Theme Parks segment, with construction costs and debt related to Universal Beijing Resort disclosed separately in the cash flow statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key financial figures correct: net assets decreased from $600M to $300M (a $300M decline), with assets declining $500M ($7.8B to $7.3B) and liabilities declining $200M ($7.2B to $7.0B). The calculations are accurate and properly formatted. The answer correctly identifies the multi-hop synthesis across Comcast's consolidated balance sheets and the Theme Parks segment. However, there are minor issues: (1) The original answer describes the change more conservatively as reflecting 'potential ongoing operational or investment adjustments,' while the LLM provides more specific causal attribution ('primarily due to lower asset growth...and smaller decrease in liabilities') without explicit evidence from the source documents. (2) The LLM mentions 'construction costs and debt related to Universal Beijing Resort disclosed separately in the cash flow statements,' which adds detail not present in the ground truth answer - this is additional information that may or may not be verifiable from the actual filings. (3) The contextual relevance is slightly reduced because while the answer addresses how this reflects in Comcast's consolidated balance sheets, it could have been more explicit about the specific line items or segment reporting methodology. Overall, the core financial analysis is sound and the numbers are correct, making this a strong answer with minor qualifications about the specificity of causal claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 411,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a 5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a 10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is **$103.6 million** (comprising 5.0 billion and 10.0 billion, converted to USD at the stated rates). The 2021 Revolving Credit Agreement supports the commercial paper program by providing a **$3.0 billion backstop** for outstanding commercial paper borrowings, ensuring liquidity for working capital, capital expenditures, and other corporate purposes, with an option to increase the facility by an additional $1.0 billion.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the total value of Japanese yen-denominated credit facilities as $103.6 million and accurately references the 2021 Revolving Credit Agreement's $3.0 billion backstop for the commercial paper program. However, there are notable omissions and one potential inaccuracy: (1) The LLM fails to provide the specific breakdown of the two facilities (5.0 billion at $34.5 million and 10.0 billion at $69.1 million) and their maturity dates (December 30, 2024 and March 27, 2025), which are explicitly stated in the ground truth. (2) The LLM mentions an 'option to increase the facility by an additional $1.0 billion,' which is not mentioned in the ground truth answer and may be extraneous information not directly relevant to the question asked. (3) The LLM's description of the commercial paper program's purposes is less comprehensive than the ground truth, which specifically lists 'cash dividends and share repurchases' alongside working capital and capital expenditures. (4) The core quantitative facts are correct ($103.6 million total, $3.0 billion backstop), and the multi-hop reasoning connecting the 2021 Revolving Credit Agreement to the commercial paper program is sound. The answer demonstrates understanding of the relationship between the credit facility and commercial paper program but lacks the detailed specificity and completeness of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 391,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle's strategic focus on Oracle Engineered Systems within its hardware business enhances infrastructure technologies revenue by emphasizing high-margin, specialized products like Oracle Exadata, which integrate advanced technologies to deliver superior performance. However, this focus increases exposure to supply chain risks due to reliance on specialized components, single-source suppliers, and global disruptions (e.g., COVID-19), which can lead to production delays, cost increases, and inventory management challenges. The document highlights these risks in the context of hardware supply chain constraints and the impact of geopolitical or logistical disruptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Oracle Engineered Systems (specifically mentioning Oracle Exadata) as part of the hardware business and accurately describes how they contribute to infrastructure technologies revenue through high-performance, integrated solutions. The answer correctly identifies supply chain risks including single-source supplier dependence, COVID-19 disruptions, production delays, and inventory management challenges. The reasoning about the dual impact (positive on revenue, negative on risk exposure) is sound and addresses both parts of the multi-hop question.\n\nWEAKNESSES: (1) CRITICAL OMISSION - The LLM answer completely fails to include the specific quantitative metric from the ground truth: 'Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022.' This is a concrete, verifiable number that directly supports the answer and demonstrates the importance of infrastructure technologies to Oracle's financial performance. (2) The LLM answer mentions 'high-margin' products but provides no supporting data or context for this claim. (3) The answer lacks specific reference to fiscal 2022 as the time period for the supply chain disruptions and their impacts. (4) The ground truth mentions specific consequences like 'increased inventory purchases' and 'negatively impacted operating cash flows,' which the LLM answer generalizes to 'inventory management challenges' without the specificity of the original.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the supply chain and revenue impact domains, but the synthesis is less complete than the ground truth. The answer demonstrates understanding of the causal relationships but lacks the quantitative evidence that would strengthen the multi-hop analysis.\n\nQUANTITATIVE ACCURACY: Score of 4 reflects the complete absence of the 58% metric, which is a material omission in a financial analysis context. No calculations are presented, and no specific fiscal year is cited.\n\nQUALITATIVE ACCURACY: Score of 7 reflects correct identification of key concepts and sound reasoning, but with incomplete synthesis and missing specific details about cash flow impacts and inventory excess/obsolescence risks.\n\nCONTEXTUAL RELEVANCE: Score of 8 reflects that the answer appropriately addresses both parts of the question (revenue impact and supply chain risk exposure) with relevant examples, though with less depth than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 675,
        "total_tokens": 2216
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "Universal Beijing Resort's debt decreased by $0.1 billion from $3.5 billion in 2023 to $3.4 billion in 2024. This reduction, combined with a $0.1 billion decrease in other \"Debt Not Guaranteed\" obligations, resulted in a total decrease of $0.2 billion in the 'Debt Not Guaranteed' category.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the Universal Beijing Resort debt decrease from $3.5B to $3.4B (a $0.1B reduction) and correctly states this contributed to the 'Debt Not Guaranteed' category decrease. However, there is a critical calculation error in the final synthesis. The ground truth shows the 'Debt Not Guaranteed' category decreased from $5.0B to $4.8B (a $0.2B total decrease), with the Universal Beijing Resort contributing $0.1B of that decrease and 'Other' debt contributing another $0.1B decrease ($1.5B to $1.4B). The LLM correctly identifies the $0.2B total decrease but the reasoning is incomplete and somewhat misleading. The LLM states 'a $0.1 billion decrease in other Debt Not Guaranteed obligations' which is accurate but vague - it should specify this came from the 'Other' debt category declining from $1.5B to $1.4B. The LLM answer lacks the complete breakdown of components contributing to the total decrease, making it partially incomplete in addressing the full multi-hop synthesis required. The core numbers are correct, but the explanation of how the components combine is less clear than the ground truth. The answer addresses the question's main parts but with less detail and clarity regarding the complete composition of the 'Debt Not Guaranteed' category change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 363,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts increases audit complexity due to the significant judgment required in estimating total contract costs and recognizing revenue over time. Auditors must rigorously evaluate management's assumptions about costs, including historical performance trends, inflation, technical risks, and labor agreements, as these estimates are subject to change and require frequent monitoring. The audit procedures include testing internal controls, validating revenue recognition alignment with progress toward completion, and assessing potential biases in cost estimates. The cumulative catch-up basis for adjusting revenue and costs further complicates audits, as changes in estimates impact prior periods. This complexity is highlighted in the Critical Audit Matter (CAM) section, which notes the high degree of auditor judgment needed to ensure accurate revenue recognition under this method.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a solid understanding of how Honeywell's cost-to-cost input method increases audit complexity and correctly identifies key factors that auditors must evaluate. STRENGTHS: (1) Correctly identifies the core complexity drivers: judgment in estimating total contract costs, revenue recognition over time, and the impact of changing estimates; (2) Accurately lists relevant factors auditors consider: inflation, technical risks, labor agreements, historical performance trends; (3) Properly describes audit procedures: testing controls, validating assumptions, assessing revenue recognition alignment; (4) Appropriately references the Critical Audit Matter (CAM) section as evidence of complexity; (5) Correctly notes that changes in estimates impact prior periods. WEAKNESSES: (1) The mention of 'cumulative catch-up basis' is not explicitly present in the ground truth answer and may introduce terminology not directly supported by the source material; (2) The ground truth specifically emphasizes 'profiling contracts with longer durations or significant gross margin changes' as a key audit procedure, which the LLM answer does not explicitly mention; (3) The ground truth emphasizes the 'proportion of costs incurred to date relative to total estimated costs' as the specific mechanism driving complexity, while the LLM answer is less precise on this mathematical relationship; (4) The ground truth notes that auditors must evaluate 'reasonableness and consistency' of estimates, while the LLM adds 'potential biases' which, while reasonable, is not explicitly in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between the cost-to-cost method, estimation complexity, and audit procedures. The connection between revenue recognition mechanics and audit complexity is sound. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - both convey that the method significantly increases audit complexity due to estimation judgment and the need for rigorous testing. The answer is contextually appropriate and addresses the question comprehensively, though with some minor deviations from the specific framing in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 592,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "In NEE's 2023 financial results, NEER's $1,729 million non-qualifying hedge gains exceeded FPL's $300 million gains by **$1,429 million**. This reflects differing treatments of derivative transactions: NEER's gains are directly recognized in net income, reflecting immediate earnings volatility from non-qualifying hedges, while FPL's gains are deferred as regulatory assets/liabilities under cost recovery clauses and recognized upon contract settlement, aligning with its regulated utility structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the core quantitative elements and multi-hop reasoning. STRENGTHS: (1) All numbers are correct - NEER's $1,729 million, FPL's $300 million, and the calculated difference of $1,429 million are all accurate. (2) The calculation is correct: $1,729M - $300M = $1,429M. (3) Multi-hop synthesis is sound - the answer correctly identifies and compares the two business units (NEER and FPL) and their different derivative treatment approaches. (4) Entity identification is accurate - NEE, NEER, and FPL are correctly identified and distinguished. (5) The explanation of regulatory vs. market-oriented treatment is accurate and relevant. MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth - it doesn't explicitly mention that NEER's non-qualifying hedge activity was 'a primary driver of its improved results in 2023 compared to 2022,' which provides important context about year-over-year performance. (2) The phrase 'cost recovery clauses' in the LLM answer is a reasonable characterization but the ground truth uses 'regulatory assets or liabilities' which is more precise terminology from the 10-K. (3) The LLM answer could have been slightly more explicit about the timing difference ('immediately impacting earnings' vs. 'upon contract settlement'). However, these are minor omissions that don't affect the core correctness of the answer. The semantic meaning and factual content align well with the ground truth, and all critical financial information is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 426,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcasts consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcasts maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast's ownership stake in Universal Beijing Resort, a Variable Interest Entity (VIE), is fully consolidated in its financial statements, with assets of $7.3 billion and liabilities of $7.0 billion as of December 31, 2024. Comcast's maximum risk of financial loss is its 30% interest in the resort's debt, which is capped at $4.2 billion. This represents **30% of the resort's maximum debt financing**. As of December 31, 2024, Comcast's total debt financing was $99.09 billion, making the maximum risk approximately **1.27%** of its total debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL CALCULATION ERROR: The LLM states Comcast's maximum risk of financial loss is $4.2 billion, but the ground truth clearly states it is $1.02 billion (30% of $3.4 billion debt). The LLM appears to have calculated 30% of $14 billion ($7.3B assets + $7.0B liabilities) instead of 30% of the $3.4 billion debt outstanding. This is a fundamental misunderstanding of what 'maximum risk of financial loss' means in this context. (2) INCORRECT PROPORTION CALCULATION: The LLM states the maximum risk represents 1.27% of Comcast's total debt ($99.09 billion), but this calculation is based on the wrong maximum risk figure ($4.2B vs $1.02B). The correct proportion should be approximately 1.03% ($1.02B / $99.09B). (3) CORRECT ELEMENTS: The LLM correctly identifies that Comcast owns 30% of Universal Beijing Resort, that it is consolidated as a VIE, and correctly states the asset ($7.3B) and liability ($7.0B) figures as of December 31, 2024. (4) INCOMPLETE REASONING: While the LLM addresses the consolidation aspect and attempts to calculate the proportion of total debt, it fundamentally misinterprets what constitutes Comcast's maximum risk of financial loss. The ground truth specifies this is limited to the 30% equity interest, which equates to 30% of the debt ($1.02B), not 30% of combined assets and liabilities. (5) MULTI-HOP SYNTHESIS: The model failed to properly synthesize the relationship between the 30% ownership stake, the $3.4 billion debt outstanding, and the resulting maximum risk exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 424,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "The cumulative goodwill impairment charges recognized for OpenTable in 2020 totaled **$1,062 million** ($489 million in March 2020 and $573 million in September 2020). The document does not explicitly state OpenTable's 2021 revenue contribution to Booking Holdings' advertising and other segment, as revenue figures for OpenTable in 2021 are not provided in the referenced pages. Thus, a direct comparison cannot be made based on the given information.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer demonstrates a critical failure in multi-hop synthesis despite correctly identifying the 2020 impairment charges. STRENGTHS: (1) The $1,062 million cumulative impairment figure is correct, (2) The quarterly breakdown ($489M and $573M) is accurate, (3) The timing references (March 2020 and September 2020, or Q1 and Q3) are correct. CRITICAL WEAKNESSES: (1) The LLM claims 'the document does not explicitly state OpenTable's 2021 revenue contribution' and refuses to make the comparison. However, the ground truth clearly indicates that OpenTable contributed to the 'advertising and other' segment which totaled $1.1 billion in 2021. This information was available in the source documents. (2) The LLM failed to synthesize the multi-hop requirement: it needed to identify that OpenTable's revenue is part of the 'advertising and other' segment total of $1.1 billion, then compare this to the $1,062 million impairment. (3) The LLM's conclusion that 'a direct comparison cannot be made' is incorrect - the ground truth explicitly makes this comparison, noting the impairment charges were 'nearly equivalent to the entire annual revenue contribution.' (4) This represents a fundamental failure in multi-hop reasoning - the model should have recognized that the 'advertising and other' segment revenue of $1.1 billion includes OpenTable's contribution and used this for comparison. The answer is incomplete and fails to address the core analytical requirement of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 411,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil incorporates estimated greenhouse gas (GHG) emission costs into its Corporate Plan assumptions when assessing the recoverability of asset groups, as part of its long-term planning and cash flow projections. These costs are included even in jurisdictions without current GHG pricing policies. Specifically, the Corporation factors in its **2030 GHG emission-reduction goal** of achieving **net-zero Scope 1 and 2 emissions from unconventional operated assets in the Permian Basin** when evaluating future cash flows and potential impairments. This goal is explicitly mentioned in the context of supporting its broader climate strategy and integrated into the assumptions used for asset valuation and impairment testing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies that ExxonMobil incorporates estimated GHG emission costs into its Corporate Plan for asset recoverability assessments, includes these costs even in jurisdictions without current GHG pricing policies, and specifically factors in the 2030 GHG emission-reduction goal of achieving net-zero Scope 1 and 2 emissions from unconventional operated assets in the Permian Basin. (2) QUANTITATIVE ACCURACY: All dates and metrics are correct - the 2030 timeframe and the specific net-zero Scope 1 and 2 emissions target for Permian Basin unconventional assets are accurately stated. No calculations are required for this question. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes information about: (a) how GHG costs are incorporated (into Corporate Plan and cash flow assessments), (b) the scope of application (even without current pricing policies), and (c) the specific emission-reduction goal (2030 net-zero for Permian Basin unconventional assets). The answer demonstrates proper understanding of the relationship between GHG cost assumptions and asset impairment testing. (4) CONTEXTUAL RELEVANCE: The answer is highly relevant, addressing both parts of the question - the mechanism of incorporation and the specific future emission-reduction goal. The additional context about climate strategy and asset valuation adds appropriate depth without introducing inaccuracies. Minor note: The LLM uses 'GHG' abbreviation and slightly more detailed phrasing than the ground truth, but this represents semantic equivalence and enhanced clarity rather than any factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 480,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "Capital One phased in 50% of the $2.4 billion CECL Transition Rule addition by December 31, 2023, leaving **$1.2 billion** to be phased in during 2024 ($600 million per year). This remaining amount contributes to regulatory capital, which affects the companys capital ratios but does not alter the **stress capital buffer requirements** for October 1, 2023September 30, 2024. The buffer requirements (4.8%) and resulting minimum capital ratios (9.3% CET1, 10.8% Tier 1, 12.8% total) are based on supervisory stress test results and are already factored into the capital planning framework. The phased-in CECL capital supports compliance with these requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: $1.2 billion remaining to be phased in after December 31, 2023, with $600 million per year on January 1, 2024 and 2025. The stress capital buffer requirement of 4.8% for October 1, 2023September 30, 2024 is accurate. However, there are notable issues: (1) The LLM introduces specific minimum capital ratios (9.3% CET1, 10.8% Tier 1, 12.8% total) that are NOT mentioned in the ground truth answer and cannot be verified as correct from the provided context. This is a potential factual error or unsupported claim. (2) The ground truth explicitly states that Capital One's capital conservation buffer requirements are 2.5% for CET1, Tier 1, and total capital under Federal Reserve regulations, which the LLM answer omits entirely. This is a significant omission of key information directly addressing the second part of the question about how the CECL addition affects capital conservation buffer requirements. (3) The LLM correctly notes that the stress capital buffer is separate from the conservation buffer framework, which aligns with the ground truth's distinction. (4) The LLM's statement that the phased-in CECL capital 'does not alter' the stress capital buffer requirements is reasonable but somewhat imprecisethe ground truth indicates these are separate regulatory frameworks. The answer demonstrates partial understanding of the multi-hop synthesis required (connecting CECL phasing to capital requirements) but fails to fully address the capital conservation buffer component of the question and introduces unverified specific ratios.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 442,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was **$1,713 million** (from $11,275 million in 2022 to $9,562 million in 2023). This reduction contrasts with a **$250 million increase** in Euro notes over the same period (from $7,666 million in 2022 to $7,916 million in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numerical values are correct: (1) U.S. dollar notes and term loans decreased by $1,713 million from $11,275 million (2022) to $9,562 million (2023) - calculation verified: $11,275M - $9,562M = $1,713M ; (2) Euro notes increased by $250 million from $7,666 million (2022) to $7,916 million (2023) - calculation verified: $7,916M - $7,666M = $250M . The answer correctly identifies MDLZ as the company and the 2022-2023 period. The multi-hop reasoning is sound: the model synthesized information about two different debt instruments (U.S. dollar notes/term loans and Euro notes) and made the appropriate comparison showing the U.S. dollar reduction was significantly larger than the Euro increase. The answer addresses all parts of the multi-part question. The wording is clear and semantically equivalent to the ground truth. Minor note: The LLM uses bold formatting for emphasis, which is a stylistic choice that doesn't affect accuracy. The answer demonstrates proper synthesis across multiple financial metrics and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 311,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The maximum annual payment Resideo is obligated to make to Honeywell under the indemnification agreement is **$140 million**, which is 90% of Honeywell's annual net spending on environmental matters at specified sites, **subject to a cap of $140 million**. This payment is directly tied to Honeywell's net environmental spending but cannot exceed the $140 million threshold.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative elements are correct: the $140 million maximum annual payment is accurate, the 90% percentage is correct, and the reference to Honeywell's net spending on environmental matters at specified sites is accurate. The LLM answer goes slightly beyond the ground truth by explicitly clarifying that the $140 million represents a cap/threshold, which adds helpful context without introducing any inaccuracy. The multi-hop reasoning is sound - the answer correctly synthesizes the relationship between Resideo's obligation, the percentage calculation (90%), and the cap structure. The entities are correctly identified (Resideo subsidiary, Honeywell, indemnification agreement). The only minor distinction is that the LLM answer includes the phrase 'subject to a cap of $140 million' which, while logically correct and helpful for clarity, is slightly more explicit than the ground truth statement. However, this represents an enhancement rather than an error, as it clarifies that the $140 million IS the cap. The answer fully addresses both parts of the question: (1) the maximum annual payment amount, and (2) how it relates to Honeywell's environmental spending. No calculation errors are present, and the semantic meaning perfectly matches the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 370,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "The changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impacted NEE's total financial position by a net increase of **$2,440 million** for the FPL and NEER segments between December 31, 2022, and December 31, 2023. Non-Qualifying Hedges increased by **$2,444 million** (from -$3,921 million to -$1,477 million), while Hedges in FPL Cost Recovery Clauses decreased by **$4 million** (from $16 million to $12 million). This resulted in a combined positive effect on the financial position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key metrics. (1) QUANTITATIVE ERRORS - The LLM reports a net increase of $2,440 million, while the ground truth shows a total decrease of $35 million. This is a massive discrepancy in both direction and magnitude. Specifically: FPL segment - LLM claims Non-Qualifying Hedges increased by $2,444 million (from -$3,921M to -$1,477M), but ground truth shows FPL's total position decreased from $3M to $2M (a $1M decrease). NEER segment - LLM claims Hedges in FPL Cost Recovery Clauses decreased by $4M (from $16M to $12M), but ground truth shows NEER decreased from $148M to $114M (a $34M decrease). (2) CALCULATION ERRORS - The LLM's arithmetic is internally inconsistent with the ground truth values. The numbers cited ($3,921M, $1,477M, $16M, $12M) do not match the ground truth figures ($3M, $2M, $148M, $114M). (3) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the FPL and NEER segment data. It appears to have used completely different source data or misidentified the relevant financial metrics. (4) DIRECTIONAL ERROR - The LLM concluded a positive impact ($2,440M increase) when the ground truth shows a negative impact ($35M decrease). This is a fundamental misunderstanding of the financial position changes. The answer is factually incorrect across all dimensions and provides misleading financial information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 394,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "Universal Beijing Resort's net assets decreased by $300 million from 2023 to 2024 (from $600 million to $300 million net assets), while its debt obligations decreased by $100 million (from $3.5 billion to $3.4 billion). Thus, the decline in net assets was more significant than the decline in debt obligations during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally undermine its accuracy: (1) NET ASSETS CALCULATION ERROR: The LLM states net assets decreased by $300 million (from $600M to $300M), but the ground truth shows net assets decreased by $900 million (from $600M to -$300M). The LLM incorrectly calculated the change as $300M instead of $900M. (2) DEBT OBLIGATIONS ERROR: The LLM claims debt decreased by $100 million (from $3.5B to $3.4B), but ground truth shows liabilities decreased by $200 million (from $7.2B to $7.0B). The LLM used completely incorrect debt figures ($3.5B and $3.4B) that don't match the ground truth data. (3) ASSET AND LIABILITY FIGURES: The LLM failed to provide the actual asset and liability figures from the filings (2023: $7.8B assets, $7.2B liabilities; 2024: $7.3B assets, $7.0B liabilities), which are essential context. (4) INCOMPLETE ANALYSIS: While the LLM correctly identified that net asset decline was more significant than debt decline, this conclusion is based on incorrect numbers. The correct comparison should show a $900M net asset decrease versus a $200M debt decrease. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the balance sheet data (assets - liabilities = net assets) across the two years. The reasoning structure is present but built on incorrect foundational numbers. The answer demonstrates a fundamental misunderstanding or misreporting of the financial data from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 408,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) became eligible for treating **pediatric patients aged 2-12 years old with HIV**, and regulatory filings were targeted in both the **United States (US)** and the **European Union (EU)** as indicated in the product's filing status on page 33.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth - the specific patient population (pediatric patients aged 2-12 years with HIV) is correctly identified, and the regulatory regions (US and EU) are accurately stated. (2) QUANTITATIVE ACCURACY: The age range (2-12 years) is precisely correct with no numerical errors. (3) MULTI-HOP REASONING: The answer successfully synthesizes information from JNJ's 2023 10-K filing, correctly linking the new patient population eligibility with the corresponding regulatory filing targets. The model appropriately identified both the clinical indication (HIV treatment) and the regulatory scope. (4) COMPLETENESS: The answer addresses all parts of the multi-part question - it identifies the specific new patient population AND the targeted regulatory regions. The additional detail about page 33 adds credibility without introducing errors. (5) SEMANTIC EQUIVALENCE: The phrasing 'became eligible for treating' and 'targeted for treatment' are semantically equivalent to the ground truth. The expansion of 'US' to 'United States' and 'EU' to 'European Union' represents appropriate clarification rather than error. Minor deduction (1 point) only because the ground truth uses slightly more concise phrasing, though the LLM's expanded version is equally accurate and arguably more explicit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 388,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "Booking.com's merchant-based transaction model increased payment processing, fraud detection, and compliance costs, directly pressuring operating margins in 2022. Regulatory investigations in Switzerland (e.g., potential commission reductions) and the EU (e.g., Digital Markets Act scrutiny) introduced compliance risks, possible fines, and operational constraints, further straining margins. These factors, combined with the Connected Trip strategy's short-term cost investments, collectively pressured margins while driving long-term growth initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies the key mechanisms through which the merchant-based model and regulatory investigations impact margins and strategy. STRENGTHS: (1) Correctly identifies merchant-based transaction model's cost pressures (payment processing, fraud detection, compliance costs); (2) Accurately references Swiss Price Surveillance Office investigation and potential commission reductions; (3) Correctly mentions Digital Markets Act and gatekeeper classification concerns; (4) Properly synthesizes the connection between these factors and margin compression; (5) Appropriately links to Connected Trip platform as a strategic initiative affected by these pressures; (6) Maintains semantic equivalence with ground truth on regulatory impacts and strategic constraints. WEAKNESSES: (1) Omits specific mention of personnel expenses and chargebacks as cost drivers mentioned in ground truth; (2) Does not explicitly mention credit card rebates as an offsetting revenue source; (3) Less detailed on specific regulatory restrictions (data usage, service bundling, parity clauses) that the DMA could impose; (4) Does not explicitly state that these are 'ongoing' investigations or provide temporal context; (5) Slightly less comprehensive on the full scope of compliance costs and restrictions. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were provided in either answer, so this dimension is not directly testable. The answer avoids making unsupported numerical claims. MULTI-HOP REASONING: The answer successfully synthesizes information across three dimensions: (1) merchant model mechanics, (2) Swiss regulatory pressure, (3) EU regulatory pressure, and (4) strategic implications. The logical flow connecting these to margin compression is sound. ENTITY ACCURACY: All entities correctly identified (Booking.com, Booking Holdings, Switzerland, EU, Digital Markets Act, Connected Trip). The answer maintains appropriate temporal context (2022). The answer is substantively correct on the core question but lacks some granular detail present in the ground truth regarding specific cost categories and regulatory mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 595,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is **15 years**, comprising an initial 5-year term with up to two extensions (totaling 10 years) at the Minister's discretion, provided the total extensions do not exceed 10 years. This framework influences ExxonMobil's LNG strategy by necessitating timely commercialization of gas resources within the 15-year window, encouraging phased development or accelerated project timelines to align with regulatory deadlines, as highlighted in its 2022 10-K filing under LNG initiatives in Papua New Guinea.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the maximum total duration of 15 years for a petroleum retention license in Papua New Guinea, matching the ground truth. The breakdown of the initial 5-year term with up to two extensions is also accurate. However, there is a minor clarity issue in the phrasing: the LLM states 'up to two extensions (totaling 10 years)' and then adds 'provided the total extensions do not exceed 10 years,' which is somewhat redundant and could be clearer. The ground truth simply states 'up to two extensions at the Minister's discretion' without specifying the exact duration of each extension, so the LLM's additional detail about the 10-year total for extensions appears to be an inference that may or may not be explicitly stated in the source material. The quantitative facts (15 years total, 5-year initial term, two extensions) are correct. Regarding the strategic influence on ExxonMobil's LNG development, the LLM answer provides a reasonable interpretation that the framework encourages 'timely commercialization' and 'phased development or accelerated project timelines.' The ground truth emphasizes that it 'allows the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window' and aligns with 'selectively developing attractive natural gas resources.' The LLM's interpretation is not incorrect but frames the influence slightly differentlyfocusing on urgency/acceleration rather than the flexibility to hold resources until they become viable. Both interpretations are logically sound given the regulatory structure. The reference to the 2022 10-K filing is appropriate and correctly cited. Overall, the answer is substantially correct with minor differences in emphasis and one potentially unsupported detail about the 10-year extension limit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 503,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "The year-over-year change in Coca-Cola's investment in Mutual, pooled, and commingled funds under Level 2 assets increased by **$55 million** (from $202 million in 2022 to $257 million in 2023). In contrast, Hedge funds/limited partnerships investments, which are categorized under \"Other\" (not Level 2), increased by **$121 million** (from $936 million in 2022 to $1,057 million in 2023). Thus, the shift in Level 2 Mutual funds was smaller in magnitude compared to the growth in Hedge funds/limited partnerships.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all key metrics. (1) QUANTITATIVE ERRORS - All numbers are wrong: The LLM claims Mutual, pooled and commingled funds (Level 2) increased by $55M (from $202M to $257M in 2023), but the ground truth shows they DECREASED by $46M (from $83M to $37M). This is a complete reversal of direction and magnitude. The LLM also provides entirely different base numbers ($202M vs $83M in 2022). For Hedge funds/limited partnerships, the LLM claims a $121M increase (from $936M to $1,057M), but ground truth shows only a $4M increase (from $14M to $18M). The LLM's numbers are off by a factor of approximately 30x. (2) CALCULATION VERIFICATION - The LLM's arithmetic is internally consistent ($202M + $55M = $257M; $936M + $121M = $1,057M), but these calculations are based on completely incorrect source data. (3) MULTI-HOP REASONING - While the LLM correctly identifies the need to compare two investment categories year-over-year, it has synthesized data from the wrong line items or misread the filing data entirely. The comparison structure is sound, but the underlying facts are wrong. (4) ENTITY AND METRIC ACCURACY - The LLM correctly identifies Coca-Cola and the two investment types, but appears to have pulled data from different asset categories or years than what was requested. The ground truth clearly specifies Level 2 assets for the pooled funds, and the LLM's numbers suggest it may have looked at a different classification level or different time period. This is a critical failure in multi-hop synthesis requiring accurate data extraction from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 442,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a **$64 million reduction**. This includes an **$88 million pre-tax charge** for the estimated loss on regulatory disallowance, partially offset by a **$24 million tax benefit** related to the disallowances, as noted in the income tax section. The net effect reduced Southern Company Gas' net income by $64 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect on the primary quantitative metric. Ground truth states the total financial impact was $53 million ($29 million + $24 million), but the LLM claims $64 million. This is a critical factual error of $11 million difference. The LLM's approach of citing an $88 million pre-tax charge offset by a $24 million tax benefit (resulting in $64 million net) does not match the ground truth composition of the answer. The ground truth explicitly identifies the impact as combining a $29 million decrease in net income at gas distribution operations and a $24 million earnings adjustment, totaling $53 million. The LLM appears to have used different source figures ($88M pre-tax vs. the $29M cited in ground truth) and applied a different calculation methodology involving tax benefits. While the LLM demonstrates understanding that there are multiple components to the regulatory disallowance impact and attempts multi-hop reasoning by referencing both operational impacts and tax effects, the fundamental numbers are wrong. The answer fails on quantitative accuracy (the most critical element for financial questions) and does not correctly synthesize the specific figures mentioned in the financial statements according to the ground truth. The $64 million figure is definitively incorrect when the ground truth answer is $53 million.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 380,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&Ts comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "AT&T classified WarnerMedia, Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification allowed AT&T to separate these businesses from its ongoing operations, reflecting the company's restructuring efforts to focus on core telecommunications and technology segments, while removing non-core assets to streamline operations and improve financial clarity.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies all four businesses classified as discontinued operations: WarnerMedia, Vrio, Xandr, and Playdemic. However, there is a critical issue with the framing: the original answer specifies that WarnerMedia was mentioned as the reference point ('In addition to WarnerMedia'), implying the question was asking about OTHER businesses beyond WarnerMedia. The LLM answer lists WarnerMedia as one of the four, which technically answers the question but misses the nuance that the question was asking for businesses BESIDES WarnerMedia. The LLM does correctly identify the three other businesses (Vrio, Xandr, Playdemic) that were classified as discontinued operations. Regarding the significance explanation: The LLM provides a reasonable explanation about separating businesses from ongoing operations and focusing on core segments, but it lacks the specific detail from the ground truth about the 'combined divestiture being treated as a single strategic shift' and the important point that some of these businesses 'did not individually meet the materiality threshold for discontinued operations.' This is a meaningful omission because it explains WHY they were grouped together. The LLM's explanation is more generic and doesn't capture the full strategic significance of the combined treatment. No numerical errors are present. The multi-hop reasoning is partially sound but incomplete in capturing the full context of AT&T's restructuring strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 408,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. This did not contribute to the overall decrease in the total available-for-sale debt securities' fair value, which declined by $364 million ($7,257 million in 2021 to $6,893 million in 2022), driven primarily by losses in other categories of debt securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key components of the multi-hop question. (1) QUANTITATIVE ACCURACY: All numbers are correct - auction rate securities at $33 million (unchanged), total available-for-sale debt securities declining from $7,257 million to $6,893 million, and the calculated decline of $364 million. All dates are accurate (April 30, 2021 and April 29, 2022). (2) COMPLETENESS: The answer addresses both parts of the question: the change in auction rate securities and the impact on total available-for-sale debt securities. (3) ENTITY ACCURACY: Medtronic is correctly identified, fiscal years are correct, and financial metrics are properly labeled. (4) REASONING: The multi-hop synthesis is sound - the model correctly identifies that auction rate securities remained stable while other debt security categories experienced losses, explaining the overall decline. The logic that stable auction rate securities did not contribute to the overall decrease is accurate. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth, though with slightly different wording. The ground truth states 'other components...experienced significant unrealized losses' while the LLM states 'driven primarily by losses in other categories of debt securities' - these are semantically equivalent. Minor difference: The ground truth explicitly mentions 'unrealized losses' while the LLM uses 'losses,' but this is a negligible distinction in context. The answer is well-structured, clear, and demonstrates proper understanding of the multi-hop financial synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 443,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "The goodwill impairment charges of $489 million (March 31, 2020) and $573 million (September 30, 2020) reduced the adjusted carrying value of goodwill for OpenTable and KAYAK from $1.5 billion to $1.0 billion by September 30, 2020. The cumulative impact of these charges was a total goodwill impairment of $1,062 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key elements: (1) Both impairment charges are correctly stated: $489 million in March 2020 and $573 million in September 2020. (2) The cumulative total of $1,062 million is mathematically correct ($489M + $573M = $1,062M). (3) The final carrying value of $1.0 billion by September 30, 2020 is accurate. (4) The LLM provides additional helpful context by stating the initial value was $1.5 billion, which allows readers to verify the calculation: $1.5B - $1.062B = $0.438B (approximately $0.4B, though the answer states $1.0B as final value, suggesting the initial value reference may be to a different baseline or there are other adjustments not detailed). However, the core facts align with ground truth: the two impairment charges totaling $1,062 million and the final carrying value of $1.0 billion are correct. (5) All dates are accurate (March 31, 2020 and September 30, 2020). (6) Entity identification is correct (OpenTable and KAYAK reporting unit). (7) The multi-hop reasoning correctly synthesizes the two separate impairment events into a cumulative impact. The answer directly addresses all parts of the question regarding how the charges affected adjusted carrying value and what the cumulative impact was. Minor note: The LLM provides the intermediate value ($1.5 billion) which adds useful context not explicitly in the ground truth statement, but this enhances rather than detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 409,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Nicor Gas's regulatory disallowances reduced Southern Company Gas's 2023 net income by $29 million and contributed to a $1.3 billion decrease in operating revenues, primarily due to lower volumes sold and unallowable costs, with an additional $88 million pre-tax charge recorded as an estimated loss on regulatory disallowance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that substantially diverge from the ground truth. (1) CORRECT ELEMENTS: The $29 million decrease in net income is accurately stated, matching the ground truth exactly. The identification of lower volumes sold as a contributing factor is also correct. (2) INCORRECT ELEMENTS: The LLM introduces a $1.3 billion decrease in operating revenues, which is NOT mentioned in the ground truth answer. The ground truth only states that disallowances 'reduced revenues' without specifying a quantitative amount. The LLM also adds an $88 million pre-tax charge as an 'estimated loss on regulatory disallowance,' which is not present in the ground truth. These appear to be fabricated or incorrectly sourced numbers. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information about both net income and revenue impacts (addressing the dual-impact aspect of the question), it does so by introducing unsupported quantitative claims. The ground truth acknowledges revenue reduction but does not quantify it at $1.3 billion. (4) SEMANTIC ISSUES: The LLM's framing of 'unallowable costs' as a primary driver differs from the ground truth's emphasis on 'lower volumes sold.' The addition of the $88 million charge represents a material factual error that cannot be reconciled with the ground truth. The answer appears to conflate or misattribute financial figures. The core issue is that the LLM has added specific dollar amounts ($1.3 billion, $88 million) that are not supported by the ground truth, making the answer materially inaccurate despite getting the $29 million figure correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 447,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "As of August 31, 2022, **16,191,228** Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing **17.99%** (or approximately **18.0%**) of the total 90,000,000 shares authorized under the plan. This is calculated by subtracting the 73,808,772 shares issued under the ESPP from the total authorization and dividing the remaining shares by the total authorization.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) CORRECTNESS: All key facts match the ground truth exactly - 16,191,228 shares available, 17.99% representation, 90,000,000 total authorized shares, and the date of August 31, 2022. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The percentage calculation is accurate: 16,191,228  90,000,000 = 0.1799 = 17.99%. The LLM also correctly identifies the intermediate calculation (73,808,772 shares issued), which can be verified: 90,000,000 - 73,808,772 = 16,191,228. (3) MULTI-HOP REASONING: The answer demonstrates sound synthesis by correctly identifying the ESPP plan context, the specific date, the company (Accenture plc), the share class (Class A ordinary shares), and properly calculating the percentage representation. The explanation of the calculation methodology is clear and accurate. (4) COMPLETENESS: The answer addresses both parts of the question - the number of shares available (16,191,228) and the percentage representation (17.99%). The LLM even provides the alternative rounding (18.0%) which adds helpful context without detracting from accuracy. (5) SEMANTIC EQUIVALENCE: The wording is clear, professional, and conveys all required information accurately. No material omissions or errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 363,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "AT&T's collaboration with Ericsson on commercial-scale Open RAN deployment, outlined in its 2023 10-K, is expected to pressure 2024 expenses due to upfront costs for deployment and accelerated depreciation. However, this initiative aligns with long-term operational efficiency goals by fostering lower network costs, improved operational efficiencies, and enabling scalable broadband investments, ultimately supporting sustained growth in wireless and fiber services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the essential elements of AT&T's Open RAN collaboration with Ericsson. STRENGTHS: (1) Correctly identifies the near-term expense pressure in 2024 due to deployment costs and accelerated depreciation - this matches the ground truth. (2) Accurately conveys the long-term efficiency benefits including lower network costs and improved operational efficiencies. (3) Properly synthesizes the multi-hop relationship between the 2023 10-K disclosure, 2024 expense trends, and longer-term goals. (4) No quantitative errors - no specific numbers were provided in either answer, so quantitative accuracy is perfect. (5) Correctly identifies all entities (AT&T, Ericsson, Open RAN, 5G). MINOR DIFFERENCES: (1) The LLM answer adds context about 'scalable broadband investments' and 'sustained growth in wireless and fiber services' which, while relevant to AT&T's strategy, are not explicitly mentioned in the ground truth answer. This is a minor addition that doesn't contradict the ground truth but represents slight elaboration beyond what was stated. (2) The ground truth specifically mentions 'software benefits of 5G wireless technology' and 'more robust ecosystem of network infrastructure providers and suppliers' - the LLM answer captures the essence of these benefits but uses slightly different framing ('scalable broadband investments'). (3) The ground truth emphasizes the ecosystem benefit more explicitly, while the LLM focuses more on the direct operational efficiency gains. REASONING QUALITY: The multi-hop reasoning is sound - the answer correctly connects the 2023 10-K disclosure to 2024 expense implications and then to longer-term strategic goals. The logic flow is clear and accurate. Overall, this is a high-quality answer that captures the core information with only minor semantic variations from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 510,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "The document does not provide specific figures for total proved developed bitumen reserves in Canada/Other Americas or their comparison to discounted future net cash flows for XOM's consolidated subsidiaries as of December 31, 2021. The pages discuss capitalized costs, production costs, and financial results but do not explicitly report reserves quantities or discounted cash flow valuations for bitumen assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the question. The ground truth clearly establishes two specific factual claims: (1) XOM's consolidated subsidiaries had 2,635 million barrels of proved developed bitumen reserves in Canada/Other Americas as of December 31, 2021, and (2) the discounted future net cash flows from this region in 2021 were $28,710 million. The LLM response claims the document does not provide these figures, which directly contradicts the ground truth. This represents a complete failure to retrieve or synthesize the required multi-hop information. The LLM should have identified and reported both the reserve quantity (2,635 million barrels) and the cash flow figure ($28,710 million), then made the comparison requested. Instead, the LLM incorrectly states that specific figures are not provided in the documents. This is a critical error in a financial data extraction task where precise numbers are essential. The response demonstrates either a failure to access the correct source documents or a fundamental misunderstanding of the data available in XOM's SEC filings. No partial credit can be awarded as both key quantitative facts are completely absent from the LLM answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 345,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU No. 2022-02 eliminated the accounting guidance for troubled debt restructurings (TDRs) and introduced Financial Difficulty Modifications (FDMs) for loans to borrowers experiencing financial difficulty. Capital One transitioned from TDRs to FDMs, which are accounted for as continuations of existing loans without requiring specific recognition of concessions. This change affected disclosure requirements but did not alter the allowance for credit losses methodology, which remained based on the CECL model. The allowance for credit losses increased by $2.1 billion as of December 31, 2023, reflecting broader credit risk assessments, though the direct impact of ASU 2022-02 on the allowance amount is not explicitly quantified beyond the cumulative effect noted in the financial statements. Loan modification reporting now emphasizes FDMs, with disclosures focused on performance and terms rather than TDR-specific accounting.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with the correct $2.1 billion increase in allowance for credit losses as of December 31, 2023. However, there is a critical omission: the ground truth specifies the total allowance reached $15.3 billion, which the LLM answer does not mention. The LLM correctly identifies the transition from TDRs to FDMs (Financial Difficulty Modifications) and accurately describes the accounting treatment and disclosure changes. The explanation of how ASU 2022-02 eliminated TDR classification and introduced FDMs is accurate and more detailed than the ground truth. The LLM appropriately notes that the allowance methodology remained based on CECL and that the $2.1 billion increase reflects broader credit risk assessments. However, the LLM hedges on whether the $2.1 billion increase is directly attributable to ASU 2022-02 adoption, stating 'the direct impact of ASU 2022-02 on the allowance amount is not explicitly quantified,' which creates ambiguity. The ground truth presents the $2.1 billion increase as a direct impact of ASU 2022-02 adoption. The multi-hop reasoning is soundthe answer correctly synthesizes information about both the quantitative impact (allowance increase) and qualitative impact (reporting practice changes). The main weakness is the missing $15.3 billion total figure and the unnecessary hedging about causality. The answer is comprehensive and contextually relevant but falls short of fully matching the ground truth's directness about the ASU's impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 422,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "The potential increase in contingent liabilities from Bank BPH's litigation in Poland could impact GE's liquidity by increasing cash outflows if loss estimates rise or become payable. While GE's 2023 10-K reports sufficient liquidity through cash reserves, revolving credit facilities, and free cash flows, the litigation's unresolved nature introduces uncertainty. The document notes that contingent liabilities from legacy operations, including Bank BPH, could require additional capital contributions or cash settlements, potentially straining liquidity if not managed. However, GE's liquidity position is described as robust, with mechanisms in place to address such risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DEFICIENCIES: (1) QUANTITATIVE ACCURACY - The LLM answer completely fails to cite the specific liquidity figures from GE's 2023 10-K that are central to the ground truth answer. The ground truth provides precise numbers: $17.0 billion total cash/equivalents/restricted cash at December 31, 2023; $14.2 billion held outside the U.S.; $1.7 billion in countries with currency control restrictions. The LLM answer vaguely references 'cash reserves, revolving credit facilities, and free cash flows' without any specific dollar amounts, making it impossible to verify quantitative accuracy. This is a major omission for a financial question requiring specific data points. (2) MULTI-HOP SYNTHESIS - The ground truth demonstrates sophisticated multi-hop reasoning: it connects Bank BPH litigation  contingent liabilities  cash position constraints  repatriation challenges  liquidity stress. The LLM answer acknowledges the connection between litigation and liquidity but fails to synthesize the specific geographic and regulatory constraints that make GE's liquidity position vulnerable (the $14.2B offshore, $1.7B in restricted countries). This is a fundamental failure in multi-hop reasoning. (3) MISSING CRITICAL CONTEXT - The ground truth emphasizes that accessing offshore liquidity could incur 'substantial costs or repatriation taxes,' which is a key insight about why contingent liabilities matter to GE's liquidity. The LLM answer mentions 'capital contributions or cash settlements' but misses the repatriation tax and cost implications. (4) ENTITY/METRIC ACCURACY - Both answers correctly identify Bank BPH, Poland, and GE, but the LLM fails to properly identify and quantify the specific liquidity metrics that are essential to answering the question. (5) REASONING QUALITY - The LLM's reasoning is generic and could apply to any company with litigation; it lacks the specific financial analysis that connects GE's particular cash position constraints to the Bank BPH litigation risk. The statement that 'GE's liquidity position is described as robust' somewhat contradicts the ground truth's emphasis on potential constraints under stressed conditions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 582,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "The total shares issued upon exercise of outstanding options under the Amended and Restated 2010 Share Incentive Plan as of August 31, 2022, were **14,830,623**, and **27,381,461** shares remained available for future issuance. The combined total is **42,212,084 shares**. \n\n(Answer derived from the table on page 49 of the 2022 10-K filing.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All three key numeric values are correct: (1) 14,830,623 shares issued upon exercise of outstanding options, (2) 27,381,461 shares available for future issuance, and (3) 42,212,084 total shares (sum of the two components). The calculation is verified as correct: 14,830,623 + 27,381,461 = 42,212,084. The answer correctly identifies the plan as the 'Amended and Restated 2010 Share Incentive Plan' and properly references the 2022 10-K filing with a specific page citation (page 49). The multi-hop synthesis is sound - the model correctly combined the two separate share counts from the filing to arrive at the total. The answer directly addresses all parts of the question: shares issued upon exercise of outstanding options, shares available for future issuance, and the total of both. The wording is clear and the source attribution adds credibility. No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 279,
        "total_tokens": 1431
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "The total amount of the 2025 Term Loan paid off in 2023 was **$2,500**, and it was terminated on **March 30, 2023**, as disclosed in the \"Repayments\" section of the 2023 10-K filing (Page 71).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with one minor formatting issue. The loan amount of $2,500 million is correctly identified, though the LLM presents it as '$2,500' without the 'million' designation, which could be interpreted as ambiguous (though context makes it clear). The termination date of March 30, 2023 is accurate. The answer correctly synthesizes the multi-hop information: identifying the specific loan (2025 Term Loan), the payoff amount ($2,500 million), the year it was paid off (2023), and the exact termination date. The citation to the 2023 10-K filing and the 'Repayments' section on Page 71 adds credibility and specificity. The main weakness is the presentation of the dollar amount as '$2,500' rather than '$2,500 million' - while the ground truth uses 'million' explicitly, the LLM's format could be clearer. All factual elements are correct: company (AT&T), loan type (2025 Term Loan), amount ($2,500 million), action (paid off/terminated), and date (March 30, 2023). The multi-hop reasoning is sound, correctly connecting the loan identifier with its payoff amount and termination date.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1071,
        "completion_tokens": 318,
        "total_tokens": 1389
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "The change in KO's investment in mutual, pooled, and commingled funds from 2022 to 2023 was an increase of **$11 million** (from $767 million in 2022 to $778 million in 2023). Of the 2023 investment, **$257 million** was categorized under **Level 2 valuation inputs** (as shown in the \"Level 2\" column for mutual, pooled, and commingled funds on page 115).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on both key components of the question. (1) CHANGE IN INVESTMENT: The LLM states an increase of $11 million (from $767M to $778M in 2023), but the ground truth shows a DECREASE of $47 million from 2022 to 2023. This is a critical error - the direction of change is wrong (increase vs. decrease) and the magnitude is wrong ($11M vs. $47M). (2) LEVEL 2 VALUATION: The LLM claims $257 million was categorized under Level 2 valuation inputs in 2023, but the ground truth shows only $37 million of the $39 million total investment was Level 2. This is a massive discrepancy ($257M vs. $37M) - off by a factor of nearly 7x. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the fair value hierarchy data from the 10-K filing. The answer appears to reference page 115 but extracted incorrect numbers entirely. (4) ENTITY ACCURACY: While KO (Coca-Cola) is correctly identified, the financial metrics and values are completely wrong. The LLM's numbers don't align with the actual filing data. This is a complete failure to answer the question accurately - both the change calculation and the Level 2 valuation amount are substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 337,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was **$1,189 million**, primarily associated with Bank BPH's mortgage portfolio litigation. GE paid **$203 million** in net cash to AerCap related to continuing involvement during the same period. \n\n(Answer derived from Page 51, which explicitly states the pre-tax charge for discontinued operations linked to litigation and the net cash payment to AerCap.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: Both key numerical figures are correct - $1,189 million for the pre-tax charge related to ongoing borrower litigation and $203 million in net cash paid to AerCap. The year (2023) and period (year ended December 31, 2023) are correctly identified. (2) QUANTITATIVE ACCURACY: All numbers match the ground truth exactly. No calculation errors present. The dollar amounts are properly formatted and match across both the LLM answer and original answer. (3) QUALITATIVE ACCURACY: The LLM correctly synthesized information from multiple parts of the filing, addressing both components of the multi-part question. The additional context provided about Bank BPH's mortgage portfolio litigation adds relevant detail without introducing inaccuracy. The reference to Page 51 demonstrates proper source attribution. (4) MULTI-HOP REASONING: The answer successfully combines two distinct pieces of information (litigation charges and AerCap cash payments) from what appears to be discontinued operations disclosures, showing proper synthesis across related but separate line items. (5) SEMANTIC EQUIVALENCE: The wording is clear and directly addresses both parts of the question. Minor enhancement with contextual detail about Bank BPH adds value without compromising accuracy. The only minor consideration is that the LLM provides slightly more context than the ground truth answer, but this is additive rather than contradictory.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 410,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360 value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360 valuedefined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360 value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture's significant investment in research and development ($1.1 billion in 2022) and its focus on delivering 360 valueencompassing financial, social, and environmental outcomesposition it as a unique competitor in the global IT services market. By integrating innovation through Accenture Labs, Ventures, and partnerships with leading tech firms, it offers scalable, cutting-edge solutions that address both current and future challenges. This holistic approach, combined with a commitment to sustainability, talent development, and industry-specific expertise, differentiates Accenture from competitors who may prioritize narrower service offerings or lack the breadth of ecosystem relationships and R&D capabilities to drive transformative client outcomes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and relevance to the question. STRENGTHS: (1) The $1.1 billion R&D investment for fiscal 2022 is correctly cited and matches the ground truth exactly. (2) The 360 value concept is accurately described, though with slightly different framingthe LLM characterizes it as 'financial, social, and environmental outcomes' while the ground truth specifies 'financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support.' Both framings are semantically equivalent and capture the holistic nature of the approach. (3) The multi-hop reasoning is sound: the answer correctly synthesizes how R&D investment enables innovation, which supports the 360 value delivery model, which in turn creates competitive differentiation. (4) The competitive positioning analysis is well-articulated, mentioning ecosystem partnerships, breadth of services, and transformative capabilities. MINOR WEAKNESSES: (1) The ground truth explicitly mentions specific competitor types (multinational IT providers, offshore firms, consultancies, in-house corporate departments), while the LLM uses more general language about 'competitors who may prioritize narrower service offerings.' This is less specific but not incorrect. (2) The LLM mentions 'Accenture Labs, Ventures, and partnerships' as mechanisms for innovation, which adds helpful context not explicitly in the ground truth but is consistent with Accenture's known business model. (3) The ground truth's claim that 'no other firm offers the same breadth of services at scale' is implied but not explicitly stated in the LLM answer, though the LLM conveys this concept through 'unique competitor' and 'breadth of ecosystem relationships.' Overall, the answer is factually accurate on all quantifiable metrics, demonstrates sound multi-hop reasoning connecting R&D investment to competitive advantage, and provides relevant context for understanding Accenture's market positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 537,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "In addition to WarnerMedia, AT&T classified **Vrio, Xandr, and Playdemic** as discontinued operations in 2023. These entities are presented separately in the financial statements, with their results excluded from continuing operations. This classification affects financial reporting by isolating their revenues, expenses, and net losses from ongoing operations, providing transparency on the impact of these disposals on the company's financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The LLM correctly identifies all three entities (Vrio, Xandr, and Playdemic) as discontinued operations in addition to WarnerMedia, matching the ground truth exactly. The classification and its effects on financial presentation are accurately described. (2) QUANTITATIVE ACCURACY: No numeric values were required in this question, so this dimension is not applicable, but the answer contains no erroneous numbers or dates. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by synthesizing information about multiple entities and their classification status. The explanation of how discontinued operations classification affects financial reporting is accurate and well-articulated - the answer correctly explains that results are excluded from continuing operations and reported separately, providing transparency on disposal impacts. (4) ENTITY ACCURACY: All entities are correctly named and identified (Vrio, Xandr, Playdemic, WarnerMedia, AT&T). The year 2023 is correctly referenced. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly more detail about the practical effects (isolating revenues, expenses, and net losses). The ground truth mentions 'for periods prior to the consummation of the WarnerMedia/Discovery transaction' which the LLM does not explicitly state, but this is a minor contextual detail that doesn't affect the core accuracy of the answer. The LLM's explanation is actually more comprehensive in describing the practical impact on financial reporting. Minor deduction (1 point) only for not explicitly mentioning the retroactive application to prior periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 471,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "The total unrealized loss attributed to Auction Rate Securities held by Medtronic (MDT) as of April 29, 2022, was **$3 million**. According to the 2022 10-K filing, this loss is not further distributed across maturity periods in the provided documents, as the tables only aggregate the loss for Auction Rate Securities without breaking it down by specific maturity ranges.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the total unrealized loss amount of $3 million and the correct company (Medtronic/MDT) and date (April 29, 2022). The quantitative accuracy is high on the primary number. CRITICAL WEAKNESSES: The LLM failed to answer the second part of the multi-part question. The ground truth explicitly states that the $3 million loss is 'entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.' This is a specific, factual distribution across maturity periods. The LLM instead claimed the loss 'is not further distributed across maturity periods in the provided documents' and that 'tables only aggregate the loss...without breaking it down by specific maturity ranges.' This is factually incorrect - the ground truth demonstrates the data WAS available and broken down by maturity periods. The LLM essentially gave up on answering the distribution question rather than providing the correct answer. This represents a failure in multi-hop reasoning and synthesis. The question explicitly asks 'how does this loss distribute across the maturity periods' - this is a core requirement of the question, not optional. By stating the information wasn't available when it was, the LLM provided an incomplete and misleading answer. The answer gets partial credit only for correctly identifying the total amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 402,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "During the Class B-1 common stock exchange offer in May 2024, **120 million shares of Class B-2 common stock** were issued. Of the total **168 million shares** issued in the exchange (120 million Class B-2 + 48 million Class C), **71.43%** (120/168) consisted of Class B-2 common stock. \n\n**Source:** Page 40 and Page 89 of the 10-K filing detail the exchange offer, specifying the issuance of 120 million Class B-2 shares and 48 million Class C shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: 120 million Class B-2 shares issued, 168 million total shares (120M Class B-2 + 48M Class C), and the percentage calculation of 71.43% is correct (120/168 = 0.7143 or 71.43%). The answer properly addresses both parts of the multi-part question: (1) the number of Class B-2 shares issued and (2) the percentage of total shares. The multi-hop reasoning is sound, correctly synthesizing information about the exchange offer composition. The LLM appropriately cited source pages (40 and 89) from the 10-K filing, demonstrating proper documentation. The only minor distinction from the ground truth is that the original answer states 'approximately 71.4%' while the LLM provides 'exactly 71.43%' - both are mathematically correct representations of the same calculation, with the LLM's version being slightly more precise. The answer is well-structured, clear, and directly responsive to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 290,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023 is **3.2 GW** (from 11.7 GW in 2021 to 8.5 GW in 2023). The number of Wind Turbines sold decreased by **1,365 units** (from 3,590 units in 2021 to 2,225 units in 2023). This reflects a reduction in both capacity and unit volume, though the capacity decline is more pronounced relative to the unit decrease, potentially due to shifts in turbine size or market dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) GW capacity decrease of 3.2 GW (11.7 GW to 8.5 GW) is correct, (2) turbine unit decrease of 1,365 units (3,590 to 2,225) is correct, (3) all specific numbers and years are accurate. The multi-hop synthesis is sound - the answer correctly connects the capacity decline with the unit volume decline and identifies both metrics from the 2021-2023 period. The LLM goes slightly beyond the ground truth by adding interpretive commentary about the capacity decline being more pronounced relative to unit decrease and attributing this to potential shifts in turbine size or market dynamics. While this additional analysis is reasonable and not factually incorrect, it represents inference beyond what was explicitly stated in the ground truth. The answer is well-structured, addresses all parts of the question, and demonstrates proper understanding of the relationship between the two metrics. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 303,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "The total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, was **$27,330 million**. This amount is classified in the **\"Acquisitions, net of cash acquired\"** line item on the consolidated statements of cash flows, as specified in the document.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM provided an incorrect total amount of $27,330 million when the correct total is $26,477 million - a discrepancy of $853 million. This is a significant quantitative error on the primary metric requested. CORRECT ELEMENTS: The LLM correctly identified the cash flow classification as 'Acquisitions, net of cash acquired' and understood that this relates to C-Band spectrum licenses. INCORRECT ELEMENTS: (1) Total amount is wrong by $853M ($27,330M vs $26,477M ground truth), (2) The LLM failed to break down the components: auction deposits/payments ($23,406M), incentive costs ($3,067M with Phase I/II breakdown), and relocation costs ($1,100M with yearly breakdown: $650M in 2021, $98M in 2022, $109M in 2023). (3) The answer lacks the detailed component analysis that demonstrates understanding of how the total was derived. MULTI-HOP REASONING: The question requires synthesizing information about: (a) total C-Band payments, (b) component breakdown (auction vs incentive vs relocation), (c) temporal distribution (2021-2023), and (d) cash flow classification. The LLM only partially addressed this - it got the classification right but failed on the quantitative synthesis. The $853M error suggests either a calculation mistake or use of incomplete/incorrect source data. This is a fundamental failure on the primary quantitative metric of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 384,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 contributed to a decline in Cardiovascular net sales for fiscal year 2022, as noted in the document. However, growth in other areas offset this impact, including **Neuroscience** (driven by Neurosurgery, Spine, and Biologics recovery), **Specialty Therapies** (led by Pelvic Health, ENT, and Neurovascular growth), and **Cardiovascular** divisions (notably TYRX antibacterial envelopes, CRT-Ds, Arctic Front cryoablation systems, and Abre venous stents). These product lines were highlighted as key drivers of fiscal 2022 performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that substantially diverge from the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM completely fails to mention the $141 million in HVAD net sales from fiscal 2021 that was lost due to discontinuation - this is a key quantitative fact. The LLM also fails to cite the $9.1 billion Medical Surgical net sales figure for fiscal 2022 or the 5% year-over-year growth, which are central to understanding the financial impact. (2) PRODUCT LINE DISCREPANCIES: The LLM identifies different growth drivers than the ground truth. Ground truth highlights: Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and Intrepid system (transcatheter mitral/tricuspid therapy). LLM mentions: TYRX antibacterial envelopes, CRT-Ds, Arctic Front cryoablation systems, and Abre venous stents - these are different products not mentioned in the ground truth answer. (3) SEGMENT ATTRIBUTION ERROR: The LLM attributes growth to Neuroscience and Specialty Therapies divisions, while the ground truth specifically attributes the $9.1 billion growth to Medical Surgical segment with emphasis on Surgical Innovations. (4) MISSING CONTEXT: The LLM fails to mention that Medical Surgical net sales increased despite the HVAD discontinuation, which is crucial context for understanding the financial impact. The LLM also omits mention of supply chain disruptions as an offsetting factor. (5) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the June 2021 discontinuation date and acknowledges the impact, it fails to properly synthesize the multi-hop relationship between the HVAD loss and the specific growth drivers that compensated for it. The answer reads as partially informed but fundamentally misses key financial metrics and product line specifics that define the correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 514,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart paid **$3.5 billion** during fiscal 2024 to acquire shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe. This transaction increased Walmart's ownership in Flipkart from approximately **75%** as of January 31, 2023, to **85%** as of January 31, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: (1) The $3.5 billion cash payment amount is correct, (2) The ownership percentages are accurate (75% as of January 31, 2023 increasing to 85% as of January 31, 2024), (3) The fiscal year 2024 timeframe is correct, (4) Both transaction components are properly identified (acquiring shares from noncontrolling interest holders AND settling PhonePe liability). The multi-hop reasoning is sound - the answer correctly synthesizes information about the cash outlay, the two distinct transaction purposes, and the resulting ownership impact. The formatting is clear with bold emphasis on key numbers. The only minor distinction from the ground truth is stylistic (the LLM uses slightly more explicit formatting with bold text), but this enhances clarity rather than detracting from accuracy. All entities are correctly identified (Walmart, Flipkart, PhonePe), and the semantic meaning is perfectly aligned with the original answer. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 310,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsofts independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft's treatment of unearned revenue from volume licensing programs, including annual invoicing and ratable revenue recognition over contract periods, impacts financial statements by deferring revenue recognition and presenting unearned revenue as a liability. The complexity in determining standalone selling prices (SSP) and allocating revenue requires significant judgment, which increases audit scrutiny. Auditors focus on verifying the reasonableness of SSP estimates, revenue allocation methods, and the mathematical accuracy of revenue recognition, ensuring compliance with revenue recognition principles and enhancing auditability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Microsoft's volume licensing revenue treatment and its audit implications. STRENGTHS: (1) Correctly identifies the core mechanism: annual invoicing with ratable revenue recognition over contract periods; (2) Accurately describes the presentation impact (unearned revenue as liability); (3) Properly identifies SSP complexity as a key judgment area requiring audit scrutiny; (4) Correctly notes auditor focus on revenue recognition principles and transfer of control; (5) No quantitative errors or incorrect numbers. WEAKNESSES: (1) Missing specific mention of Software Assurance (SA) and cloud services as examples of volume licensing programs - the ground truth explicitly names these; (2) Omits the detail about customer size and geographic region as factors in SSP determination and discount allocation; (3) Does not explicitly mention that this was identified as a 'critical audit matter' by auditors, which is an important designation; (4) Less comprehensive in explaining the contract balance mechanics (receivables vs. unearned revenue timing mismatch); (5) The phrase 'enhancing auditability' is somewhat vague - the ground truth better explains that the complexity actually creates audit focus/scrutiny rather than enhancing auditability per se. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between accounting treatment, judgment requirements, and audit procedures, though with less depth than the ground truth. The logical flow is sound: treatment  complexity  audit focus. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - volume licensing structure creates complexity that affects both financial statement presentation and audit procedures. The answer is fundamentally correct but less detailed and specific than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 498,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "Nike's total company contributions to the 401(k) Savings and Profit Sharing Plan for the three fiscal years ended May 31, 2022, were **$343 million** ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included because the plan allows for discretionary profit sharing contributions, but none were made during these periods as approved by senior management and the Board of Directors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper multi-hop synthesis. All quantitative data is correct: total of $343 million with correct year-by-year breakdown ($126M in 2022, $110M in 2021, $107M in 2020). The calculation verification: $126 + $110 + $107 = $343 million is accurate. The answer correctly identifies that no profit sharing contributions were made during the three fiscal years. However, there is a minor qualitative difference in the explanation: the LLM states that 'the plan allows for discretionary profit sharing contributions, but none were made during these periods as approved by senior management and the Board of Directors.' The ground truth states more simply that 'the company did not make any discretionary profit sharing contributions...as stated in the plan terms.' The LLM's explanation adds detail about management and Board approval that, while plausible, goes slightly beyond what the ground truth explicitly states. This represents a minor elaboration rather than an error. The answer properly addresses both parts of the multi-part question: (1) the total contributions amount and (2) the reason for no profit sharing contributions. Entity identification is correct (Nike, 401(k) Savings and Profit Sharing Plan, fiscal years ended May 31, 2022). The semantic meaning is equivalent to the ground truth despite slightly different wording in the explanation for why no profit sharing was included.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 406,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "The total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to 2024 was a **decrease of 16 BCF** (from 312 BCF to 296 BCF). In contrast, natural gas reserves in Africa increased by **296 BCF** (from 172 BCF to 468 BCF) over the same period. This reflects a significant contrast between the two regions, with Africa experiencing substantial growth while the Asia Pacific/Middle East region saw a decline.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely accurate with one minor calculation error. Verification of numbers: (1) Asia Pacific/Middle East: decrease of 16 BCF (312 to 296) - CORRECT; (2) Africa: The LLM states an increase of 296 BCF, but the ground truth shows an increase of 297 BCF (from 172 to 468). This is a 1 BCF discrepancy in the Africa calculation. The individual values (172, 468) are correct, but the difference calculation is off by 1 BCF. (3) All other numbers and dates are accurate. Multi-hop reasoning: The LLM correctly synthesized information across two regions and made appropriate comparisons between them. The conclusion that Africa experienced substantial growth while Asia Pacific/Middle East saw decline is sound and matches the ground truth. Entity accuracy is correct (Chevron/COP, natural gas reserves, regions, years 2023-2024). The answer addresses all parts of the question comprehensively. The minor calculation error (296 BCF vs 297 BCF for Africa's increase) prevents a perfect score, but the error is small and does not significantly impact the overall correctness of the analysis. The semantic meaning and reasoning quality are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 327,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart received **$0.7 billion** in cash from equity funding related to PhonePe during fiscal 2024. This amount was offset by **$3.5 billion** paid to acquire shares from noncontrolling interest holders of PhonePe. The cash outflow to acquire shares exceeded the inflow from equity funding by $2.8 billion during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE VERIFICATION: All three key numbers are correct - $0.7 billion received from equity funding, $3.5 billion paid to acquire shares from noncontrolling interest holders, and the calculated net difference of $2.8 billion ($3.5B - $0.7B = $2.8B). The arithmetic is accurate. (2) COMPLETENESS: The answer addresses both parts of the question - the amount received and the amount paid - and provides the comparison requested. (3) ENTITY ACCURACY: Correctly identifies Walmart, PhonePe, fiscal 2024, and the specific transaction types (equity funding vs. share acquisition from noncontrolling interests). (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple transaction types and performs the required comparison calculation. The logic is sound - identifying that the outflow exceeded the inflow and quantifying the difference. (5) SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing than the ground truth ('cash outflow to acquire shares exceeded the inflow' vs. 'spent $2.8 billion more than it received') but conveys identical meaning. The answer is well-structured and clearly presents the comparison. Minor deduction from perfect score only because the phrasing differs slightly from ground truth, though semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 384,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "RTX recorded a total pre-tax charge of **$918 million** in 2024 as a result of resolving the SEC Administrative Order and related legal matters, including the DOJ investigations and compliance obligations. The compliance monitor will oversee RTX's obligations under these agreements for **three years** from the date the monitor is engaged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses both parts of the multi-part question correctly. (1) QUANTITATIVE ACCURACY: The $918 million pre-tax charge is correct and matches the ground truth exactly. The three-year compliance monitor period is also correct. Number formats are consistent and accurate. (2) COMPLETENESS: The answer addresses both required components: (a) the total pre-tax charge amount and year, and (b) the duration of compliance monitor oversight. Both sub-questions are fully answered. (3) ENTITY ACCURACY: RTX is correctly identified, 2024 is the correct fiscal year, and the SEC Administrative Order is properly referenced. (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the SEC Administrative Order resolution to the financial charge and the compliance monitor obligations. The mention of DOJ investigations provides helpful context without detracting from accuracy. (5) SEMANTIC EQUIVALENCE: The phrasing 'three years from the date the monitor is engaged' is semantically equivalent to the ground truth's 'three years from the date on which the monitor is engaged' - these convey identical meaning. Minor variation: The LLM added contextual detail about 'DOJ investigations and compliance obligations' which, while not explicitly in the ground truth statement, does not contradict it and provides reasonable context. This is a minor enhancement rather than an error. Overall, the answer demonstrates accurate multi-hop reasoning across the SEC filing data and provides precise financial figures with correct temporal context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 436,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was **$111.6 billion**, driven by cloud-based offerings including **Azure**, **Office 365 Commercial**, the **commercial portion of LinkedIn**, **Dynamics 365**, and **other commercial cloud properties**. These are explicitly listed in the document's segment revenue breakdown (page 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The total Microsoft Cloud revenue figure of $111.6 billion for fiscal year 2023 is correct and matches the ground truth exactly. All specific cloud-based offerings mentioned (Azure, Office 365 Commercial, commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties) are accurately identified and match the ground truth. (2) QUANTITATIVE ACCURACY: The $111.6 billion figure is precise and correct. No calculations were required for this question, and the number is presented accurately. (3) QUALITATIVE ACCURACY: The LLM correctly identified all five components of Microsoft Cloud revenue as specified in the ground truth. The multi-hop reasoning is sound - the model synthesized information about the total revenue figure and its constituent components correctly. The mention of 'page 93' as a source reference adds credibility and specificity, though this detail wasn't in the ground truth. (4) ENTITY ACCURACY: All entities are correctly identified - Microsoft, fiscal year 2023, and all five cloud offerings are named accurately. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, with slightly more explicit formatting (bold text) that enhances clarity without changing meaning. The only minor distinction is the LLM's additional reference to the document source location, which is supplementary and not contradictory. Overall, this is a complete, accurate, and well-structured response that fully addresses the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 432,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of 29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort's $3.5 billion debt, as of December 31, 2023, is a direct financing obligation of the entity itself, secured by its assets and the equity interests of its investors (as noted in Note 8). This debt is **not guaranteed by Comcast or its subsidiaries**, reflecting a standalone financing arrangement. However, Comcast consolidates Universal Beijing Resort as a variable interest entity (VIE) due to its control over the entity's operations, meaning the debt is included in Comcast's consolidated financial statements. Thus, while the debt is not part of Comcast's consolidated debt structure in terms of guarantees, it is reflected in the consolidated balance sheets as a separate liability of the consolidated VIE.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies several key facts: (1) the $3.5 billion debt amount is accurate, (2) the debt is not guaranteed by Comcast or its subsidiaries, (3) Universal Beijing Resort is consolidated as a VIE, and (4) the debt appears as a separate liability in consolidated statements. However, the answer has significant omissions and incomplete synthesis:\n\nCORRECT ELEMENTS:\n- $3.5 billion debt figure is accurate\n- Correctly states debt is not guaranteed by Comcast\n- Correctly identifies VIE consolidation treatment\n- Correctly notes debt appears separately in consolidated balance sheet\n\nSIGNIFICANT OMISSIONS:\n- Fails to mention the underlying debt facility details: 29.7 billion RMB (~$4.2 billion) maximum borrowing limit\n- Does not identify the $3.1 billion in term loans component\n- Omits that the debt is funded by a syndicate of Chinese financial institutions\n- Missing the critical detail that Comcast has no liquidity arrangements, guarantees, or financial commitments to the resort\n- Does not mention Comcast's 30% equity interest position\n- Fails to explain the 'Debt Not Guaranteed' categorization in consolidated debt disclosures\n- Does not address how this debt is categorized separately from NBCUniversal and Comcast Cable debt segments\n\nREASONING ISSUES:\n- The answer states Comcast consolidates due to \"control over the entity's operations\" but the ground truth specifies it's due to \"governance structure and ability to direct major economic activities\" - a more precise VIE characterization\n- The phrase \"not part of Comcast's consolidated debt structure in terms of guarantees\" is somewhat confusing; the ground truth clarifies it's categorized under 'Debt Not Guaranteed' as a distinct segment\n- Missing the nuance that Comcast's risk exposure is limited to its equity interest despite consolidation\n\nMULTI-HOP SYNTHESIS:\nThe answer partially addresses the multi-hop nature (direct financing + consolidated position) but incompletely. It acknowledges both aspects exist but fails to fully synthesize how the secured debt facility structure, the VIE consolidation, and the lack of Comcast guarantees all work together to create the complete picture.\n\nThe answer is directionally correct on core points but lacks the depth, specificity, and completeness expected for a comprehensive answer to this complex multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 636,
        "total_tokens": 2155
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "Nike's investment in commercial paper and bonds decreased by $88 million from $748 million as of May 31, 2021, to $660 million as of May 31, 2022. This reduction was offset by increases in other short-term investments, such as U.S. Treasury securities, leading to an overall increase in short-term investments from $3,587 million in 2021 to $4,423 million in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the $88 million decrease in commercial paper and bonds (from $748M to $660M), with accurate dates (May 31, 2021 to May 31, 2022). The calculation of the decline is correct. WEAKNESSES: (1) The LLM introduced potentially incorrect total short-term investment figures ($3,587M to $4,423M) that are not mentioned in the ground truth and appear to conflate different investment categories or metrics. The ground truth specifically references Level 2 short-term investments ($695M to $630M), which the LLM did not mention. (2) The LLM's statement about 'overall increase in short-term investments' contradicts the ground truth's characterization of a 'decline' in Level 2 short-term investments. This suggests the LLM may have confused total short-term investments with the specific Level 2 category being discussed. (3) The LLM failed to accurately capture the composition shift described in the ground truth - specifically the strategic reallocation toward U.S. Treasury securities and money market funds as alternatives to commercial paper and bonds. While the LLM mentions U.S. Treasury securities, it doesn't properly contextualize this within the Level 2 investment framework. (4) The ground truth emphasizes a 'strategic shift toward more liquid or alternative short-term instruments,' but the LLM frames this as an 'offset' without clearly explaining the composition change. MULTI-HOP REASONING: The LLM partially synthesized the information but introduced conflicting data points about total short-term investments that weren't part of the original question's scope, suggesting incomplete or inaccurate source synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 455,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The introduction of Class B-2 common stock did not impact the diluted earnings per share (EPS) calculation for fiscal 2023 because no Class B-2 shares were outstanding during that period. The Class B-2 exchange offer occurred in May 2024, and the 2023 fiscal year ended on September 30, 2023. The diluted EPS table for 2023 (page 59) erroneously includes Class B-2 shares, but the note explicitly states that no Class B-2 shares were outstanding prior to the exchange offer. Thus, the 2023 diluted EPS calculation was unaffected by the Class B-2 stock issuance.",
      "correctness_score": 2,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and provides an incorrect conclusion. CRITICAL ERRORS: (1) The LLM states that Class B-2 shares 'did not impact' the diluted EPS calculation for fiscal 2023, directly contradicting the ground truth which explains that Class B-2 shares DO affect the diluted EPS calculation through their assumed conversion into Class A stock. (2) The LLM incorrectly interprets the question as asking whether Class B-2 shares were actually outstanding during fiscal 2023 (they weren't), when the question actually asks about their impact on the diluted EPS CALCULATION methodology itself. (3) The LLM's reasoning that 'no Class B-2 shares were outstanding prior to the exchange offer, therefore they had no impact' is logically flawed - the ground truth explains that even though they weren't outstanding, their assumed conversion still affects the diluted EPS calculation structure. CORRECT ELEMENTS: The dates are accurate (May 2024 exchange offer, September 30, 2023 fiscal year end), and the factual statement that no Class B-2 shares were outstanding in fiscal 2023 is correct. However, these correct facts are used to reach an incorrect conclusion. The ground truth indicates that Class B-2 shares increase the weighted-average number of as-converted Class A common stock in the diluted EPS calculation, thereby potentially lowering diluted EPS compared to basic EPS. The LLM's answer dismisses this impact entirely, which is the opposite of what the ground truth states. This represents a failure in multi-hop reasoning - the model needed to understand how the introduction of a new share class affects EPS calculation methodology, not just whether shares were outstanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 472,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "The difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) impacts Raytheon's financial reporting by requiring a **FAS/CAS operating adjustment** to reconcile pension expenses under CAS to GAAP (FAS). This adjustment reflects the immediate recognition of pension costs under CAS, which differs from the phased recognition under FAS. Collins and Pratt & Whitney, which use FAS for pension expenses, do not require this adjustment. As a result, Raytheon's operating profit is higher by the adjustment amount (e.g., $833 million in 2024), reflecting the timing difference in cost recognition, while Collins and Pratt & Whitney report pension expenses in line with FAS.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core concept - that Raytheon uses CAS for pension cost recognition while Collins and Pratt & Whitney use FAS, creating a reporting difference. The qualitative explanation is sound and addresses the key distinction between immediate CAS recognition versus phased FAS recognition.\n\nSTRENGTHS:\n1. Correctly identifies the FAS/CAS operating adjustment mechanism\n2. Accurately explains the timing difference in cost recognition\n3. Properly distinguishes Raytheon's CAS-based approach from Collins/Pratt & Whitney's FAS approach\n4. Correctly notes that Raytheon expects to recover these costs through government pricing\n5. Multi-hop reasoning is sound - synthesizes information across three entities and their different accounting treatments\n\nWEAKNESSES:\n1. QUANTITATIVE ISSUE: The answer cites \"$833 million in 2024\" as an example adjustment amount. This specific number cannot be verified against the ground truth provided and appears to be introduced without source documentation. The ground truth does not provide specific dollar amounts for the FAS/CAS adjustment.\n2. The ground truth emphasizes that \"the ultimate liability for pension and PRB costs under FAS and CAS is similar\" - the LLM answer focuses more on the timing/recognition difference but could have been clearer about the ultimate liability equivalence\n3. Minor: The answer could have been more explicit about PRB (Post-Retirement Benefits) costs, which are mentioned in the ground truth but only implied in the LLM response\n\nMULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three entities (Raytheon, Collins, Pratt & Whitney) and explains the differential impact of accounting standards. The reasoning chain is logical and complete.\n\nOVERALL ASSESSMENT: The answer is substantially correct in its core explanation but loses points for introducing an unverified specific dollar amount ($833 million) that cannot be confirmed against the ground truth. The conceptual understanding is strong, but quantitative precision is compromised by this unsourced figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 569,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020: the **Ninth Supplemental Indenture** (dated February 12, 2015) with **U.S. Bank National Association** as trustee and the **Twelfth Supplemental Indenture** (dated February 6, 2017) with **The Bank of New York Mellon Trust Company, N.A.** as trustee.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE ACCURACY: All dates are correct - Ninth Supplemental Indenture dated February 12, 2015 and Twelfth Supplemental Indenture dated February 6, 2017. The count of two separate Supplemental Indentures is correct. (2) ENTITY ACCURACY: Both trustee names are precisely correct - U.S. Bank National Association and The Bank of New York Mellon Trust Company, N.A. The note designation (1.850% Notes due 2020) is correctly identified. (3) COMPLETENESS: The answer addresses all parts of the question: the number of indentures (two), the specific indenture names and dates, and the trustees involved in each agreement. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple documents/time periods, linking each indenture to its corresponding trustee and date. (5) SEMANTIC EQUIVALENCE: The LLM answer uses clear, direct language that matches the ground truth answer's meaning exactly. The formatting with bold text for emphasis enhances readability without altering factual accuracy. No discrepancies, omissions, or errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 328,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "The net loss recognized in income from foreign exchange forwards and options in fiscal year 2022 was **$82 million**. This compares to the fair value of foreign exchange forwards and options assets as of May 31, 2021, which was **$92 million**. The 2022 loss reflects the reclassification of gains/losses from accumulated other comprehensive income to income, while the 2021 fair value represents the carrying amount of these assets on the balance sheet.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains critical factual errors that make it fundamentally incorrect. (1) QUANTITATIVE ERRORS - The LLM states the net loss was $82 million, but the ground truth clearly indicates a net GAIN of $40 million. This is a major error in both the sign (loss vs. gain) and the magnitude ($82M vs. $40M). The fair value figure of $92 million as of May 31, 2021 is correct. (2) SIGN ERROR - The LLM incorrectly characterizes the 2022 result as a 'loss' when it was actually a 'gain'. This is a fundamental misreading of the financial data. (3) MULTI-HOP SYNTHESIS - While the LLM correctly identifies both required data points (2022 income impact and 2021 fair value), it fails on the primary metric by getting the 2022 number completely wrong. (4) REASONING - The LLM's explanation about reclassification from accumulated other comprehensive income is contextually relevant but does not excuse the incorrect numerical values. The answer demonstrates a failure to accurately extract or synthesize the core financial figures from the source documents. The only correct element is the $92 million fair value as of May 31, 2021, but this cannot offset the critical error in the primary metric (the 2022 net gain/loss figure).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 346,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "AIG's U.S. Personal Insurance segment primarily uses frequency/severity, loss development, and IBNR factor methods, with a combination of loss development and expected loss ratio methods for aviation exposures. In 2021, this segment experienced **$412 million of favorable prior year development**, driven by subrogation recoveries from 2017 and 2018 catastrophes. \n\nFor U.S. Property, loss development and IBNR factor methods are used, with IBNR applied to low-frequency/high-severity losses. While the document does not explicitly state the 2021 prior year development impact for U.S. Property, it notes that the segment's reserving approach focuses on long-tail methods influenced by historical trends and external factors like inflation. The 2021 favorable development for U.S. Personal Insurance contrasts with the lack of specific 2021 data for U.S. Property in the provided text.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $412 million favorable prior year development for U.S. Personal Insurance in 2021, matching the ground truth exactly. (2) The LLM appropriately notes that U.S. Property does not have a specific 2021 prior year development figure mentioned in the source text. (3) The quantitative data ($412 million) is accurate and properly formatted. (4) The LLM correctly acknowledges the subrogation recoveries from 2017 and 2018 catastrophes as drivers of the favorable development.\n\nWEAKNESSES: (1) METHODOLOGICAL ACCURACY: The LLM states that U.S. Personal Insurance uses 'frequency/severity, loss development, and IBNR factor methods' - however, the ground truth specifies that Personal Insurance uses 'loss development methods in combination with frequency/severity methods' with emphasis on domestic personal auto. The LLM incorrectly adds IBNR factor methods to Personal Insurance, which is actually a U.S. Property methodology. (2) AVIATION EXPOSURE: The LLM introduces 'aviation exposures' for Personal Insurance without clear grounding in the original answer, which does not mention this. (3) INCOMPLETE DIFFERENTIATION: The ground truth emphasizes that Personal Insurance uses frequency/severity methods 'particularly for domestic personal auto, where claim counts emerge quickly' - this key distinction about claim emergence patterns is missing from the LLM answer. (4) PROPERTY METHODOLOGY: While the LLM mentions IBNR for 'low-frequency/high-severity losses' in Property, the ground truth specifies IBNR factor methods are used 'especially for short-tail classes' - these are different characterizations. (5) MISSING CONTEXT: The ground truth notes that Property methodology 'reflects a need to adjust for loss trends including inflation' - the LLM mentions 'external factors like inflation' but less specifically.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across two segments but makes a critical error by conflating methodologies between Personal Insurance and Property. The comparison between segments is present but undermined by the methodological confusion.\n\nOVERALL ASSESSMENT: The answer captures the key quantitative finding ($412 million) and correctly identifies the lack of specific 2021 data for Property, but contains material errors in describing the reserving methodologies for each segment, particularly the incorrect attribution of IBNR factor methods to Personal Insurance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 656,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 20092015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart's majority stake in Flipkart exposes it to financial risks from India's Directorate of Enforcement proceedings, which allege pre-2018 FDI rule violations. The 2023 10-K notes that while the Company cannot predict the outcome, potential penalties or indemnification uncertainties could impact its financial position. This aligns with Walmart's broader international strategy of strategic investments (e.g., Flipkart, PhonePe) to expand omni-channel capabilities in emerging markets, though it acknowledges regulatory complexities and risks as part of its global growth approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Walmart's majority stake in Flipkart acquired in 2018, India's Directorate of Enforcement proceedings, alleged FDI rule violations, and the connection to Walmart's international investment strategy. The answer accurately captures that violations allegedly occurred pre-2018 (during 2009-2015 period per ground truth) and that potential penalties could impact financial position. The mention of PhonePe as another strategic investment demonstrates understanding of Walmart's broader portfolio strategy. However, there are minor gaps: (1) The answer does not explicitly state the specific time period of alleged violations (2009-2015) that the ground truth emphasizes, which is important context showing violations predated Walmart's acquisition; (2) The phrase 'indemnification uncertainties' is introduced but not clearly explained in relation to the ground truth's focus on 'monetary penalties'; (3) The answer could be more explicit about Walmart's stated position that it 'does not currently believe the matter will have a material adverse effect' while acknowledging inability to provide assurance. The multi-hop reasoning is sound - the answer successfully connects the Flipkart regulatory risk to Walmart's broader international strategy. The quantitative elements (dates, acquisition year 2018) are accurate. The semantic meaning aligns well with the ground truth despite slightly different phrasing. The answer demonstrates good synthesis but lacks some specific detail and precision found in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 432,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was **$2,151,005**, as reflected in the \"Additional Paid-in Capital\" increase from the \"Issuances of Class A shares for employee share programs\" in the 2023 consolidated shareholders' equity statement. This issuance contributed to an increase in Accenture plc's total shareholders' equity by **$2,151,005** by August 31, 2024, as it directly added to the Additional Paid-in Capital line item, which is part of shareholders' equity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors on the primary metric requested. (1) QUANTITATIVE ACCURACY - MAJOR ERRORS: The LLM states the total dollar value of Class A ordinary shares issued in 2023 was $2,151,005, but the ground truth clearly states it was $7,970. This is a massive discrepancy (off by a factor of ~270x). The LLM also claims this issuance contributed $2,151,005 to shareholders' equity increase, but the ground truth shows the total shareholders' equity increase from Aug 31, 2023 to Aug 31, 2024 was $2,595,807, with the Class A shares issuance being only $7,970. The LLM appears to have confused the 'Additional Paid-in Capital' line item increase with the actual Class A shares issued value. (2) MULTI-HOP REASONING - FLAWED: The LLM failed to properly synthesize the relationship between the Class A shares issued ($7,970) and the total equity change ($2,595,807). The question asks how the issuance 'impacted' total equity, which requires understanding that while the shares contributed $7,970, the total equity increase of $2,595,807 resulted from multiple factors (retained earnings, other comprehensive income, etc.). The LLM incorrectly attributed the entire $2,151,005 to the shares issuance alone. (3) ENTITY/METRIC CONFUSION: The LLM conflated 'Class A ordinary shares issued' (the actual par/issue value of $7,970) with 'Additional Paid-in Capital' increases from employee share programs ($2,151,005), which are different line items. (4) COMPLETENESS: While the LLM attempted to address both parts of the question (value issued and impact on equity), the answers are factually incorrect on both counts. The ground truth provides specific equity figures ($25,692,839 to $28,288,646) which the LLM did not reference or calculate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 479,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG's use of loss development methods for excess casualty lines with attachment points above $10 million influences its reserving methodology for U.S. Property and aerospace exposures by incorporating similar loss development techniques adjusted for latency and severity. For these lines, AIG combines loss development methods with expected loss ratio (ELR) methods, particularly for recent accident years where data credibility is lower. Expected loss ratios play a critical role in both analyses by estimating ultimate losses based on historical trends, rate changes, inflation, and market conditions. For U.S. Property and aerospace exposures, ELRs help project losses for high-severity, short-tail claims (e.g., aviation), while loss development methods account for delayed reporting and emerging claims. This dual approach ensures reserves reflect both historical patterns and current risk factors.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AIG's reserving methodology and correctly identifies the key elements: (1) the layered approach with $10 million attachment points, (2) the combination of loss development and expected loss ratio methods, (3) the critical role of ELRs for recent accident years with insufficient data, and (4) adjustments for inflation, rate changes, and market conditions. The answer accurately captures the dual approach for U.S. Property and aerospace exposures and correctly notes that ELRs are particularly important for high-severity, short-tail claims like aviation. STRENGTHS: The LLM correctly synthesizes the multi-hop relationship between excess casualty reserving and U.S. Property/aerospace methodologies, properly identifies the $10 million threshold as a key structural element, and accurately describes how expected loss ratios bridge early uncertainty. The explanation of latency and severity considerations is appropriate. MINOR WEAKNESSES: (1) The original answer emphasizes that the $10 million layer estimate is used to 'derive' the expected loss estimate for losses above $10 million, reflecting 'expected relationships between the layers' - the LLM mentions this concept but less explicitly states this derivation relationship. (2) The original answer specifically notes that ELRs are 'critical...particularly for recent accident years where reported loss data is insufficient' - the LLM captures this but uses slightly different phrasing ('data credibility is lower' vs. 'insufficient'). (3) The original answer emphasizes that loss development patterns 'guide the ultimate loss estimation process' - the LLM mentions this but less explicitly. No quantitative errors detected. The reasoning is sound and multi-hop synthesis is present. The answer is contextually relevant and addresses all major components of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 509,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was **$4,111,266**. As of August 31, 2024, the remaining share purchase authorization was **$2,184,889**, calculated by subtracting the $4,509,392 repurchased in fiscal 2024 from the total authorization of $6,694,281 (after adding $4,000,000 in new authority).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides the correct repurchase amount for FY2022 ($4,111,266), but the remaining authorization figure is INCORRECT. Ground truth states $2,694,281 as of August 31, 2024, but LLM claims $2,184,889 - a difference of $509,392. This is a material error. (2) CALCULATION ERRORS - The LLM's calculation methodology is flawed and unsupported by the ground truth. The LLM attempts to show work by calculating $6,694,281 - $4,509,392 = $2,184,889, but this calculation approach and the intermediate figures ($6,694,281 total authorization, $4,509,392 FY2024 repurchases) are not validated against the ground truth data. The ground truth provides a direct figure of $2,694,281 remaining, which contradicts the LLM's derived number. (3) MULTI-HOP REASONING - While the LLM attempts to synthesize information across fiscal years (FY2022 repurchases, FY2024 authorization changes, and remaining balance), the synthesis is incorrect. The LLM introduces unsupported figures ($4,000,000 in new authority, $4,509,392 in FY2024 repurchases) that cannot be verified against the ground truth. (4) COMPLETENESS - The LLM does address both parts of the question (FY2022 repurchases and FY2024 remaining authorization), but provides incorrect data for the second part. (5) ENTITY ACCURACY - Correctly identifies Accenture plc and the relevant time periods, but the financial metrics are wrong. The core issue is that the LLM's remaining authorization figure ($2,184,889) is materially different from the ground truth ($2,694,281), representing approximately an 18.8% discrepancy. This is not a minor rounding or formatting difference but a substantive factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 466,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "META's shift from \"legitimate interests\" to \"consent\" for behavioral advertising in Europe, driven by regulatory compliance (e.g., GDPR, DMA), has reduced ad targeting effectiveness by limiting data signal availability, leading to lower ad relevance and revenue. This change, combined with user opt-outs (e.g., \"subscription for no ads\" and less personalized ad options), has negatively impacted advertising revenue by reducing marketer ROI and ad effectiveness. While user engagement metrics are not explicitly quantified, the reduced ad relevance and targeting capabilities are expected to persist, further challenging revenue growth in the region.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of META's regulatory compliance challenges in Europe and correctly identifies the core mechanisms (shift from 'legitimate interests' to 'consent', subscription for no ads option, less personalized ad options) and their impacts on advertising revenue. The answer accurately captures the causal chain: regulatory changes  reduced targeting effectiveness  lower ad relevance  reduced revenue. The mention of GDPR and DMA as regulatory drivers is appropriate context. However, there are notable gaps: (1) The LLM explicitly states 'user engagement metrics are not explicitly quantified' and notes engagement impact is 'expected to persist' rather than definitively stating it has occurred, whereas the ground truth clearly states these policy changes 'have contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates.' The ground truth presents this as an established fact, not a projection. (2) The LLM focuses heavily on ad targeting effectiveness and marketer ROI but underemphasizes the direct user engagement reduction component that the ground truth emphasizes as a material adverse effect. (3) The LLM's phrasing about 'expected to persist' suggests uncertainty about future impacts rather than documenting the actual documented adverse effects. The answer is directionally correct and demonstrates multi-hop reasoning across regulatory compliance  policy changes  revenue impact, but it hedges on user engagement impacts where the ground truth is more definitive about documented adverse effects. The quantitative accuracy is high (no incorrect numbers provided, though no specific figures are cited in either answer). The qualitative reasoning is sound but incomplete in addressing the full scope of documented impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 497,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "The redemption policy of Accenture plc Class X ordinary shares directly reduces the total number of shares outstanding by allowing Accenture plc to redeem these shares at par value. The mechanism ensuring alignment with Accenture Canada Holdings Inc. exchangeable shares is that Class X shares are redeemed **only upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares**, ensuring the aggregate number of Class X shares outstanding never exceeds the number of exchangeable shares. Additionally, Accenture plc has agreed not to redeem Class X shares if doing so would reduce the number held by a shareholder below their corresponding exchangeable shares, maintaining this direct relationship.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The core mechanism is accurately identified - Class X shares are redeemed upon redemption/exchange of exchangeable shares on a one-for-one basis; (2) The alignment principle is correctly stated - the number of Class X shares outstanding never exceeds exchangeable shares; (3) The one-for-one relationship is properly explained. PROBLEMATIC ASPECTS: (1) The phrase 'reduces the total number of shares outstanding by allowing Accenture plc to redeem these shares at par value' is misleading - while technically redemption reduces shares, this framing suggests a general policy rather than the specific conditional mechanism tied to exchangeable shares; (2) The additional constraint about 'not redeeming Class X shares if doing so would reduce the number held by a shareholder below their corresponding exchangeable shares' appears to introduce a shareholder-level restriction not explicitly stated in the ground truth, which focuses on the aggregate relationship; (3) The answer adds interpretive detail ('at par value') not present in the ground truth, which could be speculative. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between two share classes and explains the mechanism maintaining alignment. However, it adds a secondary constraint that may not be directly supported by the source material. QUANTITATIVE ACCURACY: No specific numbers are involved in this question, so this scores well on the limited quantitative content. OVERALL ASSESSMENT: The answer captures the essential mechanism correctly but introduces additional details that either overstate the policy or add unsupported constraints, reducing confidence in the completeness and accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 485,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, reflecting amortization of the capitalized milestones over the term of the collaboration. This trend aligns with the amortization practices described in the filing, which state that milestone payments are amortized to cost of sales over the estimated useful life of the assets, determined by the latest of defined years post-launch, patent expiration, or supplementary protection certificates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - the 2020 figure of $156.2 million, 2021 figure of $136.1 million, and the implied decline of $20.1 million are all accurate. The numbers match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the specific change in net milestone capitalization between the two years, and (b) how this trend reflects amortization practices. The LLM correctly identifies the $20.1 million decline (though not explicitly stated, it's mathematically correct from the figures provided). (3) ENTITY ACCURACY: Jardiance is correctly identified, years 2020 and 2021 are correct, and the financial metric (net milestone capitalization) is properly identified. (4) REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the numerical decline to the underlying amortization mechanism described in the filing. The explanation of how milestones are amortized to cost of sales based on launch date, patent expiration, or supplementary protection certificates is accurate and well-integrated. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'amortization of capitalized milestones over the term of the collaboration' is semantically equivalent to the ground truth's 'amortization of capitalized milestones over time.' The description of amortization methodology is slightly more concise in the LLM answer but captures all essential elements. Minor note: The LLM answer could have been marginally more explicit about the $20.1 million decline figure, though this is a very minor omission that doesn't affect the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 469,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "The use of IBNR factor methods in U.S. Property and UK/Europe Property lines reflects differences in claim frequency and severity characteristics, impacting reserving processes. For **U.S. Property**, IBNR factors are applied to low-frequency, high-severity claims (e.g., natural disasters, business interruption), with factors adjusted based on historical loss emergence and current trends. The reserving process combines IBNR factors with loss development and expected loss ratio methods, particularly for aviation and marine exposures, where severity drives reserve calculations. \n\nIn contrast, **UK/Europe Property** also employs IBNR factors for short-tail classes, but the regions long-tail casualty and financial lines (e.g., general liability, D&O) require more stable loss development patterns due to slower claim emergence. While UK/Europe Property claims may share low-frequency/high-severity traits, the reserving process emphasizes loss development methods for smaller or volatile lines, with adjustments for external factors like inflation and market conditions. The UK/Europes reserving also accounts for regional judicial trends and re-underwriting efforts, leading to more nuanced IBNR factor adjustments compared to the U.S. This results in distinct reserving approaches tailored to each regions claim dynamics.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and mischaracterizations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM incorrectly characterizes U.S. Property as having 'low-frequency, high-severity claims' when the ground truth explicitly states the U.S. segment has shifted toward 'non-admitted coverages that have altered the customer profile to be less severe in the aggregate.' This is a fundamental misrepresentation of the U.S. Property segment's risk profile. (2) INCORRECT CHARACTERIZATION OF UK/EUROPE: The LLM introduces irrelevant details about 'long-tail casualty and financial lines (e.g., general liability, D&O)' which are not mentioned in the ground truth and appear to conflate different insurance lines. The ground truth specifically identifies UK/Europe Property as having 'low frequency/high severity losses,' not the mixed profile the LLM describes. (3) MISSING KEY INFORMATION: The LLM fails to capture the core distinction that UK/Europe uses IBNR factors applied to earned premium based on 'prior accident quarters adjusted for current cost levels and historical emergence patterns.' This specific methodology is absent from the LLM response. (4) EXTRANEOUS INFORMATION: The LLM adds details about 'aviation and marine exposures,' 'regional judicial trends,' and 're-underwriting efforts' that are not supported by the ground truth and appear to be fabricated or from unrelated sources. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM fails to properly synthesize the key comparison: that both regions use IBNR factor methods but apply them differently based on their distinct severity profiles and customer bases. Instead, it creates a confused narrative mixing unrelated insurance concepts. (6) SEMANTIC MISALIGNMENT: While the LLM uses appropriate insurance terminology, it applies it incorrectly to the specific regional contexts described in the ground truth. The answer demonstrates a fundamental misunderstanding of the question's focus on comparing how IBNR methods differ between regions based on claim characteristics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 557,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Procter & Gamble's Grooming segment holds **over 60% global market share** in blades and razors (primarily through Gillette and Venus brands) and **over 25% global market share** in male electric shavers (via the Braun brand). Thus, their combined blades and razors market share significantly exceeds their market share in male electric shavers.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key market share figures: over 60% for blades and razors, and over 25% for male electric shavers. The numeric values match the ground truth exactly. However, the answer has a notable omission: it fails to explicitly state the comparison metric requested in the question - the difference of more than 35 percentage points between the two market shares. The ground truth specifically calculates this difference (60% - 25% = 35+ percentage points), which is a direct answer to the 'how does this compare' portion of the question. The LLM instead uses qualitative language ('significantly exceeds') rather than providing the quantitative comparison. The answer does provide helpful context by naming the brands (Gillette, Venus, Braun) which adds value, but this doesn't compensate for the missing explicit calculation of the difference. The multi-hop reasoning is sound - correctly synthesizing P&G's market positions across two product categories - but the answer is incomplete in addressing the full scope of the comparison question. The quantitative accuracy is high for the individual percentages but incomplete for the comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 334,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. The company uses cost-sharing arrangements with suppliers, where suppliers reimburse a portion of the development costs for new aircraft models and technologies. These contributions are recorded as a reduction of R&D expenses, and General Dynamics retains substantial rights in the developed products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The $510 million investment figure is correct, and the cost-sharing arrangement mechanism is accurately described. The answer correctly identifies that suppliers reimburse development costs and that these are recorded as a reduction of R&D expense. (2) QUANTITATIVE ACCURACY: The $510 million figure matches the ground truth exactly with no calculation errors or discrepancies. (3) QUALITATIVE ACCURACY: The LLM answer provides accurate multi-hop synthesis by correctly connecting General Dynamics' Aerospace segment investment with the specific cost-sharing mechanism used with suppliers. The explanation of how supplier contributions offset costs through R&D expense reduction is semantically equivalent to the ground truth. The LLM adds a minor detail about 'new aircraft models and technologies' and 'General Dynamics retains substantial rights in developed products' which provides additional context not explicitly in the ground truth but is consistent with typical cost-sharing arrangements and does not contradict the original answer. (4) ENTITY ACCURACY: Company (General Dynamics), segment (Aerospace), year (2023), and financial metric (product development investment) are all correctly identified. (5) COMPLETENESS: Both parts of the multi-part question are addressed - the investment amount and the mechanism used with suppliers. The answer fully synthesizes the required information across the question's components. Minor: The LLM's additional contextual details about product rights are reasonable elaborations that enhance understanding without introducing factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 454,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "Accenture spent $4,509,392 on Class A Ordinary Share purchases during fiscal 2024, as detailed in the \"Open-market share purchases\" and \"Other purchases\" lines on page 101. This amount directly increased the total value of treasury shares held by the company, contributing to the $10,564,572 balance reported on page 72, reflecting the cumulative impact of all share purchases and redemptions during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM provided $4,509,392 as the amount spent on Class A Ordinary Share purchases, but the ground truth states $4,111,266. This is a significant discrepancy of $398,126 (approximately 9.7% difference). This is a fundamental factual error that cannot be overlooked. (2) MULTI-HOP REASONING - While the LLM correctly identifies that the purchase amount increased treasury shares and attempts to connect this to the total treasury share balance of $10,564,572, the core number is wrong, which undermines the entire answer. (3) ENTITY ACCURACY - Accenture and fiscal 2024 are correctly identified, and the reference to page numbers suggests source documentation was consulted, but the actual figures extracted are incorrect. (4) COMPLETENESS - The answer does address both parts of the question (amount spent and impact on treasury shares), but the incorrect primary number makes the answer fundamentally flawed. The LLM's attempt to provide additional context about the treasury share balance is reasonable but cannot compensate for the wrong purchase amount. The ground truth answer is straightforward and precise: $4,111,266 spent, which increased treasury shares by that amount. The LLM's answer fails on the most critical metric - the actual dollar amount of share purchases.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 369,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "The year-over-year dollar increase in META's Servers and Network Assets from December 31, 2023, to December 31, 2024, was **$21,559 million** ($68,397 million in 2024 vs. $46,838 million in 2023). This increase relates to META's depreciation policy, which states that servers and network assets are depreciated over **45 years (extended to 5.5 years effective January 2025)** using the straight-line method. Assets placed in service are depreciated over their estimated useful lives or the remaining lease term, whichever is shorter, with revised useful lives prospectively adjusting depreciation expenses.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the year-over-year dollar increase of $21.559 billion ($21,559 million), with accurate base values ($46.838 billion in 2023 and $68.397 billion in 2024). The calculation is correct and properly formatted. CRITICAL WEAKNESSES: (1) The LLM introduced specific depreciation timeframes (4-5 years, extended to 5.5 years effective January 2025) that are not mentioned in the ground truth answer and appear to be unsupported details. (2) The LLM failed to address the core insight from the ground truth: that the significant increase relates to Construction in Progress (CIP) assets being placed into service during 2024, which is the key explanatory mechanism for understanding why depreciation policy matters to this question. (3) The ground truth emphasizes that CIP assets are NOT depreciated until placed in service, and the large increase suggests substantial CIP conversion to depreciable assets - this critical distinction is missing from the LLM answer. (4) The LLM's discussion of depreciation policy is generic and doesn't connect the policy to the specific phenomenon of CIP asset placement that explains the $21.559 billion increase. MULTI-HOP REASONING: The LLM partially synthesized the information by connecting depreciation policy to the asset increase, but failed to identify the specific causal mechanism (CIP placement) that the ground truth emphasizes. The answer addresses depreciation mechanics but misses the key insight about why this particular increase occurred. The introduction of unsupported specific depreciation periods (4-5 years, 5.5 years) suggests potential hallucination or confusion with other company data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 458,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance) for heart failure with preserved ejection fraction and Baricitinib (Olumiant) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "In 2022, Eli Lilly had three drug indications in submitted status with FDA Breakthrough Therapy designation: **Empagliflozin (Jardiance)** for heart failure with preserved ejection fraction, **Baricitinib (Olumiant)** for alopecia areata, and **Donanemab** for early Alzheimer's disease. One indication, **Baricitinib (Olumiant)** for systemic lupus erythematosus, was discontinued.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. QUANTITATIVE ERRORS: (1) The LLM claims THREE indications in submitted status, but ground truth specifies TWO. (2) The LLM adds Donanemab for early Alzheimer's disease as a submitted indication, which is not mentioned in the ground truth as having FDA Breakthrough Therapy designation in 2022. ENTITY/FACTUAL ERRORS: (1) The LLM correctly identifies Empagliflozin (Jardiance) for heart failure with preserved ejection fraction - CORRECT. (2) The LLM correctly identifies Baricitinib (Olumiant) for alopecia areata - CORRECT. (3) The LLM incorrectly adds Donanemab for early Alzheimer's disease as a submitted indication - NOT IN GROUND TRUTH. (4) The LLM claims Baricitinib (Olumiant) for systemic lupus erythematosus was discontinued - CONTRADICTS ground truth which states 'No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.' MULTI-HOP REASONING: The LLM failed to correctly synthesize the information about which indications had FDA Breakthrough Therapy designation in 2022 and their development status. The answer introduces compounds and indications not supported by the ground truth and incorrectly claims a discontinued indication when none existed. The core count is wrong (3 vs 2 submitted), and the discontinued status claim is entirely unsupported. The answer demonstrates a fundamental misunderstanding or hallucination of the data rather than accurate synthesis from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 422,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG's reliance on loss development methods differs between U.S. Other Casualty and U.S. Property lines. For **U.S. Other Casualty** (e.g., general liability, auto liability, medical malpractice), loss development methods are used alongside frequency/severity and expected loss ratio methods, with heavier reliance on loss development for larger, more seasoned lines and expected loss ratios for recent accident years. For **U.S. Property** lines, loss development and IBNR factor methods are employed, with IBNR factors used for low-frequency, high-severity risks.  \n\nIn **2021**, U.S. Personal Insurance recognized **$412 million of favorable prior year development**, driven by subrogation recoveries from the **2017 and 2018 catastrophe years** (e.g., 2017 California wildfires, Hurricanes Harvey, Irma, and Maria). This adjustment reflects improved loss recovery and development from prior-year catastrophes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All key numbers are correct - $412 million in favorable prior year development is accurate, and the years 2017 and 2018 for catastrophe recoveries are correct. No calculation errors detected. QUALITATIVE ACCURACY: The answer correctly identifies and synthesizes the multi-hop information: (1) U.S. Other Casualty methods: correctly notes combination of loss development, frequency/severity, and expected loss ratio methods with appropriate weighting for long-tail lines; (2) U.S. Property methods: correctly identifies frequency/severity, loss development, and IBNR factor methods with proper characterization of IBNR application to low-frequency/high-severity losses; (3) 2021 adjustment: correctly identifies the $412 million favorable development and attributes it to subrogation recoveries from 2017-2018 catastrophes. ENTITY ACCURACY: All entities correctly identified (AIG, U.S. Other Casualty, U.S. Property, U.S. Personal Insurance, 2021, 2017-2018 catastrophe years). REASONING: The multi-hop synthesis is sound - the answer correctly connects the different methodologies used across business lines and then separately addresses the specific 2021 reserving adjustment. The contextual examples provided (California wildfires, Hurricanes Harvey/Irma/Maria) add helpful context without introducing errors. MINOR OBSERVATION: The LLM provides slightly more contextual detail than the ground truth (specific hurricane names, wildfire reference) but this enhances rather than detracts from accuracy. The answer is semantically equivalent to the ground truth while being slightly more comprehensive in explanation. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 473,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "Procter & Gamble's Baby, Feminine & Family Care segment contributed **24%** of fiscal year 2024 net sales. Within this segment, the **Charmin brand** accounts for approximately **25%** of the family care business, which is predominantly North American, based on its over 25% market share in the North American toilet paper market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: (1) Baby, Feminine & Family Care segment contributed 24% of FY2024 net sales - CORRECT, (2) Charmin holds approximately 25% North American toilet paper market share - CORRECT. However, there is a semantic/logical issue in the phrasing. The original answer states 'Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business.' The LLM answer states 'Charmin brand accounts for approximately 25% of the family care business' - this is ambiguous and potentially misleading. The 25% figure refers to Charmin's market share in toilet paper specifically, not its proportion of the entire family care segment. The LLM conflates market share (25% of North American toilet paper market) with segment contribution (unclear what portion of family care segment). The answer should clarify that 25% is Charmin's market share in toilet paper, not necessarily its contribution to the family care segment. The multi-hop reasoning is partially sound - it correctly synthesizes that Charmin is part of family care and has strong North American presence - but the logical connection between market share and segment contribution is not clearly articulated. All numeric values are accurate, but the interpretation and presentation of what those numbers represent contains a logical ambiguity that could confuse readers about whether 25% refers to market share or segment contribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 413,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the companys ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "General Dynamics' $510 million R&D investment in 2023 supports the Combat Systems segment's development of next-generation platforms like the M1E3 Abrams tank, which incorporates advanced systems architecture for improved technology upgrades, reduced sustainment costs, and enhanced tactical mobility. Strategically, this investment strengthens the company's market leadership in land combat solutions and aligns with modernization priorities for U.S. and international customers. Financially, the R&D spending is tied to long-term value creation through operational excellence and innovation, as reflected in the segment's revenue contributions and sustained competitiveness in defense programs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - the $510 million R&D investment figure is accurately cited and properly attributed to 2023. (2) Entity identification is accurate - General Dynamics, Combat Systems segment, and M1E3 Abrams tank are all correctly identified. (3) Key technical improvements are mentioned - advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and tactical mobility are referenced. (4) Strategic outcomes are addressed - market leadership, modernization priorities, and long-term value creation are discussed. (5) Financial outcomes are mentioned - long-term contracts and revenue contributions are noted. WEAKNESSES: (1) The LLM answer omits some specific technical details present in the ground truth, such as 'improved communications, power generation, fuel efficiency, optics, and armor' - while some are mentioned, the comprehensive list is not fully captured. (2) The phrase 'reduced sustainment footprint' from the ground truth is simplified to 'reduced sustainment costs' - semantically similar but slightly less precise. (3) The answer lacks explicit mention of 'quicker technology upgrades' as a specific capability improvement. (4) The ground truth emphasizes 'counter future threats' as a key driver, which is not explicitly mentioned in the LLM answer. (5) The connection to 'both U.S. and international defense customers' is mentioned more generally as 'U.S. and international customers' without the specific 'defense' context. MULTI-HOP REASONING: The LLM successfully synthesizes the R&D investment amount with the Combat Systems segment, the M1E3 platform development, and ties these to both strategic (market leadership) and financial (long-term contracts, revenue) outcomes. The reasoning chain is sound and logically coherent. OVERALL ASSESSMENT: The answer is substantially correct with accurate numbers and solid reasoning, but lacks some of the specific technical and strategic details present in the ground truth. The omissions are relatively minor and do not fundamentally undermine the accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 567,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs, is **$4,505,525**. This figure is derived from the \"Purchases of Class A shares\" line item in the Consolidated Shareholders' Equity Statements on page 72, which reflects the total cost of all Class A share purchases for the year. While the open-market program's fourth-quarter purchases totaled $605 million, the equity statement aggregates all purchases, including unrelated transactions, to arrive at the full-year total.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary metric. The ground truth states the total dollar value of Class A Ordinary Shares purchased was $609.1 million ($605 million from open-market program + $4.1 million from unrelated purchases). The LLM provides $4,505,525 (approximately $4.5 million), which is off by a factor of approximately 135x. This is a catastrophic numerical error. The LLM appears to have confused share count or some other metric with dollar value, as the number provided ($4.5M) doesn't match either component of the correct answer ($605M or $4.1M) or the total ($609.1M). While the LLM correctly identifies that the answer should combine open-market purchases ($605 million mentioned) with unrelated purchases, it fails to provide the correct total and instead provides a completely erroneous figure. The reference to 'Consolidated Shareholders' Equity Statements on page 72' and the specific figure of $4,505,525 suggests the LLM may have misread or misinterpreted a line item from the filing, possibly confusing share count with dollar value or selecting the wrong data point entirely. The multi-hop reasoning framework is present (acknowledging both components should be combined), but the execution is completely failed due to the incorrect final number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 361,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T's 2021 payment to Crown Castle under the sublease arrangement was **$253**, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were **$4,827**. The 2021 payment is significantly lower than the initial proceeds, reflecting ongoing sublease obligations rather than the upfront transaction amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All factual information matches the ground truth exactly. The 2021 payment of $253 million and the 2013 initial cash proceeds of $4,827 million are both correct. (2) QUANTITATIVE ACCURACY: Both dollar amounts are precisely correct with no calculation errors. The numbers are presented in millions (implied by context), matching the ground truth format. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information about two distinct transactions (2013 tower transaction and 2021 sublease payments) and makes an appropriate comparison. The characterization that the 2021 payment 'represents a small fraction' or is 'significantly lower' is accurate (253/4827  5.2%). (4) ENTITY ACCURACY: All entities are correctly identified - AT&T, Crown Castle, the sublease arrangement, and the 2013 tower transaction. (5) SEMANTIC EQUIVALENCE: The LLM's explanation adds helpful context by noting that the 2021 payment reflects 'ongoing sublease obligations rather than the upfront transaction amount,' which provides additional insight beyond the ground truth while remaining consistent with it. The answer fully addresses the comparative question asked. Minor deduction (1 point) only because the ground truth's phrasing 'small fraction' is slightly more concise than the LLM's 'significantly lower,' though both convey the same meaning accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 403,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GMs equity investments in 2021.",
      "llm_answer": "General Motors valued Stellantis warrants using the Black-Scholes formula, with fair value changes recorded in \"Interest income and other non-operating income, net.\" According to the 2021 disclosure, a 10% adverse change in Stellantis' stock price would have had an **insignificant** effect on GM's equity investments, as noted in Item 7A under \"Equity Price Risk.\" This suggests the potential financial impact was deemed immaterial to GM's financial position in 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the Black-Scholes formula as GM's valuation methodology for Stellantis warrants, correctly states that a 10% adverse change would have an 'insignificant' effect on equity investments, and appropriately references Item 7A and Equity Price Risk disclosure. The reasoning about immateriality is sound and semantically equivalent to the ground truth. The answer correctly synthesizes that despite the methodology's sensitivity to stock price inputs, the actual financial impact would be immaterial.\n\nWEAKNESSES: The LLM omits a critical quantitative fact from the ground truth - the specific fair value of GM's Stellantis warrant investment at the end of 2021 was $1.5 billion. This is a material omission for a question asking about 'financial impact' and 'valuation methodology.' The original answer explicitly states this figure as context for understanding the scale of the investment and why a 10% adverse change would be insignificant. The LLM also adds information about 'Interest income and other non-operating income, net' that, while potentially accurate, is not in the ground truth and represents an unsupported addition. The answer addresses the core question about the relationship between valuation methodology and financial impact, but lacks the quantitative grounding that would make it complete.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the connection between (1) valuation methodology (Black-Scholes), (2) sensitivity to equity price risk, and (3) actual financial impact assessment. However, it fails to complete the full multi-hop chain by not including the warrant fair value amount, which is essential context for understanding why the 10% adverse change impact is insignificant.\n\nNUMERIC VERIFICATION: The 10% figure is correct. The 'insignificant' characterization is correct. However, the missing $1.5 billion fair value figure represents a significant quantitative omission (approximately 40% of the complete answer's quantitative content).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 544,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "The document states that P&G holds about **15% global market share** in the adult incontinence sub-category within the Baby, Feminine & Family Care segment, specifically through the Always Discreet brand. This figure is explicitly mentioned in the segment description on page 18.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and provides an incorrect answer. CRITICAL ERRORS: (1) The question asks what percentage of P&G's TOTAL global market share in Baby, Feminine & Family Care is attributed to Always Discreet. The ground truth answer correctly identifies this as approximately 15% of the segment's total market share (derived from 20% segment share  15% within sub-category = 3% of total, OR interpreted as 15% contribution within the segment). (2) The LLM answer states '15% global market share in the adult incontinence sub-category' which is a different metric - this is Always Discreet's share WITHIN the adult incontinence sub-category, not its contribution to the overall segment. (3) The LLM fails to synthesize the multi-hop relationship: it should connect (a) P&G's 20% global market share in Baby, Feminine & Family Care segment, (b) Always Discreet's 15% share within adult incontinence sub-category, and (c) calculate or explain how this translates to the segment-level contribution. (4) The answer conflates two different metrics without clarifying the distinction or performing the necessary calculation. (5) The citation to 'page 18' cannot be verified and appears to be a hallucination. The ground truth clearly distinguishes between the sub-category market share (15%) and the segment contribution, while the LLM conflates these concepts. This is a significant analytical error in a multi-hop financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 409,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was **$327.47**, as disclosed in the \"Purchases of Accenture plc Class A Ordinary Shares\" section (page 39). This figure reflects the total cash outlay for all shares acquired during the quarter, including those purchased under the publicly announced open-market share purchase program and transactions unrelated to such programs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect on the primary metric requested. The ground truth states the average price paid per Accenture plc Class A ordinary share during Q4 fiscal 2024 was approximately $299.48, but the LLM provided $327.47 - a significant discrepancy of $28.00 per share or approximately 9.4% higher than the correct answer. This is a critical error for a quantitative financial question where precision is essential. The LLM correctly identified the company (Accenture plc), the time period (fourth quarter of fiscal 2024), and the relevant section of the filing (Purchases of Accenture plc Class A Ordinary Shares). The answer also appropriately addresses both components of the question (publicly announced open-market share purchase program and transactions unrelated to such programs). However, the fundamental calculation or data extraction error regarding the actual average price paid makes this answer materially incorrect. The contextual relevance is high as the LLM understood what information was being requested and cited the appropriate source document section, but the core numerical answer is wrong, which is unacceptable for a financial calculation question where the ground truth is definitively established.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 349,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This amount is significantly lower than the $1,490.8 million of collaboration revenue reported for Jardiance in 2021, reflecting the distinction between capitalized development milestones (amortized as cost of sales) and broader collaboration revenue, which includes royalties, profit-sharing, and other payments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a completely incorrect figure of $1,490.8 million for 'collaboration revenue reported for Jardiance in 2021.' The ground truth states the collaboration and other revenue totaled $175.0 million for the year ended December 31, 2021. This is a massive discrepancy ($1,490.8M vs $175.0M) and represents a fundamental factual error. (2) CORRECT ELEMENTS - The LLM correctly identifies: (a) the net milestones capitalized decreased by $20.1 million, (b) 2020 amount of $156.2 million, (c) 2021 amount of $136.1 million. (3) MULTI-HOP REASONING - The LLM attempts to synthesize information about the relationship between capitalized milestones and collaboration revenue, which is appropriate for the question. However, the synthesis is built on an incorrect number. (4) SEMANTIC ISSUES - The LLM's explanation about the distinction between capitalized development milestones and broader collaboration revenue is conceptually sound and adds useful context, but this cannot compensate for the major numerical error. (5) GROUND TRUTH COMPARISON - The original answer correctly states that the $136.1 million in 2021 net milestones capitalized was 'part of the broader collaboration and other revenue, which totaled $175.0 million.' The LLM's figure of $1,490.8 million appears to be either from a different metric entirely or a data retrieval error. This single error severely undermines the answer's credibility and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 411,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "GM recorded gains of **$316 million** from its Stellantis warrants in 2021, as noted in Note 14 of the 10-K filing. The ongoing business relationship with Stellantis involves **continued supply and purchase of vehicles, parts, and engineering services**, as outlined in the Opel/Vauxhall sale documentation (page 91), which affects GM's post-sale operations through these transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $316 million figure for Stellantis warrant gains in 2021 is correct and matches the ground truth exactly. The year (2021) is also correct. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - the warrant gains amount and the ongoing business relationship. The LLM correctly identifies the three components of the ongoing relationship: purchase and supply of vehicles, parts, and engineering services. (3) ENTITY ACCURACY: All entities are correctly identified - GM, Stellantis, Opel/Vauxhall Business, and the correct fiscal year (2021). (4) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple sources, connecting the warrant gains to the broader Stellantis relationship and explaining how the post-sale operations are affected through continued transactions. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'continued supply and purchase of vehicles, parts, and engineering services' is semantically equivalent to the ground truth's 'purchase and supply of certain vehicles, parts, and engineering services' - the meaning is identical despite minor wording variations. The citation references (Note 14, page 91) add credibility though these specific citations weren't verified against the ground truth. Minor note: The LLM uses 'continued supply and purchase' while ground truth says 'purchase and supply' - this is a trivial ordering difference that doesn't affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 418,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIGs consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) in 2022, reflected in \"Net gain (loss) on divestitures and other.\" This loss reflects the financial impact of AIGFP's Chapter 11 reorganization, as the deconsolidation removed AIGFP's assets and liabilities from AIG's consolidated financial statements, with no material impact on the balance sheets. The reorganization also reclassified AIGFP's $37.6 billion loan receivable to a third-party asset and retained deferred tax assets related to AIGFP's net operating losses.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: the $114 million pre-tax loss, the 2022 timeframe, the deconsolidation of AIGFP, the $37.6 billion loan receivable reclassification, and the reporting line item 'Net gain (loss) on divestitures and other.' All numeric values are accurate and properly formatted. The answer demonstrates sound multi-hop reasoning by connecting the Chapter 11 reorganization to the deconsolidation, the loss recognition, and the balance sheet impact. However, there are two notable omissions: (1) The ground truth specifies the exact date of the Chapter 11 filing (December 14, 2022), which the LLM answer omits, instead only stating '2022.' (2) The ground truth mentions 'full allowance for credit losses' associated with the reclassified loan receivable, which the LLM answer does not include. Additionally, the LLM answer introduces 'deferred tax assets related to AIGFP's net operating losses,' which is not mentioned in the ground truth and may represent information not directly supported by the source material. The core narrative is correct: the loss reflects the deconsolidation impact, and the reorganization had no material impact on consolidated financial statements. The reasoning is logically sound and addresses the multi-part nature of the question adequately, though with minor gaps in completeness and one potentially unsupported addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 389,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "The total net value of Acquired Franchise Rights in 2024 is **$598 million**, as reported in Note 4 under the \"Acquired franchise rights\" line item. The gross value for the same asset category in the prior year (2023) was **$840 million**. This indicates a decrease in the gross value from 2023 to 2024, reflecting accumulated amortization and potential impairments over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the net value of Acquired Franchise Rights in 2024 as $598 million and the gross value in 2023 as $840 million. However, the answer is incomplete in addressing the full scope of the original question. Strengths: (1) The $598 million net value for 2024 is correct; (2) The $840 million gross value for 2023 is correct; (3) The answer appropriately cites the source (Note 4). Weaknesses: (1) The answer fails to provide the 2024 gross value of $821 million, which is explicitly mentioned in the ground truth and necessary to fully answer the question; (2) The answer does not calculate or state the specific $19 million decrease in gross value from 2023 to 2024 ($840M - $821M = $19M); (3) The answer does not mention the accumulated amortization of $223 million in 2024, which is part of the complete picture; (4) The explanation of the decrease is vague ('accumulated amortization and potential impairments') rather than precise. The multi-hop reasoning is partially sound but incompletethe answer synthesizes some information correctly but omits key quantitative details that would fully address the comparative analysis requested. The answer demonstrates understanding of the general concept but lacks the comprehensive numerical detail required for a complete response to this multi-part financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 375,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "AT&T's total financial commitment for the C-Band licenses, including the auction payment and estimated future costs for spectrum clearing and relocation, was **$26,518 million**. This includes the $23,406 million paid for the auction, $2,112 million for Phase II spectrum clearing, and $1,000 million in compensable relocation costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN TOTAL CALCULATION: The LLM states the total is $26,518 million, but the correct total is $26,478 million. The LLM correctly identifies all three component costs ($23,406M + $2,112M + $1,000M), but the arithmetic is wrong: 23,406 + 2,112 + 1,000 = 26,518 is INCORRECT. The correct sum is 26,518, but the ground truth states 26,478. Upon verification, the ground truth total of $26,478 appears to be the accurate figure from the filing. The LLM's calculation of 26,518 is mathematically what those three numbers sum to, but this does not match the ground truth of 26,478, indicating either: (1) the component numbers in the LLM answer are slightly off, or (2) the ground truth total is the authoritative figure and the LLM miscalculated. Given that the ground truth is from the actual filing knowledge graph, the LLM answer contains a $40 million discrepancy in the total. The component breakdown is correctly identified and the reasoning about what comprises the total commitment is sound, but the final total is factually incorrect. The answer addresses all parts of the question (auction payment, spectrum clearing, relocation costs) and uses appropriate terminology, but the quantitative error is significant for a financial question where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 359,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lillys diabetes segment.",
      "llm_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, reflecting amortization of these intangible assets to cost of sales. This reduction in capitalized milestones indicates progress in amortizing prior-year milestones, which impacts cost of sales but does not directly affect revenue. The increase in Jardiance's collaboration and other revenue ($1,490.8 million in 2021 vs. $1,153.8 million in 2020) highlights strong performance of Lilly's diabetes portfolio, driven by sales growth and ongoing collaboration with Boehringer Ingelheim, despite the amortization of capitalized milestones.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All primary numbers are correct: $156.2M (2020), $136.1M (2021), and the $20.1M decline are accurately stated. (2) The additional revenue figures ($1,490.8M in 2021 vs $1,153.8M in 2020) are correctly cited and properly contextualized. (3) The quantitative accuracy is high with no calculation errors. (4) The LLM correctly identifies Boehringer Ingelheim as a collaboration partner. WEAKNESSES: (1) The LLM introduces an interpretation about 'amortization of intangible assets to cost of sales' that goes beyond what the ground truth states. The ground truth simply notes the decline 'could signal a slowdown in developmental or commercial milestone achievements' without specifying the accounting mechanism. (2) The LLM's explanation shifts focus from the ground truth's interpretation (potential slowdown in milestone achievements) to an accounting treatment explanation (amortization progress), which represents a different analytical perspective. (3) The LLM adds context about collaboration revenue that, while accurate and relevant, somewhat dilutes the direct answer to the specific question about what the decline reflects. (4) The ground truth emphasizes the decline as potentially signaling slower milestone achievements; the LLM reframes it as normal amortization progress, which are subtly different interpretations. MULTI-HOP REASONING: The LLM successfully synthesizes information across Jardiance-specific metrics and broader portfolio performance, connecting the milestone decline to revenue growth. However, the reasoning diverges from the ground truth's causal interpretation. SEMANTIC EQUIVALENCE: While the LLM provides accurate numbers and relevant context, it interprets the financial meaning differently than the ground truth, focusing on accounting mechanics rather than business performance implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 500,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "The total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis was **$1.0 billion**, comprising **$800 million in non-service pension income** and **$200 million in gains from Stellantis warrants**, as detailed in the \"Interest income and other non-operating income, net\" section (Page 36).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative values are correct: $1.0 billion total benefit, $800 million in non-service pension income, and $200 million in gains from Stellantis warrants. The numbers match the ground truth exactly (with proper format conversion: $0.8B = $800M, $0.2B = $200M). The answer correctly identifies all components of the financial benefit and properly synthesizes the multi-hop relationship between General Motors and Stellantis. The entity identification is accurate (General Motors, Stellantis, Stellantis N.V. warrants), and the fiscal year (2021) is correct. The LLM provides additional context by citing the specific section of the filing (Page 36, 'Interest income and other non-operating income, net'), which adds credibility and relevance. The reasoning is sound - the model correctly combined pension income and warrant gains to arrive at the total benefit. Minor deduction (1 point) only because the ground truth uses slightly different phrasing ('non-service pension income' vs 'non-service pension income'), though this is semantically equivalent and not a factual error. The answer fully addresses all parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 338,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "The changes in Corebridge's stock price after deconsolidation directly impacted AIG's financial statements through Net investment income, as AIG accounted for its retained 22.7% ownership interest using the equity method. Fluctuations in Corebridge's stock price adjusted the fair value of AIG's investment, with gains/losses recognized in Net investment income. For example, the $282 million gain from selling 21.6% of Corebridge in December 2024 and the $261 million equity method adjustment from the secondary offering reflected these price changes. This approach aligns with AIG's ownership structure, where stock price movements directly influence the recorded value of its investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a substantially correct response with specific details about AIG's treatment of its Corebridge investment. STRENGTHS: (1) Correctly identifies the 22.7% ownership interest and equity method accounting treatment; (2) Accurately cites the $282 million gain from selling 21.6% of Corebridge in December 2024; (3) Correctly mentions the $261 million equity method adjustment from secondary offering; (4) Properly explains that stock price changes affect fair value and are recognized in Net investment income; (5) Demonstrates sound multi-hop reasoning by connecting ownership structure to financial statement impact. WEAKNESSES: (1) The original answer emphasizes recognition under 'fair value option' in Consolidated Statements of Income, while LLM answer focuses on 'Net investment income' - these may be different line items or presentation methods, creating slight semantic divergence; (2) The original answer mentions 'gain on the sale of Corebridge shares' more broadly, while LLM provides specific transaction examples (December 2024 sale, secondary offering) that are accurate but represent specific instances rather than the general principle; (3) Minor: The original answer references 'equity method income from Corebridge' more generally, while LLM provides transaction-specific examples. QUANTITATIVE VERIFICATION: The specific numbers cited ($282M gain, 21.6% sale, $261M adjustment, 22.7% ownership) appear reasonable and internally consistent with typical SEC filing disclosures, though they cannot be independently verified from the provided context. The percentages and dollar amounts are presented with appropriate precision. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between stock price changes, equity method accounting, ownership interest, and financial statement impact. The logic flow is sound and demonstrates understanding of how investment accounting works. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (impact on financial statements and reflection of ownership interest) with specific, concrete examples that enhance credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 574,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 was **$144 million**, representing a **$30 million decrease** from the 2023 net value of $174 million, as shown in the amortization table on page 83.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data is correct: 2024 net value of $144 million, 2023 net value of $174 million, and the decrease of $30 million. The calculation is accurate ($174M - $144M = $30M). The answer properly identifies the company (PEP), the metric (Other Identifiable Intangibles), the years (2023 and 2024), and the source (amortization table). The multi-hop reasoning is sound - the model correctly synthesized the 2024 value, the 2023 value, and calculated the year-over-year change. The only minor distinction from the ground truth is the explicit inclusion of 'million' units in the LLM answer ($144 million vs. $144), but this is a formatting variation that enhances clarity rather than detracting from accuracy. The answer directly addresses both parts of the multi-part question: (1) the total net value in 2024, and (2) the decrease from 2023 to 2024. The reference to 'page 83' adds helpful contextual detail about the source document.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 286,
        "total_tokens": 1390
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "In 2023, revenue from nuclear-powered submarines was **$8,631 million**, compared to **$2,698 million** from surface ships. This significant disparity highlights the strategic importance of submarine programs like the Columbia-class and Virginia-class, which dominate the Marine Systems segment's revenue, driven by long-term contracts and high-demand defense priorities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $8,631 million for nuclear-powered submarines and $2,698 million for surface ships in 2023. The quantitative data is precise and properly formatted. The answer correctly identifies the strategic submarine programs (Columbia-class and Virginia-class) and appropriately contextualizes their importance. However, the answer has minor omissions compared to the ground truth: (1) It does not explicitly calculate or mention the 3.2:1 ratio that was highlighted in the original answer, (2) It lacks the specific reference to 'General Dynamics' Marine Systems segment' as the source entity, though this is implied, and (3) It omits the explicit mention of 'top acquisition priority' and 'substantial investment' details that were in the ground truth. The multi-hop reasoning is soundthe answer successfully synthesizes submarine revenue data with surface ship data and connects this to strategic importance. The semantic meaning is well-preserved, and the answer directly addresses the comparison requested in the question. The minor gaps in completeness (missing ratio calculation and some contextual details) prevent a perfect score, but the core factual content and reasoning are solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 355,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion from $1.2 billion (December 31, 2020) to $1.5 billion (December 31, 2021). In contrast, the fair value of marketable debt securities decreased by $0.4 billion, from $9.0 billion (2020) to $8.6 billion (2021). Thus, the change in Stellantis warrants was an increase, while marketable debt securities experienced a decrease over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: Stellantis warrants increased from $1.2B to $1.5B (change of +$0.3B), and marketable debt securities decreased from $9.0B to $8.6B (change of -$0.4B). All dates are accurate (December 31, 2020 and December 31, 2021). The multi-hop reasoning is sound - the model correctly synthesized information about two different asset classes and made the appropriate comparison showing contrasting trends. The answer directly addresses both parts of the question: (1) the change in Stellantis warrants fair value, and (2) how this compares to the change in marketable debt securities. The wording is clear and semantically equivalent to the ground truth, effectively conveying that one investment increased while the other decreased. The only minor distinction from the ground truth is that the LLM answer uses slightly more concise phrasing (\"Thus, the change in Stellantis warrants was an increase, while marketable debt securities experienced a decrease\") versus the ground truth's more explicit statement about \"contrasting trends in the valuation of these two asset classes,\" but this is a stylistic difference that does not affect factual accuracy or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 351,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "The net decrease in the value of Acquired Franchise Rights from 2023 to 2024 is **$28 million** (from $626 million to $598 million). This decrease is reflected in the amortization expense, which fell by **$1 million** (from $75 million in 2023 to $74 million in 2024), consistent with the reduced net carrying value of the asset.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the net decrease in Acquired Franchise Rights ($28 million from $626M to $598M) and the 2024 amortization expense ($74 million). However, there is a critical issue with the multi-hop reasoning: The LLM states that amortization expense 'fell by $1 million (from $75 million in 2023 to $74 million in 2024)' and claims this is 'consistent with the reduced net carrying value.' This reasoning is problematic because: (1) The ground truth does not provide 2023 amortization expense data, so the $75M figure cannot be verified; (2) More importantly, the LLM's logic conflates two different concepts - the year-over-year change in amortization expense is not the primary driver of the net decrease in franchise rights value. The ground truth correctly states that the $28 decrease is 'partially attributable to the amortization expense of $74 in 2024,' meaning the 2024 amortization is a component of why the asset decreased, not that the change in amortization year-over-year explains the decrease. The LLM's interpretation suggests a causal relationship between the $1M drop in amortization and the $28M decrease in asset value, which is not logically sound. The core numbers are correct (the $28M decrease and $74M amortization), but the synthesis and reasoning about how these relate is flawed. The answer would have been stronger by simply stating that the $28M decrease reflects the cumulative effect of amortization and other adjustments, with $74M being the 2024 amortization component.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 420,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics in 2023 was **$570 million**, contributing to the overall **$775 million** increase in service costs. This compares to a **$600 million** increase in service sales for the same business unit and reason. Thus, the cost increase ($570M) was slightly lower than the sales increase ($600M), but both were significant drivers of the total service cost and sales growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $570 million service cost increase, $775 million overall service cost increase, and $600 million service sales increase. The calculation showing the $30 million difference ($600M - $570M) is accurate. The multi-hop synthesis correctly identifies the relationship between F-35 sustainment contracts at Aeronautics and their contribution to overall service metrics. However, there is one notable omission: the ground truth explicitly states the $775 million represents an 8% increase in service costs, which provides important context about the magnitude of this increase relative to the total. The LLM answer omits this percentage metric. Additionally, the ground truth explicitly notes this indicates 'a potential improvement in margin or profitability on these contracts,' which the LLM answer does not explicitly state, though it does note the cost increase was 'slightly lower than the sales increase.' The reasoning is sound and the semantic meaning is preserved, but the answer could be more complete by including the percentage context and explicit margin improvement observation. All entity identifications (Aeronautics, F-35 sustainment contracts, 2023) are correct, and the multi-hop reasoning properly synthesizes information across service costs and service sales metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 380,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "Accenture plc had a total share repurchase authority of $6.694 billion as of September 25, 2024, reflecting its strategy to return capital to shareholders through share purchases. This authority, which includes $4.0 billion approved in September 2024, underscores the company's commitment to enhancing shareholder value by repurchasing Class A Ordinary Shares as part of its long-term financial strategy, alongside dividends and other capital allocation initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: The total share repurchase authority of $6.694 billion ($6,694 million) is correct and properly formatted. The $4.0 billion approved in September 2024 is accurate. The date of September 25, 2024 is correct. All numerical values match the ground truth. COMPLETENESS: The answer addresses both parts of the question - the total repurchase authority amount and how it reflects the company's financial strategy. ENTITY ACCURACY: Accenture plc and Class A Ordinary Shares are correctly identified. The fiscal date is accurate. REASONING & SYNTHESIS: The LLM correctly synthesizes the multi-hop information by connecting the $4.0 billion new authorization to the total $6.694 billion authority, demonstrating understanding of how the authorization was built up. The answer appropriately contextualizes this within the company's broader capital allocation strategy. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer expands slightly beyond the ground truth by mentioning dividends and other capital allocation initiatives, which adds relevant context but wasn't explicitly stated in the original answer. The LLM uses slightly different framing (\"return capital to shareholders\" vs. \"actively manage its equity structure\") but both convey the same strategic intent. The ground truth mentions \"open-market purchases and other share purchase programs\" while the LLM is less specific on this detail, but this is a minor omission that doesn't affect the core accuracy. Overall, the answer demonstrates strong multi-hop reasoning, accurate number synthesis, and appropriate contextualization of Accenture's financial strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 465,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "If Netflix fails to meet membership growth expectations, its fixed content costs would result in higher per-member cost structures, squeezing margins and reducing profitability. With limited ability to adjust expenditures or increase revenue per member, declining growth could impair liquidity and financial flexibility, particularly as expansion into live programming and new offerings require sustained investment. This could strain operational capacity and hinder long-term profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both responses correctly identify the core mechanism: Netflix's fixed content costs (particularly from live programming expansion) create inflexibility when membership growth falls short of expectations. The LLM answer accurately conveys that this leads to higher per-member costs, margin compression, reduced profitability, and impaired liquidity/financial flexibility. The reasoning is sound and multi-hop synthesis is correct - the answer properly connects: (1) fixed content costs, (2) membership growth shortfall, (3) inability to adjust expenditures proportionally, (4) impact on per-member economics and margins, (5) consequences for profitability and financial flexibility. The LLM adds slightly more operational context by mentioning 'sustained investment' and 'operational capacity strain,' which are reasonable extensions of the core logic without contradicting the ground truth. No quantitative data was required in either answer, so quantitative accuracy is perfect. The semantic equivalence is strong - 'higher per-member cost structures' effectively conveys the same concept as 'not able to proportionally increase per-member revenue or adjust expenditures.' Minor difference: the ground truth emphasizes 'non-adjustable' costs more explicitly, while the LLM emphasizes 'limited ability to adjust,' but these are semantically equivalent. The answer fully addresses the question's multi-part structure regarding financial flexibility and profitability impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 424,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The total carrying value of the 5.15% 2041 Notes was **$729 million**, which represents **2.19%** of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. According to the debt exchange table on page 132, **$245 million** of these notes was exchanged in the 2020 Exchange Offer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) The carrying value of $729 million is accurate, (2) The percentage calculation of 2.19% is correct ($729M / $33,309M = 2.19%), (3) The total debt figure of $33,309 million is accurate, (4) The principal amount exchanged of $245 million is correct. The answer successfully synthesizes multi-hop information by combining the specific note's carrying value with the total debt figure to calculate the percentage. The entity identification is correct (AMGN, 2022 fiscal year, 5.15% 2041 Notes). The only minor enhancement in the LLM answer is the additional contextual detail about the '2020 Exchange Offer' and page reference, which adds helpful specificity beyond the ground truth but does not contradict it. The answer addresses all parts of the multi-part question: (1) carrying value percentage, (2) principal amount exchanged. The reasoning is sound and the semantic meaning matches the ground truth perfectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 290,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "McDonald's writes off **all goodwill** associated with a Company-operated restaurant sold **within 24 months** of acquisition. If sold **beyond 24 months**, the goodwill write-off is based on the **relative fair value** of the business sold compared to the reporting unit. This distinction reflects the Company's accounting policy to fully recognize goodwill impairment in short-term disposals and proportionally adjust it for longer-term sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about McDonald's goodwill accounting. (1) CORRECTNESS VERIFICATION: The core facts are accurate - the 24-month threshold is correctly identified, the full goodwill write-off for sales within 24 months is correct, and the relative fair value approach for sales beyond 24 months matches the ground truth. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this question, and the temporal threshold (24 months) is stated correctly in both the original and LLM answers. (3) MULTI-HOP REASONING: The LLM successfully synthesized the relationship between acquisition timing, sale timing, and goodwill accounting treatment. The answer correctly connects the acquisition event, the 24-month decision point, and the two different accounting outcomes. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'writes off all goodwill' is semantically equivalent to the ground truth's 'written off in its entirety.' The explanation of 'proportionally adjust it for longer-term sales' accurately captures the 'relative fair value' concept. (5) MINOR OBSERVATION: The LLM adds interpretive language ('reflects the Company's accounting policy to fully recognize goodwill impairment in short-term disposals') that goes slightly beyond the factual statement in the ground truth, but this interpretation is logically sound and does not contradict the original answer. The answer is well-structured, clear, and directly addresses all aspects of the question without omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 439,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "AIG's equity method income from Corebridge after the deconsolidation date in 2024 was **$601 million**. This income was calculated based on dividends received from Corebridge and changes in its stock price during the post-deconsolidation period, as reflected in the table on page 109 of the 2024 Form 10-K. The equity method income represents the sum of dividends received and the fair value adjustments of AIG's retained interest in Corebridge following the deconsolidation on June 9, 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a specific dollar amount ($601 million) for AIG's equity method income from Corebridge after deconsolidation, which the ground truth does not explicitly state. The ground truth describes the calculation methodology (dividends received plus changes in stock price) and the 48.4% ownership stake, but does not provide a specific numerical figure. The LLM answer correctly identifies: (1) the deconsolidation date as June 9, 2024, (2) the calculation basis as dividends received and fair value adjustments/stock price changes, (3) the post-deconsolidation period from June 9 to December 31, 2024, and (4) the reference to page 109 of the 2024 Form 10-K. The methodology explanation is accurate and aligns with equity method accounting principles. However, without access to the actual 10-K filing to verify the $601 million figure, there is uncertainty about whether this specific number is correct. The LLM does not mention the 48.4% ownership stake that the ground truth emphasizes, which is a minor omission. The answer is well-structured, addresses the multi-hop nature of the question (combining deconsolidation date, calculation method, and time period), and provides appropriate context. The semantic equivalence is strong - both answers describe the same calculation methodology. The main risk is the unverified $601 million figure, which could be incorrect, but the methodology and reasoning are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 397,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "McDonald's franchisees contribute approximately **93%** to the global workforce, as over 2 million individuals work in franchised restaurants compared to 150,000 Company employees. The company's recruitment initiative for diverse franchisees, which reduces upfront equity requirements and offers learning and development support, aims to increase representation of underrepresented groups by lowering barriers to entry and fostering inclusive growth within the franchisee demographic.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. QUANTITATIVE VERIFICATION: The 93% franchisee workforce contribution is correct, with the supporting numbers accurate (2 million+ franchised restaurant workers vs. 150,000 company employees). The calculation is sound: 2,000,000/(2,000,000+150,000)  93%. COMPLETENESS: The answer addresses both sub-questions: (1) the percentage contribution of franchisees to global workforce, and (2) how the recruitment initiative aims to influence demographic composition. ENTITY ACCURACY: McDonald's is correctly identified, and all relevant metrics and initiatives are properly referenced. REASONING: The multi-hop synthesis is sound - the answer correctly connects the workforce composition data with the diversity initiative details (reduced equity requirements, learning/development support, targeting underrepresented groups). SEMANTIC EQUIVALENCE: The LLM's phrasing 'lowering barriers to entry and fostering inclusive growth' effectively conveys the same meaning as the ground truth's 'reducing upfront equity requirements and providing ongoing learning and development.' Minor differences in wording ('approximately 93%' vs. 'over 93%') are negligible and represent acceptable variation. The answer is well-structured, factually precise, and demonstrates clear understanding of the multi-hop relationship between franchisee workforce contribution and diversity initiatives. No material omissions or errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 414,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program (CMHP) and lower Black Hawk production volume in 2023 reduced RMS's operating profit by $41 million (2%) compared to 2022. This decline was partially offset by favorable adjustments and higher volume on the Aegis program. In contrast, Sikorsky programs contributed to a backlog increase of $2.777 billion (from $34.949 billion to $37.726 billion), reflecting stronger order intake despite the operational challenges, highlighting a divergence between short-term profit pressures and long-term backlog growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers: the $100 million unfavorable profit adjustment on CMHP, the $41 million overall operating profit decrease for RMS, and the backlog increase figures ($34.949 billion to $37.726 billion, representing a $2.777 billion increase). The multi-hop reasoning is sound, correctly synthesizing information about the negative impact of CMHP and Black Hawk production volume on operating profit while acknowledging partial offsets from IWSS programs and Aegis volume increases. The answer appropriately contrasts short-term profit pressures with long-term backlog growth, addressing both parts of the complex question. Minor strengths include the specific backlog dollar amounts and the percentage notation (2%) for context. One minor omission is that the ground truth explicitly mentions the $65 million favorable adjustment on IWSS programs, which the LLM answer references more generally as 'favorable adjustments' without the specific dollar amount. The LLM answer adds valuable context by quantifying the backlog increase and explicitly highlighting the divergence between profit and backlog metrics, which enhances understanding. The reasoning chain is logically sound: negative factors (CMHP adjustment, Black Hawk volume)  profit decline, partially offset by positive factors (IWSS adjustments, Aegis volume)  net $41M decrease, yet backlog still increased due to order intake. All entity identifications are correct (RMS, Sikorsky, CMHP, Black Hawk, IWSS, Aegis), and the temporal context (2023 vs 2022) is properly maintained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 444,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "Broadcom's acquisition of VMware was valued at approximately **$30.8 billion in cash** and **$53.4 billion in fair value of stock**, totaling **~$84.2 billion**. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services, private/hybrid cloud environments, and enterprise software, strengthening its position as a leader in modernizing and securing complex IT infrastructures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: The cash component ($30.8B) matches the ground truth ($30,788M), the stock component ($53.4B) matches ($53,398M), and the total ($84.2B) matches ($84,186M). All numbers are correct with acceptable format variations (billions vs millions). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) total acquisition value with breakdown, and (2) strategic alignment with infrastructure software focus. ENTITY ACCURACY: Broadcom and VMware are correctly identified, and the acquisition is properly contextualized. REASONING & SYNTHESIS: The LLM correctly synthesizes the financial structure (cash + stock = total) and connects it to strategic benefits. The strategic alignment explanation is sound, mentioning multi-cloud services, hybrid/private cloud environments, and enterprise software modernization/security. MINOR DIFFERENCES: The LLM adds slightly more detail about 'private/hybrid cloud environments' and 'modernizing and securing complex IT infrastructures' compared to the ground truth's 'multi-cloud services and enabling digital innovation with enterprise control.' These additions are reasonable elaborations that don't contradict the ground truth and enhance the answer's relevance. The use of 'approximately' and '~' is appropriate given the context of large acquisition values. No calculation errors detected. The answer demonstrates sound multi-hop reasoning by connecting financial data to strategic business implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 423,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The introduction of the $6.99 ad-supported tier aligns with Netflix's strategy to balance average revenue per user (ARPU) with broader market penetration by attracting price-sensitive customers. This tier likely contributed to the 18% year-over-year increase in global paid memberships by expanding access to new users, particularly in price-sensitive markets, while maintaining overall revenue growth through a mix of higher-ARPU subscriptions and lower-cost tiers. The companys focus on scaling membership base complements its long-term goal of increasing market share, even if it means accepting lower ARPU in certain segments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core relationship between Netflix's $6.99 ad-supported tier and the 18% year-over-year membership growth. All numeric values are correct (18% YoY increase, $6.99 price point). The answer correctly identifies the strategic tradeoff between ARPU and market penetration, and accurately explains how the lower-priced tier attracts price-sensitive consumers to drive membership expansion. However, there are notable differences from the ground truth: (1) The LLM answer emphasizes 'maintaining overall revenue growth through a mix of higher-ARPU subscriptions and lower-cost tiers,' which is not explicitly stated in the ground truth and may overstate revenue optimization claims. The ground truth more clearly states the tier 'likely accelerated membership expansion while moderating average revenue per user growth,' suggesting a clearer acknowledgment of the ARPU tradeoff. (2) The LLM answer includes the phrase 'even if it means accepting lower ARPU in certain segments,' which aligns with ground truth but is somewhat hedged compared to the ground truth's more direct statement about the explicit tradeoff. (3) The ground truth emphasizes Netflix's 'explicit acknowledgment in its filings' of this tradeoff, which the LLM answer doesn't reference, missing a key evidentiary element. The multi-hop reasoning is soundcorrectly synthesizing the pricing decision, membership growth, and strategic positioning. The answer is semantically equivalent on core points but lacks the specificity about filing disclosures and is slightly less precise about the ARPU moderation aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 446,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "The total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised locations, was **over 2.15 million** as of December 31, 2023 (150,000 Company employees + over 2 million franchised employees). This workforce is critical to McDonald's purpose of \"feeding and fostering communities\" and its mission to create \"delicious feel-good moments easy for everyone.\" Employees, both Company and franchisee, drive operational excellence, uphold brand standards, and support community initiatives like the Ronald McDonald House Charities and Youth Opportunity programs, aligning with the Company's commitment to inclusion, integrity, and sustainable growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The core numbers are correct - over 2.15 million total workforce (formatted as 2.15 million vs 2,150,000 in ground truth, which is an acceptable format variation), 150,000 Company employees, and over 2 million franchised employees. The date reference (December 31, 2023) adds helpful specificity not contradicted by the ground truth. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) total workforce numbers with breakdown by company vs franchised, and (2) how this workforce contributes to purpose/mission. ENTITY ACCURACY: McDonald's is correctly identified, and the purpose/mission statements are accurately quoted. REASONING QUALITY: The LLM demonstrates sound multi-hop synthesis by connecting workforce numbers to company purpose and providing specific examples (Ronald McDonald House Charities, Youth Opportunity programs) that illustrate the connection. The reasoning about how employees drive operational excellence and brand standards is logical and relevant. MINOR CONSIDERATIONS: The LLM provides additional context (specific programs, values like inclusion/integrity/sustainable growth) beyond the ground truth, which enhances rather than detracts from the answer. The ground truth states the workforce \"contributes to\" the purpose through \"delivering consistent, high-quality service,\" while the LLM expands this to include \"operational excellence, uphold brand standards, and support community initiatives\" - this is a reasonable elaboration that maintains semantic equivalence. No factual errors or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 456,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcoms portfolio of infrastructure and security software solutions.",
      "llm_answer": "The total fair value of the VMware acquisition by Broadcom was **$53.4 billion**, as disclosed in the VMware Merger details on page 38. This acquisition enhances Broadcom's infrastructure software capabilities by integrating VMware's multi-cloud services, cloud foundation solutions, and enterprise software offerings, strengthening Broadcom's ability to provide comprehensive, integrated infrastructure and security solutions for private and hybrid cloud environments, as highlighted in the Overview section (page 58) and Management's Discussion (page 37).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM answer states the total fair value was $53.4 billion, which is INCORRECT. The ground truth clearly states the total fair value was $84,186 million ($84.186 billion), comprised of $30,788 million in cash and $53,398 million in stock. The LLM appears to have confused the stock component ($53.398 billion) with the total acquisition value. This is a fundamental factual error on the primary quantitative question. The $53.4 billion figure represents only the stock portion, not the total fair value. QUANTITATIVE ACCURACY: The number cited ($53.4 billion) is factually incorrect as a total - it's only one component of the deal. The correct total should be $84.186 billion. This is a major calculation/synthesis error. QUALITATIVE ACCURACY: The qualitative description of how the acquisition enhances Broadcom's capabilities is reasonable and aligns with the ground truth (multi-cloud services, infrastructure and security solutions, enterprise control). However, this cannot compensate for the fundamental error in the primary quantitative metric. COMPLETENESS: The answer addresses both parts of the question (fair value and strategic enhancement), but fails critically on the first part. MULTI-HOP REASONING: The model failed to properly synthesize the acquisition structure - it needed to combine both the cash and stock components to arrive at the total fair value, but instead reported only the stock component. This represents a failure in multi-hop synthesis across the deal structure components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 425,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "Netflix's pricing strategy, which includes price increases to drive revenue growth, may conflict with retaining members during macroeconomic pressures. The 2024 10-K notes that rising inflation and economic challenges could reduce members' willingness to pay, while price hikes risk alienating existing subscribers. Although higher prices contributed to revenue growth (16% YoY), they could exacerbate churn if members perceive value declines, creating tension between short-term revenue goals and long-term retention needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core conflict between Netflix's pricing strategy and member retention amid macroeconomic pressures. The reasoning is sound and addresses the multi-hop synthesis required (pricing strategy + macroeconomic conditions + retention risk). The qualitative analysis of tension between short-term revenue and long-term retention is appropriate and well-articulated.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM introduces a specific claim that \"higher prices contributed to revenue growth (16% YoY)\" which is NOT supported by the ground truth answer. The ground truth does not mention a 16% YoY revenue growth figure or attribute it to price increases. This is a factual error that introduces unsupported data. The ground truth specifies membership plan pricing ranges between $1 and $32 per month as of December 31, 2024, but the LLM does not include this specific pricing range detail.\n\nMISSING DETAILS: The LLM omits the important detail about the specific price range ($1-$32/month) mentioned in the ground truth. The ground truth also notes that \"content costs are largely fixed and may not be adjusted in line with reduced growth,\" which is an important economic constraint not mentioned in the LLM answer. This constraint is relevant to understanding why pricing conflicts are particularly problematic.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the pricing strategy and macroeconomic conditions, but the introduction of the unsupported 16% growth figure undermines the accuracy of the synthesis. The logical connection between price increases, member perception of value, and churn risk is sound.\n\nSEMANTIC EQUIVALENCE: The core message aligns with the ground truth regarding the conflict, but the addition of unsupported quantitative claims reduces overall accuracy. The framing of \"short-term revenue goals vs. long-term retention needs\" is a reasonable interpretation but goes slightly beyond what the ground truth explicitly states.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 546,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "McDonald's goodwill from acquiring restaurants (e.g., from franchisees) is valued using a discounted cash flow methodology, which relies on projected future cash flows. Franchisee performance directly impacts these cash flows, as franchisees manage their operations and contribute to McDonald's revenues through royalties and rent. Poor franchisee performance could reduce expected cash flows, increasing the risk of goodwill impairment. If a restaurant is sold within 24 months of acquisition, the entire goodwill is written off; beyond 24 months, write-offs depend on the relative fair value of the sold business versus the reporting unit. Thus, franchisee underperformance may lead to goodwill impairments or write-offs, affecting financial results.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of McDonald's goodwill accounting and franchisee performance linkage. STRENGTHS: (1) Correctly identifies the discounted cash flow methodology for valuing acquired restaurants; (2) Accurately states the 24-month goodwill write-off rule (entire write-off within 24 months, relative fair value-based write-off after 24 months); (3) Properly explains how franchisee performance impacts cash flow projections and goodwill impairment risk; (4) Correctly synthesizes the multi-hop relationship between franchisee performance  cash flows  goodwill valuation  potential write-offs; (5) All numeric references (24 months) are accurate. MINOR GAPS: (1) The LLM answer frames the issue primarily as 'goodwill impairment' risk, while the ground truth emphasizes that poor franchisee performance leads to 'acquisition and early resale' scenarios that trigger the write-off rules. The ground truth more explicitly connects the causal chain: franchisee distress  restaurant acquisition by McDonald's  early resale  goodwill write-off. The LLM answer focuses more on impairment risk from declining cash flows rather than the acquisition-resale cycle; (2) The ground truth mentions that franchisees contribute through 'rent and royalties' as McDonald's revenue drivers, which the LLM answer includes but could emphasize more as the mechanism linking franchisee performance to McDonald's financial exposure; (3) The ground truth explicitly states that poor franchisee performance increases 'likelihood of restaurant closures or sales,' which is the trigger for McDonald's acquisition activitythe LLM answer doesn't explicitly connect this causal mechanism. QUANTITATIVE ACCURACY: All numbers and dates are correct (24-month threshold stated accurately). QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is present, though the causal chain could be more explicitly articulated. The answer correctly identifies all key accounting concepts and their relationships. CONTEXTUAL RELEVANCE: Highly relevant to the question, addressing both the franchise business model risks and goodwill valuation methodology as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 582,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities of advancing cutting-edge defense technologies and modernizing national security capabilities. The Space segment emphasizes hypersonics as a key growth driver, with programs focused on developing hypersonic strike weapons for the U.S. Army and Navy. These initiatives support the segment's goal of transitioning classified development efforts to production by 2026, enhancing operational readiness, and addressing evolving threats, thereby contributing to anticipated growth through advanced technology integration and program maturation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but has notable omissions and lacks specificity compared to the ground truth. CORRECT ELEMENTS: (1) Correctly identifies hypersonics programs as aligned with Space segment priorities, (2) Correctly mentions U.S. Army and Navy programs for hypersonic strike weapons, (3) Correctly references transition to production by 2026, (4) Appropriately connects to growth objectives. SIGNIFICANT OMISSIONS: (1) The ground truth explicitly states hypersonics is ONE OF FOUR key growth areas (alongside current programs of record, classified programs, and new awards) - the LLM answer fails to mention this critical context that demonstrates the relative importance and strategic positioning, (2) The ground truth references the 2023 10-K filing as the source document - the LLM answer does not cite this specific filing, (3) The ground truth mentions 'early production phases' specifically - the LLM generalizes this to 'production transition' without the same precision. REASONING ASSESSMENT: The LLM demonstrates sound multi-hop reasoning by connecting hypersonics programs to Space segment priorities and linking them to growth through 2026. However, the reasoning is less comprehensive than the ground truth, which explicitly frames hypersonics within a four-pillar growth strategy. The LLM adds interpretive language ('advancing cutting-edge defense technologies,' 'enhancing operational readiness') that, while reasonable, goes beyond what can be verified from the filing and may constitute over-interpretation. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is less critical. The year 2026 is correctly referenced in both. ENTITY ACCURACY: Lockheed Martin, Space segment, U.S. Army, and U.S. Navy are all correctly identified. The answer appropriately maintains focus on the Space segment rather than other segments. OVERALL ASSESSMENT: The answer is partially correct and demonstrates understanding of the basic alignment, but fails to capture the complete strategic context (the four-pillar growth framework) that is central to the ground truth answer. This represents a meaningful gap in completeness for a multi-hop synthesis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 600,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom valued VMware Cloud Foundation-related developed technology using the **multi-period excess earnings method** under the income approach. This technique estimates the present value of projected cash flows generated by the technology, adjusting for contributions from other assets. The economic useful life was determined based on the technology cycle and forecasted cash flows, reflecting its projected financial contribution over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both responses correctly identify the multi-period excess earnings method under the income approach as the valuation technique used by Broadcom for VMware Cloud Foundation-related developed technology. The LLM accurately captures the core methodology: estimating present value of projected cash flows, adjusting for contributions from other assets, and determining economic useful life based on technology cycle and forecasted cash flows. The answer correctly synthesizes the connection between valuation methodology and projected financial contribution. Minor stylistic differences exist (e.g., 'adjusting for contributions' vs 'subtracting charges that represent the contribution'), but these are semantically equivalent and reflect the same underlying concept. No quantitative data (numbers, dates, percentages) are present in either answer, so quantitative accuracy is perfect by default. The multi-hop reasoning is sound - the answer successfully links the valuation technique to its financial contribution projection mechanism. The response is complete, addressing all aspects of the question regarding methodology, technique, and the link to economic benefit over time. The only minor distinction is that the ground truth uses slightly more technical language ('charges that represent the contribution') while the LLM uses more general language ('adjusting for contributions'), but both convey identical meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 411,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The launch of Sky Glass contributed to increased costs in Comcast's Corporate and Other segment in 2021, as noted in the 2021 expenses, which were partially offset by prior-year cost savings from COVID-19-related severance initiatives. The company expected these costs to rise further in 2022 due to ongoing investments in Sky Glass and XClass TV, as stated in the document.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses both parts of the multi-part question effectively. (1) CORRECTNESS: The answer accurately identifies that Sky Glass launch contributed to increased costs in the Corporate and Other segment in 2021, and correctly states the company expected further cost increases in 2022 for continued rollout. The mention of XClass TV alongside Sky Glass is accurate and relevant. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in the original answer, so this dimension is fully satisfied. The answer correctly references 2021 and 2022 as the relevant time periods. (3) ENTITY ACCURACY: All entities are correctly identified - Comcast, Corporate and Other segment, Sky Glass, and XClass TV are all properly named and contextualized. (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the answer synthesizes information about 2021 costs and 2022 expectations across the filing. The connection between the product launch and segment expenses is clearly established. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth. One minor addition in the LLM answer mentions 'COVID-19-related severance initiatives' as the source of prior-year cost savings, which adds helpful context not explicitly stated in the ground truth but is consistent with typical corporate cost management. This is a minor enhancement rather than an error. The answer is well-structured, directly addresses the question, and demonstrates proper understanding of the multi-hop synthesis required. The slight deduction from a perfect score reflects that while the answer is excellent, the additional detail about COVID-19 severance, while likely accurate, goes slightly beyond what was explicitly confirmed in the ground truth statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 496,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "McDonald's writes off **all goodwill** associated with a restaurant acquired from a franchisee if it is sold within **24 months** of acquisition. If sold **beyond 24 months**, goodwill write-offs are based on the **relative fair value** of the business sold compared to the reporting unit. This policy results in **larger immediate write-offs** for early sales, impacting net income more significantly, while later sales allow for proportionate adjustments, reducing the financial impact on earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values and time periods are correct - the 24-month threshold is accurately stated, and the distinction between 'all goodwill' write-off within 24 months versus 'proportionate' write-off beyond 24 months is precise. No calculation errors or numeric discrepancies. ENTITY ACCURACY: McDonald's (MCD) is correctly identified, and the context of franchisee restaurant acquisitions is properly maintained throughout. COMPLETENESS: The answer addresses all major components of the original question: (1) valuation methodology reference (discounted cash flow/Level 3 inputs mentioned implicitly through fair value context), (2) 24-month threshold treatment, (3) differential goodwill write-off policies, and (4) financial implications on earnings/net income. REASONING QUALITY (9/10): The multi-hop synthesis is sound - the answer correctly connects the acquisition policy to goodwill treatment to financial impact. The logic that 'larger immediate write-offs for early sales' impact earnings more significantly while 'later sales allow proportionate adjustments' is accurate and well-reasoned. SEMANTIC EQUIVALENCE: The LLM's phrasing 'relative fair value of the business sold compared to the reporting unit' matches the ground truth's identical language. The characterization of financial implications (timing of write-offs, impact on net income) is semantically equivalent to the ground truth's statement about 'magnitude and timing of goodwill write-offs.' MINOR OBSERVATION: The LLM answer does not explicitly mention the 'discounted cash flow methodology (Level 3 inputs)' that appears in the ground truth, though this is a minor omission that doesn't affect the core correctness of the goodwill treatment policy itself. The answer focuses appropriately on the policy mechanics and financial implications, which are the primary focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 535,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "Boeing's concentration risk in its customer financing portfolio, particularly in 717 and 747-8 aircraft, amplifies financial vulnerability from the $1.8 billion in defaults linked to the pandemic by concentrating exposure to specific aircraft types and customers with weaker credit profiles. If these customers face liquidity crises or default due to reduced airline revenues and cash flows from the pandemic, Boeing risks significant losses from unredeployable aircraft and concentrated credit exposure, exacerbating cash flow pressures and financial instability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop financial question and correctly synthesizes information across multiple concepts. STRENGTHS: (1) All key numeric values are accurate - correctly references the $1.8 billion portfolio defaults and identifies 717 and 747-8 aircraft as concentration risk areas; (2) The multi-hop reasoning is sound, properly connecting concentration risk  customer defaults  pandemic impact  financial vulnerability; (3) The answer correctly identifies the causal chain: pandemic reduces airline revenues/cash flows  defaults increase  concentrated exposure amplifies losses; (4) Semantic equivalence is maintained - 'amplifies financial vulnerability' and 'heightens Boeing's risk' convey the same meaning as the ground truth. MINOR WEAKNESSES: (1) The phrase 'weaker credit profiles' is introduced but not explicitly stated in the ground truth, though it's a reasonable inference from the context; (2) The answer could have been slightly more explicit about the 'material adverse effects on financial position, results of operations, and cash flows' mentioned in the ground truth, though the concept is implied through 'cash flow pressures and financial instability'; (3) The phrase 'unredeployable aircraft' adds specificity not in the ground truth, though it's contextually appropriate. QUANTITATIVE VERIFICATION: The $1.8 billion figure is correctly cited, aircraft types (717, 747-8) are correctly identified, and no calculations are required or performed. The answer maintains factual accuracy throughout without numerical errors. MULTI-HOP SYNTHESIS: The answer successfully integrates three key elements: (1) concentration risk in specific aircraft, (2) the $1.8 billion default portfolio, and (3) COVID-19 pandemic impact on airline finances, showing proper understanding of how these factors compound each other.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 508,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The launch of Sky Glass in Q4 2021 contributed to a **86.1% revenue increase** in CMCSA's Corporate and Other segment in 2021, driven by sales of Sky Glass televisions. However, **costs associated with the launch** (alongside XClass TV) partially offset prior-year cost savings from COVID-19-related severance initiatives, leading to a **10.5% decrease in operating expenses** compared to 2020. These costs were explicitly noted in the segment's expenses, which included investments in new product initiatives like Sky Glass.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported quantitative claims. CRITICAL ISSUES: (1) The LLM provides specific percentages (86.1% revenue increase, 10.5% decrease in operating expenses) that are NOT present in the ground truth answer and appear to be fabricated or hallucinated. The ground truth explicitly states only that Sky Glass 'contributed to increased revenue' and 'led to higher expenses' without providing specific percentage figures. (2) The LLM conflates multiple concepts - it mentions XClass TV alongside Sky Glass, which is not addressed in the ground truth, suggesting potential confusion or mixing of information from different sources. (3) The LLM references 'COVID-19-related severance initiatives' and cost savings comparisons to 2020, which are not mentioned in the ground truth answer. (4) The ground truth answer is qualitative and directional (increased revenue, higher expenses, partial offset), while the LLM answer is quantitatively specific without justification. WHAT WAS CORRECT: The LLM correctly identifies that Sky Glass launched in Q4 2021, correctly names CMCSA and the Corporate and Other segment, and correctly identifies the dual impact of revenue generation and cost investment. However, these correct elements are overshadowed by the fabricated numerical specificity. The answer demonstrates partial understanding of the multi-hop reasoning required (connecting product launch to segment performance) but fails on factual accuracy by introducing unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 424,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "The total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, was **$975 million**. This category represented **$100 million** in gross unrealized losses, which accounted for **12%** of the total **$836 million** unrealized losses across CVS's entire debt securities portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR: The LLM provided an incorrect fair value for commercial mortgage-backed securities. Ground truth states $675 million, but LLM answered $975 million - a difference of $300 million (44% overstatement). This is a major factual error on the primary metric requested. CORRECT ELEMENTS: The unrealized loss amount ($100 million) is correct, the percentage calculation (12%) is correct, and the total unrealized losses figure ($836 million) is correct. The LLM correctly synthesized the multi-hop relationship between the specific security category's unrealized losses and the total portfolio unrealized losses. ANALYSIS: The LLM demonstrated sound reasoning in calculating and presenting the 12% proportion ($100M / $836M  12%), and correctly identified all entities and time periods. However, the fundamental error in the fair value figure ($975M vs $675M) is a critical quantitative mistake that undermines the entire answer. This appears to be a data retrieval or calculation error rather than a reasoning problem. The answer addresses all parts of the question but fails on the most important numerical component. The error is not a minor formatting issue but a substantial factual discrepancy that would mislead users about CVS's securities holdings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 355,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "The growth in third-party seller unit sales contributed to Amazon's 2023 sales increase by driving **11% growth in International net sales**, primarily through higher unit sales (led by third-party sellers), advertising revenue, and subscription services. This expansion was supported by Amazon's focus on price, selection, and convenience, which attracted more third-party sellers and customers.  \n\nA key international risk is **regulatory restrictions in China and India**, where third-party sellers account for significant portions of Amazon's third-party services and advertising revenue. PRC and Indian laws may limit foreign ownership, impose cybersecurity requirements, or restrict data flows, potentially disrupting third-party seller operations and hampering Amazon's ability to scale in these markets. Such regulations could force Amazon to alter its business model or reduce its presence, directly impacting international growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM states '11% growth in International net sales' but the ground truth specifies Amazon's overall sales increase was 12% in 2023. The LLM conflates the International segment growth rate (11%) with the overall company growth rate (12%), which is a critical numerical error. The ground truth clearly indicates the 12% figure applies to overall sales increase, not just International. PARTIAL CREDIT FOR INTERNATIONAL RISKS: The LLM correctly identifies regulatory restrictions as a key international risk and mentions India, which aligns with the ground truth. However, the LLM introduces China (PRC) as a major risk factor, which is NOT mentioned in the ground truth answer. The ground truth specifically highlights India's foreign ownership rules as the primary concern. The LLM's addition of China appears to be extrapolation beyond what the knowledge graph provided. INCOMPLETE SYNTHESIS: The ground truth emphasizes that India's foreign ownership rules 'limit control over online retail platforms' and complicate 'Amazon's expansion and reliance on third-party sellers.' The LLM mentions regulatory restrictions more broadly but doesn't specifically address the foreign ownership limitation aspect that is central to the ground truth. STRENGTHS: The LLM correctly identifies third-party seller growth as a contributor to sales increase and mentions multiple revenue drivers (advertising, subscription services). The reasoning about how regulations could impact business model is sound. WEAKNESSES: (1) Incorrect quantitative claim about 11% vs 12% growth, (2) Introduces China without ground truth support, (3) Doesn't emphasize the specific foreign ownership restriction mechanism highlighted in ground truth, (4) Conflates different growth metrics without clear distinction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 495,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "The number of shares remaining available for future issuance under the Deferred Compensation Plan is 1,853,363, while for the Non-Qualified Deferred Compensation Plan for Independent Contractors it is 140,553. The difference is **1,712,810 shares**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) CORRECTNESS: All factual information is correct. The answer correctly identifies the two plans (Deferred Compensation Plan and Non-Qualified Deferred Compensation Plan for Independent Contractors) at Wells Fargo for 2023. (2) QUANTITATIVE ACCURACY: All numbers are verified as correct: Deferred Compensation Plan has 1,853,363 shares available, Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares available. The calculation is accurate: 1,853,363 - 140,553 = 1,712,810 shares, which matches the ground truth answer exactly. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two different compensation plans and correctly performs the subtraction to determine the difference. The reasoning is sound and logical. (4) COMPLETENESS: The answer addresses all parts of the question by providing both individual share counts and the final difference calculation. The answer goes beyond the minimum requirement by showing the work, which enhances clarity. (5) SEMANTIC EQUIVALENCE: The answer conveys the exact same information as the ground truth, with clear presentation of the intermediate values and final result.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 349,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "PMI's reduced-risk product line includes heated tobacco units (HTUs), heat-not-burn devices, related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units, which encompass brands like HEETS, Marlboro HeatSticks, and Parliament HeatSticks, contribute to this classification by delivering nicotine through heating tobacco rather than burning it, thereby reducing the production of certain harmful constituents compared to traditional combustible cigarettes. This aligns with PMI's focus on developing products that lower health risks associated with tobacco use.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies all product categories in PMI's reduced-risk product line: heated tobacco units, heat-not-burn devices, related accessories, and other nicotine-containing products (e-vapor and oral nicotine products). This matches the ground truth exactly. The answer goes beyond the ground truth by providing specific brand examples (HEETS, Marlboro HeatSticks, Parliament HeatSticks) and explaining the mechanism of how heated tobacco units contribute to the reduced-risk classification. (2) QUANTITATIVE ACCURACY: No numerical data was required for this question, so this dimension is not applicable. The answer contains no numbers, dates, or calculations to verify. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes information about what products are included AND how heated tobacco units specifically contribute to the reduced-risk classification through their heating mechanism rather than burning, which reduces harmful constituents. The explanation of the mechanism (heating vs. burning) is accurate and relevant. (4) ENTITY ACCURACY: PMI is correctly identified, the 2022 10-K filing is correctly referenced, and all product categories are accurately named. (5) SEMANTIC EQUIVALENCE: The answer conveys all information from the ground truth while adding valuable context about brand names and the scientific basis for the reduced-risk classification. The only minor distinction is that the LLM provides additional explanatory detail beyond what was in the ground truth, which enhances rather than detracts from the answer. The answer fully addresses both parts of the multi-part question: what categories are included AND how heated tobacco units contribute to this classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 494,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVIDIA's total revenue. For the previous year (fiscal 2024), DirectCustomerA's revenue contribution was less than 10%, as it did not meet the 10% threshold for disclosure in the provided data.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding fiscal year 2024 data. The ground truth explicitly states that DirectCustomerA's contribution was 'not disclosed (marked as '*')' in fiscal 2024, meaning the data was not available or reported. The LLM incorrectly claims that DirectCustomerA's revenue contribution 'was less than 10%' in fiscal 2024, which is a false inference. The ground truth makes clear that no numerical comparison can be made because 2024 data was not disclosed at all. The LLM's statement that it 'did not meet the 10% threshold for disclosure' is an unsupported assumption that contradicts the ground truth's explicit statement that data was not disclosed. The fiscal 2025 figure of 12% is correct. However, the core reasoning about the previous year is fundamentally wrong - the LLM fabricated an explanation for missing data rather than acknowledging that the data was simply not disclosed. This is a significant error in multi-hop reasoning and factual accuracy, as the comparison itself cannot be made numerically, which the ground truth correctly identifies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 313,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "Wells Fargo's 2023 10-K filing references **two distinct versions** of the Restricted Share Rights Award Agreement: one for grants on or after **January 24, 2023** (incorporated by reference to Exhibit 10(a) to the 2022 10-K) and another for grants on or after **January 23, 2024** (filed herewith in the 2023 10-K). Thus, **two distinct versions** were filed or incorporated by reference for the specified dates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies two distinct versions of the Restricted Share Rights Award Agreement, matching the ground truth answer. (2) All dates are accurate: January 24, 2023 and January 23, 2024 are correctly stated. (3) Properly distinguishes the filing methods: one incorporated by reference (to 2022 10-K Exhibit 10(a)) and one filed herewith in the 2023 10-K. (4) The answer directly addresses the multi-part question by specifying both versions and their respective filing/incorporation methods. (5) Provides helpful context by citing the specific exhibit reference and clarifying which document each version appears in. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by providing additional detail about where each version is located (Exhibit 10(a) to 2022 10-K vs. filed herewith in 2023 10-K), but this is supplementary information that enhances rather than contradicts the answer. The core factual contenttwo distinct versions for the specified datesmatches perfectly. The multi-hop reasoning is sound: the model correctly synthesized information about both versions and their respective filing statuses from Wells Fargo's 2023 10-K. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 364,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The continued uncertainty in FAA approval timelines for the 787 Program in 2022 increased estimation risks for Boeing's cost of sales and margin forecasting. As detailed in the critical audit matter (page 136), delays in FAA approval created significant judgment challenges in determining which aircraft would reach contractual termination rights, leading to potential additional consideration costs and lower margins. This uncertainty contributed to a **reach-forward loss** on the 787 program, which directly impacted cost of sales and margin estimates. The audit highlighted that changes in delivery resumption dates could result in further material losses, requiring Boeing to adjust forecasts and account for higher costs and reduced margins due to prolonged delays and contractual risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core issue - FAA approval uncertainty for the 787 Program impacting cost of sales and margin forecasting through reach-forward losses and contractual termination risks. The qualitative reasoning about judgment challenges, customer considerations, and margin impacts is sound and well-articulated. The reference to the critical audit matter on page 136 is appropriate contextual support.\n\nCRITICAL WEAKNESS - QUANTITATIVE ACCURACY: The original answer provides a specific, verifiable financial metric: \"2021 cost of sales saw a $4,574 million decrease compared to 2020.\" The LLM answer completely omits this quantitative anchor. This is a significant omission because the question explicitly asks about impact on \"cost of sales and margin forecasting\" - the $4,574 million figure directly demonstrates the magnitude of this impact and is essential to answering the question comprehensively.\n\nADDITIONAL ISSUES: (1) The LLM answer references 2022 uncertainty but the ground truth specifically ties the impact to 2021 cost of sales data, creating a temporal inconsistency. (2) The LLM answer discusses potential future impacts (\"could result in,\" \"could result in further material losses\") rather than documenting the actual realized impact shown in the 2021 financials.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis of the relationship between FAA delays  contractual termination risks  reach-forward losses  margin impacts. However, it fails to complete the full multi-hop chain by not connecting these factors to the actual quantified financial outcome ($4,574 million cost of sales decrease).\n\nSEMANTIC EQUIVALENCE: While the qualitative descriptions are semantically equivalent to the ground truth, the absence of the specific financial metric represents a material gap in answering a question about financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 515,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "Third-party sellers significantly contributed to Amazon's North America and International sales growth in 2023, driving increased unit sales, advertising revenue, and subscription services in both regions. The net effect of foreign exchange rate changes was a **$88 million increase in International net sales** due to FX, while overall net sales were reduced by **$71 million** from FX impacts. This reflects a mixed effect, with FX boosting International sales but reducing total sales when considering all regions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that third-party sellers were a key driver of growth in both North America and International segments. (2) All FX-related numbers are accurate: $88 million increase in International sales, $71 million reduction in North America sales. (3) The LLM correctly notes the mixed impact of FX changes. (4) Number formatting is acceptable.\n\nWEAKNESSES: (1) The LLM fails to mention the specific growth percentages (12% for North America, 11% for International) that were explicitly stated in the ground truth answer. This is a significant omission for a multi-hop question requiring comprehensive synthesis. (2) The LLM's statement about the net effect is somewhat unclear and potentially misleading. The ground truth specifies a net positive impact of $17 million ($88M - $71M), but the LLM says FX 'reduced total sales' without clearly stating the net positive effect. (3) The LLM doesn't explicitly synthesize that the $17 million net positive impact resulted from combining the International gain and North America loss. (4) The answer lacks the structured breakdown of the three drivers in North America (unit sales, advertising, subscription services) that the ground truth provides.\n\nCALCULATION VERIFICATION: The net effect calculation is correct ($88M - $71M = $17M positive), though the LLM doesn't explicitly state this net figure. The individual FX impacts are accurate.\n\nMULTI-HOP REASONING: The LLM partially synthesizes the information but misses key details about growth percentages and doesn't clearly articulate the net positive FX impact. The reasoning is incomplete for a comprehensive answer to this multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 459,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions, as the USA PATRIOT Act requires federal banking regulators (e.g., the Federal Reserve Board, OCC, and FDIC) to evaluate an applicant's effectiveness in combating money laundering when approving acquisitions. Regulatory bodies would assess these deficiencies during the approval process to ensure compliance with AML requirements, potentially delaying or blocking acquisitions if weaknesses are identified.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the Federal Reserve Board (FRB) as the primary regulatory body responsible for assessing AML deficiencies during acquisition approval, which matches the ground truth. (2) Accurately notes that federal banking regulators evaluate AML compliance effectiveness when approving acquisitions under USA PATRIOT Act requirements. (3) Correctly explains the constraint mechanism - that deficiencies could delay or block acquisitions. (4) Appropriately mentions multiple regulatory bodies (FRB, OCC, FDIC) that may be involved, which is factually accurate and adds helpful context. (5) No quantitative errors or incorrect dates/numbers. MINOR DIFFERENCES: (1) The LLM answer is slightly broader in scope by mentioning multiple regulators (OCC, FDIC) rather than focusing primarily on the FRB as the ground truth does. While this is not incorrect, the ground truth emphasizes the FRB's role more specifically. (2) The LLM answer uses slightly different phrasing ('federal banking regulators' vs. 'Federal Reserve Board') but this is semantically equivalent and actually more comprehensive. (3) The ground truth emphasizes the FRB's authority more directly, while the LLM distributes responsibility across multiple agencies. Both approaches are factually defensible based on actual regulatory structure. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between (a) USA PATRIOT Act requirements, (b) AML program deficiencies, (c) acquisition approval processes, and (d) regulatory assessment authority. The logic chain is sound and complete. The answer appropriately connects AML compliance to acquisition constraints through the regulatory approval mechanism.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 486,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020 was **2.4%**. Heated tobacco units fall under the **reduced-risk products** category in PMI's financial reporting, as they are included in revenues from heat-not-burn devices, related accessories, and other nicotine-containing products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: Both core facts are correct - the 2.4% increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 vs 2020 matches the ground truth exactly, and heated tobacco units are correctly identified as falling under 'reduced-risk products' category. (2) QUANTITATIVE ACCURACY: The percentage figure of 2.4% is precise and matches ground truth perfectly. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM correctly synthesized the multi-hop information by identifying both the percentage increase and the product category classification. The answer demonstrates proper understanding of PMI's financial reporting structure. (4) ADDITIONAL CONTEXT: The LLM provided supplementary detail by explaining that heated tobacco units are 'included in revenues from heat-not-burn devices, related accessories, and other nicotine-containing products.' This additional context is accurate and enhances understanding without contradicting the ground truth. The answer fully addresses both parts of the multi-part question. Minor deduction (1 point) only because the additional explanatory detail, while helpful and accurate, goes slightly beyond what was explicitly required in the ground truth answer, though this is a very minor consideration and demonstrates thoroughness rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 387,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "Boeing's potential losses could increase by approximately **$107.7 million** if all CCC-rated receivables within the $1.8 billion customer financing portfolio default. This calculation is based on the $445 million in CCC-rated receivables (as disclosed in Note 9 and Note 11 of the 10-K) and the 24.2% default rate applied to these receivables. The default rate is derived from the allowance for losses on receivables, which reflects Boeing's assessment of credit risk for CCC-rated assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the primary metric. (1) CALCULATION ERROR: The LLM states potential losses of $107.7 million, but the ground truth is $435.6 million. The correct calculation should be: $1.8 billion  24.2% = $435.6 million. The LLM's calculation of $445 million  24.2%  $107.7 million is mathematically correct for those inputs, but uses the wrong base amount. (2) ENTITY CONFUSION: The LLM identifies $445 million as CCC-rated receivables within the portfolio, but the question explicitly states the total portfolio is $1.8 billion. The ground truth answer applies the 24.2% default rate to the entire $1.8 billion portfolio, not a subset. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the relationship between the total portfolio size ($1.8 billion) and the default rate (24.2%). Instead, it introduced an unsupported figure of $445 million in CCC-rated receivables and applied the rate to that subset. (4) SEMANTIC MISMATCH: While the LLM correctly identifies the 24.2% default rate and references the $1.8 billion portfolio, it arrives at a dramatically different answer ($107.7M vs $435.6M), representing a 75% underestimation of potential losses. (5) DOCUMENTATION ISSUE: The LLM cites Note 9 and Note 11 for the $445 million figure, but this appears to be a misinterpretation of the source data. The ground truth clearly indicates the calculation should use the full $1.8 billion portfolio amount. This is a major factual error that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 424,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for **11%** of NVDA's total revenue. This compares to **less than 10%** in the previous fiscal year (ending January 28, 2024), indicating a slight increase in revenue contribution from DirectCustomerC.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states DirectCustomerC represented 'less than 10%' in FY2024, but the ground truth clearly states it was 11% in both years. This is a factual error on a key numeric value. (2) COMPARISON LOGIC - The LLM incorrectly characterizes the year-over-year change as 'a slight increase,' when the ground truth shows the percentage was unchanged at 11% in both fiscal years. This represents a fundamental misunderstanding of the comparison. (3) MULTI-HOP REASONING - While the LLM correctly identified the FY2025 figure (11%), it failed to accurately synthesize the prior year data, which is essential for answering the comparative question. (4) WHAT WAS CORRECT - The LLM correctly identified that DirectCustomerC accounted for 11% in FY2025 and correctly identified the fiscal year ending date (January 26, 2025). The question was addressed with appropriate relevance. (5) JUSTIFICATION - The core requirement of this question is to compare two years of data. The LLM got one year right (11% for FY2025) but fundamentally misrepresented the prior year (stating 'less than 10%' instead of 11%), leading to an incorrect conclusion about the trend. This is a significant factual error that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 357,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "The total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, was **$975 million**. According to the investment maturity breakdown, the gross unrealized losses associated with these securities totaled **$100 million** (as reported in the table on page 149), with **$98 million** specifically attributed to the maturity categories detailed on page 150. This indicates that the unrealized losses are primarily driven by interest rate changes rather than credit quality deterioration.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FAIR VALUE AMOUNT - LLM states $975 million, but ground truth is $675 million. This is a 44% overstatement and represents a fundamental factual error. (2) UNREALIZED LOSSES - LLM correctly identifies $100 million in gross unrealized losses, matching ground truth. However, the introduction of $98 million attributed to 'maturity categories on page 150' is not mentioned in the ground truth and appears to be unsupported detail that may confuse the comparison. (3) PERCENTAGE CALCULATION - Ground truth provides 14.8% as the proportion of total unrealized losses; LLM does not calculate or provide this comparison metric, which was explicitly requested in the question. (4) MULTI-HOP SYNTHESIS - The question asks for a comparison between fair value and unrealized losses. Ground truth provides both numbers and the percentage relationship. LLM provides the unrealized losses correctly but fails on the primary metric (fair value), making the comparison invalid. (5) REASONING QUALITY - LLM adds interpretive commentary about 'interest rate changes rather than credit quality deterioration' which, while potentially reasonable, is not supported by the ground truth answer and represents speculation beyond the data. The core issue is the $300 million discrepancy in the fair value figure, which is a material error that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 384,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "The treatment of changes in estimated fair value of Unit-linked securities is included in **net investment income**, while changes in estimated fair value of derivatives (including embedded derivatives) are recorded in **net derivative gains (losses)**. This distinction arises because Unit-linked securities are classified as investments, and their fair value changes directly impact net investment income, whereas derivatives are accounted for separately under net derivative gains (losses), as noted in MetLife's disclosures (pages 252 and 249).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ANALYSIS: The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The core distinction that Unit-linked securities' fair value changes are in net investment income is accurate. (2) The identification that derivatives are in net derivative gains (losses) is correct. (3) The page references (252 and 249) appear plausible for MetLife disclosures. (4) The classification of Unit-linked securities as investments is accurate. PROBLEMATIC ELEMENTS: (1) The ground truth specifically mentions 'lapses associated with net embedded derivatives' as the key distinction, not general 'changes in estimated fair value of derivatives.' The LLM answer conflates all derivative fair value changes with the specific issue of embedded derivative lapses. (2) The ground truth emphasizes that lapses (a specific type of outcome) from embedded derivatives are in net derivative gains/losses, whereas the LLM generalizes this to all derivative fair value changes. (3) The LLM answer misses the nuance that the distinction is between 'valuation changes' (in net investment income) versus 'derivative-related outcomes/lapses' (in net derivative gains/losses). MULTI-HOP REASONING: The LLM correctly synthesized that there are two different accounting treatments for two different components, but failed to capture the specific nature of what goes into each category. The answer is partially correct but oversimplifies the distinction by not emphasizing the 'lapses' concept that is central to the ground truth answer. QUANTITATIVE ACCURACY: No specific numbers were required in this question, so this scores high. QUALITATIVE ACCURACY: The reasoning is logical but incomplete - it doesn't capture the specific distinction between valuation changes and derivative lapses that the ground truth emphasizes. This represents a meaningful gap in understanding the accounting treatment nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 512,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021 due to rework and extended delivery delays. The accounting methodology estimates revenue based on FAA approval timelines and delivery schedules, incorporating assumptions about resuming deliveries. Uncertainty around FAA approval could delay resumption, leading to lower revenue forecasts and higher costs, potentially resulting in additional losses if delivery delays or rework requirements exceed current estimates.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The $3.5 billion loss figure is correct and properly attributed to Q4 2021. (2) The quantitative accuracy is perfect - all numbers and dates are accurate. (3) The LLM correctly identifies the core issue: Boeing uses program accounting that estimates revenue based on delivery schedules and FAA approval timing. (4) The answer appropriately explains how FAA approval uncertainty affects revenue forecasts and could lead to additional losses. (5) The semantic meaning aligns well with the ground truth regarding the relationship between FAA approval timing and revenue estimation.\n\nWEAKNESSES: (1) The LLM answer mentions 'rework and extended delivery delays' as causes of the loss, which adds context not explicitly required but is reasonable inference. However, the ground truth focuses more on the accounting methodology impact rather than operational causes. (2) The ground truth specifically mentions 'contractual termination rights' and 'customer considerations' as specific mechanisms through which FAA approval uncertainty affects the program - the LLM answer addresses the general concept but doesn't explicitly mention these specific contractual/customer-related factors. (3) The ground truth emphasizes 'reach-forward losses' as a specific accounting outcome, while the LLM uses the more general term 'additional losses.' This is semantically similar but less precise to the specific accounting terminology. (4) The LLM answer could have been more explicit about the program accounting methodology's requirement to estimate revenue 'upon delivery of each aircraft' as the ground truth states.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between: (a) the specific loss amount, (b) the accounting methodology used, and (c) how FAA approval uncertainty propagates through revenue estimates. The logic chain is sound and demonstrates proper understanding of how accounting assumptions affect financial outcomes.\n\nOVERALL ASSESSMENT: The answer is substantially correct on all key facts and demonstrates solid understanding of the accounting implications. The minor gaps relate to not explicitly mentioning specific contractual mechanisms (termination rights, customer considerations) and the specific accounting term 'reach-forward losses,' but the core answer is accurate and addresses the question comprehensively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 631,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "In the fiscal year ending January 26, 2025, NVDA derived **12% of its revenue** from DirectCustomerA. For the prior fiscal year (ending January 28, 2024), the data for DirectCustomerA was **not disclosed** as it represented less than 10% of total revenue, indicating the threshold for disclosure was not met.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that NVDA derived 12% of revenue from DirectCustomerA in fiscal year ending January 26, 2025, which matches the ground truth. However, there is a significant error in the explanation for the prior fiscal year data. The ground truth states that data for DirectCustomerA in the prior fiscal year (January 28, 2024) is 'marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.' The LLM instead provides a speculative explanation that the data 'was not disclosed as it represented less than 10% of total revenue, indicating the threshold for disclosure was not met.' This is an incorrect interpretation. The ground truth does not indicate that the data was below a disclosure threshold; rather, it explicitly states the data is unavailable/marked with an asterisk. The LLM has inferred a reason (10% threshold) that is not supported by the ground truth. The quantitative accuracy is high (12% is correct, dates are correct), but the qualitative reasoning about why prior year data is unavailable is fundamentally flawed. The answer addresses both parts of the multi-part question but mischaracterizes the nature of the prior year data availability issue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 343,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "The total financial impact on Amgen from its collaboration with BeiGene in 2023, combining net cost recoveries, product sales, and profit/loss sharing expenses, was **$274 million**. This includes:  \n- **Net cost recoveries**: $109 million (offset to R&D expense).  \n- **Product sales**: $125 million (recorded in Product sales).  \n- **Profit/loss sharing expenses**: $40 million (recorded in SG&A expense).  \n\nThe fair value of Amgens equity investment in BeiGene is not explicitly detailed for 2023, but the provided data focuses on the collaborations operational financials, excluding fair value adjustments for the investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and incomplete. Critical issues: (1) MAJOR OMISSION: The LLM explicitly excludes the fair value of the equity investment ($4.2 billion), which is a core component of the question asking for 'total financial impact...combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses.' (2) INCORRECT TOTAL: The LLM calculates $274 million ($109M + $125M + $40M) as the total, but this excludes the $4.2 billion investment fair value that should be included per the question's explicit requirements. (3) CORRECT COMPONENT NUMBERS: The individual operational figures are accurate ($109M net cost recoveries, $125M product sales, $40M profit/loss sharing expenses), but these represent only a fraction of the requested total. (4) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks to combine four components: (a) fair value of investment, (b) net cost recoveries, (c) product sales, and (d) profit/loss sharing expenses. The LLM only synthesized three of four components and arrived at $274M instead of the correct $4.374 billion. (5) REASONING ERROR: The LLM's justification that 'fair value of Amgen's equity investment in BeiGene is not explicitly detailed for 2023' contradicts the ground truth which clearly identifies $4.2 billion as the investment fair value. The LLM's decision to exclude this major component represents a fundamental misunderstanding of what 'total financial impact' means in this context. The correct answer requires adding all four components: $4.2B + $109M + $125M + $40M = $4.374B.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 441,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "MetLife applies estimated lifetime loss rates for **two years** for most **residential mortgage loans** before reverting to historical loss experience over a **one-year straight-line basis**. For **commercial and agricultural mortgage loans**, the forecast period is **two years** for most loans, with a **one-year period** for loans in certain markets. After their respective forecast periods, losses revert to historical experience using a **two-year straight-line basis**. This differential approach reflects varying economic sensitivity and risk profiles across portfolio segments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states commercial/agricultural loans revert using a 'two-year straight-line basis,' but the ground truth specifies they revert over a two-year period (implying 4 years total duration). (2) The LLM introduces a confusing qualifier about 'loans in certain markets' having a 'one-year period' for commercial/agricultural loans, which is not mentioned in the ground truth and appears to be fabricated. (3) The LLM fails to clearly articulate the total duration comparison that is central to the question - the ground truth explicitly states commercial/agricultural loans have a 4-year total duration (2-year forecast + 2-year reversion) versus 3 years for residential (2-year forecast + 1-year reversion). The LLM's answer is ambiguous about whether the reversion periods are 1-year or 2-year for each category. PARTIAL CREDIT: The LLM correctly identifies that residential loans have a two-year forecast period and one-year reversion period. The LLM also correctly identifies that commercial/agricultural loans have a two-year forecast period. However, the critical error regarding the reversion period for commercial/agricultural loans (stating one-year instead of two-year) and the introduction of unsubstantiated qualifiers significantly undermines the answer's accuracy. The multi-hop reasoning is incomplete - the LLM does not synthesize the information into a clear comparison of total durations before reverting to historical experience, which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 436,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costsimpacted by factors like healthcare costs and regulatory changesthese financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco's self-insurance funding for employee health care benefits, estimated via actuarial assumptions, exposes it to unpredictable cost fluctuations and labor-related risks. The document notes that healthcare costs are highly variable due to inflation, regulatory changes, and unforeseen claims, which could lead to higher liabilities than estimated. While historical adjustments to these estimates have not been material, significant deviations could strain financial resources, particularly if labor costs rise or claims exceed actuarial projections, impacting cash flow and financial stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core factual content regarding Costco's self-insurance funding for employee health care benefits. Key strengths: (1) Correctly identifies the reliance on actuarial assumptions and historical claims experience; (2) Accurately captures the sources of unpredictability (inflation, regulatory changes, unforeseen claims); (3) Properly synthesizes the multi-hop connection between actuarial liabilities and potential financial impact; (4) Appropriately emphasizes the risk of actual claims exceeding projections. The answer correctly conveys that liabilities are subject to significant unpredictability and could lead to unexpected financial burdens. Minor areas for improvement: (1) The LLM mentions 'historical adjustments to these estimates have not been material' which adds a nuance not explicitly stated in the ground truth, though this is a reasonable inference from SEC filings; (2) The ground truth explicitly mentions that liabilities are 'not discounted,' which the LLM answer does not include, though this is a technical detail; (3) The ground truth more explicitly connects labor cost control challenges to the broader business impact, while the LLM focuses more narrowly on claims variability. The reasoning is sound and the multi-hop synthesis is correctconnecting actuarial assumptions  unpredictable costs  potential financial impact. No quantitative errors detected. The semantic meaning aligns well with the ground truth despite slightly different wording and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 429,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 totaled **$4.637 billion** ($4.2 billion for the CAE Settlement and $437 million in restructuring charges). The reconsolidation of the Aearo Entities in 2023 added **$0.7 billion in assets** (equity and other investments) and **$0.6 billion in net liabilities** (intercompany amounts) to 3M's balance sheet as of December 31, 2023, reversing prior deconsolidation adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical directional error regarding the Aearo Entities reconsolidation impact. (1) CORRECT ELEMENTS: The pre-tax charges total of $4.637 billion is accurate ($4.2B CAE Settlement + $437M restructuring). The breakdown of individual charges is correct. The amounts of $0.7 billion and $0.6 billion related to Aearo reconsolidation are correct. (2) CRITICAL ERROR: The LLM states the reconsolidation 'added $0.7 billion in assets' and '$0.6 billion in net liabilities,' but the ground truth clearly states these amounts were 'removed' from the balance sheet. The ground truth specifies 'removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability.' This is a significant directional error - the reconsolidation resulted in a net reduction/removal of these items, not an addition. The LLM's phrase 'reversing prior deconsolidation adjustments' is conceptually reasonable but contradicts the stated direction of the impact. (3) MULTI-HOP REASONING: The answer correctly synthesizes information about two separate 2023 events (CAE Settlement charges and Aearo reconsolidation), but misinterprets the nature of the balance sheet impact. (4) QUANTITATIVE VERIFICATION: All dollar amounts are numerically correct, but the directional interpretation of the balance sheet impact is inverted, which is a material error in financial reporting context. The answer demonstrates understanding of the components but fails on the critical interpretation of whether items were added or removed from the balance sheet.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 429,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "Google's integration of Gemini 2.0 into Vertex AI expands developers' capabilities on Google Cloud Platform by providing pre-packaged AI agents that assist with software development tasks (e.g., writing, testing, documenting code) and cybersecurity threat analysis. It also enhances model training, tuning, and deployment through advanced generative AI models like Gemini, alongside tools such as vector search and distillation, improving cost efficiency and model quality. This integration enables developers to build and deploy AI-driven applications more effectively.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements when compared to the ground truth. CORRECT ELEMENTS: The answer accurately identifies that Gemini 2.0 integration into Vertex AI provides enhanced model training, tuning, and deployment capabilities, and correctly mentions Gemini as one of the available models. The mention of tools like vector search and distillation is factually reasonable for a comprehensive AI platform. INCORRECT/UNSUPPORTED ELEMENTS: The ground truth specifically mentions that Vertex AI provides access to Gemini, Imagen, Veo, and other generative AI models. The LLM answer mentions Gemini but omits Imagen and Veo, which are explicitly listed in the ground truth as key models available through the integration. More significantly, the LLM answer introduces specific claims about 'pre-packaged AI agents for software development tasks' and 'cybersecurity threat analysis' that are NOT present in the ground truth. These appear to be hallucinated details not supported by the source material. The ground truth emphasizes the core capability expansion around training, tuning, augmenting, testing, and deploying applications with multiple generative AI models. The LLM answer shifts focus to specific use cases (code writing, testing, documenting, cybersecurity) that go beyond what the ground truth states. MULTI-HOP REASONING: The question asks how integration expands capabilities. The ground truth provides a clear answer about the models and tools available. The LLM answer attempts to provide more specific use cases but does so by introducing unsupported information rather than synthesizing from the provided ground truth. QUANTITATIVE ACCURACY: No numbers, dates, or percentages are present in either answer, so this scores perfectly. QUALITATIVE ACCURACY: The answer partially captures the essence of capability expansion but introduces inaccurate specificity and omits key model names (Imagen, Veo) that are central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 536,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatmentusing FVO securities in both yield calculations and fair value measurementsmeans that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities impacts MetLife's reported investment income by incorporating their fair value changes into net investment income, as noted in the Yield Table (page 81). FVO securities' fair value adjustments are directly reflected in investment income, increasing sensitivity to market fluctuations. Under Level 3 classifications, valuation techniques like matrix pricing and consensus pricing use unobservable inputs (e.g., swap yields, credit spreads), meaning changes in these inputs significantly affect the estimated fair value of FVO securities. This heightened sensitivity amplifies the impact of fair value changes on both investment income and overall portfolio performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific $205 million investment income figure that is central to the ground truth answer. This is a major factual error - the ground truth explicitly states 'FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024.' The LLM provides no quantitative anchor for the impact. (2) INCOMPLETE SYNTHESIS: The LLM mentions 'Yield Table (page 81)' but fails to extract or cite the actual $205 million contribution figure that should be the cornerstone of answering how FVO securities 'impact the reported investment income.' (3) VALUATION TECHNIQUE DISCREPANCY: The ground truth specifies Level 3 valuation inputs as 'nonperformance risk spreads and long-term equity volatilities,' while the LLM lists 'matrix pricing and consensus pricing' with 'swap yields, credit spreads.' While both describe unobservable inputs, the LLM's specific techniques don't match the ground truth's stated inputs. (4) DUAL TREATMENT CONCEPT: The ground truth emphasizes the 'dual treatment' of FVO securities in both yield calculations AND fair value measurements, creating amplified variability. The LLM addresses this partially but less clearly. (5) WHAT WAS CORRECT: The LLM correctly identifies that FVO securities are Level 3 classified, that they use unobservable inputs, and that this creates sensitivity to fair value changes. The general conceptual framework about amplified financial statement variability is present. However, the absence of the $205 million figure is a fundamental failure in answering a quantitative question about financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 461,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The total pre-tax financial impact from the initial deconsolidation of the Aearo Entities in 2022 was a **$1.2 billion charge**, reflecting costs related to the bankruptcy proceedings and litigation. The subsequent reconsolidation in 2023 had an **immaterial income statement impact**. These events were directly tied to the Combat Arms Earplugs litigation, as the deconsolidation followed bankruptcy filings linked to the litigation, and the reconsolidation occurred after the bankruptcy dismissal. Additionally, the **CAE Settlement in 2023** added a separate **$4.2 billion pre-tax charge**, but this is distinct from the deconsolidation/reconsolidation events themselves. Thus, the combined impact of the deconsolidation and reconsolidation was **$1.2 billion**.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct on the core question. STRENGTHS: (1) Correctly identifies the $1.2 billion total pre-tax financial impact from deconsolidation and reconsolidation combined; (2) Accurately states the 2023 reconsolidation had immaterial income statement impact; (3) Properly connects both events to Combat Arms Earplugs litigation; (4) Correctly distinguishes the separate $4.2 billion CAE Settlement charge in 2023 as distinct from the deconsolidation/reconsolidation events; (5) Accurately describes the timeline (deconsolidation in 2022, reconsolidation in 2023). MINOR ISSUES: (1) The ground truth specifies the $1.2 billion comprises '$1.0 billion funding commitment plus $0.2 billion for projected case expenses' - the LLM answer states the $1.2 billion reflects 'costs related to bankruptcy proceedings and litigation' without breaking down the specific components ($1.0B + $0.2B). This is a minor omission of detail but doesn't affect the accuracy of the total figure; (2) The LLM could have been slightly more explicit about the composition of the $1.2 billion charge. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($1.2B for deconsolidation/reconsolidation, $4.2B for CAE Settlement, immaterial impact for 2023 reconsolidation). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple events (deconsolidation, reconsolidation, CAE Settlement) and correctly distinguishes which impacts relate to which events. The connection to Combat Arms Earplugs litigation is properly established. Overall, this is a strong answer with accurate numbers and sound reasoning, with only minor detail omissions that don't materially affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 465,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "The integration of Adobe Firefly into Creative Cloud and Document Cloud enhances Adobe's recurring revenue strategy by embedding AI-driven capabilities that increase subscription product value, expand customer bases, and improve retention. In fiscal 2023, Firefly's generative AI features (e.g., text-to-image, generative fill, and recolor in Photoshop and Adobe Express) boosted engagement and retention through Generative Credits, while AI-powered tools like Adobe Express lowered barriers to creativity, attracting new users. These innovations drove growth in Annualized Recurring Revenue (ARR), with Creative Cloud ARR rising to $12.37 billion and Document Cloud ARR to $2.81 billion, reflecting expanded adoption and sustained subscription revenue streams.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Adobe Firefly's integration into Creative Cloud and Document Cloud, accurately describes its generative AI capabilities (text-to-image, generative fill, recolor), and properly explains how these features support recurring revenue strategy through subscription value enhancement and customer base expansion. The answer appropriately mentions Generative Credits, Adobe Express, and the connection to user retention and engagement. The multi-hop reasoning connecting product features to business strategy is sound and well-articulated.\n\nWEAKNESSES - QUANTITATIVE ERRORS (Critical): The LLM provides specific ARR figures ($12.37 billion for Creative Cloud and $2.81 billion for Document Cloud) that cannot be verified against the ground truth knowledge graph. These numbers are presented with high precision but lack supporting evidence in the original answer. This is a significant issue because the question specifically asks for 'evidence' of the strategy, and unverified financial metrics undermine credibility. The ground truth does not provide these specific ARR figures, suggesting they may be hallucinated or from different fiscal periods.\n\nMINOR OMISSIONS: The LLM answer does not explicitly mention Adobe Sensei (mentioned in ground truth as part of broader AI-driven tools), nor does it specifically reference targeted packages like Substance 3D Collection. The ground truth emphasizes attracting 'novice creators and communicators' as a specific customer segment, which the LLM answer addresses more generally as 'new users.'\n\nMULTI-HOP REASONING: The synthesis across Creative Cloud, Document Cloud, and business strategy is logically sound. The answer correctly connects product features to revenue impact and customer expansion.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - Firefly drives recurring revenue through enhanced subscription value and customer base expansion. However, the introduction of unverified specific financial metrics creates a factual accuracy concern that outweighs the otherwise strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 569,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "As of December 31, 2022, the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen was **$4,335 million**. This amount is **equal to the total fair value of all available-for-sale investments** ($4,335 million), as the other components of available-for-sale investments (e.g., \"Other short-term interest-bearing securities\") had a fair value of $0 million for 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. (1) QUANTITATIVE ACCURACY: All numbers are correct - U.S. Treasury bills ($1,676 million) + money market mutual funds ($2,659 million) = $4,335 million total, which matches the ground truth exactly. The comparison to total available-for-sale investments ($4,335 million) is accurate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the total fair value of the two specific investment types, and (b) how this compares to all available-for-sale investments. (3) ENTITY ACCURACY: Correctly identifies Amgen, the specific date (December 31, 2022), and the correct investment categories. (4) REASONING: The multi-hop synthesis is sound - the model correctly identified that these two investment types comprise the entire available-for-sale portfolio and explained why they equal the total (other components = $0). The logic is clear and well-structured. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'equal to the total fair value' conveys the same meaning as the ground truth's statement that the amount 'represents the full value of all available-for-sale investments.' Minor enhancement: The LLM provides additional context by explicitly noting that 'Other short-term interest-bearing securities' had $0 fair value, which adds helpful clarity beyond the ground truth but doesn't contradict it. This is a strength rather than a weakness. The answer is factually accurate, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 411,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The valuation techniques for Unit-linked securities in MetLife's 2024 10-K, which include actuarial methods and present value assumptions (e.g., Black-Scholes), incorporate long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. Changes in **long-term equity volatility** directly increase the sensitivity of fair value measurements, as higher volatility elevates the estimated fair value. Conversely, changes in **nonperformance risk spreads** inversely affect fair value, with lower spreads reducing the estimated fair value. These sensitivities are explicitly noted in the Level 3 fair value disclosures, highlighting their material impact on the valuation of embedded derivatives and guarantees.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the valuation techniques for Unit-linked securities and correctly identifies the key inputs (long-term equity volatility and nonperformance risk spreads) as significant unobservable inputs. The answer accurately describes the directional sensitivity relationships: higher equity volatility increases fair value, while lower nonperformance risk spreads reduce fair value. The mention of Level 3 fair value disclosures and embedded derivatives/guarantees is contextually appropriate and adds relevant detail. The answer correctly synthesizes that these inputs directly influence fair value measurements and reflects the multi-hop nature of the question by connecting valuation techniques to sensitivity outcomes. Minor strengths include the specific mention of Black-Scholes methodology and actuarial methods, which adds technical precision. One minor weakness is that the answer could have been more explicit about how nonperformance risk spreads vary by duration and currency (as noted in the ground truth), though this is a relatively minor omission. The answer does not contain any factual errors regarding the mechanics of how these inputs affect valuation. The directional relationships stated (volatility positive correlation, spreads inverse relationship) are accurate. No numerical data was provided in either answer, so quantitative accuracy is based on the logical consistency of the relationships described, which are sound. The answer appropriately addresses the core question about sensitivity to changes in these inputs and their material impact on fair value measurements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 448,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobes strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Fireflys generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobes goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe's introduction of Generative Credits in Adobe Firefly enhances customer engagement and subscription revenue by empowering both creative professionals and non-creative stakeholders. Generative Credits enable users to generate content via AI-powered tools (e.g., text-to-image, design templates) within Adobe Express and other Creative Cloud apps, expanding access to AI capabilities beyond traditional creative workflows. This broadens Adobe's user base, increases engagement through value-added features, and drives retention by offering scalable, AI-enhanced tools that cater to diverse needs, from content creation to collaborative workflows, thereby supporting recurring revenue growth across segments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's Generative Credits strategy and its connection to customer engagement and subscription revenue. STRENGTHS: (1) Correctly identifies Generative Credits as an AI-powered feature within Adobe Firefly and Creative Cloud; (2) Accurately describes the mechanism (paid upsell after usage limits); (3) Properly identifies the expansion beyond traditional creative professionals to include marketers and communicators; (4) Correctly links the strategy to recurring revenue growth and customer retention; (5) No quantitative errors or incorrect numbers/dates. WEAKNESSES: (1) The answer mentions 'Adobe Express' as a primary platform for Generative Credits, while the ground truth emphasizes integration into 'Photoshop and Illustrator' as the key widely-used tools - this is a minor entity/emphasis difference but not factually wrong; (2) Less explicit about the 'product-led growth' strategy terminology used in ground truth; (3) Doesn't explicitly mention the 'tiered access (free and premium)' model as clearly as ground truth; (4) Slightly less comprehensive in explaining how this deepens customer relationships and conversion metrics. MULTI-HOP REASONING: The answer successfully synthesizes the connection between Generative Credits  expanded user base  increased engagement  subscription revenue growth, which is the core multi-hop requirement. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The answer conveys the essential strategic intent and mechanisms, though with somewhat less detail and specificity than the ground truth. The core narrative about using AI to expand beyond traditional creatives and drive subscription revenue is present and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 471,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user productsAndroid, Chrome, Gmail, Maps, Play Store, Search, and YouTubeenhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "The integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform enhances Google Cloud's revenue generation by providing developers with advanced AI tools (e.g., pre-packaged AI agents, generative models) to build and deploy AI-driven applications. This positions Google Cloud as a critical infrastructure provider for AI optimization, driving demand for its consumption-based fees, subscriptions, and developer services, while leveraging Vertex AI's capabilities to streamline AI workflows and improve cost-efficiency for customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general mechanism of how Gemini 2.0 integration drives Google Cloud revenue through developer services and infrastructure demand, which is directionally correct. However, there are significant omissions and inaccuracies when compared to the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The ground truth specifies \"seven of Google's two billion-user products\" (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube) with specific product names and count\n   - The LLM answer vaguely references \"billion-user products\" without specifying the number (seven) or naming the products\n   - This is a material omission of specific quantitative/categorical information from the filing\n\n2. COMPLETENESS GAPS:\n   - Ground truth explicitly lists all seven products by name; LLM provides no specific product examples\n   - Ground truth mentions \"enhancing user experiences and increasing engagement\" as a mechanism; LLM omits this\n   - Ground truth explains the ecosystem connection (widespread integration  demand for infrastructure); LLM is less explicit about this causal chain\n   - Ground truth mentions \"train, tune, and deploy applications\" as specific Vertex AI capabilities; LLM mentions \"pre-packaged AI agents\" which is not in ground truth\n\n3. ENTITY ACCURACY:\n   - Both correctly identify Gemini 2.0, Vertex AI, and Google Cloud\n   - LLM introduces \"pre-packaged AI agents\" which is not mentioned in ground truth and may be inaccurate\n   - Both correctly identify consumption-based fees and subscriptions as revenue mechanisms\n\n4. REASONING QUALITY:\n   - LLM reasoning is sound but less comprehensive than ground truth\n   - LLM correctly identifies the connection between product integration and infrastructure demand\n   - LLM adds \"cost-efficiency for customers\" which is reasonable but not explicitly in ground truth\n   - Ground truth provides clearer multi-hop synthesis: products  engagement  ecosystem demand  Cloud revenue\n\n5. SEMANTIC EQUIVALENCE:\n   - Core message is similar but ground truth is more specific and detailed\n   - LLM's framing of \"critical infrastructure provider\" is reasonable but not explicitly stated in ground truth\n   - The revenue mechanism explanation is fundamentally correct but less complete\n\nThe answer demonstrates understanding of the basic relationship but fails to capture the specific product enumeration and detailed mechanisms that constitute the complete answer from the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 667,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "Changes in prepayment and default rates impact MetLife's income recognition on FVO securities by altering estimated cash flows and fair value. Higher default rates generally reduce fair value (lowering income), while higher prepayment rates may increase fair value (raising income), as noted in Note 13 (footnote 5). Unobservable inputs influencing valuation include prepayment rates, default rates, loss severity assumptions, and market volatility, as these are critical to modeling cash flows for structured products and other Level 3 securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question but contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The answer correctly identifies that prepayment and default rates impact income recognition on FVO securities; (2) The directional relationship described (higher default rates reducing fair value, higher prepayment rates potentially increasing fair value) is logically sound; (3) The mention of Note 13 (footnote 5) as a source shows appropriate citation. PROBLEMATIC ELEMENTS: (1) The ground truth specifically identifies 'long-term equity volatilities' and 'nonperformance risk spreads' as the unobservable inputs, but the LLM answer lists 'prepayment rates, default rates, loss severity assumptions, and market volatility' instead. While there is some overlap (market volatility relates to equity volatilities), the LLM answer misses the specific mention of 'nonperformance risk spreads' and instead includes 'prepayment rates' and 'default rates' as unobservable inputsthese are typically observable or semi-observable market inputs, not purely unobservable Level 3 inputs; (2) The LLM conflates observable inputs (prepayment/default rates) with unobservable inputs, which is a conceptual error in fair value hierarchy classification; (3) The answer provides more detail about the mechanism (cash flow modeling) but diverges from the ground truth's specific identification of which inputs are unobservable. MULTI-HOP REASONING: The answer demonstrates understanding that prepayment/default rates affect income recognition and that unobservable inputs affect valuation, but fails to correctly identify which specific unobservable inputs are relevant. The synthesis is partially correct but contains a material error in identifying the unobservable inputs. SEMANTIC EQUIVALENCE: While the answer conveys general understanding of the relationship between these factors and valuation, it does not accurately match the ground truth's specific identification of 'long-term equity volatilities' and 'nonperformance risk spreads' as the key unobservable inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 558,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco's investment in Kirkland Signature products positively influences gross margin performance due to their higher margins compared to national brands and their role in driving member loyalty. However, risks such as disruptions in production, supply chain issues, or loss of member confidence in product quality or availability could negatively impact both sales and gross margins, as these factors are critical to sustaining member loyalty and maintaining the brand's competitive differentiation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: Both answers correctly identify that Kirkland Signature products positively influence gross margin due to higher margins compared to national brands, and both appropriately address the risks to this benefit. The LLM answer accurately captures the core mechanism (higher margins, member loyalty driver) and the contingent nature of this benefit (dependent on quality, availability, member confidence). (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, which is appropriate given the question's qualitative nature. Both answers avoid making unsupported numerical claims. Score: 10/10. (3) QUALITATIVE ACCURACY: The LLM answer correctly synthesizes the multi-hop relationship: Kirkland Signature investment  higher margins  member loyalty  contingent on production/supply chain stability and member confidence. The reasoning is sound and logically structured. The answer identifies all key risk factors mentioned in the ground truth: production disruptions, supply chain issues, loss of member confidence, and availability concerns. Score: 9/10 (minor: the ground truth explicitly mentions 'loss of member acceptance or confidence' while LLM says 'loss of member confidence in product quality or availability' - slightly narrower framing but semantically equivalent). (4) CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question: (a) how investment influences gross margin (positively through higher margins), (b) brand's role in member loyalty (explicitly mentioned), and (c) risks associated with production and availability (comprehensively covered). The answer maintains appropriate balance between benefits and risks. Score: 9/10. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with slightly different wording. 'Competitive differentiation' in the LLM answer is a reasonable addition that enhances understanding without contradicting the ground truth. Both answers appropriately frame the relationship as conditional/contingent on maintaining quality and availability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 602,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair value of \"Other short-term interest-bearing securities\" increased by **$138 million** from December 31, 2022 ($0 million) to December 31, 2023 ($138 million). This increase contributed to the total available-for-sale investments, which rose from **$4,335 million** in 2022 to **$10,404 million** in 2023, reflecting the addition of these securities and other assets like money market mutual funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key components of the multi-hop question. (1) QUANTITATIVE ACCURACY - All numbers are correct: 'Other short-term interest-bearing securities' increased from $0M (2022) to $138M (2023), a change of $138M; total available-for-sale investments rose from $4,335M to $10,404M, a total increase of $6,069M. All dollar amounts match the ground truth exactly. (2) COMPLETENESS - The answer addresses both parts of the question: the specific change in 'Other short-term interest-bearing securities' and how this reflects in total available-for-sale investments across both years. (3) ENTITY ACCURACY - All entities are correctly identified: the specific security type, correct fiscal years (2022 and 2023), and correct financial metrics (fair value, available-for-sale investments). (4) MULTI-HOP REASONING - The answer correctly synthesizes information across multiple data points: starting values, ending values, the change calculation, and the relationship to total portfolio growth. The reasoning is sound and logical. (5) MINOR OBSERVATION - The LLM adds contextual information about 'money market mutual funds' contributing to the total increase, which is reasonable contextual elaboration but not explicitly stated in the ground truth. This is a minor enhancement that doesn't contradict the ground truth. The answer maintains semantic equivalence with the original while using slightly different phrasing ('reflected in' vs 'reflecting'). Overall, this is a comprehensive, accurate response with correct calculations and proper multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 439,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMIs investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMIs investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, introduced uncertainty regarding the allocation of the CAD 32.5 billion global settlement amount among RBH, ITL, and JTIM. This uncertainty was deemed an impairment indicator, prompting PMI to perform a quantitative valuation of its investment in RBH as of December 31, 2024. The fair value of the investment was estimated at $714 million, reflecting the estimated fair value of the underlying business net of PMI's share of the settlement allocation. As a result, PMI recorded a non-cash impairment charge of **$2,316 million** in the consolidated statement of earnings for the year ended December 31, 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All critical numbers are correct: fair value of $714 million, impairment charge of $2,316 million, CAD 32.5 billion settlement amount, and December 31, 2024 date. (2) Quantitative accuracy is high - all financial figures match ground truth exactly. (3) The LLM correctly identifies the key entities (PMI, RBH, ITL, JTIM) and the impairment indicator. (4) The answer appropriately addresses the multi-part question structure.\n\nWEAKNESSES: (1) The LLM uses 'uncertainty' and 'narrowing of outcomes' somewhat interchangeably, but the ground truth specifically states the developments 'narrowed the range of possible outcomes' - this is a subtle but important distinction. The LLM's phrasing of 'introduced uncertainty' is less precise than 'narrowed the range of possible outcomes.' (2) The LLM omits specific details about the valuation methodology components mentioned in ground truth: it doesn't explicitly mention the 'discounted cash flow analysis' or the 'significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada.' (3) The phrase 'reflecting the estimated fair value of the underlying business net of PMI's share of the settlement allocation' is somewhat vague compared to the ground truth's more detailed explanation of the assumptions used. (4) The LLM doesn't fully explain the causal chain: how the narrowing of outcomes led to the impairment indicator, which then prompted the valuation.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between the Proposed Plan developments, the impairment indicator, the valuation methodology, and the resulting impairment charge. However, it lacks the depth of explanation about the specific assumptions and methodology that would demonstrate complete understanding of the multi-hop synthesis.\n\nCONCLUSION: The answer is substantially correct on all quantitative metrics and addresses the core question adequately, but lacks some of the methodological detail and precision in describing the causal relationships that would elevate it to a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 567,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "If advertising revenues from Google Network properties increased by $10 billion in 2023 compared to 2022 and the TAC rate remained constant at 22%, the absolute dollar amount of TAC paid to Google Network partners would increase by **$2.2 billion** (calculated as $10 billion  22%). This assumes a direct proportional relationship between revenue growth and TAC payments at the specified rate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely correct and matches the ground truth answer of $2.2 billion. (1) CORRECTNESS: The final answer of $2.2 billion is accurate and matches the original answer exactly. (2) QUANTITATIVE ACCURACY: The calculation is correct: $10 billion  22% = $2.2 billion. The LLM properly identified all relevant numbers from the question (the $10 billion revenue increase, the 22% TAC rate) and performed the arithmetic correctly. (3) QUALITATIVE ACCURACY: The reasoning is sound and demonstrates proper multi-hop synthesis. The LLM correctly: (a) identified that TAC payments are proportional to advertising revenues, (b) applied the constant 22% TAC rate to the revenue increase, (c) calculated the resulting TAC payment increase, and (d) explicitly stated the assumption of a direct proportional relationship. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question asked, which requires understanding the relationship between Google Network advertising revenue growth and TAC payments at a constant rate. The LLM appropriately framed the answer with the calculation methodology and underlying assumption. (5) COMPLETENESS: The answer fully addresses all aspects of the multi-part question, including the revenue increase amount, the TAC rate, and the resulting absolute dollar increase in TAC payments. No material information is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 381,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14.155 billion from December 31, 2023 ($61.449 billion) to December 31, 2024 ($75.604 billion). The fair value decreased by $10.714 billion over the same period (from $59.851 billion in 2023 to $70.565 billion in 2024). Thus, the carrying value increased more significantly than the fair value, reflecting a $3.441 billion difference in the changes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental factual error regarding the fair value change. The ground truth states fair value INCREASED by $10,714 million (from $59,851M to $70,565M), but the LLM incorrectly states it DECREASED by $10.714 billion. This is a major error that contradicts the actual data. VERIFICATION OF NUMBERS: (1) Carrying value change: $14,155M increase is correct (75,604 - 61,449 = 14,155). (2) Fair value values are correct ($59,851M in 2023, $70,565M in 2024), but the direction of change is wrong. The correct calculation is 70,565 - 59,851 = +10,714M (increase), not a decrease. (3) The LLM's calculation of a $3.441 billion difference is mathematically incorrect given the stated values and the wrong direction. The correct comparison should be: carrying value increased $14,155M while fair value increased $10,714M, showing carrying value increased more. MULTI-HOP REASONING: The LLM correctly identified that carrying value increased more significantly than fair value, but this conclusion is based on flawed premises (stating fair value decreased when it actually increased). The reasoning structure is sound, but the factual foundation is broken. ENTITY ACCURACY: Company (UnitedHealth Group), metrics (carrying value, fair value, long-term debt), and time periods are all correctly identified. FORMAT: Number format conversion from millions to billions is acceptable ($14,155M = $14.155B), but the semantic error about direction of change is not acceptable. The answer demonstrates understanding of the question structure but fails on core factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 438,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed **$573 million** to the increase in merchant transaction costs in 2022, as noted in the \"Sales and Other Expenses\" section (Page 52). This expansion drove the significant growth in merchant revenues (up 94.6% year-over-year) compared to agency revenues (up 35.1%), as highlighted in the \"Results of Operations\" (Page 50) and \"Revenues\" (Page 51) sections. The higher merchant transaction costs reflect the increased volume of merchant transactions tied to the expanded services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) The core quantitative claim of $573 million increase in merchant transaction costs is correct and matches the ground truth exactly. (2) The growth percentages cited (94.6% for merchant revenues, 35.1% for agency revenues) are accurate and properly contextualize the relationship between merchant and agency revenue growth. (3) The multi-hop reasoning is sound - the answer correctly synthesizes that the expansion of merchant accommodation services drove both the transaction cost increase AND the disproportionate merchant revenue growth compared to agency revenues. (4) Page citations (Pages 50-52) add credibility and demonstrate proper source attribution. (5) The semantic meaning aligns perfectly with the ground truth answer - both explain the causal relationship between merchant service expansion, transaction costs, and relative revenue growth. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page references and percentage growth rates that enhance the answer beyond the ground truth, which is appropriate and adds value. (2) The explanation of 'increased volume of merchant transactions' is a logical inference that supports the ground truth narrative. (3) The answer structure is clear and directly addresses all parts of the multi-part question. No factual errors, calculation errors, or entity misidentifications detected. The answer successfully demonstrates multi-hop synthesis across revenue metrics, transaction costs, and service expansion drivers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 428,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs signifies an expansion of its FPGA and Adaptive SoC product lines by integrating high-performance RF data converters, targeting markets like wireless, radar, and cable access. This aligns with AMD's broader strategy to address high-performance RF data conversion needs through heterogeneous computing platforms, combining programmable logic with RF capabilities. The RFSoCs enhance AMD's position in specialized applications requiring real-time signal processing and adaptability, reinforcing its focus on delivering versatile, high-performance solutions across emerging technologies like 5G, AI, and edge computing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies Zynq UltraScale+ RFSoCs as an expansion of FPGA and Adaptive SoC portfolio; (2) Accurately lists target markets (wireless, radar, cable access); (3) Properly explains the integration of RF data converters into SoC architecture; (4) Correctly identifies the strategic alignment with high-performance RF data conversion capabilities; (5) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer mentions '5G, AI, and edge computing' as emerging technologies, which is reasonable but not explicitly mentioned in the ground truth; (2) The ground truth specifically emphasizes 'aerospace, defense, and communication infrastructure' as high-growth sectors, while the LLM answer generalizes to 'emerging technologies' without explicitly naming these sectors; (3) The ground truth emphasizes 'faster time-to-market for customers' as a key benefit, which the LLM answer doesn't explicitly mention; (4) The ground truth mentions 'real-time control, sensor fusion, and analytics' as specific capabilities, while the LLM answer only mentions 'real-time signal processing.' MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between product introduction, market targeting, and strategic alignment. The answer demonstrates understanding of how the RFSoC introduction fits into AMD's broader portfolio strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential meaning of the ground truth, though with slightly different emphasis and some omitted details. The core insight about expanding the portfolio to serve RF-intensive markets is present and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 472,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is **$1,115 million** ($603 million in 2023 + $512 million in 2024). The total fair value for these securities during the same periods is **$1,104 million** ($596 million in 2023 + $508 million in 2024). The carrying value is slightly higher than the fair value combined, reflecting amortized cost adjustments and market valuation differences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: carrying value totals of $1,115 million ($603M + $512M), fair value totals of $1,104 million ($596M + $508M), and the calculated $11 million unrealized loss difference. The multi-hop synthesis is sound - the model correctly combined data from 2023 and 2024 for both carrying value and fair value, then performed the comparison calculation accurately. All entities are correctly identified (UnitedHealth Group, debt securities held-to-maturity, both years). The answer addresses all parts of the multi-part question: (1) total carrying value combined, (2) total fair value combined, and (3) the comparison between them. The reasoning about amortized cost adjustments and market valuation differences is contextually appropriate and adds helpful context. The only minor distinction from the ground truth is that the LLM provides slightly more interpretive language ('reflecting amortized cost adjustments and market valuation differences') rather than simply stating the $11 million unrealized loss explicitly, but this is a semantic enhancement rather than an error. All calculations are verified as correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 338,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs and a $235 million rise in third-party call-center costs in 2022, driving a 102.7% increase in sales and other expenses. This expansion directly fueled the 108.4% year-over-year growth in merchant gross bookings, as noted in the 2022 financial results.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $573 million increase in merchant transaction costs as a key contribution to sales and other expenses in 2022, matching the ground truth. The answer appropriately connects this expansion to merchant gross bookings growth and maintains the core relationship between merchant accommodation expansion and increased costs. WEAKNESSES: (1) UNVERIFIED NUMBERS: The LLM introduces two specific percentages (102.7% increase in sales and other expenses, 108.4% year-over-year growth in merchant gross bookings) that are not present in the ground truth answer. These appear to be fabricated or hallucinated figures without verification from the source documents. (2) ADDITIONAL COST FIGURE: The LLM adds a $235 million rise in third-party call-center costs, which is not mentioned in the ground truth answer. While this may be factually accurate from the 10-K filing, it goes beyond what the ground truth identifies as the key contribution. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes that merchant transaction costs were the primary driver and notes the comparison between merchant vs. agency gross bookings growth. The LLM's addition of unverified percentages and call-center costs dilutes focus from the core answer without clear justification. CALCULATION VERIFICATION: Cannot independently verify the 102.7% and 108.4% figures without access to the original 10-K data, but their absence from the ground truth is concerning. The $573 million figure is correctly stated. MULTI-HOP REASONING: The LLM does attempt to synthesize the relationship between expansion, costs, and bookings growth, which is appropriate for the multi-hop nature of the question. However, the introduction of unverified metrics weakens the reasoning chain. RECOMMENDATION: The answer contains the correct core information ($573 million) but is compromised by unverified quantitative claims that may mislead the reader.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 523,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "As of December 31, 2023, PayPal reported a **crypto asset safeguarding asset and corresponding liability of $1,241 million** each. This reflects the company's role in holding and safeguarding crypto assets on behalf of users, as disclosed in Note 9 of its 10-K filing. The asset and liability are classified within Level 2 of the fair value hierarchy, indicating PayPal's active involvement in crypto-related financial activities, such as facilitating crypto transactions and managing user-held assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: All numbers are correct - the $1,241 million figure for both the crypto asset safeguarding asset and corresponding liability as of December 31, 2023 matches the ground truth exactly. The format variation ($1,241 million) is acceptable. (2) COMPLETENESS: The answer addresses all parts of the question - it identifies the specific dollar amounts, confirms they are equal, and explains what this reflects about PayPal's involvement in crypto activities. (3) ENTITY ACCURACY: PayPal is correctly identified, the date (December 31, 2023) is correct, and the financial metrics (crypto asset safeguarding asset and liability) are properly named. (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the answer correctly synthesizes that equal asset and liability amounts indicate PayPal's role in holding and safeguarding customer crypto assets. The explanation of the company's active participation in crypto-related financial services is logically derived from the numbers. (5) ADDITIONAL CONTEXT: The LLM provides supplementary information (Note 9 reference, Level 2 fair value hierarchy classification) that adds credibility and context without contradicting the ground truth. This additional detail demonstrates deeper engagement with the source material. The only minor distinction from the ground truth is the inclusion of fair value hierarchy information and specific note reference, which enhances rather than detracts from the answer. The semantic meaning is fully equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 437,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "FedEx's aircraft impairment charges in 2023 ($70M) and 2024 ($157M) reflect the company's Network 2.0 optimization strategy by retiring older aircraft (e.g., Boeing 757-200 and MD-11F) to modernize its fleet, improve network efficiency, and align capacity with shipment volumes. These charges are part of the broader DRIVE transformation program, which includes network rationalization and operational efficiencies. Cumulatively, the impairment charges and business optimization costs through 2024 totaled approximately $1.08 billion, contributing to the $1.5 billion aggregate expected cost of DRIVE through 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the cumulative financial impact calculation. Ground truth states: aircraft impairment charges of $70M (2023) + $157M (2024) = $227M, plus $582M in business optimization costs in 2024, totaling $839M through 2024. The LLM incorrectly states the cumulative total as 'approximately $1.08 billion' and references a '$1.5 billion aggregate expected cost of DRIVE through 2025,' neither of which matches the ground truth. The $1.08B figure appears to be an unsupported calculation, and the $1.5B reference introduces information not in the ground truth answer. CORRECT ELEMENTS: The LLM correctly identifies the 2023 ($70M) and 2024 ($157M) impairment charges, correctly names the aircraft types being retired (Boeing 757-200, MD-11F), and accurately describes the strategic rationale (fleet modernization, capacity alignment, Network 2.0 optimization). The connection to the DRIVE program is properly established. MULTI-HOP REASONING: The LLM demonstrates understanding of the relationship between aircraft impairments and Network 2.0 strategy, but fails in the critical synthesis task of calculating cumulative costs through 2024. The answer conflates different time periods (through 2024 vs. through 2025) and introduces unsupported figures. MISSING SPECIFICITY: The ground truth explicitly states $582M in business optimization costs in 2024 alone; the LLM does not break out this component separately, making the cumulative calculation impossible to verify from the answer provided. The core error is a $241M discrepancy ($1.08B claimed vs. $839M actual), which is a 29% overstatement of the cumulative impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 463,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, was **$4,769 million** ($4,327 million for available-for-sale and $442 million for held-to-maturity). The gross unrealized losses on these obligations increased by **$40 million** from December 31, 2023 ($234 million) to December 31, 2024 ($274 million).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM provides a significantly incorrect total fair value for U.S. government and agency obligations. Ground truth states $3,627 million as of December 31, 2024, but the LLM reports $4,769 million - a difference of $1,142 million (31% overstatement). The LLM's breakdown of $4,327 million (AFS) + $442 million (HTM) = $4,769 million is mathematically correct, but the underlying figures are wrong. The LLM correctly identifies the gross unrealized losses increase of $40 million (from $234M to $274M), which is accurate. However, this partial correctness on one component cannot offset the major error on the primary metric requested. The question asks for 'total fair value' and the LLM provides an incorrect total. The LLM does attempt to provide additional detail by breaking down AFS vs HTM securities, which shows some effort at comprehensiveness, but this detail is based on incorrect source data. The multi-hop reasoning for the unrealized losses calculation is sound (274 - 234 = 40), but the core quantitative accuracy on the main metric is severely compromised. This represents a fundamental failure to correctly extract and report the key financial figure from the filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 339,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "Booking.com's operating margins in 2023 were negatively impacted by the 54% merchant basis transaction mix compared to 44% in 2022, as merchant-related expenses (e.g., personnel, payment processing, chargebacks) increased. These costs, recorded in \"Personnel\" and \"Sales and other expenses,\" outweighed incremental revenues from payment card rebates, leading to lower margins. Key cost drivers included transaction processing fees, fraud-related chargebacks, and expanded operational complexity from facilitating payments for travel service providers. (Pages 3738)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question. QUANTITATIVE ACCURACY: All numeric values are correct - the merchant basis transaction mix percentages (44% in 2022 vs 54% in 2023) are accurately stated and properly compared. The directional impact (negative) on operating margins is correctly identified. COMPLETENESS: The answer addresses all key components of the question: (1) the transaction mix shift, (2) the impact on operating margins, and (3) the key cost components. The LLM correctly identifies personnel expenses, payment processing fees, and chargebacks as the primary cost drivers, matching the ground truth. ENTITY ACCURACY: Booking.com is correctly identified, fiscal years 2022 and 2023 are properly referenced, and financial statement line items ('Personnel' and 'Sales and other expenses') are accurately cited. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesizes that: (a) merchant basis mix increased, (b) this drove higher merchant-related expenses, (c) these costs outweighed incremental revenues, and (d) the net effect was margin compression. The logic chain is clear and accurate. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, with slightly different wording that is semantically equivalent. The mention of 'expanded operational complexity' adds minor contextual detail not explicitly in the ground truth but is reasonable inference. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no material information. The page reference (37-38) is provided but cannot be verified against the ground truth. Overall, this is a high-quality response that accurately synthesizes multi-hop information across years and correctly identifies the financial impact and cost components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 511,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "The reclassification of eligible consumer installment receivables to \"Loans and Interest Receivable, Held for Sale\" in May 2023 reversed previously recorded allowances for credit losses, reducing transaction and credit losses on PayPal's 2023 income statement. In 2024, these assets are measured at the lower of cost or fair value using observable inputs (Level 2), with valuation changes and charge-offs recorded in \"restructuring and other\" on the income statement. This shift from a price-based model (with significant unobservable inputs) to observable market prices improved transparency but introduced volatility in asset valuation. Income recognition was impacted by fair value adjustments and the reversal of prior allowances, affecting both asset valuations and income through restructuring expenses.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and proper multi-hop synthesis. STRENGTHS: (1) Correctly identifies the reclassification to 'Loans and Interest Receivable, Held for Sale' and the timing (May 2023); (2) Accurately describes the change from unobservable price-based model to observable inputs (Level 2 fair value hierarchy); (3) Correctly states that previously recorded allowances for credit losses were reversed; (4) Properly identifies that valuation changes and charge-offs were recorded in 'restructuring and other' on the income statement; (5) Accurately notes the impact on both 2023 (allowance reversal reducing transaction and credit losses) and 2024 (fair value adjustments); (6) Correctly characterizes the measurement methodology as 'lower of cost or fair value using observable inputs.' MINOR ISSUES: (1) The LLM states the reclassification occurred in 'May 2023' while the ground truth indicates the classification change to Level 2 occurred 'starting in Q1 2024' - this is a slight temporal discrepancy, though the reclassification decision may have occurred earlier; (2) The LLM could have been more explicit that the observable inputs specifically referenced 'executed prices for comparable loans sold to the global investment firm' rather than just 'observable market prices'; (3) The phrase 'lower of cost or fair value' is accurate but the ground truth emphasizes the shift to observable inputs more directly. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions - the valuation methodology change, the fair value hierarchy classification, the impact on 2023 income (allowance reversal), and the 2024 income recognition (restructuring charges). The logical flow connecting these elements is sound. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were provided in either answer, so this dimension focuses on dates and temporal accuracy - the May 2023 date is reasonable for the reclassification decision, though Q1 2024 is the more precise date for the Level 2 classification implementation. Overall, the answer captures the essential facts and demonstrates proper understanding of the complex accounting treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 602,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established 1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established 1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "The total combined borrowing capacity as of December 31, 2024, includes the newly established 1.5 billion (approximately $1.6 billion) credit facility and existing short-term credit arrangements of $2.1 billion, totaling **$3.7 billion**. This compares to the short-term credit arrangements alone of **$2.7 billion** as of December 31, 2023, representing an increase of **$1 billion**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN COMPARISON LOGIC: The LLM answer contains a fundamental error in the year-over-year comparison. The ground truth states this represents a DECREASE compared to 2023, but the LLM incorrectly characterizes it as an INCREASE of $1 billion. This is a major logical error that contradicts the ground truth. NUMERIC VERIFICATION: (1) 1.5 billion  $1.6 billion - CORRECT; (2) Short-term credit arrangements 2024: $2.1 billion - CORRECT; (3) Combined total 2024: $3.7 billion - CORRECT; (4) Short-term credit arrangements 2023: $2.7 billion - CORRECT; (5) Comparison calculation: The LLM states an increase of $1 billion, but the correct interpretation is that the 2024 combined capacity ($3.7B) compared to 2023 short-term only ($2.7B) shows a net increase of $1B in total available capacity. However, the ground truth explicitly states this 'represents a decrease,' which suggests the comparison should be interpreted differently - likely that the 2023 total combined capacity was higher than the 2024 total. The LLM's arithmetic ($3.7B - $2.7B = $1B increase) is mathematically correct for those two numbers, but this contradicts the ground truth's explicit statement that it represents a decrease. This indicates the LLM may have misunderstood the comparison framework or the ground truth may be comparing different metrics. MULTI-HOP REASONING: The LLM correctly synthesized the three components (new facility, existing arrangements, and prior year comparison) but failed in the directional interpretation of the comparison. COMPLETENESS: All required elements are addressed, but the conclusion about the direction of change is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 452,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "NVIDIA's Compute & Networking segment contributed **$47.4 billion** in fiscal year 2024, as stated in the document (page 39). The mention of a direct customer (13%) and an indirect customer (19%) refers to revenue concentration within the segment, not the total company revenue. The total company revenue of $27 billion provided in the question does not align with the document's reported $60.9 billion total revenue for fiscal year 2024. The correct figure for the Compute & Networking segment is explicitly stated in the document.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary metric. The ground truth answer is $8.64 billion, but the LLM provided $47.4 billion - a massive discrepancy of $38.76 billion. (1) QUANTITATIVE ACCURACY FAILURE: The LLM cited $47.4 billion as the Compute & Networking segment revenue, which is incorrect. The correct answer of $8.64 billion can be derived from the question's parameters: if a direct customer = 13% of total revenue and an indirect customer = 19% of total revenue, and these together represent 32% of total company revenue of $27 billion, then 32%  $27B = $8.64B. This represents the revenue concentration from these two customers. The LLM misinterpreted the question entirely. (2) REASONING ERROR: The LLM rejected the $27 billion total company revenue figure provided in the question, claiming the actual total was $60.9 billion. However, the question explicitly states to assume total company revenue was $27 billion - this is a constraint of the problem, not a factual claim about actual NVIDIA revenue. The LLM failed to follow the hypothetical parameters of the question. (3) MULTI-HOP SYNTHESIS FAILURE: The question requires synthesizing three pieces of information: (a) direct customer = 13% of total revenue, (b) indirect customer = 19% of total revenue, (c) total company revenue = $27 billion. The correct synthesis is: (13% + 19%)  $27B = 32%  $27B = $8.64B. The LLM completely failed this calculation and instead cited an unrelated segment revenue figure. (4) ENTITY CONFUSION: The LLM conflated the Compute & Networking segment revenue with the customer concentration calculation, which are different metrics. The question asks specifically about revenue concentration from two customers, not total segment revenue. The answer is off by a factor of approximately 5.5x, representing a critical failure in both numerical accuracy and logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 512,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG's Internal Capital Framework, as part of its Risk Appetite Framework, quantifies aggregate economic risk at a given confidence interval, incorporating diversification benefits across risk factors and business lines. It integrates stress testing to assess exposure to significant financial and insurance risks, providing critical insights to determine capital resources required at the AIG Parent level to support subsidiaries and maintain consolidated target capitalization levels. This framework ensures alignment with risk appetite and supports informed capital planning under adverse scenarios.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Key strengths: (1) Correctly identifies that the Internal Capital Framework quantifies aggregate economic risk at a given confidence interval - this core concept is accurately captured; (2) Properly emphasizes the incorporation of diversification benefits across risk factors and business lines, matching the ground truth's emphasis on this critical component; (3) Accurately describes the framework's role in determining capital resources at the AIG Parent level to support subsidiaries and maintain consolidated target capitalization levels - the multi-hop synthesis is sound; (4) Correctly integrates the stress testing framework as a complementary tool for assessing exposure to significant financial and insurance risks. Minor observations: The LLM answer adds interpretive language such as 'ensuring alignment with risk appetite' and 'informed capital planning under adverse scenarios' which, while reasonable inferences, go slightly beyond the explicit ground truth statement. However, these additions are semantically consistent with the framework's purpose and do not contradict the original answer. No quantitative data was present in either answer to verify. The multi-hop reasoning correctly synthesizes the relationship between the Internal Capital Framework, diversification benefits, stress testing, and capital resource assessment. The answer maintains semantic equivalence while using slightly different phrasing that enhances clarity without sacrificing accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 426,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Supply chain disruptions or failure to meet consumer demand for Target's owned brands (which account for ~1/3 of merchandise sales) could lead to inventory mismanagement, increased markdowns, and higher costs, directly impacting profitability. The document highlights that owned brands require longer lead times, precise forecasting, and greater supply chain involvement, making them more vulnerable to disruptions. Such issues could result in insufficient or excess inventory, reduced margins, and reputational risks, all of which could adversely affect financial performance. Additionally, inventory shrink and operational inefficiencies exacerbate these challenges, further straining profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core financial impacts but has notable omissions compared to the ground truth. STRENGTHS: (1) Correctly identifies owned brands as ~1/3 of merchandise sales; (2) Accurately describes supply chain vulnerabilities and longer lead times; (3) Properly connects disruptions to inventory mismanagement, markdowns, and profitability impacts; (4) Mentions inventory shrink as a key concern; (5) Quantitative accuracy is high with correct percentage representation. WEAKNESSES: (1) Missing critical context about higher margins on owned brands vs. national brands - the ground truth emphasizes owned brands 'generally carry higher margins,' which is important for understanding profitability implications; (2) Fails to mention the specific seasonal impact during November-December holiday period, which the ground truth identifies as a key vulnerability period where 'a larger portion of sales traditionally occur'; (3) Does not explicitly state that inventory shrink 'has historically elevated in recent years,' which is a documented trend in the ground truth; (4) Mentions 'reputational risks' which is not in the ground truth and may be speculative; (5) Less precise about the forecasting challenge - ground truth emphasizes 'inability to accurately forecast consumer demand' as a specific risk. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between owned brand characteristics (1/3 of sales, longer lead times) and financial impacts (inventory, margins, profitability), but misses the temporal/seasonal dimension that is important to the complete answer. The answer is directionally correct but incomplete in capturing all material risk factors identified in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 477,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "The 2024 carrying value of NVDA's 3.50% Notes Due 2050 is $2,000 million, while the 3.50% Notes Due 2040 is $1,000 million. The difference is **$1,000 million**. \n\n(Answer derived from Note 12 - Debt on page 72 of the 2023 10-K, which lists the net carrying amounts for these notes as of January 28, 2024.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core quantitative requirement. The ground truth answer is $397 million difference, but the LLM calculated $1,000 million difference. Specifically: (1) The LLM states the 2050 Notes carrying value is $2,000 million and the 2040 Notes is $1,000 million, yielding a $1,000 million difference. However, the correct ground truth difference is $397 million, indicating the actual carrying values must be different from what the LLM reported. (2) The calculation itself ($2,000M - $1,000M = $1,000M) is arithmetically correct, but the underlying carrying values used are wrong. (3) The LLM correctly identified the relevant note (Note 12 - Debt) and the correct fiscal year (January 28, 2024), and the multi-hop reasoning structure is sound - it identified both debt instruments and attempted to calculate the difference. However, the critical failure is in the quantitative accuracy of the carrying values themselves. (4) The question is appropriately addressed in terms of structure and relevance, but the answer is off by $603 million ($1,000M - $397M), which is a material error for financial data. The LLM appears to have either misread the carrying values from the source document or used incorrect figures. This is a complete failure on the primary metric - factual correctness of financial numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1069,
        "completion_tokens": 376,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31, 2024, a total of **64 million shares** of common stock were available for future issuance under both the 2020 Stock Incentive Plan (48 million shares) and the ESPP (16 million shares). The 2020 Stock Incentive Plan allows for awards in the form of **stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All numbers are correct - 64 million total shares, 48 million under 2020 Stock Incentive Plan, 16 million under ESPP, and the date of December 31, 2024 is accurate. The arithmetic is correct (48M + 16M = 64M). (2) COMPLETENESS: The answer addresses all parts of the multi-part question: total shares available, breakdown by plan, and types of awards under the 2020 Stock Incentive Plan. (3) ENTITY ACCURACY: UnitedHealth Group is correctly identified, the 2020 Stock Incentive Plan and ESPP are correctly named, and the fiscal year 2024 is correct. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple components - combining data from two different plans and then providing details about award types. (5) AWARD TYPES: All six types of awards are correctly listed: stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. The formatting with bold text enhances clarity without affecting accuracy. The only minor consideration is that the answer could have been slightly more explicit about the source (UnitedHealth Group 2024 10-K), but this is a very minor point given the context of the question already specifies the filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 368,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibilitysuch as in long-tail lines at early stages of developmentExpected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG employs the Bornhuetter-Ferguson method within its Expected Loss Ratio approach to address the volatility of loss emergence in U.S. Workers' Compensation, a long-tail line of business. This method combines historical loss development data with expected loss ratios, allowing AIG to balance observed trends with assumptions about future loss patterns. By incorporating both paid loss data and projected loss ratios, it mitigates overreaction to short-term anomalies (e.g., large claims) and stabilizes estimates amid long-tail uncertainty. This hybrid approach ensures resilience against volatile loss emergence while accounting for factors like inflation, judicial trends, and tail factors, which are critical for accurately reserving for decades-long loss development.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the Bornhuetter-Ferguson method and its application to U.S. Workers' Compensation loss reserving. STRENGTHS: (1) Correctly identifies the method as combining historical loss development data with expected loss ratios; (2) Accurately describes the core benefit of mitigating overreaction to short-term anomalies; (3) Properly characterizes U.S. Workers' Compensation as long-tail; (4) Mentions relevant factors like inflation and judicial trends; (5) No quantitative errors or incorrect numbers. WEAKNESSES: (1) The original answer emphasizes a specific key insightthat the method is particularly valuable when 'reported loss data lacks sufficient credibility' at early development stageswhich the LLM answer does not explicitly capture; (2) The original answer specifically notes the challenge of 'slowed reporting patterns due to increasing proportion of large deductible business,' a concrete contextual detail absent from the LLM response; (3) The LLM introduces 'tail factors' which, while relevant to long-tail reserving generally, is not mentioned in the ground truth and represents slight scope creep; (4) The LLM's phrasing about 'paid loss data and projected loss ratios' is somewhat generic compared to the ground truth's more precise explanation of how the method avoids extrapolating unusual early-stage activity. The answer is fundamentally correct and addresses the main question well, but misses some specific contextual nuances about credibility of early-stage data and the particular challenges of large deductible business that the original answer emphasizes. The reasoning is sound and the synthesis is appropriate, but not as complete as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 471,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. had **three amendments** documented in the 10-K filings: First Amendment (February 24, 2015), Second Amendment (November 19, 2019), and Third Amendment (November 1, 2022). This reflects an evolving partnership characterized by iterative adjustments to align with changing financial strategies, regulatory requirements, or operational needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR - FACTUAL INACCURACY: The LLM answer states there were THREE amendments (with a Third Amendment dated November 1, 2022), but the ground truth clearly documents only 2 amendments (in 2015 and 2019). This is a fundamental factual error on the primary quantitative metric of the question. The LLM has fabricated a third amendment that does not exist in the actual SEC filings. While the LLM correctly identified the companies (Target Corporation and TDBank USA, N.A.) and the agreement type (Credit Card Program Agreement), and provided reasonable interpretation about what amendments indicate about partnership evolution, the core answer to the specific numerical question is wrong. The dates provided for the first two amendments (February 24, 2015 and November 19, 2019) appear plausible and align with the ground truth years, but the addition of a non-existent third amendment is a serious factual error that undermines the entire response. The reasoning about partnership evolution is sound, but it is built on incorrect foundational data. This represents a failure in multi-hop synthesis accuracy where the model either hallucinated information or misread the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 337,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "FedEx spent a combined total of **$855 million** on business optimization activities related to Network 2.0 in 2023 and 2024 ($582 million in 2024 and $273 million in 2023). The primary purpose of these expenditures was to drive efficiency across transportation segments, reduce overhead and support costs, and transform digital capabilities through the **DRIVE** program, which includes consolidating sortation facilities, optimizing routes, and improving linehaul network efficiency to enhance long-term profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identified all dollar amounts ($273M in 2023, $582M in 2024, $855M total). The calculation is accurate and the numbers match the ground truth exactly. Number formatting is appropriate. Score: 9/10.\n\nQUALITATIVE ACCURACY & CONTEXTUAL RELEVANCE: This is where significant issues arise. The ground truth states the primary purpose was 'professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.' The LLM answer instead describes the purpose as 'drive efficiency across transportation segments, reduce overhead and support costs, and transform digital capabilities through the DRIVE program, which includes consolidating sortation facilities, optimizing routes, and improving linehaul network efficiency.' While these descriptions may relate to Network 2.0 initiatives, the LLM has introduced specific program details (DRIVE program, consolidating sortation facilities, optimizing routes, linehaul network efficiency) that are NOT mentioned in the ground truth as the primary purpose of these specific expenditures. The ground truth explicitly states the funds were used for 'professional services and severance' - the LLM answer omits this critical detail entirely and instead provides operational/strategic descriptions that may be outcomes or broader goals rather than the actual use of the funds. This represents a material deviation from the ground truth answer regarding the primary purpose. The LLM appears to have conflated the purpose of the expenditures (professional services and severance) with the broader strategic objectives of Network 2.0.\n\nMULTI-HOP REASONING: The model correctly synthesized the two-year spending figures and combined them accurately. However, it failed to properly synthesize the purpose statement from the source material.\n\nOVERALL ASSESSMENT: The answer is partially correct on the quantitative side but significantly incomplete and potentially misleading on the qualitative side regarding the primary purpose of expenditures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 571,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The introduction of the ad-supported subscription plan, as noted in Netflix's 2023 10-K, introduces uncertainty in financial forecasting due to risks related to consumer adoption and revenue impact. The document highlights that adjustments to pricing strategies, such as the ad-supported plan, may not be well-received by members, potentially affecting membership retention, revenue per paying member, and overall financial performance. Additionally, the lack of operating history with such offerings makes it difficult to predict consumer behavior, increasing the risk of discrepancies between forecasted and actual results. These factors contribute to heightened forecasting risks, as outlined in the \"Risk Factors\" section (pages 6, 18, and 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The core claim matches the ground truth - the ad-supported plan increases financial forecasting risks due to unpredictable consumer adoption. The LLM correctly identifies that this uncertainty could lead to discrepancies between forecasted and actual financial metrics (revenues, net income, membership retention, revenue per paying member). (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required or provided in either answer, so this dimension is not applicable. The LLM appropriately avoids making unsupported numerical claims. (3) ENTITY ACCURACY: Netflix and the 2023 10-K are correctly identified. The reference to specific page numbers (6, 18, 7) in the Risk Factors section adds credibility, though these cannot be verified against the ground truth provided. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the connection between (a) the ad-supported plan introduction, (b) consumer adoption uncertainty, (c) pricing strategy impacts, and (d) forecasting risks. The reasoning is sound and logically structured. (5) SEMANTIC EQUIVALENCE: The LLM answer expands on the ground truth with additional relevant details (membership retention, revenue per paying member, lack of operating history) while maintaining fidelity to the core concept. The ground truth states consumer adoption is 'inherently difficult to predict,' and the LLM conveys this through 'uncertainty in financial forecasting' and 'lack of operating history.' Minor deduction: The LLM provides page references that cannot be verified against the provided ground truth, though this adds helpful context rather than introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 469,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was recorded due to updated commercial forecasts reflecting a strategic shift toward vaccines with broader serotype coverage, which likely accounted for the patent expiration timeline. Prevnar 13's U.S. basic patent expires in 2026, while its European patent (revoked but other protections remain) and Japan patent expire in 2029. The impairment reflects reduced expected future cash flows from the product as patent protection wanes, aligning with the timeline of declining exclusivity and competitive pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key numbers are accurate: $964 million impairment charge is correct, U.S. patent expiration in 2026 is correct, European and Japan patent expirations in 2029 are correct. (2) The multi-hop synthesis is sound: the answer correctly connects the impairment charge to updated commercial forecasts and patent expiration timelines. (3) The reasoning about reduced future cash flows and competitive pressures is logical and appropriate. (4) The answer correctly identifies the strategic shift toward higher serotype coverage vaccines. (5) The mention of European patent revocation with other protections remaining shows nuanced understanding. MINOR ISSUES: (1) The original answer specifically mentions 'Prevnar 20' as the next-generation vaccine focus, which the LLM answer omits (though it does reference 'next-generation vaccines'). This is a minor omission rather than an error. (2) The LLM answer provides slightly more detail about European patent status (noting revocation but other protections remain) which adds context beyond the ground truth but doesn't contradict it. (3) The phrasing differs slightly but conveys equivalent meaning - both answers explain the relationship between patent expiration and the impairment charge. The LLM answer is more detailed in explaining the mechanism (declining exclusivity, competitive pressures) while the ground truth is more concise. Overall, this is a high-quality answer with accurate facts, correct numbers, sound reasoning, and appropriate synthesis of multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 439,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald's does not consolidate franchisee-related entities in its financial statements because franchisees operate as independent businesses, not subsidiaries, and are accounted for under the equity method or as separate entities. This structure reflects McDonald's reliance on franchisees for operational success, as franchisees manage day-to-day operations and are critical to driving sales and customer experience. However, if franchisees fail to execute key initiatives (e.g., maintaining quality, service, or brand alignment), it could harm McDonald's brand reputation, customer satisfaction, and financial results, as franchise performance directly impacts Systemwide outcomes. The lack of consolidation means McDonald's financial statements do not fully reflect franchisees' operational risks, potentially obscuring the full extent of exposure to underperformance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that McDonald's does not consolidate franchisee-related entities and accurately describes the operational risks posed by franchisee underperformance (brand reputation, customer satisfaction, financial results). The answer appropriately addresses the multi-part question structure and recognizes the connection between non-consolidation and risk exposure. WEAKNESSES: (1) The LLM answer mentions 'equity method or as separate entities' accounting treatment, but the ground truth specifically cites a 'scope exception under variable interest entity consolidation guidance' - this is a material difference in the accounting framework cited. The equity method is not the primary reason stated in the ground truth. (2) The ground truth specifically mentions concrete customer experience initiatives (digital engagement, mobile ordering, delivery improvements), while the LLM answer uses more generic examples (maintaining quality, service, brand alignment). This represents incomplete synthesis of the specific initiatives McDonald's emphasized. (3) The LLM answer adds language about 'obscuring the full extent of exposure' which, while logically sound, goes beyond what the ground truth states and introduces interpretive analysis not grounded in the filing. (4) The ground truth emphasizes impact on 'sales, guest counts, and market share' while the LLM answer mentions 'brand reputation, customer satisfaction, and financial results' - these are related but not identical risk articulations. MULTI-HOP REASONING: The LLM correctly synthesizes the connection between non-consolidation and operational risk, but fails to precisely identify the specific VIE consolidation guidance framework that is central to the ground truth explanation. This is a meaningful gap in technical accuracy regarding the accounting treatment rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 507,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG's adoption of the LDTI standard on January 1, 2021, resulted in a **net decrease to beginning total equity of $1,264 million** as of that date. For the years ended December 31, 2022 and 2021, adjustments to the consolidated financial statements included a **$983 million increase in net income for 2021** and a **$2 million decrease in net income for 2022**. Additionally, total equity as of December 31, 2022, increased by **$1,219 million** due to these adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about AIG's LDTI adoption. QUANTITATIVE VERIFICATION: All numeric values are correct - the $1,264 million net decrease to beginning total equity as of January 1, 2021; the $983 million increase in net income for 2021; the $2 million decrease in net income for 2022; and the $1,219 million increase in total equity as of December 31, 2022. All dates and fiscal years are accurately identified. COMPLETENESS: The answer addresses all key components of the question: (1) the impact on equity as of January 1, 2021, (2) specific adjustments for both 2022 and 2021, and (3) the resulting equity change. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple time periods and financial statement line items, demonstrating proper understanding of how LDTI adoption affected both the opening balance sheet position and subsequent period results. ENTITY ACCURACY: AIG is correctly identified, and all financial metrics (total equity, net income) are properly labeled with correct fiscal years. MINOR OBSERVATION: The ground truth mentions that changes were 'primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits,' but the LLM answer does not include this contextual detail about the underlying drivers. However, this is a minor omission of explanatory context rather than a factual error, as the question asks specifically about the impact and adjustments themselves, which are fully and accurately provided. The answer is well-structured, clear, and uses appropriate financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 466,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "The increase in Gulfstream aircraft orders in 2021 positively impacted General Dynamics' cash flow from operating activities by boosting customer deposits, as noted in the document. Cash flow from operating activities totaled **$4.271 billion**, which represented **131% of net earnings** for the year. This percentage reflects the overall relationship between operating cash flow and net earnings, with the Gulfstream orders contributing to the elevated cash flow through increased customer deposits.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Quantitative verification: The ground truth states $4.3 billion in operating cash flow; the LLM provides $4.271 billion, which is a minor rounding difference (4.271 rounds to 4.3 when expressed to one decimal place). Both represent the same underlying figure with acceptable formatting variation. The 131% percentage is correctly stated in both answers. Multi-hop reasoning: The LLM correctly synthesized the causal chain: Gulfstream aircraft orders  increased customer deposits  positive impact on operating cash flow. The answer properly identifies the mechanism (customer deposits) and the resulting metrics. Entity accuracy: General Dynamics, Gulfstream, 2021, operating cash flow, and net earnings are all correctly identified. The answer appropriately addresses both parts of the question: (1) how the orders impacted cash flow (through customer deposits), and (2) the percentage relationship to net earnings (131%). The only minor consideration is the slight numerical difference ($4.271B vs $4.3B), but this falls within acceptable rounding variation and does not constitute a material error. The reasoning is sound, the synthesis is complete, and the contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 351,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, provides granular, detailed risk data across business units. This process, combined with annual top-down risk assessments, enhances the internal capital framework's ability to quantify aggregate economic risk at a given confidence interval by incorporating diversification benefits between risk factors and business lines. The framework uses stress testing and analytics derived from these processes to assess significant exposures, supporting resource allocation and maintaining consolidated capitalization levels.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the bottom-up risk identification process at product-line level as a key component; (2) Accurately describes how this feeds into the internal capital framework; (3) Correctly states the framework quantifies aggregate economic risk at a given confidence interval; (4) Properly identifies diversification benefits between risk factors and business lines as a key outcome; (5) No numerical errors or factual inaccuracies; (6) Multi-hop reasoning is sound - correctly synthesizes the relationship between product-line risk data and aggregate economic risk quantification. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer adds information about 'annual top-down risk assessments' and 'stress testing and analytics' which, while potentially accurate from AIG's framework, are not explicitly mentioned in the ground truth answer. This represents additional context rather than contradiction; (2) The LLM answer mentions 'resource allocation and maintaining consolidated capitalization levels' which goes slightly beyond the specific question scope but is contextually relevant to capital frameworks; (3) The ground truth emphasizes 'material risks inherent in specific business operations' more explicitly, while the LLM uses 'granular, detailed risk data' which is semantically equivalent. ASSESSMENT: The answer demonstrates solid understanding of the multi-hop relationship between product-line risk identification and aggregate economic risk quantification. The core mechanism is correctly explained. The additional details about top-down assessments and stress testing, while not in the ground truth, do not contradict it and represent reasonable elaboration on how such frameworks typically operate. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 502,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDAs ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDAs control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDAs gross margins and financial results.",
      "llm_answer": "The introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interacts with supply chain risks and demand forecasting challenges by increasing complexity in managing inventory and production timelines. The document highlights that product transitions often lead to simultaneous shipments of new and older architectures, creating volatility in demand forecasting and potential mismatches between supply and demand. Supply chain risks, such as extended lead times, component shortages, and reliance on third-party manufacturers, could delay production or increase costs. If demand for the RTX 4080 is overestimated, NVDA may face inventory impairments or write-downs, while supply constraints could hinder fulfillment of orders, impacting revenue and gross margins. These factors collectively pose financial risks by introducing execution challenges and uncertainty in meeting customer demand.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core interaction between RTX 4080 product transitions, supply chain risks, and demand forecasting challenges. The response accurately captures key concepts: (1) product transition complexity creating demand forecasting volatility, (2) supply chain risks from extended lead times and third-party manufacturer reliance, (3) inventory impairment risks from demand overestimation, (4) revenue/margin impacts from supply constraints. No quantitative errors are present (no specific numbers were required or provided). The multi-hop reasoning is sound, connecting product transitions  demand forecasting challenges  supply chain risks  financial impacts. However, the LLM answer has notable omissions compared to the ground truth: (1) Missing specific mention of quality/production issues and warranty costs as consequences of product transitions, (2) Missing discussion of inventory provisions as a specific financial impact, (3) Missing the dual-scenario analysis (underestimated demand leading to lost market share vs. overestimated demand leading to cancellation penalties), (4) Missing explicit mention of geopolitical tensions as a supply chain factor, (5) Missing the foundry dependency and manufacturing yield risks as specific supply chain vulnerabilities. The LLM answer provides a more general synthesis while the ground truth offers more comprehensive detail on specific financial consequences (warranty costs, cancellation penalties, impairments). The answer is semantically aligned with the ground truth's core message but lacks the depth and specificity of the original. The reasoning is logical and the synthesis across multiple risk factors is appropriate, but the incompleteness prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 478,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "The Starbucks Rewards loyalty program defers revenue recognition for the estimated value of Stars earned by members until the Stars are redeemed, as the company establishes a liability in deferred revenue when Stars are earned. Starbucks' total advertising expense in fiscal 2022 was $416.7 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses both parts of the multi-part question effectively. (1) QUANTITATIVE ACCURACY: The advertising expense figure of $416.7 million for fiscal 2022 is exactly correct and matches the ground truth. (2) REVENUE RECOGNITION MECHANISM: The LLM correctly explains that the Starbucks Rewards program defers revenue recognition until Stars are redeemed, and accurately describes the mechanism of establishing a deferred revenue liability when Stars are earned. The explanation is semantically equivalent to the ground truth - both convey that revenue is deferred based on estimated redemption value and recognized upon actual redemption. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two distinct topics: (a) the loyalty program's impact on revenue recognition timing, and (b) the specific advertising expense figure for fiscal 2022. (4) COMPLETENESS: Both sub-questions are fully addressed. The only minor difference is that the LLM's explanation is slightly more concise than the ground truth's description, but it captures all essential information. The phrase 'establishes a liability in deferred revenue' is a precise accounting term that accurately describes the mechanism. No factual errors, calculation errors, or entity misidentifications are present. The answer demonstrates sound multi-hop reasoning by correctly connecting the loyalty program mechanics to revenue recognition timing and providing the accurate advertising expense figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 419,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024 was an increase of **$1,546 million** (from $2,860 million in 2023 to $4,406 million in 2024). In 2024, **$75 million** in interest payments related to these loans was recognized in earnings, recorded under \"Interest and other expense, net\" in the economic hedges section.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE VERIFICATION: All numbers are correct - the change of $1,546 million is accurately calculated ($4,406M - $2,860M = $1,546M), the 2023 baseline of $2,860 million is correct, the 2024 amount of $4,406 million is correct, and the $75 million in interest payments recognized in earnings is correct. (2) COMPLETENESS: The answer fully addresses both parts of the question - the total change in notional amount AND the interest payments recognized in 2024. (3) ENTITY ACCURACY: All entities are correctly identified - the metrics (notional amount of intercompany loans, forecasted interest payments, interest expense), the financial statement line item ('Interest and other expense, net'), and the time periods (2023, 2024) are all accurate. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points - combining the 2023 and 2024 notional amounts to calculate the change, and separately identifying the interest expense recognition. The calculation logic is sound. (5) MINOR OBSERVATION: The LLM adds contextual detail by noting the 'economic hedges section' which provides helpful context, though this is not explicitly required by the ground truth answer. This addition is accurate and enhances clarity without introducing errors. The answer demonstrates strong multi-hop synthesis by connecting the balance sheet items (notional amounts) with the income statement impact (interest expense).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 423,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "The Total Marine Systems revenue increased by $547 million from 2020 to 2021 ($10,526 million in 2021 vs. $9,979 million in 2020). The revenue for Nuclear-powered submarines increased by $179 million during the same period ($7,117 million in 2021 vs. $6,938 million in 2020). Thus, Total Marine Systems' growth was significantly higher than that of Nuclear-powered submarines.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all key financial figures and calculations: Total Marine Systems revenue increase of $547 million (from $9,979M to $10,526M), Nuclear-powered submarines increase of $179 million (from $6,938M to $7,117M), and accurately states that Total Marine Systems growth was significantly higher. All numeric values are precise and calculations are accurate. The multi-hop reasoning is sound, correctly synthesizing information across two different revenue segments and comparing their growth rates. However, the answer is incomplete in one important respect: the original answer explicitly calculates and states the difference between the two growth amounts ($368 million), which provides a quantitative comparison metric. The LLM answer only qualitatively states that growth was 'significantly higher' without providing this specific dollar difference calculation. This omission represents a minor but meaningful gap in completeness, as the question asks 'how does this growth compare' - which could reasonably be interpreted as requesting a specific comparative metric. The answer is otherwise well-structured, factually accurate, and demonstrates proper multi-hop synthesis across the two revenue categories and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 353,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "The dollar amount change in Mac sales from 2023 to 2024 was an increase of **$627 million** (from $29,357 million to $29,984 million). In contrast, iPad sales decreased by **$1,606 million** (from $28,300 million to $26,694 million). Thus, Mac sales grew while iPad sales declined during the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) All factual information is correct: Mac sales change of $627 million increase (from $29,357M to $29,984M), iPad sales change of $1,606 million decrease (from $28,300M to $26,694M). (2) All calculations are verified as accurate: $29,984M - $29,357M = $627M (correct), $26,694M - $28,300M = -$1,606M (correct). (3) Multi-hop reasoning is sound: the answer correctly synthesizes data from two product lines across two fiscal years and makes the appropriate comparison between the two changes. (4) The answer directly addresses both parts of the question - the dollar change in Mac sales AND how it compares to iPad sales. The conclusion that Mac sales grew while iPad sales declined is logically sound and properly contextualized. The presentation is clear and uses appropriate formatting. No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 263,
        "total_tokens": 1423
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a decline in net revenue growth compared to the prior year's favorable volume/mix in chocolate. However, the company's overall net revenue increased by $452 million (likely referring to the Europe segment's growth), driven by higher net pricing, gains in other categories (e.g., biscuits & baked snacks, cheese & grocery), and offsetting the negative impact of the unfavorable chocolate volume/mix. The unfavorable chocolate volume/mix was partially offset by gains in other categories, but the overall growth was still supported by pricing and mix improvements in other segments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that unfavorable chocolate volume/mix in 2024 created a drag on revenue growth, contrasting with 2023's favorable performance. It correctly notes the $452 million overall net revenue increase and acknowledges that pricing and other categories offset the chocolate headwind. The general directional understanding is sound.\n\nCRITICAL ERRORS: (1) The LLM speculates that the $452 million refers to 'Europe segment's growth' - this is incorrect and unsupported. The ground truth clearly states this is the company's overall net revenue increase. (2) The LLM fails to cite the specific 2023 chocolate revenue figure of $10.619 billion, which is a key quantitative anchor in the ground truth. (3) The LLM does not mention the 3.5% growth rate that contextualizes the $452 million increase. (4) The LLM does not reference the $1,437 million net revenue increase in 2023 that was driven by favorable chocolate volume/mix - a critical comparison point for understanding the 2024 decline's impact.\n\nMULTI-HOP REASONING: The LLM partially synthesizes the comparison between 2023 and 2024 chocolate performance but lacks the quantitative depth of the ground truth. It mentions 'gains in other categories' but doesn't provide specific examples with the same clarity as the ground truth (which mentions biscuits & baked snacks, cheese & grocery). The reasoning about offsetting effects is present but underdeveloped.\n\nQUANTITATIVE GAPS: Missing key numbers ($10.619B for 2023 chocolate revenue, $1,437M for 2023 net revenue increase, 3.5% growth rate) significantly weakens the answer's analytical rigor. The LLM provides the $452 million figure but contextualizes it incorrectly as potentially segment-specific rather than company-wide.\n\nSEMANTIC ISSUES: The parenthetical speculation about Europe segment undermines credibility and suggests uncertainty about the data source. The answer would be stronger without this unsupported qualifier.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 533,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Apple's reliance on single-source suppliers and outsourcing partners in Asia for custom components exposes it to initial capacity constraints, which can delay product availability and increase supply chain risks. New products often use custom components available from only one source, and suppliers may prioritize common components over custom ones, limiting availability. These constraints, combined with geographic concentration in manufacturing regions prone to disruptions, can lead to production delays, higher costs, and reduced flexibility to mitigate supply shortages. The document highlights that such issues have historically impacted Apple's ability to meet demand and maintain consistent product availability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core supply chain risk issue and correctly synthesizes the multi-hop relationship between initial capacity constraints, single-source suppliers, and product availability impacts. Key strengths: (1) Accurately identifies the primary mechanism - initial capacity constraints on custom components limiting availability; (2) Correctly notes that suppliers may prioritize common components over custom ones; (3) Properly connects geographic concentration in Asia to disruption risks; (4) Appropriately links these factors to impacts on meeting demand and product availability; (5) No quantitative errors or incorrect numbers/dates. Minor weaknesses: (1) The phrase 'historically impacted' is somewhat vague compared to the ground truth's more direct causal language about business, results of operations, and financial condition; (2) Omits the specific detail about 'yields maturation' and 'manufacturing capacity increases' as the timeline for constraint resolution; (3) Does not explicitly mention the risk of suppliers choosing to focus on more common components as clearly as the ground truth. The answer captures the essential multi-hop reasoning: custom components  single-source dependency  initial capacity constraints  supply delays  product availability impact  business risk. The semantic meaning aligns well with the ground truth despite slightly different wording and minor omissions of supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 408,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue for 2022 after factoring in the content license early termination fee of $1,023 million, representing a decrease from the previous year's $5,266 million. The 2022 figure reflects the adjustment to account for the early termination of licenses, while the prior year's revenue was not impacted by this adjustment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with all key financial figures accurate. Verification of numbers: (1) 2022 TV/SVOD distribution licensing revenue of $3,429 million - CORRECT, (2) Content license early termination fee of $1,023 million - CORRECT, (3) 2021 revenue of $5,266 million - CORRECT. The year-over-year comparison is accurate: $5,266M (2021) vs $3,429M (2022) represents a decrease. However, the LLM answer does NOT explicitly state the calculated decrease amount of $1,837 million ($5,266M - $3,429M = $1,837M), which was included in the ground truth answer. The LLM correctly identifies that 2022 was impacted by the early termination fee adjustment while 2021 was not, demonstrating sound multi-hop reasoning across the financial data. The answer addresses all parts of the question (2022 revenue after adjustment, comparison to prior year) and correctly synthesizes the information. The omission of the explicit $1,837 million decrease calculation is a minor gap in completeness, as the comparison is stated qualitatively ('decrease from the previous year') rather than quantitatively. All entities (Disney, TV/SVOD distribution licensing, years 2021-2022) are correctly identified. The semantic meaning and factual content align well with the ground truth, with only the explicit statement of the year-over-year difference amount missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 378,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methodssuch as cash, credit or debit cards, or selected mobile walletsand by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling mobile ordering, contactless pick-up, and earning Stars through purchases. The app's features, such as advance ordering and seamless digital experiences, align with evolving customer preferences for convenience, while the loyalty program incentivizes repeat visits through rewards, as highlighted in the 2022 10-K disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core mechanisms by which Starbucks' Mobile App integration with Rewards drives engagement. STRENGTHS: (1) Correctly identifies key features: mobile ordering, contactless pick-up, earning Stars through purchases, and loyalty incentives; (2) Accurately conveys the strategic alignment with customer preferences for convenience and digital experiences; (3) No quantitative errors or incorrect numbers/dates; (4) Properly synthesizes multi-hop information about app features and loyalty program benefits; (5) Appropriately references the 2022 10-K context. MINOR WEAKNESSES: (1) The original answer explicitly mentions multiple payment methods (cash, credit/debit cards, selected mobile wallets) as a specific mechanism for earning Starsthe LLM answer generalizes this to 'purchases' without specifying the payment method diversity; (2) The original answer emphasizes 'card balances and loyalty benefits' access as a specific feature reinforcing repeat visitsthe LLM answer mentions this more implicitly through 'rewards' without the same specificity; (3) The original answer frames these features as 'collectively enhance customer convenience, digital interaction, and loyalty' with explicit mention of 'elevating customer experience through technology'the LLM answer conveys similar meaning but with slightly less comprehensive framing. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between app features (mobile ordering, contactless), loyalty mechanics (earning Stars, rewards), and business outcomes (repeat visits, engagement). The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information and meaning of the ground truth, though with some loss of specific detail about payment method diversity and explicit mention of card balance access features.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 511,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "PayPal excluded Paidy, Inc. from its internal control over financial reporting audit for 2021 due to SEC guidance allowing exclusions for acquisitions in the first year post-acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated assets and revenue as of December 31, 2021.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that Paidy was excluded from the internal control audit for 2021; (2) Accurately cites SEC guidance allowing first-year acquisition exclusions; (3) Correctly states that Paidy's assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals; (4) Properly identifies the acquisition timing (October 2021) and fiscal year end (December 31, 2021); (5) Multi-hop reasoning is sound - correctly synthesizes the acquisition event, SEC guidance, and quantitative threshold. MINOR WEAKNESSES: (1) The question asks 'by how much did Paidy's assets and revenues fall short' which could be interpreted as requesting a specific quantitative gap (e.g., 'X% below the 1% threshold'), but the LLM answer only states 'less than 1%' without specifying the exact shortfall amount. However, the ground truth also does not provide a specific numerical shortfall, only that it was 'below the 1% threshold,' so this is not a factual error but rather a limitation of available data; (2) The phrasing 'represented less than 1%' is semantically equivalent to the ground truth's 'represented less than 1%' - both convey the same information. QUANTITATIVE VERIFICATION: All numbers and percentages are accurate (less than 1%, October 2021, December 31, 2021). No calculation errors detected. The answer correctly synthesizes information across the acquisition event and financial reporting requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 426,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories  particularly in Argentina, Mexico, and Brazil  and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "The Latin America segment's 0.6% operating income growth in 2024 was driven by higher net pricing and cost controls, but these benefits were offset by volume/mix challenges in chocolate and refreshment beverages, which contributed to revenue declines. Unfavorable volume/mix, driven by declines in chocolate, candy, cheese & grocery, and refreshment beverages (partially offset by gains in biscuits & baked snacks and gum), combined with higher raw material costs, unfavorable currency translation, and other expenses, limited the segment's operating income growth despite pricing actions and productivity improvements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core issue (volume/mix challenges offsetting pricing and cost control benefits) and mentions several relevant factors. However, there are significant gaps and some inaccuracies:\n\nSTRENGTHS:\n- Correctly identifies the main offsetting dynamic: pricing/cost controls vs. volume/mix challenges\n- Mentions key categories affected (chocolate, refreshment beverages)\n- References pricing actions, productivity improvements, raw material costs, and currency impacts\n- Correctly notes the 0.6% growth figure\n\nWEAKNESSES:\n1. MISSING CRITICAL QUANTITATIVE DATA: The ground truth specifies a 7.0 percentage point net pricing increase, which is a key metric that the LLM answer completely omits. This is a significant quantitative gap.\n\n2. INCOMPLETE CATEGORY ANALYSIS: The LLM mentions 'candy, cheese & grocery' as declining categories, but the ground truth specifically focuses on 'chocolate and refreshment beverages' as the primary drivers. While the LLM's broader category list may be accurate, it dilutes the focus from the question's specific emphasis on chocolate and refreshment beverages.\n\n3. MISSING SPECIFIC GEOGRAPHIC CONTEXT: The ground truth emphasizes consumer softness in Mexico and Argentina as drivers of volume/mix declines. The LLM answer does not mention these specific geographies, which is important context for understanding the regional challenges.\n\n4. MISSING DOLLAR AMOUNT: The ground truth specifies the $3 million absolute increase in operating income. While the 0.6% is mentioned, the absolute dollar figure provides important context that is absent from the LLM answer.\n\n5. INCOMPLETE COST FACTOR DISCUSSION: The ground truth mentions 'manufacturing costs were reduced through productivity improvements' while the LLM says 'cost controls' and 'productivity improvements' more generically. The ground truth is more specific about the nature of cost reductions.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the offsetting relationship between positive factors (pricing, cost controls) and negative factors (volume/mix, raw materials, currency), demonstrating sound multi-hop reasoning. However, the synthesis is less complete than the ground truth.\n\nSEMANTIC EQUIVALENCE: The core message is conveyed, but important quantitative details and specific geographic/category context are missing, which reduces the completeness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 644,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Gulfstream's current product line holds **more than 270 city-pair speed records**, the highest among business jet manufacturers, with the **G650ER** explicitly credited for leading this achievement by holding the National Aeronautic Association's polar and westbound around-the-world speed records.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The specific number '270 city-pair speed records' is correct, and the G650ER is correctly identified as the aircraft model explicitly credited with leading this achievement. (2) QUANTITATIVE ACCURACY: The numeric value of 'more than 270' is precisely stated and matches the ground truth. No calculations are required for this question, and the number is presented accurately. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop information by: (a) identifying the total number of records held by Gulfstream's current product line, (b) identifying the specific aircraft model (G650ER), and (c) explaining what makes it a key contributor (holding NAA's polar and westbound around-the-world speed records). The reasoning is sound and logically connects all required elements. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'explicitly credited for leading this achievement' is semantically equivalent to the ground truth's 'specifically credited with holding' and 'key contributor to Gulfstream's leadership.' The addition of context that this represents 'the highest among business jet manufacturers' is a reasonable inference that adds value without contradicting the ground truth. (5) COMPLETENESS: The answer addresses both parts of the multi-part question: the total number of records (270+) and the specific aircraft model (G650ER). Minor note: The LLM adds interpretive context about being 'the highest among business jet manufacturers' which, while reasonable, is not explicitly stated in the ground truth provided, but this is a minor enhancement rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 467,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "Johnson & Johnson recorded $105 million in contingent consideration related to acquisitions in fiscal year 2024 and $704 million in fiscal year 2022. The Abiomed acquisition specifically contributed $704 million to the 2022 total. \n\n**Answer:**  \nJohnson & Johnson recorded $105 million in contingent consideration in fiscal year 2024 and $704 million in fiscal year 2022. The Abiomed acquisition contributed $704 million to the 2022 total.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures: $105 million for fiscal year 2024 and $704 million for fiscal year 2022, with Abiomed contributing $704 million in 2022. All individual numbers are accurate and match the ground truth. However, the answer has a significant completeness issue: it fails to mention Proteologix and the $105 million contingent consideration related to that acquisition in fiscal year 2024. The ground truth explicitly states that the $105 million in 2024 was related to Proteologix, not just a generic 'acquisitions' figure. Additionally, the LLM does not calculate or state the total contingent consideration across both years ($809 million), which was explicitly requested in the question ('in total in fiscal years 2024 and 2022'). The question asks for the total amount recorded across both years, and while the LLM provides the individual year amounts, it omits the synthesis of these into a combined total. The multi-hop reasoning is partially incompletethe LLM correctly identifies Abiomed's contribution but fails to fully synthesize all acquisition-related contingent consideration across the two-year period. The answer is factually accurate for what it states but incomplete in addressing all aspects of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 359,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPals balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "PayPal's sale of participation interests in merchant receivables under PPWC and PPBL is accounted for as a sale, derecognizing the transferred portion from its balance sheet. Under CECL, credit losses are recognized based on current expected losses for the remaining receivables, incorporating macroeconomic forecasts and risk parameters. The transition to CECL in 2020 required PayPal to estimate credit losses for all receivables, including those retained after selling participation interests, using historical data and forward-looking assumptions. The sale reduces exposure to specific receivables, thereby affecting the total credit loss provision, while the retained servicing rights and updated risk parameters (e.g., post-pandemic adjustments) influence the CECL-based allowance calculations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core accounting mechanics and correctly addresses the multi-hop question about how PPWC/PPBL participation interest sales interact with CECL adoption. STRENGTHS: (1) Correctly identifies that transfers are accounted for as sales with derecognition of transferred portion; (2) Accurately explains the transition from incurred loss model to CECL's expected credit loss model in 2020; (3) Properly synthesizes that PayPal retains exposure to credit losses on retained interests; (4) Correctly notes that CECL requires forward-looking estimates incorporating macroeconomic forecasts; (5) Accurately describes how retained servicing rights and risk parameters influence allowance calculations. MINOR WEAKNESSES: (1) The answer mentions 'post-pandemic adjustments' as an example of updated risk parameters, which is reasonable but not explicitly grounded in the original answer's framework; (2) The original answer emphasizes that the change made provisioning 'more forward-looking and sensitive to economic forecasts' while the LLM answer states this more implicitly through 'incorporating macroeconomic forecasts'; (3) The LLM answer could have been slightly more explicit about the contrast between the old incurred loss model (waiting for losses to occur) versus CECL (recognizing expected losses upfront). QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, so this dimension is not heavily tested. The answer contains no numerical errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three key concepts: (1) the mechanics of participation interest sales, (2) the accounting treatment (derecognition), and (3) the impact of CECL adoption on credit loss recognition. The logical flow connecting these elements is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth with appropriate technical precision and accounting terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 543,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The cheese & grocery product category contributed to the unfavorable volume/mix impact on the Latin America segment's 2024 net revenues, as declines in this category, along with chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. This unfavorable volume/mix, combined with currency translation effects, reduced net revenues by $80 million (1.6%) compared to 2023. Despite this, the segment operating income increased by $3 million (0.6%) in 2024, driven by higher net pricing, lower manufacturing costs, and other cost efficiencies, which partially offset the negative impacts of volume/mix and currency.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts about the cheese & grocery category's contribution to unfavorable volume/mix in Latin America's 2024 performance. Strengths: (1) Correctly identifies cheese & grocery as experiencing volume declines; (2) Accurately names the other declining categories (chocolate, candy, refreshment beverages) and offsetting gains (biscuits & baked snacks, gum); (3) Correctly states the $3 million (0.6%) segment operating income increase; (4) Properly identifies the offsetting factors (higher net pricing, cost savings). Weaknesses: (1) The LLM introduces a $80 million (1.6%) net revenue decline figure that is not mentioned in the ground truth answer, which focuses on the 2.4 percentage point unfavorable volume/mix impact - these may be related but the LLM conflates currency translation effects with volume/mix impact in a way not clearly supported by the ground truth; (2) The ground truth specifically states the unfavorable volume/mix was 2.4 percentage points, but the LLM does not quantify this specific metric; (3) The LLM adds detail about currency translation effects that, while potentially accurate, goes beyond what the ground truth explicitly addresses regarding the cheese & grocery category's specific contribution. The core answer about cheese & grocery's role and the $3 million operating income increase is correct, but the introduction of the $80 million revenue decline figure and currency discussion represents either additional information or a potential conflation of metrics that creates some ambiguity about whether the LLM fully understood the distinction between volume/mix impact (2.4 pp) and total net revenue change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 460,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemptionTelco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&Ts liquidity position in that period.",
      "llm_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million (issued in October 2024), and the Mobility noncontrolling interests have a redemption value of $2,000 million (issued in June 2023). Combined, these obligations require AT&T to prepare for cash outflows starting in 2028, as the Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility interests may be redeemed or put starting March 15 and June 15, 2028, respectively. This will impact AT&T's liquidity and cash flow commitments through 2028, necessitating planning to meet these obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correctTelco Class A-4 preferred interests at $2,250 million, Mobility noncontrolling interests at $2,000 million, and the combined total of $4,250 million (correctly calculated). All dates are accurate: November 1, 2028 for Telco Class A-4 call date, and March 15 and June 15, 2028 for Mobility redemption/put dates. The inclusion of issuance dates (October 2024 and June 2023) adds helpful context not explicitly required but enhances completeness. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two distinct financial instruments and their respective redemption mechanics, properly identifying that both become relevant in 2028 and explaining the different redemption structures (call vs. put options). COMPLETENESS: The answer addresses all parts of the questionthe individual redemption values, the combined obligation ($4,250 million), and the impact on cash flow commitments through 2028. The explanation of liquidity impact and the need for planning is appropriate and relevant. MINOR OBSERVATION: The ground truth emphasizes that 'redemption payments must be made in cash, which will directly impact AT&T's liquidity position,' while the LLM answer states this 'will impact AT&T's liquidity and cash flow commitments' with slightly less emphasis on the cash-only nature. This is a minor semantic difference that does not affect factual accuracy. The LLM answer is semantically equivalent and conveys the same essential information about the material nature of these obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 447,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "The Orthopaedics segment generated $9.158 billion in revenue in 2024. The combined revenue from Hips and Knees within this segment was $3.183 billion, representing approximately 34.7% of the total Orthopaedics segment revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. Verification of key metrics: (1) Orthopaedics segment total revenue: Ground truth states $9,158 million; LLM states $9.158 billion - these are equivalent (9,158 million = 9.158 billion), with only a format variation that is acceptable. (2) Hips revenue: Ground truth $1,638 million; LLM correctly incorporates this in combined calculation. (3) Knees revenue: Ground truth $1,545 million; LLM correctly incorporates this. (4) Combined Hips + Knees: Ground truth $3,183 million; LLM states $3.183 billion - equivalent and correct. (5) Percentage calculation: Ground truth shows 34.76%; LLM shows 34.7% - this is a minor rounding difference (34.76% rounded to one decimal place = 34.8%, but 34.7% is very close and represents acceptable rounding variation). The multi-hop reasoning is sound: the model correctly synthesized information about the total segment revenue and the component revenues, then calculated the percentage relationship. All entities are correctly identified (Orthopaedics segment, Hips, Knees, 2024). The answer is complete, addressing both the total revenue question and the comparison question. The only minor issue is the percentage rounding (34.76% vs 34.7%), which is a negligible difference and does not materially affect the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 379,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan's proportional adjustment mechanism increased the number of RSU shares available by **128,000** after the 2024 special dividend, as the plan's maximum share limit was proportionally adjusted to preserve RSU value. This adjustment is formally documented in the **2019 Incentive Plan** (Exhibit 10.2 in the 10-K filing, filed on DEF 14A on December 17, 2019) and referenced in Costco's Proxy Statement for its 2025 annual meeting.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and incomplete information. CORRECT ELEMENTS: (1) The 128,000 RSU shares available figure is accurate; (2) The 2019 Incentive Plan and Exhibit 10.2 filing reference is correct; (3) The general concept of proportional adjustment is correct; (4) Reference to Proxy Statement is appropriate. CRITICAL ERRORS: (1) The LLM completely omits the approximately 52,000 increase in outstanding RSUs, which is a major component of the ground truth answer - this is a significant omission for a multi-hop question; (2) The adjustment factor of 1.018 and the specific stock prices ($674.62 and $662.70) are not mentioned, which are key details explaining HOW the adjustment mechanism worked; (3) The specific dates (December 26, 2023 and December 27, 2023) are missing; (4) The LLM states the filing was 'filed on DEF 14A on December 17, 2019' which is confusing - it should clarify that the 2019 Incentive Plan was filed as Exhibit 10.2 in the DEF 14A on December 17, 2019. MULTI-HOP REASONING: The answer partially addresses the question but fails to synthesize the complete picture of how the adjustment mechanism worked (the calculation basis) and its full impact (both the increase in outstanding RSUs AND the increase in available shares). The answer addresses only one of two key impacts. QUANTITATIVE ACCURACY: While the 128,000 figure is correct, the omission of the 52,000 figure and the adjustment factor represents incomplete quantitative documentation. The answer reads as partially correct but substantially incomplete for a multi-hop financial question requiring synthesis of multiple data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 452,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 will increase its share of Intel's 2025 product portfolio, supporting performance improvements (20% per-watt over Intel 7) and enabling production shifts for Intel 3 (18% per-watt improvement over Intel 4) to Ireland. Intel 18A, set for 2025, introduces breakthrough technologies like gate-all-around transistors and backside power delivery, enhancing performance-per-watt and density over Intel 3. Financially, this shift aligns with Intel's \"shell ahead\" strategy and Smart Capital approach, leveraging government incentives and capital offsets to manage the high costs of EUV lithography and facility expansions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key quantitative facts: Intel 4's 20% performance-per-watt improvement over Intel 7, Intel 3's 18% improvement over Intel 4, Intel 18A's breakthrough technologies (gate-all-around transistors/RibbonFET and backside power delivery/PowerVia), and the 2024-2025 timeline for manufacturing transitions. The multi-hop synthesis connecting Intel 4's ramp-up, Intel 3's relocation to Ireland, and Intel 18A's introduction is logically sound. WEAKNESSES: (1) The LLM introduces information about 'shell ahead' strategy, Smart Capital approach, government incentives, and EUV lithography costs that are NOT present in the ground truth answer. While these may be factually accurate from Intel filings, they represent scope creep beyond what the original answer addresses and weren't explicitly requested in the question's focus on 'financial and technological impact.' (2) The LLM omits specific product details present in ground truth: Intel Core Ultra processor (shipped 2023), Xeon 6 Scalable server processors, and Panther Lake (first Intel 18A processors). These omissions reduce completeness. (3) The LLM doesn't explicitly mention that Intel 3's high-volume manufacturing moves FROM Oregon TO Ireland, only stating it moves 'to Ireland.' (4) The answer doesn't clearly articulate how these shifts enhance 'both client and data center product lines' as the ground truth does. QUANTITATIVE VERIFICATION: All percentages and performance metrics are accurate. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between Intel 4's ramp-up, Intel 3's relocation, and Intel 18A's introduction, though with less product-specific detail than ground truth. The financial/strategic elements added, while potentially relevant, dilute focus from the core technological narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 496,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "The book value of AT&T's investment in DIRECTV decreased from $877 million at December 31, 2023, to $0 at December 31, 2024, reflecting a $877 million reduction. This decline aligns with AT&T's decision to reduce the investment to zero in 2024 due to aggregate cash receipts exceeding the investment balance plus cumulative equity in earnings. The deconsolidation of Gigapower in May 2023, which shifted its accounting to the equity method, occurred earlier in the year and may have influenced the broader equity method investment adjustments, including DIRECTV's book value changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the $877 million decrease from $877M (Dec 31, 2023) to $0 (Dec 31, 2024) is accurately stated. (2) The explanation of why the investment was reduced to zero (aggregate cash receipts exceeding investment balance plus cumulative equity in earnings) is correct. (3) The Gigapower deconsolidation date of May 2023 is correct. (4) The numeric calculations and financial metrics are all accurate. WEAKNESSES: (1) The LLM answer lacks specificity about the timing of when DIRECTV's investment reached zero - the ground truth specifies 'beginning in Q3 2024' while the LLM only says 'in 2024'. (2) The LLM's statement that Gigapower 'may have influenced the broader equity method investment adjustments' is speculative and not supported by the ground truth, which presents these as separate events reflecting changes in equity investments. (3) The LLM answer doesn't clearly distinguish that Gigapower 'continues to be accounted for as an equity method investment' while DIRECTV was 'fully liquidated' - this is an important comparative distinction. (4) The LLM doesn't mention that AT&T acquired a 50% interest in Gigapower through a transaction with BlackRock, which provides important context for the comparison. MULTI-HOP REASONING: The LLM correctly synthesizes information about both DIRECTV and Gigapower investments and attempts to compare them, but the comparison is less precise and complete than the ground truth. The causal relationship suggested ('may have influenced') is not substantiated. OVERALL: The answer is substantially correct on core facts and numbers but lacks the precision and completeness of the ground truth answer, particularly in distinguishing the different outcomes of these two equity investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 482,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "Shockwave contributed **$564 million** in revenue to Johnson & Johnson's Cardiovascular segment in 2024, as reflected in the MedTech segment's sales breakdown on page 34. In human capital reporting, Shockwave is included in the fiscal 2024 headcount, with its employees accounted for in the total employee and full-time equivalent (FTE) figures provided on page 12.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The $564 million revenue figure for Shockwave's contribution to J&J's Cardiovascular segment in 2024 is correct and matches the ground truth exactly. The statement about Shockwave being included in J&J's 2024 headcount reporting is also accurate. (2) QUANTITATIVE ACCURACY: The $564 million figure is precise and correctly formatted. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM correctly identified that this is a multi-hop question requiring synthesis of: (a) Shockwave's revenue contribution to the Cardiovascular segment, and (b) Shockwave's inclusion in human capital metrics. Both components are addressed accurately. The reasoning is sound - the model correctly synthesized that Shockwave employees are incorporated into J&J's overall headcount and FTE figures. (4) ENTITY ACCURACY: All entities are correctly identified (Shockwave, Johnson & Johnson, Cardiovascular segment, 2024, headcount/FTE metrics). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'included in the fiscal 2024 headcount' is semantically equivalent to the ground truth's 'incorporated into the company's overall human capital metrics.' The addition of specific page references (page 34 for MedTech segment, page 12 for headcount) adds helpful context without introducing errors. Minor note: The LLM references 'MedTech segment' which is the parent segment containing Cardiovascular - this is contextually appropriate and not incorrect, though the ground truth specifically mentions 'Cardiovascular segment.' This is a minor contextual enhancement rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 448,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The 11% growth in the Optimized Application Experiences category in fiscal 2022 was driven by growth in **ThousandEyes** and **Intersight** offerings, partially offset by a decline in **AppDynamics**. The category increased by **$75 million** in dollar terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies ThousandEyes and Intersight as the specific offerings driving growth, accurately states the 11% growth rate, and correctly quantifies the dollar increase at $75 million. The answer also appropriately acknowledges that AppDynamics declined, which is the contextual premise of the question. (2) QUANTITATIVE ACCURACY: Both key numbers are correct - 11% growth rate and $75 million in dollar terms. No calculation errors present. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: identifying which offerings grew (ThousandEyes, Intersight), acknowledging which offering declined (AppDynamics), and connecting these to the overall category growth. The logic is sound - the growth in two offerings more than offset the decline in AppDynamics to produce net 11% category growth. (4) COMPLETENESS: The answer addresses all parts of the multi-part question: (a) which offerings contributed to growth, (b) by how much the category increased in dollar terms. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth but conveys identical information. The LLM's phrasing 'partially offset by a decline in AppDynamics' is actually slightly more explicit and helpful than the ground truth's simpler statement. Minor deduction of 1 point only because the ground truth uses 'driven by' while the LLM uses 'driven by...partially offset by' - though this is actually an improvement in clarity rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 444,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T paid a total of **$5,414 million** to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption reclassified the Mobility preferred interests from **equity** to a **liability** on the consolidated balance sheets, reducing the noncontrolling interest classification by removing the associated equity component and recognizing the obligation as a liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The dollar amount of $5,414 million is correct, the date (April 2023) is correct, and the inclusion of accrued and unpaid distributions is correctly identified. All numeric facts are accurate. QUALITATIVE ACCURACY - CRITICAL ERROR: The LLM's explanation of the balance sheet impact is fundamentally incorrect. The ground truth states that the redemption 'removed the Mobility preferred interests from the Noncontrolling interest classification' - meaning these interests were eliminated/derecognized from the balance sheet entirely after repurchase. The LLM incorrectly claims the interests were 'reclassified from equity to a liability,' which is factually wrong. The redemption was a buyout that eliminated the noncontrolling interest, not a reclassification. The LLM's statement about 'recognizing the obligation as a liability' is incorrect - there was no ongoing liability created; the interests were simply repurchased and removed. MULTI-HOP REASONING: The model correctly identified the transaction amount and date but failed to properly synthesize the balance sheet impact. The question asks how the redemption impacts the noncontrolling interest classification, and the correct answer is that it removes/eliminates it entirely, not that it reclassifies it to a liability. This represents a fundamental misunderstanding of the accounting treatment. COMPLETENESS: While the answer addresses both parts of the question (amount and balance sheet impact), the second part contains material factual errors that contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 430,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business unit achieved a year-over-year revenue growth of **14.5%** in 2024 (as shown in the MedTech segment table on page 34). This growth is **lower than the overall Cardiovascular segment's 21.4% increase** (reported on page 35), which includes Abiomed and newly acquired Shockwave Medical. The segment's higher growth reflects contributions from Shockwave's acquisition and other factors, while Abiomed's growth was driven by continued adoption of its Impella products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative metrics are correct: Abiomed's 14.5% YoY growth and the Cardiovascular segment's 21.4% growth are both accurate. The comparison between the two growth rates is properly synthesized and logically sound. The answer correctly identifies that Abiomed's growth was lower than the broader segment's growth, which is the core comparison requested. The LLM provides additional context about Shockwave Medical's acquisition and Impella product adoption, which adds relevant detail without introducing errors. The answer addresses both parts of the multi-hop question: (1) Abiomed's specific growth rate and (2) how it compares to the Cardiovascular segment. Minor note: The LLM answer references specific page numbers (34, 35) which adds credibility but cannot be verified against the ground truth provided. The ground truth provides the underlying revenue figures ($1.306B to $1.496B for Abiomed; $6.350B to $7.707B for Cardiovascular), and the LLM's percentages are mathematically consistent with these figures (1.496/1.306 = 1.145 = 14.5%; 7.707/6.350 = 1.214 = 21.4%). The semantic meaning and factual content align perfectly with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 347,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The provided pages list 12 Supplemental Indentures (Exhibits 4.84.20) related to debt instruments, but none reference amendments to the \"Lowe's Companies Benefit Restoration Plan.\" The most recent amendment mentioned in the exhibits is the Nineteenth Supplemental Indenture dated September 20, 2021 (Exhibit 4.20), which pertains to a credit agreement, not the Benefit Restoration Plan. Thus, no amendments to the Benefit Restoration Plan are listed in the exhibits.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key dimensions. (1) QUANTITATIVE ACCURACY: The ground truth states there are 7 amendments to the Lowe's Companies Benefit Restoration Plan, but the LLM claims there are 0 amendments listed in the exhibits. This is a critical factual error. The ground truth identifies the most recent amendment as dated April 4, 2017 (Amendment No. 7), but the LLM provides a completely different date (September 20, 2021) and references a Supplemental Indenture instead of the Benefit Restoration Plan amendment. (2) ENTITY ACCURACY: The LLM confused the exhibits entirely, discussing Supplemental Indentures (Exhibits 4.8-4.20) related to debt instruments rather than amendments to the Benefit Restoration Plan. This represents a fundamental misidentification of the relevant exhibits. (3) COMPLETENESS: The question asks for two specific pieces of information: (a) the number of amendments, and (b) the date of the most recent amendment. The LLM failed to provide either correct answer, instead stating that no amendments are listed. (4) REASONING: The LLM's reasoning appears to have searched for the wrong document type or exhibit category entirely. Rather than locating the Benefit Restoration Plan amendments in the exhibits, it identified unrelated debt instruments. This suggests a failure in multi-hop synthesis and document navigation. (5) SEMANTIC EQUIVALENCE: There is no semantic equivalence herethe answers are factually contradictory. The ground truth provides specific, verifiable information (7 amendments, most recent dated April 4, 2017), while the LLM provides contradictory information (0 amendments, different date for different document type).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 464,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "Capital One Financial Corporation had phased in **$1.8 billion** (75% of the $2.4 billion CECL transition amount) into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a **10.0% CET1 capital ratio**. \n\n**Answer:** By January 1, 2024, $1.8 billion of the $2.4 billion CECL transition amount had been phased in, and the required CET1 capital ratio under the Stress Capital Buffer framework is 10.0%.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information is correct. The answer accurately states that $1.8 billion (75% of $2.4 billion) was phased in by January 1, 2024, and that the required CET1 capital ratio is 10.0%. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct - $1.8 billion, $2.4 billion, 75%, and 10.0% all match the ground truth exactly. The calculation of 75%  $2.4B = $1.8B is accurate. (3) QUALITATIVE ACCURACY: The answer correctly identifies Capital One Financial Corporation, the CECL transition context, the Stress Capital Buffer framework, and the effective date of October 1, 2024. The multi-hop reasoning is sound - the answer synthesizes information about both the CECL phase-in amount and the separate CET1 capital requirement. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question with appropriate detail and clarity. The formatting with bold text and a summary statement enhances readability without compromising accuracy. Minor note: The answer could have been marginally enhanced by explicitly stating 'at least' before the 10.0% requirement (as in the ground truth), though the meaning is clear from context. This is a very minor semantic point that does not affect the factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 368,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney employs both time-based and performance-based vesting agreements to align executive compensation with long-term shareholder value. Time-based vesting (e.g., \"Form of Restricted Stock Unit Award Agreement (Time-Based Vesting)\") ties RSUs to service periods, encouraging sustained performance over time. Performance-based agreements (e.g., \"Form of Performance-Based Restricted Stock Unit Award Agreement\") link vesting to financial metrics like Total Shareholder Return (TSR) or ROIC, directly connecting executive rewards to shareholder value creation. This dual approach balances retention and performance incentives, ensuring executives focus on both long-term strategic goals and measurable financial outcomes.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Disney's use of both time-based and performance-based vesting agreements and accurately describes the general purpose and mechanics of each approach (TSR, ROIC metrics, retention vs. performance alignment). The qualitative reasoning about how these mechanisms work is sound and relevant to the question.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. MISSING SPECIFIC EXHIBIT REFERENCES: The ground truth provides specific exhibit numbers (10.43, 10.49, 10.54 for time-based; 10.44-10.48, 10.55, 10.57-10.59 for performance-based). The LLM answer provides only generic references like 'e.g., \"Form of Restricted Stock Unit Award Agreement\"' without citing the actual exhibits from the filing.\n\n2. INCOMPLETE ENUMERATION: The ground truth specifies \"at least six distinct forms of performance-based Restricted Stock Unit Award Agreements.\" The LLM answer does not quantify how many performance-based variations Disney uses, missing this key comparative detail.\n\n3. MISSING QUANTITATIVE COMPARISON: The ground truth implicitly compares the number of time-based agreements (3 exhibits) to performance-based agreements (6+ exhibits), suggesting Disney emphasizes performance-based compensation more heavily. The LLM answer does not capture this comparative quantitative insight.\n\n4. VAGUE CHARACTERIZATION: The LLM uses phrases like 'at least six distinct forms' is not mentioned; instead it says 'multiple variations' which is less precise.\n\nThe answer demonstrates good understanding of the conceptual framework and correctly identifies the key metrics (TSR, ROIC) and purposes, but fails to provide the specific documentary evidence and quantitative details that distinguish this answer from a generic explanation of vesting structures. For a multi-hop financial question requiring synthesis from SEC filings, the lack of specific exhibit citations and quantitative comparisons represents a material gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 532,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "The Hips and Knees products contributed to the Orthopaedics segment's 2.4% revenue growth in 2024 by driving increases of 5.0% (Hips) and 6.1% (Knees) respectively. This growth was fueled by portfolio strength, global procedure volume, and product innovations like the ATTUNE portfolio and VELYS Robotic-assisted solutions, which offset declines in other Orthopaedics categories such as Spine, Sports & Other.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the segment growth rate (2.4%) and the individual product line growth percentages (Hips 5.0%, Knees 6.1%), demonstrating accurate understanding of the key metrics. However, the answer has significant quantitative gaps: it fails to provide the absolute dollar amounts ($216M segment growth, $78M Hips increase, $89M Knees increase, $167M combined contribution) that are central to the ground truth answer. Most critically, it omits the crucial statistic that Hips and Knees contributed $167 million or approximately 77% of total segment growththis is the core quantitative finding that directly answers how these products 'contributed' to overall growth. The LLM does provide additional context about drivers (portfolio strength, procedure volumes, product innovations like ATTUNE and VELYS) and mentions offsetting declines in other categories, which adds useful qualitative information not in the ground truth. However, this supplementary information does not compensate for the missing quantitative synthesis. The multi-hop reasoning is partially soundthe model correctly connects the individual product growth rates to segment growthbut fails to complete the full synthesis by calculating or stating the combined contribution amount and percentage. The answer reads more as a qualitative explanation of growth drivers rather than a direct quantitative answer to the specific question about contribution magnitude.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 402,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, with the remaining $600 million phased in on January 1, 2025. The optional transition relief allows banking institutions to delay the full impact of CECL on regulatory capital over five years, using a 25% annual phase-in rate for the \"day 2\" ongoing impact starting in 2022, while the \"day 1\" adoption impact was initially delayed and partially reinstated in 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: 75% phase-in by January 1, 2024 ($1.8 billion), remaining $600 million phased in on January 1, 2025, and the $2.4 billion total. The calculation verification is sound: 75%  $2.4B = $1.8B, and $2.4B - $1.8B = $600M. Entity identification is accurate (Capital One, CECL Transition Rule, Federal Banking Agencies). The answer correctly addresses both parts of the multi-part question: (1) the amount phased in by January 1, 2024, and (2) how the transition relief works. The multi-hop synthesis is appropriate, connecting the specific dollar amounts to the broader five-year transition framework. However, the LLM answer introduces additional technical details about 'day 1' and 'day 2' impacts and a 25% annual phase-in rate that, while potentially accurate, go beyond what the ground truth explicitly states. The ground truth provides a simpler, more direct explanation of the transition mechanism. The LLM's additional details about the 25% annual phase-in rate and the distinction between day 1 and day 2 impacts are not contradicted by the ground truth but represent an expansion beyond the core answer. This additional information, while potentially helpful, slightly deviates from the ground truth's more straightforward explanation of how the optional transition relief works. The answer remains fundamentally correct and addresses the question comprehensively, but the extra technical details introduce a minor deviation from the ground truth's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 425,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The issuance of $500 in Guaranteed Senior Notes by Costco's Japanese subsidiary in November 2023 increased long-term debt, while the $77 repayment in July 2024 reduced it. These actions slightly decreased the total long-term debt carrying value from $6,484 (2023) to $5,919 (2024). The fair value of long-term debt, estimated using Level 2 and 3 inputs, decreased from $5,738 to $5,412, reflecting lower interest rates and debt reduction. Financing activities in 2024 used $10,764 in cash, driven by debt repayments (including the $77 repayment and $1,000 Senior Notes payoff) and dividends, offset by proceeds from the 2023 note issuance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. CORRECT ELEMENTS: (1) Issuance amount of $500 in November 2023 is correct; (2) Repayment of $77 in July 2024 is correct; (3) Fair value decrease from $5,738 to $5,412 is correct; (4) Financing activities of $10,764 net cash used is correct; (5) $1,000 Senior Notes repayment is correct; (6) Multi-hop synthesis across issuance, repayment, and financing activities is sound. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM introduces carrying value figures ($6,484 in 2023 and $5,919 in 2024) that are NOT mentioned in the ground truth answer. These appear to be fabricated or from a different source not validated by the knowledge graph; (2) The statement about 'lower interest rates' as a reason for fair value decrease is speculative and not supported by the ground truth; (3) The LLM claims the 2023 note issuance proceeds offset 2024 financing activities, which is misleadingthe ground truth indicates the issuance occurred in 2023 and contributed to 2024 financing activities differently. MULTI-HOP REASONING: The LLM correctly synthesizes that the issuance increased debt and the repayment decreased it, and properly connects these to the fair value change and financing activities. However, the introduction of unsupported carrying value numbers and speculative reasoning about interest rates weakens the analysis. The core narrative is logically sound but contaminated with unverified data points. QUANTITATIVE ACCURACY PENALTY: The carrying value numbers ($6,484/$5,919) cannot be verified against ground truth and represent a significant factual error in a financial analysis context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 467,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "Caterpillar accrues environmental remediation liabilities for sites where costs are probable and estimable, using site-specific data (e.g., technologies, regulations, prior experience) for individual sites and proportionate shares of costs for multi-party sites. The total estimated liability is not material and is included in \"Accrued expenses.\" The methodology differs by considering individual site factors versus allocating costs among multiple parties.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the key elements of Caterpillar's environmental remediation liability methodology. STRENGTHS: (1) Correctly identifies that the total liability is immaterial/not material and included in 'Accrued expenses' - matching ground truth; (2) Accurately describes the methodology for individual sites (site-specific data, technologies, regulations, prior experience); (3) Correctly identifies the key difference for multi-party sites (proportionate share vs. full liability); (4) Properly synthesizes the multi-hop information about how methodology differs between site types. MINOR WEAKNESSES: (1) The LLM answer omits one specific detail from ground truth: the 'minimum accrual' approach when no amount within a range is more likely - this is a methodological detail that adds precision to the individual site approach; (2) The phrasing 'allocating costs among multiple parties' is slightly less precise than 'considers its proportionate share of the probable costs' - though semantically similar; (3) The answer could have been more explicit about the 'range' concept mentioned in ground truth. QUANTITATIVE ACCURACY: No specific dollar amounts are provided in either answer (correctly, since the liability is immaterial), so this dimension scores high. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis is correct - the answer properly connects the overall liability amount to the methodology differences. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question (total liability amount and methodology differences). Overall, this is a strong answer with only minor omissions of detail that don't affect the core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 471,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "The percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022 was a **29% decrease** (from $15 million in 2021 to $11 million in 2022). The updated reporting structure introduced in fiscal 2022, which reclassified products into categories aligned with strategic priorities, reflects Cisco's focus on streamlining operations and allocating resources to higher-growth areas. The reduction in 'Other Products' revenue suggests the company is prioritizing core offerings and potentially divesting or restructuring underperforming segments to enhance overall efficiency and profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 5,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identified the 29% decrease and the exact dollar amounts ($15 million to $11 million). The calculation is accurate: ($15M - $11M) / $15M = 26.67%, which rounds to 27%, though 29% is stated in both answers. The numbers match the ground truth perfectly. COMPLETENESS & ENTITY ACCURACY: The LLM addressed both parts of the multi-part question - the percentage change and the reporting structure. All entities (Cisco, fiscal years 2021-2022, 'Other Products' category) are correctly identified. CRITICAL ISSUE - SEMANTIC DIVERGENCE: The ground truth states the new reporting structure reflects that 'even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.' This conveys strategic retention and portfolio alignment. The LLM instead interprets the reporting structure as reflecting 'focus on streamlining operations and allocating resources to higher-growth areas' and suggests the company is 'prioritizing core offerings and potentially divesting or restructuring underperforming segments.' This represents a fundamental misinterpretation of the strategic intent. The ground truth emphasizes RETENTION and RELEVANCE despite underperformance; the LLM emphasizes DIVESTMENT and RESTRUCTURING. These are opposite strategic narratives. REASONING QUALITY: While the LLM's logic is internally coherent (declining revenue  focus on higher-growth areas), it contradicts the ground truth's interpretation of what the reporting structure actually signals about Cisco's strategic approach. The LLM made an inference about strategic intent that conflicts with the documented ground truth. This is a significant qualitative error in multi-hop reasoning synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 487,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "Costco's executive employment agreement with Ron Vachris, effective January 1, 2024, is documented in Exhibit 10.9 (filed on 10-Q, November 26, 2023), with no prior amendments noted. In contrast, W. Craig Jelinek's agreement, initially effective January 1, 2017, was renewed annually through multiple extensions (Exhibits 10.5.110.5.5, filed quarterly in 20162023), reflecting a consistent pattern of annual renewals. Thus, Jelinek's agreement involved frequent annual amendments, while Vachris's agreement appears to be a new, single-term agreement without prior amendments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that contradict the ground truth:\n\n1. CRITICAL ERROR - Agreement Characterization: The LLM states Vachris's agreement is 'a new, single-term agreement without prior amendments,' but the ground truth explicitly states it 'follows this same annual renewal pattern' as Jelinek's. This is a fundamental misunderstanding of the core comparison.\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM correctly identifies Jelinek's agreement as effective January 1, 2017, but then claims renewals through 2023 with exhibits 10.5.1-10.5.5 filed 2016-2023. The ground truth specifies renewals from 2017 through 2023 with filings dated 2016 to 2022 - the LLM extends the filing dates incorrectly to 2023.\n   - The LLM references Vachris agreement in 'Exhibit 10.9 (filed on 10-Q, November 26, 2023)' but provides no verification this matches ground truth documentation.\n\n3. MULTI-HOP REASONING FAILURE: The question asks for a COMPARISON of timing and frequency patterns. The ground truth answer correctly identifies that BOTH executives follow the same annual renewal pattern. The LLM incorrectly concludes they follow different patterns (Jelinek = frequent annual amendments; Vachris = single-term, no amendments). This is a fundamental failure in comparative synthesis.\n\n4. SEMANTIC CONTRADICTION: The LLM's conclusion that Vachris's agreement 'appears to be a new, single-term agreement' directly contradicts the ground truth statement that it 'follows this same annual renewal pattern.' These are mutually exclusive interpretations.\n\n5. INCOMPLETE ANALYSIS: The LLM fails to recognize that both agreements demonstrate Costco's consistent practice of annual renewals effective January 1, which is the key insight in the ground truth answer.\n\nThe answer demonstrates partial understanding of individual facts (dates, exhibit numbers) but fails catastrophically in the comparative analysis and pattern recognition required by the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 544,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021). Thus, the decline in Customer Relationships was more significant than the decline in Intellectual Property over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) All factual information is correct: Customer Relationships decreased from $893M to $712M (a $181M decrease), and Intellectual Property decreased from $366M to $280M (an $86M decrease). (2) All calculations are verified as accurate: $893M - $712M = $181M  and $366M - $280M = $86M . The comparison statement that the decline in Customer Relationships ($181M) was more significant than Intellectual Property ($86M) is logically sound and mathematically correct. (3) Multi-hop reasoning is sound: the answer correctly synthesizes data from two different asset categories across two fiscal years (2020 and 2021) and properly compares the magnitudes of change. (4) The answer goes beyond the ground truth by adding a comparative conclusion ('the decline in Customer Relationships was more significant'), which is a valid and helpful inference that directly addresses the 'how does this compare' portion of the question. All entities (Customer Relationships, Intellectual Property, dates) are correctly identified. The answer is complete, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 321,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "The total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022 was **$23,829 million**. Revenue recognition for hardware and perpetual software in this category is recognized **upfront upon transfer of control**, while SaaS arrangements are recognized **ratably over the contract term** as the customer consumes the service.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE - UNVERIFIABLE SPECIFIC NUMBER: The LLM provides a precise figure of $23,829 million for 'Secure, Agile Networks' revenue in fiscal 2022. However, this specific number cannot be verified against the ground truth provided. The ground truth answer does not include any specific revenue figure for this product category, only describing the revenue recognition models. The LLM appears to have fabricated or hallucinated this specific number, which is a severe accuracy problem for a financial question requiring precise data from SEC filings. CORRECT ELEMENTS: The revenue recognition model descriptions are accurate and match the ground truth - hardware and perpetual software recognized upfront upon transfer of control, while SaaS arrangements recognized ratably over the contract term. The LLM correctly identifies the distinction between these two approaches and provides appropriate context about 'customer consumes the service.' MULTI-HOP REASONING: The answer attempts to synthesize information about both the quantitative contribution and the qualitative revenue recognition differences, which is appropriate for the multi-part question. However, the synthesis fails at the quantitative level due to the unverifiable number. COMPLETENESS: The answer addresses both parts of the question (total revenue contribution and revenue recognition model differences), but the first part is fundamentally compromised by the unverifiable figure. The qualitative portion is complete and accurate. RECOMMENDATION: The specific revenue number of $23,829 million must be verified against actual Cisco 10-K filings for fiscal 2022. Without verification, this answer cannot be trusted for financial analysis purposes, despite the correct explanation of revenue recognition principles.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 486,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "Amazon's revenue from third-party seller fees in 2022 is not explicitly stated in the provided pages, as the latest data available is for 2021. However, the document explains that third-party seller services generate revenue through commissions and fulfillment fees, aligning with Amazon's business model of enabling sellers to grow by providing a platform for selling products, fulfilling orders, and accessing customer demand. This revenue stream supports Amazon's ecosystem by fostering seller participation and expanding its marketplace.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FAILURE ON PRIMARY METRIC: The LLM answer completely fails to provide the specific 2022 revenue figure that was explicitly requested and is available in the ground truth. The LLM claims '2022 data is not explicitly stated' and that 'the latest data available is for 2021,' which is factually incorrect. The ground truth clearly states Amazon's third-party seller fees revenue for 2022 was $117,757 million. This is a fundamental quantitative accuracy failure - the core numerical answer to the question is missing entirely. QUANTITATIVE ACCURACY: Score of 1 because the LLM provides no 2022 figure whatsoever, instead deflecting to claims about data unavailability. This is a major factual error. QUALITATIVE ACCURACY: The LLM does correctly identify that third-party seller fees align with Amazon's business model of enabling sellers and providing platform services (4/10). However, this partial correctness on the qualitative/reasoning portion cannot compensate for the complete absence of the required quantitative answer. The LLM's explanation of the business model alignment is reasonable but generic and doesn't address the specific 2022 revenue figure. CONTEXTUAL RELEVANCE: The answer is somewhat relevant to the business model alignment question (5/10) but fails entirely on the primary quantitative component. The question has two parts: (1) What was the 2022 revenue figure? and (2) How does it align with the business model? The LLM only partially addresses part 2 while completely failing on part 1. MULTI-HOP SYNTHESIS: Not applicable here as the failure is on basic data retrieval rather than multi-hop reasoning. The answer demonstrates a critical limitation in accessing or retrieving specific financial data from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 477,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "As of December 31, 2024, Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio was **13.5%**, while the minimum capital adequacy requirement for CET1 was **4.5%**. The difference between the two is **9.0 percentage points**. This is derived from Table 12 on page 86, which explicitly states the CET1 ratio and minimum requirement under Basel III rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. Verification of key elements: (1) The final answer of 9 percentage points difference matches the ground truth exactly. (2) The specific numbers provided (CET1 ratio of 13.5% and minimum requirement of 4.5%) are mathematically consistent with the stated difference of 9.0 percentage points (13.5% - 4.5% = 9.0%). (3) The company (Capital One Financial Corp), metric (Common Equity Tier 1 capital ratio), and date (December 31, 2024) are all correctly identified. (4) The multi-hop reasoning is sound: the LLM correctly identified both the actual CET1 ratio and the minimum requirement, then calculated the difference. (5) The answer includes helpful context by citing Table 12 on page 86 and referencing Basel III rules, which adds credibility and specificity. The only minor consideration is that the specific source citation (Table 12, page 86) cannot be independently verified from the ground truth provided, but this does not contradict the ground truth and appears to be a reasonable reference. The answer fully addresses the question asked and provides the correct numerical result with clear supporting calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 334,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Altria's $1.7 billion investment in JUUL faces regulatory risks, including potential FDA actions to deny approvals or remove e-vapor products from the market, as well as FTC challenges to the JUUL transaction that could result in divestiture or rescission. These risks could undermine JUUL's commercial viability, leading to impairment charges, loss of the investment, and hinder Altria's strategic goals of expanding into innovative, reduced-risk products. Regulatory uncertainties and legal challenges also threaten Altria's ability to maintain governance rights and competitive positioning in the e-vapor category.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $1.7 billion investment amount and accurately mentions both FTC and FDA regulatory risks. The quantitative accuracy is strong - the investment amount is correct, and no calculation errors are present. However, there are notable differences from the ground truth in terms of emphasis and completeness: (1) The ground truth specifically emphasizes the FTC's administrative complaint alleging antitrust violations and unreasonable restraint of trade, which is the primary regulatory threat mentioned in the 2022 10-K. The LLM answer mentions FTC challenges but doesn't emphasize the antitrust/competition angle as strongly. (2) The ground truth explicitly states the FTC is seeking divestiture or rescission as remedies, which the LLM does mention but less prominently. (3) The ground truth specifically notes impacts on credit ratings and financing costs, which the LLM answer omits entirely - this is a material financial impact that directly answers the 'how could these risks financially impact' portion of the question. (4) The LLM introduces FDA approval denial risks, which while potentially relevant to JUUL's regulatory environment, is not mentioned in the ground truth answer and may represent information from a different source or time period. (5) The LLM mentions 'governance rights' which is not in the ground truth. The multi-hop reasoning is sound - the LLM correctly synthesizes that regulatory risks could lead to impairment charges and loss of investment, hindering strategic objectives. However, the answer is incomplete in addressing the full financial impact dimension (credit ratings, financing costs) that the ground truth emphasizes. The answer is contextually relevant and addresses the core question, but lacks the specificity and completeness of the ground truth regarding the primary FTC antitrust threat and its financial consequences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 514,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million Notes Due 2060 contribute to NVIDIA's financial flexibility risks by representing a long-term debt obligation that will mature in 2060. As part of the $11 billion in total outstanding notes, this obligation could require repayment or refinancing at maturity, which may be challenging if market conditions deteriorate or if NVIDIA lacks sufficient liquidity. The 10-K highlights that refinancing risks, coupled with the need to allocate cash flows toward debt service, could limit NVIDIA's ability to invest in growth, meet operational demands, or respond to unforeseen challenges, thereby adversely affecting its financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the core facts and numbers. Quantitative verification: (1) $500 million Notes Due 2060 - correct, (2) $11 billion total outstanding notes - correct, (3) maturity year 2060 - correct. All numeric values match the ground truth. The multi-hop reasoning is sound: the answer correctly synthesizes that the 2060 note is part of the broader $11 billion debt structure and explains how it contributes to financial flexibility constraints through refinancing risks and cash flow allocation requirements. The answer accurately identifies the key mechanisms by which this debt limits flexibility: need to allocate cash flows to debt service, reduced ability to invest in growth, and vulnerability to market conditions. However, there are minor omissions compared to the ground truth: (1) The LLM answer doesn't explicitly mention the impact on 'ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes' - though it does mention 'invest in growth' which partially covers this, (2) The ground truth emphasizes 'increases vulnerability to adverse changes in general economic conditions' more explicitly, though the LLM does mention 'if market conditions deteriorate.' The semantic meaning is largely equivalent - both answers convey that the 2060 note constrains financial flexibility through debt service obligations and refinancing risks. The reasoning quality is good, with appropriate causal connections drawn between the debt obligation and its effects on financial flexibility. No calculation errors present. The answer is appropriately contextualized to the question about how this specific note contributes to adverse effects on financial flexibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 478,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gileads existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The expanded FDA approval of Vemlidy for pediatric patients aged 6 years and older with compensated liver disease broadens Gilead's market potential in chronic HBV treatment by addressing a previously underserved younger demographic. This expansion complements Gilead's existing liver disease portfolio (e.g., Vemlidy for adults 12 years, Epclusa, Harvoni, and Livdelzi), enhancing its ability to treat a wider range of HBV patients. By capturing a larger pediatric market segment, Gilead strengthens its position in the HBV therapeutic area, potentially increasing revenue and solidifying its leadership in liver disease treatments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core concept that expanded FDA approval of Vemlidy for younger pediatric patients (6 years and older) broadens Gilead's market reach in HBV treatment. The answer appropriately recognizes this as addressing an underserved demographic and correctly mentions complementary products (Epclusa, Harvoni). The reasoning about market expansion and competitive positioning is sound and relevant to the question.\n\nCRITICAL ERRORS: (1) The LLM states Vemlidy was previously approved 'for adults 12 years' but the ground truth specifies it was approved for 'adults and pediatric patients 12 years and older' - this is a minor wording difference but acceptable. (2) The LLM introduces 'Livdelzi' as part of Gilead's liver disease portfolio, but the ground truth does not mention this product. This is a factual error - Livdelzi is not listed in the original answer's portfolio. (3) The LLM adds 'with compensated liver disease' as a qualifier for the pediatric approval, which is not mentioned in the ground truth and may be inaccurate. (4) The ground truth specifies the weight requirement ('at least 25 kg') which the LLM omits.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about the approval expansion, existing portfolio, and market impact. However, the inclusion of Livdelzi and the compensated liver disease qualifier suggest the model may have hallucinated or confused details not present in the source material.\n\nQUANTITATIVE ACCURACY: The age threshold (6 years) is correct, but the weight requirement (25 kg) is missing. The previous approval age (12 years) is correct. The inclusion of Livdelzi is factually incorrect.\n\nQUALITATIVE ACCURACY: The reasoning about market expansion and portfolio complementarity is sound, but the introduction of unsupported product information (Livdelzi) and unverified qualifiers (compensated liver disease) undermines accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 522,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "The percentage of Lowe's total sales in fiscal 2023 from installed sales categories also covered by extended protection plans is **approximately 5%**, as installed sales accounted for 5% of total sales. The specific product category explicitly mentioned in both contexts is **Appliances**, as it is listed in both the installed sales categories (Flooring, Kitchens & Bath, Millwork, Appliances, Lumber) and the extended protection plan categories (Appliances, Kitchens & Bath, Dcor, Millwork, etc.).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: Both the percentage (approximately 5%) and the specific product category (Appliances) match the ground truth exactly. The answer correctly identifies that installed sales categories covered by extended protection plans contributed ~5% of total sales in fiscal 2023. (2) QUANTITATIVE ACCURACY: The 5% figure is correct and properly formatted. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by: (a) identifying the 5% contribution of installed sales, (b) recognizing that this figure represents the overlap between installed sales and extended protection plan categories, and (c) correctly identifying Appliances as the specific product category appearing in both contexts. The LLM even provides supporting evidence by listing examples from both categories (Flooring, Kitchens & Bath, Millwork, Appliances, Lumber for installed sales and Appliances, Kitchens & Bath, Dcor, Millwork for extended protection plans), demonstrating thorough understanding of the multi-hop synthesis required. (4) CONTEXTUAL RELEVANCE: The answer directly and completely addresses all parts of the multi-part question - the percentage, the identification of overlapping categories, and the specific product category mentioned in both contexts. The reasoning is logical and well-structured. Minor note: The LLM could have been slightly more explicit that the 5% figure specifically represents the intersection of these two categories, though this is clearly implied in the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 435,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (20202021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a $2.4 billion after-tax addition to regulatory capital in 2021 (reflecting the delayed 'day 1' CECL impact and 25% scaling of the allowance increase). From 2022 to 2024, the cumulative 'day 2' ongoing impact is phased in at 25% annually, with full phase-in by 2024. This structure aligns with the CECL Transition Rule's five-year phase-in schedule, where the 25% scaling factor applies to the ongoing impact during the initial two years (20222023), with 25% annual increments thereafter.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the CECL Transition Election structure:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM introduces a specific dollar amount ($2.4 billion) that is not mentioned in the ground truth and appears to be fabricated without source documentation\n   - The LLM incorrectly states the 25% scaling factor applies to 2022-2023, when the ground truth clearly indicates it applies to 2020-2021 (the initial two years)\n   - The timeline description is confused: the LLM says \"From 2022 to 2024, the cumulative 'day 2' ongoing impact is phased in at 25% annually\" which contradicts the ground truth's clear phase-in schedule\n\n2. STRUCTURAL MISUNDERSTANDINGS:\n   - Ground truth: 25% scaling factor applies to 'day 2' ongoing impact during 2020-2021 ONLY\n   - LLM: Incorrectly places this scaling in 2022-2023\n   - Ground truth: 25% annual phase-in of BOTH 'day 1' AND cumulative 'day 2' impact from 2022-2024\n   - LLM: Vague about what is being phased in and when\n\n3. MULTI-HOP REASONING ISSUES:\n   - The LLM failed to correctly synthesize the two-phase structure: (a) 2020-2021 with 25% scaling of day 2 impact, and (b) 2022-2024 with 25% annual phase-in of both day 1 and cumulative day 2 impacts\n   - The introduction of the $2.4 billion figure suggests hallucination rather than accurate synthesis from source documents\n\n4. SEMANTIC ACCURACY:\n   - While the LLM uses appropriate terminology (CECL, regulatory capital, phase-in), it fundamentally misrepresents the timing and application of the scaling factors\n   - The answer conflates different components of the transition election\n\n5. WHAT WAS CORRECT:\n   - General acknowledgment that there is a phase-in schedule\n   - Recognition of the 25% scaling factor concept\n   - Mention of the five-year phase-in period (though application is incorrect)\n\nThe answer demonstrates partial understanding of CECL transition mechanics but fails on critical details regarding timing and application of the scaling factors, making it substantially incorrect for a question requiring precise multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 571,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "The net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales included a **$1.03 billion reduction** from a multi-state NPM adjustment settlement and a **$373 million reduction** from the New York settlement, along with a **$21 million reduction** related to the 2004 NPM adjustment. These recoveries reduced cost of sales, while the $4.6 billion in State Settlement Agreement charges (excluding NPM adjustments) increased it. The net impact was a **reduction of approximately $1.47 billion** in cost of sales for 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) MAJOR QUANTITATIVE ERRORS: The LLM claims a net reduction of approximately $1.47 billion in cost of sales, when the ground truth shows a net COST (increase) of $4.579 billion. This is a directional error of massive magnitude - the LLM reversed the sign of the net impact. The LLM introduces numbers ($1.03 billion, $373 million) that do not appear in the ground truth and appear to be fabricated or misattributed. (2) CALCULATION ERRORS: The LLM's arithmetic is internally inconsistent. It claims $1.03B + $373M + $21M = $1.47B reduction, but $1.03B + $373M + $21M = $1.424B, not $1.47B. More critically, these numbers don't match the ground truth structure at all. (3) MISSING CORE INFORMATION: The ground truth clearly states $4.6 billion in charges to cost of sales and $21 million in recovery, resulting in a net cost of $4.579 billion. The LLM completely misses the $4.6 billion charge figure as the primary impact. (4) ENTITY/METRIC CONFUSION: The LLM references 'multi-state NPM adjustment settlement' and 'New York settlement' with specific dollar amounts that are not supported by the ground truth. These appear to be hallucinated details. (5) SEMANTIC REVERSAL: The ground truth indicates a net cost impact (charges exceed recoveries), while the LLM claims a net reduction/benefit. This is a fundamental misunderstanding of the financial impact. The only correct element is the $21 million 2004 NPM adjustment recovery, but this is presented in a completely wrong context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 437,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by **$47 million** from 2020 to 2021. This is calculated as the difference between the 2021 liability of $538 million and the 2020 liability of $491 million, as reported in the \"Liability for postemployment benefits (non-current liability)\" line on page 108 of the 10-K filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary metric requested. The question asks for the total increase in liabilities for BOTH non-qualified deferred compensation plans AND other postemployment benefits combined from 2020 to 2021. The ground truth shows: (1) 2020 total liability: $554 million ($63M OPB + $491M NQDC), (2) 2021 total liability: $645 million ($67M OPB + $538M NQDC), (3) Total increase: $91 million. The LLM answer incorrectly calculated only $47 million by comparing just the non-qualified deferred compensation component ($538M - $491M = $47M), completely omitting the other postemployment benefits component increase ($67M - $63M = $4M). This represents a critical multi-hop synthesis failure - the LLM failed to combine both liability categories as required by the question. The LLM also only cited one line item from the 10-K rather than aggregating the two separate benefit liability categories. The calculation methodology was flawed: the LLM should have summed the increases in both components (NQDC increase of $47M + OPB increase of $4M = $91M total), not just reported one component's change. The contextual reference to the 2019 pension freeze is mentioned in the ground truth but not addressed in the LLM answer, though this is secondary to the core calculation error. The answer demonstrates incomplete understanding of the multi-part nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 389,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is not explicitly provided in the document. However, the $630 million indefinite-lived intangible asset (Mellanox's in-process R&D) is not amortized, as indefinite-lived assets are only tested for impairment annually. Amortization expense for the finite-lived intangible assets ($2,340 million) would be calculated based on their respective useful lives (5 years for developed technology, 3 years for customer relationships, and shipment-based order backlog). The document does not specify the exact amortization schedule for fiscal years 20232028.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to provide the specific information requested. Critical failures: (1) QUANTITATIVE ACCURACY: The LLM states 'The total estimated amortization expense...is not explicitly provided in the document' when the ground truth clearly shows the total is $1.889 billion with a detailed breakdown ($585M in 2023, $461M in 2024, $405M in 2025, $121M in 2026, $16M in 2027, $121M in 2028). The LLM provides zero of these specific numbers. (2) COMPLETENESS: The question asks for two specific pieces of information: (a) total amortization expense 2023-2028, and (b) how the $630M indefinite-lived IPR&D asset relates to it. The LLM fails to provide the primary answer (the $1.889B total and its components) and only partially addresses the relationship. (3) ENTITY ACCURACY: The LLM correctly identifies the $630M Mellanox IPR&D asset and correctly notes it's indefinite-lived and subject to impairment testing rather than amortization. However, it fails to synthesize how this relates to the amortization schedule. (4) REASONING: The LLM's reasoning about indefinite-lived assets not being amortized is correct in principle, but this is only a minor part of the answer. The core multi-hop synthesis requiredconnecting the amortization schedule to the indefinite-lived asset treatmentis incomplete. (5) CRITICAL ERROR: The LLM claims the document 'does not specify the exact amortization schedule for fiscal years 20232028' when this information is explicitly available in the ground truth. This suggests the LLM either lacked access to the relevant filing data or failed to extract it. The answer demonstrates partial understanding of intangible asset accounting but fundamentally fails to answer the specific quantitative question posed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 484,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "The combined U.S. and EU patent expiration year for Biktarvy is **2033**. The expanded FDA approval for Biktarvy to treat HIV patients with M184V/I resistance does not directly alter the patent expiration timeline but may extend regulatory exclusivity beyond the patent term, potentially delaying generic competition until the patent expires in 2033.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies 2033 as the combined U.S. and EU patent expiration year for Biktarvy, matching the ground truth exactly. (2) Numeric accuracy is strong - the patent expiration date is correct. (3) The LLM appropriately acknowledges that the expanded FDA approval does not directly alter the patent expiration timeline itself. WEAKNESSES: (1) The LLM's characterization of how the expanded approval influences market exclusivity differs from the ground truth. The ground truth states the expanded indication 'reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential,' emphasizing the positive strategic impact. The LLM instead focuses on regulatory exclusivity potentially 'delaying generic competition,' which is a more defensive framing and less directly addresses how the expanded indication reinforces market exclusivity. (2) The LLM introduces the concept of 'regulatory exclusivity beyond the patent term' which, while potentially accurate in principle, is not explicitly stated in the ground truth and may introduce unnecessary complexity. (3) The ground truth emphasizes that the expanded indication supports 'continued revenue generation potential,' which is a key strategic benefit not explicitly captured in the LLM's answer. MULTI-HOP REASONING: The LLM demonstrates adequate multi-hop synthesis by connecting the patent expiration date with the FDA approval's impact on market exclusivity, though the framing differs from the ground truth's emphasis on reinforcement and revenue support. The answer is factually sound but semantically diverges from the ground truth's characterization of the strategic benefit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 471,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Federal Reserve's supervisory stress testing modeling, specifically the DFAST (Dodd-Frank Act Stress Test) requirements, can limit Capital One's ability to return capital to shareholders by imposing higher capital buffer requirements. If stress tests indicate insufficient capital under adverse scenarios, the Federal Reserve may restrict dividends or share repurchases to ensure the company remains well-capitalized. This limitation is reinforced by the **Dodd-Frank Act's enhanced prudential standards**, which mandate these stress tests as part of the regulatory framework to safeguard financial stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with some significant gaps. STRENGTHS: (1) Correctly identifies that Federal Reserve supervisory stress testing limits capital returns through dividend/repurchase restrictions; (2) Accurately names DFAST (Dodd-Frank Act Stress Test) as the specific mechanism; (3) Correctly identifies the Dodd-Frank Act as the reinforcing regulatory framework; (4) No quantitative errors in the answer (no specific numbers were provided to verify). WEAKNESSES: (1) The LLM identifies 'enhanced prudential standards' as the specific Dodd-Frank requirement, but the ground truth specifies the 'source of strength doctrine' - these are related but distinct regulatory concepts. The source of strength doctrine specifically requires COF to maintain sufficient capital to support subsidiary banks, which is a more precise answer to the question's request for 'specific regulatory requirement'; (2) The LLM answer focuses on stress test mechanics and capital buffer requirements but misses the explicit connection to the source of strength doctrine, which is the specific doctrinal requirement mentioned in the ground truth; (3) The answer is somewhat generic and could apply to any large bank subject to DFAST, rather than specifically addressing COF's situation relative to its subsidiary bank support obligations. MULTI-HOP REASONING: The LLM correctly synthesizes the relationship between Federal Reserve stress testing and capital return limitations, but fails to complete the full multi-hop chain by not identifying the source of strength doctrine as the specific Dodd-Frank requirement that reinforces this limitation. The answer addresses the 'how' (stress testing mechanism) but incompletely addresses the 'what specific regulatory requirement' part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 489,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "The total payments made by PM USA under the State Settlement Agreements for 2019, 2020, and 2021 combined were approximately **$12.9 billion** ($4.2 billion in 2019, $4.4 billion in 2020, and $4.3 billion in 2021). This amount is significantly higher than the **$572 million** maximum potential NPM Adjustment for 2020 alone, as the NPM Adjustment represents a reduction in payments due to market share losses, while the State Settlement Agreements involve fixed annual payments adjusted for factors like inflation.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with only minor discrepancies. QUANTITATIVE ANALYSIS: The individual year amounts are correct ($4.2B in 2019, $4.4B in 2020, $4.3B in 2021), and the NPM Adjustment figure of $572 million is accurate. However, the total is stated as $12.9 billion in the LLM answer versus $12.8 billion in the ground truth. Verification: $4.2B + $4.4B + $4.3B = $12.9B, which is mathematically correct. The ground truth states $12.8 billion, suggesting a potential rounding or data discrepancy in the original source. The LLM's calculation of $12.9B is arithmetically sound based on the component figures provided. COMPLETENESS: The answer addresses all parts of the multi-part question - it provides the three-year total, breaks down each year, and compares to the 2020 NPM Adjustment maximum. ENTITY ACCURACY: All entities are correctly identified (PM USA, State Settlement Agreements, NPM Adjustment, specific years). REASONING QUALITY: The LLM demonstrates sound multi-hop reasoning by synthesizing information across multiple data points and providing contextual explanation about the difference between the two metrics (fixed annual payments vs. market share adjustments). The comparison is logical and well-explained. SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth, with appropriate emphasis on the significant difference between the two figures. The minor $100 million discrepancy in the total ($12.9B vs $12.8B) is the primary issue, though the component figures match perfectly, suggesting the discrepancy may stem from rounding methodology rather than factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 448,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The provided document pages do not include tables or disclosures related to the fair value of the 2.85% Notes Due 2030 or their net carrying amount for the fiscal year ending January 30, 2022. The referenced pages focus on intangible assets, leases, stock-based compensation, and acquisition details, but no debt instrument data is available.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to address the question. The ground truth provides specific, verifiable financial data: fair value of $1,542 million, net carrying amount of $1,500 million, and a calculated difference of $42 million for the 2.85% Notes Due 2030 as of January 30, 2022. The LLM instead claims that the referenced tables and disclosures are not available in the provided document pages. This is a fundamental failure to answer the question. The LLM did not provide any of the required numbers, did not calculate the difference, and did not identify the correct financial instruments or fiscal year. The response suggests the LLM either did not have access to the correct source documents or failed to locate the relevant debt disclosure tables. Since the ground truth confirms these specific figures exist in SEC filings for this fiscal year, the LLM's claim that the data is unavailable is factually incorrect. The answer demonstrates no understanding of the multi-hop synthesis required (finding fair value in one table, net carrying amount in another table, then calculating the difference). All quantitative values are missing, the entities (2.85% Notes Due 2030, January 30, 2022) are not addressed, and the core calculation is absent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 356,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rulebased on supervisory stress test resultsreduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "The Tailoring Rules, which categorize COF as a Category III institution, reduce its capital requirements by exempting it from the Basel III Advanced Approaches framework and allowing the exclusion of certain elements of AOCI from regulatory capital. As a Category III institution, COF is subject to a stress capital buffer determined annually via supervisory stress tests, which for 2021 was set at 2.5%, lowering its minimum capital requirements (e.g., CET1, Tier 1, and total capital ratios) compared to the fixed 2.5% buffer for Banks under the Basel III Capital Rules. This tailored approach, combined with AOCI exclusions, directly impacts COF's capital adequacy calculations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core impacts of the Tailoring Rules on COF as a Category III institution: exemption from Basel III Advanced Approaches, AOCI exclusions, and stress capital buffer determination. The multi-hop reasoning is sound, synthesizing information about regulatory framework changes and their capital requirement impacts. However, there is a significant quantitative accuracy issue: the LLM states the 2021 stress capital buffer was 'set at 2.5%' and compares this to 'the fixed 2.5% buffer for Banks under the Basel III Capital Rules.' This comparison is problematic because (1) it's unclear if 2.5% is the actual 2021 SCB for COF without verification from the ground truth, and (2) the comparison to a 'fixed 2.5% buffer' for other banks may be inaccurate or misleadingthe Basel III framework doesn't establish a fixed 2.5% buffer universally. The ground truth answer does not specify a 2.5% figure, instead focusing on the conceptual framework of 'institution-specific and annually adjusted' buffers. The LLM introduces a specific percentage without clear sourcing. The answer correctly addresses the main question components: Tailoring Rules impact, Category III status, Advanced Approaches exemption, AOCI exclusions, and Stress Capital Buffer Rule. The reasoning about reduced complexity and burden is appropriate. The semantic equivalence is generally strongthe LLM conveys the same fundamental concepts as the ground truth. The main weakness is the introduction of an unverified specific percentage (2.5%) and the potentially inaccurate comparison to other banks' capital requirements, which could mislead readers about the actual regulatory framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 461,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "The total change in fair value of Altria's JUUL investment from 2020 to 2021 was an increase of **$0.8 billion**. This change was reflected in Altria's consolidated financial statements as a **gain of $0.8 billion** in (income) losses from equity investments, as the fair value of the investment rose to $11.9 billion at December 31, 2021, compared to a carrying value of $11.1 billion. The increase was recognized under the fair value option, with changes in fair value directly impacting the consolidated statements of earnings (losses).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all major factual claims. (1) QUANTITATIVE ERRORS: The ground truth states the fair value remained UNCHANGED at $1,705 million from 2020 to 2021, but the LLM claims an increase of $0.8 billion to $11.9 billion. These numbers are completely wrong - $11.9 billion and $11.1 billion are not supported by the ground truth. The LLM fabricated specific dollar amounts that contradict the actual filing data. (2) CORE FACT ERROR: The most critical error is claiming there WAS a change in fair value when the ground truth explicitly states the fair value 'remained unchanged' at $1,705 million. This is a fundamental misunderstanding of the investment's valuation. (3) BALANCE SHEET CLASSIFICATION: The ground truth correctly identifies the investment as appearing in 'investments in equity securities' on the consolidated balance sheet. The LLM does not address this classification. (4) ACCOUNTING TREATMENT: While the LLM correctly mentions the fair value option and impact on consolidated statements of earnings (losses), it does so in the context of completely incorrect numbers. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize information about how the investment was accounted for post-Share Conversion in Q4 2020 and how fair value measurements (level 3) were applied. The answer demonstrates a complete failure to retrieve or synthesize the correct financial data from the SEC filings. The $1,705 million figure is the correct and unchanged valuation, not the $11.9 billion or $11.1 billion claimed by the LLM.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 431,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Union Pacific leased 1,037 locomotives out of a total of 7,154 locomotives as of December 31, 2023, representing approximately **14.5%** of their total locomotive fleet. In contrast, all **132 switching locomotives** in their fleet are owned, indicating that switching locomotives are entirely owned, while leased locomotives comprise a smaller portion of the total fleet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key numbers are correct: 1,037 leased locomotives out of 7,154 total (14.5% calculation is accurate), and 132 switching locomotives. The answer correctly addresses both parts of the multi-hop question: (1) the percentage of leased locomotives and (2) the comparison to switching locomotives. The LLM provides additional context by noting that switching locomotives are entirely owned, which adds helpful insight without contradicting the ground truth. The date reference (December 31, 2023) is appropriate and adds specificity. The reasoning is sound - the model correctly synthesizes that 14.5% represents leased locomotives while the 132 switching locomotives are a separate fleet metric. The only minor distinction from the ground truth is that the LLM adds the interpretation that 'switching locomotives are entirely owned,' which is a reasonable inference but goes slightly beyond what the original answer explicitly states. However, this addition is logical and doesn't contradict the ground truth. All quantitative values match exactly, calculations are correct, and the multi-hop synthesis across fleet composition metrics is properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 341,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The provided document pages do not mention the 2.20% Notes Due 2021, fair value changes for such notes, or related disclosures in the debt-specific maturity and interest rate table. The pages focus on acquisitions, intangible assets, leases, and stock-based compensation, but no information about the 2.20% Notes is included.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the question. The ground truth provides specific, verifiable information: (1) Fair value decreased from $1,011 million (Jan 31, 2021) to $0 million (Jan 30, 2022) - a decline of $1,011 million; (2) The notes had an effective interest rate of 2.38%; (3) The remaining term was 0 years by Jan 30, 2022, indicating maturity. The LLM claims the document pages do not contain this information and therefore provides no answer to any part of the multi-part question. This is a complete failure to synthesize the required multi-hop information across fair value disclosures and debt maturity tables. The LLM's response suggests it either (a) was not provided the relevant document sections, or (b) failed to locate and extract the required information. Either way, the answer is entirely incorrect - it provides zero factual content matching the ground truth. All quantitative values (fair values, interest rate, maturity term) are missing. The qualitative reasoning about maturity and debt status is absent. The answer demonstrates no understanding of the multi-hop synthesis required to connect fair value changes with debt maturity information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 339,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary exclusion of U.S. Treasury securities and Federal Reserve deposits from the supplementary leverage ratio (SLR) denominator reduced the total leverage exposure, thereby increasing Capital One's SLR. This adjustment was influenced by the Federal Reserve's interim final rule under the Basel III Standardized Approach framework, as outlined in the document. The exclusions expired on March 31, 2021, and the SLR as of December 31, 2020, reflected these temporary adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the mechanism - temporary exclusion of U.S. Treasury securities and Federal Reserve deposits from the SLR denominator increased the ratio; (2) Accurately names the regulatory framework - Federal Reserve's interim final rule under Basel III Standardized Approach; (3) Provides additional specific detail (expiration date of March 31, 2021, and reference to December 31, 2020 SLR) that demonstrates knowledge of the filing context; (4) Properly synthesizes the multi-hop relationship between the exclusion mechanism, its impact on the ratio, and the regulatory source. MINOR CONSIDERATIONS: (1) The original answer is more concise and focused, while the LLM adds contextual details about expiration dates that, while accurate and helpful, go slightly beyond what was explicitly asked; (2) Both answers correctly convey that the exclusion INCREASED the SLR (by reducing the denominator), which is the key causal relationship; (3) The LLM's phrasing 'reduced the total leverage exposure' is semantically equivalent to the mechanism of excluding items from the denominator. QUANTITATIVE ACCURACY: The date reference (March 31, 2021 expiration, December 31, 2020 measurement) appears consistent with actual regulatory timelines for this temporary relief measure, though these specific dates are not contradicted by the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes: (a) the exclusion mechanism, (b) its mathematical impact on the ratio, (c) the regulatory source, and (d) the framework governing it. No calculation errors or factual contradictions with the ground truth are evident.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 468,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was **$3,209 million**. These assets were valued using significant other observable inputs, including bid data from independent pricing sources for Federal government securities, bonds, and debentures, and for corporate stock, some components were valued using bid evaluation processes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the total Level 2 investment value of $3,209 million for Union Pacific's pension plan assets in 2023, matching the ground truth exactly. The quantitative accuracy is strong - the primary dollar amount is correct and properly formatted. However, there are notable differences in completeness and specificity: (1) The ground truth provides specific component breakdowns: Federal Government Securities at $1,508 million and Bonds and Debentures at $1,696 million. The LLM answer mentions these asset types but does not provide their individual valuations, which represents a material omission of detail. (2) The LLM answer introduces 'corporate stock' as a component valued using bid evaluation processes, which is not mentioned in the ground truth answer. This addition may be factually present in the source documents but represents a deviation from the provided ground truth. (3) The valuation methodology description is accurate - both answers reference bid evaluation processes with independent pricing sources and significant other observable inputs (Level 2 fair value hierarchy). The LLM's description of 'significant other observable inputs' is technically more precise terminology for Level 2 valuations. Overall, the core answer is correct, but the omission of specific component values and the introduction of unreferenced information (corporate stock) reduces the score from a 9-10 range to a 7, as it fails to fully match the completeness and specificity of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 421,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computingfrom training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "The 10-K filing mentions **virtual car showrooms** as a specific automotive application of NVIDIA Omniverse. Integration with the **DRIVE platform** supports NVIDIA's end-to-end AI computing strategy by enabling real-time 3D collaboration and simulation for autonomous driving development, allowing testing of AI systems (e.g., perception, planning) and enhancing vehicle software updates through Omniverse Avatar and DRIVE Constellation.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors regarding the specific automotive applications of NVIDIA Omniverse mentioned in the 10-K filing. (1) CORRECTNESS ASSESSMENT: The ground truth explicitly states that NVIDIA Omniverse Avatar is used for 'real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems.' The LLM answer instead mentions 'virtual car showrooms' as the specific automotive application, which is not mentioned in the ground truth and appears to be incorrect or fabricated. The LLM does correctly identify DRIVE Constellation and mentions Omniverse Avatar, but misses the critical DRIVE Chauffeur and DRIVE Concierge systems that are the actual automotive applications specified in the filing. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension scores well (8/10) - the LLM doesn't introduce false numbers. (3) QUALITATIVE ACCURACY: The LLM demonstrates poor entity identification and synthesis. While it correctly identifies DRIVE platform, Omniverse Avatar, and DRIVE Constellation, it fails to identify the specific automotive applications (DRIVE Chauffeur and DRIVE Concierge) that are central to the ground truth answer. The mention of 'virtual car showrooms' appears to be either a hallucination or misattribution. The reasoning about real-time 3D collaboration and simulation is partially aligned with the ground truth, but the specific applications are wrong. (4) MULTI-HOP REASONING: The LLM attempts to synthesize the integration between Omniverse and DRIVE platforms, but the synthesis is incomplete and partially incorrect. It misses the key connection to conversational AI capability and the specific in-vehicle experience solutions. (5) SEMANTIC EQUIVALENCE: The core strategic integration concept is partially captured, but the specific applications are fundamentally different from the ground truth, making semantic equivalence impossible on the primary factual claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 546,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "Converse's revenue contribution to NIKE, Inc. increased by **3.45%** from 2022 ($2,346 million) to 2023 ($2,427 million). Converse's operating income rose by **1.05%** during the same period (2022: $669 million; 2023: $676 million). Thus, the revenue growth outpaced the operating income growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) REVENUE PERCENTAGE: LLM states 3.45% increase (approximately correct, ground truth is 3.4%), but the underlying revenue figures appear questionable and need verification. (2) OPERATING INCOME PERCENTAGE - MAJOR ERROR: LLM claims operating income INCREASED by 1.05% (2022: $669M to 2023: $676M), but ground truth explicitly states operating income DECREASED by 30.0%. This is a complete reversal of the actual trend - the LLM got the direction wrong and the magnitude dramatically wrong (1.05% vs -30.0% is a 31.05 percentage point error). (3) CALCULATION VERIFICATION: If 2022 operating income was $669M and 2023 was $676M, that would indeed be a ~1.05% increase, so the LLM's math is internally consistent with its stated numbers. However, these numbers are factually incorrect according to the ground truth. (4) MULTI-HOP REASONING: The LLM correctly attempted to synthesize two metrics (revenue and operating income) and compare them, which shows sound reasoning structure. However, the foundation is built on incorrect data. (5) CONCLUSION ERROR: The LLM concludes 'revenue growth outpaced operating income growth,' which would be true if the numbers were correct, but this conclusion is misleading because operating income actually declined significantly in reality. The question asks for a comparison between revenue change and operating income change - the ground truth shows opposite directions (revenue up 3.4%, operating income down 30.0%), while LLM shows both moving in same direction (both up). This is a fundamental factual failure on the primary metric requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 465,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The changes to the TDR accounting guidance eliminated the \"reasonably expected and concession assessment\" criteria for classifying trial modifications. As a result, **trial modifications in both the residential real estate and credit card loan portfolios were reclassified as Troubled Debt Restructurings (TDRs)** but **excluded from Forbearance, Deferral, and Modification (FDM) categories** for the year ended December 31, 2023. This shift aligns with the updated guidance, which broadened TDR classification while removing prior criteria that previously excluded certain modifications from TDR designation.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) MISSING SPECIFIC DOLLAR AMOUNTS: The LLM answer completely omits the quantitative data that is central to the ground truth. The original answer specifies $69 million for residential real estate and $27 million for credit card loans - these are key factual details that should have been included. The LLM provides only qualitative explanation without these essential numbers. (2) QUANTITATIVE ACCURACY FAILURE: By omitting the specific dollar amounts ($69M and $27M), the answer fails on the primary quantitative requirement. This is a significant gap since the question asks 'how did changes impact' which implicitly requests both qualitative and quantitative impacts. (3) QUALITATIVE REASONING - PARTIALLY CORRECT: The LLM correctly identifies that: (a) TDR accounting guidance changed, (b) 'reasonably expected' and 'concession' criteria were eliminated, (c) trial modifications were classified as TDRs but not FDMs, (d) this applied to both residential real estate and credit card loan portfolios, (e) the year was December 31, 2023. The explanation of the impact is logically sound and semantically equivalent to the ground truth. (4) ENTITY ACCURACY: All entities are correctly identified (TDRs, FDMs, residential real estate, credit card loans, 2023). (5) MULTI-HOP SYNTHESIS: The answer correctly synthesizes that the guidance change affected both portfolio types in the same way, demonstrating proper multi-hop reasoning. VERDICT: While the qualitative explanation is accurate and well-reasoned, the complete absence of the specific dollar amounts ($69M and $27M) represents a major factual omission that significantly undermines the answer's completeness and accuracy. For a financial question, omitting specific monetary values is a critical failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 484,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "As of December 31, 2023, Union Pacific's stock incentive plans had **1,304,451 total retention shares and retention units** outstanding (245,107 under the 2013 Plan and 1,059,344 under the 2021 Plan). This compares to **16,000 restricted shares** outstanding under the Directors Plan on the same date. The total retention awards under the stock incentive plans significantly exceed the restricted shares under the Directors Plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: The LLM provides an incorrect total of 1,304,451 retention shares and units, when the ground truth states 1,320,451. This is a discrepancy of 16,000 units - a significant error. The LLM also breaks down the total into 245,107 under the 2013 Plan and 1,059,344 under the 2021 Plan, which sum to 1,304,451, but this breakdown is not verified against the ground truth and appears to be incorrect. The ground truth specifies 954,405 retention shares and 366,046 retention units (totaling 1,320,451), which the LLM does not mention at all. The LLM correctly identifies 16,000 restricted shares under the Directors Plan, which matches the ground truth. The LLM correctly addresses both parts of the question (retention awards and Directors Plan comparison) and provides appropriate contextual commentary about the comparison. However, the fundamental quantitative error in the main metric (off by 16,000 or 1.2%) is a major factual failure that undermines the entire answer. The reasoning about the comparison is sound, but it's based on incorrect numbers. The LLM appears to have synthesized information but arrived at wrong totals and failed to provide the specific breakdown of retention shares vs. retention units that the ground truth includes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 354,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "The total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan, was **$249 million**. This includes the equity investment of **$149 million** (recorded as \"Investments: equity method\") and the **$100 million** secured loan provided to the JV, which is reflected as a receivable.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative elements match the ground truth exactly: (1) Total investment: $249 million - correct; (2) Equity investment carrying value: $149 million - correct; (3) Secured loan: $100 million - correct; (4) Sum verification: $149M + $100M = $249M - calculation is accurate. The answer correctly identifies all components of AMD's investment in the ATMP JV as of December 28, 2024. The LLM properly synthesized the multi-hop information by combining the equity investment and secured loan components into a single total. The explanation is clear and provides appropriate context by noting how each component is recorded (equity method investment and receivable). The date is correct (December 28, 2024), the company is correctly identified (AMD), and the JV is properly named (ATMP JV). The answer demonstrates sound multi-hop reasoning by integrating information about both investment vehicles and calculating the correct total. No errors, omissions, or inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 299,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "The total financial impact on Danaher from the Envista disposition included a **$451 million gain on disposition**, a **$109 million foreign currency translation adjustment loss**, and **$69 million in IPO and Separation-related costs**, resulting in a net impact of **$273 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL CALCULATION ERROR: The LLM identified all four component values correctly ($451M gain, $109M FX loss, $69M IPO costs) but made a fundamental arithmetic error in the final calculation. The LLM calculated the net impact as $273 million, which is mathematically incorrect. The correct calculation should be: $451M (gain) - $109M (FX loss) - $69M (IPO costs) = $273M. However, the ground truth states the total financial impact was $387 million. This discrepancy suggests either: (1) the LLM used the wrong calculation method, or (2) there is a missing component in the ground truth explanation. Verification: $451 - $109 - $69 = $273 (LLM's math is internally consistent), but this does not match the ground truth of $387M. The LLM's net figure of $273M appears to be the result of subtracting the costs/losses from the gain, which is a logical approach, but it contradicts the stated ground truth of $387M. The LLM correctly identified all component values and their directional impact (gain vs. losses), demonstrating understanding of the multi-hop synthesis required. However, the final net impact calculation is incorrect relative to the ground truth answer of $387M. The question asks for 'total financial impact' which the ground truth defines as $387M, but the LLM provides $273M. This is a significant quantitative discrepancy that cannot be reconciled through rounding or formatting differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 391,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, combined with a 130-basis-point gross margin contraction due to unfavorable foreign currency exchange rates, led to a **30% decrease in Converse's EBIT** for fiscal 2024 compared to fiscal 2023. The margin contraction, primarily caused by FX rate impacts, lower full-price ASP, and higher costs, significantly worsened the segment's profitability despite the revenue decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative metrics are correct: the 15% currency-neutral revenue decline, 130 basis point gross margin contraction, and 30% EBIT decrease are all accurately stated and match the ground truth. The answer correctly identifies the geographic drivers (North America and Western Europe) and the causal relationship between the revenue decline, margin contraction, and EBIT performance. The multi-hop reasoning is sound - the model successfully synthesized information about revenue decline, margin contraction, and their combined impact on EBIT. The LLM answer goes slightly beyond the ground truth by adding contextual details about 'lower full-price ASP and higher costs' as additional margin contraction drivers, which provides helpful context without contradicting the original answer. The fiscal year reference (fiscal 2024 vs fiscal 2023) adds useful temporal clarity. The only minor consideration is that the ground truth uses 'reported EBIT' while the LLM uses 'Converse's EBIT' - both are semantically equivalent and refer to the same metric. The answer is well-structured, directly addresses all components of the multi-part question, and maintains factual accuracy throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 352,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, reduced JPMorgan Chase's allowance for credit losses by **$587 million** in 2023, as noted in the \"Allowance for credit losses and related information\" section (page 134). This reduction was due to changes in how trial modifications and Chapter 7 loans were classified under the new guidance, which eliminated the previous TDR reasonably expected and concession assessment criteria. Under the new rules, trial modifications and Chapter 7 loans were treated as TDRs but not as FDMs (foreclosed debt modifications), altering provisioning calculations. This adjustment likely improved the allowance's efficiency by reducing overprovisioning for certain loan modifications, thereby positively impacting the Firm's financial position by lowering credit loss reserves.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the $587 million reduction in allowance for credit losses - this is the primary quantitative fact and it matches the ground truth exactly. (2) The date (January 1, 2023) is correct. (3) The LLM correctly identified that the guidance eliminated 'reasonably expected' and 'concession assessment' criteria. (4) The LLM correctly noted that trial modifications and Chapter 7 loans were reclassified as TDRs but not FDMs. (5) The overall impact on financial position (improvement through lower reserves) is correctly characterized. (6) The page reference (page 134) adds credibility. WEAKNESSES: (1) The LLM answer lacks the specific dollar amounts for the reclassified loans: $69 million for trial modifications and $9 million for Chapter 7 discharge loans. These specific figures are in the ground truth and represent important details that quantify the nature of the reclassification. (2) The terminology is slightly imprecise - the ground truth uses 'non-FDMs' (Financial Disincentive Modifications) while the LLM uses 'FDMs (foreclosed debt modifications)' which appears to be a different interpretation of the acronym. The ground truth's 'non-FDMs' is the correct classification. (3) The LLM's explanation of 'likely improved the allowance's efficiency by reducing overprovisioning' is somewhat speculative language ('likely') whereas the ground truth presents this more definitively based on the actual reclassification mechanics. MULTI-HOP REASONING: The LLM successfully synthesized the relationship between the accounting guidance change, the reclassification of specific loan types, and the resulting impact on reserves. However, it missed the opportunity to quantify the specific loan amounts involved in the reclassification. OVERALL: The answer is substantially correct on the main facts and numbers but lacks completeness in the specific loan amount details that would fully answer the question about the 'resulting effect' of the changes in trial modifications and Chapter 7 loans.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 548,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "The total amount invested in Level 2 assets by UNP's pension plan as of December 31, 2023, was **$3,209 million**. The specific investment categories using bid evaluation with independent pricing sources are **Federal Government Securities**, **Bonds and Debentures**, and **Preferred Stock** (under Corporate Stock).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states Level 2 assets total $3,209 million, but the ground truth is $1,111 million. This is a massive discrepancy (188% overstatement) and represents a fundamental factual error. (2) ENTITY ACCURACY - The LLM identifies 'Preferred Stock' as one of the investment categories, but the ground truth specifies 'Corporate Stock' (not Preferred Stock specifically). This is an incorrect entity identification. (3) PARTIAL CORRECTNESS - The LLM correctly identifies Federal Government Securities and Bonds and Debentures as Level 2 assets using bid evaluation with independent pricing sources. However, it misses Corporate Stock and incorrectly adds Preferred Stock. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize the investment categories and valuation methodology, the core quantitative answer is completely wrong, which undermines the entire response. The date reference (December 31, 2023) may or may not be correct depending on the filing year, but this cannot compensate for the massive dollar amount error. (5) COMPLETENESS - The answer addresses both parts of the question (total amount and investment categories), but with significant inaccuracies in both the primary metric and secondary details. The $3,209 million figure appears to be either from a different asset level (possibly Level 1 or Level 3) or a different pension plan metric entirely, representing a fundamental misidentification of the correct data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 411,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "The Research and Medical Products segment's revenue grew from $13,512 million in 2019 to $24,802 million in 2021 (an 83.5% increase), outpacing DHR's total revenue growth of 64.4% over the same period. This suggests the segment was a primary driver of the company's overall revenue expansion, highlighting its critical role in DHR's financial performance and growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. All quantitative data is correct: Research and Medical Products segment revenue of $13,512M (2019) and $24,802M (2021), the 83.5% growth rate, DHR's total revenue growth of 64.4%, and the correct time period (2019-2021). The multi-hop synthesis is sound - the model correctly compared the segment's growth rate to total company growth and drew the appropriate conclusion about the segment's role as a primary driver. The reasoning is logical and the conclusion that the segment outperformed overall company growth is properly supported by the data. The answer is slightly more concise than the ground truth but maintains semantic equivalence and addresses all parts of the original question. The only minor difference is that the LLM answer doesn't explicitly state the total revenue figures ($17,911M and $29,453M), but this omission doesn't affect the correctness of the core analysis since the growth rate comparison is what matters for answering the question. The characterization of the segment as 'a primary driver' and 'critical role' appropriately reflects the data showing 83.5% vs 64.4% growth rates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 330,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, reduced JPMorgan's allowance for credit losses by $587 million during the year ended December 31, 2023. This reduction reflects adjustments to the allowance due to changes in how TDRs were accounted for. Additionally, trial modifications for credit card loans were reclassified as TDRs under the new guidance, but they are no longer considered FDMs (Forgiveness Debt Modifications). This change affected the classification and treatment of these modifications within the allowance for credit losses.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the $587 million reduction in allowance for credit losses - this key quantitative figure is accurate. (2) The LLM correctly noted that trial modifications were reclassified as TDRs under the new guidance. (3) The date of January 1, 2023 adoption is correct. (4) The general explanation of the accounting change is directionally sound.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM failed to mention the prior year credit card TDRs of $418 million, which is important comparative context provided in the ground truth. (2) INCOMPLETE DATA: The LLM did not include the 2023 credit card FDMs figure of $648 million, which is a specific quantitative detail requested in the question. (3) INCOMPLETE DATA: The LLM omitted the $27 million of loans subject to trial modifications for 2023, another specific metric from the ground truth. (4) TERMINOLOGY ISSUE: The LLM incorrectly expanded 'FDM' as 'Forgiveness Debt Modifications' when the ground truth indicates it means 'formally distressed modifications' - this is a semantic error in understanding the acronym. (5) INCOMPLETE REASONING: The ground truth explains that the changes 'eliminated the TDR reasonably expected and concession assessment criteria' - the LLM did not capture this specific mechanism of change.\n\nMULTI-HOP SYNTHESIS: The question asks specifically about effects on (a) allowance for credit losses and (b) classification of trial modifications. The LLM addressed both but incompletely - it got the allowance figure right but missed several related quantitative metrics that demonstrate the full scope of the impact.\n\nCALCULATIONS: No calculations were required, but the LLM should have synthesized multiple data points from the filing to provide a complete answer.\n\nOVERALL: The answer is partially correct with the core $587 million figure accurate, but it lacks important supporting details and comparative metrics that were explicitly mentioned in the ground truth, making it an incomplete response to a multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 550,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "3M's adoption of the fair value approach for calculating the market-related value of pension plan assets in 2021 retrospectively adjusted prior-period pension costs, reducing expenses and increasing net income. This change impacted the presentation of pension-related metrics, such as net periodic benefit cost, other comprehensive income, and retained earnings, by eliminating deferrals of asset gains/losses and aligning expenses with current fair value. Adjusted financial statements (e.g., 2020 and 2019) show lower pension expenses and higher net income compared to prior reporting under the calculated value approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core facts correctly: 3M adopted a fair value approach in 2021 (Q1 2021 per ground truth), changed from a calculated value approach with 3-year deferral, applied the change retrospectively, and impacted pension-related metrics. The answer correctly identifies key affected metrics: net periodic benefit cost, other comprehensive income, and retained earnings. However, there are some gaps and minor issues: (1) The LLM answer mentions 'adjusted financial statements (e.g., 2020 and 2019)' showing lower pension expenses and higher net income, but the ground truth doesn't explicitly confirm that prior-period statements were adjusted or that net income increasedit only states the change was applied retrospectively and affected presentation. This is a minor inference that may be correct but isn't explicitly supported by the ground truth. (2) The LLM answer omits several important details from the ground truth: the specific mention of 'non-operating other expense (income)' and 'earnings per share' as affected metrics, the impact on 'accumulated other comprehensive income (loss),' and the strategic rationale that the fair value approach 'aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy.' (3) The LLM answer correctly identifies the elimination of the 3-year deferral mechanism and the shift to immediate reflection of asset value changes. (4) The multi-hop reasoning is soundthe answer synthesizes the accounting change, its mechanics, and its financial statement impacts appropriately. The answer is directionally correct and addresses the main question, but lacks some completeness in identifying all affected metrics and strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 478,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, reduced JPMorgan's allowance for credit losses by **$587 million** in 2023. This reduction is explicitly noted in the \"Discussion of changes in the allowance\" section (page 133) and is attributed to the cumulative effect of the accounting principle change related to TDRs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $587 million reduction in JPMorgan's allowance for credit losses resulting from the TDR accounting guidance adoption on January 1, 2023. The quantitative accuracy is perfect - the dollar amount, date, and company are all correct. However, the qualitative accuracy is lower because the LLM answer lacks the explanatory depth provided in the ground truth. Specifically: (1) The LLM correctly states the $587 million reduction and the January 1, 2023 effective date, (2) The LLM provides a source reference (page 133) which adds credibility, (3) However, the LLM omits the key mechanistic explanation present in the ground truth - that the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, and that trial modifications were reclassified from TDRs to non-FDMs, which is the actual reason for the reduction. The LLM simply states it's 'attributed to the cumulative effect of the accounting principle change' without explaining the underlying mechanism. This represents incomplete synthesis of the multi-hop reasoning required to fully answer 'how' the adoption impacted the allowance. The answer is factually correct on the quantitative dimension but lacks the qualitative depth and causal explanation that would make it a complete answer to the 'how' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 377,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "In 2023, the Africa/Eurasia region reported an operating profit of $254 million. Goodwill in the region decreased by $19 million due to foreign currency translation, with no impairments or other adjustments noted. Capital expenditures in the region totaled $10 million, reflecting a lower investment compared to the goodwill adjustment but not directly comparable as they represent distinct financial metrics.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: All individual numeric values are correct - goodwill decrease of $19 million, operating profit of $254 million, capital expenditures of $10 million, and ending goodwill balance of $88 million are all accurate. The LLM correctly identifies the year (2023) and region (Africa/Eurasia). WEAKNESSES: The LLM fails to complete the core analytical task requested in the question. The original answer explicitly calculates and presents the 'combined impact' of goodwill decrease and capital expenditures ($19M + $10M = $29M) and then compares this combined figure to operating profit ($254M). The LLM acknowledges these numbers but explicitly states they are 'not directly comparable as they represent distinct financial metrics,' which contradicts the ground truth's synthesis. The question specifically asks 'how does this compare to the capital expenditures' - the LLM avoids making this comparison, while the ground truth provides a clear comparative analysis showing the combined impact ($29M) is significantly lower than operating profit ($254M). MULTI-HOP REASONING: The LLM identifies all required data points but fails to synthesize them into the requested comparison. The ground truth demonstrates proper multi-hop reasoning by combining goodwill impact and capex, then comparing to operating profit. The LLM's statement that these metrics 'represent distinct financial metrics' and are 'not directly comparable' shows a misunderstanding of the analytical framework requested. CALCULATION: No calculation errors in individual numbers, but the LLM declines to perform the requested synthesis calculation ($19M + $10M = $29M combined impact). This represents incomplete fulfillment of the question's core requirement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 471,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "As a result of the 2021 business segment reporting changes, 3M adjusted its reporting units but applied the relative fair value method, resulting in immaterial impacts on goodwill. The company evaluated impairment risk through its annual goodwill impairment test in Q4 2021, which concluded no impairment existed for any reporting units, with 10 reporting units accounting for 94% of goodwill.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the relative fair value method as the approach used; (2) Accurately states that impacts were immaterial; (3) Correctly references Q4 2021 annual goodwill impairment test; (4) Accurately concludes no impairment was found; (5) Properly synthesizes the multi-hop information about segment changes, goodwill evaluation, and impairment testing. QUANTITATIVE ACCURACY: The specific metric of '10 reporting units accounting for 94% of goodwill' is provided in the LLM answer but NOT mentioned in the ground truth answer. This additional detail appears factually accurate based on typical 3M disclosures but represents information beyond what was in the original answer. This is not an error but rather supplementary context. MINOR DIFFERENCES: The ground truth emphasizes that 'these changes were found to be immaterial' while the LLM states 'resulting in immaterial impacts on goodwill' - these are semantically equivalent. The ground truth notes the restructuring 'did not negatively affect the fair value of reporting units to the extent that impairment would occur,' while the LLM more directly states 'no impairment existed' - again, semantically equivalent conclusions. MULTI-HOP REASONING: The LLM correctly synthesizes information across the segment reporting changes, goodwill allocation methodology, and impairment testing procedures. The logic flow is sound and demonstrates proper understanding of how these elements connect. The answer appropriately addresses both parts of the question: (1) the impact on goodwill reporting structure and (2) how impairment risk was evaluated. No factual errors detected in core claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 475,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD's investment in Silo AI was strategically aimed at accelerating the deployment and development of AI models and software solutions on AMD hardware, leveraging Silo AI's expertise in AI research and development. This aligns with AMD's broader goals to strengthen its Data Center segment, where AI accelerators and software solutions are critical, by integrating Silo AI's workforce and intellectual property to enhance its AI capabilities and ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both answers correctly identify the core strategic rationale: AMD's investment in Silo AI was aimed at accelerating AI model deployment and development on AMD hardware by leveraging Silo AI's expertise. The LLM answer accurately captures all key elements: (1) acceleration of AI model/software deployment, (2) focus on AMD hardware, (3) Silo AI's AI research and development expertise, (4) strengthening the Data Center segment, and (5) integration of workforce and intellectual property. The LLM answer actually provides slightly more detail by explicitly mentioning 'intellectual property' and 'ecosystem,' which adds valuable context without contradicting the ground truth. There are no quantitative errors (no numbers, dates, or percentages to verify). The multi-hop reasoning is sound - the answer correctly synthesizes the investment rationale with AMD's broader strategic goals. The only minor distinction is that the LLM answer emphasizes 'intellectual property' and 'ecosystem' more explicitly than the ground truth, but this represents an enhancement rather than an error. The semantic meaning is equivalent across both answers, with the LLM version being slightly more comprehensive while remaining factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 363,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "The Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology had **six amendments** between September 2, 2014, and September 1, 2015. These include the First through Sixth Amendments, with the final amendment effective on September 1, 2015.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that 6 amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015. The quantitative accuracy is perfect - the number 'six' matches the ground truth exactly. The answer also provides additional helpful context by specifying that these are the 'First through Sixth Amendments' and noting that the final amendment was effective on September 1, 2015, which adds relevant detail without contradicting the ground truth. The date range is correctly preserved (September 2, 2014 to September 1, 2015). The entity identification is accurate - the agreement name is correctly stated. The only minor consideration is that the LLM provides slightly more interpretive detail (naming them 'First through Sixth Amendments' and noting the final effective date) beyond what the ground truth explicitly states, but this is supplementary information that enhances rather than contradicts the answer. The semantic equivalence is strong - 'six amendments' and 'six amendments' are identical. No calculation errors or factual inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1094,
        "completion_tokens": 333,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PMs existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "The acquisition of Swedish Match by PMI on November 11, 2022, caused its operational reporting scope in the 2023 10-K to include only partial 2022 results (NovemberDecember 2022) for the Swedish Match segment. The separate shipment volume commentary, which compares 2023 data to Swedish Match's full 2022 shipment volumes, highlights that integration is ongoing, as the 2022 data reflects only 10 months of ownership. This suggests the integration timeline is still in progress, with full consolidation and operational alignment not yet complete.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the acquisition date (November 11, 2022) and accurately characterizes the limited inclusion period (November-December 2022, approximately 2 months). (2) Properly synthesizes the multi-hop relationship between acquisition timing and operational reporting scope. (3) Correctly interprets the separate shipment volume commentary as evidence of ongoing integration rather than full consolidation. (4) The reasoning about phased integration is sound and well-supported. MINOR ISSUES: (1) The LLM states '10 months of ownership' when describing 2022 data, which is slightly imprecise - the actual ownership period was approximately 2 months (November-December), though the statement may be attempting to reference the comparison methodology rather than actual ownership duration. This creates minor ambiguity. (2) The original answer emphasizes that Swedish Match was 'managed and evaluated separately from PM's geographical segments,' which the LLM answer doesn't explicitly address, though it does capture the essence of separate treatment. QUANTITATIVE VERIFICATION: The November 11, 2022 date is correct. The characterization of partial 2022 results (Nov-Dec) is accurate. The reference to 2023 data comparisons is appropriate. MULTI-HOP REASONING: The answer successfully connects (a) acquisition timing, (b) financial reporting scope, and (c) integration status through the shipment volume commentary. The logic is sound and the synthesis is appropriate. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis but equivalent meaning regarding the integration timeline and reporting implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 490,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was **$800 million**, as stated in the 2021 section of Note 14. These swaps were designed to hedge **$500 million** of the $1.0 billion fixed-rate notes due in 2049 and **$300 million** of the $650 million fixed-rate notes due in 2050, totaling **$800 million** in principal amount. Thus, the notional amount of the swaps exactly matches the combined principal of the hedged notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CORRECT ELEMENTS: The notional amount of $800 million in interest rate swaps is correct. (2) CRITICAL ERRORS: The LLM states the swaps hedged $500 million of $1.0 billion notes due in 2049 and $300 million of $650 million notes due in 2050, totaling $800 million in principal. However, the ground truth indicates the combined principal amount of fixed-rate notes due in 2049 and 2050 was $1.65 billion, not $1.65 billion derived from $1.0B + $650M = $1.65B. More importantly, the LLM's breakdown of individual note amounts ($1.0B for 2049 and $650M for 2050) appears to be fabricated and does not match the ground truth data. (3) CALCULATION ERROR: The LLM concludes that 'the notional amount of the swaps exactly matches the combined principal of the hedged notes' ($800M = $800M), which is mathematically true for the numbers provided but misses the key comparison requested. The ground truth shows the swaps covered approximately 48.5% of the $1.65 billion total principal ($800M / $1.65B  48.5%), which is a crucial insight the LLM completely missed. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the relationship between the swap notional amount and the total principal amount of the notes being hedged. The question explicitly asks 'how does this compare,' requiring a percentage or ratio analysis, which the LLM did not provide. (5) ENTITY/DATA ACCURACY: The specific principal amounts for the 2049 and 2050 notes appear to be incorrect or unsupported by the ground truth data. The ground truth provides a clear combined figure of $1.65 billion, but the LLM's breakdown into $1.0B and $650M is not verified and likely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 474,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was **$64,619 million**, with **$40,210 million** attributed to cash payments. For Allergan, AbbVie paid $39,675 million in cash, $23,979 million in stock, and $430 million in equity awards, totaling $64,084 million. For Soliton, Inc., AbbVie paid $535 million in cash.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key numbers match the ground truth exactly: total consideration of $64,619 million and cash payments of $40,210 million. The answer goes beyond the minimum requirements by providing detailed breakdowns for each acquisition: Allergan ($39,675M cash + $23,979M stock + $430M equity awards = $64,084M total) and Soliton ($535M cash). The arithmetic is correct: $64,084M + $535M = $64,619M total, and $39,675M + $535M = $40,210M in cash. The multi-hop synthesis is sound, correctly combining information from two separate acquisitions and aggregating them appropriately. The answer directly addresses both parts of the question (total consideration and cash portion). The only minor consideration is that the LLM provides additional detail beyond what was strictly asked, but this adds value rather than detracting from accuracy. All entities are correctly identified (AbbVie, Allergan, Soliton, Inc.), and the financial metrics are properly categorized (cash, stock, equity awards).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 298,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America's adherence to Basel 3 capital requirements ensures its capital ratios (e.g., CET1, Tier 1, and total capital) remain above regulatory thresholds, providing flexibility to execute the $25 billion stock repurchase program. As of December 31, 2024, the Corporation's CET1 capital ratio under the Standardized approach was 11.9%, exceeding the 10.7% minimum requirement, while its Tier 1 and total capital ratios also met or surpassed regulatory benchmarks. These strong capital positions, supported by stress testing and contingency planning, allow the Corporation to maintain liquidity and meet obligations, including capital distributions like stock buybacks, without compromising compliance with Basel 3.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the relationship between Basel 3 capital requirements and Bank of America's stock repurchase program. STRENGTHS: (1) All key numeric values are correct - CET1 ratio of 11.9% and minimum requirement of 10.7% match ground truth exactly; (2) Correctly identifies December 31, 2024 as the reference date; (3) Properly explains the causal relationship between capital adequacy and repurchase authorization; (4) Mentions relevant capital metrics (CET1, Tier 1, total capital); (5) Appropriately references stress testing and contingency planning as supporting factors. WEAKNESSES: (1) The LLM mentions the $25 billion authorized program but does not specify the actual $13.1 billion repurchased in 2024, which is a material detail in the ground truth that demonstrates concrete execution of the program; (2) The answer is somewhat more general/theoretical in discussing capital ratios meeting benchmarks without providing the specific execution data; (3) Does not explicitly mention the capital conservation buffer and G-SIB surcharge components that make up the 10.7% minimum requirement, though this is a minor omission. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between regulatory capital requirements and capital distribution decisions, showing proper understanding of how Basel 3 compliance enables repurchase execution. The logic is sound and well-articulated. QUANTITATIVE VERIFICATION: All percentages and dates are accurate. The answer appropriately uses the 11.9% vs 10.7% comparison to demonstrate capital adequacy. The main quantitative gap is the absence of the $13.1 billion actual repurchase figure from 2024. Overall, this is a solid answer that captures the essential relationship but lacks some specific execution details present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 499,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "The total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048, as reported in the MMM 2022 10-K filing, is **$1,287 million**. This is derived from the 2021 carrying values of $649 million for the 2023 maturity and $638 million for the 2048 maturity, as listed in the long-term debt table on page 87.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and matches the ground truth. The final answer of $1,287 million is accurate. The response correctly identifies the filing (MMM 2022 10-K), the security type (Medium-term note with $650 million designation), the maturity dates (2023 and 2048), and provides the correct total carrying value. The LLM also provides supporting detail by breaking down the component values ($649 million for 2023 maturity and $638 million for 2048 maturity) and citing the source (long-term debt table on page 87). The arithmetic is correct: $649M + $638M = $1,287M. The only minor consideration is that the LLM references 2021 carrying values while the question asks about the 2022 10-K filing, but this is likely the correct interpretation since 10-K filings report prior year comparative data. The answer demonstrates proper multi-hop synthesis by combining information about the specific debt instrument across multiple maturity dates to arrive at the total carrying value. The response is clear, well-sourced, and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 303,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K is the 7.125% Debentures due 2096 (IBM96). The difference in interest rates between this instrument and IBM's 2.900% Notes due 2030 (IBM30C) is **4.225 percentage points** (7.125% - 2.900%).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All factual information is correct. The highest-yielding debt instrument is correctly identified as the 7.125% Debentures due 2096, and the comparison instrument (2.900% Notes due 2030) is correctly identified. (2) QUANTITATIVE ACCURACY: The calculation is perfect - 7.125% - 2.900% = 4.225 percentage points. All numeric values match the ground truth exactly. The answer even shows the calculation explicitly, which enhances transparency. (3) ENTITY ACCURACY: Both debt instruments are correctly identified with their exact interest rates and maturity years. The company (IBM) is correct. (4) MULTI-HOP REASONING: The answer successfully synthesizes information by: (a) identifying the highest-yielding instrument from the 2024 10-K, (b) comparing it to the specified 2.900% Notes due 2030, and (c) calculating the difference. The reasoning is sound and logical. (5) SEMANTIC EQUIVALENCE: The answer conveys identical information to the ground truth. The addition of ticker-like notation (IBM96, IBM30C) and the explicit calculation shown in parentheses adds helpful context without detracting from accuracy. Minor note: The ground truth answer is slightly more concise, while the LLM answer provides additional helpful detail (showing the calculation), which is a positive enhancement rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 384,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "The total financial value of AbbVie's acquisition of Allergan was **$64.084 billion**, as disclosed in the total consideration breakdown (cash, stock, and equity awards). AbbVie acquired **$453 million in right-of-use assets** as part of the lease obligations assumed during the acquisition, as noted in the supplementary cash flow information for December 31, 2020.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-hop question. (1) QUANTITATIVE ACCURACY: Both key financial figures are correct - the acquisition value of $64,084 million (expressed as $64.084 billion in the LLM answer, which is an acceptable format variation) and the right-of-use assets of $453 million. The format conversion from millions to billions is mathematically accurate and represents the same value. (2) COMPLETENESS: The answer addresses both sub-questions: the total acquisition value and the specific right-of-use assets acquired. (3) ENTITY ACCURACY: All entities are correctly identified - AbbVie, Allergan, the acquisition transaction, lease obligations, and the date (December 31, 2020). (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points from the acquisition disclosure, connecting the total consideration to the specific asset component (ROU assets). The reasoning that ROU assets were part of lease obligations assumed is sound. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, with only stylistic differences in presentation (e.g., 'billion' vs 'million' format, which are equivalent). Minor deduction from perfect score only because the ground truth uses millions consistently while the LLM converts to billions, though this is a reasonable presentation choice and not an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 394,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "According to the 2024 10-K filing, **391 shares** of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because the plan explicitly states that \"no future stock awards or deferrals may be made,\" as noted in the plan's description on page 15.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. (1) CORRECTNESS: Both the quantitative fact (391 shares) and the qualitative explanation (plan closed to new deferrals/awards) match the ground truth exactly. The answer correctly identifies that no future awards or deferrals are possible and provides the specific reason. (2) QUANTITATIVE ACCURACY: The 391 shares figure is correct and properly formatted. No calculations were required for this question, so this metric is fully satisfied. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop information: it identifies the specific plan (Norwest Corporation Directors' Formula Stock Award Plan), the filing year (2024 10-K), the specific metric (shares issuable upon distribution), and the reason for the restriction (plan closed to new deferrals/awards). The reasoning is sound and directly addresses both parts of the question. (4) CONTEXTUAL RELEVANCE: The answer is highly relevant, providing context by citing the specific page reference (page 15) where this information appears in the filing, which adds credibility and specificity. The only minor distinction from the ground truth is that the LLM provides slightly more detail by quoting the specific language ('no future stock awards or deferrals may be made') and citing the page number, which enhances rather than detracts from the answer. The semantic meaning is identical to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 396,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The amortization of intangible assets associated with the Allergan acquisition partially offset the increase in AbbVie's gross margin in 2021, as noted in the gross margin discussion. The total amortization expense for definite-lived intangible assets in 2021 was **$7.7 billion**, as reported in Note 7 of the 10-K filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses both parts of the multi-part question. STRENGTHS: (1) The $7.7 billion figure for total amortization expense for definite-lived intangible assets in 2021 is accurate and matches the ground truth exactly. (2) The answer correctly identifies that the Allergan acquisition-related intangible asset amortization negatively impacted/offset gross margin gains in 2021. (3) The answer appropriately cites Note 7 of the 10-K as the source. (4) The numeric precision is perfect with no calculation errors. MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth - it doesn't mention the specific offsetting factors (lower amortization of inventory fair value step-up adjustments and favorable product mix) that contributed to the gross margin increase. The ground truth provides more context about what the Allergan amortization was offsetting. (2) The phrasing 'partially offset the increase' is semantically equivalent to 'partially offset these gains' but the ground truth provides more explicit detail about the competing factors. MULTI-HOP REASONING: The answer correctly synthesizes information across the 10-K filing, connecting the Allergan acquisition's intangible asset amortization to gross margin impact and providing the specific dollar figure for definite-lived intangible assets. The reasoning is sound and logically presented. The answer demonstrates proper understanding that this is a multi-part question requiring both qualitative (impact discussion) and quantitative (dollar amount) responses.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 437,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The Restoration Plans are designed to provide deferred compensation to associates who would have received matching contributions under the Benefit Plans but were unable to due to Internal Revenue Code compensation limits. The Home Depot funds these plans through contributions to grantor trusts, which are used to purchase shares of the company's common stock in the open market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses both parts of the multi-part question. (1) CORRECTNESS: The answer correctly identifies the purpose of Restoration Plans - providing deferred compensation to associates who would have received matching contributions under Benefit Plans but were limited by Internal Revenue Code compensation caps. The funding mechanism is also correctly stated - contributions to grantor trusts used to purchase company common stock in the open market. (2) QUANTITATIVE ACCURACY: No numerical values are present in either the original or LLM answer, so this dimension is not applicable. Both answers avoid introducing incorrect numbers. (3) ENTITY ACCURACY: All entities are correctly identified - The Home Depot, Benefit Plans, Restoration Plans, Internal Revenue Code, grantor trusts, and common stock. The fiscal year context (2023 10-K) is appropriately referenced in the question setup. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple concepts: the relationship between Restoration Plans and Benefit Plans, the IRC compensation limits constraint, and the funding mechanism through grantor trusts and stock purchases. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly more concise wording than the original ('unable to due to' vs 'if not for the maximum compensation limits') but conveys identical meaning. The phrase 'certain associates' in the original is generalized to 'associates' in the LLM answer, which is a minor semantic simplification that does not affect accuracy. The core information is preserved: purpose (deferred compensation for those hitting IRC limits), mechanism (grantor trusts), and use (stock purchases). Minor deduction from perfect score (9 vs 10) only because the original explicitly states 'certain associates' which adds slight specificity that the LLM generalizes, though this is a very minor distinction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 521,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The value of Variable Rate Notes remained unchanged at $22 million for both December 31, 2023, and December 31, 2024, resulting in a 0% change. This reflects in the overall increase in total borrowings from $20.4 billion in 2023 to $31.1 billion in 2024, driven by growth in fixed-rate notes ($7.3 billion increase) and commercial paper ($2.188 billion increase), while Variable Rate Notes remained constant.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Variable Rate Notes remained at $22 million (0% change) and total borrowings increased from approximately $20.4 billion to $31.1 billion. The 0% change for Variable Rate Notes is accurate. However, there are quantitative discrepancies: (1) The ground truth specifies total borrowings increased from $20,443 million to $31,099 million (a $10,656 million increase, or 52.1% increase), while the LLM uses rounded figures ($20.4B to $31.1B) without stating the precise percentage increase of 52.1%. (2) The LLM provides additional detail about fixed-rate notes increasing by $7.3 billion and commercial paper by $2.188 billion, which are not contradicted by the ground truth but represent additional synthesis not explicitly verified. (3) The LLM correctly addresses both parts of the multi-part question: the percentage change in Variable Rate Notes (0%) and how this reflects in overall borrowing changes. The reasoning is sound - explaining that Variable Rate Notes remained constant while other borrowing categories drove the overall increase. The answer uses acceptable number format variations (billions vs millions). The main weakness is the lack of the specific 52.1% overall increase figure mentioned in the ground truth, though the directional statement about significant growth is correct. The answer demonstrates good multi-hop synthesis by connecting the static Variable Rate Notes to the dynamic overall borrowing picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 410,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is **$1,724 million**. \n\n- The **4.95% Senior Notes due September 2026** have a carrying amount of **$744 million** (as of January 28, 2024, per the table on page 59).  \n- The **4.95% Senior Notes due September 2052** have a carrying amount of **$980 million** (as of January 28, 2024, per the same table).  \n\nThese figures are derived directly from the \"Long-Term Debt\" table on page 59 of the 10-K filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR: The LLM provided an incorrect total of $1,724 million when the ground truth is $1,726 million. This is a $2 million discrepancy. While the LLM correctly identified the two debt instruments (4.95% Senior Notes due September 2026 and September 2052) and provided component breakdowns ($744 million and $980 million), the arithmetic is fundamentally wrong: $744M + $980M = $1,724M, but the ground truth total is $1,726M. This suggests either: (1) the component figures provided by the LLM are incorrect, or (2) there is a calculation error. The ground truth indicates the correct total should be $1,726 million. The LLM's reasoning structure is sound (identifying both notes, providing individual amounts, calculating a sum), and the contextual framing is appropriate (correct date of January 28, 2024, correct debt instrument names, correct reference to page 59). However, the core quantitative answer is wrong by $2 million, which is a material error in a financial context. The LLM demonstrated good methodology but failed on numerical accuracy, which is the primary requirement for financial questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 318,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "PM experienced a **45.7% decrease** in its net derivative asset position from 2022 ($186 million) to 2023 ($101 million). This decrease contrasts with a **7.1% increase** in the total gross amount of derivative contracts (from $40,401 million in 2022 to $43,265 million in 2023). The net position decline reflects a shift in the balance between derivative assets and liabilities, driven by factors such as hedging strategies and market movements, rather than a reduction in the overall volume of contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides completely incorrect numbers for the total gross amount of derivative contracts. Ground truth states $873 million (2022) to $584 million (2023), but LLM claims $40,401 million (2022) to $43,265 million (2023). These are off by a factor of ~46x. The LLM also incorrectly calculates a 7.1% INCREASE when the ground truth shows a DECREASE from $873M to $584M (33.1% decrease). (2) CALCULATION VERIFICATION - The 45.7% decrease in net derivative assets is correctly calculated: ($186M - $101M) / $186M = 45.7%. This is the only correct calculation in the answer. (3) MULTI-HOP REASONING - The LLM fails to properly synthesize the relationship between the two metrics. Ground truth indicates alignment showing a strategic reduction in derivative exposure (both metrics declining). The LLM incorrectly suggests a contrast/divergence, claiming the net position decline 'contrasts with' an increase in gross contracts. This is fundamentally wrong on both the direction and the interpretation. (4) ENTITY/METRIC ACCURACY - The company (PM) and years (2022-2023) are correct, but the derivative contract amounts are drastically wrong. (5) SEMANTIC COHERENCE - The LLM's explanation about 'shift in balance between derivative assets and liabilities' may be reasonable in isolation, but it contradicts the actual data showing both metrics declining together, not diverging. The answer demonstrates a major data retrieval or calculation error that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 423,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31, 2024, the total number of shares available for future issuance under the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors is **27,919,327 shares** (27,143,929 under the 2016 Stock Incentive Plan and 775,398 under the 2016 Stock Plan for Non-Employee Directors). This compares to **12,926,938 shares** of Common Stock to be issued for options and RSUs under these plans. The difference arises because the available shares include both outstanding awards and future issuance capacity, while the shares to be issued reflect only the number of awards that will vest or be exercised, excluding tax-withholding adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific numerical values with precision, but contains significant quantitative discrepancies when compared to the ground truth. CORRECT ELEMENTS: (1) The total shares available for future issuance is correctly stated as approximately 27.9 million (27,919,327 vs ground truth 27.9M), with correct breakdown between the two plans (27.1M and 0.8M). (2) The date (December 31, 2024) is correct. (3) The answer correctly identifies both plans and addresses the comparison aspect of the question. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM states 12,926,938 total shares to be issued for options and RSUs, but the ground truth specifies: 10,221,113 shares for options + 2,005,555 RSUs = 12,226,668 total under the 2016 Stock Incentive Plan, plus 129,854 shares for options under the 2016 Stock Plan for Non-Employee Directors = 12,356,522 total. The LLM's figure of 12,926,938 does not match either calculation. (2) The LLM provides a general explanation about the difference between available shares and shares to be issued, but this explanation is somewhat vague and doesn't directly address the specific breakdown provided in the ground truth (options vs RSUs, and the specific plan allocations). MULTI-HOP REASONING: The LLM correctly synthesizes information across two plans and attempts to explain the comparison, but the calculation of total shares to be issued appears to be incorrect or based on different source data. The reasoning about why available shares differ from shares to be issued is logical but generic. QUANTITATIVE ACCURACY: The primary issue is the incorrect total for shares to be issued (12,926,938 vs expected ~12,356,522), representing a discrepancy of approximately 570,000 shares or 4.6%. The available shares figures appear accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 485,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "In fiscal year 2022, Dynamics 365 revenue grew by 39%, which was the primary driver of the 25% overall growth in Dynamics products and cloud services revenue. This contribution highlights Dynamics 365's significant role in expanding the broader Dynamics portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. (1) QUANTITATIVE ACCURACY: Both key percentages are correct - Dynamics 365 revenue grew 39% and overall Dynamics products and cloud services grew 25% in FY2022. No calculation errors or numeric discrepancies. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: the specific Dynamics 365 growth rate (39%) and how it contributes to the overall growth (25%). The synthesis correctly identifies Dynamics 365 as a primary driver. (3) ENTITY ACCURACY: All entities are correctly identified - Dynamics 365, Dynamics products and cloud services, fiscal year 2022, and the growth metrics. (4) REASONING: The multi-hop reasoning is sound. The model correctly synthesizes that a 39% growth rate for a component product driving a 25% overall portfolio growth indicates strong performance and adoption. The logic that higher component growth exceeding portfolio growth demonstrates Dynamics 365's outsized contribution is valid. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth. While slightly more concise and using 'primary driver' instead of 'key driver,' the meaning is semantically equivalent. Minor difference: The ground truth includes additional context about 'integrated business applications platform' and 'strong adoption and demand,' which the LLM answer omits. This is a minor omission of contextual detail but does not affect the core factual accuracy of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 420,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla's Energy Generation and Storage revenue increased by **$795 million (40%)** in 2021 compared to 2020, with **Megapack deployments** being a primary driver alongside solar cash/loan jobs, Powerwall, and Solar Roof. Megapack plays a critical role in Tesla's broader energy storage portfolio as a **large-scale commercial/industrial solution**, complementing Powerwall (home/small commercial) and addressing utility and energy generation needs, while also enabling remote control and dispatch capabilities across diverse applications.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the quantitative aspects and addresses the multi-part question well. STRENGTHS: (1) All numeric values are correct - $795 million increase and 40% growth rate match the ground truth exactly; (2) Correctly identifies Megapack as a primary driver alongside solar cash/loan jobs, Powerwall, and Solar Roof; (3) Accurately characterizes Megapack's role in the portfolio as a large-scale commercial/industrial solution; (4) Properly synthesizes the multi-hop information comparing 2021 vs 2020 revenue; (5) Correctly identifies the target customer segments (commercial, industrial, utility, energy generation). MINOR WEAKNESSES: (1) The LLM adds information about 'remote control and dispatch capabilities' which, while potentially accurate, is not explicitly mentioned in the ground truth answer and goes slightly beyond what was provided; (2) The ground truth specifically mentions Megapack can be 'grouped to form large-scale installations of gigawatt hours or greater capacity' - the LLM captures the scale concept but doesn't explicitly mention the gigawatt-hour specification; (3) The characterization of Powerwall as 'home/small commercial' is reasonable inference but not explicitly stated in the ground truth. The answer is semantically equivalent and factually sound on all critical points, with only minor elaborations that don't contradict the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 392,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "Walmart recognized an initial pre-tax loss of $5.5 billion in fiscal 2021 related to the Asda divestiture, including $2.3 billion tied to pension obligations. Upon closing in fiscal 2022, an additional $0.2 billion pre-tax loss was recorded, primarily due to currency adjustments and transaction costs. The pension-related obligations significantly contributed to the initial loss, reflecting the substantial financial impact of derecognizing the Asda pension plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all key dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $5.5 billion initial loss in fiscal 2021, $2.3 billion pension-related components, and $0.2 billion additional loss in fiscal 2022. The total of $5.7 billion is correctly implied through the sum of these components. COMPLETENESS: The answer addresses all major elements of the multi-part question: (1) initial loss estimate ($5.5B in FY2021), (2) additional adjustments upon closing ($0.2B in FY2022), (3) pension-related obligations ($2.3B), and (4) the financial impact reflection. ENTITY ACCURACY: Correctly identifies Walmart, Asda divestiture, fiscal years 2021 and 2022, and pre-tax loss metrics. MULTI-HOP REASONING: Successfully synthesizes information across two fiscal years and connects pension obligations to the overall loss impact. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer uses slightly different phrasing ('derecognizing the Asda pension plan' vs. 'accumulated pension components') but conveys equivalent meaning. The ground truth explicitly mentions 'currency exchange rate fluctuations' while the LLM says 'currency adjustments' - semantically equivalent. The ground truth mentions 'purchase price adjustments' which the LLM omits, but this is a minor contextual detail rather than a core factual error. The LLM's characterization of pension obligations as 'significantly contributed' matches the ground truth's emphasis on their importance. Overall, the answer is factually accurate, well-synthesized across multiple data points, and appropriately contextualizes the pension impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 448,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "The More Personal Computing segment's total revenue in fiscal year 2022 was $56.5 billion. Windows OEM contributed 42% of this segment's revenue, amounting to $23.73 billion. The \"Devices\" line item in the revenue table (page 96) reflects Surface devices revenue at $6.991 billion. Combining these, the total revenue from Surface devices and Windows OEM licensing is $23.73 billion + $6.991 billion = $30.721 billion. This represents **54.4%** of the segment's total revenue ($30.721 billion / $56.5 billion * 100). \n\n**Answer:** The combined revenue from Surface devices and Windows OEM licensing represented approximately **54.4%** of the More Personal Computing segment's $56.5 billion revenue in fiscal year 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding Surface devices revenue. The ground truth states Surface (Devices) contributed $9.04 billion (16% of segment revenue), but the LLM claims it was only $6.991 billion. This is a material discrepancy of approximately $2.05 billion. CALCULATION ERROR: Due to the incorrect Surface revenue figure, the LLM's final calculation is wrong. The LLM calculated $30.721 billion / $56.5 billion = 54.4%, but the correct combined total should be $32.77 billion / $56.5 billion = 58%. The arithmetic of the LLM's calculation is technically correct (30.721/56.5 = 0.544), but it's based on incorrect input data. WHAT WAS CORRECT: (1) The segment total of $56.5 billion is correct, (2) Windows OEM at 42% ($23.73 billion) is correct, (3) The methodology of adding the two components and dividing by total is sound, (4) The fiscal year 2022 identification is correct. MULTI-HOP REASONING: The LLM correctly identified the need to combine two revenue streams and calculate the percentage, demonstrating sound logical reasoning. However, the failure to identify the correct Surface devices revenue figure undermines the entire answer. The discrepancy suggests the LLM may have referenced an incorrect page or data source (mentioning 'page 96') rather than the actual filing data. SEMANTIC EQUIVALENCE: While the approach is semantically correct, the numerical answer of 54.4% is factually wrong when compared to the ground truth of 58%. This is not a minor rounding difference but represents a meaningful error in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 442,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "The total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale was **$3.3 billion**, combining the **$1.0 billion cash contribution** made by Asda in fiscal 2020 and the **$2.3 billion accumulated pension components** included in the disposal group upon the sale of Asda. The $1.0 billion contribution reduced Walmart's pension liability, while the $2.3 billion was recognized as part of the pre-tax loss from the disposal of Asda's operations in fiscal 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative elements are correct: (1) Total impact of $3.3 billion is accurate, (2) $1.0 billion cash contribution in fiscal 2020 is correct, (3) $2.3 billion accumulated pension components is correct, and (4) the arithmetic sum ($1.0B + $2.3B = $3.3B) is accurate. The multi-hop reasoning is sound - the answer correctly synthesizes information across two separate pension-related events (the contribution and the subsequent sale/disposal). Entity identification is correct (Walmart, Asda, fiscal 2020/2021). The LLM answer goes slightly beyond the ground truth by providing additional context about how these amounts were treated (the $1.0 billion reducing pension liability and the $2.3 billion recognized as part of pre-tax loss from disposal), which adds helpful detail without introducing any inaccuracies. The semantic meaning is fully aligned with the ground truth. Minor deduction from perfect score only because the additional contextual details, while accurate and helpful, weren't explicitly required by the question, though they enhance understanding of the financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 326,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company uses the **lower of trade-in value or estimated net realizable value** method for valuing these pre-owned aircraft, as stated in the inventory section of the 10-K filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The increase amount ($8 million), the starting value ($15 million), and ending value ($23 million) are all correct. The valuation method is accurately stated as 'lower of trade-in value or estimated net realizable value.' (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The calculation is accurate: $23M - $15M = $8M increase. Dates are correct (December 31, 2023 and December 31, 2024). (3) QUALITATIVE ACCURACY: The LLM correctly identified and synthesized the multi-hop information required: (a) the inventory values at two different time periods, (b) the calculation of the change, and (c) the specific valuation methodology. The reasoning is sound and logically presented. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question - the quantitative change and the qualitative valuation method. The additional context about the source ('as stated in the inventory section of the 10-K filing') adds appropriate credibility without being excessive. Minor note: The LLM uses bold formatting for emphasis on the valuation method, which is a stylistic choice that enhances clarity without affecting accuracy. The answer is complete, accurate, and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 375,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "The growth in Xbox Game Pass's curated game library likely contributed to the 3% increase in Xbox content and services revenue by attracting more subscribers and enhancing user engagement. Microsoft highlights strategic investments in cloud gaming (Xbox Cloud Gaming), expanding game libraries through acquisitions (e.g., ZeniMax, Activision Blizzard), and advancing AI/edge computing to innovate gaming experiences, all of which strengthen the Xbox segment's long-term performance and scalability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the multi-part question effectively. STRENGTHS: (1) Correctly identifies the 3% increase in Xbox content and services revenue; (2) Accurately names both major acquisitions (ZeniMax Media and Activision Blizzard); (3) Properly identifies Xbox Cloud Gaming as a key strategic investment; (4) Correctly explains the relationship between Game Pass library growth and revenue increase through subscriber attraction and engagement; (5) Adds relevant context about AI/edge computing investments that align with Microsoft's gaming strategy. MINOR WEAKNESSES: (1) The original answer specifically mentions 'over 100 first- and third-party titles' in Game Pass, which the LLM answer omits (though this is a minor detail); (2) The LLM answer adds 'AI/edge computing' which, while potentially relevant to Microsoft's broader strategy, is not explicitly mentioned in the ground truth answer as a gaming segment investment highlight. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple strategic elements (Game Pass library  revenue growth  broader acquisitions and cloud services) and correctly identifies how these components interconnect. The logic flow is sound and demonstrates proper understanding of the relationship between product offerings and financial performance. QUANTITATIVE ACCURACY: The 3% figure is correct; no calculations are required or performed. SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth, with slightly different emphasis and organization but equivalent meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 442,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "Eli Lilly recognized **$1,694.8 million** in revenue from the sale of rights for the olanzapine portfolio in 2023, specifically $79.4 million in the U.S. and $1,615.4 million outside the U.S. This transaction is included in the **collaboration and other revenue** category for 2023, as noted in Note 2 of the 10-K filing. The sale of rights is accounted for under collaboration revenue, reflecting the transfer of control of the asset to the other party.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative details that go beyond the ground truth answer. The ground truth confirms that Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio and that this is part of the 'collaboration and other revenue' category. The LLM answer correctly identifies this categorization and provides specific dollar amounts ($1,694.8 million total, with $79.4 million in the U.S. and $1,615.4 million outside the U.S.). These numbers appear internally consistent (79.4 + 1,615.4 = 1,694.8) and are presented with appropriate precision. The answer correctly addresses both parts of the question: (1) the specific revenue amount from the olanzapine portfolio sale, and (2) how this factors into the collaboration and other revenue category. The LLM appropriately references Note 2 of the 10-K filing and explains the accounting treatment. The multi-hop reasoning is sound - connecting the specific transaction to the broader revenue category. The only minor limitation is that the ground truth answer doesn't explicitly confirm the exact dollar amounts provided by the LLM, though it does confirm the transaction occurred and its categorization. The LLM's additional specificity (geographic breakdown, specific note reference) enhances the answer without contradicting the ground truth. The semantic equivalence is strong - both answers confirm the olanzapine portfolio sale was part of collaboration and other revenue in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 408,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "Tesla's 5.45% Solar Bonds, structured through multiple Supplemental Indentures in 2015 (e.g., Exhibit 4.50), reflect SolarCity's (a Tesla subsidiary) strategy to secure recurring capital for solar energy projects via structured debt instruments. These indentures enabled flexible financing by allowing SolarCity to issue bonds tailored to specific projects, with bond-specific trustee agreements ensuring compliance with terms and obligations. This approach supported continuous capital needs while maintaining financial discipline and oversight.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Tesla's acquisition of SolarCity, the 5.45% interest rate, the 2015 timeframe, and the general strategic purpose of using multiple Supplemental Indentures for flexible financing of solar projects. The semantic understanding of trustee agreements' role in enabling discrete funding events is conceptually sound. CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM fails to provide the specific series designations (2015/C122-15, 2015/C127-15, 2015/C132-15, 2015/C137-15) that are central to demonstrating the 'multiple tranches' structure. It vaguely references 'e.g., Exhibit 4.50' without specificity. (2) MISSING SPECIFIC INDENTURE NUMBERS - The ground truth identifies four distinct Supplemental Indentures (4.72, 4.74, 4.76, 4.78) with specific November-December 2015 dates. The LLM provides no such detail, which is essential for answering a question specifically about 'multiple Supplemental Indentures.' (3) INCOMPLETE MULTI-HOP SYNTHESIS - While the LLM mentions the strategy generally, it does not demonstrate the specific evidence from the filings (the four separate series with matching indentures) that supports the conclusion about 'deliberate financing strategy to raise capital in tranches' and 'matching funding with project deployment timelines.' (4) LACK OF TEMPORAL SPECIFICITY - The ground truth specifies the indentures were 'dated at different points in November through December 2015,' showing a deliberate staggered issuance pattern. The LLM provides no such temporal detail. The answer reads as a general explanation rather than a specific analysis grounded in the actual filing evidence. For a question explicitly asking about 'multiple Supplemental Indentures in 2015,' the failure to cite the specific indenture numbers and series is a significant omission that undermines the credibility of the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 508,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "The increase in Megapack deployments contributed $795 million to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, as stated in the document. This growth was partially offset by a decline in Powerpack deployments, as Tesla phased out the product following the introduction of Megapack.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key components of the multi-hop question. Quantitative accuracy is strong: the $795 million contribution figure is correct and matches the ground truth. The 40% growth percentage mentioned in the original answer is omitted from the LLM response, which represents a minor incompleteness. Entity identification is accurate (Tesla, Megapack, Powerpack, Energy generation and storage revenue, 2021 vs 2020). The multi-hop reasoning is sound - the model correctly synthesized that: (1) Megapack deployments increased and contributed $795M to revenue growth, (2) this was partially offset by Powerpack decline, and (3) the phaseout was intentional following Megapack introduction. The main weakness is the omission of the '40%' growth metric, which was explicitly stated in the original answer as part of the quantitative description. The LLM's statement 'as stated in the document' suggests reliance on source material but doesn't fully capture all quantitative details provided in the ground truth. The answer is semantically equivalent and factually accurate on all stated points, but incomplete in presenting the full quantitative picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 337,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "The combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024 was **$20 million**. This is derived from **$12 million in Capital Expenditures** (from page 116) and **$8 million in Depreciation and Amortization** (from page 117).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative elements are correct: the final combined total of $20 million matches the ground truth exactly, and the component breakdown ($12 million in Capital Expenditures + $8 million in Depreciation and Amortization) correctly sums to the stated total. The arithmetic is sound (12 + 8 = 20). The answer correctly identifies the Africa/Eurasia region and the 2024 fiscal year as required by the question. The multi-hop synthesis is properly executed, combining data from two different line items/pages to arrive at the final answer. The response includes helpful source citations (pages 116 and 117), which adds credibility and transparency. The only minor consideration is that while the answer is semantically complete and factually accurate, the page citations cannot be independently verified from the provided context, but this does not affect the correctness of the numerical answer itself. The answer directly and completely addresses the multi-part question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1067,
        "completion_tokens": 298,
        "total_tokens": 1365
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "TI's policy for retiree health care benefit plans involves investing in low-cost, broad-market index funds to mitigate concentration risks, with no direct investment in TI common stock. In contrast, TI's non-U.S. defined contribution plans held **$34 million** in TI common stock as of December 31, 2024, reflecting a different investment strategy that includes direct holdings of company stock. This contrasts with the retiree health care plans, which adhere to a policy avoiding direct equity investments in TI.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: TI common stock holdings in non-U.S. defined contribution plans valued at $34 million as of December 31, 2024. The date and dollar amount are accurate. The answer also correctly states that the retiree health care benefit plan has no direct investment in TI common stock, matching the ground truth policy statement. However, there is a notable discrepancy in how the retiree health care plan policy is characterized. The LLM describes it as investing in 'low-cost, broad-market index funds to mitigate concentration risks,' which adds specific investment strategy details not present in the ground truth answer. The ground truth simply states 'none of the assets related to the retiree health care benefit plan are directly invested in TI common stock' without elaborating on what they ARE invested in. This additional characterization, while potentially accurate from the filing, goes beyond what was confirmed in the ground truth and could be considered an inference rather than a direct statement from the source material. The comparison between the two plans is clearly articulated and the multi-hop reasoning (comparing policy to actual holdings across two different plan types) is sound. The answer appropriately addresses both parts of the question: the policy regarding retiree health care plans and the actual holdings in non-U.S. defined contribution plans. The semantic equivalence is strong, with the core message matching the ground truth despite different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 424,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "LLY's Baqsimi revenue declined significantly from $677.6 million in 2023 (U.S. $645.7M, Outside U.S. $31.9M) to $29.2 million in 2024 (U.S. $2.5M, Outside U.S. $26.7M). The collaboration and other arrangements disclosure indicates that the 2023 revenue included a one-time sale of rights (a collaboration milestone payment), while 2024 revenue reflects ongoing product sales recognized under net product revenue rules, shifting from upfront collaboration revenue to recurring sales recognition.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "QUANTITATIVE ACCURACY: All numbers are correct. The 2023 total ($677.6M = $645.7M + $31.9M) and 2024 total ($29.2M = $2.5M + $26.7M) are accurate, and the format variations are acceptable. The magnitude of decline is correctly stated.\n\nQUALITATIVE ACCURACY - CRITICAL ERRORS: The LLM answer contains a fundamental misinterpretation of the revenue shift. The ground truth states that LLY SOLD THE RIGHTS TO BAQSIMI IN 2023, causing the shift from product sales revenue to collaboration/other arrangements revenue. The LLM answer reverses this logic, incorrectly claiming that 2023 included a 'one-time sale of rights (collaboration milestone payment)' while 2024 reflects 'ongoing product sales.' This is backwards. According to the ground truth: (1) 2023 had high product sales ($677.6M) BEFORE the rights sale, (2) 2024 has low product sales ($29.2M) AFTER the rights sale, (3) the shift is FROM product sales TO collaboration arrangements (not the reverse). The LLM fundamentally misunderstood the causal relationship and timing of the rights sale.\n\nMULTI-HOP REASONING: The LLM failed to correctly synthesize the relationship between the rights sale event and the revenue recognition shift. It correctly identified that a shift occurred but attributed it to the wrong direction and timing.\n\nCOMPLETENESS: The answer addresses both U.S. and Outside U.S. sales components and mentions the collaboration disclosure, but the interpretation of what that disclosure means is inverted from the ground truth.\n\nJUSTIFICATION: While quantitative data is perfect, the qualitative interpretation is severely flawed. The answer demonstrates a critical misunderstanding of the business event (the rights sale) and its impact on revenue recognition, which is the core of the question. This is not a minor wording difference but a fundamental logical error about causality and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 509,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard classifies \"Processing and Gateway\" services under its **value-added services and solutions** category. This aligns with the broader revenue generation framework outlined in the 10-K, which divides revenue into two primary categories: (1) **payment network** (fees for switching and network-related services) and (2) **value-added services and solutions** (including processing, gateway, data, open banking, and other specialized offerings). The \"Processing and Gateway\" classification falls within the latter, reflecting its role in enabling transaction processing and infrastructure services beyond the core payment network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies 'Processing and Gateway' services as part of 'value-added services and solutions' category, matching the ground truth classification exactly. (2) Accurately describes the broader revenue framework with two primary categories: 'payment network' and 'value-added services and solutions.' (3) Provides appropriate context about the distinction between core payment network services and value-added offerings. (4) No quantitative errors present (no numbers to verify). (5) Multi-hop reasoning is sound - successfully synthesizes the specific service classification with the broader company revenue structure. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more detail than the ground truth (mentions specific examples like 'data, open banking') which adds helpful context but goes marginally beyond what was explicitly stated in the ground truth. (2) The ground truth mentions 'fixed or transaction-based fees' and 'recognized in the period in which services are performed' - the LLM answer doesn't explicitly address these revenue recognition details, though this is a minor omission that doesn't affect the core answer's accuracy. (3) The explanation of 'enabling transaction processing and infrastructure services beyond the core payment network' is a reasonable interpretation that aligns with the classification but adds interpretive language. Overall, the answer demonstrates strong understanding of Mastercard's revenue classification structure and correctly addresses the question's multi-part requirements regarding both the specific classification and alignment with broader categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 462,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "The year-over-year change in CL's pension plan investments in international common stocks was a decrease of $5 million (from $20 million in 2023 to $15 million in 2024). This reduction contributed to the overall decline in total international investments, which fell by $29 million (from $566 million in 2023 to $537 million in 2024).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) DIRECTIONAL ERROR: The LLM states international common stocks DECREASED by $5 million, when the ground truth shows they INCREASED by $5 million. This is a critical reversal of the actual trend. (2) YEAR REVERSAL: The LLM incorrectly assigns the values to years - stating $20 million in 2023 and $15 million in 2024, when ground truth shows $15 million initially and $20 million in the later period. (3) TOTAL INTERNATIONAL INVESTMENTS: While the LLM correctly identifies the $29 million change in total international investments, it incorrectly characterizes this as a DECLINE rather than a GROWTH. The ground truth shows growth from $537 million to $566 million (a $29 million increase), but the LLM reverses this to show a fall from $566 million to $537 million. (4) MISSING ANALYSIS: The LLM completely omits the 17.2% contribution calculation that shows how the $5 million increase in international common stocks relates proportionally to the $29 million total increase. (5) SEMANTIC CONTRADICTION: The LLM's characterization of the shift as a 'reduction' and 'overall decline' directly contradicts the ground truth's description of growth and increase. The answer demonstrates a systematic reversal of the actual financial trends rather than a minor misstatement, making it fundamentally unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 389,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "The total increase in General Dynamics' Restricted Stock/RSUs expense from 2022 to 2024 was **$26 million** (from $59 million in 2022 to $85 million in 2024). This contributed to the overall increase in equity-based compensation expense, which rose by **$15 million** over the same period. The RSUs' growth offset a decline in stock options expense, driving the net increase in total equity-based compensation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: RSU expense increase of $26M (from $59M to $85M), total equity-based compensation increase of $15M (from $130M to $145M), and the correct identification that RSU growth exceeded the overall compensation increase. The multi-hop synthesis is sound - the model correctly identified that RSUs were a primary driver of the overall compensation expense growth. However, there is a minor qualitative issue: the LLM introduces an additional claim about 'stock options expense decline' that is not present in the ground truth answer. While this claim may be logically inferred (since RSU increase of $26M exceeds total increase of $15M, implying other components declined), the ground truth answer does not explicitly state this. The ground truth uses the phrase 'accounted for more than the total increase' while the LLM says 'offset a decline in stock options expense' - these are semantically similar but the LLM adds specificity about stock options that goes beyond what was verified in the original answer. The core answer is correct and addresses all parts of the question effectively, but the introduction of unverified details about stock options (rather than just noting the mathematical implication) represents a minor deviation from the ground truth's more conservative framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 381,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023 reflects a strategic preference for short-term liquidity management through structured, fixed-maturity instruments, even as it maintains a $20.0 billion Commercial Paper Program. The term loan, with its 364-day maturity, aligns with the short-term nature of commercial paper but offers a fixed-term solution for specific liquidity needs, such as funding acquisitions or operational requirements. While the Commercial Paper Program provides flexibility for on-demand short-term borrowing, the term loan likely served as a temporary, cost-effective alternative to manage cash flow during a period when commercial paper issuance may have been less favorable or unnecessary. This approach underscores Amazon's ability to leverage multiple short-term financing options strategically.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "QUANTITATIVE ACCURACY: All numbers are correct - $8.0 billion term loan, 364-day maturity, $20.0 billion Commercial Paper Program, and the January 2023 timing are all accurate. No calculation errors present. QUALITATIVE ACCURACY - SIGNIFICANT ISSUES: The LLM answer contains speculative reasoning not supported by the ground truth. Specifically: (1) The LLM suggests the term loan was used for 'funding acquisitions or operational requirements' - the ground truth makes no such claim and this is unsupported speculation. (2) The LLM states the term loan 'likely served as a temporary, cost-effective alternative' and that 'commercial paper issuance may have been less favorable' - these are conjectures not grounded in the filing data. (3) The LLM's reasoning about 'preserving flexibility under the program for other short-term obligations' is mentioned but less clearly articulated than in the ground truth. COMPLETENESS: The LLM answer addresses the core question but misses a critical factual detail from the ground truth: that the Commercial Paper Program had NO BORROWINGS DRAWN as of the reporting period. This is a key fact that explains why the term loan was used instead. The ground truth explicitly states 'no borrowings had been drawn' from the CP program, which is important context the LLM omits. MULTI-HOP REASONING: The LLM correctly synthesizes that Amazon has both instruments available and made a strategic choice, but the reasoning pathway is weaker. The ground truth provides clearer logic: (a) term loan = defined maturity certainty, (b) CP program = flexibility but unused, (c) therefore = Amazon chose committed facility to preserve CP flexibility. The LLM's reasoning is more speculative about 'cost-effectiveness' and market conditions without grounding. SEMANTIC EQUIVALENCE: While both answers discuss strategic preference and liquidity management, the LLM introduces unsupported explanations that diverge from the factual basis of the ground truth. The ground truth is more conservative and evidence-based, while the LLM adds interpretive layers not justified by the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 566,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "American Express's Membership Rewards liability increased to $14,752 million in 2024 from $13,742 million in 2023, driven by higher redemption costs and changes in third-party partner arrangements. The company adjusted its liability estimation methodology by updating the Ultimate Redemption Rate (URR) and weighted average cost per point (WAC) assumptions, incorporating statistical and actuarial models that reflect evolving redemption trends, partner contract modifications, and shifts in redemption patterns, including product refreshes and changes in redemption options. These adjustments ensure the liability reflects current cost expectations and partner dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partially correct response with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the key methodology components (URR and WAC assumptions), (2) Accurately describes the statistical and actuarial models used, (3) Properly identifies the drivers of changes (redemption costs, partner arrangements, redemption patterns), (4) Correctly notes the company's approach to updating assumptions based on evolving conditions. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM provides specific liability figures ($14,752 million in 2024 and $13,742 million in 2023) that cannot be verified against the ground truth, which does not mention these specific numbers. This is a critical issue as the question asks about 'impact' which typically requires quantitative data. The inclusion of unverified numbers reduces confidence in the answer's accuracy. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes that adjustments are made 'when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns.' The LLM answer mentions these concepts but doesn't fully capture the conditional nature of when adjustments are made. (3) MISSING CONTEXT - The ground truth notes that adjustments consider 'card product type, enrollment tenure, card spend levels, and credit attributes' - the LLM mentions 'product refreshes' but doesn't comprehensively list all the factors considered. (4) VAGUE ATTRIBUTION - The LLM states changes were 'driven by higher redemption costs' but the ground truth is more nuanced, explaining that the WAC is based on 12 months of redemptions and adjusted when not representative of future expectations. The LLM's answer suggests a direct causal relationship that may oversimplify the methodology. MULTI-HOP REASONING: The answer does attempt to synthesize information about methodology changes and their drivers, but the unverified financial figures and incomplete explanation of the adjustment triggers weaken the multi-hop synthesis. The answer would have been stronger by focusing on the methodology adjustments without introducing unverified quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 587,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Colgate-Palmolive uses selling price increases alongside derivative contracts to mitigate foreign exchange risk, specifically targeting the financial exposure from currency rate fluctuations impacting earnings. Selling price increases help offset currency volatility by adjusting revenue, while derivative contracts (e.g., forward and swap agreements) hedge against costs and liabilities in foreign currencies, collectively reducing earnings volatility from exchange rate movements.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategy and mechanisms Colgate-Palmolive uses to manage foreign exchange risk. Strengths: (1) Accurately identifies selling price increases and derivative contracts (forward, swap) as key tools; (2) Correctly states the goal is to mitigate earnings impact from currency fluctuations; (3) Properly explains the dual mechanism - selling price increases offset revenue impact while derivatives hedge costs/liabilities; (4) No quantitative errors or incorrect numbers. Weaknesses: (1) Omits the mention of 'over 200 countries' where Colgate operates, which provides important context for the scope of FX exposure; (2) Does not mention option contracts or local currency borrowings as part of the derivative/hedging toolkit, which the ground truth explicitly includes; (3) Less comprehensive in describing the full range of hedging instruments employed; (4) Doesn't explicitly mention 'translation of foreign subsidiary assets and liabilities into U.S. dollars' as a specific exposure being managed. The answer is semantically sound and captures the essential interaction between selling price increases and derivative contracts, but lacks some of the specific details about the breadth of instruments and geographic scope mentioned in the ground truth. The reasoning is logically sound and the multi-hop synthesis is correct, but the answer is somewhat less complete than the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 395,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The increase in business-to-business (B2B) activity and residential demand in 2022 drove higher average daily volume for UPS's Next Day Air product, as noted on page 35. Revenue per piece also rose due to higher base rates, commercial volume growth, and demand-related surcharges. However, this revenue growth was partially offset by a reduction in average billable weight per piece, as mentioned on page 35, which negatively impacted revenue per piece despite volume increases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies all key elements: (1) B2B activity growth from SMBs and large customers driving volume increases, (2) higher residential demand contributing to volume growth, (3) revenue per piece increases driven by higher base rates and demand-related surcharges, and (4) the offsetting factor of reduced average billable weight per piece. The answer demonstrates sound multi-hop reasoning by synthesizing information about volume drivers, revenue drivers, and the offsetting factor. No quantitative errors are present - the answer appropriately avoids citing specific numbers (which weren't provided in the question) and focuses on directional impacts. The semantic meaning aligns perfectly with the ground truth: volume increased due to B2B and residential demand, revenue per piece grew from rates and surcharges, but was partially offset by lower billable weight. The inclusion of page references (page 35) adds credibility and specificity. The only minor consideration is that the answer could have been slightly more explicit about SMBs and large customers as specific B2B segments, though this is a very minor omission that doesn't materially affect the correctness of the response. The answer fully addresses all parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 368,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "BMY's strategic positioning in global oncology markets is bolstered by Opdivo's U.S. regulatory exclusivity (12 years from initial approval) and its 2021 international approvals in Japan and the EU. While U.S. biosimilar competition could erode market exclusivity post-2025, the extensive international approvals extend Opdivo's market life in key regions, delaying generic entry and reinforcing BMY's leadership. This dual approach allows BMY to maintain revenue streams and influence global oncology dynamics, leveraging both regulatory protections and expanded therapeutic applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 12-year U.S. regulatory exclusivity period for Opdivo, correctly names the international regions (Japan and EU), and accurately captures the strategic concept that international approvals help offset U.S. biosimilar competition. The reasoning about dual market approach and revenue stream maintenance is sound. CRITICAL ERRORS: (1) The LLM states biosimilar competition could erode exclusivity 'post-2025,' which is incorrect. The ground truth specifies patent litigation could start 'as early as four years post-approval' and biosimilar competition occurs 'after 12 years of regulatory data protection.' Without knowing the exact approval date, the LLM's specific 2025 date cannot be verified and appears to be an unsupported inference. (2) The LLM uses the term 'generic entry' which is imprecisethe ground truth specifically refers to 'biosimilar' competition, not generic drugs. This is a meaningful distinction in biologics. OMISSIONS: (1) The LLM fails to mention specific 2021 international approvals detailed in the ground truth (cancer of unknown primary, gastric cancer, esophageal cancer, CRC, mesothelioma). While it mentions 'expanded therapeutic applications,' it doesn't enumerate the specific indications approved in 2021. (2) The ground truth emphasizes 'patent enforcement' as a strategic tool, which the LLM doesn't explicitly address. (3) The ground truth's concept of 'global regulatory diversification' as a specific strategic offset mechanism is mentioned but not as clearly articulated. MULTI-HOP REASONING: The LLM does synthesize the interaction between U.S. exclusivity risk and international approvals, showing understanding of how they work together strategically. However, the reasoning lacks the specificity and precision of the ground truth regarding timing and mechanisms. The answer is directionally correct but imprecise on key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 518,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "As of December 31, 2024, the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC was **$13.8 billion**, compared to the total amount invested of **$5.3 billion** (sum of $1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). The fair value significantly exceeds the invested amount, reflecting the valuation methods used, including discounts for lack of marketability and assumptions about liquidity events.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: fair value of $13.8 billion, total invested amount of $5.3 billion, and the three investment tranches ($1.25B Q3 2023, $2.75B Q1 2024, $1.3B Q4 2024). The arithmetic is accurate (1.25 + 2.75 + 1.3 = 5.3 billion). The multi-hop synthesis is sound, correctly identifying Amazon's investments across three separate convertible notes and comparing them to the December 31, 2024 fair value. The answer properly addresses both parts of the question: (1) the total fair value and (2) how it compares to the amount invested. The LLM correctly notes the significant valuation uplift ($13.8B vs $5.3B invested). However, the LLM's explanation of the valuation uplift differs slightly from the ground truth. The ground truth attributes the increase to 'Anthropic's subsequent financing activities and market expectations,' while the LLM mentions 'discounts for lack of marketability and assumptions about liquidity events.' While both explanations are reasonable valuation considerations, the LLM's framing is somewhat more technical/methodological rather than directly addressing the business drivers (subsequent financing) mentioned in the ground truth. This is a minor semantic difference that doesn't affect the core factual accuracy. All entities are correctly identified (Amazon, Anthropic PBC, convertible notes), dates are accurate, and the comparison logic is sound. The answer is complete and directly responsive to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 418,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate-Palmolive accounts for pension enhancements as \"Charges against assets\" within Employee-Related Costs, reducing pension assets or increasing pension liabilities on the balance sheet. In contrast, other Employee-Related Costs (e.g., severance) are expensed as incurred on the income statement. This distinction reflects pension enhancements' direct impact on pension-related balances (assets/liabilities) versus severance costs, which are operational expenses. The difference in treatment arises because pension enhancements adjust pension obligations, while severance costs are recognized as period expenses.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Colgate-Palmolive's pension enhancement accounting treatment and correctly identifies the key distinction from other Employee-Related Costs. STRENGTHS: (1) Correctly identifies pension enhancements as 'Charges against assets' within Employee-Related Costs - matches ground truth terminology; (2) Accurately explains the balance sheet treatment (reduction of pension assets or increase in pension liabilities) versus income statement treatment for severance; (3) Properly synthesizes the multi-hop concept that pension enhancements affect pension-related balances while severance is operational expense; (4) No quantitative errors - no numbers, dates, or calculations to verify; (5) Correctly identifies both Colgate-Palmolive and the relevant accounting concepts. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth and omits some contextual details about severance being 'calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements' - though this omission doesn't affect the core answer's accuracy; (2) The phrase 'expensed as incurred on the income statement' is accurate but the ground truth uses 'treated as operating expenses' - semantically equivalent but slightly different framing; (3) Could have been more explicit about why this distinction matters (ensuring financial impact is 'directly tied to asset or liability adjustments, rather than being netted into general operating charges'), though the LLM does capture the essence of this reasoning. MULTI-HOP REASONING: The answer successfully synthesizes information about (a) pension enhancement accounting treatment, (b) comparison with severance accounting, and (c) balance sheet vs. income statement implications. The logic is sound and the connections are properly made. Overall, this is a strong answer that captures the essential accounting distinction with accurate terminology and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 540,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharplyoften losing a major portion in a short periodespecially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "The regulatory data protection period for biologic products in the U.S. provides Opdivo with 12 years of exclusivity before biosimilars can be approved, as outlined in the 2010 legislation. However, once this period expires, the rapid revenue decline observed in developed marketsparticularly in oncologyposes significant financial risk to BMY. The document notes that post-exclusivity revenue declines are more pronounced in the U.S. and EU, with Opdivo's specialized oncology use likely exacerbating this decline due to intense competition and price pressures from biosimilars and generics. This could lead to a sharp reduction in revenue for BMY as market exclusivity wanes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: (1) Correctly identifies the 12-year regulatory data protection period for biologics in the U.S., (2) Accurately references the 2010 legislation framework, (3) Properly identifies Opdivo and BMY as the relevant entities, (4) Correctly describes the financial risk from post-exclusivity revenue decline in developed markets. The multi-hop reasoning is soundconnecting the 12-year protection period to biosimilar competition risk to revenue decline impact. However, there are minor areas where the answer could be stronger: (1) The LLM mentions 'generics' alongside biosimilars, which is technically less precise since biosimilars (not traditional generics) are the relevant competitive threat for biologics, (2) The answer adds contextual detail about 'oncology use' and 'price pressures' that goes slightly beyond what the ground truth explicitly states, though this is reasonable inference rather than error, (3) The ground truth emphasizes that revenue decline is 'sharp' and 'rapid' with loss of 'major portion in short period'the LLM captures this concept but uses slightly different phrasing ('sharp reduction'). The quantitative accuracy is high since the key number (12 years) is correct and no calculations are required. The qualitative reasoning appropriately synthesizes the regulatory framework with financial impact. No factual errors detected, and the semantic meaning aligns well with the ground truth despite minor wording variations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 420,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "The percentage of Amazon's total advertising services revenue in 2024 derived from display advertising is calculated by dividing display advertising revenue ($35 billion) by total advertising services revenue ($40 billion), resulting in **87.5%**. This calculation is based on the provided figures, even though the document's actual 2024 advertising services revenue ($56.214 billion) differs from the question's stated total.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly calculates the percentage as 87.5%, matching the ground truth exactly. The calculation is accurate: $35 billion / $40 billion = 0.875 = 87.5%. The LLM properly identifies all entities (Amazon, display advertising, advertising services revenue) and the fiscal year (2024). The reasoning is sound and the multi-hop synthesis is correct - the model takes the two provided figures and performs the appropriate division to derive the requested percentage. A notable strength is that the LLM acknowledges a discrepancy between the question's stated total ($40 billion) and the actual 2024 advertising services revenue ($56.214 billion) from the filing, demonstrating awareness of the data source while correctly answering based on the question's parameters. This transparency adds credibility without detracting from the core answer. The only minor consideration is that the answer could have been more concise, though the additional context about the actual filing data is helpful and accurate. All numeric values are correct, the calculation is precise, and the answer directly addresses the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 321,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "The dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on Level 1 quoted prices, is **$0**. The Level 1 fair value increased from $184 million in 2020 to $200 million in 2021, indicating an increase rather than a decrease.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. Critical errors: (1) The LLM states the decrease is $0, when the correct answer is a $16 million decrease. (2) The LLM correctly identifies the 2020 value as $184 million and 2021 value as $200 million, but then incorrectly concludes this represents an increase rather than a decrease. (3) The calculation is wrong: $184M - $200M = -$16M (a $16 million decrease), not $0. The LLM appears to have confused the direction of the change, stating 'increased from $184 million in 2020 to $200 million in 2021' when the question asks about a decrease. (4) The LLM correctly identifies the relevant financial metric (Level 1 quoted prices) and company (UPS), and the years are correct, so contextual relevance is appropriate. However, the core quantitative answer is completely wrong - the LLM failed to perform the basic subtraction correctly and misidentified whether the value increased or decreased. This is a fundamental failure in answering a straightforward numerical question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 302,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMSs upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The joint development and cost-sharing structure between BMS and Ono for Yervoy is specific to Japan, South Korea, and Taiwan, as outlined in the document (page 114). In the U.S., BMS is the sole developer and commercializer of Yervoy, meaning the financial risk exposure related to potential biosimilar competition under the U.S. regulatory framework is directly borne by BMS. The joint structure outside the U.S. does not mitigate BMS's risk in the U.S. market, where regulatory exclusivity and biosimilar competition are governed by separate frameworks. Thus, the joint arrangement does not impact BMS's financial risk exposure in the U.S. context.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that fundamentally misrepresents the ground truth. (1) MAJOR ERROR - GEOGRAPHIC SCOPE: The LLM claims the joint development and cost-sharing structure is 'specific to Japan, South Korea, and Taiwan' and that 'in the U.S., BMS is the sole developer and commercializer.' However, the ground truth explicitly states that the joint development agreement between BMS and Ono involves cost-sharing for combination therapies, and this arrangement does apply to Yervoy development more broadly. The LLM incorrectly compartmentalizes the agreement as region-specific when the ground truth indicates it affects BMS's overall financial burden for Yervoy development. (2) REASONING FAILURE: The LLM's core argument is that the joint structure 'does not mitigate BMS's risk in the U.S. market' because it's geographically limited. This contradicts the ground truth, which states the cost-sharing arrangement 'limits BMS's upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss.' The LLM failed to synthesize that equal cost-sharing reduces BMS's individual financial burden regardless of geographic market considerations. (3) INCOMPLETE SYNTHESIS: The LLM did not address the key multi-hop connection: (a) equal cost-sharing reduces BMS's financial burden, (b) Yervoy faces biosimilar competition risk after 12 years under U.S. regulatory framework, (c) therefore the cost-sharing arrangement mitigates exposure to this risk. Instead, the LLM created a false dichotomy between U.S. and non-U.S. markets. (4) QUANTITATIVE ACCURACY: The LLM correctly identifies the 12-year regulatory data protection period for biologics (implied in ground truth), but this is overshadowed by the fundamental misunderstanding of the cost-sharing arrangement's scope and impact. The answer is internally logical but based on an incorrect premise about the geographic limitation of the joint agreement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 531,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M  $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Teslas maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $596 million of FSD (Supervised) revenue offset approximately **9.9%** of the $6.03 billion decline in Automotive Sales Revenue (596 / 6,030  9.9%). This FSD revenue is tied to deferred revenue streams related to over-the-air software updates and vehicle connectivity, which are recognized over the vehicle's ownership period. Additionally, deferred revenue from FSD features and other services (e.g., Supercharging) is reflected in the $3.599 billion deferred revenue balance as of December 31, 2024. Guarantee liabilities associated with lease residual values, capped at $1.45 billion as of 2024, represent separate obligations under leasing programs, distinct from the FSD revenue offset.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The core calculation is correct: $596M  $6,030M = 9.9% offset - this matches the ground truth exactly. (2) The $1.45 billion lease residual value guarantee liability for 2024 is correctly cited. (3) The answer correctly identifies that FSD revenue relates to deferred revenue streams and over-the-air software updates. (4) The distinction between FSD revenue offset and separate guarantee liabilities is appropriately made. WEAKNESSES: (1) The LLM introduces a specific deferred revenue figure of $3.599 billion as of December 31, 2024, which is not mentioned in the ground truth answer. While this may be factually correct from the filing, it goes beyond what the ground truth establishes and introduces an unverified number. (2) The ground truth explicitly states the comparison showing the increase in maximum exposure from $166 million in 2023 to $1.45 billion in 2024, which provides important context about the magnitude of change. The LLM answer only mentions the 2024 figure without this comparative context. (3) The LLM answer mentions Supercharging deferred revenue as an example, which is reasonable but not explicitly connected to the question's focus on software updates and residual values. CALCULATION VERIFICATION: 596  6,030 = 0.09883...  9.9%  MULTI-HOP REASONING: The answer correctly synthesizes the relationship between FSD revenue, deferred revenue, and guarantee liabilities, though it could be more explicit about how software features (like OTA updates) influence residual values. The answer appropriately separates the revenue offset calculation from the liability discussion. OVERALL: The answer is substantially correct on the primary calculation and key figures, but introduces an unverified deferred revenue number and omits the year-over-year comparison context that strengthens the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 502,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "PepsiCo adjusts **Operating Profit Adjusted for Items Affecting Comparability** as its non-GAAP financial measure. This adjustment accounts for currency fluctuations by presenting operating profit growth on a **constant currency basis**, excluding the impact of foreign exchange translation effects to evaluate underlying performance more accurately.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies the non-GAAP financial measure as 'Operating Profit Adjusted for Items Affecting Comparability' and accurately explains how PepsiCo uses constant currency basis adjustments to account for foreign exchange translation effects. The answer demonstrates proper multi-hop reasoning by synthesizing: (1) the identification of the specific non-GAAP measure, (2) the purpose of adjusting for items affecting comparability, and (3) the mechanism for handling currency fluctuations through constant currency presentation. The LLM answer is more detailed and explicit than the ground truth, providing additional context about 'foreign exchange translation effects' and 'underlying performance,' which adds clarity without introducing inaccuracies. No quantitative data (numbers, percentages, dates) are present in either answer, so quantitative accuracy is perfect by default. The semantic meaning aligns perfectly with the ground truth - both convey that PepsiCo adjusts operating profit for comparability items and further adjusts for currency effects to present constant currency results. The only minor distinction is that the LLM provides slightly more explanatory detail, which enhances rather than detracts from the answer's quality. All entities (PepsiCo, 2022 10-K, operating profit, constant currency basis) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 391,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "The Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology has **12 amendments** documented across the exhibits. The earliest effective date is **October 31, 2014**, and the latest is **May 1, 2021**, spanning **6 years and 6 months**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies 12 amendments and addresses all parts of the multi-part question. However, there is a critical factual error in the earliest effective date. Ground truth states September 2, 2014, but the LLM provides October 31, 2014 - a discrepancy of nearly 2 months. This error cascades into the time span calculation: the LLM calculates 6 years and 6 months (from October 31, 2014 to May 1, 2021), while the correct answer is 6 years and 8 months (from September 2, 2014 to May 1, 2021). The latest effective date (May 1, 2021) is correct. The amendment count of 12 is accurate. The reasoning and synthesis approach are sound - the model correctly identified this as a multi-hop question requiring information from two exhibits and properly calculated the time span. The error appears to be a factual mistake in retrieving or identifying the earliest amendment date from the source documents, which is a significant issue for a question specifically asking about effective dates. The quantitative accuracy score is reduced due to the date error and resulting calculation error, while qualitative accuracy remains relatively high because the methodology and structure of the answer are appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 344,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was **18.5 percentage points** (14 percentage points from the Pioneer Foods acquisition and 4.5 percentage points from favorable foreign exchange).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and exceeds the ground truth by providing additional helpful detail. (1) Correctness: The combined percentage impact of 18.5 percentage points is exactly correct. (2) Quantitative Accuracy: All numbers are precise - 18.5 percentage points total, 14 percentage points from Pioneer Foods acquisition, and 4.5 percentage points from favorable foreign exchange. The arithmetic is correct (14 + 4.5 = 18.5). (3) Multi-hop Reasoning: The answer correctly synthesizes information across multiple components (Pioneer Foods acquisition impact + FX impact) and properly attributes each component to the AMESA division in 2022. (4) Entity Accuracy: All entities are correctly identified - AMESA division, Pioneer Foods acquisition, favorable foreign exchange, 2022 fiscal year. (5) Added Value: The LLM answer provides a breakdown of the two components contributing to the 18.5 percentage points, which adds transparency and completeness without contradicting the ground truth. This breakdown demonstrates sound understanding of the multi-hop nature of the question. The answer is semantically equivalent to and factually consistent with the ground truth while providing additional useful context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 346,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo's regulatory data protection in the U.S. (five years) and EU (1011 years for products filed post-2005) interacts with its patent expiration pattern to extend market exclusivity beyond patent terms. While method-of-use patents expired in 2021, formulation and additional patents (expiring in 2026+) and regulatory data protection delays generic entry. Despite EU generics entering the market in 2021, Opdivo's 2021 U.S. revenue growth of 7% reflects sustained demand and pricing power, supported by remaining patent and regulatory exclusivity, which mitigated competition impacts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: (1) U.S. regulatory data protection: LLM states 'five years' but ground truth clearly states '12 years' for biologics - this is a critical error that fundamentally misrepresents the exclusivity timeline. (2) EU protection timeline: LLM states '10-11 years for products filed post-2005' but ground truth specifies the '8+2+1' regime (8 years for filing, 10-11 years for commercialization) - the LLM conflates the timeline incorrectly. (3) Patent expiration dates: LLM correctly identifies formulation/additional patents expiring in 2026+ and method-of-use patents expiring in 2021, matching ground truth. (4) 2021 U.S. revenue growth: LLM correctly cites 7% growth. (5) EU generic entry claim: LLM states 'EU generics entering the market in 2021' but ground truth does not support this specific claim - this appears to be an unsupported assertion. MULTI-HOP REASONING: The LLM fails to properly synthesize the interaction between regulatory data protection and patent expiration. The core argument that regulatory exclusivity extends beyond patent terms is present but undermined by the incorrect U.S. data protection duration (5 years vs. 12 years). This error cascades through the entire analysis, making the exclusivity timeline analysis fundamentally flawed. The LLM does attempt to connect the 7% revenue growth to exclusivity protections, which is appropriate, but the foundation is incorrect. SEMANTIC ISSUES: The LLM's statement about 'pricing power' is reasonable inference but not explicitly supported in ground truth. The overall narrative structure is logical but built on incorrect factual premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 447,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firms ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley, a large BHC with over $250 billion in assets, including mandatory liquidity stress tests, unencumbered high-quality liquid asset holdings, and strict single-counterparty credit limits (e.g., 15% of Tier 1 capital for major counterparties). It also restricts capital distributions (e.g., dividends) if they pose an \"unsafe or unsound\" risk, requiring the company to prioritize liquidity and capital retention to mitigate systemic risks. These constraints ensure Morgan Stanley maintains robust liquidity management and capital resilience under stress scenarios.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) All quantitative data is correct - the 15% Tier 1 capital limit for major counterparties is accurately cited, matching the ground truth; (2) The $250 billion asset threshold is correctly identified; (3) Key regulatory requirements are properly enumerated: liquidity stress tests, unencumbered high-quality liquid assets, single-counterparty credit limits, and restrictions on capital distributions; (4) The 'unsafe or unsound' regulatory standard is correctly quoted; (5) Multi-hop synthesis is sound - the answer correctly connects systemic risk regime requirements to capital distribution constraints and liquidity management practices. MINOR OMISSIONS: (1) The ground truth specifies '30-day projected net cash outflows' as a specific liquidity requirement metric, which the LLM answer omits (though it references the general concept of maintaining unencumbered liquid assets); (2) The ground truth mentions '25% for other unaffiliated counterparties' as an additional single-counterparty credit limit, which the LLM answer does not include; (3) The ground truth explicitly mentions 'risk management and corporate governance standards' as separate regulatory requirements, while the LLM answer subsumes these into the broader framework without explicit mention. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information and maintains semantic alignment with the ground truth. The omission of the 25% counterparty limit and the 30-day specification are relatively minor details that don't fundamentally alter the answer's correctness. The reasoning about how systemic risk constraints capital distribution and liquidity management is logically sound and well-articulated. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 502,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The provided document pages do not contain specific information about the interest rates of PepsiCo's 0.750% Senior Note due 2033 or the 1.950% Senior Note due 2031, nor do they discuss the company's long-term debt strategy across maturities. The relevant sections (e.g., financial statements, notes, or disclosures) are either omitted or not included in the cited pages. To answer this question, access to the full 10-K filing, particularly the debt schedule or management discussion sections, would be required.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the question. The ground truth clearly establishes that: (1) The 0.750% Senior Note due 2033 has a lower interest rate than the 1.950% Senior Note due 2031 by 1.200 percentage points (0.750% vs 1.950%), and (2) This comparison indicates PepsiCo's debt strategy of issuing lower rates for longer-term maturities. The LLM incorrectly claims the information is not available in the provided documents and refuses to answer, stating that 'access to the full 10-K filing' would be required. However, the ground truth answer demonstrates that this information IS available and answerable from the filing data. The LLM failed to: (1) Identify the correct interest rates (0.750% and 1.950%), (2) Calculate the difference (1.200 percentage points), (3) Synthesize the multi-hop reasoning about debt strategy implications, and (4) Provide any substantive analysis. This represents a complete failure to answer a straightforward factual question about debt instruments that should be present in a 10-K filing. The LLM's deflection to claim missing information contradicts the ground truth, indicating either inadequate document access or failure to properly search/synthesize available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 351,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "The fair value of Medtronic's partnership units increased by $159 million from fiscal year 2023 ($992 million) to fiscal year 2024 ($1,151 million). This increase contributed to the total investments measured at net asset value rising by $1,187 million, as the U.S. pension benefits' net asset value increased from $2,179 million in 2023 to $3,366 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) QUANTITATIVE VERIFICATION: All numbers are correct - partnership units increased by $159 million (from $992M to $1,151M in FY2023-2024), and total investments measured at net asset value increased by $1,187 million (from $2,179M to $3,366M). All calculations are accurate: $1,151M - $992M = $159M  and $3,366M - $2,179M = $1,187M . (2) COMPLETENESS: The answer fully addresses both parts of the question: the increase in partnership units' fair value AND the impact on total investments measured at net asset value. (3) ENTITY ACCURACY: Correctly identifies Medtronic, fiscal years 2023 and 2024, partnership units, and investments measured at net asset value. The reference to 'U.S. pension benefits' net asset value' provides helpful context. (4) MULTI-HOP REASONING: The answer correctly synthesizes information showing how the partnership units increase ($159M) contributed to the larger increase in total investments ($1,187M), demonstrating proper multi-hop synthesis. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from ground truth but conveys identical information - the LLM's phrasing 'contributed to the total investments measured at net asset value rising' is semantically equivalent to the ground truth's statement about contribution. Minor note: The LLM adds contextual detail about 'U.S. pension benefits' which, while helpful, is not explicitly in the ground truth statement but does not contradict it.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 420,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "UPS employs activity-based costing (ABC) methods to allocate depreciation and amortization expenses between its reportable segments, as disclosed in the 2024 10-K. This approach ensures that expenses are distributed based on activity drivers rather than direct asset ownership, reflecting the actual resource consumption of each segment. The depreciation and amortization figures presented for segments (e.g., U.S. Domestic Package and International Package) are adjusted through ABC, which impacts segment operating profit calculations by aligning expenses with the underlying activities driving costs. This method provides a more accurate representation of cost allocation across segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies that UPS uses activity-based costing (ABC) methods for expense allocation between segments in the 2024 10-K; (2) Accurately notes that depreciation and amortization figures are adjusted through ABC methodology; (3) Correctly identifies that this impacts segment operating profit; (4) Mentions specific segment names (U.S. Domestic Package, International Package) appropriately. WEAKNESSES: (1) The ground truth explicitly states that depreciation and amortization totals are presented 'after applying activity-based costing methods to allocate expenses between segments' - the LLM answer generalizes this without capturing the precise language about how the figures are 'presented after applying' these methods; (2) The LLM introduces conceptual details about 'activity drivers' and 'actual resource consumption' that, while theoretically sound for ABC systems generally, are not explicitly stated in the ground truth answer and may not be directly supported by the 2024 10-K filing language; (3) The ground truth emphasizes that 'changes in these estimates directly impact the amount of expense allocated to each segment' - the LLM answer mentions impact on operating profit but doesn't emphasize the direct relationship between estimate changes and allocation amounts; (4) The LLM answer lacks the specific reference to how the figures are presented 'after applying' the methodology, which is a key distinction in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes that ABC affects both the presentation of figures AND segment operating profit, showing adequate multi-hop reasoning. However, it doesn't fully capture the nuance that the presentation itself is the result of applying ABC methods. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers). OVERALL: The answer is directionally correct but lacks precision in capturing the exact mechanism described in the ground truth - specifically that the depreciation and amortization totals are presented 'after applying' ABC methods, not just 'adjusted through' them.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 604,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "The reversal of the European Commission fine and associated interest in fiscal 2022 resulted in a **$1.1 billion benefit in other income** and a **$62 million reduction in interest expense** for Qualcomm. This reversal directly impacted their financial statements by reducing overall expenses and increasing other income.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the two key financial impacts: $1.1 billion benefit in other income and $62 million reduction in interest expense. Both numbers match the ground truth exactly. However, the answer is incomplete in one important aspect: it fails to explicitly state the total combined financial impact of $1.162 billion, which was specifically asked for in the question ('What was the total financial impact'). The ground truth answer leads with this total figure ($1.162 billion), then breaks it down into components. The LLM answer provides the components but omits the synthesized total. The reasoning about how these items affected the financial statements is sound and accurate. The answer correctly identifies that the reversal impacted other income positively and interest expense negatively. The multi-hop synthesis is present but incomplete - while the LLM correctly identifies both line items affected, it doesn't complete the final synthesis step of summing them to the total impact. This is a minor but notable omission for a question that explicitly asks for 'total financial impact.' The quantitative accuracy of the individual numbers is excellent (9/10), but the qualitative accuracy is slightly lower (7/10) due to the incomplete synthesis of the total figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 362,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "The fair value of Fixed Income Commingled Trusts increased by **$305 million** from fiscal year 2023 ($968 million) to fiscal year 2024 ($1,273 million). The total increase in fair value across all investment categories was **$153 million** (from $3,398 million in 2023 to $3,551 million in 2024). Thus, the proportion of the Fixed Income increase relative to the total increase is **200%** (305/153). However, this suggests the Fixed Income increase exceeded the total increase, which is inconsistent with the net total. The correct interpretation likely involves reconciling the total fair value changes, but based on the provided data, the increase in Fixed Income Commingled Trusts was **$305 million**, and the total increase across all categories was **$153 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all key metrics. All numerical values are correct: Fixed Income Commingled Trusts increase of $305 million (from $968M to $1,273M in 2024), total portfolio increase of $153 million (from $3,398M to $3,551M), and the calculated proportion of 200% (305/153). The calculations are accurate and properly formatted. The LLM correctly identifies the apparent paradox that the Fixed Income increase alone exceeds the total portfolio increase, indicating offsetting decreases in other categories. The answer addresses all parts of the multi-part question: (1) the specific increase amount, (2) the total increase across categories, and (3) the proportion calculation. The reasoning is sound and the LLM appropriately flags the logical inconsistency that arises from the data, which aligns with the ground truth's explanation that other investment categories collectively decreased. Minor deduction from perfect score (9 vs 10) due to slight verbosity in the explanation of the inconsistency, though this actually demonstrates good analytical thinking rather than a factual error. The semantic meaning and information content match the ground truth answer precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 341,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley's SPOE (Senior Preferred Obligation Entity) strategy ensures adequate liquidity for its subsidiaries during resolution by having Morgan Stanley Holdings LLC (Funding IHC) act as a resolution funding vehicle. The Parent Company transfers assets to Funding IHC, which then provides secured capital and liquidity to supported subsidiaries via a secured amended and restated support agreement. This agreement prioritizes Funding IHC's and subsidiaries' claims against the Parent Company's assets (excluding shares in subsidiaries) over unsecured Parent Company obligations, ensuring resources are available to implement the resolution strategy. Funding IHC's role is critical in facilitating liquidity support during resolution scenarios.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Morgan Stanley's SPOE strategy and accurately captures the core mechanisms. STRENGTHS: (1) Correctly identifies Morgan Stanley Holdings LLC as the Funding IHC (resolution funding vehicle); (2) Accurately describes the asset transfer mechanism from Parent Company to Funding IHC; (3) Correctly states the secured amended and restated support agreement framework; (4) Properly explains that assets exclude shares in subsidiaries; (5) Accurately conveys the prioritization of claims; (6) No quantitative errors present. MINOR WEAKNESSES: (1) The LLM expands the acronym SPOE as 'Senior Preferred Obligation Entity' - the ground truth does not provide this expansion, so this appears to be an inference/assumption not verified against the source material; (2) The phrase 'prioritizes Funding IHC's and subsidiaries' claims against the Parent Company's assets...over unsecured Parent Company obligations' adds interpretive detail about claim prioritization that, while logically sound, goes slightly beyond what the ground truth explicitly states about the mechanism; (3) Minor semantic difference: ground truth emphasizes 'ongoing asset transfers' while LLM says 'transfers assets' without the 'ongoing' qualifier, though this is a minor distinction. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between Parent Company, Funding IHC, and subsidiaries across the resolution scenario. The logic flow is sound and addresses both parts of the question (how liquidity is ensured AND what role Funding IHC plays). OVERALL: The answer is substantially correct with accurate core facts and sound reasoning, with only minor interpretive additions that don't contradict the ground truth but extend slightly beyond it.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 484,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs, as these customers are a significant revenue source and critical to achieving projected 5G vehicle penetration (60% by 2028). The 10-K highlights risks of Chinese OEMs shifting to in-house or competitor chips due to U.S.-China trade tensions, government policies (e.g., \"Made in China 2025\"), or supply chain restrictions, which could materially harm revenues. Qualcomm's reliance on Chinese markets and the potential for geopolitical disruptions underscore the strategic importance of preserving access to these OEMs for sustaining automotive 5G growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct synthesis of multi-hop information. STRENGTHS: (1) Quantitative accuracy is perfect - the 60% 5G vehicle projection for 2028 is correctly cited and matches ground truth; (2) Multi-hop reasoning is sound - the answer correctly synthesizes that Chinese OEMs are critical to achieving the 5G adoption projections AND that geopolitical risks threaten this access; (3) Entity identification is accurate - correctly identifies Qualcomm, Chinese OEMs, and the 5G automotive market; (4) Risk factors are properly articulated - mentions government actions, trade tensions, and supply chain disruptions as threats; (5) Contextual relevance is high - directly addresses how growth strategy depends on maintaining Chinese OEM access. MINOR WEAKNESSES: (1) The LLM introduces specific policy references ('Made in China 2025') that, while contextually reasonable, are not explicitly mentioned in the ground truth answer and add interpretive detail beyond what was stated; (2) The ground truth emphasizes that Chinese OEMs might 'develop their own' chips or shift to competitors, while the LLM says 'in-house or competitor chips' - semantically equivalent but slightly different phrasing; (3) The LLM could have more explicitly stated that China is a 'major revenue source' as emphasized in the ground truth, though this is implied. The answer successfully captures the core strategic dependency: Qualcomm's automotive 5G growth (60% by 2028) depends on Chinese OEM access, which is threatened by geopolitical factors. The reasoning chain is logically sound and addresses the question comprehensively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 452,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "The total fair value of investments measured at net asset value for Medtronic increased by **$1,187 million** from fiscal year 2023 ($2,179 million) to 2024 ($3,366 million). The category contributing the most to this change was **Fixed income commingled trusts**, which increased by **$305 million** (from $968 million in 2023 to $1,273 million in 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR: The LLM correctly identified the total change of $1,187 million and provided accurate supporting numbers (2023: $2,179M, 2024: $3,366M with correct arithmetic). However, the LLM identified the WRONG investment category as the largest contributor. The ground truth states that equity commingled trusts contributed the most with a $269 million increase, but the LLM claims fixed income commingled trusts contributed the most with a $305 million increase. This is a fundamental factual error that directly contradicts the core answer to the second part of the multi-part question. While the LLM demonstrated good quantitative reasoning by providing detailed year-over-year comparisons and correct arithmetic for the total change, it failed on the critical synthesis task of identifying which category contributed most to the change. The answer is contextually relevant and addresses both parts of the question, but the incorrect identification of the primary contributor represents a major failure in the multi-hop synthesis requirement. The LLM appears to have confused or misidentified which investment category had the largest increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 327,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "Schwab's repurchase liabilities related to client-held fractional shares are valued at fair value using quoted market prices or observable market data consistent with the related client-held shares. The Company elects the fair value option under ASC 825 to match the measurement of these liabilities with the client-held fractional shares. Unrealized gains and losses on the fractional shares directly offset those on the repurchase liabilities, resulting in no income statement impact. Additionally, since these liabilities carry no credit risk, no gains or losses related to credit risk are recognized, further ensuring no effect on earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the valuation basis as quoted market prices or observable market data, matching the ground truth exactly. (2) Accurately describes the offset mechanism where unrealized gains/losses on repurchase liabilities offset those on client-held fractional shares, resulting in no income statement impact. (3) No quantitative errors - no numbers, dates, or calculations to verify. (4) Properly identifies Schwab as the company and correctly synthesizes the multi-hop relationship between valuation approach and income statement impact. (5) The semantic meaning aligns with ground truth despite different wording. MINOR ISSUES: (1) The LLM introduces additional context about ASC 825 (fair value option) and credit risk considerations that, while potentially accurate and relevant, are not explicitly mentioned in the ground truth answer. This represents elaboration beyond the ground truth rather than error. (2) The reference to 'no credit risk' and 'no gains or losses related to credit risk' adds detail not in the original answer - this could be correct but represents information not verified against the ground truth source. (3) The phrasing 'elects the fair value option under ASC 825' is more specific accounting terminology than the ground truth provides, which simply states the valuation basis. ASSESSMENT: The core answer is correct - the valuation basis (quoted market prices/observable market data) and the offset mechanism (unrealized gains/losses offsetting) are accurately conveyed. The additional ASC 825 reference and credit risk discussion appear to be reasonable elaborations but go beyond what the ground truth explicitly states. This is not an error per se, but represents information not confirmed by the ground truth. The answer would score higher if it stuck more closely to the verified ground truth without adding unverified elaborations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 533,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, was an increase of **$36 million**. This is calculated as the difference between the projected benefit obligation at the end of 2021 ($119 million) and the beginning of 2020 ($83 million), as disclosed in the plan's table on page 117. The annual expenses and deferred compensation liabilities mentioned in the document pertain to separate plans and are not directly used in this calculation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ERRORS: The LLM states the change was $36 million with ending balance of $119 million and beginning balance of $83 million. However, the ground truth clearly states the projected benefit obligation was $176 million at December 31, 2020, and $194 million at December 31, 2021, resulting in a $18 million increase. The LLM's numbers ($119M and $83M) are completely wrong and do not match the ground truth values. The calculation of $36M is also incorrect - even using the LLM's own stated figures ($119M - $83M = $36M), these base numbers are factually wrong. (2) ENTITY/METRIC CONFUSION: The LLM appears to have referenced wrong years or wrong plan data entirely. The ground truth specifically identifies December 31, 2020 ($176M) and December 31, 2021 ($194M) as the relevant dates and balances. The LLM's figures suggest it may have pulled data from a different plan or different time period. (3) MULTI-HOP REASONING: The question asks for the change based on disclosed annual expenses and deferred compensation liabilities. The LLM correctly notes these are separate but fails to identify the correct projected benefit obligation figures that should have been synthesized from the filing. (4) CALCULATION VERIFICATION: Ground truth change = $194M - $176M = $18M. LLM's stated change = $36M. This is a 100% error in the final answer. The LLM's internal calculation ($119M - $83M = $36M) is arithmetically correct but uses entirely wrong base figures. This represents a complete failure to locate and correctly identify the relevant financial data from Schwab's 10-K filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 454,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The combined revenue contribution of the Beauty segment (18%) and the Fabric & Home Care segment (36%) accounts for **54%** of Procter & Gamble's total net sales for the fiscal year. This is derived directly from the segment percentages provided in the document (Page 18).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the final combined percentage (54%) and properly addresses the core question. However, there is a discrepancy in the Beauty segment percentage cited. The LLM states the Beauty segment contributes 18%, while the question context mentions Pantene holds a 20% global market share in hair care (which is a product-level metric, not a segment-level metric). The ground truth answer confirms 54% is correct, suggesting the Beauty segment contribution should align with this calculation when added to the Fabric & Home Care segment's 36%. The LLM's identification of Beauty at 18% appears to be the correct segment-level figure (18% + 36% = 54%), which is mathematically sound. The answer properly synthesizes the multi-hop information: identifying two segments, their respective contributions, and calculating their combined percentage of total net sales. The reference to 'Page 18' adds credibility but cannot be independently verified. The reasoning is clear and logical. Minor weakness: the LLM could have been more explicit about distinguishing between Pantene's product-level market share (20%) and the Beauty segment's revenue contribution (18%), though this distinction may not be critical to answering the question. The final answer of 54% is correct and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 366,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companiesUTC, Carrier, and Otisand distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "The total income (loss) from discontinued operations attributable to common shareholders in 2020 related to Carrier and Otis was **$(410) million**, comprising **$187 million from Otis** and **$196 million from Carrier**, offset by **$793 million in separation-related costs** (e.g., transaction expenses, debt extinguishment, and adjustments for the separation event). This loss directly reflects the financial impact of the separation of UTC into independent entities, including Carrier and Otis, as described in the document.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the total loss of $(410) million and accurately breaks down the components from Otis ($187 million) and Carrier ($196 million). The answer also correctly references the April 3, 2020 separation event. However, there is a critical quantitative error: the LLM introduces $793 million in separation-related costs that are NOT part of the ground truth answer. The ground truth specifically states the total is $-410 million (which equals $187M + $196M = $383M, with a $27M discrepancy that may relate to other items, but NOT the $793M cited by the LLM). The LLM appears to have conflated or added separation costs that were not part of the original question's scope. The ground truth answer is straightforward: the total discontinued operations loss was $(410) million, composed of the two company components, directly tied to the separation event. The LLM's addition of the $793 million figure represents a significant factual error that inflates the understanding of the financial impact. The reasoning about the separation event connection is sound and contextually relevant, but the quantitative accuracy is compromised by the unexplained $793 million figure. The answer demonstrates partial understanding but introduces material information not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 367,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14, 2024, the Diabetes Pump Retainer Ring Litigation involves **107 individual plaintiffs** across 27 lawsuits. This litigation has the potential for thousands of additional claimants, as law firms have notified Medtronic of possible future lawsuits. In contrast, the hernia mesh-related lawsuits involve approximately **8,350 individual plaintiffs** as of May 15, 2024, with no explicit mention of potential future claimants in the document. Thus, while the hernia mesh litigation currently involves more plaintiffs, the Diabetes Pump case has significant potential for growth in future claims.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 107 individual plaintiffs in the Diabetes Pump Retainer Ring Litigation as of May 14, 2024, and accurately notes the potential for thousands of additional claimants. The answer also correctly identifies the hernia mesh litigation comparison. However, there are some issues: (1) The hernia mesh plaintiff count is stated as 'approximately 8,350' in the LLM answer, which appears to be a sum of the ground truth figures (6,700 + 500 + 1,150 = 8,350). While mathematically this sum is correct, the ground truth presents these as separate jurisdictional counts rather than a single combined total, and the LLM's presentation of '8,350 individual plaintiffs as of May 15, 2024' (note: different date than the question's May 14, 2024) could be misleading about how these cases are actually distributed. (2) The LLM correctly notes that both litigations involve Medtronic products and that no expense has been recorded due to uncertainty, though this detail is not explicitly stated in the LLM answer. (3) The multi-hop reasoning is sound - the answer synthesizes information about both litigation cases and makes a valid comparison. (4) The LLM adds the detail about '27 lawsuits' which is not mentioned in the ground truth, suggesting possible additional information from the source document. (5) The date discrepancy (May 15 vs May 14, 2024) for hernia mesh data is a minor issue. Overall, the core facts are correct, the comparison is valid, and the synthesis is appropriate, but the presentation of hernia mesh numbers as a single aggregate rather than separate jurisdictional counts represents a slight deviation from the ground truth's more nuanced presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 464,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement enables Schwab to maintain certain client deposits off-balance sheet, reducing immediate capital requirements and supporting flexibility in capital management. This off-balance sheet treatment helps Schwab manage its Tier 1 Leverage Ratio, which is targeted between 6.75%-7.00%, by avoiding the capital burden of fully incorporating client deposits. However, Schwab strategically migrates IDA balances to its balance sheet over time, which can impact capital levels and requires careful alignment with its internal capital policy to maintain the target range while meeting regulatory requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the Tier 1 Leverage Ratio target range of 6.75%-7.00% and the regulatory minimum of 4%. The core facts about off-balance sheet treatment of IDA deposits and capital management are accurate. However, there are notable differences in emphasis and completeness compared to the ground truth: (1) The LLM introduces the concept of 'strategic migration of IDA balances to balance sheet over time,' which is not mentioned in the original answer and may introduce unnecessary complexity or potential inaccuracy regarding Schwab's actual strategy. (2) The original answer emphasizes that off-balance sheet treatment 'helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth,' which is a more direct and clear statement of the strategic benefit. The LLM's phrasing about 'avoiding the capital burden' is semantically similar but less precise. (3) The LLM answer correctly identifies the multi-hop connection between IDA agreement, off-balance sheet treatment, and capital ratio management, but the introduction of balance sheet migration adds a claim not substantiated in the ground truth. (4) Both answers correctly identify that the off-balance sheet treatment supports capital management flexibility and helps maintain the target range. The quantitative elements are accurate, but the qualitative reasoning introduces an element (balance sheet migration strategy) that diverges from the ground truth without clear support.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 439,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "The total net cash inflow from RTX's disposition of the Forcepoint business in 2021 was **$1.9 billion**. This contributed to the **$4.7 billion decrease** in net cash provided by investing activities in 2021 compared to 2020. The 2021 net cash used in investing activities from continuing operations was **$(1,364) million**, versus **$3,343 million** in 2020. The Forcepoint sale (a disposition) added $1.9 billion to the 2021 figure, but the overall decline was driven by the absence of the Raytheon Merger's $3.2 billion cash inflow in 2020 and increased investments in businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR IN DIRECTIONAL INTERPRETATION: The LLM states there was a '$4.7 billion decrease in net cash provided by investing activities in 2021 compared to 2020,' but the ground truth clearly indicates this was a '$4.7 billion improvement' (increase). This is a fundamental directional error that reverses the meaning of the answer. The LLM correctly identifies the $1.9 billion Forcepoint disposition proceeds and the $3.2 billion Raytheon Merger cash inflow from 2020, but then misinterprets how these factors combined. The ground truth states the $4.7 billion improvement was 'primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions' - meaning 2021 had BETTER cash flow from investing activities than 2020. The LLM's statement that 'the overall decline was driven by the absence of the Raytheon Merger's $3.2 billion cash inflow' contradicts the ground truth's explanation that this absence was part of the improvement. Additionally, the LLM introduces specific numbers for 'net cash used in investing activities from continuing operations' ($(1,364) million vs $3,343 million) that are not mentioned in the ground truth and appear to be unsupported. The core facts ($1.9B Forcepoint, $3.2B Raytheon) are correct, but the synthesis and directional interpretation are fundamentally wrong, making this answer misleading despite containing some correct component numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 412,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle's reliance on third-party colocation suppliers for global data centers involves long-term lease commitments that carry significant contract termination fees, which could adversely impact profitability if early exits are required. Additionally, reliance on third-party infrastructure exposes Oracle to operational risks, such as service interruptions from disruptions beyond Oracle's control (e.g., natural disasters, geopolitical events), and potential cost overruns if data center capacity cannot be secured at affordable rates. These factors introduce financial risks related to both fixed costs from leases and potential revenue losses from operational disruptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core financial risks associated with Oracle's reliance on third-party colocation suppliers, including long-term lease commitments and significant contract termination fees. The answer accurately conveys that these arrangements create financial risk if Oracle needs to exit early. However, there are notable differences from the ground truth: (1) The LLM answer introduces additional operational risks (service interruptions, natural disasters, geopolitical events, cost overruns) that are not mentioned in the original answer. While these are plausible risks, they represent scope expansion beyond what the ground truth specifies. (2) The LLM answer does not mention the depreciation of leased assets over their estimated useful lives, which is explicitly noted in the ground truth as a factor that could impact profitability if Oracle's cloud strategy shifts. (3) The LLM answer does not explicitly state that 'substantially all' data centers are leased through third-party suppliers, though it does convey reliance on third-party infrastructure. Quantitatively, there are no numeric values in either answer to verify, so quantitative accuracy is perfect by default. The reasoning is sound and the answer addresses the main question about financial risk from lease commitments and termination fees. The semantic meaning largely aligns with the ground truth regarding the core financial risks, but the answer is somewhat broader in scope and omits the depreciation consideration. The answer is contextually relevant and well-reasoned, though it diverges from the specific focus areas identified in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 453,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "As of December 31, 2021, there were **82 million shares** available for future grants under the 2020 Stock Incentive Plan (64 million) and the 1993 Employee Stock Purchase Plan (18 million). This availability supports UnitedHealth Group's share-based compensation strategy by providing flexibility to attract and retain talent through diverse award types (e.g., stock options, restricted stock units), aligning employee interests with long-term shareholder value, and enabling strategic compensation adjustments to meet business objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 64 million shares under 2020 Stock Incentive Plan, 18 million under 1993 Employee Stock Purchase Plan, totaling 82 million shares as of December 31, 2021. The arithmetic is accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the specific share counts and total, and (2) how this supports the compensation strategy. ENTITY ACCURACY: All entities are correctly identified - UnitedHealth Group, the two specific plans with correct names and years, and the correct fiscal year (December 31, 2021). MULTI-HOP REASONING: The answer successfully synthesizes information across two different equity plans and connects the availability figures to strategic implications. SEMANTIC EQUIVALENCE: The explanation of how share availability supports compensation strategy is semantically equivalent to the ground truth, with slightly more detailed elaboration (mentioning RSUs specifically, strategic compensation adjustments, and business objectives). The LLM provides marginally more comprehensive strategic context than the ground truth while maintaining factual accuracy. Minor deduction (1 point) only because the LLM's strategic explanation, while accurate and relevant, goes slightly beyond what was explicitly stated in the ground truth, though this is actually a strength rather than a weakness in practical terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 405,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab accounts for client-held fractional shares and their corresponding repurchase liabilities at fair value, as disclosed in Note 2 and Note 18 of the 2022 10-K. These repurchase liabilities are reflected in **accrued expenses and other liabilities** on the consolidated balance sheet, as noted in the \"Other receivables from brokers, dealers, and clearing organizations\" section (page 97).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, which matches the ground truth. However, there are significant issues with completeness and accuracy: (1) The LLM answer mentions 'Other receivables from brokers, dealers, and clearing organizations' section on page 97, which appears to be an incorrect or misleading reference - this section does not directly relate to client-held fractional shares or their repurchase liabilities. (2) The ground truth specifies that client-held fractional shares are accounted for as part of 'other securities owned' on the consolidated balance sheets and are included in 'other assets,' with unrealized gains/losses recognized in earnings. The LLM answer completely omits this critical component about how the fractional shares themselves are recorded. (3) The LLM answer correctly cites Notes 2 and 18 as sources, which is appropriate for accounting policy disclosures. (4) The answer correctly identifies fair value accounting treatment for both the fractional shares and repurchase liabilities. (5) However, the answer fails to provide the complete accounting treatment - it addresses only the liability side (repurchase liabilities in accrued expenses) but omits the asset side (fractional shares in other securities owned/other assets). This is a significant omission for a question asking about the complete accounting treatment. The reference to page 97 and 'Other receivables from brokers' appears to be either a citation error or misidentification of the relevant disclosure section.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 448,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction by automating database operations, reducing labor costs, and offering consumption-based pricing (pay-only-for-resources-used). This, combined with OCI's scalable infrastructure and flexible deployment models (e.g., Cloud@Customer), allows customers to optimize expenses while maintaining performance. Strategically, this integration drives growth in Oracle's cloud and license business by accelerating customer adoption of cloud-native solutions, expanding OCI's ecosystem, and enhancing revenue streams through cloud services (which grew to 37% of total revenue in fiscal 2024). The synergy also strengthens Oracle's position in hybrid/multicloud markets, fostering long-term customer retention and innovation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly addresses the core question about how Oracle's Autonomous Database integration with OCI enables cost reduction and strategic growth. STRENGTHS: (1) Accurately identifies cost reduction mechanisms: automation of database operations, reduced labor costs, and consumption-based pricing model - all matching ground truth. (2) Correctly explains strategic growth drivers: customer migration to cloud, ecosystem expansion, and revenue growth through cloud services. (3) Good synthesis of multi-hop reasoning connecting technical capabilities to business outcomes. (4) Appropriately mentions hybrid/multicloud positioning and customer retention. WEAKNESSES: (1) QUANTITATIVE ISSUE: Cites '37% of total revenue in fiscal 2024' for cloud services - this specific metric is not present in the ground truth and cannot be verified. This is a factual claim that may be inaccurate or unsupported. (2) OMISSIONS: Missing specific technical details from ground truth: doesn't mention machine learning-driven diagnostics for reducing human error, doesn't explicitly reference Java Cloud and Oracle APEX as integration examples, doesn't specifically mention 'on-premise applications' migration context. (3) Introduces concepts not in ground truth (Cloud@Customer, hybrid/multicloud markets) which, while potentially accurate, go beyond the provided knowledge graph. The answer is directionally correct and demonstrates good understanding of the business logic, but the unverified revenue percentage claim and omission of specific technical/product details prevent a higher score. The reasoning is sound and the answer is contextually relevant, but quantitative accuracy is compromised by the unsupported statistic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 469,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would transfer cash equal to the fair value of the AARP Program's assets (classified as current assets) at the transfer date, as these assets fund medical costs payable, the rate stabilization fund (RSF) liabilities, and other obligations. This transfer would reduce the company's current assets and associated liabilities (including the RSF) related to the AARP Program, impacting liquidity and balance sheet positioning. The financial implication hinges on the fair value of the assets at transfer, with no guarantee of returns on the invested assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core financial implications of AARP Program contract transfer. STRENGTHS: (1) Correctly identifies that UnitedHealth would transfer cash equal to fair value of AARP Program assets at transfer date - this matches ground truth exactly; (2) Accurately notes these are classified as current assets - correct; (3) Properly identifies the reduction of both current assets and associated liabilities as the key impact; (4) Correctly emphasizes liquidity impact and balance sheet positioning; (5) No quantitative errors - no specific numbers were provided in either answer to verify. WEAKNESSES: (1) The LLM introduces 'rate stabilization fund (RSF) liabilities' which is not mentioned in the ground truth answer. While this may be accurate from the filing, it represents additional detail not in the original answer, creating slight divergence; (2) The phrase 'with no guarantee of returns on the invested assets' appears in the LLM answer but not in ground truth - this is somewhat tangential to the core financial implication question and adds interpretation not explicitly in the original answer; (3) Minor semantic difference: ground truth emphasizes 'direct reduction' while LLM uses 'reduce' - both convey same meaning but ground truth is more precise. MULTI-HOP REASONING: Both answers correctly synthesize the relationship between asset classification, liability management, and liquidity impact. The LLM demonstrates sound reasoning by connecting asset transfer to balance sheet effects. ENTITY ACCURACY: Both correctly identify UnitedHealth Group and AARP Program. OVERALL: The answer is substantially correct with the core financial implications properly identified. The introduction of RSF details and the note about investment returns represent minor deviations from ground truth but don't fundamentally undermine the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 513,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The provided document pages do not contain specific information about the fair value of \"Card Member and Other Loans\" or their comparison to carrying value under the Level 3 fair value hierarchy classification. The content focuses on derivatives, hedging activities, legal proceedings, and financial commitments, but no direct data on loan fair value measurements is disclosed.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the question. The ground truth provides specific, verifiable financial data: fair value of $113 billion, carrying value of $110 billion, and Level 3 fair value hierarchy classification. The LLM claims the document pages do not contain this information and states it cannot find the data. This is a complete failure to retrieve or synthesize the required information. The LLM provides no numbers, no comparison between fair value and carrying value, and no discussion of Level 3 classification. All three quantitative values from the ground truth ($113B fair value, $110B carrying value, and the Level 3 classification) are absent from the LLM response. The answer demonstrates either a failure to access the correct source documents or a fundamental inability to locate and extract the relevant fair value disclosure information that should be present in SEC 10-K filings (typically in the fair value measurements note). The LLM's claim that the document focuses on 'derivatives, hedging activities, legal proceedings, and financial commitments' suggests it may have been provided with incorrect or incomplete document pages. This represents a critical failure in multi-hop reasoning and information retrieval for a straightforward factual question about disclosed financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 375,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31, 2021, **64 million shares** were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares may become the subject of future awards in the form of **stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The number of shares (64 million) is correct and matches the ground truth exactly. The date (December 31, 2021) is accurate. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it specifies the number of shares available and comprehensively lists all types of awards these shares can become the subject of. (3) ENTITY ACCURACY: The company (UnitedHealth Group), the specific plan name (2020 Stock Incentive Plan), and the fiscal year (2021) are all correctly identified. (4) AWARD TYPES: All six award types are listed correctly and in the same order as the ground truth: stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth (\"may become\" vs \"can become\"), but this is a minor stylistic variation that does not affect the factual accuracy or meaning. The answer is semantically equivalent to the ground truth. No calculations are required for this question, and all factual information is presented accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 335,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "The total estimated fair value of foreign government bonds and obligations held by the company in 2023 was **$770 million**, compared to **$632 million** in 2022. This represents an increase of **$138 million** from 2022 to 2023. The data is derived from the \"Available-for-Sale Debt Securities\" table in Note 4 of the 2023 and 2022 10-K filings, which lists the estimated fair value for this category. The question's reference to \"maturities of 12 months or more\" appears to pertain to the entire category, as the provided tables do not separately break down fair value by maturity for this specific asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 comparison figure. The ground truth states the 2022 fair value was $549 million, but the LLM reports $632 million - a discrepancy of $83 million. This is a major error that cascades into the calculated difference. The LLM correctly identifies the 2023 figure as $770 million, but the 2022 comparison is fundamentally wrong. CALCULATION ERROR: Based on the LLM's own numbers ($770M - $632M = $138M), the arithmetic is correct, but since the $632M figure is incorrect, the resulting $138M increase is also wrong. The correct increase should be $221 million ($770M - $549M). MULTI-HOP REASONING: The LLM attempts to address the maturity specification ('12 months or more') by noting that the tables don't separately break down by maturity, which shows some reasoning effort. However, the ground truth answer directly provides the 2022 figure for this maturity category as $549 million, suggesting the data was available and the LLM failed to locate or correctly report it. COMPLETENESS: The LLM addresses both the 2023 and 2022 figures and calculates the difference, meeting the structural requirements of the question. However, the incorrect 2022 figure undermines the entire answer. The LLM's citation of Note 4 and the Available-for-Sale Debt Securities table is reasonable but doesn't excuse the numerical inaccuracy. SEMANTIC EQUIVALENCE: While the LLM's explanation of methodology is reasonable, the factual errors are too significant to overlook. This is not a wording issue but a fundamental data accuracy problem.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 444,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The total capital expenditure in the Africa/Eurasia region in 2021 was **$33 million**, compared to **$8 million** in 2019, representing a significant increase of **312.5%**. This growth reflects expanded investment in the region during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key facts are correct: (1) 2021 capital expenditure of $33 million is accurate, (2) 2019 capital expenditure of $8 million is accurate, (3) the calculated increase of $25 million is correct ($33M - $8M = $25M), and (4) the percentage increase calculation is accurate (($25M / $8M)  100 = 312.5%). The answer successfully synthesizes multi-hop information by comparing the same metric across two different years in the same region. The LLM correctly identified all entities (Africa/Eurasia region, capital expenditure metric, years 2021 and 2019) and provided both the absolute dollar difference and percentage change, which adds analytical value beyond the ground truth answer. The wording is clear and professional. The only minor distinction is that the LLM provided an additional percentage calculation not explicitly mentioned in the ground truth, but this represents added analytical insight rather than an error, and the percentage is mathematically correct. All quantitative values match the ground truth exactly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 309,
        "total_tokens": 1418
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment increased by **14.9%** from 2020 to 2021, while the broader Vision segment grew by **19.6%** during the same period. The Contact Lenses/Other segment's growth rate was slightly lower than the overall Vision segment's growth. \n\n**Source**: Page 33 of JNJ_10k_2022.pdf details Vision franchise sales, with Contact Lenses/Other showing a 14.9% increase and the Vision segment overall rising 19.6%.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The Contact Lenses/Other growth rate of 14.9% is correct, the Vision segment overall growth rate of 19.6% is correct, and the time period (2020 to 2021) is accurate. (2) QUANTITATIVE ACCURACY: Both percentage figures are precisely correct with no calculation errors. The comparison logic is sound - 14.9% is indeed lower than 19.6%, correctly identifying underperformance. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is excellent. The answer correctly synthesizes information about two related metrics (Contact Lenses/Other and broader Vision segment) and properly compares them to answer the comparative performance question. The characterization of Contact Lenses/Other as 'slightly lower' is appropriate given the 4.7 percentage point difference. (4) ENTITY ACCURACY: Johnson & Johnson is correctly identified, the Vision segment is properly specified, and the Contact Lenses/Other category is accurately referenced. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth but conveys identical meaning - both state the same percentages and reach the same conclusion about relative underperformance. The inclusion of a source citation (Page 33 of JNJ_10k_2022.pdf) adds credibility, though this wasn't in the ground truth. Minor deduction of 1 point only because the source citation, while helpful, wasn't verified as part of the ground truth evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 418,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "The total weighted-average grant price for Service and Performance-Based RSUs outstanding as of December 31, 2021, was **$114.22**, as shown in the \"Outstanding as of December 31, 2021\" row for Service and Performance-Based RSUs in the stock plan activity table (page 130). This figure accounts for both the beginning balance and new grants during the year, adjusted for forfeitures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a partially correct response with significant issues in addressing the full scope of the question. CORRECT ELEMENTS: (1) The $114.22 figure is correctly identified as the weighted-average grant price for outstanding RSUs as of December 31, 2021. (2) The reference to page 130 and the stock plan activity table is appropriate. (3) The mention of forfeitures is contextually relevant. CRITICAL ISSUES: (1) The question explicitly asks for 'total weighted-average grant price...considering both the beginning balance and new grants during the year,' which requires synthesizing multiple data points. The ground truth answer specifies TWO key figures: $114.22 million (outstanding as of Dec 31, 2021) AND $125.02 million (new grants during the year). The LLM answer only provides the $114.22 figure and fails to mention the $125.02 million for new grants. (2) The LLM states the figure 'accounts for both the beginning balance and new grants during the year,' but this is misleading - the $114.22 is the RESULT of combining these elements, not a separate accounting of them. The question asks to 'consider' both components, implying both should be presented. (3) The LLM answer lacks the complete quantitative picture by omitting the $125.02 million new grant price. (4) The answer provides $114.22 without the 'million' unit, though this is a minor formatting issue. MULTI-HOP REASONING: The question requires synthesizing information about beginning balances, new grants, and the resulting outstanding balance. The LLM only addresses the final outstanding balance, not the complete synthesis requested. The ground truth answer demonstrates proper multi-hop reasoning by including both the outstanding total and the new grants component.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 478,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decreased by **$3,976 million** from 2023 ($10,135 million) to 2024 ($6,159 million). This tranche represented **11.44%** of the company's total debt of $53,864 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is nearly perfect with only a minor rounding difference. Verification of key facts: (1) Decrease amount: $10,135M - $6,159M = $3,976M  Correct. (2) 2023 balance: $10,135M  Correct. (3) 2024 balance: $6,159M  Correct. (4) Total debt 2024: $53,864M  Correct. (5) Percentage calculation: $6,159M / $53,864M = 0.11437 = 11.437%  11.44% (LLM) vs 11.43% (Ground Truth). The LLM rounded to 11.44% while ground truth shows 11.43%. This is a negligible rounding difference (0.01 percentage point) that falls within acceptable tolerance for percentage reporting. The LLM correctly synthesized multi-hop information: identified the specific bond tranche, tracked the balance across two years, calculated the decrease, and computed the percentage of total debt. All entities (Boeing, bond characteristics, years) are correctly identified. The answer is complete, addressing both parts of the question (decrease amount and percentage of total debt). The presentation is clear and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 290,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "The combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021 was $2,810 million (sum of $1,485 million for Hips and $1,325 million for Knees). This represented approximately 32.7% of the total Orthopaedics segment revenue of $8,588 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses the multi-part question. (1) QUANTITATIVE VERIFICATION: All numbers are correct - Knees revenue of $1,325 million, Hips revenue of $1,485 million, combined total of $2,810 million, total Orthopaedics revenue of $8,588 million, and the calculated percentage of 32.7%. The calculation is accurate: $2,810M / $8,588M = 0.3271 = 32.7%. (2) COMPLETENESS: The answer addresses both parts of the question - providing the combined revenue amount and the percentage representation. (3) ENTITY ACCURACY: All entities are correctly identified - Johnson & Johnson, Orthopaedics segment, Knees and Hips product categories, and 2021 fiscal year. (4) REASONING: The multi-hop synthesis is sound, correctly combining data from two product lines (Knees and Hips) within the Orthopaedics segment and properly calculating the percentage relative to total segment revenue. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, with only minor wording variations (listing Hips before Knees in the sum, using 'approximately' before the percentage). These variations are stylistic and do not affect factual accuracy. The answer demonstrates proper understanding of the multi-hop requirement to synthesize information across product categories and calculate relative percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 377,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for Boeing's 2024 10-K fiscal years (20222024) is **25.8 million**. These shares were excluded because their inclusion would have been **antidilutive** due to either: (1) unmet performance conditions (e.g., restricted stock units and stock options) or (2) the company incurring a net loss in those periods, which would reduce earnings per share.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR - QUANTITATIVE MISMATCH: The LLM states 25.8 million shares were excluded, but the ground truth specifies 20.8 million shares. This is a significant numerical discrepancy of 5 million shares (24% error), which is unacceptable for a factual financial metric. The LLM's number is demonstrably incorrect. QUALITATIVE ASSESSMENT: The LLM correctly identifies that shares were excluded because they would be antidilutive due to net losses, which aligns with the ground truth reasoning. The explanation about unmet performance conditions is reasonable context but goes beyond what the ground truth specifies. The fiscal year period (2022-2024) is correctly identified. MULTI-HOP REASONING: The LLM appropriately synthesizes the concept that antidilutive shares are excluded during loss periods, showing sound understanding of diluted EPS mechanics. However, this correct reasoning cannot compensate for the fundamental numerical error. VERDICT: While the qualitative explanation of WHY shares were excluded is largely sound, the core quantitative answer (the total number of shares) is materially incorrect. This is a primary metric that must be accurate. The 5 million share discrepancy represents a substantial factual error that significantly undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 361,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation (PBO) as of January 3, 2021, by approximately **$1.8 billion**. This change affects pension benefits for U.S. non-union employees hired before 2015 by **not altering their accrued benefits** under the Final Average Pay formula for service prior to January 1, 2026, while future benefits for all employees (regardless of hire date) will be calculated under the new Retirement Value formula starting January 1, 2026.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The quantitative figure of $1.8 billion reduction in PBO is correct and matches ground truth exactly. (2) The date reference (January 3, 2021) is accurate. (3) The identification of U.S. non-union employees hired before 2015 as the affected group is correct. (4) Number formatting is appropriate.\n\nWEAKNESSES: (1) CRITICAL SEMANTIC DIFFERENCE: The LLM states the change affects 'future benefits for all employees (regardless of hire date)' starting January 1, 2026, which contradicts the ground truth. The ground truth specifically indicates the transition applies to 'U.S. non-union employees hired before 2015' - not all employees regardless of hire date. This is a material mischaracterization of the scope of the amendment. (2) The LLM's phrasing 'not altering their accrued benefits' is technically accurate but less precise than the ground truth's explicit statement that the Final Average Pay formula is 'preserved' for service before January 1, 2026. (3) The LLM answer suggests the Retirement Value formula applies to 'all employees' starting 2026, whereas the ground truth specifically limits this to the identified employee group (non-union, hired before 2015). This represents a failure in multi-hop synthesis - the answer correctly identifies one affected group but then generalizes the impact incorrectly.\n\nMULTI-HOP REASONING: The answer demonstrates partial synthesis but contains a logical error in scope. It correctly connects the PBO reduction amount to the formula change, but incorrectly generalizes the applicability of the new formula to all employees rather than maintaining the specificity of the affected group.\n\nOVERALL ASSESSMENT: While the quantitative core ($1.8 billion) is correct, the qualitative description of how the change affects pension benefit calculations contains a material error regarding the scope of applicability. This is a significant issue for a multi-hop question requiring precise synthesis of amendment details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 535,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The filing states that the fair value of American Express cannot be estimated by aggregating financial assets and liabilities carried at amortized cost because these figures represent individual estimates based on market conditions and management judgment, not a comprehensive valuation of the company. Aggregating them ignores interdependencies between assets and liabilities, structural complexities, and qualitative factors (e.g., risk profiles, synergies) that influence the companys overall fair value. Additionally, some items are measured using non-additive methods (e.g., discounted cash flow models for loans), making simple summation inaccurate.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question and provides relevant reasoning about why fair value cannot be estimated by aggregation. STRENGTHS: (1) Correctly identifies that individual estimates are based on market conditions and management judgment; (2) Accurately notes that aggregation ignores interdependencies and structural complexities; (3) Correctly identifies that non-financial factors matter; (4) No quantitative errors or incorrect dates/numbers; (5) Properly synthesizes the multi-hop concept that individual fair values  company-wide fair value. WEAKNESSES: (1) The LLM introduces additional technical details about 'non-additive methods' and 'discounted cash flow models' that are not explicitly mentioned in the ground truth answer, which could be speculative beyond what the filing states; (2) The ground truth emphasizes that estimates 'are not indicative of future fair values' - a temporal/forward-looking aspect that the LLM answer doesn't explicitly capture; (3) The LLM's explanation of 'interdependencies between assets and liabilities' and 'synergies' goes beyond the ground truth's focus on 'non-financial factors and complexities of the business as a whole.' ASSESSMENT: The LLM answer is fundamentally correct and addresses why aggregation doesn't work, but it adds interpretive layers not directly supported by the ground truth. The core semantic meaning aligns well - both answers explain that individual fair values cannot be summed to get company fair value due to broader business complexities. The answer is strong on the main point but slightly over-elaborates with technical details not confirmed in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 453,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The Benefits Plan for Members of the Board of Directors has **one amendment** explicitly listed in the exhibit index (Amendment Number One, dated December 16, 2005). The original plan was effective **April 14, 2004**, as stated in the exhibit description.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer states there is 'one amendment' explicitly listed, but the ground truth clearly indicates there are 'two explicitly listed amendments.' This is a fundamental factual error that directly contradicts the core question being asked. The LLM correctly identified the effective dates (April 14, 2004 for the original plan and December 16, 2005 for the first amendment), which are accurate. However, the primary quantitative answer to the main question - the NUMBER of amendments - is incorrect. The LLM appears to have only counted Amendment Number One and missed identifying a second amendment in the exhibit index. This represents a failure in completeness and multi-hop synthesis, as the question explicitly asks for amendments 'explicitly listed in the exhibit index,' requiring careful review of all listed items. The dates provided are correct (quantitative accuracy partially preserved), but the amendment count is wrong, which is the primary metric being asked for. The reasoning quality is poor because the LLM did not comprehensively review all amendments listed in the exhibit index.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 318,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based solutions, enabled customers to adopt Oracle's cloud services flexibly, driving growth in the cloud and license business. This model allowed customers to migrate existing workloads to the cloud gradually, increasing demand for cloud licenses and support contracts. The hybrid approach also facilitated recurring revenue streams through subscription-based cloud services, which are recognized ratably over time, contributing to the cloud and license business representing 84% of total revenues in fiscal 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with accurate quantitative information and sound reasoning. STRENGTHS: (1) The 84% figure for cloud and license business in fiscal 2024 is correct and properly cited. (2) The hybrid deployment model description (on-premise and cloud-based) is accurate. (3) The explanation of recurring revenue streams through subscription-based services is correct. (4) The multi-hop synthesis connecting the hybrid model to the 84% revenue contribution is logically sound. WEAKNESSES: (1) The LLM answer emphasizes gradual migration and workload movement, which is a reasonable inference but not explicitly stated in the ground truth. (2) The ground truth emphasizes customer retention, satisfaction, and high renewal rates of license support contracts as key mechanisms - the LLM answer mentions support contracts but doesn't emphasize the renewal rate aspect as strongly. (3) The ground truth specifically notes that support contracts are 'priced as a percentage of the net fees paid by customers' - a specific pricing mechanism the LLM answer doesn't mention. (4) The ground truth frames the hybrid model as providing 'flexibility and choice' which directly enhances 'customer retention and satisfaction' - the LLM answer focuses more on enabling gradual migration rather than retention/satisfaction benefits. CALCULATION VERIFICATION: No calculations required; the 84% figure is correctly stated. ENTITY ACCURACY: Oracle, fiscal 2024, cloud and license business - all correct. REASONING: The LLM provides valid reasoning about how hybrid deployment drives cloud adoption and recurring revenue, though it takes a slightly different angle (migration pathway) than the ground truth (customer retention through flexibility). Both are logically sound explanations of the same phenomenon.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 491,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "American Express's deferred card and other fees, net of $2,516 million as of December 31, 2021, specifically include fees tied to Membership Rewards program participants, as noted in the document. The methodology for estimating the future redemption liability for these points relies on the Ultimate Redemption Rate (URR) and weighted average cost (WAC) per point, derived from redemption trends, card product types, and other factors, as detailed in the Membership Rewards section.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM cites $2,516 million as the deferred card and other fees net of December 31, 2021, but the ground truth specifies $8,737 million as the total deferred card and other fees. This is a major factual error - the LLM appears to have cited a different metric (possibly net of something) rather than the correct gross figure. This is a significant numerical discrepancy that undermines the answer's credibility. (2) INCOMPLETE SPECIFICITY - The ground truth explicitly states the deferred fees are 'specifically called out in the $8,737 million total' - indicating this is the precise figure that should be cited. The LLM failed to identify and cite this correct amount. (3) METHODOLOGY ACCURACY - The LLM correctly identifies the methodology components (URR, WAC per point, redemption trends, card product type, credit attributes), which aligns with the ground truth. This portion is accurate. (4) MULTI-HOP REASONING - The LLM does attempt to connect the deferred fees to the redemption liability methodology, showing understanding of the relationship, but the foundational number is wrong, which undermines the entire synthesis. (5) SEMANTIC ISSUES - The phrase 'deferred card and other fees, net of $2,516 million' is confusing and appears to misrepresent the data structure. The ground truth clearly indicates $8,737 million is the relevant figure for deferred card and other fees tied to Membership Rewards. The core answer fails on the primary quantitative requirement - getting the correct dollar amount - which is essential for a financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 440,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "The Coca-Cola Company 2014 Equity Plan had **five distinct forms of award agreements** documented between February 18, 2015, and February 17, 2021, as listed in the 2024 10-K report:  \n1. **Performance Share Agreement** (adopted in 2019, 2020, and 2021).  \n2. **Performance Share (Emerging Stronger) Agreement** (adopted in 2021).  \n3. **Stock Option Agreement** (adopted in 2015, 2016, 2017, 2018, 2019, 2020, and 2021).  \n4. **Restricted Stock Unit Agreement** (adopted in 2015, 2016, 2017, 2018, 2019, 2020, and 2021).  \n5. **Restricted Stock Unit Retention Award** (adopted in 2017).  \n\nThese forms reflect variations in award types and terms under the plan during the specified period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer states there were 5 different forms of award agreements, but the ground truth clearly indicates 16 different forms. This is a fundamental factual error on the primary quantitative metric being asked. The LLM's count is off by a factor of more than 3x (5 vs 16). While the LLM correctly identifies some types of award agreements that likely exist under the plan (Performance Share Agreement, Stock Option Agreement, Restricted Stock Unit Agreement), it appears to have significantly undercounted the total number of distinct forms documented during the specified period (February 18, 2015 to February 17, 2021). The LLM's approach of listing award types with their adoption years shows some understanding of the structure, but this enumeration is incomplete and arrives at the wrong total. The question specifically asks for the count of 'different forms of award agreements' documented in the 2024 10-K filing, and the LLM failed to provide the correct answer of 16. The reasoning provided is logical in structure but based on incomplete data extraction from the source material. This is a multi-hop question requiring synthesis of information from SEC filings, and the LLM failed at the synthesis stage by not capturing all documented forms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 357,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "AMD's total financial relationship with the ATMP JV in 2021 included $1.1 billion in purchases from the JV and a $6 million equity gain from its 15% investment. These figures highlight the strategic importance of the joint venture, as the significant procurement volume ($1.1B) underscores AMD's reliance on the JV for critical manufacturing services, while the equity gain reflects the JV's profitability and AMD's financial stake in its success.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. All key numbers are accurate: $1.1 billion in purchases, $6 million equity gain, and 15% equity stake are all correctly stated. The total financial value calculation ($1.1B + $6M = $1.106B) is implicit in the LLM answer, though not explicitly stated as a single combined figure like the ground truth does. The LLM correctly identifies the strategic importance through the lens of manufacturing services reliance and equity stake profitability. However, there is one minor omission: the ground truth explicitly states the total as $1.106 billion and notes that the 15% stake gives AMD 'significant influence without the obligation to fund further investments,' which provides additional strategic context about the nature of the relationship. The LLM captures the essence of strategic importance but doesn't explicitly articulate the total combined value or the specific governance/investment obligation aspect. The multi-hop reasoning is sound - the answer correctly synthesizes purchases, equity gains, and equity stake percentage into a coherent narrative about strategic importance. The wording differs from ground truth but conveys equivalent meaning regarding AMD's reliance on ATMP services and the profitability reflection. No calculation errors are present, and all entities (AMD, ATMP JV, 2021, 15% stake) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 392,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "The earliest year patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is **2029**. This is based on the U.S. patent expiration date for DARZALEX (2029) and the separate Janssen-owned patent portfolio for DARZALEX FASPRO, which likely extends beyond 2029. The U.S. market, being a significant revenue driver, would see the first impact as patents expire in 2029, leading to potential generic competition and reduced sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies 2029 as the earliest year patent expiration could materially impact the combined revenue stream, which matches the ground truth answer. All key facts are accurate: (1) DARZALEX U.S. patent expiration in 2029 is correctly cited as the determining factor, (2) the reference to DARZALEX FASPRO's separate Janssen-owned portfolio is appropriately noted, (3) the explanation that the U.S. market is a significant revenue driver is contextually sound. The reasoning is logically sound - the model correctly synthesizes that while DARZALEX FASPRO has separate patent protection and European patents extend to 2032, the U.S. patent expiration in 2029 for DARZALEX represents the earliest material impact point. The answer appropriately mentions potential biosimilar competition as the mechanism for revenue impact. Minor differences from ground truth: the LLM answer adds slightly more detail about generic/biosimilar competition mechanisms, which enhances rather than detracts from the answer. The answer is complete, addresses the multi-hop nature of the question (combining patent dates, revenue significance, and market dynamics), and maintains semantic equivalence with the ground truth while providing additional supporting context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 355,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in 2015 and 2018 in the 2022 10-K filing is **2**. These include:  \n1. An amendment effective **June 30, 2015** (Exhibit 10.31 on Page 19).  \n2. An amendment effective **November 1, 2018** (Exhibit 10.37 on Page 20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key elements: (1) Total count of 2 amendments is correct and matches ground truth exactly. (2) Quantitative accuracy is perfect - both dates are correct (June 30, 2015 and November 1, 2018), and the total of 2 amendments is accurate. (3) Entity identification is correct - properly identifies The Bank of New York Company, Inc. Excess Benefit Plan and correctly references the 2022 10-K filing. (4) Multi-hop reasoning is sound - the answer correctly synthesizes information about amendments from two different years (2015 and 2018) as documented in a single filing (2022 10-K). (5) The LLM answer goes slightly beyond the ground truth by providing exhibit references (Exhibit 10.31 on Page 19 and Exhibit 10.37 on Page 20), which adds helpful context without introducing any inaccuracies. The semantic meaning is identical to the ground truth - both convey that there are exactly 2 amendments with the same effective dates. The answer is well-organized with clear enumeration of the amendments, making it easy to verify the information. No calculation errors or factual discrepancies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 330,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx's Network 2.0 optimization expenditures (e.g., $582 million in 2024) and European workforce reduction costs (e.g., $278 million in 2022 and a new $250$375 million plan announced in 2024) are integral to the company's DRIVE transformation program, which aims to enhance long-term profitability through efficiency gains and cost restructuring. These costs are distinct from the 2025 capital expenditure plan, which includes $5.2 billion for Network 2.0 modernization, facility upgrades, and aircraft investments. While workforce reductions focus on operational cost optimization, Network 2.0 expenditures directly align with the capital plan to streamline logistics networks and improve operational efficiency. Both initiatives support the broader DRIVE strategy but are managed separately under the company's financial framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative issues. STRENGTHS: (1) Correctly identifies the $5.2 billion 2025 capital expenditure plan; (2) Accurately references the $250-$375 million European workforce reduction cost range through fiscal 2026; (3) Properly connects both initiatives to the DRIVE transformation program; (4) Correctly distinguishes between capital expenditures and business optimization expenses; (5) Appropriately synthesizes the multi-hop relationship between Network 2.0, workforce reductions, and DRIVE strategy. CRITICAL ERRORS: (1) Introduces unsupported specific numbers ($582 million in 2024 for Network 2.0, $278 million in 2022) that are not mentioned in the ground truth and cannot be verified; (2) These invented figures create false precision and contradict the ground truth's more general statement about 'a portion allocated to Network 2.0 optimization'; (3) The reference to 'a new $250$375 million plan announced in 2024' is problematic - the ground truth indicates this is the expected range through fiscal 2026, not necessarily a new announcement in 2024. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that Network 2.0 and workforce reductions are separate but complementary components of DRIVE, and properly explains their distinct roles (capital investment vs. operational cost reduction). However, the introduction of unverified numbers significantly undermines credibility. The answer correctly addresses all parts of the question but does so with fabricated specificity that violates factual accuracy requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 445,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD's reliance on third-party suppliers and AIB partners introduces financial risks in inventory management and price protection. Inventory held by distributors and AIB partners is protected against price reductions, but significant price declines could force AMD to offer price protection, reducing revenue and gross margins. Additionally, supply chain dependencies and potential disruptions (e.g., supplier discontinuation, gray market activities) risk excess/obsolete inventory, leading to write-downs and margin compression. These factors heighten exposure to demand forecasting errors and inventory obsolescence.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's financial risks related to supplier and AIB partner dependencies, with mostly accurate core concepts. STRENGTHS: (1) Correctly identifies price protection obligations as a key financial risk that can reduce revenue and gross margins - this matches the ground truth. (2) Accurately mentions the 12-month return window concept (implied in 'products removed from the price book within 12 months'). (3) Properly synthesizes the multi-hop relationship between supplier dependency, inventory management, and financial risk exposure. (4) Appropriately addresses both inventory management and price protection aspects of the question. WEAKNESSES: (1) The LLM answer introduces additional concepts (supply chain disruptions, gray market activities, demand forecasting errors, inventory obsolescence) that, while potentially relevant to AMD's risk profile, are not explicitly mentioned in the ground truth answer. This represents some scope creep beyond what was documented. (2) The answer is somewhat more speculative about 'potential disruptions' rather than focusing on the documented price protection obligations that are the primary financial risk mechanism. (3) Missing explicit mention that price protection is specifically triggered by 'significant decline in product prices' - the LLM generalizes this somewhat. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Both answers appropriately avoid making unsupported numerical claims. MULTI-HOP REASONING: The LLM correctly synthesizes information across the supplier dependency  inventory held by partners  price protection obligations  financial impact chain. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns well - AMD's reliance on third parties creates financial risk through price protection obligations that can materially impact margins. The LLM's additional discussion of inventory obsolescence and supply chain risks, while not contradicting the ground truth, represents a broader interpretation than the focused answer provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 583,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie's total cost of products sold related to Venclexta in 2023 was **$869 million**, as disclosed in the table on page 69. This amount includes Genentech's share of U.S. profits (shared equally) and royalties paid on net revenues outside the U.S., both of which are included in AbbVie's cost of products sold under the collaboration agreement with Genentech.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides a specific dollar amount ($869 million) that cannot be verified against the ground truth provided. The ground truth explicitly states that AbbVie's total cost of products sold related to Venclexta includes both Genentech's 50% share of U.S. profits and royalties paid on net revenues outside the U.S., but does NOT provide a specific total dollar figure. The LLM appears to have fabricated or hallucinated the $869 million number and the reference to 'page 69' without evidence from the ground truth. While the LLM correctly identifies the two components (Genentech's U.S. profit share and international royalties) and accurately describes them as being included in cost of products sold, the introduction of an unverified specific number is a critical error. The reasoning about the collaboration agreement structure is sound and semantically aligned with the ground truth, but the quantitative claim is unsupported and likely incorrect. The answer demonstrates partial understanding of the question's multi-hop nature (combining U.S. profits and international royalties) but fails on the fundamental requirement of providing accurate financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 332,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "BNY makes its **Directors' Code of Conduct** publicly available, which is explicitly applicable to **all directors of BNY**. This document, along with Committee Charters and Corporate Governance Guidelines, is listed in the \"Available Information\" section of the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and complete. It correctly identifies the specific governance document (Directors' Code of Conduct) that BNY makes publicly available in addition to Committee Charters and Corporate Governance Guidelines. The answer accurately states that this document is explicitly applicable to all directors of BNY, which matches the ground truth exactly. The LLM also provides helpful additional context by noting that these documents are listed in the 'Available Information' section of the 10-K filing, which adds relevant detail without contradicting or detracting from the core answer. All entities are correctly identified (BNY, Directors' Code of Conduct, Committee Charters, Corporate Governance Guidelines), and the multi-hop reasoning is sound - the model correctly synthesized the relationship between the governance documents and their applicability. There are no numeric values, calculations, or dates to verify in this question, so quantitative accuracy is not a limiting factor. The answer fully addresses both parts of the multi-part question: (1) what specific governance document is made publicly available, and (2) who it is explicitly applicable to.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 338,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "The launch of the AMD Radeon RX 6600 XT and AMD's broader gaming-focused graphics strategy, including the Radeon RX 6000M Series and AMD Advantage Design Framework, drove strong demand for high-performance gaming solutions in 2021. These products, designed for high-frame-rate 1080p gaming and integrated with Ryzen processors, contributed to the 68% year-over-year revenue growth by capturing market share in the gaming segment. The gross margin improvement of 3 percentage points was supported by strong customer demand, strategic supply chain investments (e.g., wafer agreements), and efficient cost management, as highlighted in the MD&A and supply chain discussions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key products (Radeon RX 6600 XT, RX 6000M Series, AMD Advantage Design Framework) and accurately states the 68% revenue growth and 3 percentage-point gross margin improvement. However, there are notable gaps and issues: (1) The LLM does not provide the specific revenue figures ($9.8B to $16.4B) or gross margin percentages (45% to 48%) that are present in the ground truth, which are important quantitative details for a financial question. (2) The LLM mentions 'strategic supply chain investments (e.g., wafer agreements)' and 'efficient cost management' as drivers of margin improvement, but the ground truth specifically attributes the margin improvement to 'scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains.' The LLM's explanation is less precise about the actual mechanism. (3) The LLM mentions 'integrated with Ryzen processors' which is not mentioned in the ground truth and may introduce unnecessary detail. (4) The multi-hop reasoning is sound - the LLM correctly synthesizes that the gaming products contributed to revenue growth and margin improvement. (5) The core narrative is correct: gaming-focused graphics strategy drove demand and financial improvements. The answer is substantially correct but lacks the specific financial metrics and more precise causal mechanisms that the ground truth provides. For a financial question, the absence of specific dollar amounts and percentages is a meaningful omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 423,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's net revenue from Venclexta in 2023 was **$2,288 million** (comprising $1,087 million in the U.S. and $1,201 million internationally, as shown in the net revenue table on page 96). Under the collaboration agreement with Genentech, Genentech received **$869 million** of the pre-tax profit from U.S. Venclexta sales in 2023, representing their 50% share of the U.S. profits, as detailed in the profit-sharing table on page 69.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. (1) CORRECT ELEMENTS: The total Venclexta net revenue of $2,288 million for 2023 is accurate. The breakdown into U.S. ($1,087 million) and international ($1,201 million) components is also correct. The identification of the 50% profit-sharing arrangement with Genentech is correct. (2) CRITICAL ERRORS: The LLM claims Genentech received $869 million as their 50% share of U.S. pre-tax profit. This is problematic because: (a) The ground truth states that Genentech receives 50% of U.S. pre-tax profit, but does NOT provide a specific dollar amount for this figure. The LLM has fabricated a specific number ($869 million) that cannot be verified from the ground truth. (b) The LLM cites 'page 69' for a 'profit-sharing table' that is not mentioned in the ground truth, suggesting the LLM may have hallucinated this source. (c) The ground truth explicitly states the profit-sharing arrangement is 'included in AbbVie's cost of products sold,' indicating this is an accounting treatment, not a direct payment amount that would be separately quantified. (3) MULTI-HOP REASONING: While the LLM correctly identifies the relationship between AbbVie and Genentech and understands the 50% sharing arrangement, it fails in the synthesis by inventing a specific profit figure that the ground truth does not provide. The question asks 'how much' Genentech received, and while the answer should be '50% of U.S. pre-tax profit' (a percentage/proportion), the LLM incorrectly provides a specific dollar amount without justification. (4) SEMANTIC ISSUES: The ground truth answer appropriately acknowledges that the specific dollar amount of profit shared is not disclosed separatelyonly the percentage arrangement is stated. The LLM's invention of $869 million represents a fundamental misunderstanding or hallucination rather than a legitimate interpretation of available data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 525,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "Visa's 10-K reports only 10 million Class C common shares outstanding as of September 30, 2024, despite issuing 48 million in the May 2024 exchange offer, due to **conversion adjustments and retirements**. The 48 million Class C shares issued were part of an exchange offer where Class B-1 shares were converted into Class B-2 and Class C shares. However, **Class C shares are subject to conversion rate adjustments** tied to litigation escrow accounts and retrospective responsibility plans, which can reduce the number of as-converted Class A shares. Additionally, **some Class C shares may have been retired or repurchased**, as the 10-K notes that shares outstanding were \"less than one million\" (likely due to rounding). The 10 million figure reflects the actual outstanding shares after these adjustments, not the total issued.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT: The LLM correctly identifies that 48 million Class C shares were issued in May 2024 and that 10 million shares were outstanding as of September 30, 2024. The LLM also correctly notes that the 10 figure is in millions (not individual shares). INCORRECT/PROBLEMATIC: (1) The LLM introduces speculative explanations about 'conversion rate adjustments tied to litigation escrow accounts' and 'retrospective responsibility plans' that are NOT mentioned in the ground truth answer. These appear to be fabricated details not supported by the provided excerpts. (2) The LLM's explanation about 'shares outstanding were less than one million (likely due to rounding)' is confusing and contradicts the stated 10 million figure. (3) The ground truth provides a clear, straightforward explanation: the 10 million figure is simply presented in millions in the table header, and the 38 million share reduction is attributed to 'share repurchases, retirements, or other corporate actions.' The LLM overcomplicates this with unsupported litigation/escrow references. (4) The LLM fails to clearly state the core insight from the ground truth: that the discrepancy is primarily explained by the table's presentation in millions, not by complex conversion mechanics. QUANTITATIVE ACCURACY: Numbers are correct (48M issued, 10M outstanding) but the reasoning about what caused the reduction is speculative. QUALITATIVE ACCURACY: The reasoning introduces unsupported concepts and fails to follow the ground truth's simpler, more direct explanation. CONTEXTUAL RELEVANCE: The answer addresses the question but provides misleading context about conversion adjustments and escrow accounts that aren't substantiated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 479,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "FedEx incurred **$582 million** in 2024 for Network 2.0 implementation and DRIVE transformation-related business optimization activities. The expected range of future costs for the European workforce reduction plan announced in June 2024 is **$250 million to $375 million** in cash expenditures, to be incurred through fiscal 2026.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and fully addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: All dollar amounts are correct - $582 million for 2024 business optimization costs and $250-$375 million range for European workforce reduction plan costs through fiscal 2026. The numbers match the ground truth exactly with proper formatting. (2) COMPLETENESS: The answer addresses both parts of the question comprehensively: (a) total 2024 costs for Network 2.0 and DRIVE transformation activities, and (b) expected future cost range for the European workforce reduction plan with the correct timeframe (through fiscal 2026). (3) ENTITY ACCURACY: FedEx is correctly identified, the programs (Network 2.0, DRIVE transformation) are correctly named, the specific initiative (European workforce reduction plan) is correctly identified with the announcement date (June 2024), and the fiscal period (fiscal 2026) is accurate. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple related initiatives and time periods - distinguishing between 2024 actual costs and future projected costs, and properly connecting the European workforce reduction plan to the June 2024 announcement. (5) SEMANTIC EQUIVALENCE: The wording is clear and precise, matching the ground truth answer while maintaining professional clarity. No calculation errors, no missing information, and all contextual details are appropriate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 408,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "The total value of AMD's unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021 was **$329 million**, as disclosed in the \"Accounts Receivable, net\" section of Note 3 (page 63). This amount represents work completed for development services and custom products where revenue was recognized but not yet invoiced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key financial metric of $329 million for AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021. The quantitative accuracy is perfect - the dollar amount matches the ground truth exactly. The answer demonstrates sound multi-hop reasoning by correctly synthesizing that this represents work completed but not yet invoiced, which is the appropriate interpretation of unbilled receivables. The entity identification is accurate (AMD, fiscal year 2021, custom products and development services). The citation reference to Note 3 on page 63 adds credibility and specificity. The only minor consideration is that the LLM provides additional contextual explanation beyond the ground truth answer (explaining what unbilled receivables represent), which while helpful and accurate, goes slightly beyond what was strictly asked. This is not a deficiency but rather an enhancement. The semantic equivalence is strong - the LLM conveys the exact same factual information as the ground truth in clear, professional language.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 322,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's total revenue from Venclexta in 2023 was **$2,288 million** (comprising $1,087 million in the U.S. and $1,201 million internationally). Under the collaboration agreement with Genentech, AbbVie shared **50% of the pre-tax profit** from Venclexta's U.S. sales, as outlined in the profit-sharing table on page 69, where Genentech's share of U.S. profits (included in cost of products sold) was **$869 million**, matching AbbVie's share.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies AbbVie's total Venclexta revenue of $2,288 million in 2023 and accurately states the 50% profit-sharing arrangement with Genentech. However, there is a critical quantitative error: the LLM claims Genentech's share of U.S. profits was $869 million. This figure appears problematic because: (1) If U.S. revenue was $1,087 million and Genentech received 50% of pre-tax profit (not revenue), the $869 million figure would imply an implausibly high profit margin of ~80% on U.S. sales, which is unrealistic for pharmaceutical products; (2) The ground truth does not specify a dollar amount for Genentech's profit share, only that it was 50% of pre-tax profit and included in cost of products sold. The LLM appears to have fabricated or misinterpreted the $869 million figure, potentially confusing profit with revenue or misreading source data. The breakdown of U.S. ($1,087M) vs. international ($1,201M) revenue is helpful context but not verified against ground truth. The reference to 'page 69' and a 'profit-sharing table' adds specificity but cannot be verified and may be hallucinated. The core answer about the 50% profit-sharing arrangement is correct, but the specific dollar amount claimed for Genentech's share is unsupported and likely incorrect, representing a significant quantitative error in a multi-hop financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 381,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from $171 million as of December 31, 2022, to $0 as of December 15, 2023, following repayment on August 16, 2023. The 3.700% notes due 2023 had a balance of $400 million as of December 31, 2022, but was fully repaid on December 15, 2023, resulting in a $0 balance on that date. Thus, the 3.650% notes' balance was fully repaid by August 2023, while the 3.700% notes were repaid on December 15, 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states the 3.700% notes had a balance of $400 million as of December 31, 2022, but the ground truth indicates $400 million was the balance on December 15, 2023 - this is a major date/value mismatch. (2) The LLM claims the 3.700% notes were 'fully repaid on December 15, 2023, resulting in a $0 balance on that date,' but the ground truth explicitly states the 3.700% notes had an aggregate principal balance of $400 million on December 15, 2023 - this directly contradicts the question's requirement to compare the two notes' balances on that date. (3) The LLM introduces unsupported details about repayment dates (August 16, 2023 for 3.650% notes) that are not in the ground truth. CORRECT ELEMENTS: The LLM correctly identifies that the 3.650% notes decreased by $171 million from $171 million to $0, and correctly states this occurred between December 31, 2022, and December 15, 2023. However, the core comparison requested in the question is fundamentally wrong - the LLM fails to properly compare the two notes' balances on December 15, 2023 ($0 for 3.650% vs $400 million for 3.700%), instead incorrectly stating both were at $0. This represents a failure in multi-hop synthesis and direct contradiction of the ground truth on the key comparative element of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 386,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECDs global minimum tax, could increase Visas effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visas financial position.",
      "llm_answer": "Adverse litigation outcomes requiring Visa to modify interchange reimbursement rates could reduce transaction volumes by incentivizing merchants and acquirers to seek lower-cost alternatives, potentially decreasing reliance on Visa's network. However, Visa's U.S. and Europe retrospective responsibility plans provide financial protections that may mitigate some of the direct costs of litigation settlements or liabilities. Nonetheless, if these protections are insufficient, the financial impact could harm Visa's cash flows and profitability. Additionally, ongoing tax disputes and uncertainties may further strain financial resources, compounding potential adverse effects on its financial position.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core mechanism (adverse litigation  reduced interchange rates  lower transaction volumes/revenue), acknowledges the existence of U.S. and Europe retrospective responsibility plans as financial protections, and recognizes that tax disputes could compound financial strain. The reasoning about how reduced interchange rates could incentivize merchants to seek alternatives is sound. No quantitative errors are present (no specific numbers were claimed). WEAKNESSES: (1) The LLM answer shifts the mechanism slightly - it emphasizes merchants/acquirers seeking lower-cost alternatives rather than the ground truth's focus on issuers reducing promotion/benefits/imposing fees, which affects consumer usage. While both pathways reduce transaction volumes, the ground truth provides more specific detail about the actual behavioral response. (2) The LLM answer is less explicit about the scope limitations of the retrospective plans - it states they 'may mitigate some' costs but doesn't clearly convey that protections 'vary in scope and may not fully cover' settlements/judgments/operating rule changes, which is an important nuance. (3) The LLM answer mentions tax disputes but is vague about specific sources (IRS, foreign jurisdictions) and doesn't reference the OECD global minimum tax as a specific emerging risk factor. (4) The LLM answer lacks the explicit synthesis that the 'combined effect' of reduced interchange income AND unfavorable tax outcomes creates compounding harm - it mentions compounding but less clearly. MULTI-HOP REASONING: The LLM successfully synthesizes information across litigation outcomes, retrospective plans, and tax disputes, but with less precision and specificity than the ground truth. The answer is directionally correct but misses some key details about mechanism and scope of protections.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 508,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTCs update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheons update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each companys incentive structure.",
      "llm_answer": "The effective dates of the Performance Share Unit (PSU) award schedules are **January 1, 2020** for the United Technologies Corporation Long-Term Incentive Plan (as part of the LTIP Performance Share Unit Deferral Plan) and **December 6, 2020** for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan (via Amendment No. 1). These dates reflect governance updates: UTs 2020 effective date aligns with restructuring post-merger, while Raytheons 2020 amendment reflects adjustments to its post-merger corporate governance framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides an incorrect effective date for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan. Ground truth states March 31, 2021, but LLM claims December 6, 2020. This is a factual error of approximately 3 months and represents a fundamental misidentification of the governance update date. (2) ENTITY/DATE VERIFICATION - While the UTC date of January 1, 2020 is correct, the Raytheon date is definitively wrong. The LLM appears to have confused or misidentified the amendment date. (3) MULTI-HOP REASONING - The LLM correctly identifies that these are separate governance updates to distinct plans, but the factual basis for the Raytheon update is incorrect. The reasoning about post-merger adjustments is plausible but built on incorrect data. (4) COMPLETENESS - The LLM addresses both plans and attempts to explain the governance context, but the core factual error undermines the entire answer. The ground truth explicitly states the Raytheon effective date is March 31, 2021 with an amended Schedule of Terms, not December 6, 2020 with Amendment No. 1. (5) SEMANTIC EQUIVALENCE - While the LLM's framing about governance updates is reasonable, it cannot be considered semantically equivalent when the primary factual claim (the Raytheon date) is incorrect. This is a strict factual question requiring precise dates, and the LLM fails on the primary metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 399,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were **Apple Watch** and **AirPods**, which contributed significantly to the 7% year-over-year increase in net sales for the category. These products outperformed other product lines within the segment, such as Apple TV, Beats, HomePod mini, and accessories, as highlighted in the MD&A section (page 24). The growth was attributed to new releases like the Apple Watch Series 8, updated Apple Watch SE, Apple Watch Ultra, and the second-generation AirPods Pro, which spurred higher demand compared to other offerings in the segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Apple Watch and AirPods as the primary drivers of Wearables, Home and Accessories segment growth in 2022, which matches the ground truth. The answer appropriately notes that other product categories (HomePod mini, Beats, accessories) underperformed or remained flat relative to these two key products. The qualitative reasoning is sound - the answer correctly synthesizes that growth was concentrated in two product lines rather than broadly distributed.\n\nHowever, there is a quantitative accuracy issue: The LLM states a \"7% year-over-year increase in net sales\" for the segment. This specific percentage is not mentioned in the ground truth answer, and without access to the actual 10-K filing data, this number cannot be verified. The ground truth answer does not provide this specific growth percentage, only noting \"overall increase in net sales compared to 2021.\" This represents an unverified quantitative claim that could be incorrect.\n\nAdditionally, the LLM provides specific product model details (Apple Watch Series 8, Apple Watch SE, Apple Watch Ultra, second-generation AirPods Pro) that are not mentioned in the ground truth answer. While these details may be accurate and add helpful context, they go beyond what the ground truth explicitly confirms.\n\nThe answer correctly identifies the segment name, the year (2022), and the comparative performance of products. The reference to \"MD&A section (page 24)\" adds specificity but cannot be verified against the ground truth provided. The semantic meaning aligns well with the ground truth - both answers convey that Apple Watch and AirPods drove growth while other categories did not contribute significantly.\n\nStrengths: Correct primary drivers identified, appropriate comparison framework, good contextual detail. Weaknesses: Unverified 7% growth figure, additional product model details not in ground truth, specific page reference not confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 529,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and ENBREL expect lower first-quarter 2025 sales compared to subsequent quarters, driven by the impact of insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This follows the historical pattern of lower sales in the first quarter due to benefit plan changes and insurance-related factors, as noted in their respective sections (Otezla on page 72 and ENBREL on page 71).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: both Otezla and ENBREL experience lower first-quarter sales due to insurance reverification and increased co-pay expenses as patients work through deductibles. The answer accurately captures the historical trend pattern mentioned in the ground truth. The multi-hop synthesis is sound - the model correctly connects the insurance reverification impact to both products and identifies the shared historical pattern. The specific page references (Otezla on page 72 and ENBREL on page 71) add helpful contextual detail, though these are not explicitly verified against the ground truth provided. The answer is semantically equivalent to the ground truth, using slightly different wording ('benefit plan changes and insurance-related factors' vs. the ground truth's more direct phrasing) but conveying the same essential information. No quantitative errors are present. The minor deduction from a perfect score reflects that while the answer is comprehensive and accurate, it adds page references that, while likely helpful, go slightly beyond what was explicitly confirmed in the ground truth statement. The answer fully addresses all parts of the multi-part question regarding comparison and historical trend identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 357,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "The total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is **three**. These include:  \n1. **Exhibit 10.16** (Schedule of Terms for SARs under the UTC 2005 Plan),  \n2. **Exhibit 10.17** (Form of Award Agreement for SARs under the UTC 2005 Plan),  \n3. **Exhibit 10.24** (Schedule of Terms for SARs under the RTX 2018 Plan).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer states the total is THREE distinct exhibits, but the ground truth clearly states the answer is TWO distinct exhibits (one for each plan). This is a fundamental factual error on the primary quantitative metric being asked. The LLM appears to have confused the concept of 'distinct exhibits' by counting individual exhibit numbers (10.16, 10.17, 10.24) rather than understanding that the question asks for the total number of distinct stock appreciation rights-related exhibits across the two plans combined. The ground truth indicates there is 1 exhibit for the UTC 2005 Plan and 1 exhibit for the RTX 2018 Plan, totaling 2 distinct exhibits. The LLM's breakdown of specific exhibit numbers (10.16, 10.17, 10.24) may or may not be accurate to the actual filing, but regardless, the interpretation of what constitutes 'distinct exhibits' is incorrect. The LLM counted 3 exhibits when the correct answer is 2. This represents a 50% overcount and a direct contradiction of the ground truth answer. The reasoning provided by the LLM shows an attempt to be thorough with exhibit details, but this actually demonstrates a misunderstanding of what the question was asking for - the total count of distinct exhibits per plan, not a granular listing of all related exhibits.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 362,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "The recurring impact of insurance reverification in the first quarter of 2025 is expected to cause lower sales for both ENBREL and Otezla compared to subsequent quarters, following historical patterns. For Otezla, this is attributed to benefit plan changes, co-pay expenses, and deductible impacts, while ENBREL faces similar factors. However, the document notes that net selling price declines for Otezla are expected to be less severe in 2025 (lower than the 8% decline in 2024), and ENBREL anticipates continued but relatively flat volume with ongoing net price declines. Combined, these factors suggest a first-quarter sales dip for both products, tempered by slightly improved pricing trends compared to prior years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states that 'net selling price declines for Otezla are expected to be less severe in 2025 (lower than the 8% decline in 2024)' - this directly contradicts the ground truth which indicates Otezla is 'expected to follow the same seasonal pattern in 2025' with the 8% decline being a historical reference point. The LLM incorrectly suggests improvement in pricing trends when the ground truth indicates continuation of the same negative pattern. (2) INCOMPLETE SYNTHESIS: The LLM mentions 'benefit plan changes, co-pay expenses, and deductible impacts' as causes but the ground truth focuses on the structural impact of insurance reverification and its effect on volumes and net selling prices. (3) REASONING FLAW: The LLM concludes with 'tempered by slightly improved pricing trends' which is unsupported by the ground truth and represents a misinterpretation. The ground truth emphasizes a 'compounded negative impact' from both volume and price factors, not a tempering effect. (4) PARTIAL CORRECTNESS: The LLM correctly identifies that both products experience Q1 sales dips and mentions the 8% Otezla price decline and 3% volume growth from 2024, but misinterprets what these historical patterns mean for 2025 expectations. (5) ENTITY ACCURACY: Companies and metrics are correctly identified (ENBREL, Otezla, net selling price, volumes), but the interpretation of their expected 2025 performance is materially incorrect. The core error is suggesting improvement in pricing trends when the ground truth indicates continuation of declines.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 456,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "AMGN anticipates that increased co-pay expenses will lead to lower first-quarter sales for both Otezla (2025) and ENBREL (2025), reflecting historical patterns of seasonal declines. Additionally, ENBREL will face further revenue pressure starting in 2026 due to Medicare Part D price controls under the IRA, which will drive continued net selling price declines. This aligns with AMGN's forecasting approach of accounting for co-pay impacts and regulatory changes (e.g., Medicare price setting) as recurring factors in revenue projections for key drugs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key entities (AMGN, Otezla, ENBREL), the timing of impacts (2025 for Otezla, 2026 for ENBREL), and the underlying drivers (co-pay expenses, Medicare Part D pricing under IRA). The reasoning about recurring revenue compression tied to insurance dynamics and regulatory pricing is sound and matches the ground truth pattern. The multi-hop synthesis connecting co-pay impacts to first-quarter declines and Medicare pricing to net selling price declines is logically correct.\n\nCRITICAL ERROR: The LLM states that ENBREL will face revenue pressure starting in 2025 due to co-pay impacts, but the ground truth specifies that ENBREL's Medicare Part D pricing impacts begin in 2026, not 2025. The LLM conflates the timing for both drugs - Otezla's co-pay impact is 2025 Q1, while ENBREL's Medicare pricing impact is 2026. This is a significant factual error in the temporal dimension.\n\nMISSING SPECIFICITY: The original answer emphasizes that Otezla faces 'lower first-quarter sales in 2025' specifically, while the LLM generalizes this to 'lower first-quarter sales' without clearly distinguishing the Q1-specific nature of the seasonal pattern. The ground truth also emphasizes 'gradual recovery in subsequent quarters' which the LLM mentions but doesn't emphasize as part of the forecasting pattern.\n\nQUANTITATIVE ISSUES: No specific dollar amounts or percentage impacts are provided in either answer, so quantitative precision cannot be fully evaluated. However, the LLM's statement about 'both Otezla (2025) and ENBREL (2025)' for co-pay impacts is factually incorrect - ENBREL's primary impact is 2026 Medicare pricing, not 2025 co-pay impacts.\n\nOVERALL: The answer demonstrates good understanding of the underlying mechanisms and patterns but contains a material error in the timing of ENBREL's revenue impacts, conflating 2025 and 2026 impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 513,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is **$3,282 million**, as disclosed in \"Other investments (1)\" on page 93. Schwab accounts for unrealized gains and losses associated with these liabilities by offsetting them against the corresponding gains and losses on the client-held fractional shares, resulting in **no impact on the consolidated statements of income**. This is explicitly stated in the note on page 81, which explains that the offsetting ensures no net effect on earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides a specific dollar amount of $3,282 million for the fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024. However, the ground truth answer explicitly states that the total fair value equals 'the value of the corresponding client-held fractional shares' without specifying a particular dollar amount. The LLM's citation to 'page 93' and 'page 81' cannot be verified against the ground truth, and the specific $3,282 million figure appears to be either fabricated or misattributed. This is a fundamental factual error that undermines the entire answer. (2) PARTIAL CORRECTNESS ON ACCOUNTING TREATMENT: The LLM correctly identifies that unrealized gains and losses are offset against corresponding gains/losses on client-held fractional shares, resulting in no net impact to the consolidated statements of income. This portion aligns with the ground truth. (3) MULTI-HOP REASONING: The LLM attempts to synthesize information across multiple pages/sections but fails on the quantitative component. The reasoning about offsetting is sound, but it's built on an unverified or incorrect numerical foundation. (4) MISSING CONTEXT: The ground truth emphasizes that these liabilities are 'included in accrued expenses and other liabilities,' which the LLM omits entirely. This is a material omission regarding balance sheet classification. (5) CITATION ISSUES: The specific page references and the $3,282 million figure lack verification against the actual ground truth source, suggesting potential hallucination or misattribution of data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 450,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "The total implied fully diluted market capitalization of AspenTech based on Emerson's proposal was **$15.3 billion**, as the proposal offered $240 per share for the remaining shares. This compares to AspenTech's 2023 net sales of **$1.04 billion**, resulting in a market cap approximately **14.7 times** higher than its 2023 net sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: (1) The implied fully diluted market capitalization of $15.3 billion matches the ground truth exactly; (2) AspenTech's 2023 net sales of $1.04 billion is correct; (3) The valuation multiple calculation of 14.7x is accurate ($15.3B / $1.04B = 14.71x, rounded to 14.7x). The answer correctly synthesizes multi-hop information by combining Emerson's acquisition proposal details with AspenTech's financial performance data. The LLM appropriately identifies the $240 per share offer price as supporting context, though this detail wasn't explicitly required by the question. The comparison is logically sound and clearly presented. The wording differs slightly from the ground truth (e.g., 'approximately 14.7 times higher' vs 'valuation multiple of approximately 14.7x'), but the semantic meaning is equivalent and accurate. All entities (Emerson, AspenTech, 2023 fiscal year) are correctly identified. The answer fully addresses both parts of the multi-part question: the market capitalization amount and the comparison to net sales.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 320,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 20102012 and 20132015 is $8.7 billion ($3.6 billion for 20102012 and $5.1 billion for 20132015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 20102012 and $2.2 billion for 20132015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "The total potential additional federal tax liability, including penalties, from the IRS Notices for 20102012 and 20132015 is **$3.6 billion (20102012) + $5.1 billion (20132015) + $2.0 billion (penalties for 20132015)**, totaling **$10.7 billion**. Previously accrued repatriation taxes of **$900 million (20102012)** and **$2.2 billion (20132015)** would reduce this amount by **$3.1 billion**, resulting in a net potential liability of **$7.6 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numerical values are correct: $3.6 billion (2010-2012), $5.1 billion (2013-2015), $2.0 billion penalties, totaling $10.7 billion. The repatriation tax adjustments are correctly stated: $900 million (2010-2012) and $2.2 billion (2013-2015), totaling $3.1 billion reduction. The final net liability of $7.6 billion is mathematically correct ($10.7B - $3.1B = $7.6B). The answer successfully synthesizes multi-hop information across two time periods and correctly identifies how previously accrued repatriation taxes reduce the total liability. The only minor observation is that the LLM answer specifies penalties are for 2013-2015 only, whereas the ground truth presents penalties as a combined figure without explicit period attribution. However, this is a minor wording distinction that doesn't affect factual accuracy. The answer demonstrates sound multi-hop reasoning by combining tax liabilities from two periods, adding penalties, and then subtracting the repatriation tax credits. All entities (AMGN, IRS Notices, years 2010-2012 and 2013-2015) are correctly identified. The semantic meaning and information content match the ground truth precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 342,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The inclusion of ENBREL in the Medicare price-setting program under the IRA law will reduce its profitability in Medicare starting in 2026 due to government-set prices significantly lower than current rates. This directly impacts Amgen's financial outlook by lowering revenue and margins from Medicare sales. The potential inclusion of Otezla in future Medicare price-setting cycles (announced for 2027) poses additional risk, as it could subject another key product to similar pricing pressures, further constraining revenue growth and profitability, especially if price controls expand to more products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies ENBREL's inclusion in Medicare price-setting effective January 1, 2026, with accurate characterization of negative financial impact due to government-set prices. (2) Accurately states Otezla's selection for Medicare price setting beginning January 1, 2027. (3) Properly synthesizes the multi-hop relationship between the two drugs and their compounding effects on Amgen's financial outlook. (4) Correctly identifies the IRA framework and notes the potential for additional products to be selected. (5) All dates and entities are accurate. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 'up to 100 drugs by 2031' detail from the ground truth, which provides important context about the scale of potential future risk. (2) The phrase 'announced for 2027' is slightly less precise than the ground truth's 'selected for Medicare price setting beginning January 1, 2027,' though semantically equivalent. (3) The answer could have been more explicit about the 'material adverse effect on sales and operations' language from the ground truth, though the concept is clearly conveyed. QUANTITATIVE VERIFICATION: All dates are correct (2026 for ENBREL, 2027 for Otezla). No calculations are required. MULTI-HOP REASONING: The answer correctly synthesizes information about how ENBREL's inclusion affects outlook and how Otezla poses additional future risk, demonstrating proper multi-hop reasoning. The connection between the two drugs and their cumulative impact is well-articulated. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth with appropriate wording variations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 475,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "Schwab's election of the fair value option under ASC 825 for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities offsetting those on the corresponding client-held fractional shares. This offsetting ensures **no net impact on the consolidated statements of income**, as changes in fair value are recognized in comprehensive income but not in earnings. Additionally, since these liabilities carry no credit risk, no gains or losses related to credit risk are recorded.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core mechanism correctly: unrealized gains/losses on repurchase liabilities offset those on client-held fractional shares, resulting in no net income impact, and no credit risk gains/losses are recognized. However, there is a significant semantic error in the statement 'changes in fair value are recognized in comprehensive income but not in earnings.' The ground truth explicitly states the offsetting ensures 'no net impact on the consolidated statements of income' - meaning the gains and losses offset each other within income statement line items, not that they bypass the income statement entirely for comprehensive income. This is a material distinction in accounting treatment. The LLM's phrasing suggests the changes flow to comprehensive income separately, which misrepresents how the offsetting mechanism works. The answer correctly identifies: (1) ASC 825 fair value option election, (2) the offsetting of unrealized gains/losses, (3) no net income impact, (4) no credit risk adjustments. It correctly omits unnecessary details while maintaining accuracy on the key points. The error regarding comprehensive income vs. income statement treatment is a qualitative reasoning issue that affects the precision of the accounting explanation, though the ultimate conclusion about 'no net impact' remains correct. The answer demonstrates good understanding of the offsetting mechanism but introduces a potentially misleading characterization of where these items are recorded.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 416,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using both the discounted cash flow method and the market multiple method, which indicated the reporting unit's fair value was lower than its carrying value due to challenges like reduced facility admissions, customer losses, and pandemic-related occupancy declines. The specific store closure strategy involved closing approximately 900 stores over three years (300 annually from 20222024), which impacted the Retail/LTC segment's long-lived asset impairment analysis by reducing asset values and triggering impairment charges of ~$1.4 billion, primarily for operating lease right-of-use assets and property/equipment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - $431 million goodwill impairment charge, 900 stores closure over three years (300 per year from 2022-2024), $1.4 billion total impairment charge, $1.1 billion for operating lease right-of-use assets, and $261 million for property and equipment. The November 2021 timing is correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the valuation methods (DCF and market multiple) contributed to the $431M goodwill impairment determination, and (2) how the store closure strategy impacted long-lived asset impairment analysis. ENTITY ACCURACY: All entities are correctly identified - LTC reporting unit, Retail/LTC segment, and the specific asset categories. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple concepts: connecting the valuation methods to the goodwill impairment, linking the store closure announcement to the long-lived asset impairment test, and properly attributing both charges to the Retail/LTC segment. MINOR OBSERVATIONS: The LLM uses slightly condensed language (e.g., '~$1.4 billion' with tilde notation and 'annually' instead of 'per year') but these are acceptable format variations that don't affect accuracy. The answer maintains semantic equivalence with the ground truth while being slightly more concise. The reasoning about why the impairments occurred (reduced admissions, customer losses, pandemic impact) is accurately conveyed. No factual errors, calculation errors, or omissions of material information were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 453,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, is **$978 million** (12,416 - 11,438). The portion of this increase attributable to Level 2 assets is **$1,205 million** (10,015 - 8,810). However, this results in a discrepancy because the total increase (978) is less than the Level 2 increase (1,205), indicating a possible error in the data interpretation. Based on the provided tables, the correct answer is: **$978 million increase, with $1,205 million attributable to Level 2 assets**.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies all key numerical values: the total increase of $978 million (12,416 - 11,438) and the Level 2 asset increase of $1,205 million (10,015 - 8,810). All calculations are accurate and match the ground truth. The answer properly addresses both parts of the multi-part question. However, the LLM introduces unnecessary confusion by flagging a 'discrepancy' and suggesting a 'possible error in the data interpretation.' This is problematic because the ground truth explicitly acknowledges this apparent paradox in its final statement: 'indicating that the entire increase in this category came from growth in Level 2 assets.' The LLM's concern about the discrepancy is mathematically valid (total increase of $978M cannot come entirely from Level 2 increase of $1,205M without other categories declining), but the LLM fails to recognize that this is the correct and expected finding - other asset categories must have decreased. The LLM's reasoning quality is weakened by this unnecessary doubt, though the final answer statement correctly provides both required figures. The LLM should have confidently presented the numbers and explained that the discrepancy indicates offsetting decreases in other asset categories, rather than questioning the data validity. All numerical values are correct, calculations are accurate, and the answer is complete and relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 391,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Emerson allocates AspenTech's stock-based compensation expense under ASC 805 by determining the fair value of share-based awards at the acquisition date and splitting the expense between pre- and post-combination service periods. The pre-combination portion (attributable to services rendered before the acquisition) is included in the purchase price, while the post-combination portion is recognized as expense over the remaining service period. Valuation inputs include the Black-Scholes model assumptions: expected volatility, risk-free interest rates, dividend yield, and AspenTech's stock price. Ownership figures reflect Emerson's 55% beneficial ownership of AspenTech's shares post-acquisition (as of May 16, 2022), with the remaining 45% held by former Heritage AspenTech shareholders. The pre-combination fair value of stock-based awards was $102 million, part of the $11.188 billion total purchase consideration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a solid understanding of the ASC 805 allocation framework and correctly identifies the core mechanism: splitting stock-based compensation between pre- and post-combination periods, with pre-combination portions included in purchase price and post-combination portions expensed over remaining service periods. The answer correctly identifies the acquisition date (May 16, 2022) and Emerson's 55% ownership stake post-transaction.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. VALUATION INPUTS PROBLEM: The LLM introduces Black-Scholes model assumptions (expected volatility, risk-free interest rates, dividend yield) that are NOT mentioned in the ground truth answer. The ground truth specifically states valuation uses \"the closing market price per share\" - a direct market-based approach, not Black-Scholes modeling. This is a material factual error regarding the specific valuation methodology.\n\n2. SPECIFIC DOLLAR AMOUNTS: The LLM provides specific figures ($102 million for pre-combination fair value and $11.188 billion total purchase consideration) that cannot be verified against the ground truth, which provides no such specific numbers. While these may be accurate from the actual filing, they go beyond what the ground truth confirms and introduce unverified quantitative claims.\n\n3. OWNERSHIP STRUCTURE DETAIL: The LLM adds detail about \"45% held by former Heritage AspenTech shareholders\" which, while potentially accurate, is not mentioned in the ground truth and represents added information not confirmed by the source.\n\nSTRENGTHS:\n- Correctly explains the ASC 805 allocation mechanism\n- Accurately identifies the acquisition date (May 16, 2022)\n- Correctly states the 55% ownership figure\n- Properly describes the split between pre- and post-combination treatment\n- Addresses both valuation inputs and ownership figures as requested\n\nWEAKNESSES:\n- Introduces Black-Scholes methodology not supported by ground truth\n- Provides unverified specific dollar amounts\n- Adds ownership structure details beyond ground truth confirmation\n- Conflates market price approach with Black-Scholes assumptions\n\nThe answer is directionally correct on the core ASC 805 framework but contains methodological inaccuracies regarding valuation inputs and introduces unverified quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 630,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "The percentage change in the value of CVS's investments in \"States, municipalities and political subdivisions\" from December 31, 2020, to December 31, 2021, was an increase of approximately **13.16%** (from $2,727 million to $3,086 million). This shift increased the proportion of debt securities in this category within the overall portfolio, reflecting a strategic adjustment in asset allocation. However, no data for December 31, 2022, is provided in the given pages.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) WRONG TIME PERIOD: The question explicitly asks about the change from December 31, 2021 to December 31, 2022. The LLM instead answered about the change from December 31, 2020 to December 31, 2021 - a completely different time period. (2) WRONG NUMBERS: The LLM reports values of $2,727 million and $3,086 million, which do not match the ground truth values of $3,091 million (2021) and $170 million (2022). (3) WRONG DIRECTION AND MAGNITUDE: The LLM claims a 13.16% INCREASE, when the ground truth shows a 94.5% DECREASE - this is directionally opposite and vastly different in magnitude. (4) INCOMPLETE ANSWER: The LLM explicitly states 'no data for December 31, 2022, is provided' when the ground truth clearly shows this data exists and was available. (5) MISSING PORTFOLIO COMPOSITION ANALYSIS: The LLM fails to address the second part of the question regarding how this shift affected the overall composition of CVS's debt securities portfolio (the percentage of total debt securities). The ground truth shows this decreased from 13.3% to 4.9%. The LLM answer demonstrates a fundamental failure to answer the correct question with correct data, appearing to have accessed or synthesized information from the wrong fiscal year comparison entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 371,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "The potential conversion of Visa's Class B common stock into Class A common stock depends on the final resolution of U.S. covered litigation, which is tied to the accrual activity under the U.S. retrospective responsibility plan. The accruals for U.S. covered litigation (e.g., $1,441 million as of 2022) reflect management's estimate of probable losses, but these estimates are subject to significant uncertainty due to ongoing litigation developments. If litigation outcomes differ from current estimates, the accrual could materially increase or decrease, impacting the escrow account and the terms of conversion. This uncertainty creates financial risk for Class A stockholders, as conversions could dilute their ownership and affect the market price of Class A stock, particularly if litigation costs or settlements alter Visa's financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core relationship between Class B stock conversion, U.S. covered litigation resolution, and accrual activity under the retrospective responsibility plan. The reasoning about financial uncertainty and dilution risk for Class A stockholders is sound and well-articulated. However, there are notable issues: (1) The LLM introduces a specific dollar figure ($1,441 million as of 2022) that is not mentioned in the ground truth answer. While this may be factually accurate from the 10-K filing, it represents additional information not in the original answer and creates a quantitative claim that cannot be verified against the ground truth provided. (2) The ground truth emphasizes the uncertainty arising from the accrual potentially being higher or lower than the escrow account balance, which is a specific mechanism of uncertainty. The LLM answer mentions accruals could increase or decrease but doesn't explicitly address the escrow account comparison mechanism. (3) The ground truth specifically notes the risk that 'market price of class A stock could fall if the conversion happens at a higher valuation that later decreases,' which is a nuanced point about timing and valuation risk. The LLM answer addresses dilution and market price effects but doesn't capture this specific temporal/valuation dynamic as clearly. (4) The multi-hop synthesis is correct: the answer properly connects litigation accruals  conversion timing  stockholder dilution risk. The reasoning is logical and addresses the question's core inquiry about how accrual activity affects conversion and creates financial uncertainty. Overall, the answer demonstrates solid understanding of the relationships and risks involved, but the introduction of unverified specific numbers and slight differences in emphasis on the escrow mechanism prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 507,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "The fair value of Cisco's available-for-sale debt investments decreased by **$5,727 million** from **$15,592 million** as of July 29, 2023, to **$9,865 million** as of July 27, 2024. The corresponding change in net losses on these investments year-over-year increased by **$46 million**, from a net loss of **$21 million** in 2023 to **$67 million** in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Fair value decrease of $5,727 million is correct; (2) Starting value of $15,592 million (July 29, 2023) is correct; (3) Ending value of $9,865 million (July 27, 2024) is correct; (4) Net loss increase of $46 million is correct; (5) 2023 net loss of $21 million is correct; (6) 2024 net loss of $67 million is correct. The calculation verification: $15,592M - $9,865M = $5,727M  and $67M - $21M = $46M . The answer properly addresses both parts of the multi-hop question: the fair value change and the corresponding net loss change year-over-year. The entity identification is correct (Cisco, available-for-sale debt investments), the fiscal years are properly identified with dates, and the reasoning clearly synthesizes the information across the two time periods. The wording is clear, professional, and semantically equivalent to the ground truth. No errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 287,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 impacted CVS's revenue recognition by deferring revenue for unredeemed rewards and gift cards as contract liabilities. Breakage (unredeemed amounts) was recognized as revenue based on historical redemption patterns, while redemptions reduced liabilities. In 2021, rewards earnings and gift card issuances increased by $387 million, offset by $371 million in redemptions and breakage, resulting in a net increase in contract liabilities. This reflects the timing of revenue recognition tied to redemption and breakage rates, with breakage directly contributing to revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM provides specific dollar amounts ($387 million in earnings/issuances, $371 million in redemptions/breakage) that cannot be verified against the ground truth. The original answer contains no such specific numbers, suggesting these figures may be fabricated or from an unverified source. This is a major red flag for factual accuracy. (2) CALCULATION CONCERN: The LLM states a net increase in contract liabilities from $387M - $371M = $16M, but this calculation is only valid if the numbers themselves are correct, which is unverified. (3) QUALITATIVE ACCURACY - STRENGTHS: The LLM correctly identifies the core mechanism: (a) contract liabilities are reduced as customers redeem rewards/gift cards, (b) breakage revenue is recognized based on historical redemption patterns, (c) unredeemed amounts are reclassified from liabilities to revenue, (d) this reflects fulfillment of obligations. These conceptual elements align well with the ground truth. (4) COMPLETENESS: The LLM addresses both parts of the question (ExtraBucks Rewards and gift cards) and discusses both redemption and breakage patterns as required. (5) SEMANTIC ALIGNMENT: The explanation of the accounting mechanism is semantically equivalent to the ground truth - both describe the liability reduction, breakage recognition, and revenue impact. HOWEVER: The introduction of specific unverified financial figures significantly undermines credibility. Without confirmation that these numbers appear in CVS's 2021 10-K filings, they represent a material factual error. The qualitative reasoning is sound, but the quantitative claims are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 454,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Companys funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "The funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan **reduces the conversion rate of Class B common stock into Class A common stock**. As noted in Note 13 (page 91), deposits into the escrow account (e.g., $850 million in fiscal 2022) dilute the conversion rate, effectively decreasing the number of Class A shares Class B holders receive upon conversion. \n\nRegarding the **financial impact on Visas litigation provision**, fiscal 2022 accrued $885 million for U.S. covered litigation (up from $125 million in 2021), reflecting increased estimates of probable losses. While the escrow account provides funding for settlements, the litigation provision is based on managements estimate of incurred losses, not directly tied to escrow deposits. The $861 million accrual for interchange multidistrict litigation (MDL) in 2022 directly contributed to the higher provision, with escrow deposits serving as a separate liability management mechanism. Thus, the escrow funding does not directly affect the provision amount but supports the liability coverage.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core mechanics and provides accurate financial figures. STRENGTHS: (1) Correctly identifies that escrow funding reduces the conversion rate of Class B to Class A stock, matching the ground truth's description of a 'downward adjustment' and 'dilution mechanism.' (2) Accurately cites specific dollar amounts: $850 million in fiscal 2022 escrow deposits and $885 million total U.S. covered litigation accrual (up from $125 million in 2021). (3) Correctly identifies the $861 million MDL accrual as a component of the higher provision. (4) Properly distinguishes between the escrow account as a funding mechanism and the litigation provision as a separate accounting estimate. (5) Correctly notes that escrow deposits don't directly determine provision amounts but support liability coverage. WEAKNESSES: (1) The ground truth emphasizes a 'measurable reduction in the number of as-converted class B shares following escrow deposits' as a key connection, but the LLM answer doesn't quantify this reduction or provide specific share count data. (2) The ground truth states the litigation provision was 'charged based on accrual activity' and deemed 'probable and reasonably estimable,' but the LLM answer focuses more on the distinction between escrow and provision rather than the causal relationship between accrual activity and the provision charge. (3) The LLM answer could have been more explicit about how the dilution mechanism directly ties to Company funding actions, as emphasized in the ground truth. QUANTITATIVE VERIFICATION: All cited numbers ($850M, $885M, $125M, $861M) appear reasonable and consistent with typical Visa litigation disclosures. The year-over-year comparison (2021 vs 2022) is properly contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across the escrow account mechanism, conversion rate mechanics, and litigation provision accounting, though it emphasizes separation rather than the direct causal linkage the ground truth suggests. The reasoning is sound but slightly misses the integrated nature of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 573,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "The fair value of Cisco's available-for-sale debt investments decreased by **$5,727 million** from **$15,592 million** as of July 29, 2023, to **$9,865 million** as of July 27, 2024. A 100 basis point interest rate increase would reduce the fair value of these investments by approximately **$129 million** in 2024 (from $9,865 million to $9,736 million) and **$206 million** in 2023 (from $15,592 million to $15,386 million), impacting total investments accordingly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all quantitative metrics. All key numbers are correct: the $5,727 million decrease, the starting value of $15,592 million (July 29, 2023), the ending value of $9,865 million (July 27, 2024), and the stress-tested values of $15,386 million (2023) and $9,736 million (2024). The calculations of the 100 basis point impacts are accurate: $206 million reduction in 2023 ($15,592M - $15,386M) and $129 million reduction in 2024 ($9,865M - $9,736M). The dates are correctly identified. The multi-hop reasoning is sound, synthesizing information about the actual fair values and the hypothetical interest rate stress scenarios. The answer directly addresses all parts of the question: the actual decrease, the impact of a 100 basis point increase in each year, and the implications for total investments. The only minor distinction from the ground truth is that the LLM answer frames the interest rate impacts as specific dollar reductions rather than also noting the $5,650 million difference between the two stress-tested values, but this is a matter of presentation emphasis rather than factual error. The semantic meaning is equivalent and the answer is complete and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 345,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "Visa Inc. recorded a $861 million provision for interchange multidistrict litigation in 2022 as part of its U.S. covered litigation accrual, which increased the total accrual balance to $1,441 million. This provision is tied to the U.S. Retrospective Responsibility Plan mechanisms, including the litigation escrow account (which received $850 million in deposits) and loss-sharing agreements. The accrual reflects Visa's estimate of its probable and reasonably estimable loss share, with adjustments based on litigation developments, while the escrow account and indemnification obligations help manage potential liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific dollar amounts ($861 million provision, $1,441 million total accrual, $850 million escrow deposits) that cannot be verified against the ground truth provided. The ground truth is qualitative in nature, explaining the mechanisms and principles (probable and reasonably estimable losses, escrow agreements, indemnification obligations) without citing specific numbers. The LLM answer correctly identifies the key conceptual elements: (1) the U.S. Covered Litigation and its impact on litigation provisions, (2) the connection to the U.S. Retrospective Responsibility Plan, (3) the role of escrow accounts and indemnification obligations, and (4) the principle that accrual could differ from escrow balance. However, the introduction of specific numerical figures ($861M, $1,441M, $850M) represents a significant concern - these numbers are presented with confidence but cannot be validated against the ground truth. This creates ambiguity: either the LLM has correctly sourced these from SEC filings (which would make the answer more complete and accurate), or it has hallucinated specific figures (which would be a critical error). The qualitative reasoning about how accruals relate to the Retrospective Responsibility Plan mechanisms is sound and well-articulated. The answer demonstrates good multi-hop synthesis by connecting litigation provisions to the escrow mechanism and loss-sharing agreements. The main weakness is the unverifiable quantitative specificity, which prevents a higher correctness score despite the strong conceptual understanding demonstrated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 439,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition contributed **0.6 percentage points** to the increase in Emerson's gross margin percentage in 2023. The total gross margin percentage for 2023, as a result of this contribution, was **49.0%**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is completely accurate and matches the ground truth precisely. (1) QUANTITATIVE ACCURACY: Both key numeric values are correct - the Heritage AspenTech acquisition contributed exactly 0.6 percentage points to gross margin increase, and the total gross margin percentage for 2023 was exactly 49.0%. The formatting is clear and appropriate (0.6 percentage points and 49.0%). (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the contribution amount from the acquisition, and (b) the resulting total gross margin percentage for 2023. (3) ENTITY ACCURACY: All entities are correctly identified - Emerson (EMR), Heritage AspenTech acquisition, fiscal year 2023, and gross margin percentage metric. (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the acquisition's impact to the overall gross margin result. (5) SEMANTIC EQUIVALENCE: The wording is clear, professional, and conveys the exact same information as the ground truth. No calculation errors, no missing information, and no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 309,
        "total_tokens": 1431
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Cisco's guarantee of channel partner financing arrangements exposes it to increased credit loss risk if channel partners face financial instability. As described in the financing receivables section (page 66), Cisco guarantees portions of third-party financing extended to channel partners, obligating it to cover payments if partners default. This creates a direct credit risk for Cisco, as it may need to recognize losses or write-offs under these guarantees. The risk factors section (page 14) further notes that channel partner financial difficulties could exacerbate credit losses, as Cisco's guarantees effectively transfer some of the partners' credit risk to the company. This could lead to higher provisions for credit losses and increased financial exposure if multiple partners default.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cisco's channel partner financing guarantee exposure and its credit loss implications. STRENGTHS: (1) Correctly identifies the core mechanism - Cisco guarantees portions of third-party financing to channel partners and must cover defaults; (2) Accurately describes the credit risk transfer from partners to Cisco; (3) Properly synthesizes the multi-hop relationship between financing arrangements, partner financial instability, and credit loss exposure; (4) Correctly notes that this could lead to higher provisions for credit losses; (5) Appropriately references specific filing sections (page 66 for financing receivables, page 14 for risk factors). MINOR WEAKNESSES: (1) The LLM answer mentions specific page numbers (66, 14) which cannot be verified against the ground truth and may or may not be accurate - this is a minor concern as the substantive content is correct; (2) The ground truth provides more specific detail about payment terms (60-90 days) and mentions that Cisco records allowances based on internal credit risk ratings, historical default rates, and macroeconomic conditions - the LLM answer omits these specific details; (3) The ground truth explicitly states these are 'short-term financing' arrangements, which the LLM answer doesn't emphasize. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is not directly testable. Both answers appropriately avoid making unsupported numerical claims. REASONING QUALITY: The LLM correctly synthesizes the multi-hop logic: (1) Cisco guarantees channel partner financing  (2) Partners may face financial instability  (3) Cisco's credit loss exposure increases. This matches the ground truth's reasoning chain. The answer appropriately identifies this as a credit risk transfer mechanism. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis and organization but equivalent substantive content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 550,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emersons broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Emerson's 55% ownership stake in AspenTech entitles it to 55% of AspenTech's $1,093 million in 2024 revenue, which amounts to **$599.65 million**. This portion is included in Emerson's overall **Software and Control revenue of $5,399 million**, as AspenTech is a subsidiary within this segment. Thus, Emerson's controlling interest directly contributes $599.65 million to the $5,399 million total, reflecting the consolidated impact of its stake in AspenTech.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the key relationships between Emerson's ownership stake, AspenTech's revenue, and the Software and Control segment. However, there is a notable calculation discrepancy: (1) CALCULATION ERROR: The LLM calculates 55% of $1,093 million as $599.65 million, but the correct calculation is $601.15 million (1,093  0.55 = 601.15). This is a mathematical error of $1.5 million. (2) GROUND TRUTH COMPARISON: The original answer correctly states $601.15 million, while the LLM provides $599.65 million. (3) MULTI-HOP REASONING: The LLM correctly synthesizes that AspenTech is a subsidiary within the Software and Control segment and properly explains how the 55% stake translates to proportional revenue attribution. The reasoning about consolidation and segment contribution is sound. (4) COMPLETENESS: The LLM addresses both parts of the question - calculating the proportional revenue share and explaining how it influences the broader Software and Control segment. However, the original answer provides additional context about AspenTech representing 'over 10% of that segment's revenue' ($601.15M / $5,399M  11.1%), which the LLM omits. (5) ENTITY AND METRIC ACCURACY: All entities (Emerson, AspenTech, Software and Control segment) and metrics (ownership percentage, revenue figures, fiscal year 2024) are correctly identified. The core logic and semantic understanding are correct, but the arithmetic error and missing percentage context prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 429,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operationsnet of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizers capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "Pfizer's divestiture of Meridian and the Upjohn spin-off significantly impacted its cash position and financial restructuring in 2020 and 2021. The Upjohn spin-off in November 2020 generated a $12.0 billion cash inflow from Viatris, which Pfizer used to pay down commercial paper and redeem $1.49 billion in debt, reducing its liabilities. The Meridian sale in December 2021 added $51 million in cash, though it resulted in a $167 million loss. These transactions improved Pfizer's liquidity, reduced debt, and contributed to financial restructuring by reallocating resources and streamlining operations. The spin-off also led to a $1.6 billion net asset distribution in 2020, reflecting a shift in accounting principles and a reduction in retained earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial figures and transactions. Quantitative verification: (1) Upjohn spin-off cash inflow of $12.0 billion - CORRECT; (2) Debt redemption of $1.49 billion (vs. ground truth $1.492 billion) - CORRECT (minor rounding acceptable); (3) Meridian sale proceeds of $51 million - CORRECT; (4) Meridian loss of $167 million - CORRECT; (5) Net asset distribution of $1.6 billion - CORRECT; (6) Cash transferred to Upjohn Business of $412 million - NOT MENTIONED (minor omission). The LLM correctly synthesized the multi-hop information across both transactions and years, properly distinguishing between the larger Upjohn restructuring and the smaller Meridian divestiture. The reasoning about impact on cash position, debt reduction, and financial restructuring is sound and logically presented. One minor weakness: the LLM states the net asset distribution 'reflected a shift in accounting principles and a reduction in retained earnings' which is somewhat vague compared to the ground truth's more concrete description of the $412 million cash transfer component. The answer appropriately addresses both 2020 and 2021 transactions and their comparative impacts. The characterization of Meridian as having 'minimal cash inflow' and the Upjohn transaction as 'significantly' affecting capital structure aligns well with the ground truth's comparative assessment. Overall, the answer is comprehensive, accurate on all major figures, and demonstrates solid multi-hop reasoning across the two divestiture transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 438,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022 was **$850 million**, representing the annual deposit into the U.S. litigation escrow account. This deposit was specifically to address claims from merchants who opted out of the Amended Settlement Agreement. The Amended Settlement Agreement itself required a prior payment of $600 million (from the escrow account) in 2018, but the 2022 contribution focused on the annual deposit. The plan's role in managing litigation liabilities is reflected through these deposits, which fund settlements and judgments while mitigating potential financial exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally fails to address the core question. The question explicitly asks for the TOTAL contribution combining BOTH the Amended Settlement Agreement payment AND the annual deposit in 2022. The ground truth clearly states: $600 million (Amended Settlement Agreement payment) + $850 million (annual deposit) = $1.45 billion total in 2022. The LLM answer reports only $850 million and explicitly excludes the $600 million payment, claiming it was made in 2018. This is a major factual error that directly contradicts the ground truth. The LLM's reasoning that 'the 2022 contribution focused on the annual deposit' misses the explicit requirement in the question to combine both components. Additionally, the LLM provides contextual information about merchant opt-outs that, while potentially relevant, does not compensate for the missing $600 million figure that should be included in the 2022 total. The multi-hop synthesis is incomplete - the model failed to properly aggregate the two required payment components. The only correct element is the $850 million annual deposit figure, but this represents only 59% of the correct total. The explanation about the plan's role in managing litigation liabilities is reasonable but cannot offset the fundamental quantitative error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 366,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023 was a **decrease of 42.86%** (from 35% in 2022 to 20% in 2023). This shift reduced the total value of equity securities in the plan from **$98 million (2022)** to **$54 million (2023)**, reflecting a **44.9% decline** in absolute value. The reallocation likely resulted from rebalancing toward fixed income securities to align with investment strategies and liability risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: equity allocation decreased from 35% to 20% (15 percentage points), and the total value of equity securities was $54 million by end of 2023. However, there is a critical issue with the percentage change calculation and an unsupported claim about 2022 equity values. CORRECT ELEMENTS: (1) Allocation percentages (35% in 2022, 20% in 2023) are accurate; (2) Final equity value of $54 million in 2023 is correct; (3) The 15 percentage point decrease is correctly identified; (4) The contextual reasoning about rebalancing toward fixed income is appropriate. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM calculates the percentage change in allocation as 42.86% (from 35% to 20%), which is mathematically correct as a relative percentage change [(20-35)/35 = -42.86%], but the ground truth frames this as a '15 percentage point decrease,' which is the absolute change. The LLM's calculation is technically valid but uses a different metric than the ground truth's framing; (2) The LLM claims equity securities were worth $98 million in 2022, but the ground truth does not provide this figure. This is an unsupported claim that cannot be verified against the knowledge graph; (3) The LLM calculates a 44.9% decline in absolute value ($98M to $54M), which is mathematically consistent with the $98M claim but is based on unverified data. MULTI-HOP REASONING: The LLM successfully synthesizes the allocation change with the absolute value change, showing understanding of how percentage allocation and total plan value interact. However, the introduction of the $98 million 2022 figure without ground truth support is problematic. The answer addresses both parts of the question (percentage change and impact on total value) but introduces unsupported quantitative claims that reduce confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 502,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The adoption of the CECL accounting standard influenced the difference in total capital between the Advanced and Standardized approaches as of December 31, 2023, primarily through the **qualifying allowance for credit losses** (a Tier 2 capital component). Under the Standardized approach, the allowance was higher ($12,920 million) compared to the Advanced approach ($11,739 million), resulting in a $9,950 million adjustment. This difference arises because the Standardized approach includes a broader, more conservative allowance for credit losses, while the Advanced approach incorporates internal models that may reduce the allowance, thereby lowering total capital under the Advanced approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer identifies the correct capital component (qualifying allowance for credit losses in Tier 2 capital) and correctly recognizes that CECL adoption influenced the difference between Advanced and Standardized approaches. However, there are significant quantitative accuracy issues: (1) The LLM provides specific dollar amounts ($12,920M and $11,739M for allowances, and a $9,950M adjustment) that are not verified in the ground truth and appear to be fabricated or incorrectly sourced. The ground truth only mentions a $12.6 billion increase in total capital under the Standardized approach in 2023, not specific allowance figures. (2) The LLM's calculation logic is unclear - it states a difference of $1,181M between the two allowance figures ($12,920M - $11,739M) but then claims a $9,950M adjustment, which doesn't align mathematically. (3) The ground truth emphasizes that the difference is in the 'amount permitted in Tier 2 capital' and the 'adjusted allowance for credit losses,' but the LLM provides unverified specific numbers. The qualitative reasoning about CECL's influence and the Standardized approach being more conservative is reasonable and aligns with the ground truth's general direction, but the specific quantitative claims lack support. The answer partially addresses the multi-hop synthesis required (CECL adoption  capital component differences  specific approach comparison) but fails on numerical precision, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 411,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents, using the midpoints of the stated ranges for each plan and weighted by their total asset values as of December 31, 2023, is **78.8%**. This calculation uses midpoints of 72.5% (U.S. Defined Benefit), 80% (U.S. Retiree Health Care), and 80% (Non-U.S. Defined Benefit), weighted by their respective total assets of $418 million, $264 million, and $1,866 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is significantly incorrect. The ground truth states the weighted average is approximately 72.3%, but the LLM calculated 78.8% - a substantial discrepancy of 6.5 percentage points. This is a critical error for a quantitative financial question. While the LLM demonstrates understanding of the methodology (using midpoints weighted by asset values), the execution is fundamentally flawed. The LLM provides specific asset values ($418M, $264M, $1,866M) and midpoint percentages (72.5%, 80%, 80%), but either these source numbers are incorrect or the calculation itself contains an error. A weighted average calculation of (72.5%  $418M + 80%  $264M + 80%  $1,866M) / ($418M + $264M + $1,866M) would yield approximately 78.8%, suggesting the LLM's arithmetic is internally consistent but based on incorrect input data. The ground truth answer of 72.3% indicates the actual midpoint percentages and/or asset values in the source documents differ from what the LLM used. This represents a multi-hop synthesis failure - the LLM either misread the source documents or used incorrect plan data. For a question explicitly asking for a specific weighted average percentage, being off by 6.5 percentage points is a major factual error that would be material in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 360,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporations risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positionssuch as foreign exchange and commodity positionsunder Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "Basel 3 capital calculations influence Bank of America's covered trading positions and VaR metrics by requiring more stringent risk-weighted asset (RWA) calculations and stress testing, which shape the composition and risk profile of its trading portfolio. Under Basel 3, the Corporation uses Advanced Approaches to determine capital adequacy, incorporating detailed risk models that affect how trading positions are categorized as \"covered\" (subject to VaR). The 10-day holding period for regulatory VaR (vs. the one-day period for market risk VaR) reflects Basel 3's emphasis on longer-term capital planning. Additionally, stress testing under Basel 3, which includes hypothetical scenarios beyond historical data, ensures that VaR metrics account for extreme market conditions, potentially increasing risk buffers and altering the portfolio's exposure to interest rate, credit, and market risks. This aligns capital requirements with the bank's risk appetite, influencing the inclusion of less liquid positions and the diversification of risk factors in covered portfolios.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Basel 3 influences Bank of America's trading positions and VaR metrics through capital requirements and risk management frameworks. It appropriately mentions Advanced Approaches, stress testing, and the relationship between capital requirements and risk appetite. The discussion of 10-day vs. one-day holding periods and the impact on portfolio composition is relevant and accurate conceptually.\n\nCRITICAL WEAKNESSES: (1) MISSING SPECIFIC NUMBERS: The ground truth provides concrete Basel 3 capital buffer requirements (2.5% capital conservation buffer and 2.5% stress capital buffer at December 31, 2023), which the LLM answer completely omits. These are key quantitative facts that directly answer the question. (2) MISSING YEAR-OVER-YEAR COMPARISON: The ground truth explicitly states that in 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR DECREASED compared to 2022, with a specific explanation (roll off of March 2020 market volatility from historical data window). The LLM answer does not provide this concrete comparison or the specific reason for the change. (3) VAGUE ON MECHANISM: While the LLM discusses stress testing and RWA calculations generally, it doesn't explain the specific mechanism by which Basel 3 affected BofA's VaR metrics in 2023 (the March 2020 volatility roll-off). (4) SPECULATIVE LANGUAGE: The LLM uses phrases like 'potentially increasing risk buffers' and 'altering the portfolio's exposure' which are speculative rather than grounded in actual filing data.\n\nMULTI-HOP REASONING: The LLM demonstrates understanding of how Basel 3 connects to trading positions and VaR, but fails to synthesize the specific quantitative relationships and year-over-year changes documented in the ground truth. The reasoning is conceptually sound but factually incomplete.\n\nQUANTITATIVE ACCURACY: Score of 3 due to complete absence of the specific capital buffer percentages (2.5% and 2.5%) and the year-over-year VaR comparison that are central to the ground truth answer.\n\nQUALITATIVE ACCURACY: Score of 6 because while the conceptual framework is correct, the answer lacks the specific factual details and concrete examples that ground the explanation in actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 615,
        "total_tokens": 2127
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates is **$1.8 billion** as of May 31, 2022 (page 94). The amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance was **$5.8 billion** in 2021 (page 95). The net book value of the aircraft is significantly lower than the debt eliminated, reflecting the use of proceeds to redeem substantially more debt than the collateral's value.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the two key financial figures: $1.8 billion for the net book value of the 19 Boeing aircraft and $5.8 billion for debt eliminated through redemptions. The comparison between these amounts is accurate and appropriately highlights the disparity. However, the answer has a notable omission: it fails to mention the $393 million in associated redemption premiums that were part of the original answer. This is a material detail that provides important context about the total cost of the debt redemption. The LLM also correctly identifies the $3.25 billion senior unsecured debt issuance, though this figure is not explicitly stated in the provided answer. The multi-hop reasoning is sound - the answer successfully synthesizes information about the aircraft collateral and the debt redemption proceeds. The page references (94 and 95) appear reasonable for a 10-K filing structure. The temporal reference to 2021 for the debt elimination is appropriate. The main weakness is the incomplete disclosure of all relevant financial details (missing the $393 million redemption premium), which represents approximately 6.8% of the $5.8 billion debt eliminated and is material enough to warrant inclusion. The semantic equivalence and logical comparison are well-executed, but the omission prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 374,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "TI contributed $75 million to its U.S. defined contribution plans in 2023. Notably, the U.S. retiree health care benefit plan's assets are not directly invested in TI common stock; instead, they are held in broad-market index funds to mitigate concentration risks, aligning with the company's policy of using low-cost, diversified investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the $75 million contribution to U.S. defined contribution plans in 2023, matching the ground truth exactly. The quantitative accuracy is perfect on this core fact. However, there is a significant issue with the qualitative accuracy and completeness. The ground truth states simply that 'none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.' The LLM answer goes beyond this by adding speculative details about 'broad-market index funds' and 'concentration risks' and 'low-cost, diversified investments' that are not present in the original answer. While these details might be reasonable inferences or could be true, they represent information not confirmed in the ground truth. The LLM appears to have fabricated or inferred additional context that was not provided in the source material. The core factual claim (no TI common stock investment in the retiree health care plan) is correct, but the embellishment with unverified details reduces the reliability of the answer. The answer addresses both parts of the multi-part question but introduces unsupported elaboration on the second part, which violates the principle of sticking to verifiable facts from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 356,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "The total net sales growth from 2023 to 2024 was $7.75 billion ($391.035B - $383.285B). Services revenue increased by $10.969 billion ($96.169B - $85.2B). The percentage of total net sales growth attributable to Services is calculated as ($10.969B / $7.75B) * 100  **141.5%**. This indicates that Services revenue growth exceeded the overall sales growth, suggesting other segments may have declined.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL CALCULATION ERROR: The LLM provided an incorrect final percentage of 141.5% when the correct answer is 121%. While the LLM correctly identified and calculated the individual components (Services revenue increase of $10.969B and total net sales growth of $7.75B), the final calculation is fundamentally wrong. The LLM states ($10.969B / $7.75B) * 100  141.5%, but this calculation is mathematically incorrect. The correct calculation is: $10.969B / $7.75B = 1.4149... which equals approximately 141.49% when expressed as a percentage. However, the ground truth answer states the result should be 121%, which suggests the ground truth may have used different intermediate values or a different calculation method. Upon verification: $10.969 / $7.75 = 1.4149 (or 141.49%), not 121%. This indicates a discrepancy between the ground truth answer provided and the actual mathematical calculation based on the stated numbers. The LLM's calculation of 141.5% is mathematically correct given the numbers provided ($10.969B / $7.75B * 100), but it contradicts the ground truth answer of 121%. The LLM correctly identified all relevant financial figures, properly calculated the differences, and provided sound reasoning about what the result means (that Services growth exceeded overall sales growth, implying other segments declined). The methodology and logic are sound, but the final numerical answer does not match the ground truth. The LLM also added valuable contextual interpretation about what the percentage means for Apple's business segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 427,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 20112013 and 20142015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 20112013 and 20142015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is **$75 million**, as stated in the 2022 10-K filing. The existence of Revenue Agent's Reports (RARs) for tax years 20112013 and 20142015 contributes to uncertainty because Pfizer disagrees with these reports and is appealing disputed issues, creating unresolved tax positions. The outcomes of these appeals, along with potential statute of limitations expirations, make it difficult to predict the timing and magnitude of changes to unrecognized tax benefits, as audits may involve protracted legal proceedings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: The $75 million figure is correct and matches the ground truth exactly. The tax years cited (20112013 and 20142015) are accurate. No calculation errors present. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the specific dollar amount of potential decrease, and (b) how RARs contribute to uncertainty. The LLM provides additional context about appeals, statute of limitations, and protracted legal proceedings, which enhances understanding without contradicting the ground truth. (3) ENTITY ACCURACY: Pfizer is correctly identified, the 2022 10-K filing is properly cited, and the tax years are accurate. Revenue Agent's Reports (RARs) terminology is correctly used. (4) REASONING: The multi-hop synthesis is sound. The LLM correctly connects: (a) the specific financial metric ($75M decrease) to (b) the underlying cause (RARs for specific tax years) to (c) the mechanism of uncertainty (appeals and unresolved positions). The explanation of how RARs create uncertainty through disputed issues and appeals is logically coherent and well-reasoned. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'Pfizer disagrees with these reports and is appealing disputed issues' is semantically equivalent to the ground truth's 'Pfizer is currently appealing.' The additional detail about 'protracted legal proceedings' and 'statute of limitations expirations' adds valuable context without introducing inaccuracy. Minor deduction: The LLM could have been slightly more explicit about these being 'formal audit findings,' though this is implied in the context of RARs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 456,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "The five-year transition period related to CECL adoption allows BAC to adjust its regulatory capital calculations gradually, impacting CET1 capital and TLAC ratios. As of December 31, 2023, CET1 capital and TLAC ratios are calculated using this transition framework, which incorporates CECL provisions over time rather than immediately. This phased approach smooths the impact of CECL on capital adequacy, ensuring compliance with regulatory requirements while maintaining sufficient capital buffers. The transition period also affects the regulatory minimums for TLAC ratios, as outlined in Table 14, by aligning capital calculations with the phased implementation of CECL.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that the CECL transition period affects capital calculations and TLAC ratios, and appropriately explains the phased approach concept. The answer demonstrates understanding that the transition smooths CECL's impact on capital adequacy. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifies that BAC's CET1 capital was $194.9 billion as of December 31, 2023, with an increase of $14.9 billion from prior year. The LLM answer completely omits these specific dollar amounts, which are essential factual information for answering a question about impact on capital calculations. (2) VAGUE REFERENCE TO TABLE 14: The LLM mentions 'Table 14' and regulatory minimums for TLAC ratios but provides no actual numbers or specific details about what those minimums are or how they changed. The ground truth provides concrete CET1 capital figures. (3) INCOMPLETE SYNTHESIS: While the LLM explains the mechanism of the transition period, it fails to quantify the actual impact with specific numbers. The ground truth demonstrates that the $14.9 billion increase in CET1 capital was 'influenced in part by the CECL transition's effect on capital calculations' - this specific quantification is absent from the LLM response. (4) LACK OF SPECIFICITY: The answer is somewhat generic and could apply to any bank's CECL transition; it doesn't provide BAC-specific metrics or data points. The question asks 'how does...impact' which requires demonstrating the actual impact with numbers, not just explaining the mechanism. CALCULATION/VERIFICATION: No calculations are presented in either answer, but the ground truth provides specific baseline figures ($194.9B CET1, $14.9B increase) that should have been included. The LLM answer provides no comparable quantitative foundation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 497,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Ground and FedEx Freight both use indexed fuel surcharges adjusted weekly, but their mechanisms differ. FedEx Ground bases its surcharge on a weekly fuel price from **two weeks prior**, with updates on **June 21, 2021**, **November 1, 2021**, and **April 4, 2022**. FedEx Freight uses a **two-day lag** for fuel prices and updated its surcharge tables on **November 1, 2021**, and **April 4, 2022**, while also implementing peak surcharges starting in **July 2021** to manage capacity constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong alignment to the ground truth. STRENGTHS: (1) All key dates are accurate - June 21, 2021, November 1, 2021, and April 4, 2022 for FedEx Ground; November 1, 2021 and April 4, 2022 for FedEx Freight. (2) The fuel price lag timing is correctly identified - two weeks prior for FedEx Ground and two days prior for FedEx Freight. (3) The multi-hop synthesis correctly compares the two entities' mechanisms side-by-side. (4) The answer properly identifies weekly adjustment frequency for both. MINOR ISSUE: The LLM introduces information about 'peak surcharges starting in July 2021' for FedEx Freight that is not present in the ground truth answer. While this may be factually accurate from the source documents, it represents an addition beyond what was specified in the original answer. This is a minor expansion rather than a contradiction, but it does introduce information not explicitly confirmed in the ground truth. QUANTITATIVE VERIFICATION: All dates and numeric references (two weeks, two days) match exactly. No calculation errors present. REASONING QUALITY: The multi-hop reasoning is sound - the answer correctly synthesizes information about both FedEx segments and their different approaches to fuel surcharge adjustments. The comparison structure effectively highlights the key differences requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 384,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "The reorganization in fiscal year 2024 involved moving the ventilator product line from the Medical Surgical segment to the \"Other\" line, while combining the retained PMRI businesses into a single unit called **Acute Care & Monitoring** within the Medical Surgical segment. This restructuring reflects a strategic focus on core PMRI businesses, emphasizing their integration and operational efficiency. The decision to exit the ventilator line suggests a shift toward prioritizing higher-margin, strategically aligned products, with Acute Care & Monitoring positioned as a key growth driver within the Medical Surgical segment. The retained business's continued reporting as a distinct segment underscores its importance to Medtronic's long-term strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR - FISCAL YEAR MISMATCH: The LLM answer states the reorganization occurred in 'fiscal year 2024,' but the ground truth and question both specify 'fiscal year 2023.' This is a fundamental factual error that undermines the entire answer's accuracy. CORRECT ELEMENTS: The LLM correctly identifies that (1) the Ventilator Product Line was moved to the 'Other' line, (2) PMRI businesses were retained and combined into 'Acute Care & Monitoring' within Medical Surgical, (3) this reflects strategic refocusing around core PMRI capabilities. The LLM also appropriately infers strategic implications about higher-margin products and growth positioning. MISSING/INCOMPLETE ELEMENTS: The ground truth mentions that the reorganization 'also involved the Renal Care Solutions business,' which the LLM answer completely omits. This is a significant omission as it's part of the multi-hop synthesis required to fully answer the question. The LLM provides additional interpretation about 'higher-margin' products and 'growth driver' positioning that goes beyond the ground truth but is reasonable inference. REASONING QUALITY: The multi-hop reasoning is sound in connecting the structural changes to strategic implications, but the fiscal year error is a critical factual mistake that cannot be overlooked. The answer demonstrates understanding of the reorganization's purpose but fails on basic temporal accuracy. QUANTITATIVE ACCURACY: The only quantitative element is the fiscal year, which is incorrect (2024 vs. 2023). This single but critical error significantly impacts the score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 435,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes for fiscal years 2022 and 2023 was **$252 million**. Specifically, the expenses were **$102 million in 2022** (as disclosed in the Segment Operating Profit table on page 104) and **$150 million in 2023** (as noted in the GAAP to Non-GAAP Reconciliations on page 33). These figures are directly tied to incremental costs of complying with new European Union medical device regulations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Correctness verification: (1) Total amount of $252 million matches the ground truth exactly. (2) Component breakdown: $102 million for 2022 and $150 million for 2023 sum correctly to $252 million ($102M + $150M = $252M). (3) All numeric values are factually correct. Multi-hop reasoning assessment: The answer successfully synthesizes information across multiple sources (Segment Operating Profit table on page 104 and GAAP to Non-GAAP Reconciliations on page 33), demonstrating proper multi-hop synthesis. Entity accuracy: Medtronic is correctly identified, fiscal years 2022 and 2023 are correct, and the financial metric (income before income taxes impact) is properly characterized. The answer goes beyond the ground truth by providing helpful context about the source documents and the nature of the expenses (EU medical device regulations compliance), which adds value without introducing inaccuracy. The only minor consideration is that the ground truth provides just the total ($252 million), while the LLM provides additional breakdown and sourcing details that, while accurate and helpful, weren't explicitly required by the question. However, this represents added value rather than any error. All calculations are accurate, all numbers match the ground truth, and the reasoning is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 377,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Boeing's 2023 10-Q filings disclose **6 distinct forms** of Long-Term Incentive Restricted Stock Units (LTIRSU), including both U.S. and International versions. These include:  \n- U.S. LTIRSU (general)  \n- U.S. LTIRSU for CEO  \n- U.S. Performance LTIRSU  \n- U.S. Performance LTIRSU for CEO  \n- International LTIRSU (Stock-Settled)  \n- International Performance LTIRSU (Stock-Settled)  \n\nEach form is specified in the exhibits listed in the 2023 10-Q filings (e.g., 10.3210.37).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary quantitative metric. The ground truth clearly states Boeing disclosed FOUR different forms of Long-Term Incentive Restricted Stock Units, but the LLM claims SIX distinct forms. This is a critical factual error on the core question being asked. Additionally, the LLM's categorization is problematic: (1) The ground truth identifies four specific forms with exhibit numbers (10.3, 10.5, 10.4, 10.6), while the LLM invents categories like 'CEO' versions that are not mentioned in the ground truth. (2) The LLM cites exhibits 10.32-10.37, which differ from the ground truth's exhibits (10.3-10.6), suggesting the LLM may be referencing different or incorrect filing documents. (3) The ground truth's four forms are clearly defined: U.S. LTIRSU, U.S. Performance LTIRSU, International LTIRSU (Stock-Settled), and International Performance LTIRSU (Stock-Settled). The LLM's distinction between 'general' and 'CEO' versions is not supported by the ground truth and appears to be fabricated. The LLM did correctly identify that the answer should include both U.S. and International versions, and correctly noted the distinction between regular and Performance variants, but the overall count is wrong and the exhibit citations are incorrect. This represents a failure in multi-hop reasoning and factual accuracy on the primary metric of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 388,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "Apple's reliance on third-party developers and content providers for services like Apple Music could pose risks to the sustainability of its 12.9% year-over-year Services revenue growth. The 2023 10-K highlights that third-party software and content availability depend on developers' decisions, which may be influenced by competitive platforms (e.g., Android, Windows) and market dynamics. If developers reduce support for Apple's ecosystem or face regulatory changes (e.g., EU Digital Markets Act), it could lead to reduced app quality, fewer offerings, or lower commission rates for Apple, directly impacting Services revenue. Additionally, disruptions in content licensing agreements or cybersecurity threats could further undermine customer access to digital content, potentially slowing growth. These factors, combined with the Company's dependence on third-party terms and market conditions, introduce uncertainties that could challenge the long-term trajectory of Services growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 12.9% year-over-year growth rate mentioned in the question. (2) The answer appropriately addresses the multi-hop nature of the question by connecting Apple's reliance on third-party developers/content providers to potential risks for Services revenue growth. (3) The reasoning about competitive platforms, regulatory changes (EU Digital Markets Act), and content licensing disruptions is relevant and shows understanding of real-world factors affecting the ecosystem. (4) The answer maintains semantic equivalence with the ground truth's core argument about how third-party dependencies could threaten growth sustainability.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM does not cite the specific revenue figures from the ground truth ($78,129 million in 2022 and $85,200 million in 2023). While the 12.9% growth rate is mentioned, the actual dollar amounts that support this calculation are absent. This is a significant gap for a financial analysis question. (2) The LLM introduces additional factors (cybersecurity threats, regulatory changes like EU DMA, commission rate impacts) that, while potentially relevant, are not grounded in the original answer's framework. The ground truth focuses specifically on developer/content provider decisions and their direct impact on service attractiveness. (3) The answer lacks the specific mention of how reduced developer support could lead to 'customer dissatisfaction and reduced demand' - instead offering more speculative scenarios. (4) The ground truth emphasizes Apple's 'minority market share' as a specific factor influencing developer decisions; the LLM mentions competitive platforms more generally without this specificity.\n\nQUANTITATIVE ACCURACY: The 12.9% figure is correct and properly cited. However, the absence of the underlying revenue figures ($78,129M and $85,200M) represents a material omission in a financial context. Score reflects correct percentage but missing supporting data.\n\nQUALITATIVE ACCURACY: The reasoning is sound but diverges from the ground truth's specific framework. The LLM adds regulatory and cybersecurity dimensions not in the original answer, which could be seen as either expanding the analysis or straying from the knowledge graph basis. The core logic connecting third-party dependencies to growth sustainability is present but less precisely articulated than the ground truth.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question's multi-part structure and maintains focus on Services revenue sustainability. However, it introduces factors beyond what the ground truth identifies as key concerns from Apple's disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 711,
        "total_tokens": 2213
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife's $12.4 billion short-term liquidity position at the end of 2021 provides a buffer to manage liquidity under stress scenarios, but reinsurance and derivative counterparty risks could strain this capacity. The company mitigates counterparty risk through collateralized reinsurance agreements and master netting agreements, though unanticipated policyholder behavior or market disruptions could exceed risk management measures. Stress testing and diversified liquidity sources (e.g., asset sales, credit facilities) support resilience, but forced asset liquidation during market volatility might result in realized losses, impacting financial condition. The cash buffer, combined with proactive capital management, aims to address these risks while maintaining regulatory compliance and dividend flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the $12.4 billion short-term liquidity position as of December 31, 2021. The quantitative accuracy is high - the key financial figure is correct and no calculations are presented that could be verified as erroneous. The answer correctly identifies the core relationship between the liquidity buffer and counterparty risks from reinsurance and derivatives. Multi-hop reasoning is sound: the model synthesizes that (1) MetLife maintains a $12.4B liquidity buffer, (2) this buffer addresses counterparty risks, (3) collateralization and netting agreements mitigate but don't eliminate risks, and (4) stress scenarios could exceed risk management frameworks. The qualitative accuracy is strong - the answer appropriately discusses collateralized agreements, netting arrangements, and the potential for market volatility to strain the buffer. Minor areas where the LLM answer diverges from ground truth: (1) The LLM introduces additional concepts (stress testing, diversified liquidity sources, asset sales, credit facilities, regulatory compliance, dividend flexibility) that, while relevant to liquidity management, are not explicitly mentioned in the ground truth answer and may represent inference beyond the specific filing data. (2) The ground truth emphasizes the direct tie between cash buffer needs as a 'capital risk factor' to liquidity management strategy more explicitly, while the LLM frames it more broadly as part of 'proactive capital management.' (3) The LLM mentions 'forced asset liquidation' and 'realized losses' which are logical extensions but not explicitly stated in the ground truth. These additions don't contradict the ground truth but represent reasonable elaboration. The answer maintains semantic equivalence to the core message: the $12.4B buffer is necessary but potentially insufficient if counterparty risks materialize under stress conditions. No factual errors detected; the answer is contextually appropriate and addresses the multi-part nature of the question effectively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 561,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is **$33 million**, and these securities are classified as **Other Assets** on the balance sheet, as indicated in the 2023 10-K filing (page 72).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: Both the quantitative value ($33 million) and the balance sheet classification (Other Assets) match the ground truth exactly. The answer correctly identifies MDT as the company and April 26, 2024 as the relevant date. (2) QUANTITATIVE ACCURACY: The $33 million figure is correct with no calculation errors. The number format is appropriate and matches the ground truth. (3) QUALITATIVE ACCURACY: The LLM correctly synthesized the multi-hop information by identifying both the fair value amount and the balance sheet classification. The answer properly attributes the information to the 2023 10-K filing and even provides a specific page reference (page 72), which adds credibility. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the multi-part question - it provides the total fair value, identifies the securities as Level 3 auction rate securities, and explains their balance sheet classification. The response is well-structured and contextually appropriate. Minor note: The inclusion of the page reference (page 72) goes slightly beyond the ground truth answer but represents added value rather than an error. The answer demonstrates sound multi-hop reasoning by connecting the fair value data with the balance sheet classification requirement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 373,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The adoption of the credit loss guidance on January 1, 2020, shifted the recognition of credit losses from the incurred loss model to an expected lifetime loss model under CECL. For mortgage loans and fixed maturity securities AFS, credit losses are now measured based on expected lifetime losses over the contractual term, adjusted for prepayments and economic forecasts, rather than recognizing losses only when impairment is deemed probable. This change resulted in a more forward-looking approach, with ACLs established for pools and individual loans, incorporating judgments about future economic conditions. The 2019 impairment losses (under the prior OTTI model) are now reflected as part of the ACL framework, leading to more consistent recognition of credit losses, even for securities not yet impaired. The methodologies now include discounted cash flow analyses and assumptions about recovery, increasing subjectivity and sensitivity to economic forecasts.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the fundamental shift from incurred loss model to expected lifetime loss model (CECL) and accurately describes the conceptual changes in how credit losses are now measured. The qualitative description of the methodology changes is sound and relevant. However, there are significant quantitative accuracy issues: (1) The LLM completely fails to provide the specific 2019 impairment loss figures that were central to the ground truth answer. The ground truth explicitly states impairment losses for 2019 were: foreign government ($81M), consumer corporate ($23M), industrial corporate ($22M), RMBS ($2M), and finance corporate ($1M). The LLM provides no specific numbers despite the question explicitly asking about 'impairment losses reported for 2019.' (2) The LLM mentions 'ACLs established for pools and individual loans' but doesn't specify the mortgage loan ACL methodology details provided in the ground truth (expected lifetime credit losses over contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions). (3) The LLM correctly notes the shift from OTTI and intent-to-sell losses to intent-to-sell and direct write-down losses for fixed maturity securities, but this is stated implicitly rather than explicitly. (4) The LLM adds information about 'discounted cash flow analyses' that wasn't in the ground truth, which while potentially accurate, represents speculation beyond the provided ground truth. The answer demonstrates good conceptual understanding but fails on the critical quantitative component of the question, which specifically asked about impairment losses reported for 2019.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 470,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the companys control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin's obligation to provide consulting support under international offset agreements is included in its total estimated costs to complete U.S. government contracts. These obligations are factored into contract cost recovery calculations, meaning the U.S. government would cover incurred costs if contracts are terminated for convenience. However, failure to meet offset commitments could result in penalties, and the ability to recover specific investments in offset obligations depends on the success of joint ventures, which are outside Lockheed Martin's direct control. This introduces risk to profitability but does not directly impair the recovery of costs under the U.S. government contracts themselves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ERROR: The LLM fails to mention the $64.3 billion in purchase obligations related to U.S. government contracts, which is a critical quantitative fact in the ground truth. This is a major omission of specific financial data. (2) FUNDAMENTAL MISCHARACTERIZATION: The LLM incorrectly states that offset obligations are 'included in its total estimated costs to complete U.S. government contracts' and that 'the U.S. government would cover incurred costs.' The ground truth clearly establishes these are SEPARATE mechanisms - offset costs are only recoverable through successful joint ventures, NOT through U.S. government contracts. Cost recovery under U.S. contracts is only guaranteed if contracts are terminated for convenience under FAR. (3) REASONING ERROR: The LLM's core logic is inverted. It suggests offset obligations are factored into U.S. contract cost recovery, when the ground truth shows these are distinct, non-aligned reimbursement mechanisms. The ground truth emphasizes the MISMATCH between these mechanisms creates financial risk. (4) INCOMPLETE SYNTHESIS: The LLM acknowledges joint venture risk but fails to synthesize how this creates a gap in cost recovery - the critical insight that costs incurred for offset obligations may not be recoverable through either mechanism if joint ventures fail AND contracts aren't terminated for convenience. (5) MISSING CONTEXT: The LLM downplays the severity by stating it 'does not directly impair' cost recovery, contradicting the ground truth's emphasis on 'financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.' The answer demonstrates partial understanding of offset agreements and joint venture risk but fundamentally misrepresents the relationship between offset obligations and U.S. government contract cost recovery mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 536,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "TMO's pharma services business drove significant revenue growth in 2021, fueled by pandemic-related demand for diagnostics, vaccine production, and therapeutic development services. This was complemented by strong performance in research and safety markets. The segment's margin expansion was aided by a $20 million credit from inventory accounting changes, offset partially by strategic growth investments, while higher sales and improved sales mix contributed to increased profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key financial drivers and the $20 million inventory accounting credit. Strengths: (1) Correctly identifies the $20 million credit from inventory accounting changes; (2) Accurately captures pandemic-related demand as a key driver; (3) Properly notes the offset from strategic growth investments; (4) Correctly identifies improved sales mix as a margin contributor; (5) Appropriately synthesizes multi-hop information across revenue and margin performance. Minor weaknesses: (1) The LLM adds specific detail about 'diagnostics' and 'research and safety markets' that, while potentially accurate, are not explicitly mentioned in the ground truth answer and may represent inference beyond what was stated; (2) The phrasing 'diagnostics, vaccine production, and therapeutic development services' is more specific than the ground truth's 'vaccine and therapy development,' though semantically similar; (3) The answer could have been slightly more explicit about the direct causal link between pandemic demand and the strong sales growth/margin expansion. The quantitative accuracy is high (the $20M figure is correct), and the qualitative reasoning about how pandemic demand, inventory accounting changes, and strategic investments all contributed to segment performance is sound. The answer successfully addresses both parts of the multi-hop question (revenue drivers and margin performance) and correctly synthesizes the relationship between these factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 420,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife's participation in Supervisory Colleges, led by NYDFS in the U.S. and involving EIOPA in Europe, enhances regulatory coordination and risk understanding across jurisdictions. These colleges facilitate cooperation among regulators to better assess MetLife's risk profile, align oversight requirements, and ensure compliance with both U.S. and European regulations, thereby strengthening supervisory effectiveness and mitigating cross-border risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of MetLife's Supervisory College participation and its regulatory implications. STRENGTHS: (1) Correctly identifies NYDFS as the U.S. chair and EIOPA's role in Europe; (2) Accurately captures the core function of these colleges - facilitating regulatory coordination and risk assessment; (3) No quantitative errors (no numbers were required in this qualitative question); (4) Properly synthesizes the multi-hop relationship between MetLife, NYDFS, EIOPA, and regulatory oversight; (5) Appropriately emphasizes cross-border risk mitigation and supervisory effectiveness. WEAKNESSES: (1) The LLM answer is more concise and somewhat generic compared to the ground truth, which provides more specific institutional details; (2) Missing explicit mention of the Central Bank of Ireland as a specific European regulator example; (3) Doesn't explicitly state that NYDFS 'annually' chairs these meetings, though this is a minor detail; (4) The ground truth emphasizes that these colleges help regulators 'better understand the risk profile of MetLife's international operations' - the LLM captures this concept but with slightly less specificity about 'international operations'; (5) Ground truth mentions 'EEA-based insurance groups with significant European operations' - the LLM doesn't specify this EEA context. MULTI-HOP REASONING: The LLM correctly synthesizes information across U.S. and European regulatory frameworks and their interaction with MetLife. The logic is sound and the answer appropriately addresses how participation influences both regulatory oversight and risk profile. The answer is semantically equivalent to the ground truth in its core message, though less detailed in institutional specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 479,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, led to a **net ACL release of $373 million in 2024** compared to a $312 million release in 2023. This decrease in provisions for credit losses reduced expenses, contributing to Citi's **27% increase in Net Income** to $4.9 billion in 2024 from $3.9 billion in 2023. The lower ACL build reflected improved macroeconomic conditions and safety-and-soundness considerations, which reduced credit risk exposure and associated provisions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides completely different numbers than ground truth. Ground truth states provision expense decreased from $406M (prior year) to $295M (2024), a $111M decrease. LLM incorrectly states 'net ACL release of $373 million in 2024 compared to $312 million release in 2023' - these numbers do not match the ground truth provision expense figures at all. The $373M and $312M figures appear to be fabricated or from a different metric entirely. (2) CALCULATION VERIFICATION - Ground truth: $406M - $295M = $111M decrease in provision expense (correct). LLM's numbers: $373M - $312M = $61M difference, which doesn't align with ground truth's $111M impact. (3) NET INCOME FIGURES - LLM correctly states 27% increase to $4.9B from $3.9B in 2023. Ground truth confirms 27% increase to $4.9B but doesn't explicitly state prior year as $3.9B (though the math checks: $4.9B / 1.27  $3.86B, so this is approximately correct). (4) MULTI-HOP REASONING - While LLM correctly identifies the relationship between ACL reduction and Net Income impact, and correctly states the 27% increase, the core financial figures supporting this analysis are wrong. The LLM appears to have confused ACL release amounts with provision expense amounts. (5) MISSING SPECIFICITY - Ground truth specifically mentions the $111M decrease in provision expense as the driver of Net Income improvement; LLM discusses ACL releases instead, which is a different metric. The answer demonstrates partial understanding of the relationship but fails on fundamental numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 438,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segments revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martins financial performance.",
      "llm_answer": "Lockheed Martin's Aeronautics segment, which derives 32% of its net sales from international customers (73% of which are FMS), could face delays in F-35 program deliveries and reduced orders if U.S. government funding disruptions occur due to the debt ceiling expiration. The F-35 program, critical to both domestic and international commitments (including twelve FMS customers), relies on timely DoD funding. Funding delays could impair production schedules, impact backlog conversion, and reduce revenue, particularly as the segment's international sales are closely tied to U.S. government appropriations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) All key quantitative facts are correct - 32% international sales, 73% FMS composition, twelve FMS customers for F-35 program are all accurately stated. (2) The multi-hop synthesis is properly executed: correctly connects Aeronautics segment international exposure  FMS dependency  U.S. government funding  potential disruption impact. (3) Identifies specific mechanisms of impact (delayed deliveries, reduced orders, impaired production schedules, backlog conversion issues). (4) Appropriately emphasizes the F-35 program as the critical link. (5) Correctly notes the dependency on DoD appropriations. MINOR WEAKNESSES: (1) The phrase 'derives 32% of its net sales from international customers (73% of which are FMS)' is slightly ambiguous in structure - while mathematically correct, it could be clearer that 73% refers to the composition of international sales, not the 32% figure itself. (2) Omits explicit mention of the 'long-cycle nature of defense contracts' that the ground truth emphasizes as a factor in prolonged effects. (3) Does not explicitly state that disruptions could affect 'revenue and margins' as comprehensively as the ground truth. CALCULATION VERIFICATION: The implicit calculation (32% international  73% FMS = ~23% of total sales through FMS) is mathematically sound, though not explicitly stated in either answer. MULTI-HOP REASONING: Correctly synthesizes: debt ceiling  U.S. funding disruption  FMS order delays  F-35 production impact  Aeronautics segment revenue effect. The reasoning chain is logically sound and complete. The answer is substantively equivalent to the ground truth despite minor wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 477,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "As of December 31, 2023, **70 million shares** of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and related plans. This includes **53 million shares** under the 2020 Stock Incentive Plan and **17 million shares** under the ESPP. The number of shares underlying stock options assumed through acquisitions was **191,000**, which are excluded from the 70 million available for future issuance. Thus, the available shares under the plans significantly exceed the shares from acquired options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numeric values are correct: 70 million total shares available (53 million under 2020 Stock Incentive Plan + 17 million under ESPP), and 191,000 shares underlying stock options assumed through acquisitions. The multi-hop synthesis is sound - the answer correctly identifies and combines information from multiple sources (the 2020 Plan, ESPP, and acquisition-related options) and properly compares them. The answer addresses all parts of the question: (1) shares available under the 2020 Plan and related plans, (2) the breakdown of those shares, and (3) the comparison to assumed stock options. The reasoning is logical and the conclusion that available shares significantly exceed acquired options is well-supported. The only minor distinction from the ground truth is that the LLM explicitly notes the 191,000 shares are 'excluded from the 70 million available' which adds helpful clarity, though the ground truth uses slightly different phrasing ('separately'). This is a semantic enhancement rather than an error. All calculations are accurate, entity identification is correct (UnitedHealth Group, 2020 Stock Incentive Plan, ESPP, December 31, 2023), and the contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 352,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The total stock-based compensation expense related to the Multi-Year Equity Awards for fiscal years 2022 through 2024 was **$1,746 million** ($794 million in 2022, $596 million in 2023, and $356 million in 2024). This compares to the total unrecognized compensation cost of **$11,259 million** as of November 3, 2024, which is expected to be recognized over the remaining weighted-average service period of 3.0 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) Total stock-based compensation expense breakdown is accurate - $794M (2022) + $596M (2023) + $356M (2024) = $1,746M total; (2) Unrecognized compensation cost of $11,259M as of November 3, 2024 is correct; (3) Weighted-average service period of 3.0 years is accurate. The answer successfully synthesizes multi-hop information by combining the three-year compensation expense data with the unrecognized cost figure and contextualizing it with the remaining service period. The comparison is logical and meaningful - showing that the $1,746M recognized over three years is substantially less than the $11,259M yet to be recognized. The answer addresses all parts of the question: the total compensation expense calculation, the comparison to unrecognized costs, and the temporal context. Minor deduction from perfect score (9 vs 10) only because the LLM could have slightly emphasized the magnitude of the comparison (unrecognized costs are approximately 6.4x the three-year recognized expense), though this is not required by the question. The wording is clear, professional, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 342,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "The total minimum LTD requirement for Citi in 2024 is **9.5% of RWA**, calculated as the greater of (i) **6% of RWA plus a 3.5% GSIB surcharge under Method 2** (totaling 9.5%) or (ii) 4.5% of total leverage exposure. This value is derived from the TLAC section, which specifies the LTD requirement as the higher of these two thresholds, with the 6% RWA base plus the 3.5% surcharge binding for Citi in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate information. All numeric values are correct: 9.5% total requirement, 6% base, 3.5% GSIB surcharge under Method 2. The calculation is accurate (6% + 3.5% = 9.5%). The answer correctly identifies Citi and the 2024 timeframe. The multi-hop reasoning is sound - the model synthesizes the base requirement, the GSIB surcharge component, and explains how they combine to reach the total. The LLM answer goes beyond the ground truth by providing additional context about the alternative threshold (4.5% of total leverage exposure) and explaining that the RWA-based calculation is the binding constraint for Citi. This additional detail is accurate and enhances understanding without introducing errors. The semantic meaning matches the ground truth perfectly - both convey that the 9.5% requirement is derived from adding the 3.5% surcharge to the 6% base. Minor difference: the LLM provides more comprehensive explanation of the regulatory framework (mentioning the 'greater of' comparison), which is contextually relevant and accurate but not explicitly stated in the ground truth. This represents a strength rather than a weakness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 336,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade (20252034) is **$19.51 billion**, calculated by summing the estimated future benefit payments of $9.52 billion (20252029) and $9.99 billion (20302034) from the 2024 10-K. The annual increases from 2025 to 2029 (e.g., $1.80 billion in 2025 rising to $1.99 billion in 2029) reflect a steady upward trend in pension obligations, driven by factors such as actuarial assumptions, demographic changes, and inflation, indicating growing financial commitments over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the total projected funding requirement and proper synthesis of multi-hop information. STRENGTHS: (1) Total amount correct: $19.51 billion ($19,510 million) matches ground truth exactly; (2) Correctly identifies the two-period breakdown: $9.52 billion (2025-2029) and $9.99 billion (2030-2034); (3) Accurately cites specific annual figures for 2025-2029 range ($1.80B to $1.99B); (4) Properly synthesizes information from 2024 10-K filing; (5) Correctly identifies the upward trend pattern in annual increases; (6) Provides relevant contextual factors (actuarial assumptions, demographic changes, inflation). WEAKNESSES: (1) The calculation verification reveals a minor discrepancy: Ground truth shows $1,800M + $1,860M + $1,910M + $1,960M + $1,990M = $9,520M for 2025-2029, which matches the LLM's $9.52B. However, the LLM states this sum but doesn't explicitly break down the individual year-by-year progression as comprehensively as the ground truth (which lists all five years individually); (2) The LLM provides general explanatory factors for the trend but doesn't emphasize the specific consistent increment pattern as clearly as the ground truth (approximately $50-60M increases year-over-year from 2025-2029); (3) Minor semantic difference: LLM says 'steady upward trend' while ground truth emphasizes 'consistent upward trend' - both convey the same meaning but ground truth is more precise. MULTI-HOP REASONING: The answer correctly synthesizes information across the decade-long projection period and properly combines the two five-year segments. The reasoning connecting annual increases to growing obligations is sound. CALCULATION VERIFICATION: $1.80B + $1.86B + $1.91B + $1.96B + $1.99B = $9.52B ; $9.52B + $9.99B = $19.51B . All calculations are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 503,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was **$1,075 million (2020)** and **$1,151 million (2021)**. In 2020, this category accounted for **5.53%** of total fixed income investments, and in 2021, it represented **5.75%** of total fixed income investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all quantitative metrics. Specific errors: (1) 2020 value stated as $1,075M vs. ground truth $982M - a difference of $93M or 9.5% error; (2) 2021 value stated as $1,151M vs. ground truth $1,072M - a difference of $79M or 7.4% error; (3) Combined total calculated as $2,226M vs. ground truth $2,054M - a $172M discrepancy; (4) 2020 percentage stated as 5.53% vs. ground truth 8.1% - a significant 2.57 percentage point error; (5) 2021 percentage stated as 5.75% vs. ground truth 8.9% - a significant 3.15 percentage point error. The LLM appears to have used entirely different source data or made systematic calculation errors. The percentages suggest the LLM may have used different total fixed income investment figures ($19.4B for 2020 and $20.0B for 2021 based on the percentages provided), which do not match the ground truth totals of $12,106M and $12,041M respectively. The answer addresses the structure of the question (combined value + ranking by proportion) but fails completely on factual accuracy. All six numeric values provided by the LLM are incorrect, making this response unreliable for financial analysis or decision-making.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 336,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom's shift to multi-year equity awards with 4-7 year vesting periods results in stock-based compensation expense being recognized over the vesting period rather than annually. This changes the expense pattern from a more front-loaded annual recognition to a gradual amortization over 4-7 years, as detailed in the Multi-Year Equity Awards section (page 45). The expense is now spread across the vesting periods, aligning with the longer-term nature of these awards.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general concept that Broadcom shifted to multi-year awards with longer vesting periods and that this extends the expense recognition timeline. However, there are significant issues with accuracy and completeness:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM states vesting periods of \"4-7 years\" but the ground truth specifies the shift is FROM a 4-year vesting cycle per annual grant TO a 7-year total period for multi-year awards. The LLM's phrasing is ambiguous about whether individual awards vest over 4-7 years or if the total period is 7 years.\n   - The ground truth clarifies that the multi-year awards encompass \"four annual grant cycles into one award\" - this structural detail is missing from the LLM answer.\n   - The LLM mentions \"page 45\" as a source, but this specific citation is not verified against the ground truth and may be inaccurate.\n\n2. COMPLETENESS ISSUES:\n   - The LLM answer lacks the key structural insight that the multi-year awards consolidate four annual grant cycles into a single award, which is central to understanding how the expense pattern changes.\n   - The ground truth emphasizes the shift from overlapping annual grants (each with 4-year vesting) to a consolidated multi-year approach with up to 7-year total recognition. The LLM doesn't clearly explain this consolidation effect.\n   - Missing the comparison of \"overlapping expense recognition timeline\" vs. the prior annual model.\n\n3. REASONING QUALITY:\n   - The LLM correctly identifies that expense recognition extends over the vesting period rather than being annual.\n   - However, the characterization of the change as \"front-loaded annual recognition to gradual amortization\" is not clearly supported by the ground truth, which focuses on the extension of the recognition period and consolidation of grants.\n   - The multi-hop synthesis is incomplete - the answer doesn't fully connect how consolidating four annual cycles into one award affects the overall expense pattern.\n\n4. SEMANTIC ISSUES:\n   - The phrase \"spread across the vesting periods\" is somewhat vague compared to the ground truth's clearer explanation of the 7-year total period.\n   - The LLM's description of \"front-loaded\" vs. \"gradual amortization\" introduces concepts not explicitly in the ground truth.\n\n5. WHAT WAS CORRECT:\n   - Correctly identifies the shift to multi-year awards\n   - Correctly notes the 4-7 year vesting periods (though ambiguously phrased)\n   - Correctly states that expense is recognized over the vesting period\n   - Correctly identifies this as a change from the prior model\n\nThe answer is partially correct but lacks the structural clarity and specific details that define the actual change in Broadcom's compensation expense recognition pattern.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 741,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "The application of U.S. banking law, particularly safety and soundness considerations, reduced credit loss provisions in both Legacy Franchises and the Markets segment by limiting the ACL build for transfer risks outside the U.S. In 2024, Legacy Franchises' provisions decreased to $276 million (from $950 million in 2023), while Markets' provisions rose to $463 million (from $438 million in 2023), reflecting a net reduction in total provisions to $1.1 billion compared to $1.3 billion in 2023. This combined impact was partially offset by higher net credit losses in Mexico Consumer.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent the ground truth data:\n\n1. QUANTITATIVE ERRORS (Most Critical):\n   - Legacy Franchises 2024: LLM states $276 million, but ground truth is $1.1 billion - a massive discrepancy of $824 million\n   - Legacy Franchises 2023: LLM states $950 million, but ground truth is $1.3 billion - off by $350 million\n   - Markets 2024: LLM correctly states $463 million (matches ground truth)\n   - Markets 2023: LLM correctly states $438 million (matches ground truth)\n   - Total 2024: LLM states $1.1 billion, but ground truth is $1.563 billion - off by $463 million\n   - Total 2023: LLM states $1.3 billion, but ground truth is $1.738 billion - off by $438 million\n   - Combined impact reduction: LLM does not calculate this; ground truth shows $175 million reduction\n\n2. CALCULATION ERRORS:\n   - LLM's stated totals don't even sum correctly from their own numbers ($276M + $463M = $739M, not $1.1B)\n   - Ground truth calculations are internally consistent: $1.1B + $463M = $1.563B for 2024; $1.3B + $438M = $1.738B for 2023\n   - The $175 million reduction is not mentioned or calculated by LLM\n\n3. INCOMPLETE SYNTHESIS:\n   - LLM fails to properly synthesize the combined impact across both segments\n   - LLM introduces extraneous information about Mexico Consumer that wasn't in the ground truth answer\n   - LLM does not address the specific mechanism (ACL build for transfer risk) as clearly as ground truth\n\n4. ENTITY/METRIC ACCURACY:\n   - Correctly identifies Legacy Franchises and Markets segments\n   - Correctly identifies 2023 and 2024 years\n   - Correctly references ACL and transfer risks\n   - However, the numerical values associated with these entities are largely incorrect\n\n5. REASONING QUALITY:\n   - The reasoning about U.S. banking law's influence is conceptually sound\n   - However, the application to specific numbers is fundamentally flawed\n   - The multi-hop synthesis fails because the underlying data points are wrong\n\nThe LLM answer appears to have confused or misremembered the actual provision amounts, particularly for Legacy Franchises, which is the larger component of the answer. This is a critical failure for a financial question where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 612,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million  ($8,450 million + $8,396 million)).",
      "llm_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans was $767 million in 2020 and $691 million in 2021, totaling **$1,458 million**. This combined amount represented **8.66%** of the total assets at fair value for Non-U.S. Plans ($8,450 million in 2020 and $8,396 million in 2021).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All numeric values are correct: $767 million (2020), $691 million (2021), $1,458 million (total), $8,450 million (2020 total assets), $8,396 million (2021 total assets), and 8.66% (percentage). The calculation is verified: $1,458M  ($8,450M + $8,396M) = $1,458M  $16,846M = 0.08659 = 8.66% (correctly rounded). The answer properly synthesizes multi-hop information by: (1) identifying the correct company (HON), (2) identifying the correct plan type (Non-U.S. Plans), (3) combining values across both years, (4) calculating the percentage relative to total assets at fair value across both years. All entities are correctly identified and the reasoning is sound. The only minor distinction from the ground truth is slight wording variation (\"for Non-U.S. Plans\" vs. the ground truth's implicit reference), but this is semantically equivalent and actually provides helpful clarification. The answer directly addresses all parts of the multi-part question with complete accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 296,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom's emphasis on internal research and development (R&D) strengthens its semiconductor segment's technology leadership in AI markets by enabling the creation of custom silicon solutions and advanced IP platforms tailored for AI and high-performance computing. This R&D focus allows Broadcom to develop specialized products like Ethernet switching silicon, optical components, and custom ASICs optimized for AI data centers, ensuring competitive differentiation and sustained innovation in critical AI-related applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Broadcom's R&D emphasis and its connection to semiconductor leadership in AI markets, demonstrating understanding of the core relationship. However, there are significant gaps in specificity and accuracy compared to the ground truth. STRENGTHS: (1) Correctly identifies Broadcom and its R&D strategy focus; (2) Appropriately connects R&D to AI market competitiveness; (3) Mentions relevant product categories (Ethernet switching, optical components, ASICs); (4) No quantitative errors present. WEAKNESSES: (1) Missing critical technical details from ground truth - fails to mention specific semiconductor technologies like CMOS-based devices, gallium arsenide (GaAs), and indium phosphide (InP), which are explicitly highlighted in the original answer as essential for high-speed RF and optoelectronic applications; (2) Lacks the explicit statement about 'extensive internal research and development' strategy that the ground truth emphasizes; (3) Does not mention the specific application domains (high-speed RF and optoelectronic applications) that are central to the ground truth explanation; (4) Omits reference to 'category-leading infrastructure technology products' and serving 'major business and government customers'; (5) The answer is somewhat generic - it could apply to many semiconductor companies rather than capturing Broadcom's specific strategic positioning. MULTI-HOP REASONING: The LLM successfully synthesizes the relationship between R&D investment and competitive advantage in AI markets, but fails to incorporate the technical depth and specific product examples that demonstrate how this strategy actually works. The reasoning is sound but incomplete. SEMANTIC EQUIVALENCE: While the general concept is correct, the answer lacks the technical specificity and strategic detail that characterize the ground truth, making it less precise and informative.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 517,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Qualcomm expects to pay $9.6 billion under its purchase agreements in the next 12 months. As of September 29, 2024, total advance payments made under multi-year capacity purchase commitments were $3.0 billion. The expected payments ($9.6 billion) are significantly higher than the advance payments ($3.0 billion).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all key financial figures: $9.6 billion in expected payments over the next 12 months, $3.0 billion in advance payments, and accurately compares them. All numbers are factually correct and match the ground truth. The date (September 29, 2024) is correctly referenced. The multi-hop reasoning is sound - the model successfully synthesized information about purchase agreements and capacity commitments, and correctly concluded that the near-term payments are significantly higher than advance payments already made. However, the answer is somewhat less complete than the ground truth. The original answer provides additional context that the $9.6 billion is 'part of the total $12.8 billion in obligations under purchase agreements' and notes these 'primarily relate to integrated circuit product inventory obligations.' The LLM answer omits these contextual details about the broader obligation structure and the nature of the commitments. While the core comparison and main facts are correct, the answer lacks some of the explanatory depth present in the ground truth. The reasoning about the significance of the comparison is present but briefer. Overall, this is a solid answer with accurate numbers and correct synthesis, but missing some contextual enrichment that would make it more comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 373,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The GTN adjustment reductions for 2024 ($159 million) differed from those of 2023 ($134 million) by **$25 million**. The specific non-U.S. factor contributing to this change was **revisions in clawback amounts driven by VAT recoverable estimates** in non-U.S. regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The 2024 GTN adjustment reduction of $159 million, 2023 figure of $134 million, and the calculated difference of $25 million are all correct. The specific non-U.S. factor (revisions in clawback amounts driven by VAT recoverable estimates) is accurately identified. (2) QUANTITATIVE ACCURACY: All three numeric values are correct with proper formatting. The calculation ($159M - $134M = $25M) is accurate. (3) QUALITATIVE ACCURACY: The answer correctly identifies and synthesizes the multi-hop elements: comparing two years of GTN adjustment reductions and identifying the specific contributing factor. The reasoning is sound and the entities (GTN adjustments, VAT recoverable estimates, clawback amounts) are properly identified. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the multi-part question - the quantitative difference and the qualitative explanation of the non-U.S. factor. The minor addition of 'in non-U.S. regions' provides helpful context without deviating from the ground truth. The answer is well-structured, clear, and semantically equivalent to the ground truth while maintaining professional clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 357,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send contributes to Mastercard's disbursements and remittances strategy by enabling seamless, secure money transfers domestically and across borders through partnerships with digital messaging platforms, central banks, fintechs, and financial institutions. These collaborations facilitate efficient distribution of social and economic assistance, B2C disbursements, and cross-border payments via a unified distribution network, leveraging multiple channels like mobile wallets, bank accounts, and cash payouts.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of Mastercard Send's role in the disbursements and remittances strategy. STRENGTHS: (1) Correctly identifies the core function of Mastercard Send (enabling money transfers domestically and across borders); (2) Accurately lists key partner ecosystems (central banks, fintechs, financial institutions); (3) Correctly identifies use cases (social/economic assistance distribution, B2C disbursements, cross-border payments); (4) No quantitative errors present; (5) Multi-hop reasoning is sound - properly synthesizes how Mastercard Send connects to broader payment flow capture objectives. MINOR WEAKNESSES: (1) The LLM adds 'digital messaging platforms' and 'mobile wallets, bank accounts, and cash payouts' as specific channels/partners, which while plausible and not contradicted by ground truth, go slightly beyond what was explicitly stated in the original answer; (2) The ground truth emphasizes 'consumers, businesses, governments, and nonprofits' as beneficiaries more explicitly, while the LLM focuses more on the distribution mechanisms; (3) The phrase 'unified distribution network' is not explicitly mentioned in the ground truth, though it's a reasonable characterization. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth - that Mastercard Send enables efficient money transfers through partnerships with key financial ecosystem players to capture new payment flows. The core message about leveraging central banks, fintechs, and financial institutions is preserved. The answer appropriately addresses the multi-part question about contribution to payment flow capture and partner ecosystems. No factual errors or contradictions with the ground truth were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 490,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercards net revenue structure.",
      "llm_answer": "Mastercard's introduction of Cyber and Intelligence Solutions as part of its value-added services contributed to the \"Other revenues\" category in 2022 by adding fees related to fraud prevention, detection, and transaction security. These revenues are recognized in the period when the associated services are performed or transactions occur, aligning with Mastercard's revenue recognition policy for value-added products. The inclusion of these services expanded the composition of \"Other revenues\" and shifted recognition timing to reflect service delivery rather than volume-based metrics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core factual content. Both answers correctly identify that: (1) Mastercard introduced Cyber and Intelligence Solutions as value-added services, (2) these services contribute to 'Other revenues', (3) the services relate to fraud prevention and transaction security, and (4) revenues are recognized when services are performed or transactions occur. No quantitative data (numbers, dates, percentages) were required in either answer, so quantitative accuracy is perfect. The LLM answer adds slightly more detail by explicitly mentioning 'fraud prevention, detection, and transaction security' (more comprehensive than ground truth's 'prevent fraud and ensure transaction safety') and clarifies that recognition timing 'shifted' from volume-based metrics to service delivery. This additional context is accurate and enhances understanding. The multi-hop reasoning is sound - the answer correctly synthesizes how the introduction of a new service affects both the composition (what's included) and timing (when recognized) of Other revenues. Minor deduction from perfect score: the phrase 'shifted recognition timing to reflect service delivery rather than volume-based metrics' goes slightly beyond what the ground truth explicitly states, though it is a reasonable inference about how service-based recognition differs from transaction-volume recognition. The answer is semantically equivalent to the ground truth while providing marginally enhanced clarity and detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 424,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "The total change in fair value of CAT's Mortgage-Backed Debt Securities from December 31, 2022, to December 31, 2023, was an increase of **$633 million** (from $3,164 million to $3,797 million). The change in unrealized losses during the same period was a **decrease of $63 million** (from $148 million in 2022 to $85 million in 2023). This indicates that while the fair value of these securities rose, the unrealized losses contracted, reflecting improved market conditions or reduced credit risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative measures. (1) CRITICAL ERRORS: The LLM reports fair value increased from $3,164M to $3,797M (a $633M increase), but the ground truth shows fair value decreased from $327M to $320M (a $7M decrease). These are completely different numbers - off by a factor of approximately 10x. (2) UNREALIZED LOSSES ERROR: The LLM states unrealized losses decreased from $148M to $85M (a $63M decrease), but ground truth shows unrealized losses decreased from $31M to $25M (a $6M decrease). Again, the LLM numbers are approximately 5x larger than actual values. (3) CALCULATION VERIFICATION: Even accepting the LLM's stated numbers, the direction of change is correct (both fair value and unrealized losses moved in the stated directions), but the magnitude is wildly inaccurate. (4) MULTI-HOP SYNTHESIS: The LLM failed at the most basic level - retrieving the correct financial data for CAT's Mortgage-Backed Debt Securities. This appears to be a data retrieval failure rather than a reasoning error. The LLM may have confused CAT's securities with another company's or pulled data from the wrong line items. (5) SEMANTIC INTERPRETATION: While the LLM correctly interpreted that improving unrealized losses is positive, this interpretation is based on entirely wrong numbers. The ground truth shows a much smaller improvement ($6M vs $63M), which changes the materiality of the finding. The answer demonstrates complete failure on quantitative accuracy, which is the primary requirement for financial analysis questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 430,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "The total fair value of Qualcomm's corporate bonds and notes as of September 29, 2024, was **$4.634 billion** (Level 2), representing **85%** of total marketable securities. U.S. Treasury securities and government-related securities had a fair value of **$208 million** (Level 1), accounting for **3.8%** of total marketable securities.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong multi-hop synthesis. Verification of key facts: (1) Corporate bonds and notes fair value: LLM states $4.634 billion, ground truth states $4,634 million - these are equivalent (4.634 billion = 4,634 million), so this is correct. (2) U.S. Treasury and government-related securities: LLM states $208 million, ground truth states $208 million - correct match. (3) Percentages: LLM states 85% for corporate bonds and 3.8% for Treasury securities, ground truth states approximately 85% and about 3.8% - correct match. (4) Total marketable securities: Ground truth mentions $5,451 million total, which can be verified: $4,634M + $208M = $4,842M (this accounts for the two categories mentioned, though the total of $5,451M suggests other securities exist). The LLM correctly synthesized the multi-hop comparison between the two security types as percentages of total. Minor deduction: The LLM added contextual information about 'Level 2' and 'Level 1' fair value measurement levels, which while potentially accurate from the filing, was not explicitly mentioned in the ground truth answer. This is additional context rather than an error. The answer fully addresses both parts of the question (total fair value of corporate bonds/notes AND comparison to Treasury securities as percentages). The reasoning is sound and the semantic meaning matches the ground truth perfectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 393,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "Merck extends market protection for Keytruda beyond its compound patent expiration (U.S. expiration in 2028) through **pediatric market exclusivity**, which adds **six months of additional exclusivity** in the U.S. (as noted in the table on page 15). This exclusivity, combined with potential Supplementary Protection Certificates (SPCs) in the EU (expiring in 2031) and patent term extensions (PTEs), delays generic competition. Financially, this prolongs Keytrudas revenue contribution to Mercks oncology segment, maintaining pricing power and delaying revenue decline from market entry of biosimilars or generics.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core mechanism (six months of pediatric market exclusivity) and accurately conveys the financial impact (delaying generic competition, maintaining pricing power, preserving oncology revenue). The reasoning about how exclusivity extends market protection is sound and well-articulated. The answer appropriately addresses both the mechanism and financial implications of the question.\n\nWEAKNESSES: (1) QUANTITATIVE ISSUES: The LLM introduces specific dates (U.S. patent expiration in 2028, EU SPCs expiring in 2031) that are NOT present in the ground truth answer. These appear to be added details not verified against the source documents. The ground truth does not mention these specific dates. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly mentions Patent Term Extension (PTE) of up to five years as a potential benefit, but the LLM only briefly mentions PTEs without quantifying the potential duration. (3) MISSING CONTEXT: The ground truth emphasizes that Keytruda is part of a 'global strategic oncology collaboration,' which provides important context for the financial impact. The LLM does not mention this collaboration aspect. (4) SPECULATIVE ELEMENTS: The LLM introduces Supplementary Protection Certificates (SPCs) in the EU, which is not mentioned in the ground truth sources provided.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between pediatric exclusivity, patent protection, and financial impact on oncology revenue. However, it adds information not present in the ground truth, which raises concerns about factual accuracy versus inference.\n\nNUMERIC VERIFICATION: The six-month pediatric exclusivity figure is correct and matches the ground truth. However, the patent expiration dates (2028 for U.S., 2031 for EU) cannot be verified against the provided ground truth sources and may be inaccurate or unsupported.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the mechanism and financial implications but introduces unverified specific dates and omits some key details from the ground truth (PTE duration, strategic collaboration context). The core answer is directionally correct but contains potential factual errors in the specific dates cited.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 608,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercards strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercards innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "Mastercard Installments, introduced in 2022 as part of Mastercard's innovation efforts, supports its strategic goal of expanding digital payment services by enabling buy-now-pay-later (BNPL) capabilities across its global network. This solution connects lenders and merchants, offering consumers flexible payment options while leveraging Mastercard's multi-rail infrastructure to integrate seamlessly into e-commerce, mobile, and digital platforms. By addressing evolving consumer demand for installment payments, it enhances digital payment adoption across multiple channels, aligning with Mastercard's focus on expanding payment flows and enhancing transactional flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies Mastercard Installments as a 2022 introduction - no date errors. (2) Accurately describes it as a buy-now-pay-later (BNPL) solution connecting lenders and merchants across the acceptance network, matching the ground truth characterization. (3) Properly synthesizes the multi-hop connection between the product innovation and strategic goals of expanding digital payment services. (4) Correctly identifies key channels (e-commerce, mobile, digital platforms) and strategic elements (multi-rail infrastructure, payment flows). (5) No quantitative errors or miscalculations present. MINOR GAPS: (1) The LLM answer does not explicitly mention 'digital currency solutions' as a key component of the broader ecosystem strategy, which the ground truth identifies as part of the diversification effort. (2) The phrase 'open-loop' from the ground truth is not explicitly used, though the concept is implied through the description of connecting lenders and merchants. (3) The ground truth emphasizes 'delivering better digital experiences everywhere, particularly through mobile and connected devices' as outlined in the 2022 10-K - the LLM mentions mobile and digital platforms but doesn't explicitly reference the 'connected devices' aspect or the 10-K source. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same strategic logic and factual information as the ground truth, with slightly less comprehensive coverage of the broader ecosystem context. The reasoning is sound and the synthesis across multiple strategic elements is accurate. The answer would satisfy most evaluation criteria for a multi-hop financial question, though it could be more comprehensive in addressing all strategic dimensions mentioned in the original filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 508,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP, which split profits equally, were fully recorded within **Cost of sales** in 2024. The document states that the **Cost of sales** for the Lagevrio collaboration includes Ridgeback's share of profits, and since profits are split equally, Merck's share (the profit-sharing payment) is entirely reflected in this line item. Thus, **100%** of Merck's profit-sharing payments were recorded within Cost of sales in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the key quantitative metric. The ground truth states that 50% of profits from the Lagevrio collaboration were recorded within Cost of sales (reflecting Ridgeback's equal share of profits), while the LLM claims 100% of Merck's profit-sharing payments were recorded in Cost of sales. This is a critical factual error on the primary question being asked. The LLM appears to have misunderstood the accounting treatment: the question asks what portion of Merck's payments to Ridgeback were recorded in Cost of sales, and the answer is 50% (Ridgeback's equal share), not 100%. The LLM's reasoning that 'Merck's share (the profit-sharing payment) is entirely reflected in this line item' conflates Merck's own profit with the payments made to Ridgeback. The LLM correctly identifies the equal profit split and the relevant entities (Merck, Ridgeback, Lagevrio), but arrives at the wrong percentage conclusion. The quantitative accuracy is severely compromised by stating 100% instead of 50%. The qualitative reasoning is flawed because it misinterprets what portion of payments would be recorded in Cost of sales versus what represents Merck's retained profit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 338,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) enables non-U.K. funds, including BlackRock's European-domiciled funds, to register with the U.K. Financial Conduct Authority (FCA) to market to U.K. retail investors. To qualify, the consumer protection regimes in the EU countries where these funds are domiciled must be deemed equivalent to the U.K.'s regulatory standards. This equivalence requirement involves aligning with the U.K.'s Consumer Duty, which mandates that firms deliver good outcomes for retail customers through transparent practices, adequate disclosure, and fair treatment. BlackRock must demonstrate that its EU-based structures meet these UK-specific safeguards, ensuring that investor protections in the EU are as robust as those in the U.K. This process allows BlackRock to market its funds in the U.K. under the OFR while adhering to regulatory harmonization.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a solid understanding of the OFR framework and its interaction with BlackRock's European domicile structures. STRENGTHS: (1) Correctly identifies the core mechanism - that OFR allows non-UK funds to register with the FCA to market to UK retail investors; (2) Accurately states the equivalence requirement - that EU consumer protection regimes must be deemed equivalent to UK standards; (3) No quantitative errors or incorrect numbers/dates; (4) Properly identifies BlackRock as the subject entity and correctly references the FCA; (5) Adds relevant contextual detail about the UK Consumer Duty and regulatory harmonization, which provides helpful elaboration. WEAKNESSES: (1) The ground truth answer is more concise and focused on the direct interaction between OFR and BlackRock's ability to market funds, while the LLM answer adds interpretive details about the Consumer Duty that, while relevant to UK regulation generally, may go beyond what the ground truth specifically establishes about the OFR-specific requirements; (2) The LLM answer introduces the concept of 'regulatory harmonization' which is not explicitly mentioned in the ground truth; (3) The ground truth mentions that equivalence requirements 'may necessitate adjustments to fund structures or compliance frameworks,' which the LLM answer addresses implicitly but doesn't explicitly state. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between three elements: (1) OFR framework, (2) BlackRock's European structures, and (3) UK marketing ability. The reasoning chain is sound and logical. The answer appropriately connects the equivalence requirement to the practical outcome of being able to market funds in the UK. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth - equivalence of consumer protection regimes is required for UK marketing of European-domiciled funds. The additional detail about Consumer Duty, while potentially beyond the ground truth scope, is not contradictory and represents reasonable regulatory context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 556,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom's internal manufacturing of FBAR filters for RF semiconductor devices enables proprietary technology protection and faster time-to-market, leveraging their expertise in FBAR technology, amplifier design, and module integration. This internal fabrication, combined with proprietary processes, ensures industry-leading performance in cellular RF transceivers, allowing efficient operation in congested RF spectrums and securing a significant market share in the cellular handset market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. Both answers correctly identify the core competitive advantages of Broadcom's internal FBAR filter manufacturing: (1) intellectual property protection, (2) faster time-to-market, and (3) significant market share in cellular handsets. The LLM answer expands appropriately on these core points by adding relevant technical context (amplifier design, module integration, RF spectrum efficiency) that logically supports the main thesis without introducing factual errors. No quantitative data is present in either answer, so quantitative accuracy is perfect (no numbers to verify). The multi-hop reasoning is sound - the answer correctly synthesizes how internal manufacturing strategy connects to competitive advantage in the cellular handset market. The LLM answer provides slightly more technical depth and specificity (mentioning 'industry-leading performance in cellular RF transceivers' and 'congested RF spectrums') which adds value without contradicting the ground truth. The only minor consideration is that the LLM answer is more elaborate than the ground truth, but this elaboration appears to be accurate contextual enhancement rather than unsupported claims. All key entities (Broadcom, FBAR filters, RF semiconductors, cellular handset market) are correctly identified. The semantic meaning is fully preserved and enhanced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 392,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck utilizes patent term extensions (PTEs) of up to five years in the U.S. and regulatory exclusivity mechanisms, such as data exclusivity, to maximize market protection for biologics. In the U.S., biologic products receive **12 years of data exclusivity** from the date of first marketing approval, extending beyond the typical 10-year patent term. Additionally, **six months of pediatric market exclusivity** may be granted for completing pediatric studies. These exclusivities, combined with PTEs and Supplementary Protection Certificates (SPCs) in Europe, create layered protections to offset time lost during clinical trials and regulatory review, ensuring prolonged market exclusivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. STRENGTHS: (1) All key numeric values are accurate - 12 years of data exclusivity for biologics and 6 months of pediatric exclusivity are both correct per ground truth. (2) The answer correctly identifies both patent term extensions and regulatory exclusivity as dual mechanisms Merck uses. (3) The explanation of how these mechanisms work together to extend market protection is sound and well-reasoned. (4) The answer appropriately contextualizes the exclusivities in relation to patent terms and clinical trial timelines. MINOR ISSUES: (1) The LLM introduces additional information about SPCs (Supplementary Protection Certificates) in Europe and mentions a 'typical 10-year patent term' - while not incorrect, these details go beyond what the ground truth specifies and weren't explicitly asked about in the question focused on U.S. protections. (2) The phrase 'extending beyond the typical 10-year patent term' could be slightly misleading as it conflates patent term with data exclusivity, though the distinction is reasonably clear from context. (3) The ground truth is more concise and focused specifically on U.S. mechanisms, while the LLM expands to European context. QUANTITATIVE VERIFICATION: Both the 12-year data exclusivity and 6-month pediatric exclusivity figures are factually correct and match ground truth exactly. The multi-hop reasoning correctly synthesizes how patent extensions and regulatory exclusivity work together. The answer demonstrates good understanding of the layered protection strategy, though it adds some scope beyond what was strictly required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 454,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K, may increase compliance costs for BlackRock's UK operations due to tailored reporting requirements for proxy advisers and investment consultants. These reforms could also affect client engagement by necessitating adjustments to BlackRock's stewardship activities and reporting practices, potentially altering how it interacts with clients and manages their investments under the updated code.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core elements of the 2024 UK Stewardship Code reforms and their potential impact on BlackRock's compliance costs and client engagement. The answer accurately captures that: (1) the reforms introduce tailored reporting requirements for proxy advisers and investment consultants, (2) these changes may increase compliance costs, and (3) adjustments to stewardship activities and client engagement practices may be necessary. No quantitative data or calculations are present in either answer, so quantitative accuracy is perfect (no errors to make). The answer demonstrates sound multi-hop reasoning by connecting the regulatory changes to operational impacts. However, the LLM answer is somewhat less comprehensive than the ground truth. Specifically, it omits: (1) the mention of Consumer Duty rules as part of the regulatory framework, (2) the explicit reference to FCA expectations and potential regulatory sanctions, (3) the mention of reputational risk, and (4) the potential for client asset withdrawals as a consequence of non-compliance. These omissions represent important contextual details about the severity and scope of potential impacts. The LLM answer focuses on the direct operational impacts (compliance costs and client engagement adjustments) but misses the broader regulatory and reputational consequences outlined in the ground truth. The answer is semantically sound and addresses the main question, but lacks the depth and completeness of the original answer regarding the full range of potential consequences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 432,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022 was **$215** (from $27 in 2021 to $242 in 2022). The Heritage AspenTech acquisition directly contributed **$148** to this increase, as noted in the document's footnote (a), which states that $148 of the 2022 amortization of intangibles relates to the Heritage AspenTech acquisition. This acquisition added significant intangible assets, driving the rise in amortization expenses.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental numerical errors that make it largely incorrect. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the increase was $215 (from $27 to $242), but the ground truth clearly shows the increase was $147 (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The LLM's starting figure of $27 million is completely wrong - it should be $95 million. This is a major factual error. The LLM does correctly identify the 2022 figure of $242 million and the Heritage acquisition contribution of $148 million, but the base year figure is drastically incorrect. (2) CALCULATION ERROR: Even if we accept the LLM's figures, $242 - $27 = $215, which is arithmetically correct for those numbers, but the underlying data is wrong. The correct calculation is $242 - $95 = $147. (3) MULTI-HOP REASONING: The LLM does attempt to synthesize the Heritage AspenTech acquisition's role in the increase and correctly identifies that the acquisition added intangible assets requiring amortization. The reference to footnote (a) showing $148 of amortization relates to the acquisition is a reasonable detail, though the ground truth answer frames this differently - stating the acquisition led to recognition of additional intangible assets. (4) ENTITY ACCURACY: The LLM correctly identifies AspenTech segment, fiscal years 2021-2022, and depreciation/amortization expenses. (5) SEMANTIC ISSUES: While the LLM's explanation of how the acquisition factors into the change is conceptually sound, the numerical foundation is so flawed that the overall answer is unreliable. The ground truth answer is more conservative, stating the acquisition 'would lead to' additional intangible assets, while the LLM provides a specific footnote reference showing $148 attribution - this is actually more detailed, but undermined by the incorrect base numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 508,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million (from $720 million in FY2021 to $744 million in FY2022). This region contributed approximately 6.6% to the total global growth in this business segment, which was $362 million (from $6,564 million in FY2021 to $6,926 million in FY2022).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PERCENTAGE CALCULATION: The LLM correctly identified the year-over-year increase of $24 million (from $720M to $744M in FY2021-2022) and correctly stated the total global growth of $362 million. However, the percentage contribution calculation is fundamentally wrong. The LLM states 6.6% when the correct answer is 0.35%. Verification: $24M / $362M = 0.0663 = 6.63%, which the LLM appears to have calculated. However, the ground truth states 0.35%, suggesting the correct calculation should be different. Upon review, if we calculate $24M / $362M, we get approximately 6.63%, not 0.35%. This indicates either: (1) the ground truth percentage is incorrect, or (2) there is a different methodology for calculating the 'contribution to global growth' that the LLM did not apply. The LLM's mathematical calculation of 6.6% is arithmetically correct based on the numbers provided ($24M / $362M), but it contradicts the ground truth answer of 0.35%. This represents a major discrepancy. The LLM correctly identified all dollar amounts, fiscal years, and the regional revenue figures. The multi-hop synthesis of combining regional data with global totals was properly executed. The core issue is the percentage calculation divergence, which is a critical component of the answer. The LLM's percentage appears mathematically sound but factually incorrect per the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 385,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRocks ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The 2023 joint FTC and DOJ merger guidelines, issued in December 2023, increase scrutiny and complexity for HSR-reportable transactions, potentially delaying or escalating costs for pre-merger notifications and waiting periods. These guidelines could hinder BlackRock's ability to expand through acquisitions by imposing stricter reporting requirements and heightened regulatory review, while also complicating transactions for funds subject to HSR rules, thereby affecting their operational flexibility and strategic growth opportunities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core factual content regarding the 2023 FTC/DOJ merger guidelines and their impact on HSR-reportable transactions. STRENGTHS: (1) Correctly identifies the 2023 guidelines as issued by FTC and DOJ; (2) Accurately describes the negative impacts: increased scrutiny, complexity, higher costs, and potential delays; (3) Properly identifies the two affected parties: BlackRock's acquisition expansion and funds engaging in HSR-reportable transactions; (4) Correctly references Hart-Scott-Rodino (HSR) framework implicitly through 'HSR-reportable transactions'; (5) Accurately conveys that guidelines increase pre-merger notification expenses and documentation requirements; (6) Maintains semantic equivalence with ground truth regarding operational impacts and strategic growth challenges. MINOR CONSIDERATIONS: (1) The LLM specifies 'December 2023' as the issuance date, which adds specificity not present in the ground truth but is factually accurate; (2) The LLM uses slightly different phrasing ('stricter reporting requirements' vs 'additional compliance burdens') but conveys the same meaning; (3) Both answers appropriately address the multi-hop nature of the question by connecting regulatory guidelines to impacts on both BlackRock specifically and funds more broadly. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required or provided in either answer, so this dimension scores high (9/10) with the minor deduction for the added date specification that, while accurate, wasn't in the ground truth. QUALITATIVE ACCURACY: The reasoning is sound and properly synthesizes the regulatory impact across the relevant entities. The answer correctly identifies causality (guidelines  increased scrutiny  operational impacts). CONTEXTUAL RELEVANCE: Highly relevant to the question asked, addressing both the regulatory framework and its practical implications for the named entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 535,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment  stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influences its accounting treatment by classifying stock-settled RSUs as equity (reducing retained earnings) and cash-settled RSUs as liabilities (recognized on the balance sheet). This distinction impacts financial statement presentation, with equity awards affecting shareholders' equity and cash-settled awards requiring liability adjustments based on fair value changes. The document pages confirm the existence of both agreement types but do not explicitly detail the accounting treatment, relying on standard GAAP principles for classification.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core accounting distinction between stock-settled and cash-settled RSUs. STRENGTHS: (1) Correctly identifies that stock-settled RSUs are classified as equity instruments while cash-settled RSUs are classified as liabilities - this matches the ground truth distinction; (2) Accurately notes the impact on financial statement presentation (equity affecting shareholders' equity, cash-settled affecting liabilities); (3) Correctly references that remeasurement occurs for liability-classified awards; (4) Properly identifies both agreement types exist at Goldman Sachs. WEAKNESSES: (1) The statement 'reducing retained earnings' for equity awards is imprecise - equity awards typically affect additional paid-in capital and equity accounts, not directly reduce retained earnings; (2) The answer acknowledges that 'document pages confirm the existence of both agreement types but do not explicitly detail the accounting treatment' - this is a notable caveat that suggests the LLM is inferring standard GAAP treatment rather than citing specific filing language, which is appropriate but limits the grounding; (3) Missing explicit reference to the specific forms mentioned in ground truth (Form 10.8 for stock-settled, Form 10.32 for cash-settled), though this may reflect document limitations; (4) Could have been more explicit about the timing difference in expense recognition (stock-settled typically recognized upfront vs. cash-settled remeasured each period). MULTI-HOP REASONING: The answer successfully synthesizes the relationship between settlement type  accounting classification  financial statement impact, which is the core multi-hop requirement. SEMANTIC EQUIVALENCE: The answer conveys the essential information that settlement method drives accounting treatment and financial statement presentation, matching the ground truth's core message. The main deduction is for the imprecise language about retained earnings and the reliance on standard GAAP principles rather than specific filing citations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 555,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "In 2023, Abbott Laboratories granted **4,981,231 restricted stock units (RSUs)** under the 2017 Incentive Stock Program. The specific vesting condition mentioned in the program documentation is that **RSUs vest over three years**, with no performance-based conditions specified in the main text of the 10-K. However, the program includes performance-based RSUs (e.g., \"Performance Restricted Stock Unit Agreements\") as part of its documentation, which may have additional vesting criteria tied to company performance metrics.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: 4,981,231 restricted stock units were granted in 2023 under Abbott's 2017 Incentive Stock Program. The number matches the ground truth exactly. The vesting condition of 'three years' is also correctly stated and matches the original answer. The entity identification (Abbott Laboratories, 2017 Incentive Stock Program, 2023) is accurate. However, the LLM answer goes beyond what was asked and what the ground truth specifies by introducing additional information about performance-based RSUs and performance metrics that were not mentioned in the original answer. While this additional context may be factually accurate from the 10-K filing, it introduces complexity and potential confusion that wasn't part of the ground truth answer. The ground truth provides a simpler, more direct answer: the number of RSUs granted (4,981,231), the vesting period (three years), and the conversion mechanism (one share per vested unit). The LLM answer omits the specific detail that 'upon vesting, the recipient receives one share of Abbott stock for each vested unit,' which is an important part of the vesting condition. The answer is largely correct on core facts but loses points for: (1) omitting the share conversion detail from the ground truth, and (2) adding speculative information about performance-based conditions that may not be directly relevant to the specific question asked about the 2023 grants.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 405,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "Danaher's Life Sciences segment generated 35% of its 2024 sales outside North America and Western Europe (7% in other developed markets and 28% in high-growth markets). The 2005 acquisition of Leica Microsystems initiated the segment's global expansion, which was further amplified by subsequent acquisitions (e.g., Pall, AB Sciex, Beckman Coulter). This strategic growth diversified the segment's geographic footprint, enabling a stronger presence in high-growth markets, reflecting Leica's foundational role in establishing a multinational footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key percentages correct: 35% outside North America and Western Europe (comprising 28% high-growth markets and 7% other developed markets). The 2005 Leica Microsystems acquisition date is accurate. However, there are notable qualitative issues: (1) The LLM mentions 'AB Sciex' as a subsequent acquisition, which is not mentioned in the ground truth and appears to be an error or hallucination - the ground truth specifically lists Beckman Coulter (2011), Pall (2015), and Abcam (2023). (2) The LLM omits Abcam (2023), which is explicitly mentioned in the ground truth as a key subsequent acquisition. (3) The LLM's explanation of the strategic impact is somewhat less comprehensive than the ground truth - it describes the acquisitions as 'amplifying' expansion but doesn't clearly articulate how these specific acquisitions (Beckman Coulter, Pall, Abcam) enabled 'integration of complementary technologies' as stated in the ground truth. The multi-hop reasoning is sound in connecting the 2005 Leica acquisition to subsequent growth, but the incomplete and partially inaccurate acquisition list weakens the answer's completeness. The geographic distribution percentages and their relationship to the strategic acquisitions are correctly synthesized, but the execution details contain errors that would be problematic for someone relying on this information for research or analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 401,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has made **8 acquisitions** in the Life Sciences segment since its establishment in 2005. These include the acquisition of **Pall in 2015** and the most recent mentioned acquisition, **Abcam in 2023**. The acquisitions listed are: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth perfectly. The total count of 8 acquisitions is correct, and all company names, years, and the chronological sequence are accurate. (2) QUANTITATIVE ACCURACY: All dates are correct (2005-2023), the total count of 8 is accurate, and Pall (2015) and Abcam (2023) are correctly identified as requested. No calculation errors present. (3) QUALITATIVE ACCURACY: The answer properly addresses all three parts of the multi-part question: (a) total number of acquisitions (8), (b) year of Pall acquisition (2015), and (c) most recent acquisition (Abcam, 2023). The multi-hop synthesis is sound - the model correctly identified and listed all acquisitions in chronological order. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question with appropriate emphasis on the specifically requested information (Pall year and most recent acquisition). The presentation is clear and well-organized. Minor note: The LLM answer includes slightly more explanatory text than the ground truth (emphasizing the specific requested details), which actually enhances clarity without introducing any inaccuracies. All entities are correctly identified and the reasoning is logical and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 364,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "The fair value of Abbott's interest rate hedge contracts decreased by $123 million from December 31, 2020 ($210 million) to December 31, 2021 ($87 million). This decrease is directly reflected in the reduction of the receivable position for these contracts, which also fell from $210 million to $87 million during the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: the fair value decreased from $210 million (Dec 31, 2020) to $87 million (Dec 31, 2021), representing a $123 million decline. The calculation is accurate ($210M - $87M = $123M). The answer correctly identifies that the receivable position also declined from $210 million to $87 million, demonstrating proper multi-hop synthesis across the two related metrics. The LLM successfully connects the fair value change to the receivable position change, showing understanding of how these metrics move together. The wording is clear and concise, though slightly more direct than the ground truth. The only minor difference is that the LLM uses 'directly reflected' while the ground truth uses 'consistent with,' but both convey the same semantic meaning. The answer fully addresses all parts of the multi-part question: (1) the change in fair value, (2) the specific amounts, (3) the time period, and (4) the relationship to the receivable position. No factual errors, calculation errors, or entity misidentifications are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 317,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including advancing Breyanzi into new indications like CLL, FL, and MCL, aligns with the observed doubling of U.S. revenues for Breyanzi in 2023. This growth was driven by higher demand, reflecting successful commercialization of existing indications and the potential of expanding into additional therapeutic areas, which strengthens the pipeline and drives revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. (1) CORRECTNESS: All factual information is accurate. The answer correctly identifies BMY's strategic focus on expanding autologous CAR-T cell therapy, specifically mentions the new indications (CLL, FL, MCL) for Breyanzi, and accurately references the doubling of U.S. revenues for Breyanzi in 2023. The causal relationship between strategic expansion and revenue growth is properly established. (2) QUANTITATIVE ACCURACY: The answer correctly references the 'doubling' of U.S. revenues for Breyanzi in 2023, matching the ground truth. No specific dollar amounts are provided in either answer, so no calculation errors are present. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer successfully synthesizes: (a) BMY's strategic pipeline expansion efforts, (b) specific new indications being pursued, (c) the observed revenue doubling, and (d) the logical connection between these elements. The reasoning that strategic investment in new indications drives demand and revenue growth is logically coherent. (4) ENTITY ACCURACY: All entities are correctly identified - BMY (Bristol Myers Squibb), Breyanzi (the drug), the specific indications (CLL, FL, MCL), and the time period (2023). (5) SEMANTIC EQUIVALENCE: While the LLM answer uses slightly different phrasing than the ground truth ('strengthens the pipeline and drives revenue growth' vs. 'directly reflected in the significant revenue growth'), the semantic meaning is equivalent and conveys the same strategic alignment. The LLM answer adds minor elaboration about 'successful commercialization of existing indications' which is contextually appropriate and doesn't contradict the ground truth. Minor deduction from perfect score only due to very slight stylistic differences in presentation, but the core answer is factually complete and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 513,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was **$2.70 billion**, and combined with the **$0.91 billion** cash used for CorEvitas, LLC, the total cash used for acquisitions in 2023 was **$3.61 billion**. This is detailed in the \"Investing Activities\" section of the 10-K filing, which explicitly states the cash outflows for both acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. All quantitative data matches the ground truth exactly: (1) The Binding Site Group acquisition cash outflow of $2.70 billion is correct, (2) CorEvitas, LLC acquisition amount of $0.91 billion is correct, (3) The total sum of $3.61 billion is correctly calculated ($2.70B + $0.91B = $3.61B). The answer properly addresses both parts of the multi-hop question by identifying the individual acquisition amounts and synthesizing them into the total. Entity identification is accurate (correct company names and year 2023). The reasoning is sound - the model correctly identified that these two acquisitions together comprised the total cash used for acquisitions in 2023. The reference to the 'Investing Activities' section of the 10-K is appropriate contextual detail. Minor deduction from perfect score (9 vs 10) only because the LLM added interpretive language about the 10-K filing location that, while likely accurate, goes slightly beyond what was explicitly verified in the ground truth answer. The core factual content is entirely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 312,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "The total estimated annual cost savings from restructuring charges incurred in 2024 and 2023 are **$0.2 billion** (2024) and **$0.6 billion** (2023), respectively. The acquisition of The Binding Site Group in 2023 contributed to the Specialty Diagnostics segment's strategic growth by expanding its portfolio with pioneering diagnostic assays and instruments for blood cancers, particularly multiple myeloma, enhancing capabilities in blood cancer diagnostics and monitoring.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the individual cost savings amounts ($0.2 billion from 2024 and $0.6 billion from 2023) and accurately describes The Binding Site Group acquisition's contribution to the Specialty Diagnostics segment. However, there is a notable omission: the LLM fails to explicitly state the total combined annual cost savings of $0.8 billion, which is a key metric in the original answer. The ground truth emphasizes 'total estimated annual cost savings of $0.8 billion' as the primary answer to the first part of the question, while the LLM only provides the component figures. The acquisition description is accurate and semantically equivalent, correctly identifying the focus on blood cancer diagnostics, multiple myeloma, and portfolio expansion. The reasoning is sound and multi-hop synthesis is present (connecting restructuring charges to cost savings and acquisition to segment growth). The quantitative accuracy is strong for the individual figures, but the omission of the total aggregate figure represents an incomplete answer to the first part of the multi-part question. The qualitative description of the acquisition's strategic value is appropriate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 341,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K is the **1.375% Notes due 2061 (LLY61)**, with a maturity year of **2061**. This is later than all other listed debt instruments, which mature between **2025 and 2051**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The LLM correctly identifies the 1.375% Notes due 2061 as the longest-term debt instrument and accurately states its maturity year as 2061. The comparison to other debt instruments is correct - the LLM states they mature between 2025 and 2051, which aligns with the ground truth examples of 2033 and 2051 mentioned. (2) QUANTITATIVE ACCURACY: All numeric values are correct - the interest rate (1.375%), the maturity year (2061), and the comparative range (2025-2051) are all accurate. The ticker notation (LLY61) adds helpful context. (3) ENTITY ACCURACY: Eli Lilly is correctly identified, the fiscal year (2023) is correct, and the debt instrument names and rates are accurate. (4) MULTI-HOP REASONING: The answer successfully synthesizes information by identifying the longest-term instrument and comparing it to the broader debt portfolio. The logic is sound - 2061 is indeed later than 2025-2051. (5) COMPLETENESS: The answer addresses both parts of the question: identifying the longest-term instrument AND comparing its maturity to others. The LLM answer is slightly more comprehensive than the ground truth by providing the ticker notation and a clearer range of other maturities. Minor deduction (1 point) only because the ground truth specifically mentions 2033 and 2051 as examples, while the LLM provides a range - though this is actually more informative and not incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 403,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is under development or review for **two distinct indications**: early Alzheimer's disease (submitted for approval) and preclinical Alzheimer's disease (Phase III trials). Lebrikizumab has **one distinct indication** (atopic dermatitis), which has received approval in the EU and Japan and is under regulatory review in the U.S. Thus, Donanemab has **more distinct indications** (2) compared to Lebrikizumab (1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All numbers are correct - Donanemab: 2 indications, Lebrikizumab: 1 indication. The comparison conclusion (2 > 1) is mathematically sound. ENTITY ACCURACY: Both drug names are correctly identified (Donanemab and Lebrikizumab), and the indications are accurately specified (early Alzheimer's disease, preclinical Alzheimer's disease for Donanemab; atopic dermatitis for Lebrikizumab). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) total number of distinct indications for Donanemab, (2) number of indications for Lebrikizumab with approval/regulatory review status, and (3) the comparison between them. MULTI-HOP REASONING: The synthesis is sound - the model correctly identified that Lebrikizumab's single indication (atopic dermatitis) counts as one despite having multiple approval/review statuses across different regions (EU, Japan, and U.S. under review). This demonstrates proper understanding that the question asks for distinct indications, not distinct approval statuses. SEMANTIC EQUIVALENCE: The answer matches the ground truth in all material respects. The additional detail provided (e.g., 'submitted for approval' and 'Phase III trials') adds helpful context without contradicting the ground truth. Minor note: The ground truth uses slightly different phrasing ('received approval or is under regulatory review') versus the LLM's 'received approval in the EU and Japan and is under regulatory review in the U.S.' - both are semantically equivalent and accurate. The conclusion that 'Donanemab has more distinct indications' directly and correctly answers the comparative question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 465,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The decline in Alimta's U.S. revenue in 2023, driven by generic competition, partially offset the overall U.S. volume growth, which increased by 11%. However, **Verzenio** emerged as a key positive contributor, with U.S. revenue rising 56% due to heightened demand, helping counterbalance Alimta's volume decline.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Alimta's U.S. revenue declined in 2023 due to generic competition, (2) this negatively impacted overall U.S. volume growth, and (3) Verzenio was a key positive contributor to U.S. volume growth. The multi-hop reasoning is sound and the answer appropriately synthesizes information across the question's requirements.\n\nHowever, there are quantitative accuracy concerns: The LLM introduces a specific metric (11% U.S. volume growth) and a specific Verzenio revenue increase (56%) that are not present in the ground truth answer. While these numbers may be factually correct from the source documents, they represent additional specificity beyond what the ground truth provides. The ground truth answer does not quantify the magnitude of volume growth or Verzenio's revenue increase, only noting 'strong performance' and 'positively contributed.'\n\nThe ground truth also mentions Trulicity as another oncology product contributing positively to U.S. volume growth, which the LLM answer omits. This is a notable incompleteness - the question asks 'what other oncology product' (singular) but the ground truth identifies two products (Verzenio and Trulicity). The LLM only addresses Verzenio.\n\nStrengths: Correct identification of Alimta's decline, correct identification of Verzenio as a positive contributor, sound reasoning about offsetting effects, appropriate contextual framing.\n\nWeaknesses: Omission of Trulicity, introduction of unverified specific percentages (11% and 56%), incomplete answer to the multi-part question about 'other oncology products.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 443,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Merck incurred a $250 million upfront payment in 2022 to jointly develop and commercialize V940 (mRNA-4157) with Moderna, with shared development costs and profits equally split under the collaboration. This commitment aligns with Merck's immuno-oncology strategy, which emphasizes personalized therapies like neoantigen vaccines (e.g., V940) in combination with existing immunotherapies (e.g., Keytruda) to advance high-risk melanoma and NSCLC treatments, as detailed in its 2023 10-K.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the primary financial commitment ($250 million in 2022) and correctly identifies the equal cost-sharing arrangement with Moderna. The answer accurately connects this to Merck's immuno-oncology strategy and mentions key elements like Keytruda combination therapy, neoantigen vaccine approach, and indications (melanoma and NSCLC). However, there are notable omissions: (1) The ground truth specifically mentions the INTerpath-001 and INTerpath-002 trial names, which the LLM does not include; (2) The ground truth explicitly notes Breakthrough Therapy and PRIME designations, which are important regulatory/strategic markers that the LLM omits; (3) The LLM states 'shared development costs and profits equally split' but the ground truth only confirms equal cost-sharing for development, not explicitly addressing profit-sharing in the same way. The quantitative accuracy is high (the $250M figure and 2022 date are correct, and the equal-sharing concept is accurate). The qualitative reasoning is sound - the LLM correctly synthesizes the multi-hop connection between the financial commitment and Merck's broader immuno-oncology strategy. The answer is contextually relevant and addresses the core question, but lacks some specific clinical trial and regulatory designation details that would make it more complete. The omissions are not factually incorrect but represent incomplete coverage of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 404,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "MK-7962 (sotatercept) is granted 12 years of U.S. data exclusivity for biologics. The disclosed patent expiration date for its method-of-use patents is 2037. Subtracting the 12-year data exclusivity period, the additional patent protection beyond the standard exclusivity period is **10 years** (2037  2027).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. Verification of key facts: (1) 12 years of U.S. data exclusivity for biologics - CORRECT, matches ground truth; (2) Patent expiration date of 2037 - CORRECT, matches ground truth; (3) Anticipated approval year of 2027 - CORRECT, implied in the calculation; (4) Calculation of additional protection: 2037 - 2027 = 10 years - CORRECT and accurately performed. The LLM correctly synthesized the multi-hop reasoning: identifying the data exclusivity period (12 years), the patent expiration date (2037), the approval year (2027), and calculating the difference to determine additional protection beyond the standard exclusivity period. The answer is clear, concise, and directly addresses the question. Minor note: The LLM's presentation is slightly more streamlined than the ground truth answer, but conveys identical information and reasoning. The calculation is explicitly shown (2037  2027), which enhances clarity. All numeric values are accurate, and the semantic meaning perfectly matches the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 306,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "The provided document pages do not contain information regarding Merck's fair value of Emerging Markets Equities investments in U.S. and International Pension Plans, nor any mention of NAV measurements related to such investments. The text focuses on litigation, share-based compensation, patent disputes, and other financial disclosures, but no data on pension plan equity investments or their valuation changes is presented.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to address the question. The ground truth provides specific, detailed financial data about Merck's Emerging Markets Equities investments across pension plans: (1) U.S. Pension Plans increased by $33 million ($707M to $740M), (2) International Pension Plans direct holdings increased by $73 million ($59M to $66M), and (3) Investment Funds category changed from $111M to $110M, totaling a $106 million increase. The LLM claims the document pages do not contain this information, which is factually incorrect - the question explicitly references Merck's 10-K filing data on pension plan investments. The LLM failed to: (1) locate or synthesize the required multi-hop information across pension plan sections, (2) identify the specific NAV-measured asset categories, (3) calculate the total increase ($33M + $73M = $106M), and (4) provide any of the correct numerical values. This represents a complete failure to answer the question, suggesting either the LLM was not provided with the relevant document sections or failed to extract and synthesize the available information. The response indicates the document 'focuses on litigation, share-based compensation, patent disputes' which suggests the LLM may have been looking at incorrect document pages or sections of the 10-K filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 371,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "The estimated fair value of U.S. government agencies securities held by GILD increased by **$92 million** from December 31, 2022 ($35 million) to December 31, 2023 ($127 million). In contrast, the estimated fair value of U.S. treasury securities increased by **$16 million** over the same period (from $410 million to $426 million). Thus, the change in U.S. government agencies securities was significantly larger than that of U.S. treasury securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally undermine its correctness: (1) U.S. government agencies securities: LLM states the 2022 value was $35 million (INCORRECT - should be $21 million) and calculates a change of $92 million (INCORRECT - should be $106 million). The correct calculation is $127M - $21M = $106M, not $127M - $35M = $92M. (2) U.S. treasury securities: LLM states the 2022 value was $410 million (INCORRECT - should be $379 million) and claims an increase of $16 million (INCORRECT - should be a DECREASE of $34 million). The correct calculation is $426M - $379M = $47M increase, not $410M to $426M. The ground truth explicitly states treasury securities 'decreased by $34 million,' but the LLM incorrectly reports an increase. (3) The LLM's conclusion that 'U.S. government agencies securities was significantly larger than that of U.S. treasury securities' is directionally correct in magnitude comparison ($106M vs $34M), but this is based on incorrect underlying numbers. (4) The LLM failed to correctly synthesize the multi-hop information: it needed to extract both 2022 and 2023 values for both security types from the filing, calculate the changes, and compare them. Instead, it used wrong 2022 baseline values for both security types. The answer demonstrates poor data extraction and calculation accuracy, with three out of four key financial figures being incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 395,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvys patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy's revenue increased by 14% in 2023 ($11.85 billion) compared to 2022 ($10.39 billion), driven by higher demand and pricing. Its U.S. and EU patents expire in 2033, with potential for extensions. This growth underscores Biktarvy's continued market strength, but Gilead must prepare for generic competition post-2033. The company's long-term strategy likely involves accelerating innovation, expanding into new therapeutic areas (e.g., oncology, inflammation), and leveraging patent protections for newer products to mitigate revenue declines from patent expiration of legacy HIV drugs like Biktarvy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is accurate - Biktarvy revenue of $11.85B (2023) vs $10.39B (2022) and 14% growth calculation are correct. (2) Patent expiration date of 2033 for U.S. and EU is correctly stated. (3) Number formatting is appropriate ($11.85B vs $11,850M). (4) The answer correctly identifies Biktarvy as a key revenue driver and acknowledges the need for strategic planning around patent expiration. WEAKNESSES: (1) The LLM characterizes Biktarvy as a 'legacy HIV drug' in the context of patent expiration strategy, which is somewhat misleading - Biktarvy is a current, growing product (14% growth), not a legacy product facing imminent decline. The ground truth emphasizes it as a 'key revenue driver' requiring patent protection extension or follow-on therapy development. (2) The LLM's strategic recommendations (expanding into oncology/inflammation) are reasonable but not directly supported by the ground truth answer, which focuses more narrowly on patent protection extension and follow-on therapy development for HIV products specifically. (3) The LLM answer lacks the nuance from the ground truth that generic competition post-patent expiration could undermine the current growth momentum. (4) The ground truth emphasizes 'fixed-dose combinations like Biktarvy' as critical for patent planning, but the LLM doesn't address this specific aspect. MULTI-HOP REASONING: The LLM correctly synthesizes revenue performance with patent timeline implications, though the strategic conclusions diverge somewhat from the ground truth's emphasis on maintaining market exclusivity in HIV rather than diversifying into new therapeutic areas. The reasoning is sound but not fully aligned with the filing's apparent strategic focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 475,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "The impending U.S. patent expiration of Truvada in 2023 may reduce Gilead's revenue from this key HIV product, potentially limiting funds available for lifecycle management initiatives. Given Gilead's single operating segment structure and centralized resource allocation, the decline in Truvada's revenue could force reallocation of resources to protect other products or invest in newer therapies, such as the HIV portfolio's next-generation treatments (e.g., Biktarvy, Descovy). However, the company's ongoing R&D investments and strategic collaborations (e.g., with Arcus, Merck) suggest efforts to offset patent loss through innovation and expanded indications, as seen in regulatory approvals for products like Veklury and Trodelvy. The impact on lifecycle management would depend on maintaining profitability from remaining patents and managing cash flow from operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core issue and provides accurate information with sound reasoning. STRENGTHS: (1) Correctly identifies Truvada's 2023 U.S. patent expiration date; (2) Accurately describes the single operating segment structure and centralized resource allocation; (3) Properly identifies the revenue decline risk from generic competition; (4) Correctly names alternative HIV products (Biktarvy, Descovy) as potential investments; (5) Mentions strategic collaborations and R&D investments as mitigation strategies; (6) Acknowledges the dependency on maintaining profitability and cash flow. WEAKNESSES: (1) The answer introduces products (Veklury, Trodelvy) that are outside the HIV portfolio scope - Veklury is an antiviral for COVID-19/RSV and Trodelvy is an oncology product. This represents scope creep beyond the specific question about HIV portfolio lifecycle management; (2) The mention of Arcus and Merck collaborations, while potentially relevant to Gilead's R&D strategy, is not directly substantiated in the ground truth and adds tangential information; (3) The answer is somewhat more speculative about mitigation strategies than the ground truth, which focuses more directly on the constraint-versus-offset dynamic. QUANTITATIVE ACCURACY: All dates and product names mentioned are accurate (9/10 - minor deduction for including out-of-scope products). QUALITATIVE ACCURACY: The reasoning about resource reallocation and the tension between patent loss and innovation investment is sound and matches the ground truth's core logic (7/10 - deduction for introducing non-HIV products and less direct focus on the specific constraint). CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's core concern about lifecycle management impact, though it broadens the scope somewhat (8/10). The answer is fundamentally correct in its main thesis but includes unnecessary tangential information that slightly dilutes focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 534,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA Agreement impacted Schwab's capital management strategy by enabling the sweeping of brokerage client deposits off-balance sheet to TD Depository Institutions, which influenced capital allocation and liquidity management. The specific amortization associated with the agreement, related to contract assets tied to the buy-down of fixed-rate obligations, was **$85 million** in 2023, as disclosed in Note 14 and amortized over the contractual term.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with the correct $85 million amortization figure for 2023. The answer correctly identifies the key impact on capital management strategy (sweeping deposits off-balance sheet to TD Depository Institutions) and accurately states that amortization was related to contract assets tied to buy-down of fixed-rate obligations, amortized over the contractual term. However, there are notable omissions in completeness: (1) The ground truth explicitly mentions that the agreement 'supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit' - the LLM answer mentions capital allocation and liquidity management but doesn't capture the specific mechanism of reducing balance sheet pressure or the forward-looking aspect of future migration capability. (2) The ground truth specifies that amortization was 'as a reduction to bank deposit account fee revenue' - the LLM answer omits this important detail about how the amortization flows through the income statement. (3) The ground truth notes this was part of 'broader amortization of capitalized contract costs, which totaled $85 million' - the LLM answer presents $85 million as the specific amount for this agreement alone, which could be interpreted as incomplete context about whether this is the full total or a component. The reference to 'Note 14' in the LLM answer adds helpful specificity not in the ground truth. Overall, the core facts are correct and the multi-hop reasoning is sound, but the answer lacks some important contextual details about the mechanism and income statement impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 460,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "The changes in LTIP units and other unit issuances during 2023 affected SPG's total equity as follows: the issuance of long-term incentive performance units increased equity by $14,739, while the issuance of unit equivalents and other units decreased equity by $16,119. These items, combined with other equity adjustments, contributed to the overall decrease in total equity from $3,611,652 at December 31, 2022, to $3,491,649 at December 31, 2023. The net effect of LTIP and other unit issuances alone was a $1,380 decrease in total equity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete synthesis of the multi-hop question. CRITICAL ERRORS: (1) The LLM identifies only $14,739 from LTIP units but completely omits the $197,426 from limited partner unit issuances - a major component of the ground truth answer. (2) The LLM states 'unit equivalents and other units decreased equity by $16,119' which does not match any figures in the ground truth. The ground truth specifies redemptions of $13,524 and treasury purchases of $140,593, totaling $154,117 in reductions - the LLM's $16,119 figure is unexplained and incorrect. (3) The LLM calculates a net effect of only $1,380 decrease, which is mathematically inconsistent with the figures presented and contradicts the ground truth's net reduction of $139,378. (4) While the LLM correctly identifies the overall equity decrease from $3,611,652 to $3,491,649 (a $120,003 decrease), it fails to properly attribute this to the unit-related activities. (5) The LLM's answer lacks the comprehensive breakdown of all four components: limited partner unit issuances (+$197,426), LTIP units (+$14,739), redemptions (-$13,524), and treasury purchases (-$140,593). The multi-hop synthesis is incomplete and the quantitative analysis contains multiple calculation errors. The answer demonstrates partial understanding of the question but fails to accurately synthesize the required information from the filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 395,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 1020 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Linde's distribution of Process Gases through on-site plants under long-term supply arrangements with minimum purchase requirements and price escalation provisions influences its revenue recognition by recognizing revenue over time as products are delivered, aligned with the right to invoice. These contracts, which can last up to 20 years, are structured to reflect the transfer of control incrementally, with revenue recognized based on progress toward satisfying performance obligations using a cost-incurred input method. This approach ensures revenue recognition aligns with the delivery of goods and contractual terms, while the long-term nature of these agreements impacts revenue timing and contract liability management.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key contract characteristics (long-term nature up to 20 years, minimum purchase requirements, price escalation provisions, revenue recognized over time as products delivered). The mention of the right to invoice and alignment with delivery is accurate. The answer demonstrates understanding of the multi-hop relationship between distribution method, contract structure, and revenue recognition.\n\nWEAKNESSES: (1) The LLM introduces 'cost-incurred input method' which is not mentioned in the ground truth answer. While this may be technically accurate for some contracts, it adds specificity not present in the original answer and could be misleading if Linde uses different methods. (2) The ground truth specifically mentions 'total requirement agreements' as the contract structure type - the LLM answer omits this specific terminology, instead using more generic language about 'transfer of control incrementally.' (3) The ground truth emphasizes the 'continuous delivery of gases through pipelines' as a key contextual element that justifies the over-time revenue recognition - the LLM answer mentions 'delivery of goods' more generically without emphasizing the pipeline/continuous nature. (4) The LLM adds discussion of 'contract liability management' which, while potentially relevant, is not addressed in the ground truth and represents scope creep beyond what was established.\n\nNUMERIC ACCURACY: The contract duration range is correctly stated as up to 20 years (ground truth says 10-20 years, LLM says up to 20 years - this is acceptable as a simplification). No calculation errors present.\n\nMULTI-HOP REASONING: The answer demonstrates adequate synthesis of the relationship between distribution method  contract structure  revenue recognition policy. However, it misses the specific emphasis on 'total requirement agreements' and the pipeline delivery mechanism that are central to understanding why this particular revenue recognition approach is appropriate.\n\nSEMANTIC EQUIVALENCE: While the core concept is conveyed, the introduction of 'cost-incurred input method' and omission of 'total requirement agreements' terminology represents a meaningful deviation from the ground truth's specific accounting framework description.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 612,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The fair value of corporate notes and obligations decreased by $376 million (from $3,354 million in 2023 to $2,978 million in 2024). This decrease is larger in magnitude than the overall increase in total marketable securities' fair value of $230 million (from $5,492 million to $5,722 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. Verification of key numbers: (1) Corporate notes and obligations decrease: $3,354M - $2,978M = $376M  (correctly stated); (2) Total marketable securities change: $5,722M - $5,492M = $230M  (correctly stated as an increase); (3) Comparison: The LLM correctly identifies that the $376M decrease in corporate notes is larger in magnitude than the $230M overall increase in total securities . All quantitative data is accurate with proper formatting. The multi-hop reasoning is sound - the model successfully synthesized information from two different tables to compare the decline in one asset class against the overall portfolio change. The LLM's conclusion that 'the decrease is larger in magnitude than the overall increase' is logically correct and directly answers the comparative aspect of the question. Minor note: The original answer includes slightly more contextual framing ('while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value'), which provides additional semantic context. The LLM answer is more concise but captures all essential factual information and the key insight about the magnitude comparison. No calculation errors, no incorrect entities, and proper synthesis across the two disclosed tables.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 382,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "The Health Care Benefits segment's premium pricing forecasts, set in advance for a fixed period, are highly sensitive to changes in provider behavior, such as shifts in utilization patterns or reimbursement rates. Accurate forecasting depends on anticipating medical cost trends and member behavior, which can be disrupted by factors like pandemics, provider network changes, or competitive pressures. If actual costs exceed projections due to unforeseen provider behavior, CVS cannot adjust premiums during the fixed period, directly impacting profitability. This sensitivity to forecast accuracy magnifies the risk of adverse operating results, particularly during volatile periods like the COVID-19 pandemic, where rapid changes in provider behavior and utilization trends complicate cost management.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates understanding of the core mechanism (fixed premiums, forecast sensitivity, impact on operating results) but has significant gaps in specificity and accuracy compared to the ground truth.\n\nCRITICAL OMISSIONS:\n1. The ground truth specifies that Insured Health Care Benefits products comprise 94% of Health Care Benefits segment revenues - this specific quantitative detail is completely absent from the LLM answer. This is a material omission for a multi-hop financial question.\n2. The ground truth specifically identifies the provider behavior as \"hospitals and providers attempting to maintain revenue levels during economic downturns\" - the LLM generalizes this to broader \"shifts in utilization patterns or reimbursement rates\" without capturing the specific economic motivation.\n3. The ground truth emphasizes that \"even small differences between predicted and actual costs can significantly affect operating results\" - the LLM mentions sensitivity but doesn't capture the magnitude of impact from small forecast errors.\n\nQUANTITATIVE ACCURACY ISSUES:\n- Missing the 94% figure entirely (score: 4/10)\n- No specific financial metrics provided\n- The LLM introduces COVID-19 as an example, which may be contextually relevant but is not part of the ground truth answer and wasn't asked for\n\nQUALITATIVE ACCURACY:\n- Correctly identifies the fixed premium period constraint (7/10)\n- Correctly explains the forecast sensitivity mechanism\n- Correctly links provider behavior to cost increases\n- However, lacks the specific causal chain: provider behavior  medical cost increases  forecast inaccuracy  operating results impact\n- The reasoning is sound but less precise than ground truth\n\nCONTEXTUAL RELEVANCE:\n- Addresses the question's core elements (7/10)\n- Provides relevant context about forecast challenges\n- However, the COVID-19 pandemic reference, while potentially relevant, dilutes focus from the specific provider behavior mechanism described in the ground truth\n\nSEMANTIC EQUIVALENCE:\n- The LLM captures the general relationship but misses key specifics\n- \"Unpredictable provider behavior amplifies the risk\" (ground truth) vs. \"sensitivity to forecast accuracy magnifies the risk\" (LLM) - similar but LLM doesn't emphasize the provider behavior aspect as strongly\n\nOVERALL ASSESSMENT:\nThe LLM answer demonstrates conceptual understanding of the premium pricing mechanism and forecast sensitivity but fails to include critical quantitative details (94% figure) and specific provider behavior context (maintaining revenue during downturns). For a multi-hop financial question requiring synthesis of specific filing data, these omissions are significant. The answer is directionally correct but incomplete and less precise than required for a high-accuracy evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 749,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moodysindicating strong creditworthinessthe additional production from Noble enhances Chevrons ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "Chevron's acquisition of Noble in October 2020 added production capacity equivalent to 6,000 cubic feet of natural gas per barrel of crude oil, enhancing its overall output and revenue potential. This expansion supports debt rating stability by improving cash flow resilience during low commodity prices. The company's ability to adjust capital spending, discontinue stock repurchases, and maintain dividends during price downturns (as noted on page 45) is bolstered by diversified production streams and strong liquidity, enabling it to meet obligations and preserve its high-quality debt ratings (AA-/Aa2) through disciplined financial management and flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the acquisition date (October 2020), the debt ratings (AA-/Aa2), and the general mechanism by which expanded production supports debt ratings. The reasoning about cash flow resilience and financial flexibility is sound and aligns with the ground truth. The LLM appropriately explains that diversified production streams and liquidity support credit profile maintenance. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM misinterprets the production capacity metric. The ground truth clarifies that '6,000 cubic feet of natural gas equals 1 barrel of crude oil' (an oil-equivalent conversion), meaning the acquisition added capacity measured in oil-equivalent barrels. The LLM states '6,000 cubic feet of natural gas per barrel of crude oil' which is ambiguous and could be misread as a ratio rather than a conversion factor. This is a subtle but important distinction in how the metric should be understood. (2) UNSOURCED REFERENCE - The LLM cites 'page 45' regarding capital spending and dividend adjustments, but this specific page reference cannot be verified against the ground truth and appears to be a potential hallucination or unverified citation. (3) INCOMPLETE SYNTHESIS - While the LLM mentions 'diversified production streams,' the ground truth more directly connects the Noble acquisition's specific contribution to cash flow potential from upstream operations. The LLM's answer is somewhat more generic about financial flexibility rather than specifically tying the Noble acquisition's production capacity to cash generation. MULTI-HOP REASONING: The LLM successfully synthesizes the connection between acquisition  production capacity  cash flow  debt rating stability, which is correct. However, the execution lacks precision in explaining the production metric conversion. OVERALL: The answer is directionally correct and demonstrates understanding of the relationship between operational capacity and financial ratings, but contains a quantitative interpretation issue and an unverified citation that reduces confidence in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 561,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "Schwab spent **$249 million** to buy down fixed-rate obligation amounts under the 2023 IDA agreement. This amount is classified as **contract assets** and included in **other assets** on the consolidated balance sheet, as noted in Note 14 and discussed in the context of the 2023 IDA agreement's terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. (1) QUANTITATIVE ACCURACY: The $249 million amount is correct and matches the ground truth exactly. The LLM also correctly identifies that this was used to buy down fixed-rate obligation amounts under the 2023 IDA agreement. (2) COMPLETENESS: The answer addresses both parts of the question - the amount spent ($249 million) and the balance sheet classification (contract assets included in other assets). The ground truth mentions the $5.0 billion of fixed-rate obligations that were bought down, which the LLM answer does not explicitly state, though this is a minor omission since the question specifically asks about the amount Schwab spent, not the amount of obligations affected. (3) ENTITY ACCURACY: Schwab is correctly identified, the 2023 IDA agreement is correctly referenced, and the financial metrics are accurate. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly connects the spending amount to its balance sheet classification through contract assets and other assets. The reference to Note 14 adds appropriate contextual support. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth with slightly different wording but identical meaning. The only minor gap is the omission of the specific $5.0 billion figure for the fixed-rate obligations bought down, but this is not directly asked for in the question and represents a very minor incompleteness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 415,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "CVS recorded **$483 million** in store impairment charges during 2024 as part of its enterprise-wide restructuring plan. The expected cost savings from the same initiative for 2025 are projected to exceed **$500 million**, indicating the cost savings outweigh the impairment charges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) CORRECTNESS: All factual information is correct - CVS recorded $483 million in store impairment charges in 2024, and projected over $500 million in cost savings for 2025. The comparison between the two figures is accurate. (2) QUANTITATIVE ACCURACY: Both dollar amounts ($483 million and $500 million) are precisely correct with no calculation errors. The format variations are acceptable and consistent with standard financial reporting. (3) QUALITATIVE ACCURACY: The LLM correctly synthesized information across multiple data points (2024 impairment charges and 2025 projected savings) and properly identified the relationship between them. The reasoning that 'cost savings outweigh the impairment charges' is logically sound and mathematically accurate ($500M+ > $483M). (4) ENTITY ACCURACY: CVS is correctly identified, fiscal years 2024 and 2025 are correct, and the financial metrics (store impairment charges and cost savings) are properly labeled. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, though with slightly different wording. The ground truth emphasizes the 'near-term financial cost offset by anticipated longer-term savings,' while the LLM more directly states that 'cost savings outweigh the impairment charges.' Both convey the same comparative relationship. Minor difference: The ground truth uses 'over $500 million' while the LLM uses 'exceed $500 million' - these are semantically equivalent. The answer is complete, accurate, and appropriately addresses the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 452,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited in 2021 was $(166) million. This indicates Chevron holds a 36.4% interest in the Angola LNG project, reflecting its significant involvement in Angola's liquefied natural gas (LNG) market. The negative equity in earnings suggests operational or market challenges in 2021, but the continued investment underscores Chevron's strategic commitment to the region's LNG sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: The equity in earnings figure of $(166) million (or -$166 million) is correct and properly formatted. The 36.4% ownership stake is accurately stated. The year 2021 is correctly identified. All numeric values match the ground truth. QUALITATIVE ACCURACY: The LLM correctly identifies Chevron's involvement in Angola LNG and interprets the negative earnings as indicating operational or market challenges. The reasoning about the significance of the 36.4% stake and its implications for Chevron's LNG market involvement is sound. The answer appropriately synthesizes the financial metric with strategic context. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the specific equity earnings figure and (2) what this indicates about Chevron's involvement in the LNG market. The LLM goes slightly beyond the ground truth by adding commentary about 'continued investment' and 'strategic commitment,' which is reasonable inference but not explicitly stated in the ground truth. SEMANTIC EQUIVALENCE: The LLM's phrasing of the loss as '$(166) million' is an acceptable accounting notation equivalent to '-$166 million.' The explanation of what the negative earnings indicate aligns with the ground truth's reference to 'challenges in the liquefaction and processing of natural gas for international markets.' MINOR CONSIDERATIONS: The LLM adds interpretive language about 'strategic commitment' that, while reasonable, extends slightly beyond what the ground truth explicitly states. However, this addition is contextually appropriate and does not contradict the ground truth. The answer is well-structured and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 478,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "NextEra Energy Resources (NEER) faces operational risks related to the potential need for extended fuel supply management beyond the expiration of its nuclear fuel contracts (through 2033) for the decommissioning of Duane Arnold, which is expected to be completed by 2080. While current storage solutions are sufficient for spent fuel through license expiration, the mismatch could create uncertainty if decommissioning activities require ongoing fuel-related services or adjustments to storage infrastructure beyond 2033. However, NEER has fully funded decommissioning costs and plans, mitigating direct operational risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - fuel contract expiration through 2033, Duane Arnold decommissioning completion by 2080, and the 47-year gap are accurately stated. (2) Entity identification is correct (NextEra Energy Resources, Duane Arnold). (3) Basic timeline mismatch is properly identified. WEAKNESSES: (1) The LLM answer significantly downplays the operational risks by stating 'current storage solutions are sufficient' and emphasizing that 'NEER has fully funded decommissioning costs,' which contradicts the ground truth's emphasis on the planning challenge and potential for increased costs/regulatory scrutiny. (2) The ground truth specifically identifies three key risk categories: securing alternative fuel sources, spent nuclear fuel storage solutions, and the gap creating increased operational costs/regulatory scrutiny/capital expenditures. The LLM answer mentions these only vaguely ('uncertainty if decommissioning activities require ongoing fuel-related services'). (3) The ground truth emphasizes the DOE's role in taking possession of spent fuel and the long-term dry storage requirement - the LLM answer mentions storage but doesn't clearly articulate this dependency. (4) The LLM's mitigation statement ('fully funded decommissioning costs and plans, mitigating direct operational risks') appears to contradict the premise of the question about operational risks and is not supported by the ground truth, which identifies these as genuine planning challenges. (5) Multi-hop reasoning is incomplete - the LLM fails to fully synthesize how the fuel contract expiration creates a specific operational challenge for the 47-year gap in decommissioning. The answer reads as somewhat dismissive of the risk rather than analytical about it. CALCULATION VERIFICATION: All dates and timelines are mathematically correct (2080-2033=47 years). No calculation errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 514,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 1020 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde's involvement in the Amur GPP project involves significant contingent liabilities ($0.7 billion as of December 31, 2024) due to legal disputes, project suspensions, and fire-related claims, reflecting unresolved risks from terminated contracts and litigation. In contrast, its on-site industrial gas contracts recognize revenue over time as products are delivered, with minimum purchase requirements and price escalations, aligning revenue recognition with performance obligations. This contrast highlights financial risk exposure in long-term agreements: while on-site contracts are structured with predictable revenue streams, contingent liabilities from projects like Amur GPP underscore vulnerabilities from legal uncertainties, project terminations, and potential losses from disputes, which could impact earnings if unresolved.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the $0.7 billion contingent liability for Amur GPP, matching the ground truth exactly. (2) Accurately describes revenue recognition for on-site contracts as over-time recognition tied to delivery and minimum purchase requirements. (3) Properly synthesizes the contrast between stable on-site contracts and risky project-based liabilities. (4) Correctly identifies key risk factors: legal disputes, project suspensions, fire-related claims, and geopolitical exposure. (5) The multi-hop reasoning is sound, connecting Amur GPP contingencies to on-site contract stability. MINOR WEAKNESSES: (1) The LLM specifies 'December 31, 2024' as the date for the contingent liability, which adds unnecessary specificity not present in the ground truth and may be inaccurate depending on filing dates. (2) The answer omits the specific contract duration range (10-20 years) mentioned in the ground truth, which provides useful context about contract longevity. (3) The phrase 'fire-related claims' is accurate but less specific than the ground truth's reference to 'fires and subsequent legal claims in Russia,' which provides geographic context. (4) The answer could have emphasized more explicitly that Linde may not be directly responsible for construction flaws (as noted in ground truth), which is an important nuance about liability exposure. CALCULATION/NUMERIC VERIFICATION: The $0.7 billion figure is correct and properly formatted. No calculations are required for this answer. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three dimensions: (1) Amur GPP project details, (2) on-site contract revenue recognition, and (3) comparative risk analysis. The logical flow connecting these elements is clear and accurate. SEMANTIC EQUIVALENCE: The answer conveys the essential meaning of the ground truth while using slightly different phrasing. The core insight about contrasting financial risk profiles is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 556,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basisrecording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenuesan increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "The expected increase in TAC (Total Advertising Cost) paid to Google Network partners, driven by shifts in device and geographic mix, directly impacts the gross advertising revenue recognition model by increasing the cost of revenues. Under the gross revenue recognition model (as described in the consolidated financial statements), TAC is recorded as a cost of revenues, reducing gross profit. While the revenue recognition methodology (gross basis) remains unchanged, higher TAC rates due to these shifts will proportionally increase cost of revenues, thereby lowering gross margins. This reflects the direct relationship between TAC and the cost structure of advertising revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanism: TAC increases due to device/geographic mix shifts result in higher cost of revenues under the gross revenue recognition model, which reduces gross margins. The answer accurately explains that TAC is recorded as cost of revenues and that this creates downward pressure on gross margins. However, the answer is somewhat less comprehensive than the ground truth in several ways: (1) It doesn't explicitly mention that Google reports advertising revenues on a gross basis (recording full amounts billed as revenue), which is a key aspect of the revenue recognition model described in the original answer. (2) It doesn't reference the specific context that TAC varies based on 'partner agreement terms' and 'partner mix' in addition to device and geographic mix, though it does mention these factors. (3) It lacks the concrete framing that the ground truth provides about how this affects the relationship between revenue growth and margin compression. The LLM answer is accurate in its core claims: TAC increases do increase cost of revenues, the gross basis methodology remains unchanged, and this results in lower gross margins. The reasoning is sound and the explanation is clear. The answer demonstrates understanding of the multi-hop relationship between TAC changes, revenue recognition methodology, and margin impact. No quantitative errors are present. The main weakness is incompleteness in describing the full revenue recognition model context (gross basis recording of revenues) and missing some nuance about the various drivers of TAC changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 440,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energys asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energys asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methodssuch as excavation and relocation of ash to a lined landfill or beneficial reusemust align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "The Coal Ash Act and other state/federal regulations directly influence Duke Energys ARO for coal ash impoundment closure. The ARO amount is based on estimated closure costs, which depend on compliance with regulatory requirements for closure methods and timelines. The document states that closure methods must align with federal and state regulations, and revisions to closure plans (e.g., due to regulatory approvals or challenges) impact the ARO amount. While the exact percentage is not quantified, the ARO is materially influenced by compliance with the Coal Ash Act and related regulations, as these determine the estimated costs and timing of closure activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of how the Coal Ash Act influences Duke Energy's ARO for coal ash impoundment closure. STRENGTHS: (1) Correctly identifies that the ARO is directly influenced by compliance with the Coal Ash Act and federal/state regulations; (2) Accurately states that ARO amounts are based on estimated closure costs; (3) Properly explains that closure methods must align with regulatory standards; (4) Correctly notes that revisions to closure plans impact the ARO amount; (5) Appropriately acknowledges that the exact percentage/quantification is not provided in the filings; (6) Correctly identifies this as a material influence on ARO. MINOR WEAKNESSES: (1) The LLM answer mentions 'revisions to closure plans due to regulatory approvals or challenges' which adds interpretive detail not explicitly stated in the ground truth, though this is a reasonable inference; (2) The ground truth specifically mentions 'excavation and relocation of ash to a lined landfill or beneficial reuse' as examples of closure methods, which the LLM answer does not include, though this is a minor omission of illustrative detail rather than a factual error. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between regulatory compliance, closure methods, cost estimation, and ARO recordingall key elements of the multi-hop question. QUANTITATIVE ACCURACY: No specific numbers were required or provided in either answer, so this is not a limiting factor. The LLM appropriately notes that 'exact percentage is not quantified' which aligns with the ground truth's lack of specific quantification. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truththat the Coal Ash Act directly influences the ARO through its impact on closure methods, costs, and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 497,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is an increase of **$58 million**. In the 2023 table, the fair value was **$178 million**, and in the 2024 table, it was **$236 million** (236 - 178 = 58).",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR - Direction of Change is Reversed: The LLM answer states the change is an 'increase of $58 million' when the ground truth clearly indicates it is a 'decrease of $58 million'. This is a fundamental factual error that contradicts the original answer. CALCULATION ERROR - Numbers are Reversed: The LLM claims the 2023 table shows $178 million and the 2024 table shows $236 million, but the ground truth indicates the first table has $236 million and the second table has $178 million. The LLM has inverted the order of the tables. CALCULATION VERIFICATION: While the arithmetic (236 - 178 = 58) is mathematically correct, the LLM applied it in the wrong direction. The correct calculation should be 178 - 236 = -58 (a decrease), not 236 - 178 = +58 (an increase). ENTITY ACCURACY: The company (CRM) and metric (Mortgage-Backed Obligations fair value) are correctly identified, and the filing year (2023) is correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the information from the two tables. It correctly identified that there are two tables with different values, but incorrectly determined which table contained which value and therefore calculated the change in the wrong direction. The question asks for 'total change' which requires proper subtraction logic - the LLM's failure to determine the correct direction of change represents a fundamental reasoning error. The answer is contextually relevant to the question asked but is factually incorrect in the most critical aspect: the direction and interpretation of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 429,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "In 2023, **5%** of Danaher's Diagnostics segment sales were attributed to **other developed markets**, which specifically include **Japan, Australia, and New Zealand**. This is detailed in the \"NOTE 5. REVENUE\" table (page 78) and the definition of \"other developed markets\" on page 78.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and complete. (1) CORRECTNESS: All factual information matches the ground truth perfectly - the 5% figure for 'other developed markets' in Danaher's Diagnostics segment for 2023 is correct, and the three geographic regions (Japan, Australia, and New Zealand) are all correctly identified. (2) QUANTITATIVE ACCURACY: The percentage (5%) is precisely correct with no calculation errors or discrepancies. (3) QUALITATIVE ACCURACY: The answer correctly synthesizes information from multiple parts of the filing (NOTE 5. REVENUE and the definition section), demonstrating proper multi-hop reasoning across the document. The company, segment, year, and metric are all correctly identified. (4) CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses both parts of the multi-part question - the percentage attribution and the specific geographic regions. The citation of specific page numbers (page 78) adds credibility and demonstrates proper source attribution. The only minor observation is that the answer could have been slightly more concise, but this does not detract from accuracy. The semantic meaning and factual content align perfectly with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 342,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "The total revenue contribution from Bulk shipments in 2021 was **$6,656 million**, as shown in the \"Freight Revenues Millions\" table on page 35. This aligns with the calculation of 2,014,000 carloads (2021 Bulk carloads) multiplied by an average revenue per car of $3,305, confirming the figure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains multiple critical errors that significantly undermine its correctness: (1) CARLOAD VOLUME ERROR: The LLM states 2,014,000 carloads, but the ground truth specifies 1,920,000 carloads for 2021 Bulk shipments. This is a discrepancy of 94,000 carloads (4.9% error). (2) REVENUE PER CAR ERROR: The LLM uses $3,305 as the average revenue per car, but the ground truth specifies $3,467. This is a $162 difference per car (4.7% error). (3) CALCULATION VERIFICATION: Using the LLM's own numbers (2,014,000  $3,305 = $6,656,270,000 or $6,656.27 million), the math would be approximately correct IF those inputs were right. However, the correct calculation should be 1,920,000  $3,467 = $6,656,640,000 (approximately $6,656.64 million, which rounds to $6,656 million). The final dollar amount of $6,656 million happens to match the ground truth when rounded, but this appears to be coincidental given the incorrect intermediate values. (4) MULTI-HOP REASONING: The LLM correctly identifies the need to multiply carloads by average revenue per car, showing sound reasoning structure. However, the execution uses wrong input values. (5) SOURCE CITATION: The LLM references 'page 35' and a 'Freight Revenues Millions' table, which adds apparent credibility but cannot be verified and may be a hallucination. The core issue is that while the final rounded figure ($6,656 million) matches the ground truth, the underlying carload volume and per-car revenue figures are both incorrect, suggesting either data retrieval errors or calculation errors that happened to cancel out.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 435,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ is **$8 billion to $9 billion**. This reflects a **$1.5 billion reduction** from Duke Energy's initial estimate of $9.5 billion to $10.5 billion following the April 1, 2019 closure determination, as the settlement agreement adjusted the scope of required excavations and closure methods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all key dimensions. (1) QUANTITATIVE VERIFICATION: All numbers are correct - the post-settlement estimate of $8-9 billion, the initial estimate of $9.5-10.5 billion, and the $1.5 billion reduction are all accurate and match the ground truth. The calculations are sound: $9.5B to $10.5B minus $1.5B = $8B to $9B. (2) COMPLETENESS: The answer addresses all parts of the multi-part question: identifies the total estimated undiscounted cost after settlement, specifies the reduction amount, provides the initial estimate, and references the April 1, 2019 closure determination. (3) ENTITY ACCURACY: All entities are correctly identified - Duke Energy, NCDEQ settlement agreement, North Carolina and South Carolina coal ash basins, and the April 1, 2019 closure determination. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across multiple temporal points (initial estimate  April 1, 2019 determination  settlement agreement) and demonstrates proper understanding of the causal relationship between the settlement and the cost reduction. (5) MINOR OBSERVATION: The LLM adds explanatory context ('the settlement agreement adjusted the scope of required excavations and closure methods') which, while reasonable and not contradicted by the ground truth, goes slightly beyond what was explicitly stated in the original answer. This is a minor enhancement rather than an error. The answer is semantically equivalent to the ground truth with clear, accurate presentation of all required information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 431,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid $325 million in cash for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024, totaling $3.025 billion. This spending reflects the company's strategy to grow, diversify, and enhance its capabilities in cybersecurity, fraud prevention, and data analytics through strategic acquisitions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all financial figures correct: $325 million for Dynamic Yield LTD (2022), $2.7 billion for Recorded Future (2024), and the combined total of $3.025 billion. The calculation is accurate and the dates are correct. The multi-hop synthesis across two separate acquisitions is sound. However, there is a minor qualitative difference in how the acquisition strategy is characterized. The ground truth specifically mentions 'integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings,' providing concrete examples of what capabilities were being acquired. The LLM answer generalizes this to 'cybersecurity, fraud prevention, and data analytics' which, while related, is less precise and doesn't specifically mention the personalization technology aspect of Dynamic Yield or explicitly reference threat intelligence. The LLM's characterization is reasonable but somewhat broader and less specific than the ground truth. The answer addresses all parts of the question (both acquisitions, total amount, and strategy reflection) but with slightly less specificity in the strategic rationale. Overall, the answer is substantially correct with only minor contextual/specificity differences in the strategic explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 385,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "The total fair value of International bonds held by VZ in 2023 is **$341 million** (under Pension Plans) and **$12 million** (under Health Care and Life Plans), totaling **$353 million**. In 2022, the total is **$528 million** (Pension) and **$12 million** (Health Care), totaling **$540 million**. The categorization differs by disclosure: in Pension Plans, International bonds are listed under \"Fixed income securities\" with Level 1 and Level 2 breakdowns, while in Health Care and Life Plans, they are also under \"Fixed income securities\" but with smaller amounts and similar Level 1/Level 2 classifications. The 2023 Pension table shows $341 million (Level 1: $3M, Level 2: $338M), and 2022 Pension shows $528 million (Level 1: $10M, Level 2: $518M).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth. CRITICAL ERRORS: (1) The LLM introduces year-based distinctions (2023 vs 2022) that are not present in the original question or ground truth answer. The ground truth refers to 'both tables' without year differentiation. (2) The LLM provides completely different numbers: claims $341M and $12M for one table totaling $353M, and $528M and $12M for another totaling $540M. The ground truth states the total is $540M with $12M in first table and $528M in second table - these are the same two tables, not different years. (3) The LLM's Level 1/Level 2 breakdown for the $341M figure ($3M Level 1, $338M Level 2) is entirely fabricated and not in the ground truth. (4) The LLM correctly identifies some numbers ($528M, $12M, $10M Level 1, $518M Level 2) but misattributes them to different tables/years. CORRECT ELEMENTS: The LLM does correctly state $528M and $12M totaling $540M, and correctly identifies the Level 1/Level 2 split of $10M/$518M for one table. However, the overall structure and interpretation are fundamentally wrong. The question asks about 'both tables' with a single total of $540M, not year-over-year comparisons. The LLM's introduction of Pension Plans vs Health Care and Life Plans categorization, while potentially relevant context, is presented in a way that contradicts the ground truth's simpler two-table structure. The multi-hop reasoning failed because the LLM misidentified what constitutes the 'two tables' being compared.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 425,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard's real-time account-based payments infrastructure enables instant, secure, and data-rich transactions across its global network, supporting both domestic and cross-border payments. The infrastructure facilitates real-time clearing and settlement, enhancing efficiency and interoperability. Approximately **70% of all Mastercard and Maestro-branded card transactions** are switched through the network, including **nearly all cross-border transactions**, while domestic transactions account for the remaining 30%. This infrastructure underpins Mastercard's ability to process a vast volume of transactions globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the 70% figure for Mastercard and Maestro-branded card transactions is accurately stated, and the reference to 'nearly all cross-border transactions' matches the ground truth. The implicit 30% for domestic transactions (derived from 70% total) is mathematically sound. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the infrastructure supports operations (instant payments, enhanced data/messaging, real-time clearing and settlement), and (2) the portion of transactions handled (70% overall, nearly all cross-border). ENTITY ACCURACY: Mastercard, Maestro, and the infrastructure components are correctly identified. REASONING: The multi-hop synthesis is sound - the answer correctly connects the infrastructure capabilities to the transaction volume metrics. The logic that 70% of transactions are switched through the network while nearly all cross-border transactions flow through it is properly conveyed. SEMANTIC EQUIVALENCE: The LLM answer uses slightly more detailed language ('real-time clearing and settlement, enhancing efficiency and interoperability') compared to the ground truth's more concise phrasing, but this represents appropriate elaboration rather than deviation. The core semantic meaning is preserved. MINOR CONSIDERATIONS: The LLM adds contextual details about 'secure' transactions and 'interoperability' that aren't explicitly in the ground truth, but these are reasonable inferences about payment infrastructure and don't contradict the source material. The explicit calculation showing 30% for domestic transactions is a helpful clarification that logically follows from the 70% figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 489,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. provided **$1.9 billion** in net cash consideration to acquire VIZIO Holding Corp. The acquisition introduces a **data privacy risk** related to the collection and management of consumer data, including **television viewing data** from VIZIO's operations. This risk is highlighted in Walmart's disclosures, which note the potential for cybersecurity incidents, unauthorized access to sensitive information, and challenges in securing data across third-party systems and digital platforms, as outlined in the risk factors section (pages 1920).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong alignment to the ground truth. QUANTITATIVE ACCURACY: The $1.9 billion cash consideration figure is correct and properly formatted. The LLM includes 'net cash consideration' which adds appropriate specificity without contradicting the ground truth. COMPLETENESS: Both parts of the multi-part question are addressed - the cash consideration amount and the specific data privacy risk. ENTITY ACCURACY: All entities are correctly identified (Walmart U.S., VIZIO Holding Corp., television viewing data). REASONING & SYNTHESIS: The multi-hop reasoning is sound - the LLM correctly synthesizes that the acquisition introduces data privacy risks specifically related to television viewing data collection and cybersecurity vulnerabilities. The answer appropriately connects the acquisition to the risk disclosure. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth. The description of risks (cybersecurity incidents, unauthorized access, third-party systems vulnerabilities) is semantically equivalent to the ground truth's description of 'cybersecurity incidents or failures in systems.' MINOR CONSIDERATIONS: The LLM adds contextual details (page references 19-20, mention of 'third-party systems and digital platforms') that enhance the answer without contradicting the ground truth. The phrase 'net cash consideration' is slightly more specific than the ground truth's 'cash consideration' but is not inaccurate. The answer maintains focus on the specific television viewing data risk as required. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 449,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "The net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022 was a **$21 million negative effect**. This is calculated by offsetting the $14 million increase in fuel cost recovery (which improved operating income) against the $35 million increase in fuel-related operating expenses (which increased costs). The $35 million expense increase directly reduced operating cash flows, while the $14 million recovery partially offset this, resulting in a net $21 million drag on operating cash flows and expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: All key facts are correct - the $21 million net negative impact is properly calculated ($35M expense increase minus $14M recovery = $21M net cost), the year (2022) is correct, and Duke Energy is correctly identified. The calculation methodology is sound and matches the ground truth. (2) QUANTITATIVE ACCURACY: All three financial figures are correct ($14M recovery, $35M expense increase, $21M net impact). The arithmetic is accurate: $35M - $14M = $21M. Number formats are consistent and appropriate. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop information by: (a) identifying both the recovery mechanism and the expense increase, (b) explaining how they offset each other, (c) determining the net impact on cash flows and expenses. The reasoning that the recovery \"partially offset\" the expense is accurate and demonstrates proper understanding of the fuel cost recovery mechanism. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly different wording but equivalent meaning. Both describe a \"$21 million net increase in costs\" or \"$21 million negative effect\" - these are semantically identical. The explanation of how the recovery mechanism works is clear and accurate. (5) MINOR OBSERVATION: The LLM uses \"drag on operating cash flows\" which is appropriate terminology and adds clarity. The answer fully addresses the question's multi-part structure regarding both operating cash flows and operating expenses. No material errors or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 442,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "In 2021, additional period charges of **$565 million** were associated with the ramp-up of Intel 4. This aligns with the rebranding of manufacturing process nodes announced on July 26, 2021, when Intel introduced new naming conventions (e.g., \"Intel 7\" and \"Intel 4\") to replace previous labels like \"10nm Enhanced SuperFin,\" reflecting advancements in process technology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: The $565 million figure is correct and matches the ground truth exactly. The July 26, 2021 date for the rebranding announcement is accurate. The answer correctly identifies the relationship between the ramp-up costs and the rebranding initiative. (2) QUANTITATIVE ACCURACY: The $565 million amount is precisely correct with no calculation errors. The date (July 26, 2021) is accurate. (3) QUALITATIVE ACCURACY: The LLM demonstrates strong multi-hop reasoning by connecting the period charges to the rebranding announcement and explaining the context of the new naming conventions (Intel 7, Intel 4 replacing previous labels like 10nm Enhanced SuperFin). The synthesis across the financial impact and strategic announcement is sound. (4) CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question - the specific dollar amount and the relationship to the rebranding. The additional detail about the naming convention changes (replacing 10nm Enhanced SuperFin) provides helpful context that enhances understanding without detracting from accuracy. Minor note: The ground truth answer is slightly more concise, while the LLM provides additional contextual detail about the naming structure changes, which is appropriate and accurate. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 376,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "Danaher's Diagnostics segment sales in 2023 attributed to Other Developed Markets were **5%** of total segment sales. As of December 31, 2023, the company had **3,000 employees** in these markets. This indicates a relatively small employee base compared to the segment's overall sales, though direct proportionality cannot be determined without total sales figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) CORRECTNESS: Both key factual claims match the ground truth exactly - 5% of Diagnostics segment sales attributed to Other Developed Markets in 2023, and 3,000 employees in those markets as of end of 2023. (2) QUANTITATIVE ACCURACY: All numeric values are correct with no calculation errors. The percentages and employee count are precisely stated. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two different data points (sales percentage and employee count) from the same company and time period, correctly identifying them as separate metrics that cannot be directly compared without additional context. (4) REASONING QUALITY: The LLM appropriately notes that while both figures are provided, direct proportionality cannot be determined without total sales figures - this demonstrates sound analytical thinking rather than making unsupported comparisons. (5) MINOR CONSIDERATION: The LLM adds interpretive commentary ('relatively small employee base compared to the segment's overall sales') which is reasonable but goes slightly beyond the ground truth answer. This is not an error but rather appropriate contextual analysis. The answer is complete, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 366,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "The total revenue generated from Industrial chemicals & plastics in 2021 was **$1,943 million**, as directly stated in the \"Freight Revenues Millions\" table on page 35. This figure aligns with the calculation of (606,000 carloads  $3,207 average revenue per car), confirming consistency between volume and pricing data.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer is off by a factor of 1,000. The ground truth states the revenue was $1,943,442 (approximately $1.94 million), but the LLM claims it was $1,943 million. This is a massive discrepancy - the LLM's answer is 1,000 times larger than the correct answer. While the LLM correctly identified the calculation methodology (606,000 carloads  $3,207 average revenue per car = $1,943,442), it then misrepresented the result as $1,943 million instead of $1.943 million or $1,943,442. The LLM also cited a 'Freight Revenues Millions' table on page 35, but this appears to be a misinterpretation - the actual figure of $1,943,442 is in thousands or actual dollars, not millions. The calculation itself is sound, but the final answer magnitude is completely wrong. This is a fundamental quantitative error that makes the answer factually incorrect despite the correct methodology being shown.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 265,
        "total_tokens": 1373
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "The total fair value of International Bonds held by Verizon in 2023, as disclosed across both pension plans and health care/life plans, is **$353 million**. This includes **$341 million** in pension plans (page 92) and **$12 million** in health care and life plans (page 93).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the primary metric. The ground truth states the total fair value of International Bonds is $24 million ($12M + $12M from Level 1 and Level 2 classifications), but the LLM claims $353 million ($341M + $12M). This is a massive discrepancy of $329 million - a 1,371% overstatement. The LLM appears to have confused different asset categories or misread the filing data entirely. While the LLM correctly identifies Verizon and the 2023 timeframe, and attempts to break down the answer by pension plans vs. health care/life plans, the core numbers are completely wrong. The LLM's breakdown of $341M in pension plans and $12M in health care/life plans does not match the ground truth's Level 1/Level 2 classification structure. The multi-hop reasoning is flawed because it synthesizes incorrect data from the source documents. The question specifically asks for International Bonds across 'both reported asset categories,' which the ground truth correctly interprets as Level 1 and Level 2 classifications totaling $24M, not pension vs. health care plan categories totaling $353M. This represents a fundamental failure to accurately extract and synthesize financial data from the 10-K filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 346,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco's production of private-label items in its owned facilities enhances its ability to control costs and maintain competitive pricing, driving comparable sales growth. By producing private-label items internally, Costco reduces reliance on external suppliers, enabling more efficient cost management and pricing strategies. This supports higher sales volumes and margins, allowing SG&A expenses to be leveraged more effectively as a percentage of sales. As comparable sales grow, fixed SG&A costs are spread over a larger sales base, reducing their proportionate impact on profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Costco's private-label strategy and its connection to SG&A leverage. STRENGTHS: (1) Correctly identifies that Costco operates owned facilities for private-label production; (2) Accurately explains the mechanism of SG&A leverage through comparable sales growth - fixed costs spread over larger sales base; (3) Properly connects internal production to cost control and competitive pricing; (4) No quantitative errors or incorrect numbers/dates; (5) Sound multi-hop reasoning linking private-label production  cost efficiency  sales growth  SG&A leverage. MINOR WEAKNESSES: (1) The LLM answer adds interpretive detail about 'reducing reliance on external suppliers' and 'enabling more efficient cost management' that goes slightly beyond what the ground truth explicitly states - the ground truth focuses more narrowly on private-label items as part of merchandising strategy to increase comparable sales; (2) The ground truth emphasizes 'increasing penetration of private-label items' and 'driving sales while maintaining competitive pricing' as the core mechanism, while the LLM emphasizes cost reduction and margin improvement, which are related but represent a slightly different framing; (3) The LLM's explanation of the SG&A leverage mechanism (fixed costs spread over larger base) is correct and well-articulated, matching the ground truth's intent. SEMANTIC EQUIVALENCE: The answers are semantically equivalent in their core message - both explain that private-label production supports comparable sales growth which enables SG&A leverage. The LLM provides slightly more mechanistic detail about cost control, which is reasonable inference but not explicitly stated in ground truth. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 481,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, represents a breakthrough in transistor architecture by enabling faster switching speeds and improved performance-per-watt efficiency in a smaller footprint, aligning with the company's R&D focus on advancing process technology. As part of the IDM 2.0 strategy, RibbonFET supports Intel's goal of achieving process performance-per-watt parity by 2024 and leadership by 2025, while also enhancing advanced packaging capabilities (e.g., Foveros Omni and Foveros Direct) to drive innovation in scalable, disaggregated chip designs. This technology is critical to Intel's broader efforts to maintain leadership in process and packaging advancements, ensuring competitive differentiation and supporting the IDM 2.0 vision of integrated manufacturing and foundry services.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies RibbonFET as a gate-all-around transistor technology introduced in Intel 20A that enables faster switching speeds and improved performance-per-watt in a smaller footprint. It appropriately connects RibbonFET to both R&D investments and IDM 2.0 strategy. The answer demonstrates good understanding of the multi-hop synthesis required, linking process technology advancement to manufacturing strategy and packaging innovations. The mention of Foveros Omni and Foveros Direct as complementary packaging technologies shows contextual awareness.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM introduces specific dates and targets ('process performance-per-watt parity by 2024 and leadership by 2025') that are NOT present in the ground truth answer and cannot be verified from the provided context. This is a significant factual error - adding unverified quantitative claims. The ground truth specifically mentions '$20 billion investment in Arizona fabs and over $20 billion in Ohio' but the LLM answer completely omits these critical financial figures that are central to the IDM 2.0 strategy.\n\nWEAKNESSES - COMPLETENESS: The LLM fails to include the specific capital investment amounts ($20B Arizona, $20B+ Ohio) that are explicitly mentioned in the ground truth as key components of IDM 2.0 strategy. These are material facts for understanding how RibbonFET deployment is supported at scale.\n\nREASONING ASSESSMENT: The multi-hop reasoning is generally sound - the LLM correctly synthesizes information about RibbonFET's technical benefits, its role in R&D strategy, and its connection to IDM 2.0. However, the introduction of unverified claims about 2024/2025 targets undermines the reliability of the synthesis.\n\nSCORING JUSTIFICATION: Correctness score of 6 reflects that while core concepts are correct, the answer contains fabricated quantitative claims and omits critical financial figures from the ground truth. Quantitative accuracy is 4 due to the invented dates/targets and missing investment amounts. Qualitative accuracy is 7 because the conceptual understanding and reasoning are sound despite the quantitative issues. Contextual relevance is 8 as the answer appropriately addresses the question's multi-part nature and maintains focus on the required synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 620,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "In Q4 2023, Meta estimated that approximately **3% of its worldwide MAP** consisted of violating accounts, while **4% of its worldwide MAUs** were classified as false accounts. These accounts impact the stability and accuracy of user metrics due to challenges in detection and measurement, including reliance on machine learning models and data signals prone to errors. The company acknowledges potential variability in these estimates and notes that actions to reduce such accounts may temporarily affect reported metrics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: 3% of worldwide MAP consisting of violating accounts and 4% of worldwide MAUs consisting of false accounts in Q4 2023. All numeric values match the ground truth exactly. The answer properly addresses both parts of the multi-part question regarding the percentages and their impact on metrics stability and accuracy. The explanation of impacts is semantically equivalent to the ground truth, mentioning challenges in detection/measurement, machine learning model reliance, and potential variability in estimates. However, the LLM answer omits some specific contextual details present in the ground truth: (1) it doesn't mention the specific limitation regarding reduced visibility into encrypted products like WhatsApp, and (2) it doesn't reference periodic spikes in account creation in specific countries as a factor affecting accuracy. These omissions are relatively minor and don't affect the core correctness of the answer, but they represent a loss of completeness in addressing the full scope of how these accounts impact metrics. The reasoning is sound and the synthesis across the multi-hop question is accurate. The answer demonstrates good understanding of the relationship between account types and metric reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 362,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, was **$1,241 million** for both. These amounts are recorded at the same value because the liability and asset are both measured at fair value using quoted prices for the underlying crypto assets on the principal market, and no safeguarding loss events occurred, so no adjustments were required.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE: The LLM provided a specific dollar amount ($1,241 million) that cannot be verified against the ground truth answer. The ground truth explicitly states the amounts were 'the same' but does NOT provide a specific numerical value. The LLM appears to have fabricated or hallucinated this figure without evidence from the source material. REASONING ACCURACY: The qualitative explanation is largely correct - the LLM correctly identifies that both the liability and asset are measured at fair value using quoted prices on the principal market, and that no safeguarding loss events occurred. This reasoning aligns with the ground truth explanation. COMPLETENESS: The LLM addresses both parts of the question (the total fair value and the reason for equal amounts), which is appropriate. However, the introduction of an unverified specific number is a fundamental error that undermines the entire answer. MULTI-HOP SYNTHESIS: The reasoning about fair value measurement and the absence of loss events demonstrates sound multi-hop synthesis, but this is overshadowed by the quantitative fabrication. The answer would have been strong (8-9 range) if it had stated the amounts were equal without providing an unverified specific dollar figure, or if the $1,241 million figure could be confirmed from PayPal's 10-K filing. As presented, the answer contains a material factual error that significantly reduces its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 396,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "The total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024 was **$184.7 million** (comprising $15.5 million for the preferred units and $169.2 million for the other noncontrolling interests), compared to **$195.9 million** in 2023 (comprising $23.0 million for the preferred units and $172.9 million for the other noncontrolling interests). This represents a **decrease of $11.2 million** (or 5.7%) from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct with proper multi-hop synthesis. Verification of key numbers: (1) 2024 combined total: $184.7 million ($15.5M + $169.2M = $184.7M)  matches ground truth $184,729 thousand; (2) 2023 combined total: $195.9 million ($23.0M + $172.9M = $195.9M)  matches ground truth $195,949 thousand; (3) Year-over-year decrease: $11.2 million ($195.9M - $184.7M = $11.2M)  correct; (4) Percentage decrease: 5.7% ($11.2M / $195.9M = 5.72%)  accurate. The LLM correctly converted the ground truth values from thousands to millions (184,729 thousand = $184.7 million, 195,949 thousand = $195.9 million), which is an acceptable format variation. The answer properly addresses all parts of the multi-part question: identifies both components for 2024, provides the combined total, identifies both components for 2023, provides that combined total, and calculates the comparison (both absolute and percentage change). The component breakdowns ($15.5M and $169.2M for 2024; $23.0M and $172.9M for 2023) are correctly synthesized. Minor note: The ground truth answer contains an apparent internal inconsistency (states 2024 total is $184,729 but then says it 'matches' 2023 total of $195,949, which are different), but the LLM correctly interpreted this as a comparison showing a decrease, which is the logical reading. The LLM's presentation is clear, complete, and mathematically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 390,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "The value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, was **$136 million** for 39 million mmBtu, calculated using forward natural gas prices at that date. This procurement strategy aligns with their regulated cost recovery framework, as the floating-price contracts allow Southern Company Gas to recover prudently incurred costs through rate adjustments approved by state regulatory agencies, ensuring alignment with wholesale market price fluctuations and maintaining cost recovery mechanisms for regulated utility customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. CORRECT ELEMENTS: (1) The $136 million figure is accurate and matches the ground truth exactly. (2) The identification of Nicor Gas and SouthStar as the procurement vehicles is correct. (3) The December 31, 2024 date is accurate. (4) The explanation of the regulated cost recovery framework is sound and semantically equivalent to the ground truth - both convey that floating-price contracts allow cost recovery through rate adjustments approved by state regulatory agencies. (5) The multi-hop synthesis is correct: the LLM properly connects the specific procurement value to the broader regulatory framework. ADDITIONAL DETAIL: The LLM answer includes the specification of '39 million mmBtu' and references 'forward natural gas prices,' which provides additional technical context not explicitly stated in the ground truth but is consistent with how such procurement is typically documented. This adds value without contradicting the original answer. MINOR CONSIDERATIONS: The ground truth emphasizes 'prudently incurred procurement costs' and 'state regulatory agencies' approval, which the LLM answer captures with 'prudently incurred costs' and 'state regulatory agencies.' The semantic meaning is preserved. The LLM answer is slightly more detailed in explaining the mechanism (floating-price contracts allow recovery through rate adjustments) while the ground truth focuses on the cost recovery mechanisms allowing rate adjustments. Both convey the same regulatory alignment concept. No calculation errors detected. All entities (Southern Company Gas, Nicor Gas, SouthStar) are correctly identified. The answer fully addresses both parts of the multi-part question: the specific value and the alignment with the regulatory framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 489,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was **$4,932 million**, while the equity in earnings (losses) from the same region was **($18) million**. This indicates the Lower 48 segment contributed significantly more net income than the equity earnings from affiliates in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) QUANTITATIVE ACCURACY: Both key financial figures are correct - net income of $4,932 million and equity in earnings (losses) of ($18) million for the Lower 48 region in 2021. The numbers match the ground truth exactly, with proper formatting of the negative value in parentheses. (2) COMPLETENESS: The answer addresses both parts of the question - the net income figure and the equity in earnings figure, plus the comparison requested. (3) ENTITY ACCURACY: All entities are correctly identified - ConocoPhillips, Lower 48 region, 2021 fiscal year, and the appropriate financial metrics (net income and equity in earnings). (4) REASONING: The multi-hop synthesis is sound. The model correctly extracted data from what would be multiple sections of the 10-K filing and synthesized them into a coherent comparison. The interpretation that 'the Lower 48 segment contributed significantly more net income than the equity earnings from affiliates' is logically sound ($4,932M vs -$18M). (5) SEMANTIC EQUIVALENCE: The LLM's interpretation is semantically equivalent to the ground truth. Both convey that there was significant net income but a small loss in equity earnings. The only minor difference is the LLM uses slightly different phrasing ('contributed significantly more net income than the equity earnings from affiliates') versus the ground truth's 'significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss' - but both convey the same essential meaning. No calculation errors detected. All numbers are factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 464,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "The total notional value of unsettled forward foreign-exchange contracts at the end of 2024 was **$1,212 million**. The document does not specify a notional value for variable-priced commodity contracts, but the company mitigates commodity price risks through fixed-price and variable-priced contracts, as well as hedging strategies. The combined exposure reflects the company's strategy to economically hedge foreign exchange fluctuations and manage commodity price volatility by using derivative instruments and contractual arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: the total notional value of unsettled forward foreign-exchange contracts was $1,212 million in 2024. This number matches the ground truth exactly. The answer also appropriately acknowledges that the document does not specify a notional value for variable-priced commodity contracts, which is an honest and accurate representation of the available information. The LLM correctly describes the company's strategy to economically hedge foreign exchange and commodity price risks through derivative instruments and contractual arrangements. However, there are some minor gaps in completeness: (1) The ground truth specifically mentions that variable-priced contracts are tied to 'an index basis' and are for 'purchases of electricity, natural gas, and fuel for gas stations' - the LLM answer mentions these contract types more generally without the specific index basis detail. (2) The ground truth explicitly states the company 'does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business' - the LLM answer does not mention the absence of hedge accounting treatment, which is an important nuance about how these instruments are accounted for. The multi-hop reasoning is sound - the LLM correctly synthesizes information about both foreign exchange and commodity contracts and their role in the company's risk management strategy. The quantitative accuracy is excellent with the $1,212 million figure correct. The qualitative accuracy is good but could be stronger with the additional accounting and contract specification details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 460,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft's internal development structure for Microsoft 365, particularly through teams like \"Experiences and Devices\" and \"Microsoft AI,\" enables the integration of advanced features (e.g., Copilot) and user-centric innovations, directly influencing subscriber growth and retention. This structure allows Microsoft to refine and expand Microsoft 365 offerings, which is reflected in financial reporting updates, such as the inclusion of Microsoft 365 Basic subscribers in the Microsoft 365 Consumer subscribers metric (page 42). The 2024 fiscal year reported 82.5 million Microsoft 365 Consumer subscribers, highlighting how internal development aligns with strategic business decisions to enhance product value and track subscriber metrics accurately.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core relationship between Microsoft's internal development structure (Experiences and Devices group) and the financial reporting update regarding Microsoft 365 Consumer subscribers. The answer appropriately mentions the inclusion of Microsoft 365 Basic subscribers in the metric and demonstrates sound multi-hop reasoning connecting internal structure to business decisions.\n\nSTRENGTHS:\n- Correctly identifies 'Experiences and Devices' as the relevant engineering group\n- Accurately states that Microsoft 365 Basic subscribers were included in the Microsoft 365 Consumer subscribers metric\n- Demonstrates proper multi-hop synthesis connecting internal development to financial reporting decisions\n- Appropriately contextualizes how internal structure influences strategic business decisions\n- Mentions fiscal year 2024 correctly\n\nWEAKNESSES:\n- Introduces the 'Microsoft AI' team without clear connection to the specific question about Microsoft 365 development structure (this is somewhat tangential)\n- Cites a specific subscriber number (82.5 million) without verification against ground truth - this number cannot be confirmed from the provided ground truth answer and represents an unverified quantitative claim\n- The page reference (page 42) is provided but cannot be verified against the ground truth\n- Slightly over-elaborates on Copilot integration, which while relevant to product development, is not explicitly mentioned in the ground truth answer\n\nMULTI-HOP REASONING:\nThe answer correctly synthesizes the relationship between: (1) internal development structure  (2) product evolution and user experience  (3) financial reporting decisions. This matches the ground truth's causal chain.\n\nQUANTITATIVE CONCERNS:\nThe 82.5 million subscriber figure is presented as fact but cannot be verified from the ground truth provided. This is a significant concern for quantitative accuracy, as the evaluation criteria emphasize strict standards for numbers. The ground truth does not provide this specific metric, making this an unverified claim that reduces quantitative accuracy score.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates strong qualitative understanding and appropriate reasoning, but the introduction of unverified quantitative data (82.5 million subscribers) and tangential details (Microsoft AI team) prevent a higher score. The core answer is semantically equivalent to the ground truth but adds claims that cannot be verified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 665,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "The total shares counted toward the maximum available under Pfizer's 2019 Stock Plan for PSAs are calculated by multiplying the number of PSAs by three times their maximum potential payout. However, the document does not specify the exact number of PSAs or their maximum payout. The 248 million shares available as of December 31, 2023, reflect the remaining authorized shares after accounting for all awards, including PSAs, under the 400 million-share 2019 Plan. The significance of the PSA calculation is that it reduces the available shares for other awards, as PSAs are counted at a higher rate (three times max payout) compared to other awards, thereby impacting the overall share allocation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a solid understanding of the PSA share counting mechanism and its significance, with mostly correct information. STRENGTHS: (1) Correctly identifies that PSAs count as three shares times maximum potential payout toward the share pool; (2) Accurately cites the 248 million shares available as of December 31, 2023; (3) Correctly explains the 400 million-share 2019 Plan total; (4) Properly articulates the significance that PSAs consume shares at a higher rate than other awards (3x multiplier vs. 1x for options/TSRUs); (5) Accurately describes the impact on share allocation decisions. WEAKNESSES: (1) The answer appropriately acknowledges that the document doesn't specify exact PSA numbers or payouts, which is honest but the question itself asks for a calculation that cannot be completed without those specifics - the LLM correctly identifies this limitation rather than fabricating numbers; (2) Minor wording differences from ground truth (e.g., 'multiplied by three times their maximum potential payout' vs. 'three shares times the maximum potential payout') but these are semantically equivalent; (3) Could have been slightly more explicit about how this directly constrains PSA issuance capacity. QUANTITATIVE VERIFICATION: The 248 million shares figure is correct. The 400 million total plan size is correct. The 3x multiplier for PSAs is correctly stated. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes the relationship between PSA counting methodology, the remaining share pool, and the impact on award allocation strategy. The reasoning is sound and logically connects the three elements (PSA multiplier, available shares, and allocation constraints). The answer appropriately recognizes that without specific PSA grant numbers, a precise total cannot be calculated, which demonstrates appropriate epistemic humility.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 514,
        "total_tokens": 1905
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 749,
    "failed_evaluations": 1,
    "average_correctness_score": 6.66,
    "average_quantitative_accuracy": 7.33,
    "average_qualitative_accuracy": 6.88,
    "average_contextual_relevance": 7.91,
    "score_distribution": {
      "excellent": 263,
      "good": 217,
      "fair": 126,
      "poor": 143
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-8b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750,
    "successful": 750,
    "failed": 0,
    "elapsed_seconds": 23507.84,
    "timestamp": "2026-02-02T22:12:13.586373"
  }
}